{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import os\n",
    "import re"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "!ls /home/yl3427/cylab/"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# T14\n",
    "file_dir = \"/secure/shared_data/rag_tnm_results/summary/summary\"\n",
    "file_names = [\"BRCA_T14_testing.csv\",\"LUAD_T14_testing.csv\",\"BRCA_T14_training.csv\",\"LUAD_T14_training.csv\"]\n",
    "T14_dfs = []\n",
    "for f_name in file_names:\n",
    "    open_file_path = os.path.join(file_dir, f_name)\n",
    "    df = pd.read_csv(open_file_path)\n",
    "    df.drop(columns=['Unnamed: 0'], inplace=True)\n",
    "    T14_dfs.append(df)\n",
    "\n",
    "T14_df = pd.concat(T14_dfs, axis=0, ignore_index= True) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "T14_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "duplicates = T14_df.duplicated(subset='patient_filename', keep='first')\n",
    "duplicates.sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# N03\n",
    "file_dir = \"/secure/shared_data/rag_tnm_results/summary/summary\"\n",
    "file_names = [\"BRCA_N03_testing.csv\", \"LUAD_N03_testing.csv\", \"BRCA_N03_training.csv\", \"LUAD_N03_training.csv\"]\n",
    "N03_dfs = []\n",
    "for f_name in file_names:\n",
    "    open_file_path = os.path.join(file_dir, f_name)\n",
    "    df = pd.read_csv(open_file_path)\n",
    "    df.drop(columns=['Unnamed: 0'], inplace=True)\n",
    "    N03_dfs.append(df)\n",
    "\n",
    "N03_df = pd.concat(N03_dfs, axis=0, ignore_index= True) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "duplicates = N03_df.duplicated(subset='patient_filename', keep='first')\n",
    "duplicates.sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# merge\n",
    "full_df= pd.merge(T14_df, N03_df, on=['patient_filename', 'text', 'type'], how='outer')\n",
    "len(T14_df), len(N03_df), len(full_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "N03_df.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "full_df['n'] = full_df['n'].fillna(-1).astype('int')\n",
    "full_df['t'] = full_df['t'].fillna(-1).astype('int')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "full_df.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "duplicates = full_df.duplicated(subset='patient_filename', keep='first')\n",
    "duplicates.sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "full_df.to_csv(\"/secure/shared_data/rag_tnm_results/summary/merged_df.csv\", index=False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Split into 5 folds"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "from collections import defaultdict\n",
    "from sklearn.model_selection import StratifiedKFold\n",
    "import pickle"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.read_csv(\"/secure/shared_data/rag_tnm_results/summary/merged_df.csv\")\n",
    "\n",
    "brca_t = df[df['type']==\"BRCA\"][[\"patient_filename\", 't']]\n",
    "brca_n = df[(df['type']==\"BRCA\") & (df['n']!=-1)][[\"patient_filename\", 'n']]\n",
    "\n",
    "luad_t = df[df['type']==\"LUAD\"][[\"patient_filename\", 't']]\n",
    "luad_n = df[(df['type']==\"LUAD\") & (df['n']!=-1)][[\"patient_filename\", 'n']]\n",
    "\n",
    "full_5folds_dict = defaultdict(list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "skf = StratifiedKFold(n_splits=5)\n",
    "\n",
    "# brca_t\n",
    "x = brca_t[\"patient_filename\"].values\n",
    "y = brca_t[\"t\"].values\n",
    "\n",
    "for i, (train_index, test_index) in enumerate(skf.split(x, y)):\n",
    "    each_fold = {}\n",
    "    each_fold['train'] = list(x[train_index])\n",
    "    each_fold['test'] = list(x[test_index])\n",
    "    full_5folds_dict['brca_t_5folds'].append(each_fold)\n",
    "\n",
    "# brca_n\n",
    "x = brca_n[\"patient_filename\"].values\n",
    "y = brca_n[\"n\"].values\n",
    "\n",
    "for i, (train_index, test_index) in enumerate(skf.split(x, y)):\n",
    "    each_fold = {}\n",
    "    each_fold['train'] = list(x[train_index])\n",
    "    each_fold['test'] = list(x[test_index])\n",
    "    full_5folds_dict['brca_n_5folds'].append(each_fold)\n",
    "\n",
    "# luad_t\n",
    "x = luad_t[\"patient_filename\"].values\n",
    "y = luad_t[\"t\"].values\n",
    "\n",
    "for i, (train_index, test_index) in enumerate(skf.split(x, y)):\n",
    "    each_fold = {}\n",
    "    each_fold['train'] = list(x[train_index])\n",
    "    each_fold['test'] = list(x[test_index])\n",
    "    full_5folds_dict['luad_t_5folds'].append(each_fold)\n",
    "\n",
    "# luad_n\n",
    "x = luad_n[\"patient_filename\"].values\n",
    "y = luad_n[\"n\"].values\n",
    "\n",
    "for i, (train_index, test_index) in enumerate(skf.split(x, y)):\n",
    "    each_fold = {}\n",
    "    each_fold['train'] = list(x[train_index])\n",
    "    each_fold['test'] = list(x[test_index])\n",
    "    full_5folds_dict['luad_n_5folds'].append(each_fold)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# saving\n",
    "with open('full_5folds_dict.pkl', 'wb') as file:\n",
    "    pickle.dump(full_5folds_dict, file)\n",
    "    \n",
    "# # loading\n",
    "# with open('full_5folds_dict.pkl', 'rb') as file:\n",
    "#     loaded_dict = pickle.load(file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# embed full report&summary"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/home/yl3427/miniconda3/envs/rag_tnm_env/lib/python3.12/site-packages/tqdm/auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import os\n",
    "import re\n",
    "from huggingface_hub import InferenceClient\n",
    "import chromadb\n",
    "import chromadb.utils.embedding_functions as embedding_functions\n",
    "import tiktoken\n",
    "from tqdm import tqdm\n",
    "import numpy\n",
    "import warnings\n",
    "warnings.filterwarnings(\"ignore\")\n",
    "from dotenv import load_dotenv, find_dotenv\n",
    "if not load_dotenv(find_dotenv()):\n",
    "    raise Exception(\"Failed to load .env file\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "openai_ef = embedding_functions.OpenAIEmbeddingFunction(\n",
    "                api_key=os.getenv('OPENAI_API_KEY'),\n",
    "                model_name=\"text-embedding-3-small\"\n",
    "            )\n",
    "client = chromadb.PersistentClient(\"/home/yl3427/cylab/chroma_db\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Collection(name=full_summary_emb),\n",
       " Collection(name=full_report_emb_2),\n",
       " Collection(name=full_report_emb),\n",
       " Collection(name=full_summary_emb_2)]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "client.list_collections()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1517\n",
      "0\n",
      "1517\n",
      "0\n"
     ]
    }
   ],
   "source": [
    "for collection in client.list_collections():\n",
    "    print(collection.count())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# for col in client.list_collections():\n",
    "#     if col.name.startswith(\"full\") or col.name.startswith(\"luad\") or col.name.startswith(\"brca\"):\n",
    "#         client.delete_collection(col.name)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# client.delete_collection(\"full_report_emb\")\n",
    "client.get_or_create_collection(\"full_report_emb_2\")\n",
    "client.get_or_create_collection(\"full_summary_emb_2\")\n",
    "client.list_collections()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "여기까지 하고 summary 생성하고 와"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['patient_filename', 't', 'text', 'type', 'n', 'prompt_for_abstract',\n",
       "       'prompt_for_extract', 'abstractive_summary', 'extractive_summary',\n",
       "       'zs_ans_from_text_t', 'zs_ans_from_abstract_t', 'zs_ans_from_extract_t',\n",
       "       'zs_ans_from_text_n', 'zs_ans_from_abstract_n', 'zs_ans_from_extract_n',\n",
       "       '0_Has_Valid_Prediction_t', '0_coded_pred_t',\n",
       "       '1_Has_Valid_Prediction_t', '1_coded_pred_t',\n",
       "       '2_Has_Valid_Prediction_t', '2_coded_pred_t',\n",
       "       '0_Has_Valid_Prediction_n', '0_coded_pred_n',\n",
       "       '1_Has_Valid_Prediction_n', '1_coded_pred_n',\n",
       "       '2_Has_Valid_Prediction_n', '2_coded_pred_n', 'is_goodsum_t',\n",
       "       'is_goodsum_n'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "summary_df = pd.read_csv(\"/home/yl3427/cylab/yewon_data/usingExtract_fs_merged_df.csv\")\n",
    "\n",
    "summary_df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(1177, 1108)"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(summary_df[summary_df[\"is_goodsum_t\"]]), len(summary_df[summary_df[\"is_goodsum_n\"]])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# df_n = pd.read_csv(\"/secure/shared_data/rag_tnm_results/summary/backup_5_folds_summary/OnlyCorrectSummary_N_withSummary_merged_df.csv\")\n",
    "# df_t = pd.read_csv(\"/secure/shared_data/rag_tnm_results/summary/backup_5_folds_summary/OnlyCorrectSummary_T_withSummary_merged_df.csv\")\n",
    "# len(df_n), len(df_t)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "def num_tokens_from_string(string: str, encoding_name: str) -> int:\n",
    "    \"\"\"Returns the number of tokens in a text string.\"\"\"\n",
    "    encoding = tiktoken.get_encoding(encoding_name)\n",
    "    num_tokens = len(encoding.encode(string))\n",
    "    return num_tokens\n",
    "\n",
    "def update_collection(report_df, collection):\n",
    "    pbar = tqdm(total=report_df.shape[0])\n",
    "\n",
    "    for _, report in report_df.iterrows():\n",
    "        report_text = report[\"text\"]\n",
    "        meta = {}\n",
    "        meta[\"patient_filename\"] = report[\"patient_filename\"]\n",
    "        meta[\"cancer_type\"] = report[\"type\"]\n",
    "        meta[\"t_label\"] = report['t']\n",
    "        meta[\"n_label\"] = report['n']\n",
    "        meta['is_goodsum_t'] = report['is_goodsum_t']\n",
    "        meta[\"is_goodsum_n\"] = report[\"is_goodsum_n\"]\n",
    "        meta[\"report_length_cl100k_base\"] = num_tokens_from_string(report_text, \"cl100k_base\")\n",
    "        meta[\"abstract\"] = report['abstractive_summary']\n",
    "        meta[\"extract\"] = report['extractive_summary']\n",
    "\n",
    "        collection.update(\n",
    "            ids=meta[\"patient_filename\"],\n",
    "            embeddings=openai_ef([report_text])[0],\n",
    "            metadatas=meta,\n",
    "            documents=report_text\n",
    "        )\n",
    "        pbar.update(1)\n",
    "    pbar.close()\n",
    "\n",
    "def embed_reports_in_chroma(report_df, collection):\n",
    "    \n",
    "    pbar = tqdm(total=report_df.shape[0])\n",
    "\n",
    "    for _, report in report_df.iterrows():\n",
    "        report_text = report[\"text\"]\n",
    "        meta = {}\n",
    "        meta[\"patient_filename\"] = report[\"patient_filename\"]\n",
    "        meta[\"cancer_type\"] = report[\"type\"]\n",
    "        meta[\"t_label\"] = report['t']\n",
    "        meta[\"n_label\"] = report['n']\n",
    "        meta['is_goodsum_t'] = report['is_goodsum_t']\n",
    "        meta[\"is_goodsum_n\"] = report[\"is_goodsum_n\"]\n",
    "        meta[\"report_length_cl100k_base\"] = num_tokens_from_string(report_text, \"cl100k_base\")\n",
    "\n",
    "        collection.add(\n",
    "            embeddings=openai_ef([report_text])[0],\n",
    "            metadatas=meta,\n",
    "            documents=report_text,\n",
    "            ids=meta[\"patient_filename\"]\n",
    "        )\n",
    "        pbar.update(1)\n",
    "    pbar.close()\n",
    "\n",
    "def embed_summary_in_chroma(report_df, collection):\n",
    "    \n",
    "    pbar = tqdm(total=report_df.shape[0])\n",
    "\n",
    "    for _, report in report_df.iterrows():\n",
    "        report_text = report[\"extractive_summary\"]\n",
    "        meta = {}\n",
    "        meta[\"patient_filename\"] = report[\"patient_filename\"]\n",
    "        meta[\"cancer_type\"] = report[\"type\"]\n",
    "        meta[\"t_label\"] = report['t']\n",
    "        meta[\"n_label\"] = report['n']\n",
    "        meta['is_goodsum_t'] = report['is_goodsum_t']\n",
    "        meta[\"is_goodsum_n\"] = report[\"is_goodsum_n\"]\n",
    "        meta[\"report_length_cl100k_base\"] = num_tokens_from_string(report_text, \"cl100k_base\")\n",
    "\n",
    "        collection.add(\n",
    "            embeddings=openai_ef([report_text])[0],\n",
    "            metadatas=meta,\n",
    "            documents=report_text,\n",
    "            ids=meta[\"patient_filename\"]\n",
    "        )\n",
    "        pbar.update(1)\n",
    "    pbar.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 1517/1517 [05:00<00:00,  5.05it/s]\n"
     ]
    }
   ],
   "source": [
    "full_report_collection = client.get_collection(\"\")\n",
    "# embed_reports_in_chroma(summary_df, full_report_collection)\n",
    "update_collection(summary_df, full_report_collection)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 1517/1517 [04:41<00:00,  5.39it/s]\n"
     ]
    }
   ],
   "source": [
    "full_summary_collection2 = client.get_collection(\"full_summary_emb_2\")\n",
    "embed_summary_in_chroma(summary_df, full_summary_collection2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'abstract': 'The patient has a non-mucinous, papillary adenocarcinoma in the right lower lobe of the lung, measuring 4.5 cm with poorly differentiated areas, involving the pleura and blood vessels, and with hilar lymph node metastases. The tumor is classified as stage IIIA (pT2, pN2, pMx) according to the TNM staging system.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a peripheral, non-mucinous, papillary adenocarcinoma in the right lower lobe of the lung, measuring 4.5 cm with foci of poor differentiation, pleural infiltration, and invasion of blood vessels. There are hilar lymph node metastases present. The tumor classification is M-8140/3, G3, pT2, pV0, pN2, pMx, and the stage is IIIA. The resection is R0.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-05-4244.3a844132-f813-4d8e-8f7d-dbae0b23d7fd',\n",
       "  'report_length_cl100k_base': 109,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated, non-mucinous pulmonary adenocarcinoma tumor with a maximum size of 3.2 cm in the upper lobe of the lung. The tumor is classified as stage IIIA, with no metastasis (pM X), but lymph node involvement (pN 2). Immunohistological findings support the diagnosis of primary pulmonary adenocarcinoma.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with stage III A pulmonary adenocarcinoma. The tumor is poorly differentiated and non-mucinous, with a maximum size of 3.2 cm. It is classified as M-8140/3, G3, pT2, pV1, pN2, pMX. The immunohistological follow-up report shows an absence of cytokeratin 5 expression, with some tumor cells co-expressing cytokeratin 7 and 20. Most of the tumor cells show nuclear expression of TTF-1, and there is marked CEA expression. The proliferation marker Mib-1 is moderately high, with staining of about 30% of tumor cell nuclei. The marker spectrum supports the diagnosis of primary pulmonary adenocarcinoma.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-05-4245.902fe548-5b93-49c9-81db-2af4a4a88f3c',\n",
       "  'report_length_cl100k_base': 214,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has a well-differentiated papillary, non-mucinous adenocarcinoma tumor measuring 50 mm in the right lower lobe, extending to the visceral pleura with no lymph node involvement (pN0) and no distant metastasis (pMX). The tumor is classified as stage IB (T2, N0, M0). The resection margins are tumor-free, and the patient's recovery is proceeding well.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a well-differentiated papillary, non-mucinous adenocarcinoma in the right lower lobe of the lung, measuring 50mm, extending to the visceral pleura with no lymph node involvement (pN0), no distant metastasis (pMX), and a tumor-free bronchial resection margin. The tumor is classified as stage IB (M-8140/3, G1, pT22).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-05-4249.7e920317-d5c2-4160-9e2b-ef0101eb5a23',\n",
       "  'report_length_cl100k_base': 127,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated, adenosquamous carcinoma in the right lower lobe, measuring at least 65 mm, with almost complete pleural infiltration, and penetration of S6. There are tongue-shaped extensions in the peribronchial, hilar fatty connective tissue, and lymph node metastases with necrotic destruction. The tumor is classified as M-8140/3, G3, pT3, pV1, pN1, pMx, stage III A, and complete removal is not definite.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a poorly differentiated, adenosquamous carcinoma measuring at least 65 mm with almost complete pleural infiltration, penetration of S6, and tongue-shaped extensions in the peribronchial, hilar fatty connective tissue with lymph node metastases showing necrotic destruction. The tumor classification is M-8140/3, G3, pT3, pV1, pN1, pMx, stage III A. R2, indicating a locally advanced, stage 3a cancer with lymph node involvement but no distant metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-05-4250.5574f2f8-f247-40e6-a285-7793edcf5358',\n",
       "  'report_length_cl100k_base': 161,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has a peripheral bronchopulmonary mixed large-cell and clear-cell adenocarcinoma in the left upper lobe (T2), with no lymph node involvement (N0), and no distant metastasis (M0), resulting in a stage IB cancer. The tumor has focally infiltrated the visceral pleura, but the resection margins, bronchus, vessels, and lymph nodes are tumor-free.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a mixed large-cell and clear-cell adenocarcinoma of the left upper lobe (pT2), with no lymph node involvement (pNO), and no distant metastasis (pMX R0), classifying it as stage IB. The tumor has focally infiltrated the visceral pleura, but the resection margins of bronchus and vessels, as well as all removed lymph nodes, are tumor-free.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-05-4382.952c0f32-1472-49e1-8334-b0f1de4ac921',\n",
       "  'report_length_cl100k_base': 128,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a peripheral mixed bronchopulmonary adenocarcinoma with a tubulopapillary structure and partly bronchioloalveolar growth pattern. The tumor is classified as pT2, with no lymph node involvement (pNX), and no metastasis (pMX). The immune profile confirms the bronchopulmonary adenocarcinoma diagnosis.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a peripheral mixed bronchopulmonary adenocarcinoma with an acinar and papillary component and partly bronchioloalveolar growth pattern. The tumor has focally infiltrated the visceral pleura and extends as far as the basal row of metal clamps. The TNM classification is pT2 pNX pMX RX. The immune profile confirms the bronchopulmonary adenocarcinoma.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-05-4384.b70e95c5-2e6c-4409-8bbd-80e03e302b4c',\n",
       "  'report_length_cl100k_base': 233,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a mixed bronchopulmonary adenocarcinoma (pT1) with no lymph node involvement (pNo) and no evidence of metastasis (R0), classifying it as stage IA. The tumor was completely removed through wedge excision, and the resected margins, bronchus, vessels, and lymph nodes were found to be tumor-free.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a mixed bronchopulmonary adenocarcinoma, classified as pT1, pNo, and R0, indicating stage IA cancer. The tumor was completely removed through wedge excision and no lymph nodes were found to be involved. The report is awaiting confirmation through immunohistological investigations.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-05-4389.924f5877-07dc-48dc-b920-c59ba743498e',\n",
       "  'report_length_cl100k_base': 153,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a mixed adenocarcinoma in the right upper lobe of the lung, with a tumor size of T2 and no lymph node involvement (N0). The cancer has not metastasized (M0), resulting in a stage IB classification. The tumor has infiltrated the retracted visceral pleura and the resection margins, including bronchus and vessels, are tumor-free with no cancer found in the removed lymph nodes (samples 1-7).',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with stage IB lung cancer, specifically adenocarcinoma in the right upper lobe. The tumor size is T2 and there is no lymph node involvement (pN0). The cancer has not metastasized (R0). The tumor has infiltrated the retracted visceral pleura and the resection margins, as well as all removed lymph nodes, are tumor-free.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-05-4390.2e3faad1-3a5e-4efb-96ea-8c44839fec6e',\n",
       "  'report_length_cl100k_base': 146,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a mixed, highly mucigenous adenocarcinoma of the left upper lobe of the lung, which is classified as T4 (tumor size), N2 (lymph node involvement), and V1 (metastasis status), indicating stage IIIB. The tumor is primarily peripheral, has infiltrated the parietal layer, and extends close to the hilar resection margin. One lymph node metastasis is present, while the resection margins of bronchus, vessels, pericardial specimen, and lymph nodes from samples 4 and 5 are tumor-free.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with stage IIIB lung adenocarcinoma (T4, N2, V1) with a mixed, highly mucinous tumor in the left upper lobe. The tumor has infiltrated the parietal layer and possibly extends into the hilum of the superior lobe, with a separate satellite focus in S3. The tumor has also infiltrated the pulmonary venous wall and is close to the hilar resection margin. One lymph node metastasis was found, and the resection margins of bronchus and vessels, as well as the pericardial specimen and lymph nodes of samples 4 and 5, are tumor-free.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-05-4395.601b48ca-e99c-4d4b-854e-4aa923b63237',\n",
       "  'report_length_cl100k_base': 312,\n",
       "  't_label': 3},\n",
       " {'abstract': 'The patient has a mixed adenocarcinoma with tumor size pT4, lymph node involvement pN1, and no metastasis (R0). The tumor is located in segments 6 and 9 of the resected right lower lobe, with satellite nodes in the lipsilateral lobe. The largest metastasis in the regional lymph nodes is 1.2 mm. The cancer is classified as stage IIIB.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with a pneumonia-like, mixed adenocarcinoma of the lung. The tumor is classified as pT4 with lymphogenous metastatic spread (pN1) and no evidence of distant metastasis (R0). The tumor has a predominantly tubulopapillary and bronchioloalveolar pattern with minimal pleural invasion. There are numerous small foci within the parenchyma, and the largest metastasis found in the regional lymph nodes is 1.2 mm. The tumor is classified as stage IIIB, but there is a possibility that it could be interpreted as a primary multifocal tumor manifestation, which would correspond to stage IIB. The main tumor mass is located in segments 6 and 9 of the resected right lower lobe.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-05-4396.96f3b48a-c5c4-40c3-a3d1-64477499c6e6',\n",
       "  'report_length_cl100k_base': 331,\n",
       "  't_label': 3},\n",
       " {'abstract': \"The patient's bronchopulmonary adenocarcinoma is classified as pT2, with partial necrotic alteration and invasion of large pulmonary vessels and pleura. The tumor is stage IIB, with one lymph node (pN1) involved and no distant metastasis (M0). The tumor has a mixed histology of maturing tubuloglandular cells, medium to large cells, and clear cells.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a bronchopulmonary adenocarcinoma (G3) with partial necrotic alteration and invasion of large pulmonary vessels and pleura. The tumor is classified as pT2 pN1 V2 RX, stage IIB. The lymph node with tumor is located in the hilus region adjacent to the tumor-infiltrated large pulmonary vessels.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-05-4397.e3f87d2c-61b5-435a-a095-318d2bf58bb3',\n",
       "  'report_length_cl100k_base': 304,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a stage IIIB, T4N3M1 lung adenocarcinoma with a mixed histology of large-cell, polymorphocellular and clear-cell solid components. The tumor is located in the right upper lobe and has invaded small blood vessels and lymph nodes. Lymph node metastases are present in samples 1-4, 6-8, and 10, while the visceral pleura, resection margins of the bronchus and vessels, and lymph nodes in samples 5-9 are tumor-free.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a mixed adenocarcinoma of the right upper lobe of the lung, classified as T4 (tumor size), N3 (lymph node involvement), and L1 (metastasis status), indicating stage IIIB. The tumor has invaded small blood vessels and lymph nodes, with lymph node metastases found in samples 1-4, 6-8, and 10. The visceral pleura, resection margins of the bronchus and vessels, and lymph nodes of samples 5-9 are tumor-free.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-05-4398.37d9ee69-f24e-4dda-a283-078243db1fa8',\n",
       "  'report_length_cl100k_base': 218,\n",
       "  't_label': 3},\n",
       " {'abstract': 'The patient has a mixed adenocarcinoma in the lower lobe of the lung with predominant acinar component and a smaller large-cell solid component. The tumor has infiltrated the visceral pleura and extends to the basal margin of the preparation after the row of metal clamps is removed. The tumor classification is pT2 pNX pMX L1 RX, with localization code C34.3 and morphology code M825/3.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with a mixed adenocarcinoma located peripherally in the lower lobe of the lung, with a predominant acinar component and a smaller large-cell solid component. The tumor has infiltrated the visceral pleura and extends to the basal margin of the preparation after the row of metal clamps is removed. The tumor classification is pT2 pNX pMX L1 RX, with localization code C34.3 and morphology code M825/3.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-05-4402.8099c860-5c8d-4200-8c8f-07f9e1b71780',\n",
       "  'report_length_cl100k_base': 182,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a mixed adenocarcinoma of the right upper lobe of the lung, with a predominant bronchiolo-alveolar and mucinous type. The tumor size is T2, with no lymph node involvement (N0), and no evidence of metastasis (M0), resulting in a stage IB classification. The resected margins, bronchus, vessels, and lymph nodes are tumor-free.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with stage IB adenocarcinoma of the right upper lobe of the lung, which is a mixed, highly mucinous tumor, predominantly of bronchiolo-alveolar mucinous type. The tumor size is T2, with no lymph node involvement (N0) and no evidence of distant metastasis (M0). The resection margins, bronchus, vessels, and lymph nodes removed are tumor-free.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-05-4403.96181bb6-7944-4674-83ba-5268ef8b10a5',\n",
       "  'report_length_cl100k_base': 141,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has a mixed adenocarcinoma of the right lower lobe of the lung, with a tumor size of T2 and no lymph node involvement (N0). There is no evidence of metastasis (M0), and the cancer is classified as stage IB. The tumor has infiltrated blood vessels, but the resection margins, bronchi, and lymph nodes removed are tumor-free.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a mixed adenocarcinoma of the right lower lobe of the lung, with a tumor size of T2 and no lymph node involvement (N0). There is no evidence of metastasis (M0), and the cancer is classified as stage IB. The tumor has infiltrated blood vessels, but the resection margin, bronchi, and lymph nodes removed are tumor-free.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-05-4405.AB2C32B2-3CB1-4977-8C79-7B19F9022DFB',\n",
       "  'report_length_cl100k_base': 118,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathological report indicates a stage IB adenocarcinoma with a mixed tumor composition, showing tubular, acinar, and papillary patterns. The tumor is characterized as pT2 (tumor size 3-5 cm), pNO (no lymph node involvement), and pMX (metastasis cannot be assessed) based on the available samples. Further immunohistological analysis is pending for a more precise origin determination.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with a peripheral mixed bronchopulmonary adenocarcinoma (stage IB) with a predominantly tubular or acinar structure, and areas of bronchioloalveolar growth pattern and small solid and papillary component. The tumor has foci of infiltration in the visceral pleura, extending to the basal resection margin, and shows no lymph node involvement (pNO), with no distant metastasis (pMX). The immune profile confirms the bronchopulmonary origin of the tumor.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-05-4410.13c40632-79e2-485c-9ef2-da6d075b054c',\n",
       "  'report_length_cl100k_base': 243,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a T4N2MX V1 R0, stage IIIB bronchopulmonary large-cell and polymorphocellular adenocarcinoma of the left lung with mucin inclusions. The tumor involves the upper and lower lobes, with obliteration and stenosis of central bronchus segments and continuous infiltration of parabronchial lymph nodes. There is a lymph node metastasis in sample 3, and tumor invasions are present in small intratumoral blood vessels. The resection margins of the bronchus, vessels, and hilar resection surface of the main preparation, as well as the lymph nodes of samples 2 to 6, are tumor-free.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with stage IIIB bronchopulmonary, large-cell and polymorphocellular, in part also giant-cell adenocarcinoma of the left lung with mucin inclusions. The tumor is classified as pT4, with pN2 lymph node involvement and pMX metastasis status. The primary tumor involves both the upper and lower lobes, with obliteration and stenosis of central bronchus segments and continuous infiltration of parabronchial lymph nodes. The peripheral manifestation is in S6 and leaves the visceral pleura tumor-free. Sample 3 contains a further lymph node metastasis. The resection margins of the bronchus and vessels and the hilar resection surface of the main preparation and the lymph nodes of samples 2 and 4-6 are tumor-free.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-05-4415.e8871f29-3623-4975-be19-bda98dbbc33b',\n",
       "  'report_length_cl100k_base': 224,\n",
       "  't_label': 3},\n",
       " {'abstract': 'The patient has a mixed adenocarcinoma of the right upper lobe of the lung, with a tumor size of T2 and no lymph node involvement (pNO), and no metastasis (pMX R0), resulting in a stage IB classification. The tumor has extended into adjacent segments S4 and S5, but the resection margins and removed lymph nodes are tumor-free.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a mixed adenocarcinoma of the right upper lobe of the lung, with a large-cell and clear-cell component, and slight mucin formation. The tumor has extended over the oblique fissure of the lung into adjoining segments of S4 and S5. The resection margin of the bronchus and vessels and all the lymph nodes removed are tumor-free. The tumor is classified as pT2, pNO, pMX R0, and stage IB.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-05-4417.0b795830-d3bf-4a94-8355-b76a5f4469a5',\n",
       "  'report_length_cl100k_base': 130,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a locally advanced, mixed adenocarcinoma of the left lower lobe lung (T3), with lymph node metastases (N2), no distant metastasis (MX), and a tumor-free resection margin. The cancer has infiltrated the pericardial fatty tissue, and the overall stage is IIIA.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with stage IIIA lung cancer, specifically a mixed adenocarcinoma of the left lower lobe. The tumor has infiltrated the pericardial fatty tissue and there are lymph node metastases in the hilar region. The resection margin of the bronchus and vessels, as well as the pericardial resection material and lymph nodes of samples 3 and 5, are tumor-free. The cancer has not metastasized to other organs.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-05-4418.4d77e536-98f2-4e34-9e76-adb4bc79bf5e',\n",
       "  'report_length_cl100k_base': 202,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has a mixed adenocarcinoma of the right lower lobe lung, with tumor size T2, no lymph node involvement (N0), and no distant metastasis (MX). The cancer has extended to S4 of the middle lobe, the resection margin of the bronchus, and vessels. All removed and identified lymph nodes are tumor-free. The stage is IB.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient has a mixed adenocarcinoma of the right lower lobe of the lung, with a predominant papillary and small acinar component, and slight mucin formation. The tumor has extended to S4 of the middle lobe and the resection margin of the bronchus. The patient is classified as T2 N0 MX R0, stage IB. All lymph nodes removed and identified are tumor-free.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-05-4420.682a1fdc-41dd-441b-831c-fe3cf834638e',\n",
       "  'report_length_cl100k_base': 140,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a peripheral bronchopulmonary, well-differentiated mixed adenocarcinoma of the left lower lobe of the lung, classified as T2 (tumor size), N0 (no lymph node involvement), and R0 (no distant metastasis), stage IB. The tumor has a compact, low stromal structure with predominantly tubulopapillary differentiation and a small bronchioloalveolar component. It extends below the pleura but has not infiltrated it, and has invaded a peripheral bronchus, causing a tumor plug and marked distension.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with stage IB peripheral bronchopulmonary, histologically well-differentiated mixed adenocarcinoma of the left lower lobe of the lung (TNM classification). The tumor has a compact, low stromal structure, of predominantly tubulopapillary differentiation and shows a small bronchioloalveolar component at the margin. It extends to below the pleura, which it has not however infiltrated on the basis of the sample examined. In a central direction, the carcinoma has invaded a peripheral bronchus, this being markedly distended and largely obstructed by a tumor plug.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-05-4422.b51045ca-f7ae-459f-90b7-631683d84e0f',\n",
       "  'report_length_cl100k_base': 196,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a mixed adenocarcinoma of the right upper lobe of the lung, with tumor size T3, no lymph node involvement (pNO), and metastasis (pMX) to the chest wall, classifying it as stage IIB. The tumor has spread to the visceral pleura and 3rd rib but has negative resection margins and no lymph node involvement.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a mixed adenocarcinoma of the right upper lobe of the lung, classified as T3 (tumor size), N0 (no lymph node involvement), MX (metastasis status unknown), and V1 (invasion of the chest wall) with a stage IIB. The tumor has spread to the adhesive part of the chest wall, infiltrating soft tissue and the 3rd rib, and extending to the outer resection surface at the thoracic skin. The resection margins of the bronchus, vessels, and lung parenchyma are tumor-free, as well as all identified and removed lymph nodes.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-05-4424.da7dff31-acbb-4d15-b607-e3c0a4fa5901',\n",
       "  'report_length_cl100k_base': 242,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has a mixed adenocarcinoma of the lung with pleural invasion, a small satellite nodule of tubular adenocarcinoma, and bronchioalveolar growth component. The tumor is classified as stage IV with no lymph node involvement and distant metastasis (pT2, pNO, pM1). Immunohistochemical analysis confirms the classification of the smaller focus as a metastasis from the larger tumor. Vascular invasion is present in the larger tumor.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a mixed adenocarcinoma of the middle with pleural invasion, a small focus of tubular adenocarcinoma, and bronchioalveolar growth component. The tumor is classified as stage IV with TNM classification pT2, pNO, and pM1 (PUL) V1 RX. The smaller focus is believed to be a metastasis of the larger tumor, which is supported by immunohistochemical analysis. There is vascular invasion in the larger tumor, and the tumor cells remain in the pleural space. The tumor is positive for CK7 and negative for CK20, with isolated tumor cells staining for surfactant protein B.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-05-4425.adafa26d-044f-4b01-804a-5066ee20ceb6',\n",
       "  'report_length_cl100k_base': 417,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a mixed adenocarcinoma of the left lower lobe of the lung, with a partially bronchioloalveolar pattern of spread and localization in S9 and S10. There is no lymph node involvement (pNO) and no evidence of metastasis (pMX R0). The tumor size is classified as T2(2) and the cancer stage is IB.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a mixed adenocarcinoma of the left lower lobe of the lung, with a partially bronchioloalveolar pattern of spread and localization in S9 and S10. There is also a small, non-mucinous bronchioloalveolar carcinoma peripherally in S6. The tumor size is pT2(2), with no lymph node involvement (pNO), and no metastasis (pMX R0). The cancer stage is IB.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-05-4426.0c54267d-6868-4aa3-a2a3-6c2eb309f6a7',\n",
       "  'report_length_cl100k_base': 127,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a stage IIB lung adenocarcinoma with a predominantly undifferentiated mixed large-cell and polymorphocellular tumor in the left upper lobe. It has minimal visceral pleural invasion and central bronchopulmonary and hilar lymph node metastases (pT2, pN1, R0). Immunohistochemical analysis revealed a high proportion of tumor cells positive for low molecular weight keratins and a small proportion positive for high molecular weight keratins, confirming the mixed-type adenocarcinoma classification.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with stage IIB lung adenocarcinoma (T2, N1, R0) with a predominantly undifferentiated mixed large-cell and polymorphocellular solid component. The tumor has minimal visceral pleural invasion and central bronchopulmonary and hilar lymph node metastases. Other hilus lymph nodes removed are tumor-free. Immunohistochemical analysis shows a high proportion of tumor cells positive for low molecular weight keratins and a small proportion positive for high molecular weight keratins, confirming the mixed-type adenocarcinoma classification.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-05-4427.06c7cdb1-5048-4c75-9002-090997275eff',\n",
       "  'report_length_cl100k_base': 268,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a mixed-cell adenocarcinoma of the left lower lobe of the lung, with a predominant acinar and small large-cell solid component, and a bronchioloalveolar pattern of spread. The tumor has infiltrated the visceral pleura. The resection margin of the bronchus and vessels are tumor-free, and no lymph nodes were involved. There is no evidence of metastasis. The cancer is classified as stage IB (T2, N0, M0).',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a mixed-cell adenocarcinoma of the left lower lobe of the lung, with a predominant acinar and small large-cell solid component, and a bronchioloalveolar pattern of spread. The tumor has infiltrated the visceral pleura. The resection margin of the bronchus and vessels are tumor-free, and all lymph nodes removed are tumor-free. The TNM classification is pT2 pNO pMX R0, stage IB.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-05-4430.0c8a524e-3241-4cde-8d22-1330aaf8c603',\n",
       "  'report_length_cl100k_base': 140,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a mixed adenocarcinoma of the right upper lobe of the lung, with a predominant large-cell and partly clear-cell component. The tumor size is T2, with local invasion and no distant metastasis (pMX). There is lymph node involvement (pN1), and the cancer has been staged as IIB. The resection margins, bronchus, vessels, and surrounding lymph nodes are tumor-free.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with stage IIB lung cancer (T2, N1, MX) with a mixed adenocarcinoma tumor in the right upper lobe, which has infiltrated and perforated the visceral pleura and caused a hilar lymph node metastasis. The tumor margins, bronchus, vessels, middle lobe resection material, and lymph nodes are tumor-free.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-05-4432.f99933b1-6f7b-4e5e-87a4-4f902d031c76',\n",
       "  'report_length_cl100k_base': 194,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has been diagnosed with peripheral bronchopulmonary mucinous adenocarcinoma, showing predominantly bronchioloalveolar differentiation. The tumor size is classified as T2, with no lymph node involvement (N0) and no distant metastasis (M0), resulting in a stage IB classification. The resected margins, bronchus, vessels, and lymph nodes are tumor-free.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with peripheral bronchopulmonary mucinous adenocarcinoma with a predominantly bronchioloalveolar pattern. The tumor size is classified as T2, with no lymph node involvement (N0) and no metastasis (M0), resulting in a stage IB classification. The carcinoma has not infiltrated the visceral pleura, and the resection margins, bronchus, vessels, and lymph nodes are tumor-free.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-05-4433.eeae318d-a517-48b6-9a21-5c72dc4bd510',\n",
       "  'report_length_cl100k_base': 129,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a stage IV adenocarcinoma of the right lower lobe of the lung with pleural invasion and metastatic dissemination to both pleural layers and lymph nodes. The tumor is classified as pT4, pN1, and pM1 (P/E) V1 RX. The tumor is mixed with large-cell solid, glandular tubulopapillary, and bronchioloalveolar differentiation. The immunohistochemical analysis confirms the diagnosis of an adenocarcinoma of the lung.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with stage IV lung adenocarcinoma, with a tumor size of pT4, lymph node involvement of pN1, and metastasis of pM1 (P/E) V1 RX. The tumor has pleural invasion and metastatic dissemination to both pleural layers and lymph nodes. The tumor is mixed, with a predominant large-cell solid component and glandular tubulopapillary and bronchioloalveolar differentiation. The RX category is due to the tumor extending to the pleural surface and carcinoma cells being detected in the pleural effusions. The resection margins of the central bronchus, large pulmonary vessels, and parietal pleura are tumor-free. Immunohistochemical analysis confirms the diagnosis of an adenocarcinoma of the lung with mixed differentiation.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-05-4434.0e9e74b2-7fd5-47b0-adf5-83c83b0c2d3d',\n",
       "  'report_length_cl100k_base': 440,\n",
       "  't_label': 3},\n",
       " {'abstract': \"The provided text is not a complete pathology report and only includes instructions for filling out a missing pathology report form. It does not contain any specific information about the patient's cancer, tumor size, lymph node involvement, or metastasis status.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The provided text does not contain any specific information about the patient's cancer staging, therefore, no summary can be generated.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-05-5425.6367B293-BF9C-4651-9B73-7B9D1764948D',\n",
       "  'report_length_cl100k_base': 251,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a well-differentiated mixed adenocarcinoma in the left upper lobe of the lung, with a tumor size of T2a and no lymph node involvement (N0). There is no evidence of metastasis (M0), resulting in a stage IB classification. The tumor exhibits luminal mucus, a bronchioloalveolar pattern, and partial pseudopapillary structure. The resection margins, bronchus, and vessels are tumor-free, as well as the lymph nodes from samples 2 to 8.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with intermediate to peripheral bronchopulmonary, well differentiated mixed adenocarcinoma (G1) in the left upper lobe of the lung, specifically in S1. The tumor size is classified as T2a, with no lymph node involvement (N0) and no distant metastasis (M0), resulting in a stage IB classification. The carcinoma displays luminal mucus, a bronchioloalveolar pattern of spread, and a partly pseudopapillary structure. The resection margins, bronchus, and vessels are tumor-free, as well as the lymph nodes from samples 2 to 8.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-05-5715.b764fced-b638-48c6-82a6-4d3663bb2168',\n",
       "  'report_length_cl100k_base': 187,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The pathology report indicates that the patient has been diagnosed with adenocarcinoma lung cancer, with a tumor size of 2 cm and no lymph node involvement (T2, N0). There is no information on metastasis status (M), and no details are provided about treatment or staging.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient is diagnosed with adenocarcinoma lung cancer, with a primary tumor tissue specimen obtained via OCT. The tumor size is not specified, and there is no information on lymph node involvement or metastasis. The report does not provide details on treatment or staging.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-35-3615.ffc829b9-9e11-41c9-9532-b6303ad48a9f',\n",
       "  'report_length_cl100k_base': 229,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The provided pathology report lacks sufficient information for accurate cancer staging. It mentions a primary tumor tissue specimen of adeno-squamous carcinoma, but there is no data on tumor size, lymph node involvement, or metastasis status, which are essential for determining TNM stage. Additional information is needed to properly stage the cancer.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The pathology report does not provide any specific information about the tumor size, lymph node involvement, or metastasis status for this patient's cancer. It only mentions that the primary tumor tissue is an adeno-squamous carcinoma and that the treatment plan includes chemotherapy and hormone therapy.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-35-4122.a970d363-3ea8-4f28-a3a5-81c28dcb799f',\n",
       "  'report_length_cl100k_base': 214,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The pathology report indicates that the patient has been diagnosed with adenocarcinoma of the lung, with a tumor size of 2 cm and no lymph node involvement (T2, N0). There is no information provided about metastasis status (M), and no details are given regarding treatment or staging.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The pathology report indicates a primary tumor in the lung, specifically an adenocarcinoma with a TNM stage of 2, meaning the tumor is between 3 and 5 cm in size and there is no lymph node involvement. There is no information on metastasis (M) status. No treatment details are provided.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-35-4123.7f74ee3b-0ecf-468d-9280-d30686d67d3a',\n",
       "  'report_length_cl100k_base': 224,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The pathology report describes a squamous, non-keratinizing carcinoma in the left lung upper lobe, with a tumor size of 3 cm and no lymph node involvement (N0). There is no information on metastasis (M) or treatment details provided.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The pathology report provides information on a left lung tumor, which is a squamous, non-keratinizing carcinoma, with a TNM stage of 3, 2, and 0, indicating tumor size, lymph node involvement, and metastasis status. The report also mentions a blood draw, but no details on metastasis or treatment are provided.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-35-5375.a93477c8-5ebe-436b-978a-61b573f65471',\n",
       "  'report_length_cl100k_base': 228,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has a poorly differentiated adenocarcinoma in the right upper lobe of the lung, with a tumor size of 5.0 cm. The surgical margins are free of tumor, and no tumor is seen in the hilar lymph nodes or in the lymph nodes from stations 11, R4, and 7. There is no evidence of pleural involvement or invasion. The patient is considered to have stage IA lung cancer.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient was diagnosed with poorly differentiated adenocarcinoma in the right upper lobe of the lung, with a tumor size of 5.0 cm. The surgical margins were free of tumor, and no tumor was seen in the two hilar lymph nodes from the lobectomy specimen. Additionally, no tumor was seen in the lymph nodes from stations 11, R4, and 7. The pleura biopsy showed reactive mesothelial cells, fibrosis, and acute and chronic inflammation, but no tumor was seen. The tumor was located peripherally and was not invading into the pleura, but the pleura over the nodule was hemorrhagic and contained thick adhesions. There were no satellite tumor nodules present. The patient's cancer has not metastasized.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-38-4625.ede2780e-09fd-43ad-a29b-6ca1667d2965',\n",
       "  'report_length_cl100k_base': 912,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's left upper lobe lobectomy revealed a poorly differentiated adenocarcinoma, measuring 5.3 cm in diameter. There was no involvement of the bronchial or pleural margins. No metastatic carcinoma was identified in the removed lymph nodes (0/8). The tumor was not involved in the lymph nodes at stations 5, 10, or 11 (0/2 for each). The patient's cancer has not metastasized.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a poorly differentiated adenocarcinoma in the left upper lobe of the lung, with a tumor size of 5.3 cm. The bronchial and pleural margins are not involved, and there is no evidence of metastatic carcinoma in the lymph nodes (0/8). The lymph nodes at stations 5, L10, and 11 are also negative for metastatic carcinoma (0/2 for each station). The tumor is not involving the bronchus and is 1.1 cm away from the stapled surgical margin. There are no satellite tumor nodules, and the remaining lung tissue is red/tan and diffusely aerated. The patient has no lymph node involvement and no evidence of extracapsular extension of the tumor in the lymph nodes.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-38-4626.9ac3c8f7-8399-46b1-9f2c-4e994faf88a3',\n",
       "  'report_length_cl100k_base': 1002,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's right upper lobe lobectomy revealed a 2.7 cm moderately differentiated adenocarcinoma without angiolymphatic invasion or pleural involvement. One out of four peribronchial lymph nodes contained metastatic adenocarcinoma without extracapsular extension. No metastatic carcinoma was identified in lymph nodes R4 and station 11.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with right upper lobe adenocarcinoma, moderately differentiated, with a tumor size of 2.7 cm. There is no angiolymphatic invasion or pleural involvement, and the bronchial margin is not involved. One out of four peribronchial lymph nodes has metastatic adenocarcinoma without extracapsular extension. Lymph nodes R4 and station 11 have no metastatic carcinoma identified. The tumor is not close to the staple line and there are no satellite tumor nodules. The patient's clinical history indicates right NSCLC, and the specimen received is a right upper lobectomy. The tumor is not close to the bronchial margin and there is no involvement of attached structures. The histologic assessment of surgical margins is negative, and there is no in situ carcinoma or perineural invasion identified.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-38-4627.255a7ca7-4aa4-4014-884c-33c331af765d',\n",
       "  'report_length_cl100k_base': 827,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive moderately differentiated adenocarcinoma. The tumor size is 3.5 cm and it is located near the bronchial margin without invasion of the pleura. There is metastatic adenocarcinoma in one hilar lymph node, and multiple other lymph nodes are negative for carcinoma. No perineural or angiolymphatic invasion is identified. Hyalinized granulomata are found in the lymph nodes and lung parenchyma.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an invasive moderately differentiated adenocarcinoma. The tumor size is 3.5 cm and it is located near the bronchial margin. It is not invading the pleura and there is no involvement of attached structures by the tumor. There is metastatic adenocarcinoma involving 1 (of 5) hilar lymph node and hyalinized granulomata involving hilar lymph nodes and pulmonary parenchyma. Multiple (2) lymph nodes are negative for carcinoma.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-38-4628.0a4269d2-d168-4750-ab8c-3c27907c45ef',\n",
       "  'report_length_cl100k_base': 1265,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has been diagnosed with poorly differentiated adenocarcinoma of the right upper lobe of the lung, with a tumor size of 5.5 cm. The tumor extends through the pleura and involves the chest wall, but does not involve the bronchus or pulmonary resection margins. There is no evidence of lymph node metastasis (0/14) or distant metastasis.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient was diagnosed with poorly differentiated adenocarcinoma of the right upper lobe of the lung, with a tumor size of 5.5 cm. The tumor extended through the pleura and involved the chest wall. No metastatic carcinoma was identified in the lymph nodes (0/14). The tumor was not involved in the bronchial or pulmonary vascular margins, but it was present in the chest wall margin. The patient also had patchy acute bronchopneumonia and subpleural fibrous scar with smoking-associated changes in the non-tumorous lung.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-38-4629.9546e974-686d-4d97-b5bd-771972cb4b82',\n",
       "  'report_length_cl100k_base': 1107,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, poorly differentiated, with a tumor size of 4.5 cm. There is no lymph node involvement (0/7 total) and no metastasis identified. The tumor has focal papillary architecture and is angiolymphatic-positive. The bronchial margin is not involved, but the pleural margin is focally involved.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has non-small cell lung carcinoma of the right upper lobe, with a 4.5 cm tumor size, poorly differentiated and with focal papillary architecture. The tumor is not involved in the bronchial margin, but it is focally involved in the pleura. There is no evidence of lymph node metastasis (0/7 total) and no satellite tumor nodules.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-38-4630.63d133eb-0aa7-4c76-bf48-b9206df8975f',\n",
       "  'report_length_cl100k_base': 854,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has non-small cell carcinoma of the left lung, with a tumor size of 4.6 cm. There is no evidence of vascular or perineural invasion, but the tumor extends to the pleura. Three lymph nodes from station 12, two lymph nodes from station 10, two lymph nodes from station 4L, and three lymph nodes from station 7 were removed, with no tumor found in any of them.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has non-small cell carcinoma of the left lung, with a tumor size of 4.6 cm x 4.2 cm x 4.3 cm. The tumor is located in the apex of the left upper lobe and extends close to the pleura but does not penetrate it. There is no evidence of satellite tumor nodules or involvement of attached structures. Three lymph nodes from station 12, two lymph nodes from station 10, two lymph nodes from station 4L, and three lymph nodes from station 7 were removed and showed no tumor. The tumor is poorly differentiated and has vascular space invasion. The patient's lymph nodes at stations 5, 9, and 10 were negative for tumor.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-38-4631.fe8cedaf-e5d1-4836-b6d7-6f21e5e8cd53',\n",
       "  'report_length_cl100k_base': 1452,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathology report indicates a poorly differentiated adenocarcinoma in the left upper lobe of the lung, with a tumor size of 5.8 cm. The tumor extends to but not through the visceral pleura, with free surgical margins and no metastasis to mediastinal lymph nodes. There is extensive hemorrhage in the non-tumorous lung tissue around the tumor. Two of seven hilar nodes from the lobectomy specimen show metastatic adenocarcinoma. Lymph nodes from stations 5, 9, and 11 show no tumor, while station 7 shows follicular hyperplasia and hyalinized granulomas.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient has a poorly differentiated adenocarcinoma in the left upper lobe of the lung, with a tumor size of 5.8 cm. The tumor extends to but not through the visceral pleura, with fibrinopurulent and granulation tissue, and extensive recent and old hemorrhage in the non-tumorous lung around the tumor. Two of seven hilar nodes from the lobectomy specimen are positive for metastatic adenocarcinoma. There is no tumor seen in the mediastinal lymph nodes from station 5, 9, and 11, but follicular hyperplasia and hyalinized granulomas are present. No tumor is seen in three lymph nodes from the pulmonary fissure biopsy.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-38-4632.8a178633-5c59-47fe-b1ce-c15e03c66198',\n",
       "  'report_length_cl100k_base': 435,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is classified as stage pT2b pN2, with a moderately differentiated adenocarcinoma tumor of 5.5 cm in size, unifocal, with venous, arterial, and lymphatic invasion. The tumor is located in the left upper lobe of the lung and has extended to the visceral pleura and lobar bronchus. Ten out of fourteen lymph nodes are positive for metastasis, with three positive lymph nodes in Station 5 and two positive lymph nodes in Station 10. No metastasis is found in the R4 and Station 7 lymph nodes. The bronchial margin is positive for tumor, and perineural invasion is suspected. The largest metastasis measures 1.3 cm.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient's cancer is classified as stage pT2b pN2, with a moderately differentiated adenocarcinoma tumor of 5.5 cm in size, unifocal, and with venous, arterial, and lymphatic invasion. The tumor is located in the left upper lobe of the lung and has extended to the visceral pleura, lobar bronchus, and one peribronchiolar lymph node. Ten out of fourteen lymph nodes are positive for metastasis, with three out of three lymph nodes positive in Station 5 and two out of two lymph nodes positive in Station 10. No perineural invasion is observed, but there is a focus that is suspicious for perineural invasion. The bronchial margin is positive, and extracapsular extension is present in the lymph nodes.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-38-6178.c2b33805-c417-4d5b-97ff-ec0d93afee8c',\n",
       "  'report_length_cl100k_base': 1477,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient is a female with a 2.5 cm moderately differentiated adenocarcinoma in the right upper lobe of the lung, with no pleural invasion and surgical margins not involved. There is no evidence of lymph node involvement or metastasis. The tumor is positive for TTF-1 and HER2, and negative for GCDFP and ER, supporting a lung primary diagnosis.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient is a female with a 2.5 cm moderately differentiated adenocarcinoma in the right upper lobe of the lung, consistent with a lung primary tumor without pleural invasion. The surgical margins are not involved, and special stains were requested to exclude metastasis. The patient has a history of grade 3 ductal breast carcinoma. The tumor is positive for TTF-1 and HER2, supporting a lung primary diagnosis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-38-7271.7eb95f4d-3fb0-4312-89d1-4d5ec9f4f677',\n",
       "  'report_length_cl100k_base': 604,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive lung adenocarcinoma with a maximum tumor size of 3.2 cm, unifocal, without involvement of other structures, lymph nodes, or metastasis. The tumor is classified as T2a (pT2a) in the AJCC PATHOLOGIC TNM STAGE. One lymph node was examined and showed no tumor presence (pNO).',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient was diagnosed with invasive lung adenocarcinoma, with a maximum tumor size of 3.2 cm. The tumor was unifocal and not involved in other structures. There was no lymph node involvement or metastasis found. The patient's AJCC pathologic TNM stage is pT2a pNO. The report notes that molecular studies have been ordered and will be reported separately.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-38-A44F.FC3ACA4F-AA49-47F4-9BA3-7B18C56F64AD',\n",
       "  'report_length_cl100k_base': 740,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive ductal carcinoma with a size of 3.2 x 3.0 x 3.0 cm, with focal micropapillary features and moderate differentiation. There is no evidence of carcinoma in 14 lymph nodes, but the sentinel node biopsy shows extensive replacement and extranodal extension. The tumor is 0.6 cm from the deep margin and 2.5 cm from the lateral margin. Vascular space invasion is present, and calcifications are noted in both malignant and benign areas. The patient's cancer is stage T2, N1, M0.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is invasive ductal carcinoma with a size of 3.2 x 3.0 x 3.0 cm, moderately differentiated with focal micropapillary features. There is no evidence of carcinoma in 14 lymph nodes from the right axilla dissection, but the sentinel node biopsy shows carcinoma in 1 sentinel node following carcinoma of the right breast. The tumor has vascular space invasion and calcifications are present in both malignant and benign areas. The patient's cancer is stage T1, N1, M0.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-3C-AALI.84E6A935-1A49-4BC1-9669-3DEA161CF6FC',\n",
       "  'report_length_cl100k_base': 1545,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient has invasive ductal carcinoma, poorly differentiated, with a tumor size of 3.5 x 3.0 x 2.0 cm. The cancer is multifocal with lymphatic invasion and has metastasized to 1/23 axillary lymph nodes. The patient's pathological stage is pT2N1.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a case of invasive ductal carcinoma, poorly differentiated, multifocal, with lymphatic invasion, with a tumor size of 3.5 x 3.0 x 2.0 cm. The cancer is staged as pT2N1, with metastases found in 1/23 axillary lymph nodes.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-3C-AALJ.265E5A9A-64FD-4B86-89BC-5E89F253C118',\n",
       "  'report_length_cl100k_base': 1390,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma (2cm) and invasive lobular carcinoma (0.6cm) in the right breast, with ductal carcinoma in situ present in 15 of 26 slides. The tumors are estrogen and progesterone receptor positive and HER2 equivocal/indeterminate. One sentinel lymph node contained a single focus of carcinoma (<10 cells), while the other was negative for carcinoma. The patient's skin and nipple were involved by DCIS, but the tumor was negative for vascular space invasion and there was no metastasis to the axillary lymph nodes.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma (2cm) and lobular carcinoma in situ in the right breast, with ductal carcinoma in situ in 15 of 26 slides. The cancer has spread to the lymph nodes, with one focus of carcinoma found in sentinel lymph node #2. There is no evidence of vascular space invasion or metastasis. The tumor is hormone receptor positive and HER2 overexpression is equivocal/indeterminate for invasive carcinoma #1 and positive for invasive carcinoma #2.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-3C-AALK.F43B01E6-E1DB-44B1-8003-93870606346A',\n",
       "  'report_length_cl100k_base': 2685,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an infiltrating moderately differentiated adenocarcinoma of the lung, with a tumor size of 1.5 cm. There is no direct extension of the tumor, and the margins of resection are negative for tumor. At least 11 lymph nodes were examined, all of which were negative for metastatic disease (pNO). There is no evidence of distant metastasis (pM). The lung parenchyma shows mild to moderate emphysematous change.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathology report indicates a posterior segment right wedge resection of the lung, which measures 9.5 x 3 x 2.3 cm. The tumor is an infiltrating moderately differentiated adenocarcinoma with a peripheral bronchoalveolar growth pattern, measuring 1.5 cm in gross maximum dimension. The margins of resection are negative for tumor, and there is no direct extension of the tumor or lymphatic or arterial invasion. At least 11 regional lymph nodes are present, all negative for metastatic disease (pNO). There is no evidence of distant metastasis (pM). The remaining lung parenchyma is soft and spongy, with mild to moderate emphysematous change. The report also mentions nonspecific subpleural scarring and anthracosis in the lymph nodes.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-2655.ebae1e0e-18fb-48c8-b2f3-282dab7352d4',\n",
       "  'report_length_cl100k_base': 1808,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, moderately differentiated, measuring 2.0 cm and invading the visceral pleura. There is no lymphatic (small vessel) invasion identified, and regional lymph nodes (pN) are negative for metastasis (pNO). The cancer has not spread to distant sites (pM), but the report comments that this cannot be fully evaluated by the specimen provided.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient was diagnosed with adenocarcinoma of the right upper lobe of the lung, measuring 2.0 cm and invading the visceral pleura. There was no evidence of lymphatic invasion or regional lymph node metastasis (pN0). The patient had no distant metastasis (pM0). The resected specimen contained a secondary lesion measuring 0.8 x 0.7 x 0.4 cm, which was also found to be adenocarcinoma. The patient had granulomatous inflammation in some lymph nodes, but no organisms were detected on stains for AFB or fungal organisms.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-2656.3c7e7f0d-f1b6-42cf-895e-df6cc52f4c2a',\n",
       "  'report_length_cl100k_base': 1144,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a moderately differentiated adenocarcinoma in the left upper lobe of the lung, with a tumor size of 2.2 x 2.2 x 1.2 cm and focal visceral pleural invasion. The margins of resection are negative, and there is no definitive evidence of vascular invasion. Regional lymph nodes (pN) are not assessed, and distant metastasis (pM) is also not assessed. The specimen shows focal fibrosis.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with moderately differentiated adenocarcinoma, with a tumor size of 2.2 x 2.2 x 1.2 cm and focal visceral pleural invasion. The margins of resection are negative, and there is no definitive evidence of vascular invasion. Regional lymph nodes (pN) are not available for assessment, and distant metastasis (pM) is also not identified. The specimen shows focal fibrosis.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-44-2657.d31fa48b-949c-48b7-bc78-6954ede98172',\n",
       "  'report_length_cl100k_base': 390,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathology report describes two separate adenocarcinomas in the left lower and upper lobes of the lung, both with negative margins. There is no mention of lymph node involvement or metastasis. The tumors measure 1.7 cm and 1.8 cm in diameter, respectively. Additional samples from levels 5, 6, and 7 were taken, but specific details about them are not provided in the report.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has two adenocarcinomas, one in the left lower lobe and one in the left upper lobe, both with negative margins. The left lower lobe tumor is 1.7 cm in diameter, and the left upper lobe tumor is 1.8 cm in diameter. There is no mention of lymph node involvement or metastasis.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-44-2659.9015ab9c-ad9f-44f1-af94-3c7bf34f12fd',\n",
       "  'report_length_cl100k_base': 514,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has been diagnosed with adenocarcinoma of the left upper lobe of the lung, with a tumor size of 1.5 cm and no vascular invasion. The lung margin of resection is negative for malignancy, and the lymph node level 5 is also negative for malignancy. The tumor is T1 NO, and there is no evidence of metastasis.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with adenocarcinoma of the left upper lobe of the lung, with a tumor size of 1.5 cm and no vascular invasion. The pulmonary margin of resection is negative for malignancy, and the lymph node level 5 is also negative for malignancy. The tumor is classified as T1 NO, and there is no evidence of metastasis. The tumor is positive for TTF-1 and negative for BRST-2, ER, and PR.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-2661.17e596f5-74fe-46cc-bee2-fa1355b01721',\n",
       "  'report_length_cl100k_base': 578,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a poorly differentiated non-small cell carcinoma in the right upper lobe of the lung, with a tumor size of 8 cm and no involvement of the visceral pleural surface. The margins of resection are negative, and there is no direct extension of the tumor. The regional lymph nodes (level 10, R4, and level 7) are all negative for metastatic carcinoma. Distant metastasis status is unknown.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has a poorly differentiated non-small cell carcinoma in the right upper lobe of the lung, with a tumor mass measuring 8x7x6cm. The tumor does not involve the visceral pleural surface, and there is no direct extension of the tumor or large vessel invasion. The margins of resection are negative, and regional lymph nodes level 10, R4, and level 7 are all negative for metastatic carcinoma (pN0). Distant metastasis (pM) could not be assessed (pMx). The patient's cancer is classified as T2, N0, and Mx.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-2662.76bab538-e95a-48a6-9f83-36b9a472252b',\n",
       "  'report_length_cl100k_base': 870,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathological report indicates that the tumor size is 2.5 cm in greatest dimension, with no evidence of visceral pleural invasion, large vessel invasion, or lymphatic invasion. The regional lymph nodes (pN) are not identified, and distant metastasis (pM) cannot be evaluated by this specimen. The level 12 lymph nodes demonstrate four nodes with evidence of metastasis, while the level 7 and level 11 lymph nodes show no evidence of metastasis. The level 9 lymph node tissue does not identify any nodes. The diagnosis is adenocarcinoma, poorly differentiated.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient was diagnosed with adenocarcinoma of the right lung lower lobe, with a tumor mass measuring 2.5cm in greatest dimension. The surgical margins were uninvolved, and there was no evidence of large vessel invasion. Four lymph nodes from level 12 had metastasis, while levels 7, 9, and 11 had no evidence of metastasis in the resected lymph nodes (0/2, 0/7, and 0/3, respectively). The patient's cancer stage is T2 (tumor size 2.5cm), N1 (metastasis in 4 lymph nodes), and M0 (no distant metastasis).\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-2664.8ac6aec3-d709-411f-9233-f264bac80972',\n",
       "  'report_length_cl100k_base': 1237,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma of the lung, with a 6 cm tumor in the right upper lobe and metastasis to two of three peribronchial lymph nodes. There is no evidence of metastasis in the level 7 or R4 lymph nodes.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma of the lung, with a moderately differentiated primary tumor measuring 6 cm in the right upper lobe. The tumor extends to within 0.1 cm of the pleural surface and 1.8 cm of the bronchial stump. Two out of three peribronchial lymph nodes and one out of four level 10 lymph nodes contain metastatic carcinoma. There is no evidence of arterial or venous invasion, but lymphatic invasion is present. The level 7 and R4 lymph nodes are clear of metastasis. The cancer is classified as T2 (tumor size 3-5 cm), N1 (metastasis in 1-2 lymph nodes), and Mx (no distant metastasis found).\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-44-2665.262e300a-7b16-4f2b-80bf-29decfe84d33',\n",
       "  'report_length_cl100k_base': 1117,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has an invasive moderately differentiated adenocarcinoma in the right upper lobe of the lung, with a tumor size of 4.5 cm (pT2a). The stapled resection margin is negative for tumor, and there is no direct extension of tumor into the pleura. Regional lymph nodes (E, C, and D) are negative for metastatic tumor (pN0). There is no evidence of distant metastasis (pMX). The patient also has emphysematous blebs with focal areas of hemorrhage and prominent pigmented macrophages within expanded alveolar spaces, consistent with prominent hemosiderin deposition. No infectious organisms were identified.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient was diagnosed with stage I non-small cell carcinoma of the right upper lobe of the lung. The tumor size was 4.5 cm, and the margins of resection were negative for tumor. There was no direct extension of tumor into the pleura, and no large vessel invasion was identified. The regional lymph nodes (E, C, and D) were negative for metastatic tumor (pN0). Distant metastasis (pM) was not evaluated, and no infectious organisms were identified. The final diagnosis was invasive moderately differentiated adenocarcinoma, tumor size 4.5 cm (pT2a), with associated pleural scar but no pleural infiltration identified.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-2666.bbc3c899-16af-41e4-9ba5-57963305df6f',\n",
       "  'report_length_cl100k_base': 964,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a moderately to poorly differentiated adenocarcinoma, with a tumor size of 3 x 2.4 x 2.4 cm. The tumor invades the visceral pleura and is negative for vascular invasion. The bronchial resection margin is negative for malignancy, and there is no evidence of malignancy in the adjacent bronchiolitis or lung tissue. The patient's lymph nodes at levels 11, 4R, 2R, and 7 are negative for malignancy. The cancer is classified as T2 NO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with moderately to poorly differentiated adenocarcinoma in the right upper lobe of the lung, with a tumor size of 3cm. The bronchial margin is negative for carcinoma, but the tumor invades the visceral pleura. There is no evidence of vascular invasion or attached lymph nodes. The patient is classified as T2 NO. The right middle lobe nodule is negative for malignancy, as are the lymph nodes at levels 11, 4R, 2R fat pads, and 7.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-2668.d5ebaec8-79c6-493b-ae2a-bbc96e6e5ddc',\n",
       "  'report_length_cl100k_base': 988,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is a poorly differentiated non-small cell lung carcinoma. The tumor measures 5.5 cm and is present within 0.2 cm of the bronchial margin. There is invasion of the visceral pleura and multifocal extension into the pleural space. The cancer has spread to the pericardial reflection node (pN2) and one lymph node (pN1), but the other lymph nodes examined were negative for metastatic carcinoma. There is no evidence of distant metastasis (pMX).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'Non-small cell lung cancer, poorly differentiated adenocarcinoma, 5.5 cm in size, present within 0.2 cm of bronchial margin, multifocal extension up to and focally into the pleural, vessel invasion present, metastatic carcinoma identified in pericardial reflection node (pN2), no distant metastasis (pMx), regional lymph nodes involved (pN2) with direct extension or metastases, stage T2N2M0.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-44-3396.6a7ec9e8-ea86-4c3b-9d0e-9564e41311b5',\n",
       "  'report_length_cl100k_base': 1883,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's pathology report indicates a poorly differentiated non-small cell carcinoma in the right lower lobe of the lung, with a tumor size of 2.5 cm and no evidence of vascular invasion. The patient's lymph nodes at levels 3, 7, 10, and R4 are negative for malignancy, and there is no evidence of metastasis. The patient's cancer is classified as T1b NO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is a poorly differentiated non-small cell carcinoma, with a tumor size of 2.5 cm and tumor grade 3 out of 3. The cancer is classified as T1b NO, with no evidence of malignancy found in lymph nodes level 3, 7, 10, and R4. No vascular invasion is present, and the bronchial and pulmonary margins of resection are negative for malignancy.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-3398.7dc9c668-3304-47d8-9c33-5b72352672db',\n",
       "  'report_length_cl100k_base': 716,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is a poorly differentiated adenocarcinoma in the right upper lobe of the lung, measuring 3.2 cm. There is no direct extension of the tumor and no large vessel invasion. The tumor is negative for lymphatic invasion and regional lymph nodes are clear of metastatic disease (pN0). Distant metastasis cannot be assessed (pM).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is a poorly differentiated adenocarcinoma, with a 3.2 cm tumor in the right upper lobe of the lung, invading and ulcerating the bronchial tissue. There is no evidence of venous or arterial invasion, and all margins and pleural surfaces are negative for tumor. Three lymph nodes from level 10, and two lymph nodes from the right upper lobe, are negative for metastatic disease (pN0). The report also mentions multiple reactive lymph nodes with anthracotic pigmentation, all negative for metastatic disease (pN0), from the R4 lymph node right side and level 7 lymph node right side. There is no distant metastasis (pM0).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-3917.240f6268-ffef-488e-855d-9c39e3969c65',\n",
       "  'report_length_cl100k_base': 1134,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a moderate to poorly differentiated adenocarcinoma, with a tumor size of 2.2 cm, confined to the left upper lobe of the lung. The bronchial and vascular margins are free of tumor. There is no direct extension of the tumor, and there is no venous or arterial invasion. All sampled lymph nodes, including hilar and mediastinal nodes, are negative for metastatic carcinoma (pNO). Distant metastasis status is unknown (pMx).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's left upper lobe lobectomy revealed a poorly differentiated adenocarcinoma tumor measuring 2.2 cm in size. The tumor was confined to the lung without involvement of the visceral pleural surface, and bronchial and vascular margins were free of tumor. Seven bronchial lymph nodes, including levels 1, 4, 5, 7, and 9, were negative for metastatic carcinoma (pNO). There was no evidence of venous or arterial invasion, and distant metastasis could not be assessed (pMx). The diagnosis is moderate to poorly differentiated adenocarcinoma (pT1b, pNO, pMx).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-3918.da381e6d-f69d-424f-ab84-5c300ca19435',\n",
       "  'report_length_cl100k_base': 1040,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, moderately differentiated, with a tumor size of 2.5 cm (pT1) and no evidence of lymphatic (small vessel) invasion (pN0). There is no metastasis found in the regional lymph nodes (pM0). The tumor extends to the staple line of the wedge resection and is present at the staple line of the right lobe of the lung, measuring 1.5 cm. No metastasis is found in the level 10, R-4, or level 7 lymph nodes.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient was diagnosed with adenocarcinoma of the right upper lobe of the lung, measuring 2.5 cm. The margins of resection were negative, and there was no evidence of metastasis in the level 10 and R-4 lymph nodes. The right lobe of the lung had residual adenocarcinoma, 1.5 cm, located at the staple line. There was no evidence of metastasis in six lymph nodes. The level 7 lymph nodes were also negative for metastasis. The patient's cancer was classified as stage IA.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-3919.d609482c-704a-4aa9-a0b6-feb9822cbe96',\n",
       "  'report_length_cl100k_base': 1218,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is a poorly differentiated adenocarcinoma. The tumor measures 5 cm and invades the pleura, with focal presence on the pleural surface. Vessel invasion is present. Lymph node metastasis is identified in one of four hilar lymph nodes and two of ten R4 lymph nodes. There is no evidence of distant metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is a poorly differentiated adenocarcinoma. The tumor measures 5 cm and invades the pleura, with focal presence on the pleural surface. Vessel invasion is present. Lymph node metastasis is identified in one of four hilar lymph nodes and two of ten R4 lymph nodes. There is no evidence of distant metastasis.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-4112.9f214c90-f9a8-458c-8a53-ca8e8b09a2b2',\n",
       "  'report_length_cl100k_base': 1350,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is a poorly differentiated non-small cell carcinoma of the right lower lobe of the lung, measuring 6.8 cm in size. The tumor is confined to the lung, with negative margins of resection and no direct extension. There is large vessel invasion present, as well as lymphatic invasion. Eight peribronchial and perihilar lymph nodes were negative for metastatic carcinoma, but one of four level 7 mediastinal nodes contained metastatic adenocarcinoma. There is no information on distant metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient was diagnosed with poorly differentiated non-small cell carcinoma involving the right lower lobe of the lung. The tumor measured 6.8 cm and did not extend beyond the visceral pleural surface. The bronchial and vascular margins of resection were free of tumor. The patient had lymphovascular space invasion and medium-sized venous invasion by tumor. Eight peribronchial and perihilar lymph nodes were negative for metastatic carcinoma, but one of four level 7 mediastinal nodes contained metastatic adenocarcinoma. There was no evidence of distant metastasis. The patient also had post-obstructive pneumonitis and pulmonary edema. The 4R and 2R lymph nodes were negative for tumor. The superior vein stump was negative for malignancy.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-44-5643.3117a24b-6125-47a8-a05b-4ada99e68dfa',\n",
       "  'report_length_cl100k_base': 1524,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma with a tumor size of 3.5 cm, no lymph node involvement, and no evidence of metastasis. The tumor grade is 2 out of 3, with a mitotic index of 26 mitoses/10 HPFs. The pulmonary margin of resection and pleura are negative for malignancy, and there is no vascular invasion. The patient's cancer is classified as pTNM Stage T2a NO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma with a tumor size of 3.5 cm, grade 2 out of 3, and a mitotic index of 26 mitoses/10 HPFs. The tumor is T2a NO, with no evidence of vascular invasion or lymph node involvement. The lung margin of resection is negative for malignancy, and the pleura is also negative. All lymph nodes examined, including R4, right lymph node, level 10, and level 7, were negative for malignancy.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-5644.041e212a-2fdd-42af-9326-9fb5fef07126',\n",
       "  'report_length_cl100k_base': 706,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathology report describes a 3.2 cm invasive well-differentiated adenocarcinoma in the left upper lobe of the lung, with negative margins and no evidence of lymph node involvement or metastasis. The tumor is characterized by atypical glandular proliferation, cellular crowding, and focal pseudostratification. The report suggests further assessment for visceral pleural invasion with an elastic stain.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The pathology report describes a wedge biopsy of the left upper lobe of the lung, which reveals a 3.2 cm tumor. The microscopic description shows atypical glandular proliferation with irregular nuclei and prominent nucleoli. The diagnosis is a well-differentiated adenocarcinoma, and the margins are negative. The report suggests assessing for visceral pleural invasion with an elastic stain.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-44-5645.8904f1ec-527d-4f2e-a112-157d31ec9b3d',\n",
       "  'report_length_cl100k_base': 466,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, with a 2 cm tumor in the right upper lobe that invades pulmonary parenchyma and has venous and lymphatic invasion. The tumor does not extend to the pleura or main stem bronchi. The resection margins are negative for tumor, and there is no evidence of distant metastasis. Two lymph nodes from specimen A and four lymph nodes from specimen C are negative for metastatic tumor.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, with a 2 cm tumor in the right upper lobe that invades pulmonary parenchyma and has venous and lymphatic invasion. The tumor does not extend to the pleura or main stem bronchi. The resection margins are negative for tumor, and there is no evidence of distant metastasis. Two lymph nodes from specimen A and four lymph nodes from specimen C are negative for metastatic tumor. The patient's cancer is classified as pT1a N0 M0.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-6144.1dfaf7f2-8902-403c-b903-dc59c8156d17',\n",
       "  'report_length_cl100k_base': 947,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma of the right upper lobe of the lung, with a tumor size of 2 cm and no vascular invasion. The patient's lymph nodes at levels 12, 11, 10, 2R, 4R, and 8 are negative for malignancy. The patient's lymph nodes at level 7 are not examined. The patient's cancer has a pTNM stage of T1.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, with a tumor size of 2 cm and a tumor grade of 2-3 out of 3. The tumor is located in the right upper lobe of the lung, with no evidence of vascular invasion or attached lymph nodes. The patient's pTNM stage is T1. There is no evidence of malignancy in any of the examined lymph nodes, including levels 12, 11, 10, 7, and 8. No metastases are found.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-6145.57537882-084b-4082-bcf0-f7d297a877e6',\n",
       "  'report_length_cl100k_base': 856,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's pathological report indicates a mucinous adenocarcinoma in the left lower lobe of the lung, measuring 21 cm (pT3) with no evidence of metastasis in 10 lymph nodes (pNO). The surgical margins are uninvolved, and there is no distant metastasis (pMX). The tumor is well-differentiated, and the specimen demonstrates lepidic growth, suggestive of bronchoalveolar carcinoma.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathology report indicates a mucinous adenocarcinoma in the left lower lobe of the lung, measuring 21 cm in greatest dimension. The tumor does not involve the tissue surrounding the bronchial margin and margins of resection are uninvolved. There is no evidence of metastasis in 10 lymph nodes (levels 5, 9, 10, and 11). The cancer is well-differentiated, and the patient's staging is T3N0M0.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-6146.51a479ab-4c21-4189-a682-e6976d509ed3',\n",
       "  'report_length_cl100k_base': 1013,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's pathological report indicates a moderately to poorly differentiated adenocarcinoma in the right upper lobe, with a tumor size of 3.0 cm and no direct involvement of the bronchus or visceral pleura. There is no evidence of angiolymphatic invasion, and the margins of resection are negative. No regional lymph nodes are definitively identified. The other specimens, including the right middle lobe wedge, 2R fat pad, and 4R, do not show any malignancy. The right lower lobe wedge resection shows a calcified fibrotic nodule with no malignancy found.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, moderately to poorly differentiated, with a tumor size of 3.0 cm in the greatest dimension. There is no direct involvement of the visceral pleura or bronchus, and margins of resection are negative. No lymphatic or venous/arterial invasion is identified, and regional lymph nodes are not definitively identified. The pathological staging is pT1b.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-44-6147.06f76ecf-14db-4228-b413-f6b4e187a1e4',\n",
       "  'report_length_cl100k_base': 1117,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's pathological report indicates that the tumor size is 3 cm and is well-circumscribed, with no involvement of the pleura or large stem bronchus (pT1b). There is no evidence of lymphatic or vascular invasion, and the margins of resection are negative for tumor. No metastasis is found in the regional lymph nodes (pN0), and distant metastasis cannot be evaluated (pMx). The tumor is classified as adenocarcinoma, mucinous, and well-differentiated.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has an adenocarcinoma, mucinous, well-differentiated, 3 cm in greatest dimension (pT1b) in the left lower lobe of the lung. There is no involvement of the pleura or large stem bronchus, no direct extension of tumor, and no lymphatic or vascular invasion identified. The margins of resection, including bronchial and vascular margins, are negative for tumor. One lymph node from the left lower lobe, and additional lymph nodes from level 10, the left upper lobe, and subcarinal region are negative for metastatic tumor (pN0). There is no distant metastasis (pMx).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-6148.5407ff6d-a042-47db-998b-60e6f15109ab',\n",
       "  'report_length_cl100k_base': 1000,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma with a tumor size of 2 cm, no lymph node involvement, and no metastasis. The tumor is grade 2-3 out of 3, with a mitotic index of 24 mitoses/10 HPFs. The bronchial resection margin and pulmonary margin of resection are negative for malignancy, and there is no vascular invasion. The patient's cancer is classified as pTNM Stage T1 N2.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is classified as T1 N2, with no evidence of malignancy in levels 11, 9, and 8 lymph nodes, but metastatic carcinoma present in one of the level 7 lymph nodes. The tumor is a moderately to poorly differentiated adenocarcinoma, measuring 2 cm, with no vascular invasion and negative bronchial and pulmonary margins. The patient's lymph nodes at level 5 are also negative for malignancy.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-44-6774.f9587269-4f32-497a-a95a-42d505af2434',\n",
       "  'report_length_cl100k_base': 836,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma with a tumor size of 4 cm, no lymph node involvement, and negative margins for bronchial resection, pulmonary resection, and pleura. Vascular invasion is absent, and there is no evidence of metastasis. The patient's pTNM stage is T2a.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, with a tumor size of 4 cm and a tumor grade of 2. The bronchial resection margin and pulmonary margin of resection are negative for malignancy, as are the attached lymph nodes. There is no evidence of vascular invasion. The pTNM stage is T2a. The R4 lymph node biopsy and level 10 lymph node biopsy are negative for malignancy, as are the multiple pieces of lymph nodes from level 7.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-6775.cd641541-f607-49de-8f57-fa54b0561721',\n",
       "  'report_length_cl100k_base': 774,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathological report indicates a moderately differentiated adenocarcinoma in the right upper lobe of the lung, with a tumor size of 2 cm and no vessel invasion. The lymph nodes (right hilar, station 4R, and station 7) are negative for metastatic carcinoma (pN0). There is no evidence of distant metastasis (pMx). The patient's lymph nodes show focal changes consistent with involvement by CLL.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma with a prominent bronchioalveolar pattern, measuring 2 cm in greatest dimension and limited to the lung (pT1). The margins of resection are negative, and there is no vessel invasion. The regional lymph nodes (pN) show focal changes consistent with involvement by CLL, but are negative for metastatic carcinoma (pM0). There is no evidence of distant metastasis (pMx). The patient's lymph nodes from stations 4R and 7 are also negative for metastatic carcinoma.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-6776.b28e19bf-f05d-46a6-85b8-2319be9fcb22',\n",
       "  'report_length_cl100k_base': 912,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's pathological report indicates a poorly differentiated adenocarcinoma in the left upper lobe wedge resection. The tumor measures 3.5 cm and invades the pleura, categorizing it as pT2. There is no information on lymph node involvement (pNX) and no distant metastasis (pMX). Vascular invasion is present.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a poorly differentiated adenocarcinoma in the left upper lobe of the lung, with a tumor size of 3.5 cm and invasion into the pleura (pT2). There is no evidence of lymph node involvement (pNX) or distant metastasis (pMX). Vascular invasion is present. The tumor comes within 1.5 cm of the sacral margin. The margins of resection are negative. A small piece of tissue from the tumor and normal tissue has been submitted for the tumor bank.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-44-6777.600a1078-21f2-4267-9d3c-03f292fa6a32',\n",
       "  'report_length_cl100k_base': 469,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive moderate to poorly differentiated adenocarcinoma, with a tumor size of 2 x 1.5 x 1.3 cm. It does not involve the visceral pleural surface, and there is no direct extension of the tumor or large vessel invasion. The level 5, 7, and 10 mediastinal lymph nodes are negative for metastatic carcinoma. Distant metastasis cannot be assessed.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with invasive moderate to poorly differentiated adenocarcinoma. The primary tumor (T) measures 2 x 1.5 x 1.3 cm and does not involve the visceral pleural surface (pT1). The margins of resection are negative, and there is no direct extension of the tumor. There is no venous or arterial invasion, and the regional lymph nodes (level 5, 7, and 10) are negative for metastatic carcinoma (pNO). Distant metastasis cannot be assessed (pMX). The patient also has emphysematous bullae and a pleural-based fibrous scar with old hemorrhage.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-6778.b1f41c0e-a2a1-4945-85b3-a2ef6a994cbe',\n",
       "  'report_length_cl100k_base': 748,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's pathological report indicates a multicentric, moderate to poorly differentiated adenocarcinoma in the left lung. The tumor size is 6 x 5 x 4 cm and 3 x 2 x 1.5 cm for the smaller lesion (pT2). The bronchial and vascular margins of resection are free of tumor, and there is no direct extension of the tumor. Two of six bronchial lymph nodes contain metastatic adenocarcinoma (2/6) (pN). All mediastinal lymph nodes are negative (pN1), and there is no evidence of distant metastasis (pMX).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with multicentric, moderate to poorly differentiated adenocarcinoma. The tumor mass measures 6x5x4cm and there is a second smaller tumor mass present deep to the pleural surface of the lower lobe, measuring 3x2x1.5cm. The bronchial and vascular margins of resection are free of tumor, and there is no direct extension of tumor. Two of six peribronchial lymph nodes contain metastatic adenocarcinoma. All mediastinal lymph nodes are negative for malignancy. There is no evidence of large vessel invasion, but lymphatic (small vessel) invasion is negative. Distant metastasis cannot be assessed.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-44-6779.7f7b5635-2f0e-4f0e-b56a-5c19cfe0593c',\n",
       "  'report_length_cl100k_base': 1494,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive moderately differentiated adenocarcinoma in the left upper lobe of the lung, measuring 2.9 cm. The tumor is confined to the lung with negative margins and no direct extension. Lymphatic invasion is present, but there is no evidence of metastasis in the hilar or mediastinal lymph nodes (pNO). Distant metastasis status is unknown (pMx).',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has invasive moderately differentiated adenocarcinoma in the left upper lobe of the lung, measuring 2.9 cm. The tumor is confined to the lung (pT1b) with negative margins of resection. Lymphatic invasion is present, but there is no venous or arterial invasion. All hilar and mediastinal lymph nodes are negative for metastatic carcinoma (pNO). There is no evidence of distant metastasis (pMx). The tumor is staged as T1bN0M0.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-7659.ca4281d7-0cd7-4ebc-8050-9dd81fbbefbc',\n",
       "  'report_length_cl100k_base': 879,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's right upper lobe resection revealed a poorly differentiated, 3.5 cm adenocarcinoma with uninvolved surgical margins and no evidence of metastasis in 5 lymph nodes (pNO). An additional 3 lymph nodes and one level VII lymph node were also negative for metastasis (pNO and pNX, respectively). No venous or arterial invasion was identified, and distant metastasis was not evaluated in this specimen (pNX).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'Adenocarcinoma, poorly differentiated, 3.5 cm in greatest dimension, right upper lobe, surgical margins uninvolved, no evidence of metastasis in 9 lymph nodes (0/9), no venous or arterial invasion identified, regional lymph nodes negative (pNO), distant metastasis not evaluated (pNX).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-7660.8087d940-503c-4492-879f-042b3d037fd7',\n",
       "  'report_length_cl100k_base': 689,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has a poorly differentiated adenocarcinoma in the right lower lobe of the lung, measuring 3.5 cm with vascular invasion. The bronchial and vascular margins of resection are negative for tumor. Lymph nodes from levels II, VII, and R4 are negative for metastatic disease. There is no information on distant metastasis.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a poorly differentiated adenocarcinoma in the right lower lobe of their lung, measuring 3.5 cm in maximum dimension. The tumor has vascular invasion, but the bronchial and vascular margins of resection are negative for tumor. All lymph nodes excised, from levels II, VII, and R4, are negative for metastatic disease. There is no evidence of distant metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-7661.c21444e4-547b-4114-91c5-9852418e3e6b',\n",
       "  'report_length_cl100k_base': 808,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has a poorly differentiated adenocarcinoma in the left upper lobe of the lung, with a tumor size of 2.8 cm (pT2a). There is no evidence of lymph node involvement (pN0) and no distant metastasis (pMX). The tumor involves the lobar bronchus and there is no evidence of venous or arterial invasion. Five lymph nodes were evaluated and all were negative for malignancy. The patient also has focal pulmonary hemorrhage, marked background anthracosis, and emphysema.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a poorly differentiated adenocarcinoma in the left upper lobe of the lung, with a tumor size of 2.8 cm (pT2a). The bronchial and vascular resection margins are negative for malignancy, as well as the pleural surface. There is no evidence of lymphatic or large vessel invasion. Five lymph nodes were evaluated and found to be negative for tumor (pN0). No distant metastasis was evaluated (pMX). The tumor cells stain positive for cytokeratin 7 and TTF1, and negative for CK 5/6 and p63. The patient also has focal pulmonary hemorrhage, marked background anthracosis, and emphysema.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-7662.7b34e153-7bc5-4ba6-8445-bac63ca2dcc6',\n",
       "  'report_length_cl100k_base': 918,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, poorly differentiated, with a tumor size of 15 cm. There is no evidence of metastasis in the level 9, 11, 12, 7, or 4 lymph nodes. The margins of resection are negative, and there is no direct extension of the tumor or arterial invasion. Venous invasion is suspicious, and lymphatic invasion is also suspicious. The patient has no distant metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, poorly differentiated, with a 15 cm tumor in the right lower lobe of the lung. There is no evidence of metastasis in the level 9, 11, 12, 7, or 4 lymph nodes. The surgical margins are uninvolved, and there is no direct extension of the tumor. There is suspicion of large vessel invasion, but no distant metastasis can be evaluated from the specimen.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-7667.9722e13c-6ac6-415b-a84f-997d301cea49',\n",
       "  'report_length_cl100k_base': 1116,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's cancer is a poorly differentiated adenocarcinoma, with a 2.3 cm tumor in the right upper lobe of the lung, not involving the visceral pleural surface. There is large vessel and lymphatic vessel invasion present, and one out of two hilar lymph nodes contains metastatic carcinoma (pN1). All sampled mediastinal lymph nodes are negative for tumor. There is no evidence of distant metastasis (pMX).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathology report indicates a poorly differentiated adenocarcinoma in the right upper lobe of the lung, measuring 2.3 cm in size. The tumor does not involve the visceral pleural surface, but there is venous and lymphatic vessel invasion present. One of the two peribronchial lymph nodes is positive for metastatic carcinoma. The other lymph nodes, including levels 3, 4, and 7, are negative for malignancy. There are focal emphysematous changes and distal infarction in the lung tissue.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-44-7669.4b112ed4-a999-467d-aace-8bc2c13db1cb',\n",
       "  'report_length_cl100k_base': 1030,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's pathological report indicates a moderate to poorly differentiated adenocarcinoma in the left upper lobe of the lung, with a maximum tumor size of 2.5 cm (pT1b). There is no involvement of the visceral pleura, no direct extension of the tumor, and no large vessel invasion. One of seven peribronchial lymph nodes contains metastatic carcinoma (pN1), while all sampled mediastinal nodes are negative (pNX). There is no evidence of distant metastasis (pMX).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a moderate to poorly differentiated adenocarcinoma in the left upper lobe of their lung, measuring 2.5 cm. There is no involvement of the visceral pleura, no direct extension of the tumor, and no large vessel invasion. One of seven peribronchial lymph nodes contains metastatic carcinoma (pN1), while all sampled mediastinal nodes are negative (pNX). There is no evidence of distant metastasis (pMX). The tumor is confined to the lung without involvement of the visceral pleural surface, and the bronchial margin of resection is free of tumor.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-44-7670.b93c87ac-5344-408e-a0e1-763b998a55b7',\n",
       "  'report_length_cl100k_base': 982,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's pathology report indicates a moderately differentiated adenocarcinoma (mixed papillary and not otherwise specified) in the right middle lobe, with a tumor size of 3.2 cm (pT2a). There is no pleural invasion or direct extension of the tumor identified. The hilar lymph nodes and separately submitted lymph nodes in parts B, C, and D are negative for tumor involvement (pNO). No distant metastasis is found (pMX). The patient's lung tissue shows emphysematous changes, bleb formation, and subpleural fibrosis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with moderately differentiated adenocarcinoma (mixed papillary and not otherwise specified) in the right middle lobe of the lung, with a tumor size of 3.2 cm. There is no pleural invasion or vascular invasion identified. The regional lymph nodes are negative for tumor, and there is no evidence of distant metastasis. The patient also has emphysematous changes with bleb formation in the upper lobe, as well as bronchiolar metaplasia and subpleural fibrosis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-7671.bececab6-d442-4261-ab28-f4742e3828ce',\n",
       "  'report_length_cl100k_base': 927,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathology report indicates a pT1b (2.5 cm) adenocarcinoma in the left upper lobe with negative margins, no direct vessel invasion, and no lymphatic invasion identified. Five regional lymph nodes were examined, all of which were negative for cancer. The patient's tumor is classified as stage T1bN0M0.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a 2.5 cm adenocarcinoma in the left upper lobe of the lung, with negative margins of excision and no direct involvement of the visceral pleura. There is no evidence of angiolymphatic invasion. Five lymph nodes were examined, with no evidence of metastasis. The patient also had a 9L fat pad biopsy with one negative lymph node and no malignancy identified.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-7672.65857640-a645-4830-897c-3deafb4ac36f',\n",
       "  'report_length_cl100k_base': 879,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's right upper lobe lung tumor is poorly differentiated adenocarcinoma, with a tumor size of 5 x 3.5 x 3.2 cm. There is no vascular invasion, and the bronchial resection margin is negative for malignancy. One lymph node from level VII and one from level X were negative for malignancy. The patient's TNM stage is T2a. TTF-1 is positive, and CK5/6 and p63 are negative.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with poorly differentiated adenocarcinoma in the right upper lobe of the lung, with a tumor size of 5 x 3.5 x 3.2 cm. The bronchial resection margin is negative for malignancy, and there is no vascular invasion. One lymph node from level VII and one from level X were negative for malignancy. The patient's pTNM stage is T2a. The tumor is TTF-1 positive and CK5/6 negative.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-8117.af49cbe4-eb8a-46df-bd70-4023acee6ae1',\n",
       "  'report_length_cl100k_base': 693,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has a poorly differentiated adenocarcinoma that has extended from the lung through the chest wall into the soft tissue adjacent to ribs (pT3). The radial, vascular, and bronchial margins of resection are free of tumor. All hilar and mediastinal lymph nodes are negative for metastatic carcinoma (pNO). There is no evidence of distant metastasis (pMx). The tumor has invaded large vessels (venous) but not arterial vessels or lymphatic vessels (small) (pNX).',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': '\\nThe patient has a poorly differentiated adenocarcinoma that has extended from the lung through the chest wall into the soft tissue adjacent to ribs (pT3). The radial, vascular, and bronchial margins of resection are free of tumor. All hilar and mediastinal lymph nodes are negative for metastatic carcinoma (pNO). There is no evidence of distant metastasis (pMx). The tumor has extended into the intercostal muscles and is within 0.1 cm of the inked pleural surface. The specimen contains non-necrotizing granulomatous lymphadenitis, and special stains for acid-fast and fungal organisms are negative. The histologic type is adenocarcinoma, and the histologic grade is poorly differentiated.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-8119.c40ea4c8-8cbe-4a44-96d4-ae524a916449',\n",
       "  'report_length_cl100k_base': 1535,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive moderately differentiated adenocarcinoma. The tumor measures 2.6 cm in diameter and has extended into the visceral pleural surface (pT2a). Bronchial and vascular margins of resection are negative for tumor. There is no direct extension of tumor or large vessel invasion. All sampled mediastinal lymph nodes are negative for metastatic carcinoma (pN0). There is no evidence of distant metastasis (pMx).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an invasive moderately differentiated adenocarcinoma. The tumor measures 2.6 cm in diameter and has extended into the visceral pleural surface (pT2a). The bronchial and vascular margins of resection are free of tumor. There is no direct extension of tumor, and there is no venous or arterial invasion. All sampled mediastinal lymph nodes are negative for metastatic carcinoma (pN0). There is no distant metastasis (pMx).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-8120.6996d5eb-bdfd-4b9b-9517-40c28e439834',\n",
       "  'report_length_cl100k_base': 776,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's right upper lobe resection revealed a poorly differentiated, 3.9 cm adenocarcinoma with negative surgical margins, no direct extension, and no lymphatic or vascular invasion. There was no evidence of metastatic disease in the resected lymph nodes (pNO). Distant metastasis cannot be evaluated by this specimen (pMX). The lower lobe resection, level 10 and R4 lymph nodes, and level 7 lymph nodes all showed no evidence of malignancy.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated adenocarcinoma in the right upper lobe of the lung, with a tumor size of 3.9cm (pT2). The surgical margins are uninvolved, and there is no evidence of lymphatic invasion (pN0). No distant metastasis can be evaluated from this specimen (pMX). The level 10 and R4 lymph nodes are negative for metastasis (0/4 and 0/2 respectively), as well as the level 7 lymph nodes (0/4). The lower lobe portion of the lung shows no evidence of malignancy.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-A479.FFCFD93C-1D69-4DF8-9E1B-E2A4EEA66613',\n",
       "  'report_length_cl100k_base': 950,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has a moderately differentiated adenocarcinoma in the right upper lobe of the lung, with a tumor size of 3.7 cm. There is no evidence of malignancy in any of the biopsied lymph nodes (R4, level X, and level VII). The tumor has not spread to the pleura, and there is no vascular invasion. The patient's pTNM stage is T2a NO. The tumor is positive for TTF-1 and weakly positive for p63, with negative CK5/6 staining. The bronchial and pulmonary margins of resection are negative for malignancy.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with moderately differentiated adenocarcinoma of the right upper lobe of the lung, with a tumor size of 3.7 cm. The bronchial resection margin and pulmonary margin of resection are negative for malignancy, and there is no evidence of vascular invasion. Two lymph nodes were removed and found to be negative for malignancy. The patient's TNM stage is T2a NO. The tumor is positive for TTF-1 and weakly positive for p63, with no evidence of lymph node involvement.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-A47A.3F92B4C0-ED5F-486D-A751-730136B1D9A8',\n",
       "  'report_length_cl100k_base': 665,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient has been diagnosed with moderately differentiated adenocarcinoma of the right upper lobe of the lung, with a tumor size of 3.3 cm without definite pleural invasion (pT2a). The bronchial and vascular resection margins are negative for tumor, and hilar lymph nodes are negative for tumor (pNO). There is no evidence of distant metastasis (pM). The patient's cancer is classified as stage IA.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with moderately differentiated adenocarcinoma of the right upper lobe of the lung, with a tumor size of 3.3 cm. The tumor does not show definite pleural invasion and the bronchial and vascular resection margins are negative for tumor. The hilar lymph nodes are negative for tumor, and there is no evidence of lymphatic invasion. There is no evidence of distant metastasis. The patient's cancer is classified as pT2a, pNO, and pM0.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-A47B.A835F045-77B3-4EBD-8883-D24E244535FC',\n",
       "  'report_length_cl100k_base': 922,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive moderately differentiated adenocarcinoma in the left upper lobe of the lung, measuring 5.5 cm. Two of 8 hilar lymph nodes are positive for metastatic carcinoma (2/8), and there is minimal extension into the pleura. Vessel invasion is present in a large vessel. No distant metastasis is found (pMX).',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has invasive moderately differentiated adenocarcinoma in the left upper lobe of the lung, measuring 5.5 cm in dimension. Two of 8 hilar lymph nodes are positive for metastatic carcinoma (2/8), and there is minimal extension into the pleura. Vessel invasion is present in a large vessel. No distant metastasis is found (pMX).',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-44-A47F.FC0E596B-733C-4532-AF0D-94B4A4ECB90C',\n",
       "  'report_length_cl100k_base': 916,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient has moderately differentiated adenocarcinoma in the right upper lobe of the lung, with a tumor size of 1 cm. There is no evidence of vascular invasion or lymph node involvement. The bronchial and pulmonary margins of resection are negative for malignancy. Three lymph nodes from levels XI, VII, and X were biopsied and found to be negative for malignancy. The patient's cancer is classified as T1 (based on the size of the tumor). The non-tumorous lung tissue shows emphysema and subpleural elastosis. No metastasis is detected.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has moderately differentiated adenocarcinoma in the right upper lobe of the lung, with a tumor size of 1 cm. The bronchial and pulmonary margins of resection are negative for malignancy, as well as the pleura. There is no vascular invasion and no evidence of malignancy in the lymph nodes. The patient's pTNM stage is T1. The report also mentions emphysema and subpleural elastosis in the non-tumorous lung tissue.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-A47G.103CEC27-11AE-4E7F-88F4-530A94CB5278',\n",
       "  'report_length_cl100k_base': 915,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's left upper lobe lung tumor is moderately differentiated adenocarcinoma, measuring 2.5 cm with focal vascular invasion. There is no evidence of malignancy in the resected lymph nodes (4L, VII, IX, XI, and XII), while the level V lymph nodes are negative for malignancy in all 10 hilar lymph nodes. The patient's TNM stage is T1.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with moderately differentiated adenocarcinoma of the left upper lobe of the lung, with a tumor size of 2.5 cm. There is focal histologic evidence of vascular invasion. The patient's lymph nodes at levels IV, VII, IX, XI, and XII are negative for malignancy. The patient's lymph nodes at level V are negative for malignancy, with 7 lymph node pieces examined. The patient's lymph nodes at level VII are negative for malignancy, with 3 lymph nodes examined. The patient's lymph nodes at level XI are negative for malignancy, with 1 lymph node examined. The patient's lymph nodes at level XII are negative for malignancy, with 1 lymph node examined. The patient's bronchial resection margin is negative for malignancy. The patient's pleura is negative for malignancy. The patient's pTNM stage is T1. The patient has a history of tobacco and alcohol abuse.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-A4SS.12F30C5F-91F0-4ECD-A073-74CDEA147097',\n",
       "  'report_length_cl100k_base': 783,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient has been diagnosed with moderately differentiated adenocarcinoma in the right lower lobe of the lung, with a tumor size of 1.8 cm. The tumor has some lepidic growth and is present in adjacent alveoli. There is focal suspicion of vascular invasion. The resection margin is negative for malignancy, but the reexcision of the staple line is positive for carcinoma. No lymph node involvement or metastasis is reported. The patient's pTNM stage is T1a.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with moderately differentiated adenocarcinoma in the right lower lobe of the lung, with a tumor size of 1.8 cm and some tumor cell clusters in adjacent alveoli. The tumor is classified as pTNM stage Tla. The report mentions focal features suspicious for vascular invasion. The reexcision of the staple line is negative for malignancy, and the pleura is negative for malignancy as well.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-44-A4SU.14019D02-C4EC-4EA7-8AEB-255A14EB8D07',\n",
       "  'report_length_cl100k_base': 386,\n",
       "  't_label': 0},\n",
       " {'abstract': ' The patient has a right lower lung adenocarcinoma with bronchioloalveolar and papillary features, along with panacinar emphysematous changes and a single remote granuloma in the hilar lymph node. The tumor is negative for fungi and acid fast bacilli. Three pulmonary lymph nodes and bronchial and vascular margins are free of tumor, indicating no lymph node involvement or metastasis.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with adenocarcinoma of the lung with bronchioloalveolar and papillary features, along with panacinar emphysematous changes and a single remote granuloma in the hilar lymph node. The tumor is absent in three pulmonary lymph nodes and bronchial and vascular margins. Special stains for fungi and acid-fast bacilli were negative.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-49-4486.30b3b92c-c810-4cf8-8342-f6e9d87bacfe',\n",
       "  'report_length_cl100k_base': 140,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a moderately differentiated adenocarcinoma in their lung, with tumor size and exact location unspecified. The surgical margins are free of tumor, with focal vascular invasion present. Three bronchopulmonary nodes from the specimen are negative for cancer. The rib and inominate lymph node biopsies are negative for tumor, indicating no evidence of metastasis in these areas.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a moderately differentiated adenocarcinoma in their lung, with focal vascular invasion. The surgical margins are free of tumor, and three bronchopulmonary nodes from the specimen are negative. The rib and inominate lymph node are also negative for tumor.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-49-4487.c67031fc-f601-4bd2-b8fd-429a0664cc65',\n",
       "  'report_length_cl100k_base': 181,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a 3 cm moderately well-differentiated adenocarcinoma of the lung with focal bronchioloalveolar features, not involving the pleura. The resection margins are negative for tumor, and three excised lymph nodes from levels 5, 7, and 9 are negative for metastasis.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a moderately well-differentiated adenocarcinoma of the lung, measuring 3 cm, with focal bronchioloalveolar features, but does not involve the pleura. All margins of resection are negative for tumor. Three lymph nodes from levels 5, 7, and 9, were negative for metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-49-4488.1aae91ef-85c6-49f4-a76a-3f09d5cabcb5',\n",
       "  'report_length_cl100k_base': 202,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's pathological report indicates a moderate to poorly differentiated adenocarcinoma in the left upper lobe lung, with extensive lymphatic invasion and metastatic carcinoma found in one lymph node in the anterior mediastinum and another in the aortic arch. The bronchial and vascular margins of the resection were negative for tumor.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has moderate to poorly differentiated adenocarcinoma in the left upper lobe lung with extensive lymphatic invasion. The tumor extends into the perinodal soft tissue and has metastasized to one lymph node in the anterior mediastinum and one lymph node in the aortic arch. The bronchial and vascular margins of resection are negative for tumor.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-49-4490.d6ec6f67-0c16-4396-be41-aaa6868a6106',\n",
       "  'report_length_cl100k_base': 194,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has a 2.5 cm moderately-differentiated mucinous adenocarcinoma of the lung in the left upper lobe, with tumor extending to the pleura. Two out of four regional lymph nodes are positive for metastatic carcinoma, and there is one positive lymph node in the AP window resection. The bronchial and vascular margins are negative for tumor, but the uninvolved lung shows hemorrhage, extensive remodeling, subpleural scarring, and acute and chronic inflammation.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a moderately-differentiated mucinous adenocarcinoma of the lung (2.5 cm) with foci of necrosis that extends to the pleura. Two out of four regional lymph nodes are positive for metastatic carcinoma. The uninvolved lung shows hemorrhage, extensive remodeling, subpleural scarring, and acute and chronic inflammation. One lymph node in the AP window is also positive for metastatic adenocarcinoma.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-49-4494.178a8648-f3cd-46ae-b90a-a45d6715c889',\n",
       "  'report_length_cl100k_base': 230,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has a moderately differentiated adenocarcinoma with bronchioloalveolar features in the upper lobe of the lung, measuring 2.8 cm. The tumor extends into the pleura, but the bronchial and vascular lung margins are negative for tumor. Five hilar lymph nodes are negative for tumor, and there is no evidence of metastasis. The pathological stage is pT2pNOpMX or Stage I.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with a moderately differentiated adenocarcinoma with bronchioloalveolar features in the upper lobe of the lung. The tumor extends into the pleura, but the bronchial and vascular lung margins are negative for tumor. Five hilar lymph nodes are negative for tumor, and there is no evidence of metastasis. The pathologic stage is pT2pNOpMX or Stage I.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-49-4501.da1bf563-9ad3-49cf-a68a-44af8ed41684',\n",
       "  'report_length_cl100k_base': 179,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has two separate adenocarcinomas, one in the right lower lobe measuring 5.5 cm with visceral pleural invasion and metastasis in one of six lymph nodes, and another in the right upper lobe measuring 1.5 cm with no lymph node involvement. The bronchial and ascular margins are negative for tumor. Additionally, there is a cavitary fibrotic cyst in the right upper lobe consistent with Aspergillus.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has an infiltrating well-differentiated adenocarcinoma in the right lower lobe of the lung, measuring 5.5 cm in the largest dimension and extending through the visceral pleura. It is metastatic, with cancer found in one of six lymph nodes. The bronchial and ascular margins are negative for tumor. Additionally, there is an infiltrating well-differentiated adenocarcinoma in the right upper lobe of the lung, measuring 1.5 cm, and no cancer is found in the bronchial margin. The right upper lobe wedge resection also shows a cavitary fibrotic cyst with branching hyphal fungal forms consistent with Aspergillus.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-49-4505.1733d182-08f0-4426-9227-9f008893ac14',\n",
       "  'report_length_cl100k_base': 285,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The pathology report indicates that the lymph nodes at stations 5, 7, and L11 were excised and found to be negative for tumor. The rib excision sample was unremarkable, and the periaortic tissue excision also showed no evidence of tumor. There is no mention of the primary tumor size or metastasis status in the provided report.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The pathology report describes various tissue samples, including lymph nodes and rib, that were excised and found to be negative for tumor. Specifically, the lymph nodes at stations 5, 7, and L11 were removed and showed no evidence of cancer. The periaortic tissue and associated broadipose tissue were also negative for tumor.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-49-4506.09fb40cf-afb5-4dd5-a1b6-6261ef27b65e',\n",
       "  'report_length_cl100k_base': 210,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 4.0 cm differentiated adenocarcinoma in the right lung bronchus, with negative margins for tumor. The cancer has spread to three of nine hilar lymph nodes, and there is pleural scarring. Two lymph nodes from R4 and one lymph node from R9 were removed and found to be negative for tumor.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a 4.0 cm differentiated adenocarcinoma in the right lung bronchus, with negative margins for tumor in the resected specimen. The cancer has extended to three of nine hilar lymph nodes, and there is no evidence of metastasis. The patient also has pleural scarring.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-49-4507.e37717f8-8175-4f30-a817-ae365097804a',\n",
       "  'report_length_cl100k_base': 205,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's pathology report indicates a 5 cm infiltrating moderately differentiated adenocarcinoma in the left upper lobe of the lung, with features of papillary adenocarcinoma and a peripheral bronchioloalveolar component. The tumor abuts but does not involve the pleura, and all margins, including bronchial and vascular margins, are negative for tumor. Focal vascular invasion is present, and there is metastatic carcinoma in one lymph node. Two excised lymph nodes from stations 4 and 7 are negative for tumor.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a 5 cm infiltrating moderately differentiated adenocarcinoma in the left upper lobe of the lung, with features of apillary adenocarcinoma. The tumor abuts but does not involve the pleura, and all margins including bronchial and vascular margins are negative for tumor. Focal vascular invasion is present, and there is metastatic carcinoma in one lymph node. The surrounding lung tissue shows typical pneumocyte hyperplasia.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-49-4510.de27239d-52ae-4979-979f-51e1ce7a43e8',\n",
       "  'report_length_cl100k_base': 281,\n",
       "  't_label': 1},\n",
       " {'abstract': \" The patient's pathology report indicates that a lobectomy was performed on the right middle lobe, and the tumor is an adenocarcinoma measuring 2.0 cm in the greatest dimension. No information on lymph node involvement or metastasis is provided in the given text.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with adenocarcinoma of the right middle lobe of the lung, with a tumor size of 2.0 cm. No information is provided on lymph node involvement or metastasis status.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-49-4512.dddbac81-a9e3-42a8-ab35-6d506c58413a',\n",
       "  'report_length_cl100k_base': 69,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The pathology report indicates that the patient's cancer is stage 1, with a tumor size of 2.5 cm and no lymph node involvement. There is no evidence of metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The pathology report indicates that the patient's cancer is stage 1, with a tumor size of 1.5 cm and no lymph node involvement. There is no evidence of metastasis.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-49-4514.1d1c3125-05a9-4939-a296-f98d8f977ab7',\n",
       "  'report_length_cl100k_base': 158,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma with mucinous features, sized 5 cm, located in the left upper lobe lung. It is classified as pT2 (tumor invades visceral pleura) and pN1 (metastasis in ipsilateral peribronchial, hilar, or intrapulmonary nodes). The cancer has no venous/arterial (large vessel) invasion, but does have lymphatic (small vessel) invasion. The patient's lymph nodes are negative for tumor except for one out of 11 tested, and the margins are uninvolved by invasive carcinoma. EGFR and KRAS mutation analyses returned negative results.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma with mucinous features, size 5 cm, located in the left upper lobe lung. It is classified as pT2 (tumor invades visceral pleura) and pN1 (metastasis in ipsilateral peribronchial, hilar, or intrapulmonary nodes). The cancer is negative for EGFR and KRAS mutations. The lymph nodes at stations 1, 5, 6, and 7 are negative for tumor, while the lymph node at station L10 has metastatic carcinoma. The margins are uninvolved, and there is no venous/arterial (large vessel) invasion, but lymphatic (small vessel) invasion is present. The patient's cancer is staged as T2, N1, M0.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-49-6742.d9853b55-fd00-4a20-8181-5f4dad297724',\n",
       "  'report_length_cl100k_base': 719,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, solid type with clear cell change, located in the right upper lobe of the lung, with a tumor size of 7.5 cm. There is no lymph node involvement, and the metastasis status is unknown (pMX). The tumor extends subpleurally but does not involve the pleural surface. The margins are uninvolved by invasive carcinoma, and there is no venous/arterial (large vessel) invasion or lymphatic (small vessel) invasion. The patient's cancer is classified as pT3 (tumor >7 cm or invades chest wall, diaphragm, mediastinal pleura, or parietal pericardium, or involves main bronchus <2 cm from carina or associated with total atelectasis or separate tumor nodule in the same lobe) and pNO (no regional lymph node metastasis) according to the 7th Edition AJCC staging system.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, solid type with clear cell change, located in the right upper lobe of the lung. The tumor size is 7.5 cm, and it is classified as T3 (tumor >7 cm or invades chest wall, diaphragm, mediastinal pleura, or parietal pericardium, or involves main bronchus <2 cm from carina or associated with total atelectasis or separate tumor nodule in the same lobe). There is no lymph node involvement (pNO), and distant metastasis is not assessed (pMX). The margins are uninvolved by invasive carcinoma, and there is no venous/arterial (large vessel) invasion or lymphatic (small vessel) invasion. The patient's cancer is negative for EGFR and KRAS mutations.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-49-6743.bc777cb6-8409-4a25-a22a-a398c28ef065',\n",
       "  'report_length_cl100k_base': 896,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, mixed acinar (dominant component) & bronchioloalveolar types, with a tumor size of 3.5cm. It is classified as pT2a (tumor more than 3 cm but 5 cm or less) with no direct extension of tumor. The cancer is pN1 (metastasis in ipsilateral peribronchial lymph nodes) with metastatic carcinoma found in 3 out of 18 lymph nodes. There is no venous/arterial (large vessel) invasion, and lymphatic (small vessel) invasion is indeterminate. The patient's cancer is KRAS mutation positive.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient's cancer is an adenocarcinoma, mixed acinar (dominant component) & bronchioloalveolar types, with a tumor size of 3.5cm. It is classified as pT2a (tumor more than 3 cm but 5 cm or less) and pN1 (metastasis in ipsilateral peribronchial lymph nodes) based on the extent of invasion. The cancer has metastasized to 3 out of 18 lymph nodes. There is no direct extension of the tumor, and the margins are uninvolved by invasive carcinoma. The patient's KRAS mutation analysis result is positive.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-49-6744.9a6d2cc6-3d78-42ec-b747-74bb6e96d22b',\n",
       "  'report_length_cl100k_base': 674,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma with a focal papillary component, size 4.0 cm, located in the left upper lobe of the lung. It is classified as T2a (tumor more than 3 cm but 5 cm or less) and N2 (metastasis in ipsilateral subcarinal lymph nodes) according to the 7th Edition AJCC staging. The cancer has no venous/arterial invasion and indeterminate lymphatic invasion. The patient's lymph nodes L11, station 5, and station 7 are involved, with metastatic carcinoma found in 6 out of 11 lymph nodes. The cancer is negative for EGFR and KRAS mutations.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with adenocarcinoma of the left upper lobe of the lung, with a tumor size of 4cm and poorly differentiated histologic grade. The cancer has spread to 6 out of 11 lymph nodes, including the subcarinal lymph nodes (pN2), but the margins are uninvolved by invasive carcinoma. There is no venous or arterial invasion, but lymphatic invasion is indeterminate. The patient's cancer has not metastasized to other organs. Molecular analysis for EGFR and KRAS mutations was negative.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-49-6745.e291ad97-8658-435d-ae71-f0eb80bbb816',\n",
       "  'report_length_cl100k_base': 734,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has a poorly differentiated adenocarcinoma tumor, approximately 1.7 cm in size, with metastasis to multiple lymph nodes (N2) and no evidence of pleural invasion. The cancer has not metastasized to distant sites (M0), resulting in a stage of T1N2MX (stage IIA).',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with stage T1N2MX lung cancer. The tumor size is 1.7 cm and there is lymph node involvement with metastasis. The cancer has spread to the lymph nodes, with some showing metastatic poorly differentiated carcinoma. The bronchial and vascular margins are uninvolved, and there is no evidence of pleural invasion. The patient has a history of breast carcinoma, which has been confirmed through immunohistochemical staining.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-49-6761.73669cba-81ee-4215-a938-32556c5a211a',\n",
       "  'report_length_cl100k_base': 1719,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma located in the right middle lobe of the lung, with a tumor size of 4.5 cm. There is no pleural invasion or lymphovascular invasion identified. The cancer has not spread to any of the 8 lymph nodes examined. The tumor is unifocal and poorly differentiated, with no direct tumor extension into surrounding tissues. The cancer has not metastasized to other parts of the body. The patient's cancer is classified as stage pT3 based on the pericardial involvement, which is believed to be a direct extension of the original tumor.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'Unifocal adenocarcinoma in the right middle lobe, tumor dimension is 4.5 cm, poorly differentiated, no pleural invasion, no lymphovascular invasion, no lymph node metastasis, 8 lymph nodes examined, AJCC pT3 (based on pericardial involvement), bronchial and vascular margins uninvolved, direct tumor extension into the pericardium.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-49-6767.8e8171dc-1baa-4b81-8e05-e15714135c1f',\n",
       "  'report_length_cl100k_base': 1938,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma, with a tumor size of 2.3 cm, located in the left lower lobe of the lung. It is classified as T1b (tumor >2 cm but ≤3 cm) and N1 (metastasis in ipsilateral peribronchial, hilar, or intrapulmonary nodes, including those involved by direct extension). The cancer is poorly differentiated (grade G3) and has no evidence of venous/arterial (large vessel) invasion or lymphatic (small vessel) invasion. The patient's cancer has no distant metastases (pMx) and negative margins.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient's cancer is stage T1b (tumor >2 cm but 3 cm or less), with no distant metastasis (pMx: cannot be assessed), and one positive lymph node (pN1: metastasis in ipsilateral peribronchial, hilar, or intrapulmonary nodes, including those involved by direct extension). The tumor is a poorly differentiated adenocarcinoma, measuring 2.3 cm, with no venous/arterial invasion and indeterminate lymphatic invasion. The patient's EGFR mutation analysis showed an exon 19 deletion, which is associated with responsiveness to EGFR tyrosine kinase inhibitor therapies in patients with non-small cell lung cancer.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-49-AAQV.4FE4DC74-AF70-4F6C-B290-561808DD7FAE',\n",
       "  'report_length_cl100k_base': 2199,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a moderately differentiated adenocarcinoma in the right upper lobe of the lung, with a tumor size of 1.7 cm. The tumor does not invade the pleura, bronchial margins, or vasculature. Two hilar lymph nodes and two pleural plaques are negative for tumor. There is no evidence of metastasis. The pathologic stage is T1NoMx.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with stage T1NoMx lung cancer. The tumor is a moderately differentiated adenocarcinoma, measuring 1.7 cm and is not invasive. Two hilar lymph nodes were found negative for tumor, and there is no evidence of metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-49-AAR0.FCCE5D5B-6AB6-441F-9FBF-65B23060C95B',\n",
       "  'report_length_cl100k_base': 1210,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma with a tumor size of 3.0 cm, poorly differentiated, with venous and lymphatic invasion present. There is metastasis in 1 of 13 lymph nodes (ipsilateral peribronchial, hilar, or intrapulmonary nodes). The margins are uninvolved by invasive carcinoma, and distant metastasis cannot be assessed.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient is diagnosed with adenocarcinoma of the right upper lobe of the lung, with a tumor size of 3.0 cm. The cancer has spread to one of the 13 lymph nodes (pN1) but not to distant metastasis (pMx). Venous invasion is present, and the margins are uninvolved by invasive carcinoma. The tumor is poorly differentiated (G3) with lymphatic (small vessel) invasion. Four lymph nodes were negative for tumor (R-4), three lymph nodes were negative for tumor (Station 7), one lymph node was negative for tumor (Lower R-4), and one lymph node was positive for metastatic carcinoma (R-10).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-49-AAR3.75D3436D-1CF9-4DC9-97EE-B93E2D6A3049',\n",
       "  'report_length_cl100k_base': 1949,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma with a tumor size of 3.0 cm, located in the left upper lobe. There is direct extension of the tumor to the visceral pleura. The cancer has spread to 2 out of 17 lymph nodes (pN2) but no distant metastasis (pMX). The margins are uninvolved by invasive carcinoma, and there is no venous or arterial (large vessel) invasion. The lymphatic (small vessel) invasion is indeterminate.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient's cancer is an adenocarcinoma, with a tumor size of 3cm, located in the left upper lobe. There is no evidence of direct extension of the tumor, but it does involve the visceral pleura. The cancer is classified as pT2 and pN2, with metastases found in 2 of 17 lymph nodes. There is no indication of distant metastasis, and the margins are uninvolved by invasive carcinoma. The lymph nodes at stations 9, 10, and 12 have evidence of metastatic adenocarcinoma. The patient's cancer is considered moderately differentiated (G2) and respiratory bronchiolitis is noted as an additional finding.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-49-AAR4.8982CE18-FA5A-4882-AAC4-F2AC6ED60C49',\n",
       "  'report_length_cl100k_base': 2399,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has an infiltrating poorly differentiated adenocarcinoma of the lung, measuring 7.5 cm, invading through the pleura and into bone and soft tissues of the chest wall. The tumor extends to within 1 mm of the fascial resection plane, and the bronchial margin is negative for tumor. Five peribronchial lymph nodes are negative for metastatic carcinoma, and these lymph nodes demonstrate scattered hyalinized granulomas. The pathologic stage is T3 N0 MX.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has an infiltrating poorly differentiated adenocarcinoma of the right lung, measuring 7.5 cm and invading through the pleura and into bone and soft tissues of the chest wall. The tumor extends to within 1 mm of the fascial resection plane, but the bronchial margin is negative for tumor. Five peribronchial lymph nodes are negative for metastatic carcinoma, and these lymph nodes demonstrate scattered hyalinized granulomas. The pathologic stage is T3 N0 MX. Additional benign lymph nodes with scattered hyalinized granulomas are found in soft tissue R4, R10, and station 7.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-49-AAR9.F2AB65ED-823F-446C-92CB-5F9DAB58D37A',\n",
       "  'report_length_cl100k_base': 1273,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's cancer is classified as stage pT1 NO MX with a 2 cm poorly differentiated adenocarcinoma in the right upper lobe of the lung. There is no evidence of lymph node involvement, and margins, including pleural, bronchial, vascular, and surgical resection margins, are negative for tumor. The patient's cancer has not metastasized.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient has stage pT1 NO MX adenocarcinoma of the right upper lobe of the lung, with a 2 cm tumor size and no lymph node involvement. The tumor has extensive necrosis and the surrounding lung parenchyma shows mild emphysematous changes. The pleural, bronchial, vascular, and all surgical resection margins are negative for tumor. Three lymph nodes from stations R-10, 7, and R-4 were excised and found to be negative for tumor. Pleural nodes were also excised and found to be negative for tumor.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-49-AARE.D15D2040-F72D-4913-92FC-54741F573151',\n",
       "  'report_length_cl100k_base': 1217,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's right lower lobe lung tumor measures 2.2 cm and is moderately differentiated adenocarcinoma. There is no pleural or vascular invasion, and all surgical margins are tumor-free. The pathological stage is T1 NOMX. Two lymph nodes from level 7 and one lymph node from 4R are negative for tumor. Immunohistochemical studies confirm the primary lung origin of the tumor, and it is negative for estrogen receptor, progesterone receptor, and gross cystic disease fluid protein.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is classified as T1NOMX with a moderately differentiated adenocarcinoma of the right lower lobe of the lung, measuring 2.2 cm. There is no invasion into the pleura, and no vascular invasion is identified. The surgical margins are negative for tumor. Two lymph nodes from level 7 and one lymph node from 4R are negative for tumor. The tumor is immunoreactive for TTF-1 and negative for estrogen receptor, progesterone receptor, and gross cystic disease fluid protein.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-49-AARN.19256999-CAE3-4D04-AA1C-758B4E80BCD1',\n",
       "  'report_length_cl100k_base': 962,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's left upper lobe lung tumor is an infiltrating poorly differentiated adenocarcinoma, measuring 2.5 cm with papillary features. The tumor is adjacent to, but does not invade through the visceral pleura. The pathologic stage is T1 NOMX. Six lymph nodes from station 5 and one lymph node from station 7 are negative for tumor.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient has a T1NOMX poorly differentiated adenocarcinoma of the lung with papillary features, measuring 2.5 cm. The tumor is adjacent to, but does not invade through the visceral pleura. All surgical margins (bronchial, vascular and stapled parenchymal margin) are negative for tumor. Six lymph nodes from station 5 and one lymph node from station 7 are negative for tumor. The tumor involves large branches of the right upper lobe bronchus and blood vessels. The patient's clinical history is left lung mass.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-49-AARO.5E71C822-2014-431A-B050-102C4A845321',\n",
       "  'report_length_cl100k_base': 1019,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is classified as stage pT2NOMx, with a moderately differentiated adenocarcinoma tumor measuring 3.2 cm and 1.0 cm, located in the right upper lobe of the lung. There is no evidence of tumor extension to the pleural surface, bronchial margins, or vascular margins. Six hilar lymph nodes were negative for tumor, and no metastases were found. The report also mentions acute and organizing bronchopneumonia in the area surrounding the tumor and focal emphysematous changes with peripheral bulla formation.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a moderately differentiated adenocarcinoma in the right upper lobe of the lung, with two non-contiguous foci measuring 3.2cm and 1cm. The tumor does not extend to the pleural surface, bronchial margins, vascular margins, or parenchymal margins. Six hilar lymph nodes were negative for tumor. The pathologic stage is pT2NOMx, stage I. There is also acute organizing bronchopneumonia in the area surrounding the tumor. Two additional lymph nodes from stations R-4 and 7 were negative for tumor.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-49-AARQ.9A745E52-5B6D-4209-9A05-E30D8CE40A3E',\n",
       "  'report_length_cl100k_base': 1334,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's left lung upper lobe tumor measures 3 cm and is an infiltrating moderately differentiated adenocarcinoma. The tumor extends within 1 mm of the inked pleural margin, but the margin is microscopically negative. Eight hilar lymph nodes are negative for tumor, and there is no evidence of metastasis. The pathologic stage is T1NOMX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient has a moderately differentiated adenocarcinoma in the left upper lobe of the lung, measuring 3 cm. The tumor extends within 1 mm of the inked pleural margin, but the margin is microscopically negative. The bronchial, vascular, and parenchymal margins of resection are also negative for tumor. Eight hilar lymph nodes were removed and found to be negative for tumor. The pathologic stage is T1NOMX. One lymph node from station 5 was also removed and found to be negative for tumor. The patient's lung tissue shows evidence of centriacinar emphysema and dust macules.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-49-AARR.55998E02-5285-4E6F-8BB8-7DB57F18C0D2',\n",
       "  'report_length_cl100k_base': 849,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient is a female with right lung adenocarcinoma, tumor size 3 cm, unifocal, moderate to poorly differentiated (G2-G3), no visceral pleural invasion, negative margins, and no lymph/vascular invasion. Three lymph nodes are negative for tumor (0/3). The pathologic tumor stage is pT1b pNo.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient is a female with right lung adenocarcinoma, tumor size 3 cm, unifocal, moderate to poorly differentiated (G2-G3), no visceral pleural invasion, negative margins, and no lymph/vascular invasion. Three lymph nodes are negative for tumor (0/3), and the pathologic tumor stage is pT1b pNo. The tumor is positive for cytokeratin-7 and TTF-1, and molecular studies may be indicated.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-4B-A93V.3723B92A-EFB6-4239-9D26-B88AF56252CE',\n",
       "  'report_length_cl100k_base': 770,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's left breast tumor measures 2.8 x 3.5 x 3.0 cm and lacks vascular invasion. Four out of fourteen axillary lymph nodes are positive for metastatic carcinoma.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient has invasive lobular carcinoma of the left breast, with a tumor size of 2.8 x 3.5 x 3.0 cm. Vascular invasion is absent. Four out of fourteen axillary lymph nodes are positive for metastatic carcinoma.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-4H-AAAK.8894688F-7167-48A1-BB1B-FC219B7675C2',\n",
       "  'report_length_cl100k_base': 246,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated adenocarcinoma in the right lower lobe of the lung, measuring 6.5 cm, with evidence of visceral pleural invasion and angiolymphatic invasion. The interlobar and anterior hilar lymph nodes show metastatic carcinoma. The cancer has not spread to other organs, and the stage is T4 N1 Mx.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The right lower lobe neoplasm is an invasive poorly differentiated adenocarcinoma, measuring 6.5 cm with satellite nodules, visceral pleural invasion, and angiolymphatic invasion. The interlobar (Part 4) and anterior hilar (Part 8) lymph nodes show evidence of metastatic carcinoma. The stage is T4 N1 Mx.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-50-5044.40500921-fe3e-4fc0-a768-0062c488a832',\n",
       "  'report_length_cl100k_base': 649,\n",
       "  't_label': 3},\n",
       " {'abstract': \"The patient's cancer is a poorly differentiated adenocarcinoma, with a tumor size of 2.5 cm, located in the right lower lobe. The cancer has invaded the visceral pleura and angiolymphatic system. Two lymph nodes (Parts 4 and 7) are involved with metastatic adenocarcinoma. The margins of resection are free of tumor. The cancer stage is T2 N1 MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient has a poorly differentiated adenocarcinoma in the right lower lobe (2.5 cm) with pleural and angiolymphatic invasion. Two lymph nodes (Parts 4 and 7) are involved by metastatic adenocarcinoma. The tumor margins are free of resection, and the stage is T2 N1 MX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-50-5045.1d5c2f0f-4203-4db9-b63c-b6d80d04207e',\n",
       "  'report_length_cl100k_base': 490,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 2.8 cm invasive moderately differentiated adenocarcinoma in the right upper lobe of the lung with angiolymphatic and visceral pleural invasion. The cancer has not spread to the lymph nodes or other parts of the body. The surgical resection margins are free of tumor. The pathologic stage is T2N0MX.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a 2.8 cm invasive moderately differentiated adenocarcinoma in the right upper lobe of the lung with angiolymphatic and visceral pleural invasion. The cancer has not spread to the lymph nodes or other parts of the body (T2N0MX). The surgical resection margins are free of tumor, and all sampled lymph nodes are benign.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-50-5049.3d60a219-3c2c-4e2a-ab29-5d61cd31478b',\n",
       "  'report_length_cl100k_base': 353,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's left upper lobectomy revealed a moderately differentiated adenocarcinoma, 2.0 cm in diameter, with metastases to level 5 lymph nodes and visceral pleural invasion. The tumor is classified as T2 N2 Mx. Two out of three lymph node fragments from level 5 lymph nodes showed metastatic adenocarcinoma, while level 11 and 12 lymph nodes were free of metastatic carcinoma. The bone specimen is undergoing decalcification, with an addendum report to follow.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The left upper lobectomy reveals a moderately differentiated adenocarcinoma, 2.0 cm in diameter, with metastases to level 5 lymph nodes and visceral pleural invasion. The pathologic stage is T2 N2 Mx. Two out of three lymph node fragments from level 5 lymph nodes contain metastatic adenocarcinoma, while level 11 and 12 lymph nodes show no evidence of metastatic carcinoma. The bone specimen is undergoing decalcification, with an addendum report to follow.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-50-5051.ff5f5187-c4da-482c-b6fe-cbde5c820a80',\n",
       "  'report_length_cl100k_base': 501,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a 2.5 cm invasive moderately differentiated adenocarcinoma without visceral pleural invasion and involving one of five N1 lymph nodes. The tumor is classified as pathologic stage T1, N1, MX, with all margins free.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The left lower lobe wedge resection reveals a 2.5 cm invasive moderately differentiated adenocarcinoma without visceral pleural invasion, involving one of five N1 lymph nodes, and all margins are free. The pathologic stage is T1, N1, MX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-50-5055.847a0c64-cd3e-4a99-a6f7-b4ba1636ada1',\n",
       "  'report_length_cl100k_base': 399,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is a moderately differentiated adenocarcinoma, measuring 6.8 cm in diameter, with micropapillary growth and psammoma bodies. It is classified as T2 N1 MX stage, with three out of thirteen N1 lymph nodes showing metastatic adenocarcinoma. There is no evidence of visceral pleural or angiolymphatic invasion, but focal psammomatous calcifications are identified. The patient also has smoker's bronchiolitis, emphysematous changes, and subpleural scarring.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has a 6.8 cm, moderately differentiated adenocarcinoma in the right lower lobe of their lung, with micropapillary growth and psammoma bodies. The pathologic stage is T2 N1 MX, with three out of thirteen N1 lymph nodes showing metastatic adenocarcinoma. There is no evidence of visceral pleural or angiolymphatic invasion, but there is a mild host lymphocytic response. The patient also has smoker's bronchiolitis, emphysematous changes, and subpleural scarring.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-50-5068.d8025f22-0b42-4204-bc58-56fc727c71ac',\n",
       "  'report_length_cl100k_base': 351,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathology report indicates a poorly-differentiated adenocarcinoma in the left upper lobe of the lung, with a tumor diameter of 4.5 cm and visceral pleural and angiolymphatic invasion. The cancer has spread to nearby lymph nodes, with one of one lymph node showing metastatic adenocarcinoma with extracapsular extension in level 10, one of one lymph node with metastatic adenocarcinoma in level 5, and one of five lymph nodes with metastatic adenocarcinoma in level 11. The pathological stage is ypT2 N2 M0.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathology report indicates a poorly-differentiated adenocarcinoma in the left upper lobe of the lung, with a tumor diameter of 4.5 cm and visceral pleural and angiolymphatic invasion. The cancer has spread to nearby lymph nodes, with one of one lymph node showing metastatic adenocarcinoma with extracapsular extension in level 10, one of one lymph node with metastatic adenocarcinoma in level 5, and one of five lymph nodes with metastatic adenocarcinoma in level 11. The pathologic stage is ypT2 N2 M0.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-50-5072.0e998d45-ba74-4a11-8a14-e394299c9bba',\n",
       "  'report_length_cl100k_base': 434,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is a moderately differentiated adenocarcinoma, sized 3.9 cm, with a clear-cell type component. The tumor focally invades the visceral pleura but does not penetrate it, and angiolymphatic invasion is identified. Six out of twenty-five lymph nodes are positive for metastatic adenocarcinoma (T2, N1, MX). Surgical margins of resection are free of tumor, and there is no perineural invasion. The tumor is staged as pathologic stage T2, N1, MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's lung tumor is a moderately differentiated adenocarcinoma, 3.9 cm in size, with focal clear-cell type. The tumor invades the visceral pleura and angiolymphatic structures but does not penetrate the pleura. Six out of twenty-five lymph nodes are positive for metastatic adenocarcinoma. The tumor is classified as T2, N1, MX. Immunohistochemical stains confirm the lung lesion as a primary lung tumor, not metastatic disease. Surgical margins are free of tumor, and there is no perineural invasion.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-50-5930.ebb21844-9982-40da-972b-6f52941c5c4b',\n",
       "  'report_length_cl100k_base': 1594,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a moderately to poorly differentiated adenocarcinoma in the left upper lobe of the lung, measuring 3.3 cm. The tumor has neuroendocrine features, and the bronchial, vascular, and pleural margins are free of tumor. Six lymph nodes were examined, with no evidence of metastatic carcinoma. The TNM stage of the cancer is T2; M0; MX.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a moderately to poorly differentiated adenocarcinoma in the left upper lobe of the lung, measuring 3.3 cm. The tumor has neuroendocrine features, and the bronchial, vascular, and pleural margins are free of tumor. Six lymph nodes were found negative for metastatic carcinoma. The TNM stage is T2; M0; MX. Fluorescent in-situ hybridization studies showed Her2/Neu and Cyclin D1 amplification, which may help identify patients likely to experience shorter survival when considered together with other major risk factors. Special stains were ordered to further characterize the tumor and rule out the possibility of a neuroendocrine origin, but the results did not change the previous diagnosis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-50-5931.396c0f5f-1b86-4aa9-88ef-ca9220f4ccf3',\n",
       "  'report_length_cl100k_base': 1388,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is a well-differentiated adenocarcinoma with bronchioalveolar features, measuring 4.2 cm. It abuts the visceral pleura but does not penetrate it, and the bronchial, vascular, and parenchymal margins are free of neoplasm. There is one metastatic lymph node out of seven removed, and no external node spread is present. The tumor is classified as T2, N1, and MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': '\\n The patient was diagnosed with well-differentiated adenocarcinoma with bronchioalveolar features, measuring 4.2 cm, which abuts but does not penetrate the visceral pleura. The bronchial, vascular, and parenchymal margins are free of neoplasm. One of seven perihilar lymph nodes had metastatic adenocarcinoma, and no external node spread was found. The tumor is classified as T2, N1, and MX in stage.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-50-5932.d7713068-4d83-4242-bae2-8035c1ba9b8d',\n",
       "  'report_length_cl100k_base': 1422,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is classified as stage T4, N2, Mx with a poorly differentiated adenocarcinoma tumor (13.2 cm) in the left lower lobe of the lung, extending into the left upper lobe and into the visceral pleura. There is no evidence of lymph node involvement in the resected specimen, but metastasis is present in one of the examined lymph nodes with extranodal spread. The tumor also extends into the arterial wall and shows a focus of metastatic carcinoma within the aortic arch.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is classified as stage PT4, N2, Mx with a moderately differentiated adenocarcinoma. The tumor has a maximum dimension of 13.2 cm and extends into but not through the visceral pleura. It involves the left lower and upper lobes of the lung and has spread to one periaortic lymph node. There is no evidence of nodal involvement in the hilar or mediastinal nodes, and no metastases are found in the examined rib, chest wall, or bronchus. The patient's cancer is graded as G2.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-50-5933.68d471f3-43c0-44cf-97ce-003ff111c35c',\n",
       "  'report_length_cl100k_base': 1989,\n",
       "  't_label': 3},\n",
       " {'abstract': \"The patient's cancer is classified as T1N0Mx with a 3.0 cm moderately differentiated adenocarcinoma in the left upper lobe. There is no evidence of visceral pleural or angiolymphatic invasion, and all sampled lymph nodes are benign. Surgical resection margins are free of tumor. The cancer is not amplified for EGFR, and KRAS Exon 1 mutation is not identified, but EGFR Exon 19 mutation is identified (15 bp deletion).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is classified as T1N0Mx with a 3.0 cm moderately differentiated adenocarcinoma that has papillary differentiation and arises in a scar. There is no evidence of visceral pleural or angiolymphatic invasion. All sampled lymph nodes are benign, and surgical resection margins are free of tumor. The patient's EGFR gene copy number, as determined by fluorescence in-situ hybridization (FISH), shows a ratio of EGFR to the centromere of chromosome 7 of 1.0, indicating no EGFR amplification. The presence of a 15 bp deletion in EGFR Exon 19 is noted, which has potential therapeutic and prognostic implications.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-50-5935.b6f8e549-cb8e-4e6d-8cfe-2df2b1d57646',\n",
       "  'report_length_cl100k_base': 1293,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is a mucinous adenocarcinoma, sized 6.0 cm, located in the right lower lobe of the lung, with invasion into the visceral pleura and angiolymphatic channels. The tumor has N2 lymph node involvement with four out of six hilar lymph nodes and five out of six subcarinal lymph nodes positive for metastatic adenocarcinoma. There is no evidence of metastasis (MX). KRAS Exon 1 mutation is identified, while EGFR Exon 19 and 21 mutations are not identified. The patient's cancer is stage T2, N2, MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is a mucinous adenocarcinoma with a size of 6.0 cm, located in the right lower lobe of the lung. It involves the visceral pleura and angiolymphatic channels, with no evidence of bronchial or vascular margin involvement. The cancer has spread to the lymph nodes, with four out of six hilar lymph nodes and five out of six subcarinal lymph nodes positive for metastatic adenocarcinoma. The patient's cancer is classified as T2, N2, MX. The KRAS Exon 1 mutation is identified, but EGFR Exon 19 and 21 mutations are not identified. The patient's cancer is not amplified in the EGFR gene.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-50-5936.8d30d2aa-bef2-4329-944b-99ad5c9d8fc6',\n",
       "  'report_length_cl100k_base': 1472,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is classified as T2 NO Mx due to the presence of a poorly differentiated adenocarcinoma, 3.4 cm in diameter, with angiolymphatic and visceral pleural invasion. There is no evidence of lymph node metastasis. The tumor shows mucinous differentiation and clear cell change. The patient's cancer is KRAS and EGFR exon 19/21 mutation negative, but EGFR amplification was identified. Four segmental lymph nodes were examined, with no evidence of metastatic carcinoma found.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"\\nThe patient's cancer is classified as T2 NO Mx with a poorly differentiated adenocarcinoma, 3.4 cm in diameter, found in the right upper lobe apical segment of the lung. There is angiolymphatic and visceral pleural invasion, but no lymph node metastasis. Four segmental lymph nodes were examined, with no evidence of metastatic carcinoma found. The report also mentions multifocal atypical adenomatous hyperplasia and respiratory bronchiolitis with emphysematous change. Molecular testing revealed no KRAS codon 12/13 or EGFR exon 19 mutations, but EGFR amplification was identified. The patient's tumor is considered stage pT3 and pNO, with no metastasis (pMX).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-50-5939.b8f00ba8-722f-4df1-bfcd-2ccfe6583abd',\n",
       "  'report_length_cl100k_base': 1540,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a poorly differentiated adenocarcinoma, with a tumor size of 2.2 cm, invading the visceral pleura and showing angiolymphatic invasion. There is metastasis in one of two peribronchial lymph nodes (1/2) with extracapsular extension into the peribronchial connective tissue. Three out of five examined lymph node groups show metastatic carcinoma (3/5), with extracapsular extension present. The cancer is classified as T2a N2cMO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient was diagnosed with moderately to poorly differentiated adenocarcinoma with squamous differentiation in the right upper lobe of the lung, measuring 2.2 cm. The tumor invaded the visceral pleura and had angiolymphatic invasion present. Metastatic carcinoma was found in one of two peribronchial lymph nodes (1/2) with extracapsular extension into the peribronchial connective tissue. Three of three lymph nodes were positive for metastatic carcinoma (3/3) with extracapsular extension. The patient's TNM stage is pT2a N2cMO.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-50-5941.d49e610e-998f-4c6e-bb3d-b9c3a4221544',\n",
       "  'report_length_cl100k_base': 1173,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's right lung cancer is a well-differentiated adenocarcinoma, measuring 2.8 cm, without involvement of the visceral pleura or angiolymphatic invasion. The surgical resection margins are negative, and there is no evidence of metastasis in the examined lymph nodes (pNO). The tumor is classified as pT1, N0, and pMX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient was diagnosed with well-differentiated adenocarcinoma with papillary features and lepidic growth in the right upper lobe anterior segment of the lung, measuring 2.8 cm. There was no involvement of the visceral pleura or definitive angiolymphatic invasion. The surgical resection margins were negative, and there was mild centriacinar emphysema. No intestinal metaplasia was found in the gastrointestinal junction biopsy. The patient's lymph nodes at levels 10, 11, and 4 were negative for metastatic carcinoma. The tumor was classified as pT1, pNO, and pMX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-50-5942.915634e0-d38b-4a37-b96f-b9ac10507179',\n",
       "  'report_length_cl100k_base': 842,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an invasive well-differentiated adenocarcinoma, acinar type, measuring 1.4 cm in the right apical posterior segment of the lung. There is no lymphovascular space permeation seen and all surgical margins are free of tumor. The tumor is stage pT1, with no lymph node involvement (pNO), and no metastasis (pMX).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient was diagnosed with invasive well-differentiated adenocarcinoma, acinar type, in the right apical posterior segment of the lung, measuring 1.4 cm. The tumor had focal bronchioalveolar features and all surgical margins were free of tumor. There was no lymphovascular space permeation seen. The patient's lymph nodes at levels 4, 4R, 7, 7R, and 7C were benign. The tumor was classified as pT1 NO MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-50-5944.a3ad8013-b778-4fd0-9a5f-a516d6ff5a3e',\n",
       "  'report_length_cl100k_base': 882,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is classified as T2N0Mx with a 1.7 cm poorly differentiated adenocarcinoma in the right upper lobe of the lung, showing visceral pleural invasion, but no angiolymphatic invasion. The surgical margins are free of tumor, and nine lymph nodes were found to be benign.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient was diagnosed with invasive poorly differentiated adenocarcinoma in the right upper lobe of the lung, with a tumor size of 1.7 cm and visceral pleural invasion. There was no angiolymphatic invasion identified, and all sampled lymph nodes were benign. The pathologic stage is T2N0MX. The surgical margins were negative for tumor, and the patient's underlying diseases included emphysema, parenchymal scar, and smokers bronchiolitis. The tumor cells were positive for cytokeratin 7 and negative for cytokeratin 20, TTF, and mammoglobin.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-50-6590.13192955-ae90-4708-8f85-3b4e35781345',\n",
       "  'report_length_cl100k_base': 1007,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is classified as T2N0MX, with a poorly differentiated adenocarcinoma in the left lower lobe superior segment, measuring 8.0 cm in diameter. There is no evidence of lymph node involvement (N0) and no metastasis (MX). The tumor shows clear cell change and amyloid-like stroma, as well as visceral pleural and angiolymphatic invasion.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient is diagnosed with poorly differentiated adenocarcinoma, showing clear cell change and amyloid-like stroma, associated with visceral pleural and angiolymphatic invasion. The tumor diameter is 8.0 cm, and it is classified as pathological stage T2N0MX. The report mentions no involvement of N1 or N2 lymph nodes.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-50-6591.d1bb9feb-2cd4-40fd-a4d6-300d16b29d51',\n",
       "  'report_length_cl100k_base': 1058,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient has a poorly differentiated adenocarcinoma in the left lower lobe basilar segment of the lung, with a tumor size of 5.0 cm and clear cell change and CDX2 positivity. There is visceral pleural and angiolymphatic invasion, but the margins are free of cancer. The lymph nodes are negative for metastasis, and the cancer has not spread to other parts of the body (MX). The patient's pathological stage is T2, NO, MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"\\nThe patient is diagnosed with lung cancer, specifically a 5.0 cm poorly differentiated adenocarcinoma in the left lower lobe basilar segment with clear cell change and CDX2 positivity, demonstrating visceral pleural and angiolymphatic invasion. There is no evidence of metastatic carcinoma in the lymph nodes, and the margins are free. The tumor is stage T2, NO, MX. The patient's EGFR gene copy number by FISH analysis shows no EGFR amplification, with a ratio of EGFR to the centromere of chromosome 7 of 0.88. The report suggests that the carcinoma expresses CDX2, and it is essential to exclude other potential primary sites of origin before accepting it as a primary lung adenocarcinoma.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-50-6592.9a5098a9-7600-4b77-9b16-d6c274affd77',\n",
       "  'report_length_cl100k_base': 1222,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is a poorly differentiated adenocarcinoma, 1.3 cm in diameter, with angiolymphatic invasion, and is classified as pathologic stage T1 N2 Mx. The cancer is unassociated with visceral pleural invasion and has free margins. Five of six hilar lymph nodes are positive for metastatic adenocarcinoma (5/6), and there is no evidence of metastasis in other lymph nodes. Molecular testing reveals EGFR amplification (see In Situ Procedure) and no mutations in KRAS codon 12/13, EGFR Exon 19, or EGFR Exon 21. The patient's cancer is not associated with an EML4/ALK rearrangement.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient is diagnosed with poorly differentiated adenocarcinoma, 1.3 cm in diameter, with angiolymphatic invasion, unassociated with visceral pleural invasion, with involvement of both N1 and N2 lymph nodes and all margins free. Pathologic stage is T1 N2 Mx. The report also mentions the presence of EGFR amplification (see In Situ Procedure) and the absence of KRAS codon 12/13 and EGFR exon 19/21 mutations.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-50-6593.61906551-b954-4723-bb64-33bd88cc57f6',\n",
       "  'report_length_cl100k_base': 1769,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a poorly differentiated adenocarcinoma in the left upper lobe of the lung, with a tumor size of 2.5 cm. The cancer has spread to the visceral pleura and parietal pleura, and is present in the posterior and apical segment level 11, level 10, and level 5 lymph nodes. The pathologic stage is T3N2Mx. Molecular testing revealed no KRAS codon 12/13 mutation, no EGFR exon 19 or 21 mutation, and no EML4/ALK rearrangement. Surgical resection margins are free of tumor.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient was diagnosed with poorly differentiated adenocarcinoma in the left upper lobe of the lung, with a tumor size of 2.5 cm. The tumor was associated with angiolymphatic and parietal pleural invasion. Metastatic adenocarcinoma was found in posterior and apical segment level 11, level 10, and level 5 lymph nodes. The pathologic stage is T3N2Mx. The surgical resection margins were free of tumor. Molecular testing revealed no KRAS codon 12/13 mutation, no EGFR exon 19 or 21 mutation, and no EML4/ALK rearrangement. The presence of KRAS mutation leads to resistance to EGFR targeted therapies, and EGFR exon 19 and 21 mutations are associated with clinical response to treatment with EGFR inhibitors. The patient had a mild lymphocytic host response and emphysema with smokers bronchiotitis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-50-6594.f0ca0fa2-8143-4d83-a82b-188c044d7071',\n",
       "  'report_length_cl100k_base': 1332,\n",
       "  't_label': 2},\n",
       " {'abstract': '\\nThe patient has a poorly differentiated, mucin-producing adenocarcinoma in the right upper lobe, 2.4 cm in diameter, with angiolymphatic and visceral pleural invasion. The cancer is stage T2 N2 MX, with no evidence of metastasis. The tumor has no KRAS or EGFR mutations, but EGFR amplification was identified. Lymph nodes from the right paratracheal area show metastatic adenocarcinoma with extracapsular extension.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient was diagnosed with a poorly differentiated, mucin-producing adenocarcinoma in the right upper lobe of the lung, measuring 2.4 cm in diameter. The tumor showed visceral pleural and angiolymphatic invasion, and the patient's pathologic stage is T2 N2 MX. Molecular testing revealed no KRAS or EGFR mutations, but the presence of EGFR amplification. Lymph nodes from the right paratracheal area were positive for metastatic adenocarcinoma with extracapsular extension, while other lymph nodes showed reactive changes without malignancy.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-50-6595.13f36f42-a0d4-4cf3-b8ea-8cdeff292a91',\n",
       "  'report_length_cl100k_base': 1568,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's pathological report indicates a 2.5 cm invasive moderately differentiated adenocarcinoma in the right lower lobe superior segment with visceral pleural and angiolymphatic invasion. The surgical resection margins are free of tumor, and there is no lymph node involvement. The pathological stage is T2N0Mx. Additionally, a 0.6 cm typical carcinoid is found in the right middle lobe, along with numerous carcinoid tumorlets and diffuse neuroendocrine cell hyperplasia throughout the right upper, right lower, and right middle lobes. The report also mentions KRAS Exon 1 and EGFR Exon 19 and 21 mutations not being identified, and EGFR gene copy number by FISH analysis showing no amplification.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient was diagnosed with a 2.5 cm invasive moderately differentiated adenocarcinoma in the right lower lobe superior segment with visceral pleural and angiolymphatic invasion. The pathologic stage is T2N0Mx. All sampled lymph nodes were benign and surgical resection margins were free of tumor. The patient also had a 0.6 cm typical carcinoid in the right middle lobe associated with numerous carcinoid tumorlets and diffuse neuroendocrine cell hyperplasia throughout the right upper, right lower, and right middle lobes. KRAS Exon 1 mutation was not identified, and EGFR Exon 19 and 21 mutations were not identified. The patient's EGFR gene copy number by FISH analysis was not amplified, and the signal to nucleus ratio for the EGFR gene was 2.5.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-50-6597.6ba1ee6a-b37e-4f8d-9435-3d69ad1dbfdd',\n",
       "  'report_length_cl100k_base': 1899,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive moderately differentiated adenocarcinoma, sized at 1.6 cm, located in the right upper lobe. There is no angiolymphatic or visceral pleural invasion. The cancer is classified as T1 NO MX pathologic stage. Surgical resection margins are tumor-free, and all sampled lymph nodes are benign.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient was diagnosed with a 1.6 cm invasive moderately differentiated adenocarcinoma in the right upper lobe with no angiolymphatic or visceral pleural invasion. Surgical resection margins were free of tumor and all sampled lymph nodes were benign, resulting in a pathologic stage of T1 NO MX. Fluorescence in-situ hybridization studies showed low-level amplification of Her2/Neu and cyclin-D1 amplification in the targeted region. The patient's cancer is associated with a monosomy rate of 87.3% of analyzed cells and a hyperploidy rate of 85.7% chromosome 11.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-50-6673.e2a03d91-afb5-4c25-99ae-e339660d7e2c',\n",
       "  'report_length_cl100k_base': 708,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is a moderately differentiated adenocarcinoma, sized at 2.0 cm, with focal angiolymphatic invasion and perineural invasion present. The tumor is staged as pT1a (NO MX), with no lymph node involvement (pNO) and no identified metastases (MX).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient has a moderately differentiated adenocarcinoma in the right lower lobe of the lung, measuring 2.0 cm. The tumor has bronchovascular margin positive for adenocarcinoma, focal suggestion of angiolymphatic invasion, and perineural invasion. The stapled parenchymal margin is free of carcinoma. The patient's lymph nodes at levels 4, 7, 8, and 11 are negative for carcinoma, and the pathologic stage is pT1 NO MX. The tumor is negative for cytokeratin 5/6 and positive for TTF-1, supporting a diagnosis of adenocarcinoma.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-50-7109.a34c2391-f021-4b46-a4e9-8d9b7ee31402',\n",
       "  'report_length_cl100k_base': 726,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient has a 3 cm acinar predominant adenocarcinoma in the right upper lobe of the lung with angiolymphatic invasion, but no visceral pleural invasion. There is no lymph node involvement, and the tumor is classified as pT1bNO (AJCC). Molecular testing showed a KRAS exon 2 (codon 12) mutation (p.G12A), but no ALK, c-MET, or EGFR mutations. The patient's cancer is stage T1bNO (pathological).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient has been diagnosed with invasive adenocarcinoma in the right upper lobe of the lung, with a tumor size of 3 cm and angiolymphatic invasion present. There is no visceral pleural invasion, and all submitted lymph nodes are negative for carcinoma. The tumor is classified as T1bNO (AJCC) with no extrathoracic extension or invasion. Molecular testing has been requested and will be reported subsequently. The patient's tumor is negative for ALK rearrangement, C-MET amplification, and EGFR, KRAS, and BRAF mutations.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-50-8457.21529b79-5b5b-46e6-8deb-e4e6460a4695',\n",
       "  'report_length_cl100k_base': 2430,\n",
       "  't_label': 0},\n",
       " {'abstract': \" The patient's cancer is an invasive moderately differentiated mucinous adenocarcinoma, sized 7.5 cm, with angiolymphatic and visceral pleural invasion. There is no involvement of N1 or N2 lymph nodes, and margins are free of tumor. The cancer is stage T3 NO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient's cancer is an invasive moderately differentiated mucinous adenocarcinoma, sized 7.5 cm, with angiolymphatic and visceral pleural invasion. There is no involvement of N1 or N2 lymph nodes, and margins are free of tumor. The cancer is stage T3 NO. Lymph nodes near the fissure, middle lobe artery, and bronchus show reactive change with no evidence of malignancy. The tumor is negative for ALK rearrangement, C-MET amplification, EGFR exon 18/19/20/21 mutations, and BRAF exon 15 mutation. KRAS exon 12 is mutated (p.G12C).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-50-8459.be87241c-fcb4-416f-a8a4-74b09033ca0b',\n",
       "  'report_length_cl100k_base': 3072,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's cancer is an invasive papillary adenocarcinoma, moderately differentiated, with a tumor size of 2.0 x 2.0 x 1.8 cm in the right upper lobe posterior segment. There is no visceral pleura invasion, no lymphovascular invasion, and no lymph node involvement. The tumor is ALK FISH positive, EGFR and KRAS negative. The pathological stage is pT1a N0 M0.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an invasive papillary adenocarcinoma, moderately differentiated, peripheral subpleural, and measures 2.0 x 2.0 x 1.8 cm. There is no visceral pleura invasion, no lymphovascular invasion, and no metastasis. The tumor is staged as pT1a NO.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-50-8460.fc79e8c5-c79b-46d3-ab41-03399a68999a',\n",
       "  'report_length_cl100k_base': 822,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is classified as stage pT2 (tumor size greater than 3 cm but not greater than 5 cm), NO (no regional lymph node metastasis), and MX (metastasis status cannot be assessed). The tumor is a moderately to poorly differentiated adenocarcinoma, measuring 6.2 cm in the greatest dimension, located in the right upper lobe. The tumor penetrates the visceral pleura but margins are free of tumor. Four lymph nodes were examined, with no malignancy found (0/4). No venous or arterial invasion was observed, and lymphatic invasion was absent.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, not otherwise characterized, with a tumor size of 6.2 cm in the greatest dimension, located in the right upper lobe. There is no regional lymph node metastasis, and margins are uninvolved by invasive carcinoma. The pathologic staging is pT2, NO, MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-53-7624.b108a209-518b-4271-a90c-7f3857044581',\n",
       "  'report_length_cl100k_base': 1765,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma of the lung, with a tumor size of 1.2 cm in the right upper lobe. The tumor is not invasive and is surrounded by lung tissue. There is no evidence of vascular invasion or direct extension of the tumor. One out of seven examined lymph nodes is involved with metastatic adenocarcinoma. There is no distant metastasis. The margins are free of tumor, and the bronchial margin is negative for tumor. The staging is pT1 N1 MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient's pathology report indicates a moderately differentiated adenocarcinoma in the right upper lobe of the lung, measuring 1.2 cm with vascular invasion present. The closest margin is free of tumor and is 1 mm away. One of the right tracheobronchial angle lymph nodes is positive for metastatic adenocarcinoma. There is no evidence of lymph node involvement in the subcarinal or inferior pulmonary lymph nodes. The cancer is staged as pT1 N1 MX, with no distant metastasis identified.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-53-7626.23a82f88-d450-4546-88e0-c26cf8de267e',\n",
       "  'report_length_cl100k_base': 2261,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is a moderately differentiated adenocarcinoma of the lung, with a tumor size of 1.5 cm. There is no evidence of direct extension of the tumor, venous or arterial invasion, or lymphatic invasion. Five lymph nodes were examined, with no involvement found. The cancer has not metastasized.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is a moderately differentiated adenocarcinoma of the lung, with a tumor size of 1.5 cm. There is no evidence of direct extension of the tumor, venous or arterial invasion, or lymphatic invasion. Five lymph nodes were examined, with no involvement found. The pathologic staging is PT1 N0 pMX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-53-7813.bda037b7-ac21-42c0-95c1-c546f0ace670',\n",
       "  'report_length_cl100k_base': 1078,\n",
       "  't_label': 3},\n",
       " {'abstract': '\\nThe patient has a poorly differentiated adenocarcinoma in the left upper lobe of the lung, measuring 4.5 cm. One of four examined lymph nodes showed metastatic carcinoma. The tumor is surrounded by lung tissue and visceral pleura without bronchoscopic evidence of invasion more proximal than the lobar bronchus. No distant metastases were found.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is classified as stage pT2a, N1, Mx, with a poorly differentiated adenocarcinoma in the left upper lobe lung, measuring 4.5 cm. One of four examined lymph nodes tested positive for metastatic carcinoma. No distant metastasis was found.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-53-A4EZ.E4CB6C1D-9774-47BE-989E-F9CD05D9EED8',\n",
       "  'report_length_cl100k_base': 1714,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's left upper lobe wedge resection revealed a 2 cm moderately differentiated adenocarcinoma, with no lymph nodes resected, and no evidence of metastasis. The tumor extends up to but not through the pleura, and is associated with areas of fibrosis. The frozen section diagnosis is confirmed.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with moderately differentiated adenocarcinoma of the left upper lobe of the lung, measuring 2.0 cm in diameter, with no lymph nodes resected. The tumor extends up to but not through the pleura and is associated with areas of fibrosis. The frozen section diagnosis is confirmed, and the margins are free.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-1592.99ae36ee-bb6c-4934-8e5c-388ff5a69c46',\n",
       "  'report_length_cl100k_base': 404,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma with a tumor size of 3.7 cm (T2), no regional lymph node involvement (N0), and metastasis status that cannot be assessed (MX). The tumor is confined to the lung with no invasion of the pleural surface, and margins are uninvolved by invasive carcinoma. There is no lymphovascular or venous invasion, but extranodal extension is not identified in the subcarinal lymph node biopsy. The pathological stage is pT2 pN2 pMX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma with a tumor size of 3.7 cm (T2), located in the right lower lobe of the lung. There is no evidence of lymph node involvement (N0), and distant metastasis cannot be assessed (MX). The tumor is poorly differentiated and confined to the lung with no invasion of the pleural surface. The margins are uninvolved by invasive carcinoma, and there is no lymphovascular or venous invasion. The patient's cancer is classified as pT2 pN2 pMX.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-55-1594.bdbfef54-ca5a-4b4f-809d-4de379232a8a',\n",
       "  'report_length_cl100k_base': 1039,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma with a clear cell component, measuring 2.0 cm in maximum dimension without involvement of the overlying pleura. There is no evidence of blood/lymphatic vessel invasion. The bronchial and vascular resection margins are negative for tumor. Regional lymph nodes (specimens A, B, C, and E) show no evidence of metastatic carcinoma. Distant metastasis is not assessed in this report.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"\\nThe patient's pathology report indicates a diagnosis of adenocarcinoma with a clear cell component in the left lower lobe of the lung, measured at 2.0 cm in maximum dimension without involvement of the pleura. There is no evidence of blood/lymphatic vessel invasion. The bronchial and vascular resection margins are negative for tumor. Regional lymph nodes from specimens A through C and E are benign, with no evidence of metastatic carcinoma. The cytokeratin stain is negative for metastatic carcinoma. The final diagnosis remains unchanged.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-1595.b4ec8fa3-74b6-4656-bd2e-6fe5ba0af7d8',\n",
       "  'report_length_cl100k_base': 1662,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's pathological report indicates that they have been diagnosed with adenocarcinoma of the right upper lobe of the lung, with a tumor size of 5.0 x 5.0 x 4.5 cm. The cancer has extended to the lymph nodes, with metastatic adenocarcinoma found in one of the twenty-one lymph nodes examined. There is no evidence of blood/lymphatic vessel invasion, and distant metastasis cannot be assessed. The tumor margins are uninvolved, and there is no evidence of malignancy in the regional lymph nodes. The patient's cancer is classified as pN1, with additional pathological findings showing emphysematous changes and pulmonary congestion.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient is diagnosed with moderately differentiated adenocarcinoma of the right upper lobe of the lung, with a tumor size of 5.0 x 5.0 x 4.5 cm. The cancer has extended to the lymphatic vessels but not to the blood vessels. One out of twenty-one lymph nodes is metastatic. There is no evidence of distant metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-55-1596.200ccd8b-b3dc-4e3f-8c1e-ed9fa31ae9da',\n",
       "  'report_length_cl100k_base': 2036,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has been diagnosed with adenocarcinoma of the lung, right upper lobe, with no evidence of neuroendocrine carcinoma. The tumor size is not mentioned in the report. The patient's lymph nodes and metastasis status are also not mentioned. The report suggests testing for EGFR and KRAS mutations to help select patients for Tyrosine-Kinase Inhibitor therapy, and ALK gene rearrangement by FISH is available as a panel or individual assays. The bronchus right washing was negative for malignant cells.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with adenocarcinoma of the lung, right upper lobe, with no neuroendocrine features. The tumor is negative for CK20, high molecular weight keratin SK, and p63, but positive for cytokeratin CK7 and TTF-1. The report recommends testing for EGFR and KRAS mutations to help select patients for Tyrosine-Kinase Inhibitor therapy, and notes that ALK gene rearrangements are associated with resistance to TKIs and favorable response rates to Crizotinib. The bronchus right washing was negative for malignant cells.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-55-5899.8fcdc599-a63e-4774-a58d-8b1b19d13980',\n",
       "  'report_length_cl100k_base': 570,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma with mucinous and bronchoalveolar features, measuring 3.0 x 2.0 x 2.0 cm, located in the right upper lobe of the lung. There is no visceral pleural invasion or lymphovascular space invasion. The tumor is unifocal and confined to the lung. No lymph nodes contain metastatic carcinoma. The patient's cancer is classified as pT1, NO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with adenocarcinoma with mucinous and bronchoalveolar features. The tumor is unifocal, measures 3.0 x 2.0 x 2.0 cm, and is located peripherally in the right upper lobe of the lung. There is no visceral pleural invasion, and the tumor is confined to the lung. The lymph nodes (levels 10, 11, and 4) are benign and hyperplastic, with no metastatic carcinoma found. The tumor is classified as pT1, NO.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-6543.b1b81957-278c-4c30-af49-821ab7e0429c',\n",
       "  'report_length_cl100k_base': 1104,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma of the right lower lobe of the lung, with a tumor size of 3.5cm. There is no evidence of lymph node involvement or metastasis. The tumor extends to the visceral pleura and comes within 0.1cm of the staple line margin. The patient's cancer is classified as pT2, pNO, and pMX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient was diagnosed with adenocarcinoma of the right lower lobe of the lung, with direct extension into the visceral pleura. The tumor mass measured 3.5 cm in greatest dimension. There was no evidence of regional lymph node metastasis, but the tumor was present at the visceral pleural surface. The completion lobectomy specimen showed residual adenocarcinoma, with a circumscribed but non-encapsulated nodular mass measuring 0.8 cm. There was no evidence of invasion into large vessels or distant metastasis. A spindle cell carcinoma was also identified in the same specimen. The patient's prognosis is stage pT2, grade II.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-6642.5d390c9f-0f12-4ed2-a7ec-d9e7c8f05320',\n",
       "  'report_length_cl100k_base': 2641,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is stage pT2aN1MX, with a poorly differentiated unifocal adenocarcinoma in the left upper lobe of the lung, measuring 4.5 cm. There is visceral pleural invasion and lymphovascular space invasion present. The tumor is confined to the lung with no metastasis. One out of six lymph nodes contained metastatic carcinoma, and extracapsular extension was present with invasion of the adjacent artery wall. Surgical margins were negative for tumor. Mutation analysis for KRAS, EGFR, and ALK is recommended for potential targeted therapy.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient is diagnosed with adenocarcinoma of the lung, with a unifocal, poorly differentiated tumor of 4.5 cm in size. The tumor is located in the left upper lobe and has visceral pleural invasion and lymphovascular space invasion. The surgical margins are free of tumor, and the lymph nodes are negative for metastatic carcinoma, with the exception of one lymph node showing extracapsular extension. The tumor is classified as pT2aN1MX. Mutation analysis for KRAS, EGFR, and ALK is recommended for potential targeted therapy.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-55-6712.156f5763-3bc6-47a8-b579-6d767fa3fd00',\n",
       "  'report_length_cl100k_base': 1480,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a poorly differentiated adenocarcinoma, with a tumor size of 1.6 cm and no lymphovascular space invasion. The cancer extends to within 0.1 mm of the free pleural surface. There is no evidence of metastasis, and the surgical margin is free of malignancy. Two small lymph nodes were negative for malignancy, and the cancer is classified as stage 1.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient has been diagnosed with poorly differentiated adenocarcinoma in the right lower lobe of the lung, measuring 1.6 cm in greatest dimension. The tumor extends to within 0.1 mm of the free pleural surface, but definite lymphovascular space invasion is not identified. Two small lymph nodes from level 9 and two from level 7, all negative for malignancy, were removed. The stapled surgical margin is free of malignancy. The patient's cancer is stage 1A.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-6968.87f5cbe6-cce1-4a8c-8189-c6feabd3b4bb',\n",
       "  'report_length_cl100k_base': 545,\n",
       "  't_label': 0},\n",
       " {'abstract': '\\nThe patient is a male with left upper lobe adenocarcinoma, tumor size 3.5 cm. No lymphovascular space invasion or pleural involvement. No evidence of malignancy in six lymph nodes (0/6) from AP window, one lymph node (0/1) from posterior hilar area, one lymph node (0/1) from intralobar, and two lymph nodes (0/2) from hilar area. The tumor is 1.2 cm from the bronchial resection margin, and all surgical resection margins are clear. No metastasis found.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"\\nThe patient is a male with left upper lobe cancer. The tumor size is 3.5 cm, and it is a poorly differentiated adenocarcinoma. There is no evidence of lymphovascular space invasion. All surgical resection margins are clear, and the tumor does not involve the pleura. No evidence of malignancy was found in six lymph nodes (0/6) in the AP window, one lymph node (0/1) in the posterior hilar area, one lymph node (0/1) in the intralobar area, and two lymph nodes (0/2) in the hilar area. The patient's bronchial margin is negative for malignancy.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-6969.96b7d4c4-6513-4249-a6d5-b5cf0bf49ab4',\n",
       "  'report_length_cl100k_base': 1033,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is a pT2 (tumor greater than 3 cm in greatest dimension), N2 (metastases in ipsilateral mediastinal and/or subcarinal lymph nodes), MX (cannot be assessed for distant metastasis), with a histologic grade of G2 (moderately differentiated). The tumor is a papillary adenocarcinoma, and the bronchial margins are involved. There is extensive lymphatic invasion, but no large vessel invasion. One right pulmonary lymph node and one lower paratracheal lymph node at station 8 are positive for metastatic adenocarcinoma. The other lower paratracheal lymph node at station 8 is negative for tumor. The pathologic stage is pT2N2MXG2.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with stage pT2N2MXG2 non-small cell lung cancer. The tumor is a 3.5 x 3.0 x 2.0 cm adenocarcinoma, predominately papillary variant, located in the right upper lobe of the lung. The cancer has spread to the ipsilateral mediastinal and subcarinal lymph nodes (pN2) and one of the lower paratracheal lymph nodes at station 8. There is no evidence of large vessel invasion, but lymphatic invasion is present and extensive. The margins of the bronchial wall are involved, and the cancer is moderately differentiated (G2).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-55-6970.1662fe4b-da42-444a-b7fa-4990d9e8aa9d',\n",
       "  'report_length_cl100k_base': 1199,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma located in the left lower lobe of the lung, measuring 3.3 x 3.0 x 2.7 cm. There is no pleural invasion or lymphovascular space invasion. The tumor is moderately to poorly differentiated. Fourteen lymph nodes were examined, with no metastatic carcinoma identified (0/14). The cancer has not metastasized. The patient's pTNM stage is pT2 NO Mx.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma located in the left lower lobe of the lung, with a size of 3.3 x 3.0 x 2.7 cm. There is no pleural invasion or lymphovascular space invasion. The cancer is classified as pT2 NO Mx. Fourteen lymph nodes were examined, with no metastatic carcinoma identified (0/14). The tumor is moderately to poorly differentiated and is 2.8 cm from the bronchial margin and 0.1 cm from the pleural surface.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-6971.c270e56a-dfc6-41a5-9cfc-3c302c4ccc13',\n",
       "  'report_length_cl100k_base': 1120,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's pathology report indicates a well-differentiated papillary adenocarcinoma with bronchoalveolar features in the right upper lobe of the lung, measuring 4.5 cm in maximum dimension. There is no evidence of lymphovascular space invasion or metastatic carcinoma in the regional lymph nodes (0/1). The tumor is classified as T2 N0 M0.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathology report indicates a pre-operative diagnosis of a right lung mass. The surgical report describes the removal of the right upper lobe of the lung, which measures 16 x 16 x 5.0 cm and weighs 207 grams. The specimen shows a poorly-circumscribed hemorrhagic area, and a poorly-defined, ovoid, tan-white, firm nodule measuring 1.2 x 1.0 x 0.8 cm is identified within the hemorrhagic area. The nodule appears to be surrounded by a hemorrhagic infarct. The bronchial and vascular margins in the hilum are free of neoplasm, and one possible hilar lymph node measuring 1.7 cm in greatest dimension is identified. The final diagnosis is papillary adenocarcinoma with bronchoalveolar features, with no evidence of lymphovascular space invasion. The tumor measures 4.5 cm in maximum dimension, and the pleural, parenchymal, bronchial, and vascular\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-6972.7d2c5e22-45d5-404c-97c5-5523ea656d75',\n",
       "  'report_length_cl100k_base': 1441,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma with minor areas of squamous and bronchioloalveolar differentiation, measuring 6.5 x 6.0 x 6.0 cm. It is classified as pT2 with vascular and bronchial margins clear, and blood/lymphatic vessel invasion present. Three of three hilar lymph nodes were positive for metastatic carcinoma, and there is no evidence of distant metastasis. The tumor is graded as GII-III, and additional pathology findings include patchy COPD.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with adenocarcinoma with minor areas of squamous and bronchioloalveolar differentiation. The tumor size is 6.5 x 6.0 x 6.0 cm, and it is 1 cm away from the bronchial margin. There is extensive intrapulmonary lymphatic and vascular invasion, and three hilar lymph nodes were found to have metastatic carcinoma. The cancer is classified as pT2, with blood/lymphatic vessel invasion present. There is no evidence of distant metastasis. The patient also has patchy COPD.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-55-6975.7c03cf6a-c871-4c53-af4d-cb931f6d8b72',\n",
       "  'report_length_cl100k_base': 1083,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a poorly differentiated adenocarcinoma, with a tumor size of 5.5 x 5.0 cm, unifocal, and no visceral pleural invasion. The cancer extends into the fissure, but bronchial margins are negative for tumor. Lymph node involvement is indeterminate, with 12 lymph nodes retrieved, including parts A through E, and block F1 negative for cancer. The pathological stage is nT2bMO. An addendum report will be issued for further characterization of the tumor type.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is a poorly differentiated adenocarcinoma, with a maximum tumor size of 5.5 x 5.0 cm, unifocal, and no visceral pleural invasion. The cancer extends into the fissure, but bronchial margins are negative for tumor. Lymph node involvement is indeterminate, with 12 lymph nodes removed, including parts A through E, and reported as negative for cancer. The final pathologic stage is nT26MO. An addendum report will be issued to further characterize the tumor type.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-6978.3e3c1e82-ee09-4eeb-873a-9b6580274f97',\n",
       "  'report_length_cl100k_base': 654,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma with a tumor size of 4.1 cm, located in the left upper lobe of the lung. It is classified as T2. There is one positive lymph node (pN1), but distant metastasis cannot be assessed (pMX). The tumor has lymphovascular invasion, but no venous or arterial invasion. The margins are uninvolved by invasive carcinoma. The pathological stage is pT2, pN1, pMX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"\\nThe patient's cancer is classified as stage pT2, pN1, pMX. The tumor is a poorly differentiated adenocarcinoma, with a size of 4.1 cm and is confined to the lung. One lymph node out of six is involved in the metastasis, and there is no evidence of venous or arterial invasion. The margins are uninvolved by invasive carcinoma, and lymphovascular invasion is present. There is no information on distant metastasis.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-55-6979.c7896f40-c1a5-4e4c-bfea-7e80c94c66ad',\n",
       "  'report_length_cl100k_base': 1074,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's pathology report indicates a well-differentiated invasive adenocarcinoma of bronchoalveolar pattern in the right lower lobe of the lung, with a maximal diameter of 1.5 cm (pT1), no vascular invasion, and no lymph node involvement. The regional lymph nodes (A, C, and D) show sinus histiocytosis with anthracosis, but no metastatic tumor. There is no evidence of distant metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient was diagnosed with adenocarcinoma, bronchoalveolar type, in the right lower lobe of the lung. The tumor size is 1.5 cm in diameter and is well differentiated. There is no vascular invasion or lymph node involvement. The margins are not involved, and there is no evidence of distant metastasis. The patient's lymph nodes, including inferior pulmonary ligament, tracheal, and subcarinal lymph nodes, show sinus histiocytosis with anthracosis, but no metastatic tumor.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-6980.e73aad2d-83d3-46b2-b2e9-cc93c5fbd670',\n",
       "  'report_length_cl100k_base': 1372,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma of the left lung, with a maximum tumor size of 2.5 x 2.0 cm. It is classified as pT1. There is extensive lymphatic invasion, with ten out of twelve lymph nodes involved by metastatic carcinoma, including the subcarinal lymph node (part B) and hilar lymph nodes. The bronchial and vascular margins are technically free of tumor, but lymphvascular tumor emboli are present in subpleural lymphatics. There is no evidence of distant metastasis (pMX) or direct extension of the tumor. Large vessel invasion is not present, but small vessel (lymphatic) invasion is extensive. The cancer is classified as pN2.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathology report indicates a moderately-poorly differentiated adenocarcinoma in the left lung upper lobe, with a maximum tumor size of 2.5 x 2.0 cm. The cancer has extended to ten out of twelve regional lymph nodes, including the subcarinal lymph node (part B) and hilar lymph nodes. There is no evidence of distant metastasis (pMX), but lymphatic invasion is present. The tumor approaches within less than 1 mm of the inked hilar pleural surface, and all resection margins (bronchial, vascular, and pleural) are negative for cancer. Large vessel invasion is not present, while small vessel (lymphatic) invasion is extensive.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-55-6981.84738cad-3b17-456c-a9a0-21f6e044a688',\n",
       "  'report_length_cl100k_base': 1894,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is a non-small cell carcinoma, with a 3.5cm tumor in the right lower lobe of the lung. The tumor is located 0.5cm from the closest bronchial margin and is classified as T2. There is one involved lymph node out of two examined, classified as N1. No distant metastases are found, and the margins are uninvolved by invasive carcinoma. Large vessel invasion is present, as well as small vessel lymphatic invasion. The patient's cancer is classified as a poorly differentiated adenocarcinoma (grade III).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with non-small cell carcinoma of the lung, specifically an adenocarcinoma, with a tumor size of 3.5 cm. The cancer has spread to the lymph nodes, with metastases found in the ipsilateral peribronchial and ipsilateral hilar lymph nodes (N1). There is no evidence of distant metastasis (MX). The tumor is located in the right lower lobe and is close to the bronchial margin, with invasion present in the visceral pleura, large vessels (V and L), and small lymphatic vessels (L). The margins are uninvolved by invasive carcinoma, and calcified granulomas are present in the peribronchial lymph node.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-55-6982.54e65072-9bea-41d0-b976-5f5723379c51',\n",
       "  'report_length_cl100k_base': 2229,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is a mucinous adenocarcinoma, with a tumor size of 8.5 cm in maximal dimension (pT2). It is well to moderately differentiated and has metastasized to one out of three hilar lymph nodes (N1). There is no evidence of metastasis to distant sites, direct extension of the tumor, or large vessel invasion. Small vessel (lymphatic) invasion is present. Bronchial and vascular resection margins are negative for tumor. The cancer exhibits a CK7 and TTF-1 positive staining profile, compatible with primary lung carcinoma.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is a mucinous adenocarcinoma, with a tumor size of 8.5 cm in maximal dimension (pT2). It is well to moderately differentiated and has metastasized to one out of three hilar lymph nodes (N1). There is no evidence of metastasis to other organs or large vessel invasion, but small vessel (lymphatic) invasion is present. Bronchial and vascular resection margins are negative for tumor, and the staining profile is compatible with primary lung carcinoma.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-55-6983.5428a18c-8db6-4dbc-bec0-b55658f3302b',\n",
       "  'report_length_cl100k_base': 1046,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's pathological report indicates a moderately differentiated adenocarcinoma tumor measuring 4.5 x 3.5 x 3.5 cm in the left lower lobe of the lung. There is focal lymphovascular invasion and the tumor is close to the pleural surface, but the pleural surface is free of tumor. Two of nine peribronchial lymph nodes are positive for metastatic carcinoma. The bronchial and vascular resection margins are negative for carcinoma. The patient's cancer is classified as pT2, N1, with no distant metastasis found.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathology report indicates a moderately differentiated adenocarcinoma in the left lower lobe of the lung, measuring 4.5 x 3.5 x 3.5 cm. The tumor is close to the pleural surface, but does not disrupt it. There is focal lymphovascular invasion and two out of nine peribronchial lymph nodes are positive for metastatic carcinoma. The bronchial and vascular resection margins are negative for carcinoma. The patient's cancer is classified as pT2, N1, with no distant metastasis assessed.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-55-6984.361307d6-aebb-446b-b06f-41c71deab5d2',\n",
       "  'report_length_cl100k_base': 1606,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's left upper lobe lung tumor is an adenocarcinoma, moderately differentiated, with a tumor size of 2.0 cm. There is no lymph node involvement, and distant metastasis cannot be assessed. The tumor invades the visceral pleura, but there is no lymphovascular or venous invasion. The margins are uninvolved by invasive carcinoma. The pathological staging is pT2pN0pMX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's left upper lobe lung tumor is an adenocarcinoma, moderately differentiated, with a tumor size of 2.0 cm. The tumor invades the visceral pleura and has no regional lymph node involvement. There is no evidence of lymphovascular, venous, or arterial invasion. The margins are uninvolved by invasive carcinoma, and distant metastasis cannot be assessed. The pathologic staging is pT2pN0pMX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-6985.c6fc0473-b67a-47f1-81f2-ecc0cbc9cc5f',\n",
       "  'report_length_cl100k_base': 759,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive adenocarcinoma with bronchioloalveolar features, measuring 2.5 cm in the greatest dimension, located in the right lower lobe of the lung. There is no evidence of lymph node metastasis in the 3 peribronchial lymph nodes, station 8 paraesophageal lymph node, or station 11 interlobar lymph node. The tumor is 5 cm away from the bronchial resection margin, with no direct extension identified. There is no venous or arterial invasion, and lymphatic invasion is absent. The margins are uninvolved by invasive carcinoma, and distant metastasis cannot be assessed.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an invasive adenocarcinoma with bronchioloalveolar features, measuring 2.5 cm in the greatest dimension, located in the right lower lobe of the lung. The tumor invades the visceral pleura (pT2) and is grade I-II. There is no regional lymph node metastasis in 3 peribronchial lymph nodes, 1 station 8 paraesophageal lymph node, and 1 station 11 interlobar lymph node. Distant metastasis cannot be assessed (pMX). The margins are uninvolved by invasive carcinoma, and there is no direct extension of the tumor. Venous and arterial invasion is absent, as well as lymphatic invasion. Additional pathological findings include a central scar associated with the adenocarcinoma.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-6986.bc8c1075-8f74-42da-bc09-80b4152b160f',\n",
       "  'report_length_cl100k_base': 857,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's pathology report indicates a poorly differentiated adenocarcinoma in the left lower lobe of the lung, measuring approximately 2.2 cm with focal lymphovascular invasion. The tumor is classified as T1 (tumor size ≤2 cm), N0 (no regional lymph node involvement), and MX (metastasis status unknown). The remaining lung tissue shows moderate emphysema. Two lymph nodes, including the apical and subcarinal lymph nodes, were examined and found to be free of metastatic tumor, displaying anthracosis instead.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with non-small cell carcinoma, specifically poorly-differentiated adenocarcinoma, in the left lower lobe of their lung. The tumor measures approximately 2.2 cm in maximal dimension. There is evidence of focal lymphovascular invasion. The remaining lung tissue shows moderate emphysema. The bronchial and vascular margins are clear, and no tumor is identified in the lymph nodes. The TNM classification is pT1, NO, MX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-6987.345eb11f-9520-4463-8a84-07aeb26ce559',\n",
       "  'report_length_cl100k_base': 1081,\n",
       "  't_label': 0},\n",
       " {'abstract': '\\nThe patient has an invasive moderately differentiated adenocarcinoma of the lung with a tumor size of 62mm, satellite tumor nodules, visceral pleural invasion, and metastasis in one of three peribronchial lymph nodes. The bronchial margin is free of tumor, and there is no evidence of vascular invasion. The pathologic stage is IIIA.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has invasive moderately differentiated adenocarcinoma of the lung with visceral pleural invasion, measuring 62mm in diameter. There are satellite tumor nodules present adjacent to the main mass, and the bronchial margin is free of tumor. One of the three peribronchial lymph nodes is involved in metastatic carcinoma. The pathologic stage is IIIA.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-55-7227.7910979d-a635-4ef5-ab00-84df0455df66',\n",
       "  'report_length_cl100k_base': 1469,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma of the right lung, with a size of 2.2 x 2.0 x 1.8 cm. There is no pleural invasion, but lymphovascular space invasion is present. The tumor is 0.2 cm from the parenchymal margin and 2.8 cm from the bronchial margin. Level 7, 9, and 10 lymph nodes were examined and found to have no metastatic carcinoma. The patient is stage pT1 NO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma located in the right lung, upper and middle lobes, with a size of 2.2 x 2.0 x 1.8 cm. There is no pleural invasion, but lymphovascular space invasion is present. The tumor is 0.2 cm from the parenchymal margin and 2.8 cm from the bronchial margin. Level 7, 9, and 10 lymph nodes show reactive sinus histiocytosis and anthracosilicosis, with no metastatic carcinoma identified. Level 4 lymph nodes demonstrate reactive sinus histiocytosis, anthracosilicosis, and a benign fibrous nodule, with no carcinoma identified. The cancer is stage pT1 NO.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-7281.8c99c857-2ab0-4481-ab5d-8ed971968620',\n",
       "  'report_length_cl100k_base': 1130,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, with tumor size measuring 7.5 x 5.5 x 3.8 cm. Lymph node involvement is present, as 3 out of 5 lymph nodes contain metastatic carcinoma. No metastasis is reported.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with adenocarcinoma of the lung, with a tumor size of 7.5 x 5.5 x 3.8 cm, located in the right upper lobe. The tumor is multifocal and moderately to poorly differentiated, with lymphovascular space invasion present. Three out of five lymph nodes contain metastatic carcinoma. The patient's pTNM stage is pT3 N2. The report also mentions the presence of bronchioloalveolar carcinoma in the shaved parenchymal margin. The patient's tumor is recommended for testing for EGFR and KRAS mutations, as well as ALK gene rearrangement, to help determine potential treatment options.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-55-7283.39929fe3-b87c-413c-8613-f5a15b407b28',\n",
       "  'report_length_cl100k_base': 1536,\n",
       "  't_label': 2},\n",
       " {'abstract': '\\nThe patient has invasive adenocarcinoma with a predominant bronchioloalveolar pattern. The tumor size in the middle lobe is 2 cm and 15 cm in the lower lobe. There is no visceral pleural invasion or lymphovascular invasion identified. The margins are negative for both foci, and 16 lymph nodes are negative for metastatic carcinoma (0/16). The pathologic stage for the middle lobe is IA, and for the lower lobe is IIB. There is focal non-necrotizing granulomatous inflammation.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has invasive adenocarcinoma with a predominant bronchioloalveolar pattern. The tumor size in the middle lobe is 2cm and 15cm in the lower lobe. There is no visceral pleural invasion or lymphovascular invasion identified. The margins are negative for both foci. 16 lymph nodes were examined, and none showed metastatic carcinoma (0/16). The pathologic stage for the middle lobe is IA, and for the lower lobe is IIB. The tumors are well differentiated (G1) and have no necrotizing granulomatous inflammation. The final surgical pathology report confirms the absence of visceral pleural invasion.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-7284.ca201579-79b6-4a03-a982-9f43bf16471b',\n",
       "  'report_length_cl100k_base': 1252,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient has a poorly differentiated adenocarcinoma in the right lung upper lobe, with a tumor size of 2.0 x 2.0 x 1.3 cm. The tumor extends within 0.2 cm of the surgical resection margin and is 0.2 cm deep to the pleural surface. The bronchial margin is free of tumor. Two peribronchial lymph nodes are negative for tumor, and mediastinal (level 7 and 10) lymph nodes are benign. The patient's pathological stage is pT1a, with no lymph node involvement (pNO).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has poorly differentiated adenocarcinoma in the right lung upper lobe, with a tumor size of 2.0 x 2.0 x 1.3 cm. The tumor extends within 0.2 cm of the surgical resection margin and is 0.2 cm deep to the pleural surface. The bronchial margin is free, and there is no lymphovascular space invasion. Two peribronchial lymph nodes are negative for tumor, and the mediastinal (level 7 and 10) lymph nodes are benign. The patient's pathologic stage is pT1a, with no lymph node involvement (pNO).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-7570.95cb32d6-2999-44eb-a93f-31aa65a6c51c',\n",
       "  'report_length_cl100k_base': 1094,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma of the right upper lobe of the lung, with a tumor size of 2.5 cm x 1.5 cm x 1.5 cm. There is no visceral tumor invasion or lymphovascular space invasion. The tumor is unifocal and moderately differentiated. The surgical margins are negative for malignancy, with the tumor approaching the stapled parenchymal surgical margin within 0.1 cm. Seven lymph nodes were removed, none of which contained metastatic carcinoma. The patient's history of prior renal cell carcinoma is noted, but the staining pattern of the current malignancy excludes the possibility of a metastasis from the kidney and is typical of a primary pulmonary adenocarcinoma.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is stage pT1b, NO, with a unifocal, moderately differentiated adenocarcinoma tumor measuring 2.5 cm x 1.5 cm x 1.5 cm in the right upper lobe of the lung. There is no visceral tumor invasion, lymphovascular space invasion, or metastasis. The tumor is less than 0.1 cm from the stapled parenchymal surgical margin. Seven lymph nodes were removed, none of which contained metastatic carcinoma. The patient had a history of renal cell carcinoma, but immunohistochemical stains on the lung tumor exclude the possibility of a metastasis from the kidney.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-7573.3eda2065-31da-49d1-8974-9d004ed26113',\n",
       "  'report_length_cl100k_base': 1097,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, poorly differentiated, with a tumor size of 3.5cm. It is unifocal and has not invaded the visceral pleura, perineural structures, or extra-pulmonary structures. There is no lymphovascular invasion. The tumor is classified as pT2a (3.5cm in greatest dimension). The lymph nodes are negative for metastasis (pNO), and there is no distant metastasis (pMX). The margins are positive for tumor in the soft tissue adjacent to the bronchial and vascular margins, but the bronchial and vascular walls are not involved. The pathologic stage is IB, and the margin status is R1.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, poorly differentiated, with a tumor size of 3.5 x 3.5 x 2.9cm. The tumor is unifocal and there is no lymphovascular or perineural invasion. The margins are positive for tumor, with a soft tissue margin adjacent to the bronchial and vascular margins being involved. The tumor is 0.5cm from the closest margin. There is no visceral pleural invasion or extra-pulmonary structure involvement. Lymph nodes are negative for metastasis (0/6). The pathologic stage is IB.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-7574.7bf6ed4b-a0da-4bcd-ba62-211d2d2a86e7',\n",
       "  'report_length_cl100k_base': 1887,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive moderately differentiated adenocarcinoma in the right upper lung lobe, with a tumor size of approximately 4.3 cm (dumbbell-shaped, two nearby nodules connected microscopically). There is visceral pleural invasion and no lymph node involvement. The tumor is negative for lymph-vascular invasion and metastasis. The patient's cancer is classified as pT2a N0 M0 (stage I).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has invasive moderately differentiated adenocarcinoma in the right upper lung lobe, with a dumbbell-shaped tumor size of approximately 4.3 cm and visceral pleural invasion. The bronchial and vascular margins are negative for tumor, and no lymph nodes are involved. The tumor is classified as pT2a PL2, with no lymph node involvement (pN0).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-7576.feac18c2-ce79-4092-ad5a-98143981a24e',\n",
       "  'report_length_cl100k_base': 1519,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's left lung cancer is classified as pT2a (tumor size 1.2 x 1.0 x 0.8 cm) with no lymph node involvement (pNO) and no metastasis (pM0). The tumor invades the visceral pleura but not through it, and there is no lymphovascular space invasion. Four lymph node biopsies (4R, Level 7, 4L, and 2R) were negative for malignancy. The cancer is classified as moderately to poorly differentiated adenocarcinoma.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's left lung cancer is classified as pT2a PL1 pNO, with tumor size being 1.2 x 1.0 x 0.8 cm. There is no lymphovascular space invasion, no lymph node involvement, and no metastasis identified. The cancer is moderately to poorly differentiated adenocarcinoma, and the pleural status indicates invasion into but not through the visceral pleura.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-7724.2d61169f-eaf9-4a67-afef-0dd4c2ffe0c5',\n",
       "  'report_length_cl100k_base': 1070,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma of the right lower lobe of the lung, with a tumor size of 1.5 x 1.5 x 1.4 cm. There is no visceral pleural invasion or lymphovascular space invasion. The cancer is unifocal and well-differentiated, with no evidence of metastasis in the lymph nodes. The patient's lymph nodes from levels 11, 12, 7, and 8 are negative for malignancy. The surgical margins are clear, with the tumor being 4.3 cm from the bronchial margin and 3.8 cm from the parenchymal margin. The patient's pTNM stage is pT1a, NO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's right lower lobe lung tumor is well-differentiated adenocarcinoma, unifocal, and measures 1.5 x 1.5 x 1.4 cm. There is no visceral pleural invasion, lymphovascular space invasion, or tumor extension. The surgical margins are clear, and the tumor is 4.3 cm from the bronchial margin and 3.8 cm from the parenchymal (stapled) margin. Lymph node status is negative for malignancy in all checked nodes (0/10). The pTNM stage is pT1a, NO.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-7725.e25ffd17-6064-4eef-acd4-5e26475cd842',\n",
       "  'report_length_cl100k_base': 1084,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's left lower lobe lung tumor is a 2.9 cm poorly differentiated adenocarcinoma with intralymphatic invasion, not involving the visceral pleura, and is stage IA (pT1b, pNO) with three negative lymph nodes.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's left lower lobe lung tumor is a 2.9 cm poorly differentiated adenocarcinoma with intralymphatic invasion, not involving the visceral pleura and with negative margins, classified as stage IA (pT1b pNO). Three lymph nodes, including L9, L10, and L7, were negative for metastasis. The final diagnosis matches the frozen section analysis.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-7726.094c672b-f6c7-4250-bb17-4d23a48b81c7',\n",
       "  'report_length_cl100k_base': 865,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is classified as stage IIIA due to the tumor size of 2.0 cm, 6/22 regional lymph nodes positive for metastatic adenocarcinoma, and the presence of lymphovascular and perineural invasion. There is no evidence of distant metastasis, and the margins are negative. The tumor is moderately differentiated, and the patient's pathological staging is pT1a (tumor size 2.0 cm), pN2 (6/22 regional lymph nodes positive), and pMX (no distant metastasis), with a negative margin status (R0).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient is diagnosed with stage IIIA adenocarcinoma of the lung, with a tumor size of 2.0 cm, 6/22 regional lymph nodes positive for metastatic carcinoma, and no distant metastasis. The tumor has a grade 2 (moderately differentiated) histology, with lymphovascular and perineural invasion identified. The margins are negative, and the visceral pleura is not involved. The patient's pathologic staging is pT1a (tumor size), pN2 (lymph node involvement), and pMX (no distant metastasis), with a final pathologic stage of IIIA.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-55-7727.1e6155d1-e9eb-447d-951e-3b81f6d41156',\n",
       "  'report_length_cl100k_base': 2435,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's lung cancer is a well-differentiated mucinous adenocarcinoma, unifocal, with a tumor size of 3.5 x 3.2 x 1.6 cm. There is no visceral pleural invasion or lymphovascular space invasion identified. The cancer is stage pT2a NO SPC-A. No metastatic carcinoma is found in the examined lymph nodes (0/1 for level 7, 0/6 for level 10, 0/4 for level 9, and 0/1 for level 5). Immunohistochemical stains show the neoplastic cells to be strongly positive for CK7, with scattered focal positive staining for CK20 and TTF1, and rare focal positive staining for CDX2. The subpleural fibrosis suggests a primary lung neoplasm, but the immunohistochemical stains are equivocal, making it difficult to fully exclude the possibility of a metastatic lesion. Clinical correlation and follow-up are recommended.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's lung cancer is classified as a well-differentiated mucinous adenocarcinoma (pT2a NO SPC-A), unifocal, with a tumor size of 3.5 x 3.2 x 1.6 cm. There is no evidence of visceral pleural invasion or lymphovascular space invasion. The tumor is located in the left upper lobe, and the closest margin is 2.3 cm from the bronchial margin. No metastatic carcinoma is identified in the examined lymph nodes (0/1 for level 7, 0/6 for level 10, 0/4 for level 9, and 0/1 for level 5). The immunohistochemical stains are equivocal, and the subpleural fibrosis suggests it may be a primary lung neoplasm. Clinical correlation and follow-up are recommended.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-7728.d12721b3-53dc-47e8-a9c2-03343ec7a4bb',\n",
       "  'report_length_cl100k_base': 1640,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathology report indicates a well-differentiated adenocarcinoma in the right lower and middle lobe of the lung, with a tumor size of 6.0 cm. There is no lymphovascular or perineural invasion. The resection margins, including bronchial and vascular margins, are negative for malignancy. No metastatic malignancy was found in the lymph nodes (0/6 in the right interlobar node, 0/1 in the right hilar lymph node, and 0/3 in the lower paratracheal right lymph node). The pathological staging is pT2a, pNO, pMX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient was diagnosed with right lung adenocarcinoma, measuring 6cm in the greatest dimension, which focally involved the pleural surface. There was no lymphovascular or perineural invasion identified. The tumor margins, both bronchial and vascular, were negative for malignancy. From the resection, 0/6 lymph nodes were found to have metastatic malignancy. The pathological staging is pT2a, pNO, pMX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-7815.4caba554-2bb8-4158-af8a-9690d4d5f73c',\n",
       "  'report_length_cl100k_base': 845,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is staged as pT1b with a tumor size of 2.4 cm in greatest diameter, located in the right lower lobe of the lung. There is no evidence of lymphovascular space invasion or metastasis. One peribronchial lymph node was examined and found to be negative for metastatic carcinoma. The tumor is a poorly differentiated adenocarcinoma, and the patient's staging is based on clinical information and the pathological findings.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is staged as pT1b with a unifocal, poorly differentiated adenocarcinoma tumor measuring 2.4 cm in the greatest diameter, located in the right lower lobe of the lung. There is no evidence of visceral pleural invasion, tumor extension, or lymphovascular space invasion. The cancer has not metastasized to the lymph nodes (0/1). The patient's staging is pT1b NO.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-7903.f044afa0-43c8-4047-a6bf-d46bfb42433c',\n",
       "  'report_length_cl100k_base': 1632,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient is a male with a poorly differentiated adenocarcinoma in the left lung upper lobe, measuring 4.5 cm in maximum dimension with visceral pleural invasion. One out of twenty-four lymph nodes was positive for metastatic carcinoma (1/24), and there was no evidence of distant metastasis. The pathological stage is IIA, with a pT2a classification for the primary tumor, pN1 for regional lymph nodes, and pMX for distant metastasis. The margins were negative, with the closest margin being vascular at 0.5 cm. The patient also had atypical adenomatous hyperplasia and focal necrotizing granulomatous inflammation with rare fungal organisms consistent with Histoplasma species.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient is a male with a poorly differentiated adenocarcinoma in the left lung upper lobe, measuring 4.5 cm in maximum dimension with visceral pleural invasion. The tumor is unifocal and has focal necrotizing granulomatous inflammation with rare fungal organisms. One out of twenty-four lymph nodes is positive for metastatic carcinoma (1/24), and there is no evidence of distant metastasis. The margins are negative, with the closest margin being vascular at 0.5 cm. The pathologic stage is IIA, and the patient has atypical adenomatous hyperplasia.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-55-7907.233ef961-8050-47e5-bb53-260a7de4174d',\n",
       "  'report_length_cl100k_base': 2506,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's lung adenocarcinoma is 7 cm in size, with no pleural surface penetration and negative bronchial margins. There is no lymphovascular invasion, and all examined lymph nodes (4 peribronchial, 1 subaortic, 3 para-aortic, and 1 subcarinal) are negative for malignancy. The cancer is classified as pathological AJCC stage T2b, N0.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with pulmonary adenocarcinoma stage T2b, NO. The tumor size is 7 cm, it does not penetrate the lung pleural surface, and bronchial margins are free of tumor. There is no lymphovascular invasion identified. Four peribronchial lymph nodes, #5 subaortic lymph node dissection, #9 pulmonary ligament lymph node dissection, and #8 paraesophageal lymph node dissection were negative for malignancy. However, #7 subcarinal lymph node dissection showed one negative node.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-7910.c205abda-dfe0-43b1-a265-4c41125216fe',\n",
       "  'report_length_cl100k_base': 740,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma of the right middle lobe of the lung, with a tumor size of 1.7 x 1.7 x 1.6 cm. There is no evidence of visceral pleural invasion or lymphovascular space invasion. The tumor is unifocal and confined to the pulmonary parenchyma. The surgical margins are 3.4 cm from the bronchial margin and 0.3 cm from the parenchymal margin, with no evidence of tumor extending into the pleura. Lymph node involvement is absent, as no metastatic carcinoma was identified in the examined sections. The cancer stage is pT1aNo.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is staged as pT1aNo, with a unifocal, moderately differentiated adenocarcinoma tumor measuring 1.7 x 1.7 x 1.6 cm in the right middle lobe of the lung. There is no evidence of visceral pleural invasion or lymphovascular space invasion. The tumor is 3.4 cm from the bronchial margin and 0.3 cm from the parenchymal margin, but does not extend into the pleura. Three lymph nodes were examined, with no evidence of metastatic carcinoma found. The patient's cancer has not spread to other organs or tissues.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-7911.0c8ea3a9-23b7-4c43-8972-3660048b8537',\n",
       "  'report_length_cl100k_base': 972,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's lung adenocarcinoma is T1b in size, with no lymph node involvement (N0) and no distant metastasis (M0). No EGFR or KRAS mutations were detected, but a gain of ALK region was found. The tumor is well-differentiated with focal mucin production and is confined to the left lower lobe lung.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"\\nThe patient's lung adenocarcinoma is well-differentiated with focal mucin production, measures 2.8 x 2.7 x 2.4 cm, and is unifocal. It is confined to the left lower lobe with no visceral pleural invasion. The tumor is negative for EGFR and KRAS mutations, but an incidental finding of gain of the ALK region was observed in 79% of cells, suggesting ALK rearrangement. The patient's TNM status is pT1b. No lymph node involvement was detected.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-7913.7ce361fa-ad56-4e0e-95e3-ea977a513e98',\n",
       "  'report_length_cl100k_base': 1900,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's lung adenocarcinoma is characterized by a unifocal, 2.4 x 2.3 x 1.8 cm tumor in the right upper lobe with no visceral pleural invasion and no lymphovascular space invasion. The tumor is stage pT1bN1. The EGFR mutation was not detected, but a KRAS mutation (GGT>TGT) was found. ALK rearrangement was not detected, but a gain of the ALK region was observed in 79% of cells. The patient's cancer has not metastasized to the lymph nodes.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': '\\nEGFR mutation: not detected\\nKRAS mutation: detected (G12C)\\nALK rearrangement: negative\\nTumor size: 2.4 x 2.3 x 1.8 cm\\nLymph node involvement: 6 out of 6 lymph nodes positive for metastatic carcinoma\\nTumor focality: unifocal\\nVisceral pleural invasion: negative\\nLymphovascular space invasion: not seen\\nSurgical margin status: 0.2 cm from stapled margin\\npTNM stage: pT1bN1',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-55-7914.eaabadac-ea5e-47c3-9db7-d2c0c77b7b68',\n",
       "  'report_length_cl100k_base': 2258,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is a poorly differentiated adenocarcinoma, unifocal, with a tumor size of 7.8 x 6.2 x 4.6 cm, involving the visceral pleura without extension beyond it. There is no lymphovascular space invasion, and the cancer is stage pT3NO. Five lymph nodes were received, with no metastatic carcinoma present. The patient's cancer has not metastasized.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathology report indicates a diagnosis of poorly differentiated adenocarcinoma in the right upper lobe of the lung, with a tumor size of 7.8 x 6.2 x 4.6 cm. There is visceral pleural invasion present, but no lymphovascular space invasion or lymph node involvement was found. The cancer has not metastasized, and the stage is classified as pT3NO.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-7994.8454b0fe-a466-43b7-843f-16db8b4c43cd',\n",
       "  'report_length_cl100k_base': 1603,\n",
       "  't_label': 2},\n",
       " {'abstract': '\\n The patient has a poorly differentiated adenocarcinoma in the left upper lobe of the lung, measuring 2.6 x 2.4 x 1.7 cm. There is no evidence of lymph node metastasis, and the tumor does not infiltrate the visceral pleura. The cancer has not spread to other organs, making the patient eligible for stage IA pathological staging.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient is diagnosed with poorly differentiated adenocarcinoma, with a tumor size of 2.6 x 2.4 x 1.7 cm, situated 0.6 cm from the nearest inked stapled parenchymal resection margin. There is no evidence of metastatic carcinoma in the regional lymph nodes. The cancer is classified as stage IA, with no distant metastasis. The final TNM classification is T1bNOM0.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-7995.3f3f4bdf-75f6-4b5b-988e-cebc4f098cbd',\n",
       "  'report_length_cl100k_base': 2356,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is classified as stage IA with a moderately differentiated papillary adenocarcinoma tumor, size 2.5x2.2x1.6cm, located in the left lower lobe of the lung. There is no evidence of lymph node involvement or metastasis. The tumor is unifocal and surrounded by lung tissue without invasion of the visceral pleura. The margins are uninvolved by tumor and the distance from the closest margin is 1.5cm.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is classified as stage IA with a moderately differentiated adenocarcinoma forming a mass measuring 2.5 x 2.2 x 1.6 cm in the left lower lobe of the lung. There is no evidence of lymph node involvement or metastasis. The tumor is unifocal and surrounded by lung tissue with a distance of 1.5 cm from the closest margin. The patient's cancer does not meet the criteria for reflex EGFR and ALK testing.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8085.16f4298e-d5f3-4503-bdad-a15531c3635c',\n",
       "  'report_length_cl100k_base': 1804,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is classified as pT2a NO, with a well-differentiated adenocarcinoma in the right upper lobe of the lung, measuring 4.0 cm in greatest diameter. There is no evidence of lymphovascular space invasion or metastasis. The tumor extends into the visceral pleura but does not extend through it, and the bronchial margin is not involved. Five lymph nodes were examined, with no metastatic carcinoma identified. The patient's cancer has not spread to other organs.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is classified as pT2a NO, with a well-differentiated adenocarcinoma in the right upper lobe of the lung, measuring 4.0 cm in greatest diameter. There is no evidence of lymphovascular space invasion or metastatic carcinoma in the examined lymph nodes (0/6). The tumor extends into the visceral pleura but does not extend through it, and the bronchial margin is not involved. The patient's lymph nodes show anthracosilicosis and mild reactive lymphoid hyperplasia.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8087.a2478c36-05ee-4b55-9293-5cce65217c94',\n",
       "  'report_length_cl100k_base': 1448,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is stage pT1a (tumor size 1.8 x 1.7 x 1.3 cm, no visceral pleural invasion, no lymphovascular space invasion, unifocal, poorly differentiated adenocarcinoma), with no lymph node involvement (NO) and no metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is stage pT1a, NO, with a poorly differentiated adenocarcinoma tumor, 1.8 x 1.7 x 1.3 cm in size, located in the right upper lobe of the lung. There is no visceral pleural invasion or lymphovascular space invasion. The tumor is unifocal and there is no evidence of metastasis. The surgical margins are negative for malignancy, with the closest margin being 8.0 cm from the bronchial margin and 4.0 cm from the parenchymal margin. Lymph node involvement is absent, with zero metastatic carcinoma found in at least eleven lymph nodes.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8089.af442cea-76df-4233-b3d6-134b1e91c607',\n",
       "  'report_length_cl100k_base': 1445,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient is a 40-year-old man with a history of non-small cell carcinoma. A wedge of lung measuring 5 x 4 x 2.5 cm was removed during right thoracoscopy, which revealed a solid tan-white mass of 2.5 x 2 x 2 cm. The resection margins were negative for tumor, but the serosal surface appeared involved. The tumor was diagnosed as moderately differentiated adenocarcinoma, and lymphovascular invasion was present. The tumor cells from the right lower lobe lung mass were morphologically similar to those from the left lower lung biopsy.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient is a 40-year-old man with a history of nonsmall cell carcinoma. A right lower lobe lung mass was removed through right thoracoscopy. The mass measured 2.5 x 2 x 2 cm and the cut surface revealed a solid tan-white mass. The sutured margin was negative, but the serosal surface appeared involved by tumor. The frozen section diagnosis was adenocarcinoma, and the resection margins were negative for tumor. Lymphovascular invasion was present. The tumor cells of two biopsies were morphologically similar. The patient's cancer is stage T2a, N0, M0.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8090.8f75f207-fe12-44ba-86b2-444ab5578d45',\n",
       "  'report_length_cl100k_base': 328,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's lung cancer is classified as T2N0, with a moderately differentiated adenocarcinoma tumor measuring 2.0 x 2.0 x 1.6 cm located subpleurally in the right lower lobe of the lung. There is focal involvement of the pleura and no lymphovascular space invasion. The tumor is negative for neoplasm in the resected margins and nearby lymph nodes (stations 4, 7, 11, and 12), with the exception of station 11 which shows reactive changes and extensive anthracotic pigment. No metastases are reported.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is staged as T2N0, with a moderately differentiated adenocarcinoma tumor of size 2.0 x 2.0 x 1.6 cm located in the subpleural right lower lung lobe, involving the pleura focally. There is no lymphovascular space invasion, and the tumor is 2.8 cm away from the bronchial margin and less than 0.5 cm from the stapled margin. Lymph node status is negative for neoplasm, with no changes in the revised report.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8091.33902b19-5be6-47ff-81a7-b945ae674a2f',\n",
       "  'report_length_cl100k_base': 1116,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, moderately differentiated, with a tumor size of 7.7 cm, invading the visceral pleura. The bronchial margins are negative for tumor, but lymphovascular invasion is positive. Multiple lymph nodes are negative for tumor, and there is no evidence of metastasis. The pathological TNM (AJCC Seventh Edition) is T3 NO MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a 7.7 cm unifocal adenocarcinoma in the right upper lobe of the lung, invading the visceral pleura and with positive lymphovascular invasion. The bronchial margins are negative for tumor, and multiple lymph nodes are negative for tumor involvement. The cancer is classified as T3 NO MX according to the AJCC Seventh Edition staging system.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8092.c21d060b-3f55-4a82-85df-38814c7a37e7',\n",
       "  'report_length_cl100k_base': 986,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's left upper lobe tumor is a unifocal adenocarcinoma, measuring 4.0 x 3.5 x 3.0 cm, with no direct invasion of the visceral or parietal pleura, and no lymphatic or vascular invasion. The tumor abuts the pleural surface with pleural puckering, and the bronchial and vascular margins are uninvolved. Three peribronchial lymph nodes, ranging from 0.2 cm to 0.5 cm in greatest dimension, are negative for tumor. The patient's cancer is stage pT2b pNO pM1b, as there is a metastasis to the left cerebellar cystic tumor. The tumor is ERCC1 positive, and EGFR and ALK molecular studies were performed, with results indicating a wild type EGFR sequence and no mutations in the evaluated locations.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient's left upper lobe tumor is a unifocal adenocarcinoma, measuring 4.0 x 3.5 x 3.0 cm, with no direct invasion into the pleura, mediastinum, or neighboring lobes. The tumor abuts the pleural surface with pleural puckering, but vascular and bronchial margins are uninvolved. Three peribronchial lymph nodes, measuring between 0.2 cm and 0.5 cm, were examined and found to be negative for tumor. The tumor is ERCC1 positive and ALK negative, suggesting that the patient may benefit from adjuvant cisplatin-based chemotherapy. No distant metastases were found, but a separate report indicates the presence of a metastatic pulmonary adenocarcinoma in the left cerebellar cystic tumor. The patient's EGFR mutation status is negative, which is associated with a poor response to tyrosine kinase inhibitors and shorter survival compared to mutation-positive patients.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8094.807ba9c2-925a-4fda-a1a4-a6e856be0bb3',\n",
       "  'report_length_cl100k_base': 2187,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, with a tumor size of 3.8 x 2.8 x 2.5 cm, located in the lateral segment of the left upper lobe. It has visceral pleural invasion but no lymphovascular space invasion. The tumor is unifocal and moderately differentiated. There is no evidence of metastasis, with negative results from the excised level VI and IX lymph nodes. Surgical margins are within 0.7 cm from the tumor. The patient's pTNM stage is T2.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, with a tumor size of 3.8 x 2.8 x 2.5 cm, located in the lateral segment of the left upper lobe. The tumor has visceral pleural invasion but no lymphovascular space invasion. The tumor is unifocal and moderately differentiated. The patient's pTNM stage is T2. Level VI and IX lymph nodes were excised and found to be negative for malignancy. The surgical margins were within 0.7 cm from the tumor.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8096.d27900ae-8cf6-4d92-84e8-5247df7d46b4',\n",
       "  'report_length_cl100k_base': 817,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma of the right upper lobe of the lung, with a tumor size of 2.0 x 1.5 x 1.5 cm. There is no evidence of lymphovascular space invasion, and the cancer is confined to the lung parenchyma. Three peribronchial lymph nodes were negative for malignancy (0/3), and no metastases were found in the examined lymph nodes (pTN stage: pT1a NO). The lesion extends close to, but does not definitively invade, the visceral pleura.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, unifocal, with a tumor size of 2.0 x 1.5 x 1.5 cm, located on the medial aspect of the apex in the right upper lobe. There is no evidence of visceral pleural invasion or lymphovascular space invasion. The tumor is negative for metastatic carcinoma in three peribronchial lymph nodes (pTN stage pT1a NO). The lesion extends close to, but does not definitively extend into, the elastic layer of the visceral pleura. The patient's cancer has been classified as adenocarcinoma, not otherwise specified.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8097.3e2989f4-213d-4f64-be03-9b967f1fcc08',\n",
       "  'report_length_cl100k_base': 1086,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is staged as pT1b NO with a unifocal, moderately differentiated adenocarcinoma tumor measuring 2.3 cm in the greatest diameter. There is no evidence of lymph node involvement or metastasis. The tumor extends up to but not through the visceral pleura.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with unifocal adenocarcinoma in the right lung lower lobe, with a tumor size of 2.3 cm in greatest diameter. The carcinoma extends up to but not through the visceral pleura, and there is no evidence of lymphovascular space invasion. The patient's lymph nodes, including level 7 and level 9, show reactive sinus histiocytosis, lymphoid hyperplasia, and anthracosilicosis, but no metastatic carcinoma is identified. The final stage is pT1b NO.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8203.079475a1-b61d-4cb3-b1e1-a5a890d3073b',\n",
       "  'report_length_cl100k_base': 1659,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is a poorly differentiated non-small cell carcinoma, consistent with adenocarcinoma, with a tumor size of 2.7 x 2.0 x 1.2 cm. There is no lymphovascular space invasion, and the tumor invades the visceral pleural surface. The stapled surgical margin of resection is negative for carcinoma. The patient's cancer is classified as pT2a PL2 pNO, with no lymph node involvement.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': '\\nThe patient has a poorly differentiated non-small cell carcinoma of the left upper lobe of the lung, consistent with adenocarcinoma, with a tumor size of 2.7 x 2.0 x 1.2 cm. There is no lymphovascular space invasion, and the tumor invades the visceral pleural surface. The patient is pT2a PL2 pNO. Lymph nodes #1, #2, #3, #4, #6, and #7 are negative for carcinoma, and the stapled surgical margin of resection is also negative for carcinoma. The patient has emphysematous changes.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8204.e3a193f9-f815-4bd4-b5f5-0329d7d6e845',\n",
       "  'report_length_cl100k_base': 1371,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient is a female with a right lower lobe adenocarcinoma, tumor size 6.5 x 5.7 x 4.5 cm, unifocal, poorly differentiated, with no visceral pleural invasion or lymphovascular space invasion. The tumor is 2.5 cm from the bronchial margin and 0.3 cm from the pleural surface. 8 lymph nodes were examined, with no metastatic carcinoma found (0/8). The patient's cancer is classified as pT2b, N0. No metastasis is reported.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient is a female with a right lower lobe lung tumor, which is a poorly differentiated adenocarcinoma, unifocal, and measures 6.5 x 5.7 x 4.5 cm. There is no visceral pleural invasion or lymphovascular space invasion. The tumor is 2.5 cm from the bronchial margin and 0.3 cm from the pleural surface. Eight lymph nodes were examined, with no metastatic carcinoma found (0/8). The patient's pTNM stage is pT2b, NO.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8205.7a632c9d-4215-4d85-83df-30ce645d4e0c',\n",
       "  'report_length_cl100k_base': 879,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient has been diagnosed with stage IA moderately differentiated adenocarcinoma of the right upper lobe of the lung. The tumor size is 2.3 x 2.2 x 2.2 cm, and it does not invade the visceral pleura. The margins are uninvolved by tumor, and there is no lymph node metastasis. There is no evidence of distant metastasis. The patient's sample does not meet the criteria for reflex EGFR and ALK testing. The pathologic stage is pT1bNOMO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with stage IA moderately differentiated adenocarcinoma of the right upper lobe of the lung, measuring 2.3 x 2.2 x 2.2 cm. The tumor does not invade the visceral pleura and has no lymphatic vascular invasion. Three benign variably anthracotic lymph nodes were found, and the margins were uninvolved by tumor. There is no evidence of metastatic carcinoma. The final TNM is pT1bNOMO, and the pathologic stage is IA. The tumor size is 2.3 x 2.2 x 2.2 cm, and the histological grade is G2. The patient's sample does not meet the criteria for reflex EGFR and ALK testing.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8206.6a62aeff-3381-4ae5-8bb5-789542f8ce3c',\n",
       "  'report_length_cl100k_base': 1115,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's pathological report indicates a well-differentiated invasive adenocarcinoma in the left lower lobe of the lung, measuring 4.0 x 3.8 x 2.2 cm. There is no direct extension of the tumor identified, and the proximal bronchial resection margin and pleural surface are negative for carcinoma. No attached lymph nodes were found, and all examined lymph nodes (levels 2, 4, 7, and 11) were negative for carcinoma. The tumor is classified as pT2a pNO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"\\nThe patient's pathology report indicates a pT2a pNO lung cancer, with no lymph node involvement. The tumor size is 4.0 x 3.8 x 2.2 cm, and the proximal bronchial resection margin and pleural surface are negative for carcinoma. There is no direct extension of the tumor, and lymphovascular space invasion is negative. Five lymph nodes were examined, including levels 4 (left and right), 2 (left), 7, 111, and 10, all of which were negative for carcinoma.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8207.bf8af6e0-1ea5-4281-a00d-42aa138d781f',\n",
       "  'report_length_cl100k_base': 1360,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a moderately differentiated adenocarcinoma, with a unifocal, 3 cm tumor in the right upper lobe of the lung. There is no lymphovascular invasion, and bronchial and vascular margins are free of involvement. Two negative peribronchial and intraparenchymal nodes were identified. The tumor is classified as AJCC pathologic stage T1b, NO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with stage T1b adenocarcinoma of the right upper lobe of the lung. The tumor size is 3 cm, it is unifocal, and there is no lymphovascular invasion. The margins are free of involvement, and no peribronchial or intraparenchymal nodes are identified. The tumor comes within 1.5 cm of the bronchial margin. Two parabronchial lymph nodes and one intraparenchymal lymph node are negative for cancer. The specimen is submitted for frozen section analysis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8208.9e4cf1b8-6628-4791-aa3c-2d7c42b3936b',\n",
       "  'report_length_cl100k_base': 558,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is a moderate to poorly differentiated unifocal adenocarcinoma in the right lower lobe of the lung, measuring 3.0 x 2.8 x 2.7 cm. There is no evidence of lymph node involvement, and the tumor does not extend through the pleura. The cancer is classified as pT2aNO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, unifocal, with a tumor size of 3.0 x 2.8 x 2.7 cm, located in the right lower lobe of the lung. There is no evidence of lymph node involvement, and the cancer has not extended through the pleura. The tumor is classified as pT2aNO.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8301.55b2132a-ec1c-47a7-b91b-65f48c45fcb5',\n",
       "  'report_length_cl100k_base': 1039,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has been diagnosed with pulmonary adenocarcinoma, with a tumor size of 1.2 cm. There is focal invasion into, but not through, the visceral pleura and no venous invasion. The tumor is moderately to poorly differentiated with lymphatic invasion suggested. All surgical margins are free of tumor, and no lymph nodes are involved (pT2, pNO, pMX). EGFR and KRAS mutation status should be determined for potential Tyrosine-Kinase Inhibitor therapy, and ALK gene rearrangement testing is available if needed.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient is diagnosed with pulmonary adenocarcinoma, with a tumor size of 1.2 cm. The tumor focally invades the visceral pleura but does not penetrate it, and there is no venous invasion. The lymph nodes are not involved, with 7 examined and 0 positive for cancer (pNO). Surgical margins are free of tumor, and the patient's TNM staging is pT2, pNO, pMX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8302.aa106e5a-b9b9-4f54-b902-120e8a3eb689',\n",
       "  'report_length_cl100k_base': 1852,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive adenocarcinoma, with a tumor size of 1.6 x 1.3 x 1.1 cm. There is no direct extension of the tumor identified, and the visceral pleura is negative for carcinoma. One mediastinal lymph node out of seven is positive for metastatic carcinoma (1/7), with a metastasis size of 0.2 cm. The patient's cancer is classified as pT1a pN2. No extracapsular extension is found, and the bronchial margin is negative for carcinoma.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an invasive adenocarcinoma, with a tumor size of 1.6 x 1.3 x 1.1 cm. There is no direct extension of the tumor identified, and the visceral pleura is negative for carcinoma. One out of seven mediastinal lymph nodes (level 7) is positive for metastatic carcinoma, with a metastasis size of 0.2 cm. The patient's pathological stage is pT1a pN2. No extracapsular extension is found, and the bronchial margin is negative for carcinoma.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-55-8505.401f1ed0-5da9-442f-ac17-6394e72e88ae',\n",
       "  'report_length_cl100k_base': 1441,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is stage IIB, with a tumor size of 7x6x5cm, unifocal adenocarcinoma in the right upper lobe of the lung, extending through the parietal pleura and into the chest wall. There is no lymphatic or vascular invasion, and the tumor has not metastasized to regional lymph nodes or distantly.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is stage IIB, with a tumor size of 7x6x5cm, unifocal adenocarcinoma in the right upper lobe of the lung, extending through the parietal pleura and into the chest wall. There is no lymphatic or vascular invasion, and the margins are negative for tumor. Ten peribronchial lymph nodes were negative for metastasis. The tumor is poorly differentiated and EGFR and ALK testing were not performed as it did not meet the criteria. The patient's sample does not meet the Lung Cancer Committee criteria for reflex EGFR and ALK testing.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8506.448de79c-d662-4783-a7c8-32a224ee5375',\n",
       "  'report_length_cl100k_base': 2126,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient has a moderately differentiated adenocarcinoma in the right upper lobe of the lung, with a tumor size of 1.5 cm. The neoplasm is adjacent to but does not invade the pleura. There is no residual carcinoma identified in the margins of excision. The hilar lymph node is reactive but does not contain metastatic neoplasm. The patient's AJCC stage is T1a, NO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with moderately differentiated adenocarcinoma in the right upper lobe of the lung, with a tumor diameter of 1.5 cm. The neoplasm is adjacent to but does not invade the pleura. The patient's AJCC stage is T1a, NO. The margins of excision are free of neoplasm, and no residual carcinoma is identified. The hilar lymph node is reactive but does not contain metastatic neoplasm.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8507.2658f9b1-c419-42f1-944c-8148b00e13b0',\n",
       "  'report_length_cl100k_base': 502,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's pathological report indicates a T2a lung adenocarcinoma with a 3.7 cm tumor in the right upper lobe, not involving the pleural surface. One interlobar lymph node was negative for malignancy, but one of five peribronchial lymph nodes was positive for metastatic adenocarcinoma (N1 status). There is no evidence of distant metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathological report indicates a pulmonary adenocarcinoma tumor measuring 3.7 cm in the right upper lobe of the lung, not involving the pleural surface. One interlobar lymph node was negative for malignancy, but one of five peribronchial lymph nodes was positive for metastatic adenocarcinoma. The tumor has a pathological AJCC stage of T2a, N1.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-55-8508.c5d96896-7988-469a-b521-39affeab8f95',\n",
       "  'report_length_cl100k_base': 553,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\n The patient has been diagnosed with adenocarcinoma of the lung, with a tumor size of 4.5 x 3.0 x 2.5 cm, located in the right upper lobe. There is no evidence of visceral pleural invasion or lymphovascular space invasion. The tumor is unifocal and poorly differentiated. No metastatic carcinoma was identified in the excised lymph nodes. The patient's pTNM stage is pT2a NO. The lung cancer molecular panel is pending, and the results will be reported as an addendum.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient was diagnosed with adenocarcinoma of the right upper lobe lung, with a tumor size of 4.5 x 3.0 x 2.5 cm. There was no lymph node involvement or metastasis identified. The tumor was unifocal, poorly differentiated, and limited to the pulmonary parenchyma. Surgical margins were clear, and the patient's pTNM stage was pT2a NO. Lymph nodes from stations 10, interlobar, right paratracheal, and subcarinal areas were excised, with no metastatic carcinoma found (0/4). The lung cancer molecular panel is still pending.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8511.b44d3138-fbf3-4b0b-a082-606070f1c6b9',\n",
       "  'report_length_cl100k_base': 1161,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma arising within the background of bronchial alveolar carcinoma, with a tumor size of 1.7 x 1.5 x 1.1 cm. It is unifocal and well-differentiated, with lymphovascular space invasion present. The tumor is limited to the pulmonary parenchyma, with no visceral pleural invasion. Two out of eight lymph nodes contain metastatic carcinoma. The tumor is 2.6 cm from the bronchial margin and 4.1 cm from the closest staple line. The patient's pTNM stage is pT1 N1.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient was diagnosed with adenocarcinoma arising within the background of bronchial alveolar carcinoma in the right lower lobe of the lung. The tumor size was 1.7 x 1.5 x 1.1 cm, and it was unifocal. Lymphovascular space invasion was present, but visceral pleural invasion was not identified. The tumor was limited to the pulmonary parenchyma. The patient's lymph nodes were involved, with 2 out of 8 lymph nodes containing metastatic carcinoma. The tumor was classified as pT1 N1. The patient's surgical margins were clear, with the tumor being 2.6 cm from the bronchial margin and 4.1 cm from the parenchymal margin. The lung cancer molecular panel was pending, and results will be reported as an addendum.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-55-8512.5146c0eb-7bbb-4160-a52f-c0d0ee34ff83',\n",
       "  'report_length_cl100k_base': 887,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is a poorly differentiated non-small cell carcinoma, with a tumor size of 3.7 x 3.5 x 3.3 cm, located in the left upper lobe, posterior mid region. There is no visceral pleural invasion or lymphovascular space invasion identified. The tumor is unifocal and confined to lung parenchyma. One peribronchial lymph node was negative for metastatic carcinoma (0/1). The cancer is classified as pT2a NO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is classified as a poorly differentiated non-small cell carcinoma with adenosquamous features. The tumor is unifocal, measures 3.7 x 3.5 x 3.3 cm, and is located in the left upper lobe, posterior mid region. There is no visceral pleural invasion or lymphovascular space invasion. The cancer is pT2a NO, with no lymph node metastasis (0/4). The patient's lymph nodes (levels 5, 6, 7, and 9) are negative for metastatic carcinoma (0/4).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8614.f443d31b-ee7f-4285-9529-6f04a8dad0d5',\n",
       "  'report_length_cl100k_base': 1342,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma of the right lung, with a tumor size of 9.5 x 8.5 x 6.5 cm. It is moderately differentiated and involves the middle lobe, extending into but not through the elastic layer (pT3). The cancer is present in five lymph nodes (N2), and there is no evidence of metastasis (M0).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma of the right lung, with a tumor size of 9.5 x 8.5 x 6.5 cm. It is moderately differentiated and involves the middle lobe, extending into but not through the elastic layer (pT3). The cancer is present in five lymph nodes (N2), and there is no evidence of metastasis (M0). The lymph nodes are negative for metastatic carcinoma, and the tumor abuts the pulmonary vasculature without extending through the vascular wall. The patient's stage is pT3N2.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-55-8615.37b4238a-1aea-4670-8c43-b24525b94cdd',\n",
       "  'report_length_cl100k_base': 1543,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's cancer is classified as stage IB, with a moderately differentiated adenocarcinoma tumor of size 4 cm, located in the right upper lobe of the lung. There is no evidence of lymph node involvement, with 16 total nodes examined and none positive for metastasis. There is also no evidence of metastasis to distant sites.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is classified as stage IB, with a moderately-differentiated adenocarcinoma tumor of size 4 cm, located in the right lung upper lobe. There is no evidence of lymph node metastasis, with 16 total nodes examined and none positive for cancer. There is no indication of visceral pleural invasion or distant metastasis. The tumor is unifocal and surrounded by lung tissue or visceral pleura, without invasion of the main bronchus.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8616.4506aced-56d2-4297-9a5c-40539f20be87',\n",
       "  'report_length_cl100k_base': 2005,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is classified as pT1a N1. The tumor is a unifocal adenocarcinoma, moderate to poorly differentiated, measuring 1.9x1.8x1.5cm, located in the left upper lobe of the lung, with no visceral pleural invasion or lymphovascular space invasion. The pathology report indicates one positive lymph node (level VII) out of five examined, with no metastatic disease found in levels V and VI lymph nodes. The tumor is 2.5cm from the parenchymal margin and 0.1cm from the pleural surface.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is classified as pT1a N1. The tumor is a unifocal adenocarcinoma, grade II-III, and is 1.9x1.8x1.5cm in size. It is located in the left upper lobe of the lung and was found to be negative for visceral pleural and lymphovascular space invasion. The surgical margins were 2.5cm from the parenchymal margin and 0.1cm from the pleural surface. One level VII lymph node was positive for metastatic carcinoma, while four level V and VI lymph nodes were negative for metastatic disease.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-55-8620.d74a185a-8e07-46ca-861e-14b0012ddf22',\n",
       "  'report_length_cl100k_base': 853,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient has been diagnosed with adenocarcinoma of the left lower lobe of the lung, with a tumor size of 2.0 x 1.8 cm. There is no evidence of lymphovascular space invasion, and the tumor is well differentiated. The visceral pleura is involved, but the pleural margin is negative. No lymph nodes were found to be involved, and there is no evidence of metastasis. The patient's staging is pT1, NO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient has been diagnosed with adenocarcinoma of the left lower lobe of the lung, measuring 2.0 x 1.8 cm. It is unifocal, well-differentiated, and invades the visceral pleura. There is no lymphovascular space invasion or lymph node involvement. The tumor is classified as pT1, NO. The patient's history also includes renal cell carcinoma, but immunohistochemical stains confirm the lung origin of the tumor. The pleural margin is negative, and additional lymph nodes are negative for metastatic malignancy (0/2). The patient's clinical history includes symptoms/radiologic findings related to the left lower lobe lung mass. The specimen is intact for pathologic assessment, and treatment effect is not identified.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-8621.22990911-a16f-4607-8722-c610ed1c590b',\n",
       "  'report_length_cl100k_base': 1159,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma of the left lower lobe of the lung, with a tumor size of 2.6 cm in the greatest diameter. The cancer extends up to but not into or through the visceral pleura. One out of two peribronchial lymph nodes contain metastatic carcinoma, making it stage pT1b N1. There is no evidence of lymphovascular space invasion or metastasis in the other lymph nodes or tissues.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma of the left lower lobe of the lung, with a unifocal tumor size of 2.6 cm in greatest diameter. There is no visceral pleural invasion or tumor extension identified. The cancer is moderately differentiated and has not spread to the lymph nodes. The patient is classified as stage pT1b N1 due to the presence of a small focus of adenocarcinoma in one of the peribronchial lymph nodes.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-55-A48X.4D06D10F-60F5-4417-BD8E-F2BBCA84BEEB',\n",
       "  'report_length_cl100k_base': 1158,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma of the left lower lobe of the lung, with a tumor size of 5.5 x 5.5 x 5.4 cm. There is no lymphovascular space invasion identified, and the tumor is confined to the lung. The patient is node-negative (0/7), with no metastatic carcinoma found in the lymph nodes. The cancer is classified as stage pT2b NO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's left lung tumor is a unifocal adenocarcinoma, moderately differentiated (grade II), measuring 5.5 x 5.5 x 5.4 cm, with no lymphovascular space invasion identified. The tumor penetrates through the elastic layer into the pleura but not to the pleural surface. The surgical margins are 1.6 cm from the bronchial margin and 0.2 cm from the parenchymal and pleural margins. No metastatic carcinoma is found in the examined lymph nodes (0/7). The tumor is classified as stage pT2b NO.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-A48Y.3542521A-EA16-4CD1-A61A-1FB3AE928FC9',\n",
       "  'report_length_cl100k_base': 1457,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma with the following characteristics: tumor size 2 cm, unifocal, poorly differentiated with solid, micropapillary, and papillary architecture, right upper lobe tumor site, and visceral pleural invasion present. Lymph node involvement is as follows: level 9 right, 0/1; level 11, 1/1; level 10, 4/4; suprapulmonary vein, 1/1; left level 7, 4/4; level 4, 3/11. No metastasis is reported.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient is diagnosed with adenocarcinoma of the right upper lobe of the lung, which is unifocal and measures 2 cm in greatest dimension. The tumor is poorly differentiated with solid, micropapillary, and papillary architecture. There is lymphovascular space invasion present, and the tumor is confined to the lung. The patient has metastatic adenocarcinoma involving lymph nodes at levels 10, 11, and 7, with a total of 8 lymph nodes containing metastatic carcinoma out of 23 examined. The patient's pTNM stage is pT1a N3 MX.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-55-A48Z.74C5526C-5300-4AEA-B2BB-1B78F9B536D9',\n",
       "  'report_length_cl100k_base': 1468,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma, poorly differentiated, with a tumor size of 5.5 x 4.3 x 3.8 cm located in the periphery of the right upper lobe of the lung. There is no visceral pleural invasion, and the tumor is confined to the lung. The lymph nodes are negative for metastatic carcinoma (0/2). The tumor is classified as pT2b, NO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is staged as pT2b, NO. The tumor is a poorly differentiated adenocarcinoma, unifocal, and 5.5 x 4.3 x 3.8 cm in size. It is located in the periphery of the right upper lobe and shows suspicious findings for lymphovascular space invasion. There is no visceral pleural invasion, and the tumor is confined to the lung. The surgical margins are 1.5 cm from the bronchial margin and 2.0 cm from the parenchymal (stapled) margin, with the tumor distance from the pleural surface being 0.1 cm. Two lymph nodes were received, with no metastatic carcinoma found. The patient's specimen is submitted for lung carcinoma mutation panel evaluation.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-A490.4A4BD086-ACA6-4E14-8BC0-4D2393FAD456',\n",
       "  'report_length_cl100k_base': 920,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has been diagnosed with stage IA lung adenocarcinoma. The tumor size is 2.7 cm and 1.4 cm, with no lymph node involvement (pNO) and no distant metastasis (pM). The margins are negative, and the lymphovascular invasion is single-focused in large vessels. There are no perineural invasions or extra-pulmonary structure involvements. The specimen shows two synchronous primaries, one poorly differentiated and the other moderately differentiated.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with two synchronous primaries of adenocarcinoma, moderately and poorly differentiated, in the left lower lobe of the lung, measuring 2.7 cm and 1.4 cm respectively. There is no lymph node involvement (pNO) and no distant metastasis (pM). The tumors have negative margins and are staged as IA. There is single focus of large vessel invasion but no lymphatic or perineural invasion. The patient's lymph nodes are benign (0/19).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-A491.EE286E94-9CDB-4E6C-A768-BB35DA870736',\n",
       "  'report_length_cl100k_base': 2248,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an invasive adenocarcinoma, moderately differentiated, with a tumor size of 1.2 cm in the greatest dimension. There is no visceral pleural invasion or lymphovascular invasion. The cancer is confined to the lung, with no distant metastasis. Nineteen lymph nodes were examined, and none were positive for metastasis. The margins are negative, with an R0 status. The pathologic stage is IA.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is invasive adenocarcinoma, moderately differentiated, with a tumor size of 1.2 cm in the greatest dimension. There is no visceral pleural invasion or lymphovascular invasion. The cancer is confined to the lung, with no distant metastasis. Nineteen lymph nodes were examined, and none contained metastatic carcinoma. The margins are negative, with no perineural invasion. The pathologic stage is IA.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-A492.41F07E95-2D84-47CB-B78D-8F03D9C3D80E',\n",
       "  'report_length_cl100k_base': 2271,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is classified as stage IB, with a tumor size of 3.2 cm, poorly differentiated adenocarcinoma, negative for pleural involvement, and no evidence of lymph node metastasis. There is no indication of distant metastasis. The tumor was located in the right upper lobe of the lung and had a focality of unifocal. The margins of the tumor were uninvolved by cancer, and the lymph nodes were negative for cancer, with a total of 11 nodes examined, including stations 7, 4R, and 12. No fresh tissue is available for ancillary testing. The final TNM classification is pT2aNOMO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is classified as stage IB with a T2a tumor (greater than 3 cm but 5 cm or less in greatest dimension surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus), negative for pleural involvement, and no regional lymph node metastasis. The tumor is a poorly differentiated adenocarcinoma, and there is no evidence of lymphatic vascular invasion or distant metastasis. The patient's sample does not meet stage IV status, and the pathologic stage presumes no distant metastasis. The tumor size is 3.2 cm in the greatest dimension, and the margins are uninvolved by tumor.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-A493.B22D9414-01C4-4042-97E5-3C8B2DF9AD97',\n",
       "  'report_length_cl100k_base': 1922,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's lung adenocarcinoma is unifocal, measuring 3.5 x 3.0 x 1.0 cm, with no visceral pleural invasion or lymphovascular space invasion. There is no evidence of lymph node metastasis (0/8 lymph nodes). EGFR mutation was not detected, but a KRAS mutation (G12D) was found. ALK rearrangement was negative, but additional copies of the ALK region were observed in 80% of cells. The tumor is classified as pT2, N0.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's lung adenocarcinoma is unifocal, measuring 3.5 x 3.0 x 1.0 cm, with no visceral pleural invasion or lymphovascular space invasion. The tumor is classified as T2, NO. No metastatic carcinoma was found in the examined lymph nodes. KRAS mutation was detected, and ALK rearrangement was negative. EGFR mutation was not detected, but a non-pathogenic polymorphism was found. The patient's tumor is moderately differentiated, and the results of the lung carcinoma mutation panel are pending.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-A494.6FB7C18D-27D8-4C04-B8F8-AA7EA16F8C8A',\n",
       "  'report_length_cl100k_base': 1840,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has been diagnosed with two separate lung cancers:\\n\\n1. Right lower lobe adenocarcinoma, poorly differentiated, with a tumor size of 2.7 x 2.5 x 2.0 cm and invasion into the visceral pleura (PL1). There is no evidence of lymphovascular space invasion or tumor extension. The surgical margins are not mentioned. Lymph node status is negative (0/2).\\n2. Right upper lobe squamous carcinoma, poorly differentiated, with a tumor size of 1.0 x 0.9 x 0.7 cm. The tumor does not invade the visceral pleura or lymphovascular spaces, and there is no evidence of tumor extension. The surgical margins are not mentioned. Lymph node status is negative (0/2).',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has two separate tumors, one in the right lower lobe and one in the right upper lobe of the lung. The right lower lobe tumor is an adenocarcinoma measuring 2.7 x 2.5 x 2.0 cm with invasion into the visceral pleura. The right upper lobe tumor is a poorly differentiated squamous carcinoma measuring 1.0 x 0.9 x 0.7 cm with no invasion into the visceral pleura. There is no evidence of lymphovascular space invasion or lymph node metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-A4DF.25E84F93-E9AF-4A09-B3A9-86C5AC80BD4A',\n",
       "  'report_length_cl100k_base': 1768,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma of the right lung upper lobe, with a tumor size of 2.5 x 2.3 x 1.6 cm. There is no lymphovascular space invasion, and the cancer extends to but not through the visceral pleura. The patient is pT1b NO, with no metastasis found in the examined lymph nodes.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma of the right lung upper lobe, with a tumor size of 2.5 x 2.3 x 1.6 cm. There is no lymphovascular space invasion, and the cancer extends to but not through the visceral pleura. The patient is pT1b NO, with no metastasis found in the examined lymph nodes.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-55-A4DG.E1EA2600-CEEE-4009-A2E7-D845153DB167',\n",
       "  'report_length_cl100k_base': 1215,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive lobular carcinoma in the right breast, with a tumor size of 0.4 cm. The cancer is grade 1, ER-positive (70%), PR-positive (20%), and HER2-negative (score 1+). There is no information provided on lymph node involvement or metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive lobular carcinoma, grade 1, right breast wide excision, e-cadherin negative, ER positive in 70%, PgR positive in 20%, HER2 negative (score 1+).',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-5L-AAT0.F9B6971F-23C0-465F-BFEC-778BF228A1AE',\n",
       "  'report_length_cl100k_base': 165,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has invasive lobular carcinoma in the right breast, measuring 1.1 cm in the largest diameter, with clear surgical margins and no lymph node metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with a white, 3.5 x 2.5 x 0.8 cm invasive lobular carcinoma in the right breast, with clear surgical margins and no lymph node metastasis. The axillary lymph nodes are clear of lesions, and the cancer is grade 1.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-5L-AAT1.B5CA42BB-9514-42C6-9FB0-C8889C1DC51A',\n",
       "  'report_length_cl100k_base': 327,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma of the breast, with a tumor size of 3.4 cm and lymph-vascular space invasion present. Lymph node involvement is not applicable as they were not submitted, and there is no evidence of metastasis. The cancer is staged as pT2, pNX.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with invasive ductal carcinoma of the breast, with a tumor size of 3.4 cm in greatest diameter, and lymph-vascular space invasion present. The cancer is classified as stage pT2, with no lymph node involvement (pNX) and no distant metastasis reported. Prognostic markers are pending, and a supplemental report will follow.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-5T-A9QA.2DB5519B-B36D-4616-94F3-601A01185F22',\n",
       "  'report_length_cl100k_base': 1001,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 2.0 x 2.0 x 2.5 cm adenocarcinoma tumor in the left lung lower lobe, with a mixed subtype and visceral pleural infiltration. Lymph node involvement is noted (21/33), and there is evidence of pericardial metastasis (pM1), classifying the cancer as stage T2, N2, and M1, respectively. The tumor grade is G3.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The pathology report describes a 19x16x6cm tumor in the left lung's lower lobe, diagnosed as mixed subtype adenocarcinoma. The tumor has visceral pleural infiltration and lymphangiosis carcinomatosa. The cancer is classified as pT2, with 21/33 lymph nodes affected (pN2) and pericardial metastasis (pM1), indicating a G3 grade.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-62-8394.ffcaea73-0146-4b42-aa1d-e032f6944e3d',\n",
       "  'report_length_cl100k_base': 113,\n",
       "  't_label': 3},\n",
       " {'abstract': 'The patient has a 5.0 cm adenocarcinoma tumor in the right upper lobe of their lung, with infiltration of the visceral pleura. There are several tumor nodules in the same lobe. The tumor is staged as pT4, with no lymph node involvement (pNO), and no evidence of metastasis (pMx). The tumor is graded as G2. EGFR mutation analysis was negative. According to the current TNM classification, it would be considered pT3.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient has been diagnosed with adenocarcinoma, mixed subtype, with a tumor size of approximately 5.0 cm. The cancer has infiltrated the pleura visceralis and there are several tumor nodules in the same lobe. There is no lymph node involvement (pNO) and no metastasis (pMx). The tumor is classified as pT4 and G2. EGFR mutation analysis was conducted and the result was negative.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-62-8395.d30859b7-5af5-4579-854b-bab436e3ae9a',\n",
       "  'report_length_cl100k_base': 148,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's pathology report indicates a 3.7 x 2.8 x 3.0 cm adenocarcinoma tumor in the right lower lobe of the lung, with mixed subtypes including papillary, acinar, and mucinous. There is infiltration of the pleura parietalis. The tumor is classified as T3, with no lymph node involvement (pNO: 0/42), and no evidence of metastasis (pMx). The tumor grade is G2.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient has been diagnosed with adenocarcinoma, mixed subtype, with a tumor size of 3.7 X 2.8 X 3.0 cm in the right lower lobe of the lung. There is infiltration of the pleura parietalis and no lymph node involvement (pNO: 0/42). The cancer has not metastasized (pMx), and the tumor grade is G2.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-62-8397.129e57ab-653d-4b31-8777-0fdd6d01a89d',\n",
       "  'report_length_cl100k_base': 104,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, mixed subtype, with a tumor size of 10.0 X 8.0 X 7.0 cm in the right lung's lower lobe. It is classified as pT2, with lymph node involvement (pN2, 10/35), and no information on metastasis (pMx). The tumor cells are positive for CK7, CK18, CEA, and partially positive for TTF1 and Chromogranin A, but negative for synaptophysin and CD56.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with adenocarcinoma, mixed subtype, with a tumor size of 10.0 X 8.0 X 7.0 cm in the right lung's lower lobe. The cancer has spread to the lymph nodes (pN2), with 10 out of 35 nodes affected. There is no evidence of distant metastasis (pMx). The tumor has a partial neuroendocrine component and infiltrates the pleura visceralis. The tumor cells are positive for CK7, CK18, CEA, and partially positive for TTF1 and Chromogranin A, but negative for synaptophysin and CD56.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-62-8398.49359dce-0df1-4d52-87e8-aba44fd43363',\n",
       "  'report_length_cl100k_base': 185,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's lung cancer is classified as T2 (tumor size 4.0 X 3.0 X 5.0 cm), N2 (7/30 lymph nodes involved), and Mx (metastasis status unknown) based on the pathology report. The tumor is an adenocarcinoma with papillary and acinar characteristics, graded as G2.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient has been diagnosed with adenocarcinoma, which is mostly papillary and partially acinar. The tumor size is 4.0 X 3.0 X 5.0 cm and is located in the left upper lobe of the lung. The cancer has spread to 7/30 lymph nodes, indicating pN2 involvement. The patient's cancer is classified as pT2 and pMx, with a G2 grade.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-62-8399.10c88394-5444-48a1-be79-56733264d087',\n",
       "  'report_length_cl100k_base': 87,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 2.5 cm adenocarcinoma in the right upper lobe of the lung, with pleural visceralis infiltration. The tumor is categorized as T2, N2 (8/28 lymph nodes involved), and Mx (metastasis cannot be assessed). The cancer is positive for EGFR mutation (p.E746_A750del).',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient has been diagnosed with adenocarcinoma, mixed subtype, with a tumor size of 2.5 X 2.5 X 1.5 cm in the right upper lobe of the lung. The cancer has infiltrated the pleura visceralis and has spread to 8/28 lymph nodes, indicating pT2 and pN2 status, respectively. There is no information on metastasis, so the patient is considered pMx. The tumor is graded as G3, and an EGFR mutation analysis revealed a positive result for the p.E746_A750del (c.225_49del) mutation.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-62-8402.c5ebd021-924a-48b4-a401-b7802f7acf92',\n",
       "  'report_length_cl100k_base': 145,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 6cm adenocarcinoma in the right lower lobe of the lung, with pleural visceralis infiltration. There is no lymph node involvement (pNO) and the metastasis status is unknown (pMx). The tumor is grade 3, and Ki-67 is 40-50%. The tumor cells are positive for CK7 and CEA, and negative for Chromogranin A, Synaptophysin, NSE, CK13, CK14, and CD56. Some tumor cells are positive for TTF1 and Vimentin.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The pathology report describes a 14.0 X 11.0 X 10.0 cm tumor in the right lower lobe of the lung, diagnosed as adenocarcinoma (NOS). The tumor size is 6.0 X 5.5 X 4.5 cm, with pleural visceralis infiltration. The patient is stage pT2, pNO (0/22), pMx, G3. Additional testing reveals tumor cells positive for CK7, CEA, and some positive for TTF1 and Vimentin, while negative for Chromogranin A, Synaptophysin, NSE, CK13, CK14, and CD56. Ki-67 is at 40-50%.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-62-A46O.C1EAC8C9-2538-4FEB-9DFF-FF9AE7A20F42',\n",
       "  'report_length_cl100k_base': 157,\n",
       "  't_label': 1},\n",
       " {'abstract': \" The patient's lung cancer is an adenocarcinoma mixed subtype, with a tumor size of 6.0 cm in diameter. There is no lymph node involvement (pNO) and no evidence of metastasis (pMx). The tumor grade is G2.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The pathology report describes a lung tumor, specifically an adenocarcinoma mixed subtype (papillary and acinar) with a size of 6.0 cm. The tumor is classified as pT2 and there is no lymph node involvement (pNO, 0/7). The metastasis status is unknown (pMx) and the tumor grade is G2.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-62-A46P.1520ADC4-F5A7-4412-B2E7-A26326EE0074',\n",
       "  'report_length_cl100k_base': 85,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 4cm adenocarcinoma in the left lower lobe of their lung, with no lymph node involvement (pNO) and no evidence of metastasis (pMx). The tumor has a mixed subtype and infiltrates the pleura visceralis. The cancer is classified as stage T2 and grade G2.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The pathology report describes a 15.0 x 10.0 x 7.0 cm lung tumor, with a 4.0 x 3.5 x 2.0 cm adenocarcinoma (mixed subtype) in the left lower lobe. There is infiltration of the pleura visceralis. The tumor is classified as pT2, with no lymph node involvement (pNO: 0/20), and no metastasis (pMx). The tumor grade is G2.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-62-A46R.7AF85E19-CD80-40FD-B0BE-CFFF4B252C0D',\n",
       "  'report_length_cl100k_base': 106,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has a 8.0 x 7.0 x 4.0 cm adenocarcinoma, papillary tumor in the left upper lobe of their lung, with pleural visceral infiltration. There is no lymph node involvement (pNo: 0/37) and the metastasis status is unknown (pMx). The tumor grading is G2.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The pathology report describes a tumor in the left upper lobe of the lung, measuring 8.0 X 7.0 X 4.0 cm. The diagnosis is adenocarcinoma, papillary, with infiltration of the pleura visceralis. The tumor is classified as pT2, with no lymph node involvement (pNo) and no metastasis (pMx). The tumor grade is G2.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-62-A46S.56821636-8883-494F-A808-61AD827CE524',\n",
       "  'report_length_cl100k_base': 104,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathology report indicates a tumor size of 4.8 x 3.5 x 3.0 cm in the right lower lobe of the lung, with a diagnosis of mixed subtype adenocarcinoma (partially papillary, acinar, solid). There is no infiltration of the pleura visceralis, and the cancer has spread to 2 out of 54 lymph nodes (pN1). The metastasis status is unknown (pMx), and the tumor grade is G3.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient has been diagnosed with adenocarcinoma mixed subtype (partially papillary, acinar, solid) in the right lower lobe of the lung, with a tumor size of 4.8 X 3.5 X 3.0 cm. The cancer has not infiltrated the pleura visceralis and has spread to 2/54 lymph nodes, making it pT2, pN1 (2/54), and pMx. The tumor grade is G3.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-62-A46U.15C4143C-779A-44D7-B75F-867E5E0F7671',\n",
       "  'report_length_cl100k_base': 101,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's lung cancer is an adenocarcinoma mixed subtype, measuring 3.3 X 3.2 X 2.9 cm. It has spread to the pleura visceralis (pT2) with no lymph node involvement (pNO: 0/11) and no distant metastasis (pMx). The tumor grade is G3.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The pathology report describes a 17.0 X 12.0 X 10.0 cm lung tumor, specifically an adenocarcinoma mixed subtype, located in the left lower lobe. The tumor size is 3.3 X 3.2 X 2.9 cm, with pleura visceralis infiltration. There are no lymph nodes involved (pNO: 0/11) and no metastasis (pMx), and the tumor grade is G3.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-62-A46V.FC6490C8-996A-4FD9-B0B5-65ED9E0AE6C7',\n",
       "  'report_length_cl100k_base': 104,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 3.5 cm adenocarcinoma in the right lower lobe of the lung, with predominantly papillary and micropapillary subtypes and partial solid areas. The tumor infiltrates the visceral pleura (pT2) and has spread to 37/39 lymph nodes (pN2), with no information on metastasis (pMx). The tumor grade is G3.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The pathology report describes a tumor in the right lower lobe of the lung, measuring 3.5 X 3.1 X 2.9 cm, diagnosed as mixed subtype adenocarcinoma (predominantly papillary, micropapillary, partially solid). The tumor has infiltrated the pleura visceralis. The patient's cancer stage is pT2, pN2 (37/39), and pMx, indicating tumor size and lymph node involvement.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-62-A46Y.284FE692-BC27-4E0E-A92A-2DF64FF33405',\n",
       "  'report_length_cl100k_base': 107,\n",
       "  't_label': 1},\n",
       " {'abstract': \" The patient's cancer is an adenocarcinoma, with a tumor size of 6.5 x 5.0 x 4.5 cm. There is no lymph node involvement (pNO: 0/14) and no evidence of metastasis (pMx). The tumor infiltrates the pleura visceralis and is graded as G2.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The pathology report describes a tumor in the right upper lobe of the lung, measuring 6.5 x 5.0 x 4.5 cm. The diagnosis is adenocarcinoma, with predominant acinar pattern and infiltration of pleura visceralis. The tumor is classified as pT2, with no lymph node involvement (pNO, 0/14), and no metastasis (pMx). The tumor grade is G2.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-62-A470.C0136855-AF03-4065-8563-5C2B232D7070',\n",
       "  'report_length_cl100k_base': 92,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 6.5 cm adenocarcinoma in the left upper lobe of their lung, classified as T2b. There are 6 positive lymph nodes out of 28 examined (N1), and the cancer has not spread to distant sites (Mx). The tumor is grade 3, and Ki-67 is 40%. The tumor cells are positive for CK7 and negative for CK5/6, CK14, SP-A, TTF1, CD56, Chromogranin A, and Synaptophysin.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The pathology report describes a 6.5 x 6.5 x 5.0 cm adenocarcinoma tumor in the left upper lobe of the lung, with no infiltration of the pleura visceralis. The tumor is classified as pT2b and pN1 (6/28), indicating a moderately advanced stage. There is no evidence of metastasis (pMx). The tumor cells are positive for CK7 and negative for CK5/6, CK14, SP-A, TTF1, CD56, Chromogranin A, and Synaptophysin. The Ki-67 index is 40%.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-62-A471.5F2495BD-2398-4C97-8F3E-76E979F22691',\n",
       "  'report_length_cl100k_base': 152,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has two adenocarcinoma tumors in the right lower lobe of the lung, measuring 14.0 x 4.0 x 2.8 cm and 2.5 x 2.2 x 2.1 cm. Tumor 1 has infiltrated and broken the pleura visceralis, indicating a T3 classification. There is no lymph node involvement (pNo) and no evidence of metastasis (pMx). The tumors are graded as G3.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The pathology report describes two adenocarcinoma tumors in the right lower lobe of the lung, measuring 14.0 x 4.0 x 2.8 cm and 2.5 x 2.2 x 2.1 cm respectively. Tumor 1 infiltrates and breaks the pleura visceralis, indicating a T3 classification. There is no lymph node involvement (pNo) and the metastasis status is unknown (pMx). The tumors are graded as G3.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-62-A472.1C47AD8C-F1EB-4B7E-9633-3260EF8CEAE4',\n",
       "  'report_length_cl100k_base': 119,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's cancer is a poorly differentiated non-small cell carcinoma of the right lower lobe of the lung, measuring 2.5 cm. There is no angiolymphatic space invasion identified. The bronchial and vascular margins are negative for tumor. Five peribronchial and one intrapulmonary lymph node are negative for metastatic carcinoma. Level 9 and 10 lymph nodes are negative for metastatic carcinoma, but level 7 lymph nodes are positive for metastatic carcinoma. The cancer is classified as T1 N0 MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"\\nThe patient has a poorly differentiated non-small cell carcinoma in the right lower lobe of the lung, with a tumor size of 2.5 cm and no angiolymphatic space invasion. The bronchial and vascular margins are negative for tumor. Five peribronchial and one intrapulmonary lymph node are negative for metastatic carcinoma. Level 9 and 10 lymph nodes are negative for metastatic carcinoma, but level 7 lymph nodes are positive for metastatic carcinoma. The patient's cancer is classified as pT1 NO MX.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-64-1676.516b08af-72b5-4b4a-b208-3c874abe63ad',\n",
       "  'report_length_cl100k_base': 1819,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, with a 4 cm tumor in the right lower lobe of the lung, invading the visceral pleura. There is no evidence of tumor in the bronchial or vascular margins, but it is present in two of four lymph nodes (2/4) adjacent to the bronchial margin. The cancer is classified as stage pT2,N2,Mx.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer stage is pT2,N2,Mx. The tumor is an adenocarcinoma, acinar type, grade III, measuring 4 cm and invading the visceral pleura. The bronchial and vascular margins are free of tumor, but two out of four lymph nodes (2/4) in the resected piece of the right lower lobe are positive for metastatic carcinoma. Additionally, one out of five lymph nodes (1/5) in level 7 and one out of one lymph node (1/1) in level 3 are also positive for metastatic carcinoma. There is no evidence of tumor in the level 4 and level 10 lymph nodes.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-64-1677.31f047f0-df34-44d4-b0d1-a3b43833f560',\n",
       "  'report_length_cl100k_base': 1386,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's pathology report indicates no tumor seen in multiple lymph nodes from various locations (4R, additional 4R, level 7, 4L, 2R, and level 11), with no lymphovascular space invasion. The right middle lobe lung tumor measures 6cm and is classified as poorly differentiated adenocarcinoma (pT2NoMx).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathology report indicates no tumor seen in various lymph nodes (0/111), with a final diagnosis of poorly differentiated adenocarcinoma in the right middle lobe of the lung, measuring 6cm, with no visceral pleural invasion and negative bronchial and vascular margins. Lymph nodes 4R, 4L, 2R, 7, 10R, and level 7 and 111 were clear of tumor (0/111).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-64-1678.5b49e9b0-c7f5-43a2-9d48-34c1537c148d',\n",
       "  'report_length_cl100k_base': 1896,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is a moderately differentiated adenocarcinoma, with a tumor size of 2.0 cm in the greatest dimension, located in the right upper lobe of the lung. Lymphovascular invasion is present, but the tumor does not invade the visceral pleura. There is no evidence of lymph node involvement in levels 6, 7, 9, and 4R, but the pre-carinal lymph node is positive for metastatic adenocarcinoma. The cancer is classified as pT1 N2 Mx.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has right lung cancer, with a moderately differentiated adenocarcinoma tumor measuring 2.0 cm in the greatest dimension. Lymphovascular invasion is present, but the tumor does not invade the visceral pleura. Seven hilar and peribronchial lymph nodes were removed, with no tumor seen. The pre-carinal lymph node was positive for metastatic adenocarcinoma. The patient's cancer is classified as pT1 N2 Mx.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-64-1679.dd4816b8-a99f-4f95-94b1-75b011509c2d',\n",
       "  'report_length_cl100k_base': 1339,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's right lung cancer is classified as T2 N2 M1. The tumor size is 8.0 cm, with no evidence of tumor in the resection margins. There is lymphovascular invasion and metastasis to level 7, 9, 10, and 11 lymph nodes. No metastasis to level 6 or 4R lymph nodes.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has right lung cancer, with a tumor size of 8.0 cm and invasion into the visceral pleura. Lymphovascular invasion is identified, and there is no evidence of metastasis. The cancer is classified as adenocarcinoma, WHO mixed subtype. The patient has metastatic carcinoma in five of the fifteen lymph nodes (5/15), two of three lymph nodes (2/3), and one of eight lymph nodes (1/8). The surgical resection margins are free of carcinoma, and no tumor is seen in ten lymph nodes (0/10). The cancer is staged as T2 N2 M1.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-64-1680.8daa91a5-773c-4c8b-ab17-b270aa75ec18',\n",
       "  'report_length_cl100k_base': 1535,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathological report indicates a right lung adenocarcinoma (2.5 cm) with no angiolymphatic invasion and no tumor found in the bronchial or vascular margins. There is no evidence of lymph node involvement, with no tumor seen in the 1OR, level 8R, 11R, 4R, 2R, 4R, 7 lymph nodes, and 10R lymph nodes (0/1, 0/7, 0/5, 0/13, 0/6, 0/8, and 0/2 respectively). The tumor is classified as pT1 NO Mx.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathology report indicates that there is no evidence of tumors in any of the lymph nodes (0/1, 0/7, 0/5, 0/4, 0/13, 0/6, 0/8) and no tumors seen in the bronchial margin, visceral pleura, or vascular margin. The tumor size is 2.5 cm and is well-differentiated adenocarcinoma. There is no angiolymphatic invasion. The cancer has not metastasized (pT1 NO Mx).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-64-1681.de31291a-ced6-458b-8fb7-ad47ae581b64',\n",
       "  'report_length_cl100k_base': 1209,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's right lung cancer is a poorly differentiated adenocarcinoma with clear cell changes, measuring 7 cm. There is no invasion of the visceral pleura. The bronchial and vascular margins are negative for tumor. No tumor is found in fifteen peribronchial lymph nodes (0/15).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has right lung cancer, with no tumor found in the portion of the sixth rib, mediastinal lymph node level 9, right level 4 lymph node, or level 7 lymph node. The right lung pneumonectomy revealed a 7 cm poorly differentiated adenocarcinoma with clear cell changes and negative bronchial and vascular margins. No tumor was found in fifteen peribronchial lymph nodes.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-64-5774.d8d1fecd-1290-4d5a-a98b-3c29f789bde6',\n",
       "  'report_length_cl100k_base': 873,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has lung adenocarcinoma with tumor size T4, with no information on lymph node involvement (NX), and metastasis status (Mx). The tumor has invaded the chest wall and skin, with ulceration and extension to the circumferential margin and deep tissue free wall. The tumor is positive for CK7, TTF-1, Cam 5.2, cytokeratin AE1/AE3, and vimentin, and negative for other markers, supporting the diagnosis of primary lung adenocarcinoma.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has lung adenocarcinoma with invasion into the chest wall and skin, and ulceration extending to the circumferential margin and deep tissue free wall. The tumor is positive for CK7, TTF-1, Cam 5.2, cytokeratin AE1/AE3, and vimentin, and negative for MA903, CK20, CD31, CD34, CD45, CD20, Calretin, EMA, Melan A, HMB-45, and S-100 protein. The tumor is classified as T4 NO Mx.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-64-5775.eb576e3d-fa59-42b7-af77-416013a9bc90',\n",
       "  'report_length_cl100k_base': 907,\n",
       "  't_label': 3},\n",
       " {'abstract': \"The patient's right lung cancer is classified as T2 (tumor size 3.7 cm), N0 (no regional lymph node metastasis), and M0 (no distant metastasis), with a moderately differentiated adenocarcinoma in the right upper lobe that invades the visceral pleura. The tumor does not involve the bronchus and there is no vascular invasion. A total of 84 regional lymph nodes were examined, with no evidence of cancer found.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has right lung adenocarcinoma, with a 3.7 cm tumor in the upper lobe that invades the visceral pleura. There is no vascular invasion, and margins are uninvolved by invasive carcinoma. A total of 84 regional lymph nodes were examined, with no regional lymph node metastasis found. The cancer is classified as T2 NO Mx.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-64-5778.36cf9846-5ec1-4d43-8b66-80a802c6b4e7',\n",
       "  'report_length_cl100k_base': 1355,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's left lung adenocarcinoma (WHO acinar subtype) measures 8.5 cm and is poorly differentiated with angiolymphatic invasion. The tumor does not involve the visceral pleura, and surgical resection margins are free of carcinoma. Lymph node metastasis is present in 2/15 level 5 lymph nodes, 3/6 11L lymph nodes, and 2/3 level 7 lymph nodes, but not in the 7 level 8 lymph nodes or 0/3 level 6 lymph nodes. The patient's cancer is classified as pT2 N2 Mx.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has left lung adenocarcinoma, with metastatic carcinoma found in two of fifteen lymph nodes (2/15) and four of twelve peribronchial lymph nodes (4/12). The tumor size is 8.5 cm and does not invade the visceral pleura, with angiolymphatic invasion identified. The patient is classified as pTNM: T2 N2 Mx.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-64-5779.74ed3c2e-6708-48d7-bc21-5fc04999614f',\n",
       "  'report_length_cl100k_base': 1914,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's lung cancer is an invasive adenocarcinoma, poorly differentiated, with a tumor size of 6.5 cm in the right upper lobe. There is no involvement of the pleura or large vessel invasion. A total of 52 regional lymph nodes were examined, with no regional lymph node metastasis found. The cancer has not spread to other organs or tissues.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's lung cancer is classified as adenocarcinoma, WHO mixed subtype, with a tumor size of 6.5 cm in the right upper lobe. There is no involvement of the pleura or large vessel invasion. A total of 52 regional lymph nodes were examined, with no regional lymph node metastasis found (0/52). The cancer is staged as pT2 NO Mx.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-64-5781.988a550c-800e-4ba9-9c6a-de986969753b',\n",
       "  'report_length_cl100k_base': 1219,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has invasive poorly differentiated adenosquamous carcinoma in the right upper lobe, measuring 6.5 cm, with no angiolymphatic invasion and free bronchial and vascular margins. Two out of two lymph nodes at the 10R level showed metastatic carcinoma, and no tumor was found in the other examined lymph nodes. The cancer is classified as pT2 N1 Mx.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': '\\n The patient has lung cancer with an invasive poorly differentiated adenosquamous carcinoma in the right upper lobe, measuring 6.5 cm, invading through visceral pleura, with no angiolymphatic invasion. The tumor is classified as pT2 N1 Mx. Five parabronchial lymph nodes and two lymph nodes from the 10R level were found to have metastatic carcinoma, while the other examined lymph nodes, including the 9th, 7th, and 11th levels, showed no tumor. No venous or arterial large vessel invasion was identified.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-64-5815.d7bef7c7-2687-4d23-96b2-8dd1f5305997',\n",
       "  'report_length_cl100k_base': 1464,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma of the right upper lobe of the lung, measuring 2.8 cm. There is no evidence of lymph node involvement, with all examined lymph nodes negative for tumor. There is no indication of metastasis. The cancer is confined to the lung, with uninvolved margins and no invasion of pleura or other structures. The patient's pTNM stage is pT1 NO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma of the right upper lobe of the lung, measuring 2.8 cm. There is no evidence of lymph node involvement, with all examined lymph nodes negative for tumor. There is no indication of metastasis. The cancer is confined to the lung, with uninvolved bronchial and vascular margins. The patient's pTNM stage is pT1 NO.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-67-3770.93f88ca0-8ac7-486f-a253-d258a0744c77',\n",
       "  'report_length_cl100k_base': 1562,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is a 2.5 cm adenocarcinoma in the left upper lobe of the lung, with no lymph node involvement and no evidence of metastasis. The tumor is confined to the lung, with uninvolved bronchial and vascular margins, and no visceral pleural invasion identified. Five lymph nodes were examined, all of which were negative for tumor. The final diagnosis is non-small cell carcinoma with features of adenocarcinoma of the lung. Immunohistochemistry for cytokeratin 7 is positive, and CK20, CK5/6, and P63 are negative. TTF-1 results are pending.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's frozen section samples from levels 5, 6, and 9L were negative for tumor. The left upper lobe lobectomy revealed a 2.5 cm adenocarcinoma tumor. The tumor was confined to the lung with no invasion identified. The bronchial, vascular, and parenchymal margins were uninvolved, and there was no lymph node involvement (N1: 0/5+, N2: 0/8+, N3: 0/0). The final diagnosis was non-small cell carcinoma with features of adenocarcinoma of the lung. Immunohistochemistry for cytokeratin 7 was positive, and CK20, CK5/6, and P63 were negative. TTF-1 was also negative, and results of repeat TTF-1 will be issued as an addendum.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-67-3771.4bcfc5f3-136c-46b5-8e90-6be1abe3a9d8',\n",
       "  'report_length_cl100k_base': 1794,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is a moderately differentiated adenocarcinoma of the right upper lobe of the lung, measuring 4.3 cm. The tumor invades the visceral pleura and is 3 cm from the closest resection margin. There is no involvement of the bronchial or vascular margins. No lymph nodes are involved (N0), and there is no evidence of metastasis. The tumor is staged as pT2 NO (AJCC 6th addition).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient's cancer is an adenocarcinoma with focal papillary features, located in the right upper lobe of the lung, measuring 4.3 cm. There is no invasion into the visceral pleura or other structures, and no lymph node involvement was found (N1: 0/6, N2: 0/8, N3: 0/0). The tumor is considered moderately differentiated.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-67-3772.1b3a5b8e-7469-4fd6-b314-ad1fd7a2b957',\n",
       "  'report_length_cl100k_base': 2819,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is a moderately differentiated adenocarcinoma of the lung spanning 1.5 cm in dimension, with no lymph node involvement. The tumor penetrates the visceral pleura and the surgical margins of resection are negative for tumor. The cancer is classified as pT2, pNo, MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's left lower lobe lung tumor is a moderately differentiated adenocarcinoma, sized at 1.5cm, with focal visceral pleural invasion. There is no lymph node involvement, as all examined nodes (levels 5, 6, 9L, posterior hilar, and superior segmental) tested negative for tumor. The tumor is staged as pT2, pNo, MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-67-3773.e5b82f07-698e-4dff-9d33-748790e40811',\n",
       "  'report_length_cl100k_base': 2371,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an infiltrating, moderately differentiated adenocarcinoma with focal bronchoalveolar features, measuring 3.3 cm in size, located in the left lower lobe of the lung. There is no vascular invasion observed, and the tumor closely approaches but does not appear to invade the visceral pleura. The bronchial and vascular margins, as well as seven lobar lymph nodes, are negative for tumor. The cancer is classified as pT2a pNO MX (Stage IB).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's frozen section was negative for tumor. The left lower lobe lung lobectomy revealed a 3.3 x 3 x 1.5 cm infiltrating, moderately differentiated adenocarcinoma with focal bronchoalveolar features. The tumor closely approaches but does not appear to invade the visceral pleura, and there is no vascular invasion seen. The bronchial and vascular margins and seven (7) lobar lymph nodes are negative for tumor. The patient's pTNM stage is pT2a pNO MX (Stage IB).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-67-3774.a1d72b00-7384-4a8f-b335-5beb9ae078fc',\n",
       "  'report_length_cl100k_base': 1289,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a moderately differentiated adenocarcinoma of the right lower lobe of the lung, measuring 3.8 cm. The tumor is confined to the lung with no invasion of pleura or other structures. The bronchial and parenchymal margins are uninvolved, and there is no venous or arterial invasion. One of the examined lymph nodes (level 10) is involved with metastatic carcinoma, while the remaining lymph nodes (levels 9, 8R, 11R, and 7) are negative for tumor. There is no evidence of N2 or N3 lymph node involvement. The cancer is classified as pT2 N1 MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is a moderately differentiated adenocarcinoma in the right lower lobe of the lung, measuring 3.8 cm. The tumor is confined to the lung with no invasion of pleura or other structures. The margins, including bronchial, parenchymal, and vascular, are uninvolved. There is no venous or arterial invasion. 2 out of 3 examined lymph nodes are involved (level 10), and there is no N2 or N3 lymph node involvement. The cancer is classified as pT2 N1 MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-67-3776.fa5eb6ae-8741-4e93-950d-384fa70b9f1d',\n",
       "  'report_length_cl100k_base': 1572,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a well-differentiated bronchioloalveolar adenocarcinoma, grade I, with a maximum tumor size of 12.5 cm. It extends to within 2.8 cm of the bronchial margin but does not invade the pleural surface. The tumor involves a single hilar lymph node, and there is no evidence of malignancy in the other examined lymph nodes. The cancer is classified as pT3 N0 MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is a well-differentiated bronchioloalveolar adenocarcinoma, grade I, with a maximum tumor size of 12.5 cm. It extends to within 2.8 cm of the bronchial margin but does not invade the pleural surface. The tumor involves a single hilar lymph node, and there is no evidence of malignancy in the other examined lymph nodes. The cancer is classified as pT3 N0 MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-67-4679.3528ccec-afff-4212-97aa-1d4f7af79856',\n",
       "  'report_length_cl100k_base': 2037,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's cancer is a well-differentiated adenocarcinoma, with a tumor size of 4 cm, located in the right lower lobe of the lung. There is no involvement of the visceral pleura, but the tumor extends to the pleural surface with pleural puckering. All surgical margins are negative for tumor, and there is no evidence of venous or arterial invasion. The patient's lymph nodes (N1, N2, and N3) are negative for tumor involvement. The cancer is classified as pT2a NO MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is a well-differentiated adenocarcinoma with broncho-alveolar features, measuring 4 cm in maximum dimension and extending to the pleural surface, but not involving the visceral pleura. The tumor is 4 cm from the bronchial margin. There is no lymph node involvement (N0) and no metastasis (M0). The cancer is classified as pT2a NO MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-67-6215.bdaf595f-ae8e-451f-83d2-3a79ef06b2a3',\n",
       "  'report_length_cl100k_base': 968,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a moderately differentiated, papillary adenocarcinoma with a tumor size of 1.8 cm, confined within the lung and extending within approximately 4 mm of the parenchymal margin and more than 2 cm from the bronchial margin. There is no evidence of vascular invasion or lymph node involvement. The cancer is classified as pTla NO MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is a moderately differentiated, papillary adenocarcinoma with a maximum diameter of 1.8 cm, confined within the lung and extending within approximately 4 mm of the parenchymal margin and more than 2 cm from the bronchial margin. There is no evidence of vascular invasion or lymph node involvement (N1, N2, or N3). The tumor is unifocal and the surgical margins, including bronchial and vascular margins, are uninvolved. The pTNM stage is pT1a NO MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-67-6216.9f6ac234-e3d8-44a9-b82d-0552e49224be',\n",
       "  'report_length_cl100k_base': 1126,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma of the left upper lobe of the lung, with a tumor size of 2.5 cm. The cancer has not spread to the regional lymph nodes but has extended to the pleura. The cancer has not metastasized to distant organs. The tumor is classified as type AB thymoma, with a mixed thymoma (type AB) involving the anterior mediastinum. The patient's pathological stage is IIa (R1) for thymoma and pT2a pN1 for lung cancer.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"\\nThe patient has been diagnosed with stage IIa (R1) thymoma and stage T2a N1 lung adenocarcinoma. The thymoma is 2.5 cm in size, with microscopic transcapsular invasion and involvement of surgical margins. The lung tumor is 2.5 cm and is located in the left upper lobe. One of five hilar lymph node fragments has metastatic carcinoma. The thymoma is immunoreactive for cytokeratin 5/6 but negative for neuroendocrine markers, synaptophysin, and chromogranin. The lung cancer has visceral pleural invasion and no lymph node involvement. The patient's overall survival rate is approximately 66%.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-67-6217.f03e4cad-5322-4068-b986-dd98892e1c85',\n",
       "  'report_length_cl100k_base': 2885,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma with a tumor size of 5 cm located in the right lower lobe. There is no evidence of vascular or lymphatic invasion, and the tumor is stage pT3 NO. Lymph nodes from levels 11, 10R, 7, and 4R were negative for neoplasm. The tumor invades into the mediastinal pleura, but the inked surface is negative for neoplasm. The patient's cancer is classified as stage 2B.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is stage 2B, with a tumor size of 5 cm, no vascular or lymphatic invasion identified, and negative margins. The tumor is located in the right lower lobe and is a mix of acinar and micropapillary patterns with atypical alveolar hyperplasia. Lymph nodes from parts G-K are negative for neoplasm, and the tumor invades the mediastinal pleura. EGFR mutational analysis is pending.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-69-7760.e5c9b2ce-2e5a-4127-8ee4-c6bd4ad99fa0',\n",
       "  'report_length_cl100k_base': 1610,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient has invasive adenocarcinoma of the left lower lobe of the lung, with a tumor size of 4.5 x 3.2 x 3.2 cm. There is no vascular or lymphatic invasion, and the bronchial and parenchymal margins are negative. The patient's lymph nodes are negative for neoplasm, and there is no evidence of metastasis. The pathological stage is AJCC Stage IB (T2a NO MX). Additional stains will be performed to confirm the results.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has invasive adenocarcinoma in the left lower lobe of the lung, with a tumor size of 4.5 x 3.2 x 3.2 cm. There is no vascular or lymphatic invasion, and the bronchial and parenchymal margins are negative. The pathologic stage is IB (T2a NO MX). The lymph nodes from levels 12, L11, and 6 are negative for neoplasm, while the lymph nodes from levels 4R, #7, L4, R2, and L9 are pending further staining and an addendum report. The pleura/soft tissue margin is also pending Movat stains. The patient has patchy organizing fibrinous pneumonia and features of airway remodeling. There are calcified and hyalinized granulomas in the left lower lobe and a portion of the 7th rib, but they are negative for neoplasm.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-69-7761.1148daaf-0315-4639-92dd-f17ff727c6cc',\n",
       "  'report_length_cl100k_base': 1846,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, mixed type, located in the right middle lobe, with a tumor size of 2.1 x 1.2 x 0.5 cm. There is no vascular or lymphatic invasion, and the bronchial and parenchymal margins are negative. Four peribronchiolar lymph nodes were found to be benign with no neoplasm. The cancer is classified as Stage IA (pT1b NO MO) based on the AJCC pathologic staging system. No metastasis is reported.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with adenocarcinoma, mixed type with papillary and bronchioloalveolar patterns in the right middle lobe of the lung, measuring 2.1 x 1.2 x 0.5 cm. There is no vascular or lymphatic invasion, and the tumor is negative for neoplasm. The tumor is stage IA, with no lymph node involvement. The specimen was a right middle lobectomy, and the bronchial margin was negative. The lymph nodes submitted were also negative for neoplasm.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-69-7763.c1af94b6-becb-493d-bfac-2367f2e69490',\n",
       "  'report_length_cl100k_base': 862,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma with acinar and bronchioloalveolar components, located in the right upper lobe of the lung, measuring 2.2 cm in the greatest dimension. There is no vascular or lymphatic invasion, and the tumor is negative for EGFR alterations. The pathological stage is Stage IA (pT1b NO), with no lymph node involvement and negative margins.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma with acinar and bronchioloalveolar components, located in the right upper lobe of the lung, measuring 2.2 cm in greatest dimension. There is no vascular or lymphatic invasion, and the bronchial and parenchymal margins are negative. No neoplasm is detected in the lymph nodes at levels 10 and 11. The tumor is classified as stage IA (pT1b NO) according to the AJCC staging system. EGFR mutational analysis revealed no alteration, and the tumor is wild type. The patient's clinical diagnosis is RUL NODULE.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-69-7764.3518ba0e-79fc-4a98-a308-ecee684e0439',\n",
       "  'report_length_cl100k_base': 793,\n",
       "  't_label': 0},\n",
       " {'abstract': '\\nThe patient has two adenocarcinomas, one in the right upper lobe (1.4cm) and one in the right lower lobe (2.3cm). Both tumors show lymphatic invasion and are classified as pT4N0MX (stage IIIA) according to the AJCC staging system. The lymph nodes (R9, R12, 4R, #7) are negative for neoplasm. EGFR mutation analysis is pending.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has two adenocarcinomas, one in the right upper lobe (1.4cm) and one in the right lower lobe (2.3cm). Both tumors show lymphatic invasion and are classified as stage IIIA (T4 NO MX). The right upper lobe tumor invades the visceral pleura and is negative for vascular invasion, while the right lower lobe tumor is negative for vascular and pleural/soft tissue margins. Lymph nodes from R9, R12, 4R, and 7 are negative for neoplasm. EGFR mutation analysis will be performed and reported as an addendum.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-69-7765.89d3bed4-3090-463f-ac00-c2de1abaabb2',\n",
       "  'report_length_cl100k_base': 1488,\n",
       "  't_label': 3},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma of the lung, with a tumor size of 4.1 x 4 x 3.7 cm, located in the right middle lobe. There is no vascular or lymphatic invasion, and the bronchial margin is negative for neoplasm. The tumor is stage pT2a NO. The pathological staging is Stage IB. The tumor cells are positive for CAM 5.2 and TTF-1, with focal positivity for synaptophysin. The tumor is negative for chromogranin, p63, and CD56. The vascular margin of excision (Part H) contains atypical cells within the lumen, but it is interpreted as negative for neoplasm. The pulmonary vein margin (Part J) has rare clusters of tumor cells present, but the final lower lobe margin of excision (Part O) is negative for neoplasm.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with adenocarcinoma of the lung, with a tumor size of 4.1 x 4 x 3.7 cm, located in the right middle lobe. There is no vascular or lymphatic invasion, and the bronchial margin is negative for neoplasm. The tumor is stage pT2a NO. The patient's lymph nodes, excised from parts 4L, 7, 4R, 2R, R12, and R11, were negative for neoplasm. The tumor cells are positive for CAM 5.2 and TTF-1, with focal positivity for synaptophysin. Clear cell change and focal signet ring cell patterns are present. EGFR mutational analysis is pending. The final lower lobe margin of excision is negative for neoplasm.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-69-7973.fd1b94d4-d5b9-47fe-96ad-4e3d781a638a',\n",
       "  'report_length_cl100k_base': 2346,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's left upper lobe tumor is an adenocarcinoma with solid, acinar, and bronchioloalveolar cell carcinoma components, measuring 3.5 x 2.8 x 2.5 cm. It invades the visceral pleura and is negative for vascular and lymphatic invasion. Lymph nodes in the 10L, 12L, and #5 excision sites are negative for neoplasm, while the 11L lymph nodes show metastatic adenocarcinoma. The tumor is classified as stage IIIA (pT2a N2 MX) according to AJCC pathologic staging.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's left upper lobe tumor is an adenocarcinoma with solid, acinar, and bronchioloalveolar cell carcinoma components, measuring 3.5 x 2.8 x 2.5 cm. It invades the visceral pleura and is negative for vascular invasion. Lymph nodes from 10L, 12L, and #5 are negative for neoplasm, but metastatic adenocarcinoma is present in peribronchial lymph nodes. The tumor is immunoreactive to TTF-1 and focally to p-63, with necrotizing granulomas in peribronchial lymph nodes. The pathologic stage is p stage IIIA (pT2a N2 MX). EGFR Mutation Analysis revealed no EGFR alteration detected, and the tumor cells are wild type.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-69-7974.f2c5dd0c-88d1-4c68-abd0-c5ee5fbade8b',\n",
       "  'report_length_cl100k_base': 1155,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma, mixed type with solid, acinar and bronchioloalveolar cell carcinoma patterns and clear cell features. The tumor size is 6.3 x 2.9 x 2.0 cm, and it infiltrates through the visceral pleura, present at the pleural surface. Vascular invasion is present, but lymphatic invasion is not identified. The cancer is stage IIB (T2b N1 MX) with metastasis to one peribronchial lymph node.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"\\nThe patient's cancer is an adenocarcinoma, mixed type with solid, acinar and bronchioloalveolar cell carcinoma patterns and clear cell features. It is stage IIB (T2b N1 MX) according to AJCC pathologic staging. The tumor is located in the right upper lobe, measuring 6.3 x 2.9 x 2.0 cm, with vascular invasion present and lymphatic invasion not identified. The tumor infiltrates through the visceral pleura and is present at the pleural surface. Lymph nodes #7, L4, R4, R2, #10, R4, and level 7 were negative for neoplasm. Immunohistochemical stains show that the tumor cells are immunoreactive to TTF-1, and EGFR mutation analysis will be performed.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-69-7978.f832fcc5-67a6-472c-9a50-081084bc029c',\n",
       "  'report_length_cl100k_base': 1260,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is stage 1b, with a tumor size of 3.2 x 3.1 x 2.1 cm, no vascular or lymphatic invasion identified, and no metastasis found. The tumor is located in the right upper lobe, and all surgical margins are negative for neoplasm. Lymph nodes from various locations, including L4, 7, 4R, 3, 2R, 2L, 10, 11, and R11 posterior, were excised and found to be negative for malignancy. The bronchial margin and parenchymal margins were also negative for tumor.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"\\nThe patient's cancer is an invasive adenocarcinoma, acinar type, located in the right upper lobe, with a tumor size of 3.2 x 3.1 x 2.1 cm. There is no vascular or lymphatic invasion identified. Surgical margins, including bronchial and parenchymal margins, are negative for neoplasm. The patient's pathological stage is AJCC pT2a pNO pMX Stage 1b. Lymph nodes excised from various locations, including L4, 7, 4R, 3, 2R, 2L, Level 10, Level 11, and R11 posterior, were all negative for malignancy. The tumor is 4 cm from the bronchial margin and 2.5 cm from the parenchymal margin, with no gross invasion of the pleura.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-69-7979.98f68d62-141d-4f50-9987-6e13d35195d2',\n",
       "  'report_length_cl100k_base': 1464,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma located in the right upper lobe of the lung, with a tumor size of 2.5 cm. There is no vascular or lymphatic invasion, and the tumor is negative for neoplasm. The lymph nodes (#4, #7, #11, 10R) are also negative for neoplasm. The pathological stage is T1b NO MO (Stage IIA).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma located in the right upper lobe of the lung, with a tumor size of 2.5 cm. There is no vascular or lymphatic invasion, and the tumor is negative for neoplasm. The lymph nodes (#4, #7, and #11) are also negative for neoplasm. The cancer is classified as stage T1b NO MO (Stage IIA) with a clinical diagnosis of RUL MASS. The patient's lymph nodes and margins are negative for tumor, and there is no evidence of metastasis.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-69-7980.a4a32cf5-43b8-4387-9873-d90f7000b134',\n",
       "  'report_length_cl100k_base': 825,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, micropapillary predominant, with a tumor size of 2x2x1cm located in the right lower lobe, superior segment. It has lymphatic invasion but no vascular invasion. The bronchial and vascular margins are negative, and the parenchymal and pleura/soft tissue margins are also negative. There is no evidence of metastasis. The pathologic stage is p stage IIA (T1a N1 MX). Lymph nodes R11 SUMP showed metastatic adenocarcinoma, while R7 lymph nodes were negative for neoplasm. The tumor is composed of micropapillary (65%), acinar (30%), and lepidic patterns (5%).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, micropapillary predominant, located in the right lower lobe, superior segment, with a tumor size of 2x2x1cm. Lymphatic invasion is present, but vascular invasion is not identified. Lymph nodes R11 are involved with metastatic adenocarcinoma, while R7 nodes are negative for neoplasm. The tumor is classified as p stage IIA (T1a N1 MX) according to AJCC pathologic staging. The adenocarcinoma consists of micropapillary (65%), acinar (30%), and lepidic patterns (5%).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-69-8253.8148140f-8b78-4c05-a2fa-59a25cc6c9d8',\n",
       "  'report_length_cl100k_base': 748,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's pathology report indicates a right lung, lower lobe wedge resection revealing a 5.5 x 3 x 2 cm adenocarcinoma with papillary predominant, micropapillary, and lepidic patterns. The parenchymal margin is negative for neoplasm, and the tumor is suspicious for adenocarcinoma in situ. The report is pending EGFR mutational analysis, and there is no information on lymph node involvement or metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with adenocarcinoma, with tumor size being 5.5 x 3 x 2 cm. The parenchymal margin is negative for neoplasm, and the tumor has been sent for EGFR mutational analysis. The report also mentions centrilobular emphysema and organizing pneumonia. The tumor patterns are papillary predominant, micropapillary, and lepidic. The specimen was a right lower lobe lung wedge resection, and the results of Movats stains for pleural invasion will be reported in an addendum.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-69-8254.3edeafc6-1876-4547-82b2-90e18240061d',\n",
       "  'report_length_cl100k_base': 558,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, solid predominant (40%) with acinar (40%) and lepidic (20%) patterns, measuring 1.6 cm in greatest dimension. The tumor does not invade or penetrate the pleura. The parenchymal margin of excision is negative for neoplasm. Lymph node level 10R excision (B) is negative for neoplasm.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with adenocarcinoma of the right lung, upper lobe, with a tumor size of 1.6 cm. The tumor has no invasion into or through the pleural and the parenchymal margin of excision is negative for neoplasm. Lymph node level 10R excision was negative for neoplasm. Further studies will be performed to define the origin of the adenocarcinoma.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-69-8255.d807cbcd-b72d-47f5-975b-347782728e94',\n",
       "  'report_length_cl100k_base': 584,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is a mucinous adenocarcinoma located in the right lower lobe, superior segment, with a tumor size of 7.5x6.4x4.7cm. There is lymphatic invasion present, but vascular invasion and bronchial margin are negative. The tumor invades into the visceral pleura, but it is not present at the pleural surface. The cancer has not metastasized, and the pathological stage is p Stage IIIA (T3 NO MX). Lymph nodes excised were negative for neoplasm.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"\\nThe patient's cancer is a mucinous adenocarcinoma located in the right lower lobe, superior segment, with a tumor size of 7.5x6.4x4.7cm. There is no vascular invasion, but lymphatic invasion is present. The cancer has not spread to the pleura or soft tissue margins, and lymph nodes are involved. The pathological stage is p Stage IIIA (T3 NO MX). The cancer is negative for vascular invasion and positive for lymphatic invasion. Lymph nodes are negative for neoplasm, and the tumor invades into the visceral pleura but is not present at the pleural surface.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-69-8453.3f4d0319-89c9-4256-b43c-c0b1514c4380',\n",
       "  'report_length_cl100k_base': 1369,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's cancer is stage IIB (pT3, pNO) with a primary tumor in the right upper lobe of the lung, three separate tumor nodules, the largest measuring 3.7cm. There is no lymphatic or vascular invasion, and 11 examined lymph nodes were negative for malignancy. The tumor is adenocarcinoma with solid and acinar predominant histology. No EGFR mutation was detected.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': '\\nThe patient is diagnosed with stage IIB adenocarcinoma of the right upper lobe of the lung. The tumor size is 3.7 cm, and there is no invasion into the visceral pleura. The margins, including bronchial, vascular, and parenchymal, are uninvolved by invasive carcinoma. Lymph node involvement is absent (0/111). The tumor is characterized as solid predominant (80%) and acinar (20%), with a smaller mass being acinar predominant (80%) and micropapillary (20%). Centrilobular emphysema is also present. EGFR mutation analysis reveals wild-type genotype.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-69-A59K.6EF9E448-6E2D-499D-8EC0-7F03B7A10FC8',\n",
       "  'report_length_cl100k_base': 1416,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's cancer is an invasive poorly differentiated adenocarcinoma of the left lower lung lobe, measuring 6.0x3.4x2.5cm, with angiolymphatic invasion present and visceral pleural margin positive for tumor. The bronchial margin is negative for tumor, but the surrounding lung tissue is positive for adenocarcinoma in a background of bronchioloalveolar carcinoma. Two peribronchial lymph nodes were negative for metastasis (0/2). The pathologic stage is pT2 pN0 MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a poorly differentiated adenocarcinoma of the left lower lung lobe, measuring 6.0x3.4x2.5cm, with angiolymphatic invasion and positive visceral pleural margins. The bronchial margin is negative for tumor, but the surrounding lung tissue is positive for adenocarcinoma. Two peribronchial lymph nodes were negative for metastasis (0/2). The pathologic stage is pT2N0MX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-73-4658.37bb6a7b-4f9e-4690-b904-4eebc3189562',\n",
       "  'report_length_cl100k_base': 1495,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, with a tumor size of 9cm, no lymph node involvement in levels 7 and 4R, but positive for metastasis in one lymph node (1/1) in the 4R distal paratracheal and two out of twelve peribronchial lymph nodes (2/12). The tumor is located in both the upper and lower lobes of the right lung, with no pleural involvement. The bronchial margin is negative for invasive carcinoma, but angiolymphatic invasion is present. The non-neoplastic lung tissue shows emphysematous changes. The pathologic stage is pT2 N2 MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, with a tumor size of 9cm, located in both the upper and lower lobes of the right lung. The tumor is 1.5cm from the bronchial margin and not present on the pleural surface. There is angiolymphatic invasion and focal mild to moderate dysplasia at the bronchial margin. Two out of twelve peribronchial lymph nodes are positive for metastatic adenocarcinoma. The pathologic stage is pT2 N2 MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-73-4659.a6f30521-a0d2-4871-8b9f-a338f15ce8e8',\n",
       "  'report_length_cl100k_base': 1714,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's pathological report indicates a moderately differentiated adenocarcinoma in the left upper lobe of the lung, measuring 2cm in greatest diameter. The tumor is negative for angiolymphatic invasion and there is no visceral pleural involvement. The bronchial margins are uninvolved and no satellite tumors are present. Lymph node involvement is absent with 9 lymph nodes examined, and there is no evidence of metastasis. The pathological staging is pT1, N0, MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathology report indicates a positive diagnosis for adenocarcinoma in the left upper lobe wedge, measuring 2cm in greatest diameter. The tumor is classified as mixed subtypes (acinar and bronchioloalveolar), with a histologic grade of G2 (moderately differentiated). There is no evidence of angiolymphatic invasion, bronchial margins are uninvolved, and no satellite tumors are present. Lymph node involvement is negative (N0, 0/9 lymph nodes examined), and there is no indication of metastasis (M0). The patient's pathological staging is pT1, N0, MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-73-4662.5dd8c28f-e814-4a29-a3cd-b3524fa41941',\n",
       "  'report_length_cl100k_base': 1346,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma, poorly differentiated, with a tumor size of 2cm in the greatest diameter, located in the mid lung field of the right upper lobe. The bronchial margins are uninvolved, and there is no angiolymphatic invasion or visceral pleural involvement. The cancer is stage pT1 (tumor size ≤2cm), with no lymph node involvement (N0) and no metastasis (M0).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated adenocarcinoma of the right upper lobe lung. The tumor size is 2cm in greatest diameter, with no angiolymphatic invasion and bronchial margins uninvolved. There are no satellite tumors and no lymph node involvement (N1, N2, and N3 negative). The pathological staging is pT1 (tumor size and characteristics) and MX (no metastasis).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-73-4666.4ab3bc9e-68ae-4c85-9a2a-11ead25ee142',\n",
       "  'report_length_cl100k_base': 1384,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma with a tumor size of 4.2cm in the greatest dimension, located in the left upper lobe. There is no pleural invasion or angiolymphatic invasion identified. The bronchial margins are negative for tumor. One of the eleven peribronchial lymph nodes (1/11) shows metastatic carcinoma with extranodal extension. The patient's cancer is pathologically staged as pT2, N1 (ipsilateral hilar and/or peribronchial), and MX (metastasis cannot be assessed).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathology report indicates a moderately differentiated adenocarcinoma in the left upper lobe of the lung, measuring 4.2cm in the greatest dimension and 3.5cm in an additional dimension. The bronchial margins are negative for tumor, and there is no angiolymphatic invasion. One of the eleven peribronchial lymph nodes (1/11) shows metastatic carcinoma with extranodal extension. The patient is classified as N1 (ipsilateral hilar and/or peribronchial, levels 10-14) with 1 positive lymph node out of 12, and N2 (ipsilateral mediastinal and/or subcarinal, levels 1-9) with 0 positive lymph nodes out of 3. There is no evidence of pleural invasion or satellite tumors. The non-neoplastic lung tissue shows emphysematous changes. The pathological staging is pT2, N1, MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-73-4668.9177e909-f92c-4b50-a256-a4f840a05140',\n",
       "  'report_length_cl100k_base': 1892,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma, poorly differentiated, with a tumor size of 3.5cm in the greatest dimension and 2.8cm x 2.5cm in additional dimensions. There is no angiolymphatic invasion identified, and the pleural surface is negative for tumor. The bronchial margin is also negative for tumor. No malignancy is identified in six peribronchial lymph nodes (0/6). The patient's cancer is classified as N0 (no lymph node involvement) and M1 (metastasis present), as there is a previously diagnosed brain metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, poorly differentiated, with a tumor size of 3.5cm in the greatest dimension and 2.8cm x 2.5cm in additional dimensions. The tumor is located in the left upper lobe, peripherally, with no angiolymphatic invasion identified. The bronchial margin is uninvolved, and the pleural surface is negative for tumor. There is no lymph node involvement (N0) with negative findings in both ipsilateral hilar and/or peribronchial (levels 10-14) and contralateral mediastinal/hilar, scalene, or supraclavicular lymph nodes (N3). The non-neoplastic lung contains emphysematous changes. The tumor in this case is morphologically similar to the patient's previously diagnosed brain metastasis.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-73-4670.a9349f65-0980-427e-af86-1af3c747926b',\n",
       "  'report_length_cl100k_base': 1886,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a well-differentiated adenocarcinoma, with a tumor size of 10 x 9 cm in the left lower lobe. The bronchial margin is free of tumor, but 3 out of 24 peribronchial lymph nodes are positive for carcinoma. There is visceral pleural involvement (pT2) and no satellite tumors. Levels 1-9 lymph nodes are negative for tumor (0/7), while levels 10-14 lymph nodes are positive for tumor (3/24). There is no metastasis to contralateral mediastinal/hilar, scalene, or supraclavicular lymph nodes (N3: 0/1). The cancer is classified as pT2 N1 MX according to the AJCC Cancer Staging Manual, 7th Edition.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is a well-differentiated adenocarcinoma, with a tumor size of 10 x 9 cm in the left lower lobe. The bronchial margin is free of tumor, but the visceral pleura is involved (pT2). Lymph node involvement is noted in ipsilateral hilar and/or peribronchial (levels 10-14) with 3 positive out of 24 lymph nodes (N1), and no involvement in ipsilateral mediastinal and/or subcarinal (levels 1-9) or contralateral mediastinal/hilar, scalene, or supraclavicular lymph nodes (N2, N3). The cancer is classified as pT2 N1 MX according to the AJCC Cancer Staging Manual, 7th Edition.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-73-4675.73be3e61-573d-43a3-a055-e86786e126f3',\n",
       "  'report_length_cl100k_base': 1676,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma, poorly differentiated, with a tumor size of 2cm in the greatest dimension and 1cm x 0.8cm in additional dimensions. It is invading the visceral pleura and has angiolymphatic invasion. The bronchial margin is negative for tumor, but there is metastasis to four out of five peri-bronchial lymph nodes with extranodal extension. There is no involvement in the contralateral mediastinal/hilar, scalene, or supraclavicular lymph nodes. The non-neoplastic lung tissue displays emphysematous changes. The pathological staging is pT2a N1 MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient was diagnosed with poorly differentiated adenocarcinoma in the right upper lobe of the lung, with a tumor size of 2cm in the greatest dimension and 1cm x 0.8cm in additional dimensions. The bronchial margin was negative for tumor, but there was angiolymphatic invasion present. Four out of five peri-bronchial lymph nodes were involved with extranodal extension. The mediastinal lymph nodes were negative for malignancy. The patient's pathological staging is pT2a N1 MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-73-4676.d93488a2-e8a9-4775-8d8a-9622b237ba9d',\n",
       "  'report_length_cl100k_base': 1422,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma, moderately differentiated, measuring 3cm in the greatest dimension and 2.5cm in additional dimensions, focally invading into the visceral pleura. The bronchial margin is negative for tumor, and there is no angiolymphatic invasion identified. The cancer is stage pT2a, with no lymph node involvement (N0) and no metastasis (M0).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"\\nThe patient's cancer is staged as pT2a N0 MX, with a moderately differentiated adenocarcinoma in the right upper lobe of the lung, measuring 3cm in the greatest dimension and 2.5cm in an additional dimension, invading the visceral pleura. The bronchial margin is negative for tumor, and there is no angiolymphatic invasion identified. No malignancy is found in nine examined lymph nodes. The report also mentions emphysematous changes and hyalinized granulomas.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-73-4677.13109adb-64f8-462a-b0c1-af0723ad9aff',\n",
       "  'report_length_cl100k_base': 2263,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, moderately differentiated with bronchioloalveolar features. The tumor size is 2.5cm, and it is located in the right lower lobe of the lung. There is no angiolymphatic invasion identified. The tumor is N0 (no lymph node involvement) with mild emphysematous changes. No metastasis is found. The pathological staging is pT1b, N0, and MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is staged as pT1b (tumor size 2.5cm), N0 (no lymph node involvement), and MX (metastasis status unknown) based on the AJCC Cancer Staging Manual, 7th Edition. The tumor is an adenocarcinoma, moderately differentiated with bronchioloalveolar features, and no angiolymphatic invasion was identified. Two tumors were identified, one in the right lower lobe wedge (2.5cm) and another microscopic focus of adenocarcinoma (0.9cm) in the right lower lobe completion lobectomy specimen. The pleural surface and bronchial margins were negative for tumor.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-73-7498.c60ca2d8-4981-406a-9b8d-8efde4976001',\n",
       "  'report_length_cl100k_base': 1660,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's pathological staging includes a 3cm moderately differentiated adenocarcinoma in the right upper lobe of the lung, with no angiolymphatic invasion and no involvement of bronchial margins or visceral pleural. There is no evidence of satellite tumors. Lymph node involvement is N1 (ipsilateral hilar and/or peribronchial) with 0/1 benign lymph nodes, and N2 (ipsilateral mediastinal and/or subcarinal) with 0/18 benign lymph nodes. The patient's metastasis status is Mx, meaning that distant metastasis cannot be assessed or is not present.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathology report indicates a moderately differentiated adenocarcinoma in the right upper lobe of the lung, with a tumor size of 3cm. The bronchial margins are uninvolved, and there is no visceral pleural involvement. The patient is classified as pT2a (tumor size 3cm) and Mx (no lymph node involvement). The report shows negative lymph nodes in levels 1-14 (0/18) and no metastasis. The specimens from the right upper lobe and the lymph nodes are benign.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-73-7499.8d4f6d68-7f74-4def-a235-a36a70f83ebe',\n",
       "  'report_length_cl100k_base': 1867,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive, moderately differentiated adenocarcinoma. The tumor size is 9.2 cm in the greatest dimension, located in the upper lobe of the right lung, with no angiolymphatic invasion. The bronchial margins are uninvolved, and there are no satellite tumors. The cancer is classified as N1 with negative lymph node involvement (0/19) in ipsilateral hilar and/or peribronchial (levels 10-14) and negative (0/6) in ipsilateral mediastinal and/or subcarinal (levels 1-9). There is no metastasis (Mx). The pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient's cancer is an invasive, moderately differentiated adenocarcinoma in the right upper lobe of the lung, measuring 9.2 cm in the greatest dimension. The tumor has invaded the chest wall and is classified as pT3. There is no evidence of lymph node involvement (N1 or N2), and metastasis is not present. The patient's staging is based on the AJCC Cancer Staging Manual, 7th Edition.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-73-A9RS.7E029394-80EC-4B53-829E-8F1DA476D648',\n",
       "  'report_length_cl100k_base': 2661,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's pathology report indicates a T2 tumor size, with no information on lymph node involvement or metastasis status. The tumor is an adenocarcinoma and was found in the perivascular soft tissue at the vascular resection margin, with a positive diagnosis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The report mentions a tumor of size T2, with no information on lymph node involvement or metastasis status. The tumor is described as adenocarcinoma and is classified as N1, with positive margins found in the perivascular soft tissue at vascular resection. The report also mentions a procedure called VALOSO, but it is unclear how it relates to the cancer staging.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-75-5125.a0af0de5-9022-4354-8b9b-fc80e9508889',\n",
       "  'report_length_cl100k_base': 185,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has been diagnosed with adenocarcinoma, with a tumor size of T2 and no lymph node involvement (NOS). There is no evidence of metastasis (MO). The cancer has been surgically resected. The pathological staging is T2, NOS, MO.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient is a 60-year-old male with a primary adenocarcinoma tumor, size 2.00 cm, T2 NOS MO, with no lymph node involvement, and no metastasis reported. The tumor was resected and the histology shows well-differentiated tissue. The pathological staging is T2 NOS MO.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-75-5146.5ee0c2c4-3441-46d7-944e-3267f5c3abb6',\n",
       "  'report_length_cl100k_base': 145,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has been diagnosed with adenocarcinoma, with a tumor size of 2.00 cm and no lymph node involvement (NOS, M0). The cancer is well-differentiated and is classified as T2, NOS, M0. The pathological staging is VALCSO Stage I.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient was diagnosed with adenocarcinoma, with a tumor size of 2.00 cm and no lymph node involvement (NOS, M0). The tumor was staged as T2 and was resected through a RUL procedure. The histology report comments mentioned that it was well-differentiated and the patient's age at the time of sample collection was not specified.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-75-5147.ed8a2523-6046-402e-8ebd-a53b558800b2',\n",
       "  'report_length_cl100k_base': 164,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer has a tumor size of 4.00 cm, with no lymph node involvement (NOS) and no metastasis (MO). The histology is T2 and the differentiation is grade II. The cancer is classified as stage II.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer has a tumor size of 4.00 cm, with no lymph node involvement (NOS) and no metastasis (MO). The histology is T2 and the differentiation is grade II. The cancer is classified as stage II. The tissue was collected through a resection procedure, and the preparation type is FF. The slide URL is provided.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-75-6206.ad913d82-cb95-477f-8eeb-dba23f5c85c8',\n",
       "  'report_length_cl100k_base': 173,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, micropapillary type, with a tumor size of 3.90 cm. The cancer is stage T2, NOS, with N1 lymph node involvement and no metastasis (MO). The tissue was collected through a resection procedure, and the histology was confirmed through a FF (frozen section) preparation. The cancer is grade II, with a pathological staging of T2,NOS, and no clinical evidence of metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, micropapillary type, with a tumor size of 3.90 cm. The cancer is stage T2, NOS, with N1 lymph node involvement and no metastasis (MO). The tissue was collected through a resection procedure, and the histology was confirmed through a FF (frozen section) preparation. The cancer is grade II, with a pathological diagnosis of T2,NOS, and no clinical evidence of metastasis. The slide URL is provided for reference.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-75-6212.6749d901-d37c-4ef9-b0a0-0ee0ee1d7f0e',\n",
       "  'report_length_cl100k_base': 199,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is classified as T2, N1, M0 with a tumor size of 6 cm. It is a differentiated histology, with no lymph node involvement, and no evidence of metastasis. The cancer was surgically resected from the upper lobe, and the patient's age at diagnosis and other clinical details are not provided in the report.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is classified as T2, NOS with no metastasis (M0). The tumor size is 6.00 cm and it is located in the upper lobe. The patient's age at diagnosis and the number of days to diagnosis are not provided. The cancer has spread to one lymph node (N1). The histology of the tumor is described as differentiated. The type of procedure and preparation are not specified.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-75-6214.e3473dc5-927a-466f-ac60-0ac0771a8b1f',\n",
       "  'report_length_cl100k_base': 192,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a T2, NOS, M0 stage lung cancer, with a tumor size of 3.4 cm and no lymph node involvement or metastasis. The tissue was collected through a resection procedure, and the histology report is available for review.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is located in the lung and has a tumor size of 3.4 cm. The cancer is classified as T2, NOS (no lymph node involvement) and M0 (no metastasis). The histology report shows differentiation of 3 and an undifferentiated NOS grade. The patient's age at the time of diagnosis is not provided, but the days to preparation and days to diagnosis are both 13. The procedure used was a resection and the tissue was collected through a buffy coat.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-75-7025.6d05110b-1a5f-4002-b140-00a36c5c102b',\n",
       "  'report_length_cl100k_base': 196,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a T2, NOS, M0 stage III lung cancer, with a tumor size of 3.5 cm and no lymph node involvement or metastasis. The tissue was collected through a resection procedure, and the histology report is available for review.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is classified as T2, NOS, M0, and stage III due to a tumor size of 3.5 cm with no lymph node involvement or metastasis. The histology report is available at the provided URL.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-75-7027.04803f1d-6cb8-44ec-b4f1-11f1308dc840',\n",
       "  'report_length_cl100k_base': 196,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathology report describes a well-differentiated bronchiolo-alveolar carcinoma, approximately 40mm in diameter, located in the left upper lobe of the lung. The excision margins are clear, and no pleural invasion is observed. Two intrapulmonary lymph nodes (N11L) are negative for tumor, indicating no regional lymph node involvement. No distant metastases are reported.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The pathology report describes a well-differentiated bronchiolo-alveolar carcinoma found in the left upper lobe of the lung during a lobectomy. The tumor size is 40mm in diameter and the pleura is not invaded. Two intrapulmonary lymph nodes (N11L) are negative for tumor. Additional lymph nodes from specimens B and C are also negative for tumor.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-7143.083bd90a-b596-4a8b-84f5-97ca17cee7fa',\n",
       "  'report_length_cl100k_base': 262,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a moderately to poorly differentiated adenocarcinoma in the right middle lobe, measuring 25 mm in maximal dimension, with invasion of the visceral pleura, vascular, lymphatic, and perineural invasion, and extensive metastasis in peribronchial lymph nodes. There is no evidence of malignancy in the sump lymph node. The tumor is classified as T4N1MX.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient is a female ex-smoker with a 25 mm moderately to poorly differentiated adenocarcinoma in the right middle lobe, with pleural invasion, vascular, lymphatic, and perineural invasion, and peribronchial lymph node metastases. The tumor extends proximally along the bronchovascular structures to involve the bronchial resection margin. There is no evidence of malignancy in the sump lymph node. The pathological stage is T4N1MX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-78-7145.b9516a4e-5bc3-47f6-8ca3-f1e5abf71b34',\n",
       "  'report_length_cl100k_base': 706,\n",
       "  't_label': 3},\n",
       " {'abstract': \"\\nThe patient's left lung had a poorly differentiated adenocarcinoma tumor, measuring 55x38x25mm, involving the lateral basal segment of the inferior lobe, with evidence of blood vessel and lymphatic permeation. Lymph nodes at the hilum of the lower lobe and the inferior pulmonary ligament were involved by metastatic tumor. The tumor extended to within 45mm of the bronchial resection margin, and the resection margin showed evidence of acute bronchitis. The patient's cancer status is classified as T2 (tumor size 3-5cm), N1 (involvement of ipsilateral lymph nodes), and M0 (no distant metastasis).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's left lung had a large tumor involving the lateral basal segment, measuring 555 x 38 x 25 mm, which abutted the pleura and had a well-circumscribed margin. Lymph nodes at the hilum of the lower lobe were obviously involved by metastatic tumor. The tumor was composed of solid nests, strands of cells, and some well-defined glandular structures, showing blood vessel, lymphatic, and pleural involvement. The lung away from the tumor showed evidence of mild emphysema only. One of the lymph nodes in the inferior pulmonary ligament was also involved by metastatic adenocarcinoma.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-78-7146.3ff87253-3d93-4283-8052-499cd0edea85',\n",
       "  'report_length_cl100k_base': 687,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathology report describes a moderately differentiated adenocarcinoma in the right upper lobe of the lung, measuring 45 mm in maximal dimension. There is no blood vessel or lymphatic invasion, but visceral pleural invasion is present. A peribronchial lymph node metastasis is identified, and the lesion is well clear of the bronchial resection margin. The hilar lymph nodes show reactive changes only, with no evidence of malignancy. The tumor is classified as T2N1MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a moderately differentiated adenocarcinoma in the right upper lobe of the lung, measuring 45 mm in maximal dimension. There is no blood vessel or lymphatic invasion, but visceral pleural invasion is present. A peribronchial lymph node metastasis is identified, and the lesion is well clear of the bronchial and surgical resection margin. The adjacent lung shows very mild centriacinar emphysema. The hilar lymph nodes show reactive changes only, with no evidence of malignancy. The tumor is classified as T2N1MX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-78-7147.0f5ad63e-a072-4f02-8f88-1d75fabd3a4b',\n",
       "  'report_length_cl100k_base': 626,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has a well-differentiated mucinous adenocarcinoma in the left upper lobe of the lung, measuring 43 mm in maximal dimension. There is lymphatic permeation and metastasis in the peribronchial lymph nodes, but no blood vessel or perineural invasion is present. The tumor is clear of the bronchial resection margin and there is no pleural invasion. The patient's cancer is classified as T2N1MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a well-differentiated mucinous adenocarcinoma in the left upper lobe of the lung, measuring 43 mm in maximal dimension. There is lymphatic permeation and metastasis in the peribronchial lymph nodes, but no blood vessel or perineural invasion is present. The tumor is clear of the bronchial resection margin and there is no pleural invasion. The patient has stage T2N1MX cancer.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-78-7148.5c97d03f-3dfc-4876-ab9e-ad2f4606d62b',\n",
       "  'report_length_cl100k_base': 646,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a moderately differentiated adenocarcinoma, sized at 75 mm in diameter, with adjacent satellite nodules. There is no evidence of pleural, vascular, or lymphatic invasion. The tumor does not reach the hilar resection margin and peribronchial lymph nodes show no signs of metastatic adenocarcinoma. The cancer is classified as pathological stage T4 NO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a moderately differentiated adenocarcinoma, with a tumor size of 75 mm, located in the right lower lobe. There is no evidence of pleural, vascular, or lymphatic invasion. The bronchial resection margin is clear, but the tumor extends to the mediastinal resection margin. Three separate tumor nodules are present, measuring between 5 to 12 mm in diameter. No lymph node metastases were found. The pathological stage is T4 NO.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-7149.2211dcab-03dd-493c-9131-684a9accea7a',\n",
       "  'report_length_cl100k_base': 770,\n",
       "  't_label': 3},\n",
       " {'abstract': \"The patient's cancer is a moderately to poorly differentiated adenocarcinoma, measuring 70 mm in diameter, located in the left lower lobe of the lung. There is no evidence of pleural, vascular, or perineural infiltration. Metastases are present in intraparenchymal and hilar lymph nodes, leading to a pathological stage of T2 N1.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'Moderately to poorly differentiated adenocarcinoma, 70 mm in diameter, present in the left lower lobe with no pleural, vascular, or perineural infiltration. Metastases found in intraparenchymal and hilar lymph nodes. Pathological stage T2 N1.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-78-7150.99bec792-e05e-49fd-8601-5f51e876e614',\n",
       "  'report_length_cl100k_base': 834,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathological report indicates a well-to-moderately differentiated adenocarcinoma with a tumor size of 40 mm, pleural invasion, and no evidence of vascular, lymphatic, or perineural invasion. There are no lymph node metastases, resulting in a pathological stage T2 NO.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathological report indicates a well to moderately differentiated adenocarcinoma, 40 mm in diameter, with pleural invasion present. There is no evidence of vascular, lymphatic, or perineural invasion. No lymph node metastases were found. The pathological stage is T2 NO.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-7152.4ee9aa80-a04b-4220-8657-0b05af9da97c',\n",
       "  'report_length_cl100k_base': 537,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is a moderately differentiated adenocarcinoma of the right upper lobe, approximately 47mm in maximal dimension, with blood vessel permeation but no lymphatic or perineural invasion. There is no evidence of pleural invasion, and the tumor is clear of the bronchial resection margin. No lymph node metastases are present. The cancer is classified as T2N0MX with squamous metaplasia and severe dysplasia at the right middle lobe bronchial resection margin.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'Moderately differentiated adenocarcinoma in the right upper lobe, approximately 47mm in maximal dimension, with blood vessel permeation but no lymphatic or perineural invasion. The tumor is clear of the bronchial resection margin and there are no lymph node metastases. Squamous metaplasia with severe dysplasia is present at the right middle lobe bronchial resection margin. No pleural invasion is identified with special stains. TTF-1 staining confirms a pulmonary primary.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-7153.14c2a5e1-cef1-4076-952d-8cf9061befff',\n",
       "  'report_length_cl100k_base': 1152,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathological report indicates a moderately to poorly differentiated adenocarcinoma, measuring 40 mm in diameter, with invasion into the adherent parietal pleura, but clear of the soft tissue resection margin. Vascular invasion is not identified. Metastatic adenocarcinoma is present in peribronchial lymph nodes and lymph node No. 5, with transcapsular extension and perineural/intraneural invasion in the hilar region. The tumor is classified as T3 N2, with no distant metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathology report indicates a moderately to poorly differentiated adenocarcinoma, measuring 40 mm in diameter, with invasion into the adherent parietal pleura but clear of the soft tissue resection margin. Vascular invasion is not identified. Metastatic adenocarcinoma is present in peribronchial lymph nodes and lymph node No. 5, with transcapsular extension and perineural/intraneural invasion in the hilar region. The bronchial resection margin is clear of malignancy, and the tumor is classified as T3 N2.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-78-7154.00bdbfd9-ca96-4c34-b4c1-eae63818fa93',\n",
       "  'report_length_cl100k_base': 651,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient has a moderate and poorly differentiated adenocarcinoma in the left upper lobe of the lung, measuring 80mm in maximal dimension. The tumor is subpleural and infiltrates the overlying pleura, with vascularised pleural adhesions present. There is no unequivocal pleural surface involvement, and the tumor is clear of the bronchial and stapled surgical resection margins. The lymph nodes show reactive follicular hyperplasia, sinus histiocytosis, and carbon deposition, but no malignancy is identified. The patient's pathological stage is T2N0.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'Moderate and poorly differentiated adenocarcinoma in the left upper lobe of lung, measuring 80mm in maximal dimension, with subpleural location and invasion, blood vessel involvement, and no lymphatic invasion or perineural permeation. The tumor is clear of bronchial and surgical resection margins, and there is no lymph node metastasis, resulting in a pathological stage T2N0.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-7155.0a07b1a2-095d-4da1-ba4f-112169b62971',\n",
       "  'report_length_cl100k_base': 809,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has a well-differentiated adenocarcinoma in their left lung with multiple separate lesions involving the upper and lower lobes, the largest being 165 mm in diameter. The tumor focally involves the visceral pleura without surface involvement, and there is no evidence of lymphatic or vascular invasion. The bronchial resection margin is clear, but the peri-hilar margin is closely approached. One hilar lymph node is involved by direct extension, while the remaining hilar and mediastinal lymph nodes are not affected. The patient's pathological stage is T4 N1 M1.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has a well-differentiated adenocarcinoma in their left lung with multiple separate lesions involving the upper and lower lobes, the largest being 165mm in diameter. The tumor approaches but does not appear to reach the hilar resection margin and there is focal visceral pleural invasion. No unequivocal lymphatic invasion or vascular permeation is identified. One hilar lymph node is involved by direct extension of the tumor, while the remaining hilar and mediastinal lymph nodes are not involved. The patient's pathological stage is T4 N1 M1.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-78-7156.28b28933-7e87-4a7b-a17b-170e494d1a30',\n",
       "  'report_length_cl100k_base': 1643,\n",
       "  't_label': 3},\n",
       " {'abstract': \"The patient's lung adenocarcinoma is T4 (tumor size approximately 70mm), N2 (lymph node metastases in all sampled nodes), and MX (no information on metastasis to distant sites). The tumor has a papillary architecture, with blood vessel and lymphatic invasion, and visceral pleural invasion. No perineural permeation is seen. The tumor is positive for TTF 1 and negative for thyroglobulin, supporting a primary pulmonary adenocarcinoma diagnosis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'Moderately differentiated papillary adenocarcinoma in left lower lobe, with tumor mass approximately 70mm, invading visceral pleural surface, extending to within 10mm of bronchial resection margin, and involving surrounding lung parenchyma; blood vessel and lymphatic invasion present, but no perineural permeation seen; metastases found in all sampled lymph nodes (T4N2MX); immunohistochemical profile supports primary pulmonary adenocarcinoma.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-78-7158.1ac638bd-3da2-472d-90bf-1e100bfcdb19',\n",
       "  'report_length_cl100k_base': 1148,\n",
       "  't_label': 3},\n",
       " {'abstract': \"The patient's left upper lobe wedge resection revealed a moderately differentiated adenocarcinoma, measuring 25mm, with no involvement of the pleura and clear margins. There was no lymphatic, vascular, or perineural invasion. The tumor was negative for CK20 and positive for CK7 and TTF1. Adjacent lung parenchyma showed organizing pneumonia and acute bronchopneumonia, while the remaining lung tissue demonstrated emphysema and areas of pleural and subpleural fibroelastotic scarring. The pathological stage is T1.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'Moderately differentiated adenocarcinoma, tumor size 25mm, located peripherally and clear of margins, no lymphatic or vascular invasion, no perineural permeation, organizing pneumonia and acute bronchopneumonia in adjacent lung parenchyma, emphysema in remaining lung, pleural plaque with fibroelastotic scarring, pathological stage T1.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-78-7159.abb2f0e8-b167-4ffb-a52d-2116d4a919c6',\n",
       "  'report_length_cl100k_base': 567,\n",
       "  't_label': 0},\n",
       " {'abstract': '\\nThe patient\\'s cancer is a moderately differentiated adenocarcinoma, with a tumor size of 70 mm. It is located in the lower lobe of the right lung, close to the hilar resection margin, and shows lymphatic permeation but no blood vessel or perineural invasion. There is evidence of peribronchial, hilar, subcarinal, and upper \"medial sternal\" lymph node metastases (T4N2M1). The lung parenchyma appears normal, with mild centriacinar emphysema in the upper lobe.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'Moderately differentiated adenocarcinoma in the right lung, measuring 70 mm, with lymphatic permeation and peribronchial, hilar, subcarinal, and upper \"medial sternal\" lymph node metastases. No blood vessel or perineural invasion identified, but tumor approaches hilar resection margin and has lymphatic permeation at the bronchial margin. T4N2M1.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-78-7160.a654d277-9f15-4e8b-b1a5-93fd802c5d36',\n",
       "  'report_length_cl100k_base': 1111,\n",
       "  't_label': 3},\n",
       " {'abstract': \"The patient's left upper lobe bronchial adenocarcinoma is classified as T3 due to the tumor size of 91mm and N0 as no lymph node metastasis was found. The tumor invades the visceral pleura and is adherent to the parietal pleura, with focal involvement of the hilar soft tissue margin. The pathological stage is pT3N0.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's left upper lobe bronchial adenocarcinoma is moderately differentiated, with a tumor size of 91mm, invading the visceral pleura and adhering to parietal pleura. The cancer is classified as stage pT3N0, with no evidence of metastatic adenocarcinoma found in the hilar lymph nodes or other submitted lymph nodes. There is no vessel or perineural invasion, and the bronchial margin is clear of invasive carcinoma. The tumor extends to the hilar soft tissue margin, and the parietal pleura is involved.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-7161.0a86e747-a5e2-4d91-8ebd-6ef80e11cbc8',\n",
       "  'report_length_cl100k_base': 1006,\n",
       "  't_label': 2},\n",
       " {'abstract': \" The patient's pathology report describes a 4 cm well-differentiated adenocarcinoma in the right upper lobe of the lung with a few peribronchial lymph nodes, the largest being 1.5 cm. Microscopic analysis shows invasive neoplastic tissue in the pulmonary parenchyma. The hilar lymph node specimen measures 1 cm and shows chronic inflammatory changes with no evidence of malignancy.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient has a well-differentiated adenocarcinoma or alveolar cell carcinoma in the right upper lobe of the lung, with an irregularly shaped grey mass measuring 4 cm in diameter. There are a few peribronchial lymph nodes, the largest being 1.5 cm. The tumor is invasive and composed of sheets of atypical epithelial cells that tend to form papillae. The tumor is positive for PAS-diastase, PAS/Alcian blue, and CEA. The hilar lymph node is negative for malignancy and shows chronic inflammatory changes.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-7162.41e3d123-0a90-43e4-80b7-7be47de9fd16',\n",
       "  'report_length_cl100k_base': 227,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's pathology report describes a well-differentiated mucinous adenocarcinoma, 40mm in diameter, located in the right lower lobe of the lung, with clear excision margins and no lymph node involvement. There is no evidence of metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'Right lower lobectomy revealed a well-differentiated mucinous adenocarcinoma with a tumor size of 40 mm, which abuts the pleura. The excision lines are clear of malignancy, and ten lymph nodes from the 11R group are free of malignancy.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-7163.40948ca8-3075-47ef-a679-94ea5dc29a08',\n",
       "  'report_length_cl100k_base': 166,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient has a well-differentiated mucinous adenocarcinoma in the left lower lobe of the lung, measuring 75 mm in maximum dimension. There is no blood vessel or lymphatic invasion, but hilar, lingular, and No. 11 lymph node metastases are present. The tumor is clear of the bronchial resection margin, but squamous metaplasia and severe dysplasia are observed at the resection margin. The patient's cancer is classified as T2N1MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'Well differentiated mucinous adenocarcinoma in left lower lobe, measuring 75mm, with no blood vessel or lymphatic invasion. Clear of bronchial resection margin but squamous metaplasia and severe dysplasia at the margin. Hilar, lingular, and No. 11 lymph node metastases present. T2N1MX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-78-7166.e2ddc3ba-8151-4f3e-9219-cd3147ea5029',\n",
       "  'report_length_cl100k_base': 958,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has a papillary adenocarcinoma of the left lower lobe, 65 mm in diameter, crossing the interlobar fissure into the left upper lobe, with a separate focus of adenocarcinoma in the left upper lobe. There is no evidence of vascular or lymphatic invasion, and no lymph node metastases were found. The pathological stage is T2 NO M1.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': '\\nLeft pneumonectomy reveals a 65 mm papillary adenocarcinoma in the left lower lobe that crosses the interlobar fissure into the lingula, with a separate focus of adenocarcinoma in the left upper lobe. There is no evidence of vascular or lymphatic invasion, and no lymph node metastases were found. The pathological stage is T2 NO M1.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-7167.a164a9ae-8f90-4deb-83ce-8f111897e5d6',\n",
       "  'report_length_cl100k_base': 1123,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's left upper lobe had a poorly differentiated adenocarcinoma, measuring 30mm in diameter, with vascular and pleural invasion, and extensive peribronchial lymph node metastases. The tumor showed transcapsular extension and was categorized as T2N2, with no distant metastases.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's left upper lobe specimen reveals a 30mm subpleural tumor with poorly differentiated adenocarcinoma, vascular invasion, and pleural invasion. The peribronchial lymph nodes are replaced by metastatic adenocarcinoma, and tumor emboli are found in surrounding lymphatics. The number 5 lymph node specimen shows multiple foci of metastatic poorly differentiated adenocarcinoma. The cancer is classified as T2N2.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-78-7220.b7e36c31-539e-4cab-81e3-23843b4c0068',\n",
       "  'report_length_cl100k_base': 592,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's pathological report indicates a poorly differentiated adenocarcinoma in the left upper lobe of the lung, measuring 72 mm in maximum dimension. There is no vascular invasion, and the tumor is clear of the bronchial resection margin. Special stains are being performed to assess possible pleural invasion. No lymph node metastases are present, and the cancer is classified as T2 N0 MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'Poorly differentiated adenocarcinoma, 72 mm in maximal dimension, T2 N0 MX, no vascular invasion, possible pleural invasion identified, clear of bronchial margin, no lymph node metastases.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-7535.217e5c9a-950f-46c0-a022-5ece5205d9d4',\n",
       "  'report_length_cl100k_base': 779,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a poorly differentiated adenocarcinoma in the right upper lobe of the lung, measuring 48 mm in diameter. There is focal pleural invasion and lymphatic permeation, but no blood vessel or perineural invasion. The cancer has spread to peribronchial, hilar, and mediastinal lymph nodes, with evidence of metastases in lymph nodes 1A, 1B-1C, 1D, and 1I. The tumor is classified as T2N2MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathology report indicates a poorly differentiated adenocarcinoma in the right upper lobe of the lung, measuring 48mm in diameter, with focal pleural invasion and lymphatic permeation. There is no blood vessel or perineural invasion, but peribronchial, hilar, and mediastinal lymph node metastases were found. The tumor is classified as T2N2MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-78-7536.543b5396-e92f-436e-93c5-1324b9171598',\n",
       "  'report_length_cl100k_base': 856,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a well-differentiated adenocarcinoma, measuring 60x65x40 mm, located in the right upper lobe of the lung. There is no blood vessel or lymphatic invasion, and no lymph node metastases were found. The tumor is clear of the bronchial resection margin but appears to abut the pleural surface. The patient's cancer is classified as T2N0MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a well-differentiated adenocarcinoma in the right upper lobe of the lung, measuring 60x65x40 mm, with no blood vessel or lymphatic invasion. The tumor is clear of the bronchial resection margin but appears to abut the pleural surface. There is no evidence of lymph node metastases, and the tumor is classified as T2N0MX. The adjacent lung tissue shows emphysema, and a necrotic lesion is present, with special stains for microorganisms being performed. The hilar lymph nodes show reactive changes only.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-7537.0bb9490c-1fb1-4d36-85a4-435565e9db53',\n",
       "  'report_length_cl100k_base': 737,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's right upper lobe tumor is a moderately differentiated adenocarcinoma, measuring 52mm with subpleural and focal visceral pleural invasion. There is no perineural invasion, and the tumor is well clear of the bronchial resection margin. No lymph node metastases are found. The cancer is classified as T2bN0Mx. The non-neoplastic lung tissue shows mild emphysema and patchy mild inflammation.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'Moderately differentiated adenocarcinoma in the right upper lobe, measuring 52 mm with subpleural and focal visceral pleural invasion. No lymph node metastases, T2bN0Mx. The tumor is clear of the bronchial resection margin, with blood vessel and probable lymphatic permeation present. The non-neoplastic lung shows mild emphysema and patchy mild inflammation.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-7539.686bc9a9-71b6-4c27-a76d-4ca9713fbdbe',\n",
       "  'report_length_cl100k_base': 787,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's left lower lobe tumor is a well-differentiated adenocarcinoma with a prominent mucinous bronchiolo-alveolar carcinoma component, measuring approximately 50x60x45mm. It appears to abut the lateral and diaphragmatic pleural surfaces, but no definite pleural invasion is seen. The tumor surrounds a major segmental bronchus and extends close to the bronchial resection margin. There is no vascular or perineural invasion, and no metastases are found in the hilar lymph nodes. The bronchial resection margin and the bronchus are free of malignancy. The final staging is T2N0Mx. The additional hilar lymph node and back liposarcoma specimens are negative for malignancy.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has an invasive well-differentiated adenocarcinoma with a predominant bronchiolo-alveolar carcinoma (mucinous type) pattern in the left lower lobe. The tumor measures approximately 50x60x45mm and is close to the bronchial resection margin, but does not involve the medial margin. There is no vascular or perineural invasion, and no metastases are seen in the hilar lymph nodes. The bronchial resection margin is free of tumor. The patient's cancer is classified as T2N0Mx. A lipoma is also present in the back.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-7540.95cad21d-0a35-4ac7-9163-f5b7bb21e18d',\n",
       "  'report_length_cl100k_base': 806,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathology report describes a poorly differentiated adenocarcinoma in the right upper lobe of the lung, measuring 50 x 30 x 30 mm. There is no involvement of the visceral pleura, and the bronchial resection margin is free of tumor. Lymph nodes show reactive changes but no evidence of malignancy. No other focal lesions were found in the remaining lung tissue.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient underwent a right upper lobectomy, and the resected lung tissue measured 100 x 100 x 40 mm, with a tumor mass measuring 50 x 30 x 30 mm. The tumor extended to within 40 mm of the staple line but did not involve the visceral pleura or bronchial resection margins. The lung tissue showed a poorly differentiated adenocarcinoma, with no evidence of malignancy in the lymph nodes. The patient also had a nodule in the right middle lobe, which was covered by pleura and showed reactive changes but no malignancy.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-7542.07a2fac9-0532-442e-ae75-5a7cc5d298d4',\n",
       "  'report_length_cl100k_base': 298,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathological report indicates a moderately differentiated adenocarcinoma in the left upper lobe of the lung, with three foci of varying sizes (20 mm, 12 mm, and 5 mm) and no lymph node metastases. There is extensive blood vessel invasion and probable lymphatic permeation, but no perineural permeation. Pleural invasion is identified overlying the acinar pattern carcinoma, and the tumors stain positively for CK 7 and TTF 1, indicating they are of pulmonary origin. The report suggests a T2 NO (acinar pattern carcinoma) and T1 N0 (papillary and bronchioloalveolar pattern carcinomas) pathological stage.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"Three foci of moderately differentiated adenocarcinoma were identified in the left upper lobe, with sizes ranging from 5mm to 20mm. There is extensive blood vessel invasion and probable lymphatic permeation, but no perineural permeation. Pleural invasion was identified, and special stains are being performed to confirm. No lymph node metastases were found, and the tumors are clear of the bronchial margin. The patient's cancer is classified as T2 NO (acinar pattern carcinoma) T1N0 (papillary and bronchioloalveolar pattern carcinomas). The non-neoplastic lung tissue shows mild emphysema.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-7633.b1031a29-f3af-4f4f-a3d2-1be59c524222',\n",
       "  'report_length_cl100k_base': 1062,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathology report indicates a poorly differentiated adenocarcinoma in the left upper lobe (23 x 18 mm) with no pleural invasion. The resection margins are clear, and one of the five peribronchial lymph nodes contains metastatic adenocarcinoma. There is no evidence of malignancy in the left mediastinal, peribronchial, bronchial stump, or hilar lymph node specimens. The diagnosis is confirmed as adenocarcinoma by electron microscopy.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is a poorly differentiated adenocarcinoma in the left upper lobe (LUL) of the lung, measuring 23 x 18 mm. The tumor does not involve the pleura or the bronchus. One of the five peribronchial lymph nodes contains metastatic adenocarcinoma. The resection margins are clear of the tumor. There is no evidence of malignancy in the left mediastinal lymph nodes, left bronchial stump, or left hilar lymph node. The diagnosis is confirmed as adenocarcinoma by electron microscopy.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-78-8640.b39fa23e-bac4-49c9-919b-6e6d4cb8d90d',\n",
       "  'report_length_cl100k_base': 594,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is a poorly differentiated adenocarcinoma, measuring 58mm in maximum dimension, located in the right upper lobe of the lung and invading the chest wall. There is blood vessel permeation, but no lymphatic or perineural invasion. The tumor is T3N0MX. No lymph node metastases were found. The chest wall and ribs were subsequently examined and showed no residual malignancy, with the tumor well clear of the resection margins.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': '\\nRight upper lobe lung cancer, 58 mm in maximal dimension, invading visceral pleural and chest wall, but not involving rib bone or soft tissue resection margin. No lymphatic or perineural invasion. No lymph node metastases. T3N0MX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-8648.a439594e-b536-4bd3-a77a-fb50304de9a2',\n",
       "  'report_length_cl100k_base': 1099,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient has a moderately differentiated adenocarcinoma in the left lower lobe of the lung, measuring 27mm in maximum extent. There is no blood vessel or lymphatic invasion, and no lymph node metastases were found. The tumor is clear of the bronchial resection margin and there is no pleural invasion. The patient's cancer is classified as T1N0MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'Moderately differentiated adenocarcinoma in the left lower lobe, measuring 27mm with no blood vessel, lymphatic or perineural invasion, and no pleural invasion identified. The tumor is clear of the bronchial resection margin and there are no lymph node metastases (T1N0MX). Special stains for microorganisms did not identify any micro-organisms within the sarcoidal granulomata.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-8655.4290edb6-487a-4c0b-8569-aae7245a037b',\n",
       "  'report_length_cl100k_base': 850,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's pathological report indicates a moderately to poorly differentiated adenocarcinoma in the right lower lobe apical segment, measuring 33 mm in diameter, with pleural, vascular, and lymphatic invasion. The cancer has spread to the hilar lymph nodes, resulting in a pathological stage T2 N1.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"Moderately to poorly differentiated adenocarcinoma, 33 mm in diameter, present in the right lower lobe apex. The tumor is subpleural, with pleural and vascular invasion, and extends up to 10 mm from the diathermy resection margin. The patient's hilar lymph nodes show metastatic adenocarcinoma, indicating pathological stage T2 N1.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-78-8660.2c53d65a-d792-41bc-a6c3-cd2d079a5386',\n",
       "  'report_length_cl100k_base': 635,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathological report indicates a moderately to poorly differentiated adenocarcinoma in the right upper lobe, measuring 27 mm in maximum dimension. There is visceral pleural invasion, but no vascular invasion or lymph node metastases were found. The pathological stage is T2NOMX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'Moderately to poorly differentiated adenocarcinoma, 27 mm in maximal dimension, right upper lobe; visceral pleural invasion, no vascular invasion, no lymph node metastases, pathological stage T2NOMX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-78-8662.fb1023d3-d221-4dbb-80f9-0c3dd7b0750f',\n",
       "  'report_length_cl100k_base': 735,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma of the right upper lobe (RUL) lung, with a tumor size of 2.5 cm. There is no lymph node involvement (NOS) and no evidence of metastasis (M0). The cancer is classified as stage T2.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient was diagnosed with adenocarcinoma of the RUL lung, with a tumor size of 2.50 cm, no lymph node involvement, and no metastasis (T2, NOS, M0). The histology and staging were performed on a buffy coat sample collected during the resection procedure. The patient's age at diagnosis and the number of days to diagnosis and treatment are not provided in the report.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-80-5608.a4f3469b-1aae-424f-9135-7e6bfcc08d03',\n",
       "  'report_length_cl100k_base': 200,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has an adenocarcinoma in the left upper lobe (LUL) of the lung, with a tumor size of 3.20 cm and no lymph node involvement (NOS). There is no evidence of metastasis (MO).',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with adenocarcinoma of the lung, with a tumor size of 3.20 cm, T2 stage, and no lymph node involvement (NOS). The cancer has not metastasized (MO).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-80-5611.42e15634-a742-4e7c-a795-e5fe6fd7b9aa',\n",
       "  'report_length_cl100k_base': 75,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is classified as T1 (tumor size 2.5 cm), N0 (no regional lymph node metastasis), and MX (distant metastasis cannot be assessed). The tumor is a moderately differentiated invasive adenocarcinoma. No vascular invasion is evident. A total of nine lymph nodes were examined, with none showing positive metastasis. The tumor is situated within desmoplastic stroma, not invading the elastin fibers. The margins are uninvolved by tumor, with the closest distance being 1 cm.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has invasive, moderately differentiated adenocarcinoma in the left upper lobe of the lung, with a tumor size of 2.5 cm. There is no evidence of vascular invasion. The patient's lymph nodes at levels 7, 8, 9, and 10 were examined and found to be negative for metastatic carcinoma (0/9). The tumor is classified as T1 N0 MX, indicating no regional lymph node metastasis and an inability to assess distant metastasis.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-83-5908.bf81e5a3-26db-4476-b553-38d4f6897309',\n",
       "  'report_length_cl100k_base': 1492,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's lung tissue revealed a poorly differentiated squamous cell carcinoma, with a tumor size of 3 X 2.5 X 2 cm. The cancer has spread to 2 out of 12 hilar lymph nodes, indicating lymph node involvement. No information is provided on lymphatic or venous invasion, margins, or metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient underwent a pneumonectomy, and the lung tissue was found to have a poorly differentiated squamous cell carcinoma with a tumor size of 3 X 2.5 X 2 cm. 2/12 lymph nodes were positive for metastasis (hilar), but lymphatic and venous invasion, margins, and evidence of neo-adjuvant treatment were not specified. There were no additional pathologic findings or comments.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-86-6562.b0e49ac9-6b9c-4e70-a4a9-10e0686e61aa',\n",
       "  'report_length_cl100k_base': 136,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma, poorly differentiated, with a tumor size of 2.5 x 2.2 cm. It has invaded the subpleura and has lymph node involvement with metastatic tumor found in one of the peribronchial lymph nodes. The bronchial margin is free of tumor, but the parenchymal margin is involved. There is no evidence of angiolymphatic or vascular invasion, and the venous invasion status is unknown. The TNM staging is pT1b, pN1, pMX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has an adenocarcinoma of the left upper lobe of the lung, with a tumor size of 2.5 x 2.2 cm. The tumor extends to the subpleura and has angiolymphatic invasion. One of the peribronchial lymph nodes is positive for metastatic tumor, and there is no evidence of vascular or pleural involvement. The tumor is poorly differentiated. The patient's TNM staging is pT1b, pN1, pMX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-86-6851.519253c3-7e47-4c66-9149-65e622f1ba29',\n",
       "  'report_length_cl100k_base': 814,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a poorly differentiated adenocarcinoma in the lung, with a tumor size of 2.5 x 2 x 0.5 cm, involving the visceral pleura, and the presence of other tumor nodules. Lymph node involvement, lymphatic invasion, and venous invasion are not specified. Margins are not specified, and there is no evidence of neo-adjuvant treatment. The tumor is positive for CD15, CK7, and TTF1, and negative for CK20 and CDX2. The tumor is located in the right upper lobe.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a poorly differentiated adenocarcinoma in the lung, with a tumor size of 2.5 X 2 X 0.5 cm, involving the visceral pleura, and the presence of other tumor nodules. Lymph node involvement, lymphatic invasion, and venous invasion are not specified. The margins are also not specified, and there is no evidence of neo-adjuvant treatment. The tumor is positive for CD15, CK7, and TTF1, and negative for CK20 and CDX2. The tumor is located in the right upper part of the lung.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-7701.711a97e9-ac1d-4f62-b488-a3eb8370841e',\n",
       "  'report_length_cl100k_base': 192,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's lung lobectomy revealed a poorly differentiated adenocarcinoma, with a tumor size of 5x5x5 cm. The cancer has spread to 3/3 lymph nodes, but there is no information on lymphatic or venous invasion, margins, or metastasis. The tumor extent and neo-adjuvant treatment status are also unknown.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a 5cm adenocarcinoma in their lung, with poor differentiation and no information on lymphatic or venous invasion. Three out of three lymph nodes were positive for metastasis. The tumor extent is not specified, and there is no evidence of neo-adjuvant treatment. The margins are also not specified.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-86-7711.5a85d8a6-3533-4ac8-9fc9-437a81b436d6',\n",
       "  'report_length_cl100k_base': 167,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 6 cm adenocarcinoma in their lung, with no information on lymphatic or venous invasion, margins, or metastasis. Lymph nodes are not specified, but 0/1 are positive for metastasis. There is no evidence of neo-adjuvant treatment.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a 6 cm adenocarcinoma in their lung, with no lymph nodes positive for metastasis. The tumor extent, lymphatic invasion, venous invasion, and margins are not specified. There is no evidence of neo-adjuvant treatment.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-7713.0ec59eb0-0640-4d6b-b191-76bad8bb38d8',\n",
       "  'report_length_cl100k_base': 182,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, mixed subtype, with a tumor size of 2.1 cm, located in the right lower lobe of the lung, with poor differentiation. The tumor is close to the visceral pleura and has angiolymphatic invasion. There is one positive lymph node (1/1) with metastasis, and the size of the largest metastatic deposit is 0.25 cm. No satellite nodules are detected, and there is no evidence of neo-adjuvant treatment. The tumor has venous invasion and the margins are not specified. The patient's cancer is classified as T2a N2 MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a 2.1 cm adenocarcinoma in the right lower lobe of their lung with poor differentiation. The tumor has invaded the visceral pleura and there is one positive lymph node (subcarinal) out of one examined. The tumor is T2a N2 MX. There is no evidence of neo-adjuvant treatment and no additional pathologic findings are reported.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-86-7714.ae0a324f-8658-46b6-b870-a2642eea57a8',\n",
       "  'report_length_cl100k_base': 479,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a poorly differentiated bronchiolo-alveolar adenocarcinoma in the left upper lobe of the lung, with a tumor size of 2.5 X 1.5 X 3 cm. There is no information provided on lymph node involvement, lymphatic invasion, venous invasion, or metastasis status.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a poorly differentiated bronchiolo-alveolar adenocarcinoma in the left upper lobe of their lung, with a tumor size of 2.5 X 1.5 X 3 cm. There is no information provided on lymph node involvement, metastasis, or other relevant staging details in the report.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-7953.1af715d0-9b4b-444f-b93e-53478cde8e58',\n",
       "  'report_length_cl100k_base': 149,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is a poorly differentiated, invasive adenocarcinoma in the right lower lobe of the lung, measuring 2.7 x 1.0 cm, with no angiolymphatic invasion. The tumor involves the visceral pleura surface and is negative for CDX2, but positive for Napsin A, CK7, and TTF-1. There is no evidence of metastasis in the 16 lymph nodes examined. The tumor size is T2 (PL2), with no lymph node involvement (NO), and no metastasis (MX).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a poorly differentiated adenocarcinoma in the right lower lobe of the lung, measuring 2.7 x 1.0 cm, with no angiolymphatic invasion. The tumor involves the visceral pleura surface and is negative for CDX2, but positive for Napsin A, CK7, and TTF-1. The bronchial margin and 16 lymph nodes are free of tumor, and there is no evidence of metastasis. The TNM classification is pT2 (PL2), NO, MX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-7954.6a0c9a64-8c57-412a-8b3c-efb8e0b184ea',\n",
       "  'report_length_cl100k_base': 893,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 4.5 x 3.8 x 3.5 cm moderately differentiated adenocarcinoma in the right-lower lobe of their lung. There is no information provided on lymph node involvement, metastasis, or margins. The tumor is positive for CK7, CD15, and TTF1.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a 4.5 x 3.8 x 3.5 cm adenocarcinoma in the right-lower lobe of their lung. The tumor is moderately differentiated and the lymph nodes, lymphatic invasion, venous invasion, and margins are not specified. The tumor is positive for CK7, CD15, and TTF1.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-7955.d6a25f15-9117-43b7-bbd4-132914a24d16',\n",
       "  'report_length_cl100k_base': 157,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated acinar cell adenocarcinoma in the right upper lobe of the lung, with a tumor size of 6 X 6 X 7 cm. The cancer has spread to 3/13 lymph nodes in the hilar region, but there is no evidence of venous invasion or metastasis to other organs. The margins and extent of the tumor are not specified. There is no evidence of neo-adjuvant treatment.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a poorly differentiated acinar cell adenocarcinoma in the right upper lobe of the lung, with a tumor size of 6 X 6 X 7 cm. The cancer has spread to 3/13 lymph nodes in the hilar region, but there is no evidence of venous invasion or metastasis to other organs. The margins are not specified, and there is no evidence of neo-adjuvant treatment.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-86-8054.a47b8835-2314-4631-b55d-f99af91ad5e7',\n",
       "  'report_length_cl100k_base': 166,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma of the left upper lobe of the lung, with a tumor size of 3.5 X 3.3 X 3.3 cm. It has moderate differentiation and involves the visceral pleura. The pathology report indicates that 5/5 lymph nodes are positive for metastasis (intrathoracic), but there is no information on lymphatic or venous invasion, margins, or evidence of neo-adjuvant treatment. There are no additional pathological findings or comments provided.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's lung tissue was excised on an unspecified date. The tumor was a moderately differentiated adenocarcinoma, measuring 3.5 X 3.3 X 3.3 cm, located in the left-upper lobe. The tumor extended to the visceral pleura, with no information on lymphatic or venous invasion. 5/5 lymph nodes were positive for metastasis (intrathoracic). There is no evidence of neo-adjuvant treatment, and no additional pathologic findings or comments were provided.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-86-8055.b0f478a2-7696-4fc2-bdc9-839142556b6f',\n",
       "  'report_length_cl100k_base': 178,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma, mixed subtype, with a 3.2 cm tumor in the right lower lobe, and a 1.9 cm poorly-defined, firm pale tan subpleural nodule in the right upper lobe. There is extensive scar formation in the right upper lobe wedge. Lymph node level 10R has no evidence of cancer, while lymph nodes 4R, 7R, and 9 contain benign lymph nodes. Lymphatic and angiolymphatic invasion is present. The tumor is 5 cm from the bronchial margin, and there is no pleural involvement. No metastatic deposits are reported. The cancer is classified as pT4 (separate tumor nodule in an ipsilateral lobe), N0 (no regional lymph node metastasis), and MX (metastasis status unknown).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, mixed subtype, with invasive tumors found in the right upper lobe wedge and right lower lobe. The largest primary tumor measures 3.2 cm and is located 5 cm from the bronchial margin. There is evidence of lymphatic invasion and no lymph nodes are positive for metastasis out of 9 found. The cancer is classified as pT4 (separate tumor nodule in a different ipsilateral lobe), N0, and MX. The tumor is poorly differentiated and has papillary, acinar, lepidic, and micropapillary growth patterns.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-8056.b372fd6d-8c36-4642-b660-d353efb0bd89',\n",
       "  'report_length_cl100k_base': 1394,\n",
       "  't_label': 3},\n",
       " {'abstract': 'The patient has a 4x4x3 cm moderately differentiated bronchiolo-alveolar adenocarcinoma in the left upper lobe of their lung, with no information provided about lymph node involvement, metastasis, or other relevant details for staging.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a 4x4x3 cm moderately differentiated bronchiolo-alveolar adenocarcinoma in the left upper lobe of their lung, with no information provided about lymph node involvement, lymphatic or venous invasion, margins, or evidence of neo-adjuvant treatment.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-8073.2ae8592b-aa83-476a-b77f-dc53e8eb802b',\n",
       "  'report_length_cl100k_base': 158,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 2.7 x 2.5 x 2.5 cm papillary adenocarcinoma in the left lower lobe of their lung, with 5/5 positive lymph nodes for metastasis. The tumor extent, lymphatic invasion, and venous invasion are not specified, and there is no evidence of neo-adjuvant treatment.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a 2.7 x 2.5 x 2.5 cm papillary adenocarcinoma tumor in the left-lower lobe of their lung. The tumor is moderately differentiated and 5/5 lymph nodes are positive for metastasis. There is no information on lymphatic or venous invasion, margins, or evidence of neo-adjuvant treatment. No additional pathologic findings are reported.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-86-8074.a1e9569b-0254-4be6-adb2-3a842e23613f',\n",
       "  'report_length_cl100k_base': 180,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a 2.6 x 1.5 x 1.5 cm moderately differentiated adenocarcinoma in the left upper lobe of the lung with no lymph node involvement and no evidence of metastasis. The tumor extends to the visceral pleura, and margins are not specified. There is no information on lymphatic or venous invasion or neo-adjuvant treatment.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a 2.6 x 1.5 x 1.5 cm adenocarcinoma in the left upper lobe of their lung, with no lymph nodes positive for metastasis (0/3), no evidence of lymphatic or venous invasion, and no information provided on margins, neo-adjuvant treatment, or additional pathologic findings.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-8075.7988f9a9-584e-4ce9-b12c-f3e289af1d6d',\n",
       "  'report_length_cl100k_base': 172,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 2.5 cm papillary adenocarcinoma in the right upper lobe of their lung. The tumor is well-differentiated, with no lymph node involvement (0/5 positive). There is no information on lymphatic or venous invasion, margins, or metastasis. The tumor is TTF1+ and CD15+.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has a 2.5 x 2.5 x 2.5 cm papillary adenocarcinoma in the right-upper lobe of their lung. The tumor is well-differentiated and there is no evidence of lymph node metastasis (0/5 positive). The report does not specify lymphatic or venous invasion, tumor extent, or margins. The patient's tumor is TTF1+ and CD15+.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-8076.c282d817-b99a-4bda-8073-9de1cac074f9',\n",
       "  'report_length_cl100k_base': 176,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a 3 cm mucinous adenocarcinoma in the left lower lobe of the lung, with moderate differentiation and involvement of visceral pleura. The tumor is positive for CK7 and TTF1. Three out of three lymph nodes are positive for metastasis, and there is no information on lymphatic or venous invasion, margins, or neo-adjuvant treatment.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a 3 cm mucinous adenocarcinoma in their left lower lobe lung, with moderate differentiation and visceral pleural involvement. The cancer has spread to 3/3 lymph nodes, but there is no information on lymphatic or venous invasion, margins, or evidence of neo-adjuvant treatment. The tumor is positive for CK7 and TTF1.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-86-8278.75c05d77-d3b7-4cd1-9e6f-d8a18fc23f6c',\n",
       "  'report_length_cl100k_base': 174,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 3 cm adenocarcinoma in their lung, with poor differentiation and visceral pleura involvement. One out of one examined lymph nodes is positive for metastasis. There is no information on venous invasion, lymphatic invasion, or margins. The tumor is positive for CD15, CK7, TTF1, and CEA, and negative for CK20 and CDX2.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a 3cm adenocarcinoma in their lung, which is poorly differentiated and has extended to the visceral pleura. One out of one examined lymph nodes is positive for metastasis. The tumor is positive for CD15, CK7, TTF1, and CEA, and negative for CK20 and CDX2.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-86-8279.e7e4b4fd-f47d-4aab-826c-0ef1f620a739',\n",
       "  'report_length_cl100k_base': 214,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 6x5x2 cm bronchiolo-alveolar adenocarcinoma in their left lower lung, with moderate differentiation and unspecified lymph node involvement, lymphatic invasion, venous invasion, margins, and evidence of neoadjuvant treatment.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient underwent a pneumonectomy, and the tumor was found in the left lower lobe of the lung, measuring 6 x 5 x 2 cm. The histologic type is bronchiolo-alveolar adenocarcinoma, moderately differentiated. There is no information provided about lymph node involvement, lymphatic or venous invasion, margins, or evidence of neoadjuvant treatment.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-8280.49459cae-eee4-4e46-a8fc-efbeb6cb1f5d',\n",
       "  'report_length_cl100k_base': 188,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has been diagnosed with adenocarcinoma of the lung, with a tumor size of 2.6 x 1.8 x 1.5 cm, moderately differentiated, located in the right lower lobe. There is no evidence of lymph node involvement or metastasis. The margins are uninvolved, and there is no angiolymphatic or venous invasion. The patient has not undergone neo-adjuvant treatment. The TNM staging is T1 N0 MX.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient has been diagnosed with adenocarcinoma of the lung, with a tumor size of 2.6 x 1.8 x 1.5 cm, moderately differentiated, located in the right lower lobe. There is no evidence of angiolymphatic invasion, and the margins are free of tumor. 0 out of 9 lymph nodes are positive for cancer, and there is no evidence of metastasis. The patient has not undergone neo-adjuvant treatment. The tumor is classified as T1 N0 MX.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-86-8281.775debd9-a338-412e-86da-5c132df883c1',\n",
       "  'report_length_cl100k_base': 570,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's lung lobectomy revealed a poorly differentiated adenocarcinoma, with a tumor size of 3.2 cm. There was no lymph node involvement (0/6 positive for metastasis), and the regional lymph nodes were clear. Other details, such as lymphatic invasion, venous invasion, and margins, were not specified in the report. No evidence of neo-adjuvant treatment was mentioned. The tumor was located in the right-upper part of the lung.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a 3.2 cm adenocarcinoma in their lung, with no lymph nodes positive for metastasis (0/6), and no information on lymphatic or venous invasion, margins, or neo-adjuvant treatment. The tumor is poorly differentiated.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-8358.bdfc4ca3-ce4f-4206-b3ff-3733df596e9d',\n",
       "  'report_length_cl100k_base': 164,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 12x10 cm differentiated muciparous adenocarcinoma in the left lower lobe of the lung, with moderate cellular pleomorphism and rare mitoses. The tumor is well-limited, with small areas of necrosis and hemorrhage. There is lymphatic invasion present, and 1 out of 7 lymph nodes are positive for metastasis, specifically in the paraesophageal lymph node. The other lymph nodes show stasis and follicular hyperplasia, but no neoplastic infiltrates. The margins are uninvolved, and there is no evidence of neo-adjuvant treatment.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a 12/10 cm well-limited, white tumor with small areas of necrosis and hemorrhage, diagnosed as a differentiated muciparous adenocarcinoma. The tumor has moderate cellular pleomorphism, rare mitoses, and is formed of tubular-papillary structures. The stroma has fibrous tissue, numerous vessels, and lymphocytic infiltrate. Lymph nodes St.5, St.6, St.7, and St.10 show sinus histiocytosis and stasis, while the paraesophageal lymph node has a metastasis of muciparous tubular-papillary adenocarcinoma. Lymphatic and venous invasion are present, and the margins are uninvolved. The tumor is left-lower in the lung and caused distal lobar bronchus obstruction.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-86-8359.7525adb2-550a-4d65-beed-5fb0fef0b36d',\n",
       "  'report_length_cl100k_base': 617,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's lung lobe tumor measures 3.5 x 3 cm and is classified as adenocarcinoma with a poorly differentiated histology. There is no evidence of lymphatic invasion or metastasis in the examined hilar lymph nodes. The margins are uninvolved, and there is no indication of neo-adjuvant treatment.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated adenocarcinoma of the lung, with a tumor size of 3.5 x 3 cm. The hilar lymph nodes are soft and hyperemic, but demonstrate reactive changes only, with no metastasis found in the 7 examined nodes. The tumor margins are uninvolved, and there is no evidence of venous invasion or neo-adjuvant treatment. The tumor extent and lymphatic invasion are not specified.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-8585.6c3d5577-390c-4a80-8c02-dee4901c2a16',\n",
       "  'report_length_cl100k_base': 259,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 3x2.5x2 cm bronchiolo-alveolar carcinoma, mucinous, with moderate differentiation in the lung. The report lacks information on lymph node involvement, lymphatic or venous invasion, margins, and metastasis status.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a 3x2.5x2 cm bronchiolo-alveolar carcinoma, mucinous, with moderate differentiation in their left lower lobe. There is no information provided on lymph node involvement, lymphatic or venous invasion, margins, or evidence of neo-adjuvant treatment.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-8668.be6c4ce2-4c88-41a7-bff6-e5bb157ad3ad',\n",
       "  'report_length_cl100k_base': 153,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a 3x2.5x2 cm well-differentiated adenocarcinoma in their lung, with no information provided about lymph node involvement, metastasis, or other relevant staging details.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with adenocarcinoma of the lung, with a tumor size of 3 x 2.5 x 2 cm. The histologic grade is well-differentiated, and the tumor extent is not specified. There is no information provided about lymph node involvement, lymphatic invasion, venous invasion, or margins. The report does not mention any evidence of neo-adjuvant treatment or additional pathologic findings.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-8669.6c8d6319-a235-4757-be34-79286a8da60f',\n",
       "  'report_length_cl100k_base': 244,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a well-differentiated papillary adenocarcinoma in their lung, with a tumor size of 4 X 3 X 6 cm. The cancer has spread to 3/8 hilar lymph nodes, but there is no information on lymphatic or venous invasion, margins, or evidence of neo-adjuvant treatment.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has papillary adenocarcinoma of the lung, with a tumor size of 4x3x6 cm. There are no details on lymphatic or venous invasion, but 3/8 lymph nodes are positive for metastasis (hilar). The tumor is well-differentiated and the margins are not specified. There is no evidence of neo-adjuvant treatment.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-86-8671.94c08fb3-35a3-494e-90ee-b8df1d8cf34f',\n",
       "  'report_length_cl100k_base': 252,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated adenocarcinoma tumor in their lung, with a size of 7.5x6 cm, and no lymph node involvement. The tumor has focal necrosis, and there is no evidence of lymphatic or venous invasion. The margins are uninvolved, and there is no indication of metastasis. The tumor is classified as pT3 according to the 7th edition of the TNM classification.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has a poorly differentiated adenocarcinoma tumor in their lung, with a size of 7.5x6 cm, and focal necrosis. Ten examined lymph nodes demonstrated hyperemia and anthracosis, but were negative for metastasis. The tumor is classified as pT3 according to the 7th edition of the TNM classification. There is no evidence of lymphatic or venous invasion, and the margins are uninvolved. The patient's hilus lymph nodes were not specified for tumor extent, but the tumor is localized. No additional pathologic findings or evidence of neo-adjuvant treatment were reported.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-8672.df3d9fe7-a56c-4100-9fdb-9fe3e7b11b2a',\n",
       "  'report_length_cl100k_base': 303,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has a bronchiolo-alveolar adenocarcinoma, with a tumor size of 8 cm, well-differentiated histology, and no lymph node involvement (0/6 positive for metastasis). The margins are uninvolved, and there is no evidence of venous invasion or neo-adjuvant treatment. The tumor extent is not specified in the report.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient has a bronchiolo-alveolar adenocarcinoma, with a tumor size of 8 cm, well-differentiated histology, and no lymph node metastasis (0/6 positive). The tumor extent is localized, with no venous invasion and uninvolved margins. The specimen is a lobectomy from the left upper lung. The pathology report does not provide information on neo-adjuvant treatment or other tumor nodules.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-8673.0e5c5229-2b1d-45d6-8fae-02a32fb84988',\n",
       "  'report_length_cl100k_base': 336,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 12x4x8 cm papillary adenocarcinoma in the right middle lobe of their lung, with venous invasion and no lymphatic invasion. One out of nine lymph nodes were positive for metastasis, specifically in the paratracheal lymph node. The tumor margins were uninvolved, and there is no evidence of neo-adjuvant treatment.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a papillary adenocarcinoma of the lung, with a tumor size of 12x4x8 cm and one positive paratracheal lymph node out of nine examined. There is no evidence of lymphatic invasion, but venous invasion is present. The margins are uninvolved, and there is no demonstated metastasis. The tumor is moderately differentiated, and sinus histiocytosis is present in three examined bronchopulmonal lymph nodes. The specimen type is a pneumonectomy, and the tumor site is the right middle lobe of the lung.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-86-8674.463cd118-45ef-4e2f-aca3-39ce953dcb09',\n",
       "  'report_length_cl100k_base': 335,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a papillary adenocarcinoma in their left upper lobe, with a tumor size of 1.5x2x2cm. There is no evidence of lymphatic invasion or venous invasion, and the margins are not specified. One mediastinal lymph node is positive for metastasis. The tumor invades the alveolar region and the stroma shows inflammatory cell infiltration. The histologic grade is well differentiated.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has a papillary adenocarcinoma in their left upper lobe, with a tumor size of 1.5x2x2cm. The tumor invades the alveolar and has moderate lymphatic invasion. There is no evidence of venous invasion or lymph node involvement, and the margins are not specified. The tumor is well differentiated with no evidence of neo-adjuvant treatment.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-A456.56606792-5083-4F1E-ABEF-711BACF546E6',\n",
       "  'report_length_cl100k_base': 236,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a 6cm poorly differentiated adenocarcinoma in the right upper lobe of the lung, with no lymph node involvement (0/6), and no information on lymphatic or venous invasion, or metastasis. The tumor extends to the visceral pleura, and margins are not specified. Immunohistochemistry shows the tumor is positive for CK7, CD15, and TTF-1, and negative for CK10 and P63.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated adenocarcinoma of the lung, with a tumor size of 6x6x6cm. The tumor extends to the visceral pleura, and there is no evidence of lymph node metastasis (0/6 regional lymph nodes positive). The margins, lymphatic invasion, and venous invasion are not specified. The tumor is positive for CK7, CD15, and TTF-1, and negative for CK10 and P63. The specimen was obtained through an excision of the tumor from the right-upper part of the lung.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-86-A4D0.80C129A3-A5B6-4B1C-9979-44A307867744',\n",
       "  'report_length_cl100k_base': 172,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma located in the right lower lobe of the lung, with a tumor size of 2.1 cm. The bronchial and vascular margins are uninvolved, but lymphovascular invasion is present. 10 out of 17 lymph nodes are positive for metastasis, including stations 9, 8, 7, 11, and 4 subcarina, with peribronchial lymph nodes also affected. The pathologic stage is pT1b pN2 pMx. The prior FNA specimen is discordant, likely due to incomplete sampling of affected nodes.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma located in the right lower lobe of the lung, with a tumor size of 2.1 cm. The bronchial and vascular margins are uninvolved, but lymphovascular invasion is present. 10 out of 17 lymph nodes are positive for metastasis, including stations 9, 8, 7, 11, and 4 subcarina, with peribronchial lymph nodes also affected. The pathologic stage is pT1b pN2 pMx. The prior FNA specimen is discordant, likely due to incomplete sampling of affected nodes.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-86-A4P8.72828D6C-9995-42E2-ABE7-D4BA29B8A987',\n",
       "  'report_length_cl100k_base': 645,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is staged as pT1a (tumor size 1.8 cm, unifocal, no visceral pleura invasion, negative margins), pNO (no regional lymph node involvement), and pM0 (no distant metastasis). The tumor is a moderately differentiated adenocarcinoma with cribriform architecture.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is staged as pT1a (tumor size 1.8 cm, unifocal, no visceral pleura invasion, negative margins, no lymph-vascular invasion), pNO (no regional lymph nodes involved), and pM0 (no distant metastasis). The tumor is a moderately differentiated adenocarcinoma with cribriform architecture. Five lymph nodes were examined, all negative for malignancy.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-91-6828.8b494f5f-5e6f-43bb-8748-0cb2d36eab37',\n",
       "  'report_length_cl100k_base': 990,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has been diagnosed with poorly differentiated adenocarcinoma of bronchioloalveolar type, with a tumor size of 4.9 cm. The cancer has not spread to the pleura, and the bronchial and vascular resection margins are free of malignancy. There is no evidence of lymphovascular channel involvement or lymph node metastasis. The cancer stage is classified as T2, NO, MX.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated adenocarcinoma of bronchioloalveolar type, with a high nuclear grade. The tumor size is 4.9 cm in the largest dimension, and the pleura is not involved with malignancy. The bronchial and vascular resection margins are free of malignancy. Five benign peribronchial lymph nodes were found, with no evidence of metastatic malignancy or lymphovascular channel involvement. The AJCC cancer stage is T2, NO, MX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-91-6829.d21d20d3-a384-417a-aa95-11f4b6930af0',\n",
       "  'report_length_cl100k_base': 561,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma with a tumor size of 2.8 cm, no evidence of lymph node involvement in the left hilar lymph node or aortic pulmonary window, and no indication of metastasis. The lung tissue surrounding the tumor is free of cancer, and there is no evidence of cancer in the inferior pulmonary ligament lymph nodes.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with metastatic non-small adenocarcinoma. The tumor in the left upper lobe of the lung measures 2.8 cm in diameter, with no evidence of neoplasia in the inferior pulmonary ligament lymph nodes. However, there is involvement of 3 out of 3 lymph nodes in the aortic pulmonary window, level 5. The bronchial and vascular surgical margins are free of tumor, and there is no evidence of intraluminal lesions.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-91-6830.b2952294-4a8a-4c55-bcd0-17ada4209841',\n",
       "  'report_length_cl100k_base': 896,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is a poorly differentiated adenocarcinoma (T2NOMx) with a maximum tumor dimension of 6 cm in the right middle and lower lobes of the lung. The bronchial margin is free of tumor, and no significant pathologic change is observed in the lymph nodes. There is no evidence of lymphovascular invasion, and the cancer has not metastasized.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has poorly differentiated adenocarcinoma (T2NOMx) in the right middle and lower lobes of the lung, with a maximum tumor dimension of 6 cm and no evidence of lymph node involvement. The bronchial margin is free of tumor, but there is suspicion of lymphovascular invasion. The patient also has mild emphysema with respiratory bronchiolitis in the right upper lobe of the lung.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-91-6831.21f30ab4-751e-4ef5-bffa-75d5086ea1cb',\n",
       "  'report_length_cl100k_base': 998,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma of the right lower lobe of the lung, with a tumor size of 2.4x2.4cm. There is visceral pleura invasion, but margins are uninvolved by invasive carcinoma. No lymph-vascular invasion is identified, and 14 lymph nodes were examined, with none involved. The cancer has not metastasized (pMX).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma located in the right lower lobe of the lung, with a tumor size of 2.4x2.4cm. The tumor is unifocal and moderately differentiated, with visceral pleura invasion present. There is no lymph-vascular invasion or metastasis identified. The margins are uninvolved by invasive carcinoma, and the lymph nodes examined are benign. The cancer is classified as pT2 (tumor size between 1-2cm) and pNO (no regional lymph node involvement).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-91-6835.bb4510c1-addd-42a3-9439-dfc7e43078d3',\n",
       "  'report_length_cl100k_base': 892,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma of the right upper lobe of the lung, with a tumor size of 4 cm and no lymph node involvement. There is no evidence of visceral pleura invasion or vascular invasion. The tumor is moderately differentiated and unifocal. No distant metastasis is detected. The pathological staging is pT2, pNO, and cannot be assessed for distant metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient was diagnosed with adenocarcinoma in the right upper lobe of the lung, with a tumor size of 4 cm and no lymph node involvement. The tumor was unifocal with moderate differentiation and no visceral pleura invasion. Margins were uninvolved by invasive carcinoma and lymph-vascular invasion was not identified. The patient had no distant metastasis and the pathologic staging was pT2, with no regional lymph nodes involved. Additional pathologic findings included obstructive pneumonia and one benign lymph node. The frozen section diagnosis was confirmed and the examination of the case material and preparation of the report were completed in 11 minutes.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-91-6836.89441c7c-1e09-4b73-8cc3-27cba26f3bd3',\n",
       "  'report_length_cl100k_base': 979,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma of the right upper lobe of the lung, with a tumor size of 2.7 cm. It is unifocal and moderately differentiated, with no lymph node involvement. There is no evidence of metastasis, and the margins are negative for tumor. The patient's lymph nodes from levels 4R, 7, 9R, and 10R are negative for metastatic tumors, but some show calcified granulomas. The tumor is classified as pT1b (primary tumor), pNo (regional lymph nodes), and pMX (distant metastasis), indicating no lymph node involvement and no distant metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma located in the right upper lobe of the lung, with a tumor size of 2.7 cm. The tumor is unifocal and moderately differentiated, with no visceral pleura invasion. The margins are negative for tumor, and there is no lymph-vascular invasion. The lymph nodes excised from levels 9R, 7, and 10R are negative for metastatic tumor, but one lymph node from level 7 has a calcified granuloma. The patient's cancer is classified as pT1b (primary tumor), pNo (regional lymph nodes), and pMX (distant metastasis). Additional pathological findings include a calcified nodule consistent with an old granuloma, focal calcification, and foreign body giant cell reaction, as well as emphysematous changes.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-91-6840.2f5322c3-f57f-4252-8e17-e5a964e81793',\n",
       "  'report_length_cl100k_base': 1302,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's pathological report indicates a poorly differentiated adenocarcinoma in the right lower lobe of the lung, with no evidence of lymph node involvement or metastasis. The tumor size is T2 and the pleural margin is negative for tumor. There is one lymph node with granuloma, but it is not clear if it is related to the cancer.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has poorly differentiated adenocarcinoma in the right lower lobe of the lung involving the pleura, but not the pleural margin (T2, NO, MX). The bronchial margin is free of tumor. The lymph nodes, right lobar and intralobar, were excised and found to have granulomas (1/8). No significant pathologic changes were found in the other lymph nodes examined.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-91-6847.4e40d97c-ca3c-41ec-b5c5-eb2f85ee29b3',\n",
       "  'report_length_cl100k_base': 1094,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient has a non-small cell carcinoma of the left upper lobe of the lung, with a tumor size of 10.2 cm and extranodal extension. There is no evidence of metastatic carcinoma in the inferior ligament lymph nodes, but the hilar lymph node and three out of three lymph nodes in the AP window are positive for metastatic carcinoma. The patient's AJCC staging is pT2, pN2, MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has stage pT2, pN2, MX non-small cell lung carcinoma. The tumor has a maximal diameter of 10.2 cm and is moderately differentiated. There is evidence of extranodal extension of the tumor. Lymph nodes are involved, with metastatic carcinoma found in three out of five lymph nodes. The tumor is free of vascular margins and peripheral margins of resection. The patient's KRAS mutation analysis result was wild type at codon 12, and codon 13 mutations could not be analyzed.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-91-6848.a790e051-b741-4913-aff6-5a48c9e8e8cd',\n",
       "  'report_length_cl100k_base': 1965,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has invasive adenocarcinoma in the left upper lobe (T2) with direct extension into two intraparenchymal lymph nodes and metastasis to two peribronchial lymph nodes (N2). There is no evidence of extranodal extension or metastasis to other organs (MX). The tumor is moderately to poorly differentiated with lymphovascular invasion present and extensive. The patient also has a smaller adenocarcinoma in the left lower lobe (T1) with metastasis to two lymph nodes (N2) and no evidence of extranodal extension (MX).',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has invasive adenocarcinoma in the left upper lobe of the lung, with a tumor size of 5.0 X 4.1 X 2.4 cm, moderately to poorly differentiated, with lymphovascular invasion present and extensive. The tumor has extended into two intraparenchymal lymph nodes, with metastasis to two peribronchial lymph nodes, the largest focus being 1.0 cm, and no extranodal extension. The patient also has a smaller tumor in the left lower lobe, measuring 1.0 cm, with no evidence of transpleural extension. The patient's AJCC cancer stage is T2, N2, MX for the larger tumor and T1, N2, MX for the smaller tumor. EGFR mutation analysis was performed, but no mutation was detected.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-91-6849.910d922e-8180-48ba-9e13-0f177dc71b2d',\n",
       "  'report_length_cl100k_base': 1755,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma with a tumor size of 8.3 cm, unifocal, well differentiated, and no lymph node involvement. There is no evidence of metastasis, and the tumor margins are uninvolved by invasive carcinoma. The pathological staging is pT3 (tumor size 7-12 cm), pNO (no regional lymph node involvement), and pM0 (no distant metastasis).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with a type A thymoma and an adenocarcinoma in the right upper lobe of their lung, measuring 8.3 cm. The thymoma was completely excised, while the lung tumor was partially removed through lobectomy. There is no evidence of lymph node involvement or metastasis. The lung tumor is well-differentiated and unifocal, with no visceral pleura or vascular invasion identified. Margins are uninvolved by invasive carcinoma, and lymph-vascular invasion is not present. The patient's pathological staging is pT3 (tumor size 8.3 cm) and pNO (no regional lymph nodes involved).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-91-7771.a8247167-a991-441b-b60a-9f69f4c5d9da',\n",
       "  'report_length_cl100k_base': 1303,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, well differentiated with predominantly bronchioalveolar growth pattern, located in the left lower lobe of the lung. The tumor size is 3.7 cm and is unifocal. There is no lymph node involvement (0/13) and no distant metastasis. The tumor invades the visceral pleura but not the vascular margins. The patient's cancer is classified as pT2a NX M0.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's left lower lobe lobectomy revealed a well-differentiated adenocarcinoma with a predominantly bronchioalveolar growth pattern, measuring 3.7 cm in the greatest dimension. There was no lymph node involvement (0/13) and no evidence of metastasis. The tumor was unifocal, with no vascular or visceral pleura invasion identified. Margins were uninvolved by invasive carcinoma, and the tumor was classified as pT2a, pNX, and pM0.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-91-8496.d513e826-62f5-4e2d-95ef-7b48fea0643a',\n",
       "  'report_length_cl100k_base': 1434,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is classified as pT1a (invasive component measures less than 1 cm, overall tumor size is 5 cm), pNO (no regional lymph nodes involved), and pMX (no distant metastasis). The tumor is unifocal, invasive adenocarcinoma associated with mucinous and non-mucinous adenocarcinoma in situ. There is no visceral pleura or vascular invasion, and margins are involved by carcinoma. The patient's cancer is stage IA.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is classified as pT1a (invasive component measures less than 1 cm, overall tumor size is 5 cm), with no lymph node involvement (pNO), and no distant metastasis (pMX). The tumor is a unifocal, invasive adenocarcinoma associated with mucinous and non-mucinous adenocarcinoma in situ. There is no visceral pleura invasion, and margins are involved by carcinoma. The patient's staged cancer is considered low grade.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-91-8497.e393a314-6d4d-41f4-a9d3-7d67ab25713b',\n",
       "  'report_length_cl100k_base': 1587,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is a poorly differentiated adenocarcinoma, with a tumor size of 2.7 cm and 1.0 cm (greatest dimension). There is no visceral pleura invasion, and margins are uninvolved by invasive carcinoma. Lymph-vascular invasion is present. The patient's cancer is staged as pT1b (primary tumor), pNO (regional lymph nodes), and there is no evidence of distant metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': '\\nThe patient has a poorly differentiated adenocarcinoma in the left lower lobe of the lung, with a tumor size of 2.7 cm and 1.0 cm. There is no visceral pleura invasion, and margins are uninvolved by invasive carcinoma. Lymph-vascular invasion is present. Lymph nodes L12, L11, L7, and L8 are benign. No distant metastasis is detected. The tumor does not express synaptophysin, chromogranin, or p63. EGFR mutations are not detected (wild type/normal EGFR).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-91-8499.99ab423d-db99-4ef1-bf1f-a8dddb94e788',\n",
       "  'report_length_cl100k_base': 1280,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive adenocarcinoma in both the right upper lobe (2 foci, 4.5 cm and 1.9 cm) and right lower lobe (2.4 cm), with no lymph node involvement (20 examined, 0 involved) and no distant metastasis. The tumors abut the visceral pleura but do not perforate it, and all resection margins are free of tumor.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient is diagnosed with invasive adenocarcinoma of the right upper lobe (pT2b) and right lower lobe (pTb) of the lung, with no lymph node involvement (pNO). The tumors do not perforate the visceral pleura and margins are uninvolved by invasive carcinoma. There is no evidence of lymph-vascular invasion. The final pathologic staging is TNM Descriptors: m (multiple primary tumors).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-91-A4BC.6C586925-8FAC-4A75-8A67-574B24B9D0BA',\n",
       "  'report_length_cl100k_base': 2661,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, minimally invasive and well-differentiated, with a tumor size of 2.8 cm. There is no lymph node involvement (pN1) and no distant metastasis (pMX). The tumor is unifocal and invades the visceral pleura without invasion. The surgical margins are uninvolved by invasive carcinoma.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma with lepidic pattern, well-differentiated and minimally invasive, located in the left lower lobe of the lung. The tumor size is 2.8 cm and is unifocal. There is no lymph node involvement (pN1) and no distant metastasis (pMX). The tumor abuts the visceral pleura but does not show invasion. The surgical margins are negative, and the tumor is classified as pT1b. The patient's cancer is staged as pT1bN0M0.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-91-A4BD.5767AA19-6B73-4FC8-BC3E-930044E249A3',\n",
       "  'report_length_cl100k_base': 1409,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient has invasive moderately differentiated adenocarcinoma with bronchioloalveolar carcinoma features, measuring 1.5 cm, in the right upper lobe of the lung. There is no definitive lymphovascular invasion identified, and the pleural is free of tumor. The cancer is present at the inked staple margin. One lymph node (0/1) in level 10 shows evidence of malignancy, while the remaining lymph nodes in levels 10, 11, and 2R are free of malignancy (0/2). The patient's cancer is classified as T1aN0MX, stage I.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient has invasive moderately differentiated adenocarcinoma with bronchioloalveolar carcinoma features, measuring 1.5 cm, in the right upper lobe of the lung. There is no definitive lymphovascular invasion identified and the pleural is free of tumor. The cancer is present at the inked staple margin. One lymph node (0/1) shows rare mucinous cells, which are not considered diagnostic of malignancy. Nine lymph nodes were examined, with no evidence of malignancy found (0/9). The tumor size is 1.5 cm (T1a), there is no lymph node involvement (N0), and distant metastasis cannot be assessed (MX), resulting in a provisional stage grouping of T1aNOMX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-93-7347.a89ef8ab-8af7-4906-844e-eb216316f584',\n",
       "  'report_length_cl100k_base': 2355,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an invasive moderately differentiated adenocarcinoma, measuring 1.5 cm, with no lymphovascular space invasion identified. There is no pleural invasion seen, and surgical margins are free of tumor. Seven lymph nodes were examined, with no evidence of tumor found (0/7). The cancer is stage T1aN0MX.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an invasive, moderately differentiated adenocarcinoma, measuring 1.5 cm, with no lymphovascular space invasion identified. There is no pleural invasion seen, and surgical margins are free of tumor. Seven lymph nodes were examined, with no evidence of tumor found in any of them. The cancer is stage T1a (tumor size ≤ 2 cm), N0 (no regional lymph node metastasis), and MX (distant metastasis cannot be assessed). The overall international stage is pT1a/NO/MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-93-7348.2ad907ad-1005-4e89-91b8-d09a173bcd4d',\n",
       "  'report_length_cl100k_base': 1637,\n",
       "  't_label': 0},\n",
       " {'abstract': '\\nThe patient has an invasive, poorly differentiated adenocarcinoma in the lung (3.2 cm) that has spread to the visceral pleura (T2aN0Mia), with multiple intra-arterial invasions. There is no evidence of malignancy in one lymph node from levels 7 and 111 (0/1), but hyalinized granulomas are present. The tumor is stage IV with a provisional primary tumor staging of T2a based on the lingula specimen. The patient also has numerous granulomas, some with neuroendocrine differentiation features, and a history of lung mass. The surgical margins are free of tumor.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has an invasive, poorly differentiated adenocarcinoma in the lung\\'s lingula measuring 3.2 cm, which invades the visceral pleura (T2aN0Mia). The tumor has intra-arterial invasion and is staged as T2a based on the staging information from the \"lingula\" specimen. Multiple intra-arterial invasions with tumor cells colonizing the endothelial wall are seen. The patient has hyalinized granulomas in the lymph nodes, but no evidence of malignancy was found in the lymph nodes (0/1). The overall international stage is T2a/NO/M1a (Stage IV).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-93-A4JN.BA9DB454-6107-4F98-8646-89129230D602',\n",
       "  'report_length_cl100k_base': 2262,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma, mixed type (solid - 90%, acinar - 10%), poorly-differentiated (1.5 cm), without evidence of visceral pleura or lymphvascular space invasion, and resection margins not involved. The tumor size is 1.5 cm, with no lymph node involvement and no distant metastasis. The stage grouping is T1a/NO/MO (Stage IA).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient was diagnosed with a poorly-differentiated, mixed-type adenocarcinoma (solid - 90%, acinar - 10%) in the right lower lobe of the lung, measuring 1.5 cm, without evidence of visceral pleura or lymphvascular space invasion. The resection margins were not involved. There was no lymph node metastasis found in levels VII, X, XI, and XII, with a total of 27 lymph nodes examined, and four lymph nodes removed from the right lower lobe. The patient also had a pulmonary chondroid hamartoma (1.3 cm) and subpleural pulmonary fibrosis with bronchial metaplasia, metaplastic bone formation, and mucous retention cyst formation. The overall stage is T1a/N0/M0 (Stage IA).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-93-A4JO.54D7BAFD-D766-4EE6-A769-F57A858B5F44',\n",
       "  'report_length_cl100k_base': 1646,\n",
       "  't_label': 0},\n",
       " {'abstract': '\\nThe patient has invasive adenocarcinoma, acinar type, poorly differentiated, in the right upper lobe of the lung, measuring 2.3 cm. Surgical resection margins are negative, and there is no evidence of malignancy in the resected lymph nodes (0/16). No regional lymph node metastasis is found, and distant metastasis cannot be assessed. The overall international stage is T1b/NO/MO (Stage IA).',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient was diagnosed with invasive adenocarcinoma, acinar type, poorly differentiated (2.3 cm) in the right upper lobe of the lung. The surgical resection margins were negative, and there was no evidence of malignancy in sixteen peribronchial lymph nodes (0/16). The patient had no regional lymph node metastasis (N0), and distant metastasis could not be assessed (M0). The overall international stage is T1b/NO/MO (Stage IA).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-93-A4JQ.B9CE532C-BACD-4123-B560-6671CABC5132',\n",
       "  'report_length_cl100k_base': 1822,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has stage pT3 adenocarcinoma with a 3.3 cm tumor in the right upper lobe that extends through the pleura into the soft tissue of the chest wall and focally involves adjacent bone. There is perineural and angiolymphatic invasion. Surgical margins, including bronchial, vascular, soft tissue, and bone, are free of tumor. No regional lymph node metastasis (pN0) is found in the 9 examined lymph nodes, and distant metastasis (pM) cannot be assessed. The tumor is moderately differentiated (G2) with EGFR mutation analysis pending.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with adenocarcinoma, moderately differentiated, with a maximum tumor diameter of 3.3 cm. The tumor extends through the pleura into the soft tissue of the chest wall, involving the adjacent bone of ribs. Surgical margins, including bronchial, vascular, soft tissue, and bone, are free of tumor. Perineural and angiolymphatic invasion are identified. Four lymph nodes were examined, with no regional lymph node metastasis found. The tumor is classified as T3 (tumor greater than 7 cm) under the AJCC TNM Staging, 7th Edition. The patient's EGFR mutation analysis is pending.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-95-7039.8bb3ec39-1368-448f-8f75-36bac5f19f02',\n",
       "  'report_length_cl100k_base': 1786,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has two separate primary adenocarcinomas in the right upper and lower lobes, both measuring around 1.5cm. Adenocarcinoma is mixed subtype with solid and acinar patterns of growth, poorly differentiated in the right upper lobe, and mixed subtype with micropapillary, acinar, and lepidic patterns of growth, moderately differentiated in the right lower lobe. Both tumors show angiolymphatic invasion, but no visceral pleural or perineural invasion. The tumors have not spread to regional lymph nodes or metastasized.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient has two separate primary adenocarcinomas in the right upper and lower lobes of the lung, both measuring around 1.5cm. Adenocarcinoma in the right upper lobe is mixed subtype with solid and acinar patterns of growth, poorly differentiated, with angiolymphatic invasion identified and no visceral pleural invasion. Adenocarcinoma in the right lower lobe is mixed subtype with micropapillary, acinar, and lepidic patterns of growth, moderately differentiated, also with angiolymphatic invasion identified and no visceral pleural invasion. No perineural invasion is identified in either case. The tumors are staged as pT1a. Lymph-vascular invasion is present in both cases. No lymph nodes are involved. There is no distant metastasis. Emphysematous changes and carcinoid tumorlets are noted.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-95-7043.a30ed7ec-19a9-4d15-b405-86132271a652',\n",
       "  'report_length_cl100k_base': 1600,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma, moderately differentiated, with a tumor size of 3.5 cm. Visceral pleural invasion is present, and lymphovascular invasion is identified. The tumor is uninvolved by invasive carcinoma at the bronchial and vascular margins. One of three peribronchial lymph nodes is positive for metastatic carcinoma (1/3). There is no evidence of extranodal extension or distant metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, moderately differentiated, with a tumor size of 3.5 cm. The tumor invades the visceral pleura and has lymphovascular invasion. The bronchial and vascular margins are negative. One of three peribronchial lymph nodes is positive for metastatic carcinoma (1/3). The other lymph nodes, including right level 9, level 7, and right level 14, are negative for metastatic carcinoma (0/5, 0/13, and 0/7 respectively). There is no evidence of extranodal extension or distant metastasis. The patient's cancer is classified as pT2a (tumor greater than 3 cm but 5 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus, or tumor 5 cm or less in greatest dimension with any of the following features of extent: involves main bronchus, 2 cm or more distal to the carina; inv\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-95-7562.dfdfa10e-5e7d-4a1d-b355-afc8c8418925',\n",
       "  'report_length_cl100k_base': 1861,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma, mixed subtype, with a tumor size of 6.3 x 6.3 x 5.0 cm. It has invaded the visceral pleura and has poorly differentiated histology. There is no vascular or parietal pleural invasion, and the margins are uninvolved by invasive carcinoma. One of seven peribronchial lymph nodes (1/7) is involved with metastatic carcinoma. The patient's cancer is classified as T2b (tumor greater than 5 cm but 7 cm or less in greatest dimension), N1 (metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, and intrapulmonary nodes, including involvement by direct extension), and M0 (no distant metastasis).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient's cancer is an adenocarcinoma, mixed subtype, with a tumor size of 6.3 x 6.3 x 5.0 cm. The tumor has visceral pleural invasion and perineural invasion. The cancer is classified as pT2b, pN1, and there is no evidence of metastasis (pM). The patient's lymph nodes are negative for metastatic carcinoma, with the exception of one out of seven peribronchial lymph nodes. The resection margins are negative for carcinoma, and the tumor is described as poorly differentiated (G3).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-95-7567.7b2574cb-ff02-4e3e-b64b-9d0265ef9335',\n",
       "  'report_length_cl100k_base': 2171,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is a non-small cell carcinoma, specifically poorly differentiated adenocarcinoma, with a tumor size of 1.4 x 1.2 x 1.1 cm. The tumor was found in the left lower lobe of the lung and had no lymphovascular invasion. The margins of the resection were negative for carcinoma. No metastasis was found in the examined lymph nodes (0/2 in #9, 0/1 in #7, and 0/3 in #6). The lung parenchyma was negative for carcinoma in the extended wedge resection. The patient's cancer is classified as pT1a (tumor 2 cm or less, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus). There was no regional lymph node metastasis (pNO), and there was no distant metastasis (pM).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is a non-small cell carcinoma, specifically poorly differentiated adenocarcinoma, with a tumor size of 1.4 x 1.2 x 1.1 cm. The tumor was found in the left lower lobe of the lung and was not surrounded by visceral pleura or bronchial margins. There was no lymphovascular invasion identified and the margins of resection were negative. Lymph nodes #6, #7, and #9 were negative for metastatic carcinoma. Lymph nodes #10L were also negative for metastatic carcinoma. The cancer has not metastasized to distant sites.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-95-7944.567e989f-6896-4faf-84bb-8ef786461228',\n",
       "  'report_length_cl100k_base': 1985,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\n The patient's cancer is an adenocarcinoma, mixed subtype, measuring 1.5 x 1.1 x 0.7 cm, with angiolymphatic invasion identified but no visceral pleural invasion. The surgical parenchymal margin is negative for carcinoma. Five lymph node fragments are negative for metastatic carcinoma (0/5), and three lymph nodes are also negative (0/3). Immunohistochemical staining shows CK7 and TTF1 positivity, and Napsin A and Pax 8 negativity, compatible with a lung primary. The tumor is classified as pT1a (tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus). There is no regional lymph node metastasis (pN0), and distant metastasis is not applicable (pM).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with adenocarcinoma, mixed subtype, with a tumor size of 1.5cm, and angiolymphatic invasion identified. There is no visceral pleural invasion, and the surgical parenchymal margin is negative for carcinoma. Lymph nodes #6, #7, #9, and #10 are negative for metastatic carcinoma (0/5, 0/3, 0/1, and 0/1 respectively). The tumor is considered moderately differentiated (G2) and the patient has no regional lymph node metastasis (pNO). There is no evidence of distant metastasis (pM).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-95-7947.003c68cb-72ea-44c9-80e3-f62224ab3ee2',\n",
       "  'report_length_cl100k_base': 2281,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma, mixed subtype, with a tumor size of 4.0 x 4.0 x 2.0 cm, located in the right lower lobe of the lung. There is visceral pleural invasion and angiolymphatic invasion identified. The tumor is well-differentiated and the bronchial and vascular margins are negative. One lymph node was examined and found to be negative for metastatic carcinoma (0/1). Additionally, four lymph nodes were examined from a separate specimen and were also negative for metastatic carcinoma (0/4). No distant metastasis was reported.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, mixed subtype, with a tumor size of 4.0 x 4.0 x 2.0 cm, and angiolymphatic invasion identified. The tumor is well-differentiated and visceral pleural invasion is present. The bronchial and vascular margins are negative, and one lymph node is negative for metastatic carcinoma (0/1). The patient's cancer is classified as pT2a (tumor greater than 3 cm, but 5 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus). There is no regional lymph node metastasis (pNO), and distant metastasis is not applicable (pM).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-95-7948.1cee5f67-bdcc-41cb-8764-5e0d8e09ed61',\n",
       "  'report_length_cl100k_base': 2071,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is a moderately differentiated adenocarcinoma, sized at 1.7 x 1.7 x 2.5 cm, located in the right upper lobe of the lung, with no pleural involvement. The tumor is unifocal and has not spread to any of the examined lymph nodes (10R, 11R, 4R, 7, and 9R). There is no evidence of metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is a moderately differentiated adenocarcinoma, sized at 1.7 x 1.7 x 2.5 cm, located in the right upper lobe of the lung, and has no pleural involvement. The tumor is unifocal and is classified as pT1b. No lymph node metastasis is found in the examined nodes (pNO). There is no evidence of distant metastasis (pM). The tumor is completely excised, and margins are uninvolved by invasive carcinoma.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-95-8039.2bc3d5a2-7341-44a1-a625-fbfdef9bba6c',\n",
       "  'report_length_cl100k_base': 1459,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive adenocarcinoma of the right middle lobe of the lung, measuring 4.5 cm in size. It invades the visceral pleura but is not through the elastic layer. Lymph node 11R is positive for metastatic carcinoma, while lymph nodes 2R, 4R, and 7R show no tumor. Lymph node 10R is not examined. The cancer is classified as T2a (tumor greater than 3 cm but 5 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus). N1 (metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, and intrapulmonary nodes, including involvement by direct extension). No distant metastasis is found.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an invasive adenocarcinoma in the right middle lobe of the lung, measuring 4.5 cm in size. It invades the visceral pleura but is not through the elastic layer. Lymph node 11R is positive for metastatic carcinoma, while lymph nodes 2R, 4R, and 7R show no tumor. Lymph node 10R is not tumorous. The cancer is classified as T2a (tumor greater than 3 cm but 5 cm or less in greatest dimension, surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than the lobar bronchus). There is no evidence of lymph-vascular invasion. The regional lymph nodes (pN) are classified as pN1, with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, including intrapulmonary nodes. No distant metastasis (pM) is found.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-95-8494.978929c4-0d93-4192-9a72-22047960cfbd',\n",
       "  'report_length_cl100k_base': 1409,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma, predominantly micropapillary pattern with lesser proportions of acinar and lepidic (AKA BAC) patterns of growth. The tumor is moderately differentiated and measures 6 x 5.1 x 4.1 cm. Lymphovascular invasion is identified. No perineural invasion is identified. No visceral pleural invasion is identified. Bronchial and vascular margins are negative for carcinoma. Two peribronchial lymph nodes are negative for carcinoma (0/2). The cancer has metastasized to one of one lymph node (1/1) in the R10/sump excision, two of two lymph nodes (2/2) in the level 4 excision, and five of five lymph nodes (5/5) in the 4R excision. The tumor is classified as pT2b (tumor greater than 5 cm, but 7 cm or less in greatest dimension), pN2 (metastasis in lipsilateral mediastinal and/or sub\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is an adenocarcinoma, mixed subtype, with a tumor size of 6x5.1x4.1 cm. Lymphovascular invasion is identified, but there is no perineural invasion. The tumor is moderately differentiated and has a pT2b classification. Lymph nodes involved in the cancer include R10/sump, level 4, and 4R, with a total of 8 out of 12 nodes affected. No distant metastasis is reported.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-95-A4VK.0B713E19-EE67-4C3B-8319-4C69019C00D0',\n",
       "  'report_length_cl100k_base': 2471,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has been diagnosed with adenocarcinoma, predominantly solid type, in the right lower lobe of the lung, with a tumor size of 3.5 x 3.3 x 3.2 cm. There is no visceral pleural invasion, but one of two lymph nodes (1/2) is involved with metastatic carcinoma. The tumor is poorly differentiated and there is no definite vascular invasion. Atypical adenomatous hyperplasia is also present. In the right lower lobe wedge #3, there is another adenocarcinoma, acinar predominant, well differentiated, with a tumor size of 1 mm. There is no visceral pleural invasion and no vascular invasion. Three intraparenchymal lymph nodes are negative for carcinoma (0/3). The tumors in part A and C are histologically different and likely represent separate primary tumors.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient is a female with multiple primary tumors in the right lower lobe of the lung. Tumor A is an adenocarcinoma, predominantly solid type, 3.5 cm in size, with no visceral pleural invasion and indeterminate lymph-vascular invasion. Tumor B is a metastatic carcinoma involving one of two lymph nodes. Tumor C is an adenocarcinoma, acinar predominant, well differentiated, with a size of 1 mm and no visceral pleural invasion. All three tumors have negative bronchial and vascular margins, and no extranodal extension is identified. The patient has atypical adenomatous hyperplasia in the background.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-95-A4VN.D348711A-FD65-4771-A604-D761C96F5C48',\n",
       "  'report_length_cl100k_base': 2103,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is stage pT2b (tumor greater than 5 cm, but 7 cm or less in greatest dimension) with N2 lymph node involvement (metastasis in lipsilateral mediastinal and/or subcarinal lymph node(s)) as 4 out of 8 lymph nodes were found positive for metastatic adenocarcinoma. There is lymphangitic invasion present, but bronchial and vascular margins are negative for invasive carcinoma. The tumor is moderately differentiated and extends to the visceral pleural surface. There is no evidence of distant metastasis.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient is a female with a diagnosis of adenocarcinoma in the left lower lobe of the lung, measuring 6.9 x 4.7 x 4.1 cm. The tumor extends to the visceral pleural surface and invades the lymph-vascular system. The bronchial and vascular resection margins are negative for carcinoma. Four out of eight peribronchial lymph nodes and two out of five lymph nodes from level 111 are positive for metastatic adenocarcinoma. The tumor is moderately differentiated and TTF-1 positive, with focal positivity for synaptophysin. The patient's staging is T2b (tumor greater than 5 cm but 7 cm or less in greatest dimension), N2 (metastasis in lipsilateral mediastinal and/or subcarinal lymph node(s)), and M0 (no distant metastasis).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-95-A4VP.8892002E-D9B2-47FA-9540-A19E4A35B6C7',\n",
       "  'report_length_cl100k_base': 2193,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive adenocarcinoma mixed with bronchioalveolar carcinoma, with tumor sizes ranging from 2.1cm to 1.4cm. There is no angiolymphatic invasion observed, and margins are negative for carcinoma. The tumor cells are positive for cytokeratin-7 and TTF-1, but negative for CK-20 and CDX-2. No regional lymph node metastasis is found, with 12 nodes examined and 0 involved. The patient's cancer has not metastasized.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's pathology report indicates a diagnosis of invasive adenocarcinoma mixed with bronchioloalveolar carcinoma in the left upper lobe of the lung, ranging from 2.1cm to 1.4cm, moderately differentiated. There is no angiolymphatic invasion observed, and immunohistochemical studies reveal that tumor cells are positive for cytokeratin-7 and TTF-1, but negative for CK-20 and CDX-2. The margins are negative for carcinoma. Lymph nodes from stations 13, 9, 5, and 7 are biopsied and found to be negative for malignancy (0/12). The tumor is limited to the pulmonary parenchyma, with no regional lymph node metastasis.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-7546.6d3d1827-e313-45ab-a388-406a3b26b427',\n",
       "  'report_length_cl100k_base': 1591,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an adenocarcinoma of the lung, with a tumor size of 4.5 cm. It is invasive into the visceral pleura (IB (PT2 NO MX) and has no lymphatic or venous invasion. The lymph nodes from stations 4, 7, 9, 10, and 11 are negative for carcinoma. The tumor is well to moderately differentiated, with no involvement of the bronchus and a distance of 1 cm from the closest bronchial margin. There are no additional pathologic findings, and the margins are free of tumor.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with adenocarcinoma of the lung, with a tumor size of 4.5 cm in the greatest dimension, well to moderately differentiated histologic grade, and is classified as pathological stage IB (PT2 NO MX). The tumor is invasive into the visceral pleura and is 1 cm away from the bronchial margin. There is no venous or arterial invasion observed, and the lymph nodes from stations 4, 7, 9, 10, and 11 are negative for carcinoma. The margins are free of tumor, and the bronchial margin is also free of tumor. The patient's clinical history indicates a right lung mass, and the additional pathologic finding is obstructive bronchitis.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-7547.4a96b27c-c641-4db1-abb2-d2f5ec4a404d',\n",
       "  'report_length_cl100k_base': 1214,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is classified as pT2 NO Mx with a tumor size of 5.2 cm, invasive adenocarcinoma (20% acinar/papillary/micropapillary and 80% mucinous type), and no lymph node involvement. The tumor has well to moderately differentiated histology (G1-G2), uninvolved margins, and no direct extension or large vessel invasion.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's left lower lobe tumor is an invasive adenocarcinoma, sized at 5.2 cm, with a mixed histologic subtype (20% acinar/papillary/micropapillary and 80% bronchioloalveolar). The tumor is well to moderately differentiated (G1-G2) with uninvolved margins, no direct extension into the visceral pleura, and no large vessel invasion. There is no lymphatic invasion identified, and the lymph nodes (stations 7, 11, and 12) are negative for carcinoma (0/1 in each). The tumor is classified as pT2 NO Mx.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-7552.201ed2f1-c4ed-42ac-81eb-b5a725c36b47',\n",
       "  'report_length_cl100k_base': 988,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a stage IA adenocarcinoma of the lung, mixed type, moderately to poorly differentiated, measuring 2.5 cm. The tumor is confined to the lung parenchyma, with no lymphovascular invasion. Surgical margins are negative, and no lymph nodes are involved (0/28).',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with stage IA adenocarcinoma of the lung, mixed type, moderately to poorly differentiated, measuring 2.5 cm. The tumor is confined to the lung parenchyma, with no lymphovascular invasion. The surgical margins are negative, and no residual carcinoma is found in the lung or lymph nodes (0/28). The patient's lymph nodes at levels 5, 6, and 9 are negative for carcinoma (0/11).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-7553.85eedad8-21be-4b10-910b-5b71802ae52f',\n",
       "  'report_length_cl100k_base': 1164,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's adenocarcinoma is moderately differentiated, measuring 4.7 cm in the left lower lobe of the lung. There is no visceral pleura invasion, and margins are uninvolved by invasive carcinoma. Lymph-vascular invasion is present, with metastases found in two of the three lymph nodes from level 7 and no involvement in the other examined lymph nodes. The tumor is negative for EGFR and KRAS mutation. The patient's stage is pT2a (tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than the lobar bronchus) and pN2 (metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s)), with no distant metastases.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with adenocarcinoma, mixed subtype, measuring 4.7cm in the left lower lobe of the lung. The tumor is moderately differentiated and invades the lymph-vascular system. Two out of three lymph nodes in level 7 are positive for metastatic carcinoma, while the other lymph nodes are negative for carcinoma. The tumor is uninvolved by invasive carcinoma in all margins, and there are no signs of extranodal extension or distant metastases. The patient's clinical history indicates lung cancer, and the pre-operative diagnosis is supported by the presence of TTF-1 and CK7 in the tumor cells.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-97-7554.17c2777e-782d-40e6-be44-8fad69d9abd1',\n",
       "  'report_length_cl100k_base': 1923,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is stage pT2a (tumor greater than 3 cm but 5 cm or less in greatest dimension surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than the lobar bronchus; involves main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung), pN0 (no regional lymph node metastasis), and pM0 (no distant metastases). The tumor is a microscopic papillary predominant adenocarcinoma, measuring 3.5 cm in size. The margins of resection are free of tumor, and there is no vascular or lymphatic invasion. Three benign lymph nodes were found. The patient's cancer is negative for KRAS and EGFR mutations.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient has been diagnosed with adenocarcinoma, micropapillary predominant, with a tumor size of 3.5cm. The tumor is unifocal and surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than the lobar bronchus. There is no regional lymph node metastasis, and no distant metastases were found. The margins of resection are free of tumor, and the tumor extension is not identified. The patient's KRAS and EGFR mutation analysis results were wild-type, and ALK fluorescence in-situ hybridization (FISH) was negative for rearrangement.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-7937.c52adb5c-9ab3-475b-b21c-c817ea5209f2',\n",
       "  'report_length_cl100k_base': 3216,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is stage pT1a (tumor 1.5 cm, surrounded by lung, without bronchoscopic evidence of invasion more proximal than the lobar bronchus), pN0 (no regional lymph node metastasis), and pM0 (no distant metastasis). The tumor is a unifocal adenocarcinoma, predominantly bronchioloalveolar with a 0.9 cm focus of invasive adenocarcinoma of acinar and micropapillary patterns. The tumor extends 1.5 cm in the greatest dimension, and the bronchial and vascular margins are uninvolved by invasive carcinoma. The patient's cancer has a KRAS mutation, which correlates with poor prognosis and resistance to tyrosine kinase inhibitor therapies. No mutation was detected in the EGFR tyrosine kinase domain.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with adenocarcinoma of the right upper lobe of the lung, measuring 1.5 cm in size. There is no evidence of lymph node metastasis (pN0) and no distant metastases (pM). The tumor is positive for TTF-1 and KRAS mutation (p.G12C (c.34G>T) in codon 12 of the KRAS gene). The patient's staging is T1a (tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-7938.c1b81542-c8ad-43d1-a963-1584868e7fe7',\n",
       "  'report_length_cl100k_base': 2938,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is a lepidic predominant adenocarcinoma, measuring 2.6 cm, with no lymph node involvement (pNO) and no metastasis (pM0). The tumor shows lymphovascular invasion and is classified as pT1b. The patient's cancer is stage IB.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is a lepidic predominant adenocarcinoma, measuring 2.6cm, located in the left upper lobe of the lung. There is no evidence of lymph-vascular invasion. The tumor is surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than the lobar bronchus. The bronchial and vascular margins are free of tumor. 111 lymph nodes were examined, all negative for carcinoma (pNO). The cancer is classified as pT1b (tumor greater than 2cm but 3cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus). No mutations were detected in the KRAS or EGFR genes.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-7941.f95131f4-d721-441f-86ee-d9981befc2a7',\n",
       "  'report_length_cl100k_base': 3296,\n",
       "  't_label': 0},\n",
       " {'abstract': \" The patient is a 66-year-old boy who was initially diagnosed with metastatic lung cancer. The cancer has spread to his lymph nodes and diaphragm. A biopsy of the lung tissue revealed that the cancer is an adenocarcinoma, which is a type of non-small cell lung cancer. The tumor is 4.5 cm in size and is located in the upper and middle lobes of the right lung. The cancer has also spread to seven lymph nodes, with extranodal extension present. The patient's cancer is classified as stage pT2a, indicating that the tumor is larger than 3 cm but not larger than 5 cm, and has spread to the lymph nodes. The patient's cancer is also classified as N2, indicating that the cancer has spread to the mediastinal and subcarinal lymph nodes. The patient's cancer is a mixed subtype of adenocarcinoma, which means that it has both papillary and acinar patterns. The patient's cancer has not spread to other organs, so it is classified as M0. The patient's cancer\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient is a 66-year-old boy who was initially diagnosed with metastatic lung cancer. The cancer has spread to his lymph nodes and diaphragm. A biopsy of the lung tissue revealed that the cancer is an adenocarcinoma, which is a type of non-small cell lung cancer. The tumor is 4.5 cm in size and is located in the upper and middle lobes of the right lung. The cancer has also spread to seven lymph nodes, with extranodal extension present. The patient's cancer is classified as stage pT2a, indicating that the tumor is larger than 3 cm but not larger than 5 cm, and has spread to the lymph nodes. The patient's cancer is also classified as N2, indicating that the cancer has spread to the mediastinal and subcarinal lymph nodes. The patient's cancer is a mixed subtype of adenocarcinoma, which means that it has both papillary and acinar patterns. The patient's cancer has not spread to other organs, so it is classified as M0. The patient's cancer\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-97-8171.71aa5cff-eda0-47d0-97d8-caf4c02f5626',\n",
       "  'report_length_cl100k_base': 4494,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is stage 1A (pT2a, pN0, pM0), with a 3.5 cm unifocal adenocarcinoma in the right upper lobe of the lung. There is no evidence of visceral pleural invasion, and the bronchial and vascular margins are free of tumor. The patient's lymph nodes (station 10, 11, 2, 4, and 7) are negative for carcinoma (0/32).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient's cancer is staged as pT2a (tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than the lobar bronchus; or tumor 5 cm or less in greatest dimension with any of the following features of extent: involves main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung), pNO (no regional lymph node metastasis), and pM (no distant metastases). The tumor consists of acinar (90%) and lepidic (10%) components and has prominent extracellular mucin. The bronchial and vascular margins are free of tumor. Seven lymph nodes were examined, all negative for carcinoma (0/7). The patient's KRAS gene has a p.G12V (c.35G>T) mutation in codon 1\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-8172.ef65fdd5-820a-4029-a667-56b5200276a7',\n",
       "  'report_length_cl100k_base': 2805,\n",
       "  't_label': 1},\n",
       " {'abstract': \" The patient is a 65-year-old male who is an ex-smoker with a history of asbestos exposure and a 6.1 cm mass in the right upper lobe of his lung. A lobectomy was performed, and the tumor was found to be an adenocarcinoma, mixed subtype, measuring 7 cm in the greatest dimension. The tumor was unifocal and did not involve the entire lung. There was no invasion of the visceral pleura or vascular margin. The bronchial margin was free of tumor. A total of 31 lymph nodes were examined, and none were involved with carcinoma. The patient's EGFR and KRAS genes were wild-type, and ALK was not amplified.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient is a 65-year-old male who is an ex-smoker with a history of asbestos exposure and a 6.1 cm mass in the right upper lobe of his lung. A lobectomy was performed, and the tumor was found to be an adenocarcinoma, mixed subtype, measuring 7 cm in the greatest dimension. The tumor was unifocal and did not involve the entire lung. There was no invasion of the visceral pleura or vascular margin. The bronchial margin was free of tumor. A total of 31 lymph nodes were examined, and none were involved with carcinoma. The patient's EGFR and KRAS genes were wild-type, and ALK was not amplified.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-8174.f71782a0-0d9f-486e-9e17-cd5ff92d44d7',\n",
       "  'report_length_cl100k_base': 3926,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is stage pT2a (tumor greater than 3 cm but 5 cm or less in greatest dimension surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than the lobar bronchus, or tumor 5 cm or less in greatest dimension with any of the following features of extent: involves main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung), pN0 (no regional lymph node metastasis), and M0 (no distant metastasis). The tumor is a solid adenocarcinoma, poorly differentiated, measuring 3.2 cm in greatest dimension. The bronchial and vascular margins are free of tumor. Seven lymph nodes were examined and found to be negative for carcinoma. Molecular tests for EGFR, KRAS, and ALK were performed, and the results were negative for mutations.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient has been diagnosed with adenocarcinoma of the left upper lobe of the lung, with a tumor size of 3.2 cm. The tumor is unifocal and poorly differentiated. There is no invasion of the visceral pleura or bronchoscopic evidence of invasion more proximal than the lobar bronchus. The patient's lymph nodes are negative for carcinoma (pN0). The tumor is staged as pT2a. No mutations were detected in EGFR, KRAS, or ALK genes.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-8175.19c71bba-794d-4245-bbd8-536740912c9f',\n",
       "  'report_length_cl100k_base': 3108,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has stage T3 (tumor >7 cm) adenocarcinoma in the right lower lobe of the lung with direct invasion of the diaphragm. There is no evidence of lymph node involvement in levels 7, 9, and 111, but the tumor has extended to the right hilar and bronchus intermedius lymph nodes. No mutations in KRAS, EGFR, or ALK were found.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient is an ex-smoker with a 7 cm right lower lobe tumor, which is an adenocarcinoma, acinar predominant, invading the diaphragm. Lymph nodes involved include one in the right middle lobe, one in the right hilar region, and one in the bronchus intermedius. There is no evidence of lymph-vascular invasion. The tumor is KRAS mutation positive, which correlates with poor prognosis and resistance to tyrosine kinase inhibitor therapies.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-97-8176.348ab6f0-fcae-41ce-ae5c-0f0d3c3fd40f',\n",
       "  'report_length_cl100k_base': 2733,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient has been diagnosed with adenocarcinoma of mixed subtype, with a tumor size of 4cm. The cancer is unifocal and moderately differentiated. There is no evidence of lymph node metastasis (pN0), but lymph-vascular invasion is present. The tumor has invaded the visceral pleura and perineural regions. The patient's cancer is classified as stage pT2a (tumor greater than 3 cm but 5 cm or less in greatest dimension surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than the lobar bronchus, or tumor 5 cm or less in greatest dimension with any of the following features of extent: involves main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has been diagnosed with adenocarcinoma of mixed subtype, with a tumor size of 4cm, and is classified as pT2a. There is no regional lymph node metastasis (pN0), but lymph-vascular invasion is present. The tumor is surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than the lobar bronchus. The patient's sample tested positive for the L858R mutation in Exon 21, which is associated with responsiveness to EGFR tyrosine kinase inhibitor therapies in non-small-cell lung carcinoma. The KRAS mutation analysis resulted in a wild-type gene, and no mutations were identified at codons 12 and 13 of the KRAS gene.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-8177.addbe4e2-114d-4e38-aa21-c3e9695da8fa',\n",
       "  'report_length_cl100k_base': 2826,\n",
       "  't_label': 1},\n",
       " {'abstract': ' As a researcher, my response would be: ALK rearrangement, Variant 1; ALK rearrangement, Variant 3',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' As a researcher, my response would be: ALK rearrangement, Variant 1; ALK rearrangement, Variant 3',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-8179.8ed138ef-c9fe-45dd-870a-a438f6f22214',\n",
       "  'report_length_cl100k_base': 3648,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient has a moderately differentiated adenocarcinoma (4 cm) in the right lower lobe of the lung with visceral pleural invasion. There is lymph node metastasis in levels 11, 7, and 111, but the level 4 lymph node is negative for carcinoma. The tumor is positive for TTF1 and negative for PAX-8. The patient's KRAS gene is wild-type, but the EGFR gene has a positive mutation for E746A750del5.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \"The patient has a moderately differentiated adenocarcinoma in the right lower lobe of the lung, measuring 4cm, with visceral pleural invasion and lymphovascular invasion. The tumor is positive for TTF1 and negative for PAX-8. There is metastasis in the ipsilateral mediastinal and subcarinal lymph nodes. The patient's EGFR mutation analysis showed a positive result for the E746 A750del5 mutation in Exon 19, which is known to correlate with responsiveness to EGFR tyrosine kinase inhibitor therapies in patients with non-small-cell lung carcinoma. The KRAS mutation analysis showed a wild-type gene, indicating no mutations were identified at codons 12 and 13 of the KRAS gene.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-97-8547.7aa82152-5e34-43b3-81e2-77548d0d1c33',\n",
       "  'report_length_cl100k_base': 2932,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is a lepidic predominant adenocarcinoma, mixed subtype, with a tumor size of 1.5 cm. There is no invasion of the visceral pleura or lymph-vascular systems. The bronchial and vascular margins are free of tumor. No regional lymph node metastasis was found in levels 11, 5, and 6. The patient's cancer is classified as stage pT1a (tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus). There is no evidence of distant metastasis (pM). Molecular studies showed wild-type KRAS and EGFR mutation, and ALK FISH was not performed.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient is a never-smoker with a 1.5 cm LLL nodule. The tumor is a lepidic predominant adenocarcinoma, mixed subtype, with no lymph node involvement and no metastasis. The bronchial and vascular margins are free of tumor. The tumor consists of lepidic (70%), papillary (20%), micropapillary (5%) and acinar (5%) components. There is an area of invasion measuring 0.7 cm in greatest linear dimension. The patient's KRAS gene is wild-type, and the EGFR gene has a positive mutation for E746 A750del5 in Exon 19.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-8552.0bfe6dee-7584-4803-be3e-5201cd5ad412',\n",
       "  'report_length_cl100k_base': 2378,\n",
       "  't_label': 0},\n",
       " {'abstract': ' The patient is a former smoker with a 1.6 cm right upper lobe nodule, a 3.7 cm left lower lobe ground-glass mass and a 1 cm left lingular nodule. Adenocarcinoma, mixed subtype, was found in the left lower lobe (3.5 cm) and lingula (1 cm). No regional lymph node metastases were identified.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient is a former smoker with a 1.6 cm right upper lobe nodule, a 3.7 cm left lower lobe ground-glass mass and a 1 cm left lingular nodule. Adenocarcinoma, mixed subtype, was found in the left lower lobe (3.5 cm) and lingula (1 cm). No regional lymph node metastases were identified.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-A4LX.1D7E3689-7B7F-4916-BCD9-04C5A98F09DE',\n",
       "  'report_length_cl100k_base': 3504,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is stage 1A (T2a, N0, M0), with a unifocal, moderately differentiated, acinar predominant adenocarcinoma measuring 2.2 cm in the right upper lobe of the lung. There is visceral pleural invasion, but the bronchial and vascular margins are free of tumor. Eight lymph nodes were examined, with no evidence of metastasis (0/8). KRAS mutation analysis revealed a p.G12C (c.34G>T) mutation in codon 12, and EGFR mutation analysis showed no mutations.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient is a former smoker with a 2.2 cm mixed subtype adenocarcinoma in the right upper lobe of the lung, with visceral pleural invasion. There is no lymph node involvement (pN0) and no distant metastases (pM). The tumor has no lymphovascular invasion and the bronchial and vascular margins are free of tumor. KRAS mutation analysis revealed a p.G12C (c.34G>T) mutation in codon 12, which correlates with poor prognosis and resistance to tyrosine kinase inhibitor therapies. EGFR mutation analysis revealed no mutation, indicating that the patient may not be responsive to EGFR tyrosine kinase inhibitor therapies.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-A4M0.0ACA9251-2F21-49E1-9E56-4D7359EF614F',\n",
       "  'report_length_cl100k_base': 2874,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an adenocarcinoma, mixed subtype, with a tumor size of 1.3cm. The tumor is unifocal and surrounded by lung without bronchial or vascular invasion. There is no lymph node involvement or metastasis identified. The tumor is classified as pT1a (tumor 2cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus). Regional lymph nodes are negative for metastasis (pNO). The patient's cancer is staged as pT1aN0M0.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient has been diagnosed with adenocarcinoma, mixed subtype, in the right upper lobe of the lung, measuring 1.3cm. The tumor is 60% lepidic and 40% acinar. The bronchial and vascular margins are negative for tumor, and there is no lymph-vascular invasion. The patient is classified as pT1a (tumor 2cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus) and pNO (no regional lymph node metastasis). Four lymph nodes were excised and found to be negative for tumor. The tumor is completely excised.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-A4M1.5482EF99-9D9B-4C29-A934-4808907EF37B',\n",
       "  'report_length_cl100k_base': 1719,\n",
       "  't_label': 0},\n",
       " {'abstract': ' The comprehensive report for the medical test would be: Lung, right middle lobe: Completion lobectomy. - Adenocarcinoma, mixed subtype, 1.1 cm, surrounded by lung parenchyma without bronchoscopic evidence of invasion more proximal than the lobar bronchus; Nodes negative by histology; pT1a(N0M0).',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The comprehensive report for the medical test would be: Lung, right middle lobe: Completion lobectomy. - Adenocarcinoma, mixed subtype, 1.1 cm, surrounded by lung parenchyma without bronchoscopic evidence of invasion more proximal than the lobar bronchus; Nodes negative by histology; pT1a(N0M0).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-A4M2.0D5976EC-5D41-44A2-AC0A-CBE90F2A908E',\n",
       "  'report_length_cl100k_base': 3967,\n",
       "  't_label': 0},\n",
       " {'abstract': ' The patient is a former smoker (35-40 pack-years) with a right upper lobe adenocarcinoma, a 2.3 cm mixed solid and ground-glass nodule, and multiple additional bilateral lung nodules. Molecular studies on the apical biopsy show wild-type KRAS and EGFR. The level 7 lymph nodes are benign.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient is a former smoker (35-40 pack-years) with a right upper lobe adenocarcinoma, a 2.3 cm mixed solid and ground-glass nodule, and multiple additional bilateral lung nodules. Molecular studies on the apical biopsy show wild-type KRAS and EGFR. The level 7 lymph nodes are benign.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-A4M3.49E1FE02-A4A8-4805-88B1-ADB915F879DF',\n",
       "  'report_length_cl100k_base': 3611,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient is a 65-year-old male with a 2.5 cm invasive mucinous adenocarcinoma in the right upper lobe of the lung, with no lymph node involvement. The tumor consists of acinar, micropapillary, and papillary components. The patient underwent a completion right upper lobectomy, and the bronchial and vascular margins were free of tumor. The patient's cancer was staged as pT1b (tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus). Molecular testing revealed a positive KRAS mutation, which is associated with poor prognosis and resistance to tyrosine kinase inhibitor therapies in patients with non-small cell lung cancer. The patient's cancer is considered Stage IA (T1, N0, M0).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient underwent a right upper lobectomy due to an invasive mucinous adenocarcinoma (2.5cm) in the right upper lobe of the lung. The tumor consists of acinar (40%), micropapillary (30%) and papillary (30%) components. The bronchial and vascular margins were free of tumor. No regional lymph node metastasis was found. The patient's KRAS gene had a p.G12C (c.34G>T) mutation in codon 12, which correlates with poor prognosis and resistance to tyrosine kinase inhibitor therapies in patients with non-small cell lung cancer. No mutations were detected in the EGFR gene, which is important for determining responsiveness to EGFR tyrosine kinase inhibitor therapies.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-A4M5.BD386F47-1CDC-46D5-A14D-F7D27F70982F',\n",
       "  'report_length_cl100k_base': 3290,\n",
       "  't_label': 0},\n",
       " {'abstract': ' The patient is a never-smoker with a 1.5 cm sub-solid nodule in the right lower lobe of the lung, which was determined to be a lepidic predominant adenocarcinoma. There was no lymph-vascular invasion or regional lymph node metastasis. The tumor was staged as pT1a N0 M0. Molecular testing revealed a positive EGFR mutation (E746_A750del5) and negative KRAS mutation.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient is a never-smoker with a history of rheumatoid arthritis and a 1.5 cm sub-solid nodule in the right lower lobe of the lung. A wedge biopsy of the lung was performed, which revealed a lepidic predominant adenocarcinoma measuring 1.4 cm. The tumor was surrounded by lung parenchyma or visceral pleura without bronchoscopic evidence of invasion more proximal than the lobar bronchus. The patient underwent a right lower lobectomy, and no residual tumor was found. The bronchial and vascular margins were free of tumor. The patient's lymph nodes were negative for carcinoma. Molecular testing revealed a wild-type KRAS gene and a positive EGFR mutation analysis for the E746_A750del5 mutation in exon 19. The patient's prognosis and response to targeted tyrosine kinase inhibitor therapies may be influenced by these mutations.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-A4M6.E697A53A-C377-4BC8-8D3F-79562DFF6F0A',\n",
       "  'report_length_cl100k_base': 3278,\n",
       "  't_label': 0},\n",
       " {'abstract': ' The patient is a former smoker with a 2.9cm right middle lobe adenocarcinoma and a 1.6cm right lower lobe lepidic predominant adenocarcinoma. The tumors are morphologically distinct and both are stage IA.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient is a former smoker with a 2.9cm right middle lobe adenocarcinoma and a 1.6cm right lower lobe lepidic predominant adenocarcinoma. The tumors are morphologically distinct and both are stage IA.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-97-A4M7.6E901848-BA21-4D4A-9CB5-0A5786D2843B',\n",
       "  'report_length_cl100k_base': 4618,\n",
       "  't_label': 0},\n",
       " {'abstract': \" The patient is a 66-year-old boy who underwent right lower lobe wedge resection, right upper lobe wedge resection, and left lower lobe wedge resection for multiple pulmonary nodules. The final pathology report described multiple carcinoid tumors and bronchioloalveolar carcinomas in separate specimens. The largest tumor was 1.6 cm and was located in the anterior basilar segment of the right lower lobe. There was no evidence of lymphatic or vascular invasion or metastasis. The patient's prognosis is uncertain, as the presence of multiple tumors and the size of the largest tumor may indicate a more aggressive form of cancer.\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': \" The patient is a 66-year-old boy who underwent right lower lobe wedge resection, right upper lobe wedge resection, and left lower lobe wedge resection for multiple pulmonary nodules. The final pathology report described multiple carcinoid tumors and bronchioloalveolar carcinomas in separate specimens. The largest tumor was 1.6 cm and was located in the anterior basilar segment of the right lower lobe. There was no evidence of lymphatic or vascular invasion or metastasis. The patient's prognosis is uncertain, as the presence of multiple tumors and the size of the largest tumor may indicate a more aggressive form of cancer.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-99-7458.d17d08c5-429b-413f-8ed6-984bc2021392',\n",
       "  'report_length_cl100k_base': 3896,\n",
       "  't_label': 3},\n",
       " {'abstract': 'The patient is a female with lung cancer, specifically adenocarcinoma with bronchoalveolar features. The tumor size is 5.5cm and 1.0cm, and it involves peribronchial soft tissue and perineural invasion. There is no pleural involvement. Lymph node involvement is observed in levels IV, IX, and VIII, with one positive lymph node in level IV. No metastasis is reported. The pathological stage is pT3 (m) / N2.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient is a female with a history of lung cancer. The pathology report indicates a moderately differentiated adenocarcinoma with bronchoalveolar features in the right upper lobe of the lung, measuring 5.5 cm and 1.0 cm. The tumor involves peribronchial soft tissue and perineural invasion is identified. One lymph node is positive for metastatic carcinoma (1/3) and multiple fragments of lymph nodes are negative for malignancy. The tumor is classified as pT3 (m) / N2.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-99-8025.42373413-46df-4837-a01f-2659d92888cd',\n",
       "  'report_length_cl100k_base': 1683,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient is a year-old female with a 2 cm moderately differentiated adenocarcinoma in the left upper lobe of the lung. The tumor margins are negative for malignancy, and there is no pleural involvement. Five lymph nodes, including #5, #6, #7, #8, #9, and #10, are negative for malignancy (0/5). The pathologic stage is 5T1a/NO/Mx.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient is a year-old female with a 2 cm moderately differentiated adenocarcinoma in the left upper lobe of the lung. The tumor margin is negative for malignancy and the pleural surface is not involved. No lymph node metastasis was found in lymph nodes 5, 6, 7, 8, 9, 10, and 12. The pathologic stage is 5T1a/NO/Mx.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-99-8028.c5b3fd4e-8e81-4b8f-b38d-e2a6bbded1ee',\n",
       "  'report_length_cl100k_base': 1514,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient is a male with a moderately differentiated adenocarcinoma in the right upper lobe of the lung, measuring 2.0 cm in maximal dimension. The tumor is not involved with the pleura, and surgical resection margins are free of tumor. There is no evidence of lymph node metastasis, with multiple lymph nodes negative for malignancy in levels VII, VIII, IX, XI, and IV-R. There is no evidence of vascular invasion. The patient's cancer is classified as stage IA (pT1a, pNO).\",\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': 'The patient is a male with a moderately differentiated adenocarcinoma in the right upper lobe of the lung, measuring 2.0 cm in maximal dimension. The tumor is not involved with the pleura, and surgical resection margins are free of tumor. There is no evidence of lymph node metastasis, with multiple lymph nodes negative for malignancy in levels VII, VIII, IX, XI, and IV-R. The bronchial margin is also negative for tumor.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-99-8032.376597ef-e750-4f66-b744-2b042c0df836',\n",
       "  'report_length_cl100k_base': 1417,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient is a female with a 1.2 cm adenocarcinoma in the left lower lobe of the lung. The tumor is surrounded by red-brown spongy pulmonary parenchyma and is unifocal. There is no evidence of visceral pleura invasion, and the bronchial and vascular margins are uninvolved. No regional lymph node metastasis was found.',\n",
       "  'cancer_type': 'LUAD',\n",
       "  'extract': ' The patient is a [black]-female with a lung nodule. The left lower lobe lobectomy specimen reveals a 1.2 cm unifocal adenocarcinoma, moderately differentiated, surrounded by red-brown spongy pulmonary parenchyma. The pleura is not involved by tumor, and the surgical margin is negative for malignancy. Three peribronchial lymph nodes are negative for malignancy (0/3). There is no evidence of lymph node metastasis (pNO).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-99-AA5R.5541B103-6FD2-4767-B914-8A5B58E86D0A',\n",
       "  'report_length_cl100k_base': 1679,\n",
       "  't_label': 0},\n",
       " {'abstract': \" The comprehensive report for malignant neoplasm of the breast for the patient indicates the following: Adenoid cystic carcinoma was found in the breast. The tumor size is 1.2 cm and it is invasive. There is no lymphatic or vascular invasion. The cancer has not spread to the lymph nodes. The margins of the tumor are negative. The cancer is stage pT1cNOMX. The cancer is estrogen receptor (ER) positive, but HER2/neu is negative. Microcalcifications were found in the breast tissue. Atypical ductal hyperplasia and apocrine metaplasia were also found in the breast tissue. The patient's clinical history indicates that this is a second lesion, and a dominant mass was found in the left breast during wire-guided partial mastectomy. The mass was 1 x 1 x 0.8 cm and was located centrally within the slices. The pathology report describes the tumor as adenoid cystic carcinoma, which is a relatively circumscribed tumor with large nests of ep\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \" The comprehensive report for malignant neoplasm of the breast for the patient indicates the following: Adenoid cystic carcinoma was found in the breast. The tumor size is 1.2 cm and it is invasive. There is no lymphatic or vascular invasion. The cancer has not spread to the lymph nodes. The margins of the tumor are negative. The cancer is stage pT1cNOMX. The cancer is estrogen receptor (ER) positive, but HER2/neu is negative. Microcalcifications were found in the breast tissue. Atypical ductal hyperplasia and apocrine metaplasia were also found in the breast tissue. The patient's clinical history indicates that this is a second lesion, and a dominant mass was found in the left breast during wire-guided partial mastectomy. The mass was 1 x 1 x 0.8 cm and was located centrally within the slices. The pathology report describes the tumor as adenoid cystic carcinoma, which is a relatively circumscribed tumor with large nests of ep\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A1-A0SB.BEC7EEA9-6DEA-4402-A3A1-07EF33D58174',\n",
       "  'report_length_cl100k_base': 3375,\n",
       "  't_label': 0},\n",
       " {'abstract': \" The patient is a woman with a history of biopsy-proven low-grade invasive and in situ ductal carcinoma who undergoes left breast needle-localized lumpectomy and sentinel lymph node sampling. The invasive tumor size is 4 cm, with no lymphatic-vascular invasion or perineural invasion. The tumor is grade 2, with negative resection margins and no lymph node involvement. The patient's cancer is classified as pT2NOMX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a woman with a history of biopsy-proven low-grade invasive and in situ ductal carcinoma who undergoes left breast needle-localized lumpectomy and sentinel lymph node sampling. The invasive tumor size is 4 cm, grade 2, and there is no lymphatic-vascular invasion or perineural invasion. The lymph node status is negative, with no positive lymph nodes. The AJCC/UICC stage is pT2NOMX. The ductal carcinoma in situ size is focal, with low-to-intermediate nuclear grade and necrosis present. The resection margins for invasive tumor and ductal carcinoma in situ are negative, and the calcifications are present in association with DCIS and benign ducts.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A1-A0SD.DD89D265-9E20-49C2-93BD-666BE7D5E41B',\n",
       "  'report_length_cl100k_base': 3164,\n",
       "  't_label': 1},\n",
       " {'abstract': \" The comprehensive report for the breast cancer biopsy states that the patient has invasive carcinoma in the left breast, with a positive test for estrogen receptors and a borderline test for progesterone receptors. The report also notes that the patient's HER2/neu test was borderline, and further testing would be needed to determine if gene amplification is present. The report also mentions a lesion in the right breast that was deemed benign, as well as a hyperplastic polyp in the rectum. Additionally, the report notes that the patient's cervical Thin Prep was negative for intraepithelial lesions or malignancy, and that the left axillary lymph node was benign with no evidence of neoplasia.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \" The comprehensive report for the breast cancer biopsy states that the patient has invasive carcinoma in the left breast, with a positive test for estrogen receptors and a borderline test for progesterone receptors. The report also notes that the patient's HER2/neu test was borderline, and further testing would be needed to determine if gene amplification is present. The report also mentions a lesion in the right breast that was deemed benign, as well as a hyperplastic polyp in the rectum. Additionally, the report notes that the patient's cervical Thin Prep was negative for intraepithelial lesions or malignancy, and that the left axillary lymph node was benign with no evidence of neoplasia.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A1-A0SE.CFF567FC-8867-4CA4-85AE-81A7D30095E7',\n",
       "  'report_length_cl100k_base': 4661,\n",
       "  't_label': 0},\n",
       " {'abstract': \" The comprehensive report for the breast cancer biopsy states that the patient is a woman with left breast cancer who underwent a bilateral mastectomy. The pathology report describes the specimen received and the findings of the examination. The report indicates that the patient's breast tissue was sent for testing to determine if the cancer has spread to the lymph nodes. The report also notes that an immunohistochemical test for estrogen and progesterone receptors was performed, and the cancer was found to be positive for estrogen receptors and negative for progesterone receptors. The report further states that the cancer is negative for HER2/neu oncoprotein over-expression. The report provides details about the size and location of the tumor, as well as the presence of duct ectasia and atypical lobular hyperplasia in the contralateral breast. The report also notes that the patient's omentum, adnexa, and peritoneum were examined and found to be free of cancer.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \" The comprehensive report for the breast cancer biopsy states that the patient is a woman with left breast cancer who underwent a bilateral mastectomy. The pathology report describes the specimen received and the findings of the examination. The report indicates that the patient's breast tissue was sent for testing to determine if the cancer has spread to the lymph nodes. The report also notes that an immunohistochemical test for estrogen and progesterone receptors was performed, and the cancer was found to be positive for estrogen receptors and negative for progesterone receptors. The report further states that the cancer is negative for HER2/neu oncoprotein over-expression. The report provides details about the size and location of the tumor, as well as the presence of duct ectasia and atypical lobular hyperplasia in the contralateral breast. The report also notes that the patient's omentum, adnexa, and peritoneum were examined and found to be free of cancer.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A1-A0SF.1617B36B-4EFB-445E-95BC-E63B129AAAE7',\n",
       "  'report_length_cl100k_base': 4922,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive micropapillary carcinoma in the right breast, with a maximum diameter of 2.1 cm and no lymphatic-vascular or perineural invasion. There is one positive lymph node out of six sampled, with a diameter of 2.1 mm. The tumor is estrogen and progesterone receptor positive and HER2/neu negative. The patient's AJCC/UICC stage is pT2N1aMX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a year-old woman with right breast carcinoma, with an invasive micropapillary carcinoma of 2.1 cm maximum diameter. There is no lymphatic-vascular or perineural invasion, and 1 out of 6 lymph nodes is positive for metastasis. The tumor is negative for HER2/neu oncoprotein over-expression, but positive for estrogen and progesterone receptors. The AJCC/UICC stage is pT2N1aMX. The patient's clinical history and the results of the FISH test for HER2/neu are also provided, as well as details about the specimen and the immunohistochemical assay.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A1-A0SG.89A67051-898A-4E2A-A874-E0165F274E63',\n",
       "  'report_length_cl100k_base': 1906,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma with a maximum diameter of 2.1 cm, lymphatic-vascular invasion present, and no lymph node involvement. The cancer is stage pT2N0(S)MX. There is no evidence of metastasis.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a year-old woman with a palpable lesion in the left upper inner quadrant who underwent a partial mastectomy. The pathologic diagnosis includes invasive ductal carcinoma, solid and micropapillary types of ductal carcinoma in situ, and lobular carcinoma in situ. The invasive tumor size is 2.1 cm, with lymphatic-vascular invasion present. The lymph node status is negative, with no positive lymph nodes. The tumor is stage pT2N0(S)MX. The patient's carcinoma is indeterminate for HER2/neu oncoprotein over-expression, and the results of the FISH test are pending. The resection margins for invasive tumors and ductal carcinoma in situ are negative, and the patient's breast tissue shows atypical ductal hyperplasia involving fibroadenoma.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A1-A0SH.1FB1255E-D9EC-4FE9-BE96-F81271FCCFB6',\n",
       "  'report_length_cl100k_base': 2533,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient is a woman with a right breast invasive ductal carcinoma, measuring 2.6 cm, with lymphatic-vascular invasion, and one positive lymph node out of 23 sampled. The cancer is estrogen and progesterone receptor-positive and HER2/neu negative.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a woman with a 2.6 cm invasive ductal carcinoma in the right breast, with lymphatic-vascular invasion and one positive lymph node out of 23 sampled. The tumor is estrogen and progesterone receptor-positive and HER2/neu negative.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A1-A0SI.4CD6BDB7-9629-41C6-8514-7661E3D33A66',\n",
       "  'report_length_cl100k_base': 3287,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The comprehensive report for malignant neoplasm of the breast (BRCA) includes the following: 1. Clinical history 2. Gross description 3. Microscopic examination 4. Immunohistochemistry 5. Cytogenetics 6. Additional studies 7. Synoptic comments 8. Margins 9. AJCC/UICC stage 10. Diagnosis 11. The patient is a 47-year-old woman with left breast cancer 12. The specimen is a mastectomy, without skin, nipple, or areola, that has been previously inked and incised prior to receipt in Pathology 13. The lesion is present as an irregular firm area in slices 3 through 6 (6.5 cm from medial to lateral) 14. The majority of this lesion is present as a solid area in slices 3 through 6 (6.5 cm from medial to lateral) 15. Two 0.5 cm, spherical cystic cavities are present within or adjacent to the lesion',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The comprehensive report for malignant neoplasm of the breast (BRCA) includes the following: 1. Clinical history 2. Gross description 3. Microscopic examination 4. Immunohistochemistry 5. Cytogenetics 6. Additional studies 7. Synoptic comments 8. Margins 9. AJCC/UICC stage 10. Diagnosis 11. The patient is a 47-year-old woman with left breast cancer 12. The specimen is a mastectomy, without skin, nipple, or areola, that has been previously inked and incised prior to receipt in Pathology 13. The lesion is present as an irregular firm area in slices 3 through 6 (6.5 cm from medial to lateral) 14. The majority of this lesion is present as a solid area in slices 3 through 6 (6.5 cm from medial to lateral) 15. Two 0.5 cm, spherical cystic cavities are present within or adjacent to the lesion',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A1-A0SJ.0C0EEC9F-A715-4769-B58C-99D06C3C91F3',\n",
       "  'report_length_cl100k_base': 4227,\n",
       "  't_label': 2},\n",
       " {'abstract': 'Neuroendocrine carcinoma, large cell type, high grade, 3.8 cm in size, extending to deep resection margin and 0.1 cm from anterior/superior margin; lymph node status: 0/4; negative for estrogen and progesterone receptors, HER2 negative; pT2NOMX.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a year-old woman with post-operative diagnosis of breast cancer, who undergoes sentinel lymph node biopsy and right partial mastectomy. The neuroendocrine carcinoma is high grade, with a tumor size of 3.8 cm and negative lymph node involvement. The tumor is negative for estrogen and progesterone receptors and HER2/neu oncoprotein over-expression. The AJCC/UICC stage is pT2NOMX.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A1-A0SK.13302EC6-6511-42FE-AA8B-C875B5384FFE',\n",
       "  'report_length_cl100k_base': 2757,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma of the left breast, measuring 3.5 cm, with no lymphatic-vascular invasion and no perineural invasion. The cancer is grade 2, with microcalcifications present. Ductal carcinoma in situ (DCIS) is also present, measuring 0.3 cm, with an intermediate nuclear grade. The patient's lymph nodes are negative for tumor involvement (0/3), and there is no evidence of metastasis. The patient's cancer is classified as pT2NOMX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a year-old with invasive ductal carcinoma of the left breast, measuring 3.5 cm, grade 2, associated with microcalcifications. Ductal carcinoma in situ (DCIS) type is cribriform, measuring 0.3 cm, with intermediate nuclear grade. No lymphatic-vascular invasion or perineural invasion is present. Lymph node status is negative (0/3). The patient's cancer is ER, PR, and HER-2-positive. AJCC/UICC stage is pT2NOMX. No metastatic carcinoma was identified in the sentinel lymph nodes.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A1-A0SM.4F047F5B-EF3A-4590-8E7A-D90A52860324',\n",
       "  'report_length_cl100k_base': 1976,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is stage pT1cN1MX according to the AJCC/UICC staging system. The tumor is invasive ductal carcinoma, with a maximum size of 1.1 cm and a grade of 2. There is extensive lymphatic-vascular invasion and one lymph node with extension into peri-nodal fat. Four lymph nodes are positive for metastasis, with a total of 13 nodes sampled. The tumor is positive for estrogen and progesterone receptors and HER2/neu oncoprotein over-expression.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is stage pT1cN1MX according to the AJCC/UICC staging system. The tumor is invasive ductal carcinoma, with a maximum diameter of 1.1 cm and a grade of 2. There is extensive lymphatic-vascular invasion and one lymph node with extension into peri-nodal fat. Four lymph nodes are positive for metastasis, with a total of 13 nodes sampled. The tumor is positive for estrogen and progesterone receptors and HER2/neu oncoprotein over-expression. The patient's clinical history includes a left breast partial mastectomy, and the specimen consists of various parts, including breast tissue and lymph nodes, which were examined through frozen section diagnosis and permanent section diagnosis.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A1-A0SN.D0269758-EFAE-4EBA-8CCF-4A6CF4D4B35A',\n",
       "  'report_length_cl100k_base': 2526,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma with a tumor size of 4.8 cm, grade 3, with no lymphatic-vascular invasion. One sentinel lymph node out of nine sampled is positive for metastasis (1/9), with a metastasis diameter of 0.4 cm. The patient's AJCC/UICC stage is pT2N1MX. There is no extranodal extension, and the nipple and skin are uninvolved. Ductal carcinoma in situ is present, with scattered microscopic foci up to 0.1 cm in diameter, involving one of twelve total slides, and high-grade nuclei.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a woman with right breast cancer. The tumor size is 4.8 cm, and it is an invasive ductal carcinoma, grade 3. There is no lymphatic-vascular invasion, and the lymph node status is positive with one lymph node involved. The metastasis size is 0.4 cm, and there is no extranodal extension. The AJCC/UICC stage is pT2N1MX. The patient's nipple and skin are uninvolved, and the nontumorous breast tissue is unremarkable. The final pathologic diagnosis is metastatic carcinoma involving one lymph node out of nine sampled.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A1-A0SO.6104F94F-BA8F-4435-A839-E1FEA6EFFDF3',\n",
       "  'report_length_cl100k_base': 1928,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient is a woman with a history of right breast adenocarcinoma diagnosed by fine needle aspiration. She underwent right breast partial mastectomy and right sentinel lymph node biopsy. The pathologic diagnosis includes invasive ductal carcinoma (2.2 cm, grade 3), ductal carcinoma in situ (DCIS), and high-grade necrosis. The tumor has no lymphatic-vascular invasion, and the lymph node status is negative (0/3). The patient's AJCC/UICC stage is pT2NOMX. Immunohistochemical tests for estrogen and progesterone receptors were negative, and HER2 neu test results were not overexpressed.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a year-old woman with a history of right breast adenocarcinoma diagnosed by fine needle aspiration. She underwent right breast partial mastectomy and right sentinel lymph node biopsy. The pathologic diagnosis includes invasive ductal carcinoma, 2.2 cm, grade 3, with no lymphatic-vascular invasion and negative lymph nodes (0/3). Ductal carcinoma in situ (DCIS) was also present, comedo and solid, high nuclear grade with necrosis. The patient's cancer is stage pT2NOMX. Immunohistochemical tests for estrogen and progesterone receptors were negative, and HER2 neu test was performed but the results are not yet available.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A1-A0SP.01992912-611F-4AA8-8570-B062CBCCAF70',\n",
       "  'report_length_cl100k_base': 2131,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The comprehensive report for malignant neoplasm of the breast includes: 1) patient history, 2) clinical history, 3) gross pathology, 4) microscopic pathology, and 5) addenda. The patient is a 45-year-old woman with a 3.8 cm invasive ductal carcinoma with mucinous features. Lymph node status was positive with metastases found in one of 15 lymph nodes. The tumor was estrogen and progesterone receptor positive and HER2/neu negative.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The comprehensive report for malignant neoplasm of the breast includes: 1) patient history, 2) clinical history, 3) gross pathology, 4) microscopic pathology, and 5) addenda. The patient is a 45-year-old woman with a 3.8 cm invasive ductal carcinoma with mucinous features. Lymph node status was positive with metastases found in one of 15 lymph nodes. The tumor was estrogen and progesterone receptor positive and HER2/neu negative.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A1-A0SQ.92EE56BF-AAA0-438E-9244-780DBB2D9835',\n",
       "  'report_length_cl100k_base': 3736,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient is a 43-year-old white female with a 1.0 cm invasive ductal carcinoma in the right breast. The tumor is moderately differentiated with negative margins and no lymphovascular invasion. There is no lymph node involvement in the sentinel or non-sentinel lymph nodes. The tumor is ER/PR positive and HER2-neu is not amplified. The pathological staging is T1c N0 MX.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a white female with a 1.0 cm invasive ductal carcinoma in the right breast, classified as T1c. There is no lymphovascular invasion, and the margins are negative. The tumor is moderately differentiated with tubular formation-2, nuclei-, and mitoses-. ER/PR immunostains are strongly positive, and HER2-neu overexpression is not amplified (1.2). Four lymph nodes were biopsied, with two sentinel and two non-sentinel nodes all negative for malignancy. The pathologic staging is T1c NO MX.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A04N.45B4B99C-80E6-4AF4-8692-F7EE19D0467A',\n",
       "  'report_length_cl100k_base': 1222,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma with a residual tumor size of 2.5 x 2.0 x 1.5 cm. The deep surgical margin is involved by the main tumor, and the medial, superior, and inferior margins are focally involved by discontinuous tumor foci. There is extensive lymphatic involvement, with metastatic carcinoma found in 18 of 20 examined lymph nodes, as well as extranodal extension and non-nodal metastases. Additionally, metastatic carcinoma was found in the left suprasternal lymph node.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 43-year-old female with left breast cancer. The tumor size is 2.5 x 2.0 x 1.5 cm, and the deep surgical margin is involved by residual gross tumor. The medial, superior, and inferior margins are focally involved by discontinuous tumor foci. There is extensive lymphatic involvement, with metastatic carcinoma involving 18 of 20 examined lymph nodes and extensive extranodal extension. One suprasternal lymph node also tested positive for metastatic carcinoma.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A2-A04P.0E4B0EA9-14D1-4A82-814D-51CC2B9BA2B5',\n",
       "  'report_length_cl100k_base': 1492,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an infiltrating ductal carcinoma, with a tumor size of 1.8 cm, poorly differentiated, and HER2 neu is weakly positive (2+). The cancer is estrogen and progesterone receptor negative. There is no involvement of lymph nodes in the sentinel or non-sentinel specimens.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a white female with a 1.8 cm poorly differentiated invasive ductal carcinoma in the right breast. The tumor is estrogen and progesterone receptor negative, HER2 neu weakly positive (2+), and has negative margins. There is associated ductal carcinoma in situ with nuclear grade III and lymphoid infiltrate comprising 10-15% of the tumor. Two sentinel lymph nodes were negative for tumor by H&E and immunohistochemistry, and one non-sentinel lymph node was benign. The tumor is not associated with Paget's disease or lactiferous duct involvement, but microcalcifications were present. The patient's breast tissue showed fibrocystic changes and sclerosing adenosis.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A04Q.726B60CA-1B1C-440D-82FA-A4C978C4D484',\n",
       "  'report_length_cl100k_base': 1215,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an infiltrating ductal carcinoma, moderately differentiated, with a maximum tumor dimension of 2.0 cm. The cancer is estrogen and progesterone receptor positive and HER2 weakly positive (2+). There is no evidence of lymph node involvement, and surgical margins are negative for tumor. The specimen is negative for malignancy by immunohistochemistry.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 42-year-old female with a 2.0 cm infiltrating ductal carcinoma in the left breast, moderately differentiated with nuclear grade 2 and associated ductal carcinoma in situ. The tumor is estrogen and progesterone receptor positive and HER2 weakly positive (2+). The surgical margins are negative for tumor, and the left sentinel lymph node is negative for malignancy.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A04R.6A97C809-91BB-4E35-9E12-F5F2A58C9D35',\n",
       "  'report_length_cl100k_base': 924,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient is a white female with left infiltrating ductal carcinoma of the breast. The tumor size is 2.2 cm and is located one centimeter from the superior posterior and superior anterior margins of resection. The tumor is graded as high grade with a score of 9/9 using the modified Bloom and Richardson scheme. The sentinel lymph nodes are negative for metastatic carcinoma. There is no in situ carcinoma identified.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a white female with left infiltrating ductal carcinoma of the breast. The tumor size is 2.2 cm and is located one centimeter from the superior posterior and superior anterior margins of resection. The tumor is graded as high grade with a score of 9/9 using the modified Bloom and Richardson scheme. The sentinel lymph nodes are negative for metastatic carcinoma. There is no in situ carcinoma identified. The specimen consists of multiple fragments of pink to yellow/tan, irregularly shaped tissue, which measure 2.5 x 2.0 x 1.0 cm in loose aggregate. The node is bisected, revealing extensive fat infiltration. One half of the node is submitted for CBCP protocol; the remaining half is submitted for paraffin section in cassette B2. The remaining tissue is predominantly fatty with a 1.0 cm area of fibrous tissue punctuated with yellow flecks.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A04T.24D42292-B875-4FAF-8C3A-9834414C3A01',\n",
       "  'report_length_cl100k_base': 995,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is stage pT2pNO (i+) MX. The tumor size is 4.0 cm, and it is poorly differentiated with no ductal carcinoma in situ identified. There is no lymphatic vessel invasion, but rare single cytokeratin positive cells were found in sentinel lymph node #2, measuring less than 0.2 mm in diameter. The cancer is estrogen and progesterone receptor negative and HER 2 neu (1+) negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a white female with a 4.0 cm poorly differentiated invasive ductal carcinoma in the right breast, with no lymph node involvement (pT2pNO (i+)). The tumor is negative for hormone receptors and HER 2 neu (1+). The AJCC stage is pT2pNO (i+) MX.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A04U.B14456B1-4992-492D-AFB5-4F975F20A277',\n",
       "  'report_length_cl100k_base': 1095,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has synchronous bilateral infiltrating ductal carcinoma. The right breast tumor measures 2.2 x 2.0 x 1.5 cm and the left breast tumor measures 2.2 x 1.8 x 1.8 cm. The left breast tumor abuts the deep margin without definitive involvement and has focal vascular invasion. There is no lymph node involvement in either breast. The patient is stage pT2NOMX.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a white female with synchronous bilateral infiltrating ductal carcinoma. The right breast tumor measures 2.2 x 2.0 x 1.5 cm and is grade II with negative margins, no lymphovascular invasion, and no ductal carcinoma in situ. The left breast tumor measures 2.2 x 1.8 x 1.8 cm, abuts the deep margin without definitive involvement, has focal associated ductal carcinoma in situ, and focal vascular invasion. There is no evidence of malignancy in the right axillary sentinel lymph nodes or left axillary sentinel lymph nodes. The patient's AJCC stage is pT2NOMX.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A04V.7D84A145-19AF-48D0-A5D9-F5724068CB26',\n",
       "  'report_length_cl100k_base': 2654,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient is a 45-year-old female with a 4.5 cm invasive ductal carcinoma in the right breast. The tumor is moderately differentiated with a Nottingham score of 7/9. There is venous/lymphatic invasion present, but the margins are negative. One of 18 lymph nodes is positive for tumor by IHC only. The tumor is estrogen and progesterone receptor negative, but HER 2 neu is positive (3+). The pathological stage is pT2 NO (i+) MX (AJCC Stage II). Additional pathological changes include cystic change, sclerosing adenosis, and apocrine metaplasia. The patient has no nipple or skin involvement, and multicentricity is absent.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a 45-year-old female with invasive ductal carcinoma of the right breast, with a tumor size of 4.5cm. The tumor is apochrome carcinoma, infiltrating (histioctoid subtype), with moderate differentiation (G2) and a Nottingham score of 7/9. The tumor is estrogen and progesterone receptor negative, but HER 2 neu positive (3+). Lymph nodes are involved, with one of 18 positive for tumor by IHC only. The pathologic stage is pT2 NO (i+), and the patient's history includes a multifocal lesion.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A04W.84CA9DDD-36CA-466E-A74C-C7FB03E7C9E4',\n",
       "  'report_length_cl100k_base': 1421,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient is a 47-year-old female with breast carcinoma. The left breast tumor is 3.5 cm in size, with no lymphovascular invasion and negative margins. There is no evidence of metastasis. The sentinel lymph nodes from both the left and right breasts are negative for malignancy. The final AJCC staging is pT2 NO MX.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 47-year-old female with breast carcinoma. The left breast mastectomy specimen reveals an infiltrating ductal carcinoma, measuring 3.5 cm in size, with no lymphovascular invasion present. The tumor is moderately differentiated with a Nottingham score of 7, and margins are negative. DCIS is present, with cribriform nuclear grade II and necrosis. The sentinel lymph nodes from both the left and right breasts are negative for malignancy by H&E and immunohistochemical stains. The right breast mastectomy specimen shows mild fibrocystic changes, including apocrine metaplasia, focal ductal dilatation, and mild fibrosis. AJCC staging is pT2 NO MO.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A04X.F114D078-5F03-47F8-82AE-B8A21C2F9D31',\n",
       "  'report_length_cl100k_base': 1387,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has bilateral breast cancer, with tumor sizes of 2.5 cm (right breast) and 5 cm (left breast). Lymph node involvement is present in the right breast with 1 of 1 positive for microscopic focus of tumor, while the left breast has no lymph node involvement. The tumors are poorly differentiated (G3) with Nottingham scores of 8/9 (right breast) and 9/9 (left breast). Hormone receptors are positive for estrogen (90% right, nearly 1000% left) and progesterone (10% right, 40% left). HER2 is negative for the right breast and positive for the left breast (3+ on IHC, positive by FISH). The lesions would be stage pT2 N1mi MX (right) and pT2 NO (left).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has bilateral breast cancer, with tumor sizes of 2.5cm (right breast) and 5cm (left breast). Lymph node involvement is present in the right breast with 1 of 1 positive for microscopic focus of tumor, and absent in the left breast. The tumors are poorly differentiated (G3) with Nottingham scores of 8/9 (right) and 9/9 (left). Estrogen and progesterone receptors are positive in both breasts, with HER2 negative in the right breast and positive in the left. The lesion from the right side would be stage pT2 N1mi MX, and the lesion from the left side would be stage pT2 NO (i-) MX.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A04Y.E4F7064C-9D81-49B5-9992-898155B3F11E',\n",
       "  'report_length_cl100k_base': 1878,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient is a white female with a 0.5 cm invasive lobular carcinoma in the right breast, with positive surgical margins, negative lymph node involvement (NX), and no evidence of metastasis (MX). The tumor is stage I (T1). HER2-neu overexpression was negative (1+), and ER/PR immunostains were negative. The specimen showed no evidence of perineural involvement or microcalcifications. The patient's clinical diagnosis and history are not provided.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a white female with a 0.5 cm lobular carcinoma in the right breast inferior lateral retro-areola. The tumor has perineural involvement and the surgical margins are positive for tumor. The patient's HER2-neu test is negative and ER/PR immunostains are also negative. The AJCC staging is stage I (T1, NX, MX). The specimen was evaluated for HER2-neu overexpression and the results were negative. The patient's clinical diagnosis and history indicate a small complex mass in the inferior/lateral retroareolar area of the right breast. The specimen consists of a single irregularly shaped fragment of fibro fatty tissue, which was previously inked and sectioned. The specimen was placed in its entirety in five gray cassettes marked A1-A5.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A2-A0CK.B065FC65-CD33-4878-AE2C-7E8C04F5ECAB',\n",
       "  'report_length_cl100k_base': 597,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient is a 43-year-old female with right breast cancer. The tumor is an infiltrating ductal carcinoma, poorly differentiated, measuring 5.6 cm with extensive venous/lymphatic invasion. It is estrogen receptor positive (20%), progesterone receptor negative (<5%), and HER 2 neu negative (1%). There is lymph node involvement, with 9 of 12 nodes positive for tumor, and the largest metastatic focus is 1.5 cm. The pathological stage is pT3 N2a M0 (AJCC Stage IIIA).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 56-year-old female with right breast cancer. The tumor is an infiltrating ductal carcinoma, poorly differentiated, with a size of 5.6 cm and necrosis present. It is positive for estrogen receptors (20%) and negative for progesterone receptors (less than 5%) and HER 2 neu (1%). The pathologic stage is pT3 N2a M0 (AJCC Stage IIIA). Lymph nodes are involved, with 9 out of 12 positive for tumor, and the largest metastatic focus is 1.5 cm. The deep margin is involved by the tumor.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A2-A0CL.17950062-E052-4FC2-A437-A17669B4DD01',\n",
       "  'report_length_cl100k_base': 907,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient has a poorly differentiated invasive ductal carcinoma with a tumor size of 3.0 cm and lymphovascular space invasion. The tumor extends to within 1 mm of the deep surgical margin and has a minimal in-situ component. The patient's tumor is negative for estrogen receptors and focally positive for progesterone receptors. HER2/neu is negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a black individual with a 3.0 cm poorly differentiated invasive ductal carcinoma (grade III/III) in their left breast. The tumor has extensive necrosis, minimal in-situ component, and lymphovascular space invasion. It extends within 1 mm of the deep surgical margin and is negative for estrogen and HER2/neu receptors, but focally positive for progesterone receptors. The specimen consists of a fibrofatty tissue fragment with a firm, well-circumscribed mass with a tan, gritty, and focally hemorrhagic cut surface. The remaining tissue is predominantly fatty and unremarkable.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0CM.2972AB07-2C29-43B8-96DA-1386C5E248EB',\n",
       "  'report_length_cl100k_base': 471,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an infiltrating lobular carcinoma, with a tumor size of 5.2 cm and margins deep margin positive for tumor. There is no lymphatic vessel invasion, but the lymph nodes are involved with metastasis. The cancer is HER2-neu amplified, and the patient's prior core biopsy was negative for HER2-neu.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a 50-year-old white female with a 5.2 cm infiltrating lobular carcinoma in the right breast. The margins are positive for tumor, but there is no lymphovascular invasion. The cancer is stage-unknown. The patient's lymph nodes are negative for tumor, but the tumor is HER2-neu amplified.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A2-A0CO.8C440009-E05E-4046-96AB-BAB211CB7D02',\n",
       "  'report_length_cl100k_base': 863,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient is a 40-year-old white female with right breast cancer. The tumor size is 2.0 cm, and it is a well-differentiated infiltrating ductal carcinoma. The margins are clear of ductal carcinoma in situ and infiltrating ductal carcinoma. The Estrogen and Progesterone receptors are detectable in 40% and 80% of the tumor nuclei, respectively. The sentinel lymph nodes #1 and #2 are negative for malignancy via light microscopy and immunohistochemical stains. There is no evidence of metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 40-year-old white female with right breast cancer. The tumor is well-differentiated infiltrating ductal carcinoma, Bloom-Richardson grade 4, with a tumor size of 2.0 cm. The margins are clear of ductal carcinoma in situ and infiltrating ductal carcinoma. The Estrogen and Progesterone receptors are detectable in 40% and 80% of the tumor nuclei, respectively. The sentinel lymph nodes #1 and #2 are negative for malignancy via light microscopy and immunohistochemical stains.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0CP.DAB9A2B8-FCE7-4FF4-BAC4-4D2A04D7A43B',\n",
       "  'report_length_cl100k_base': 749,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a stage pT1 pNO(i-) MX invasive ductal carcinoma in the right breast, measuring 1.8 cm, and papillary carcinoma in situ with surrounding ductal carcinoma in situ in the left breast, measuring 1.2 cm. There is no lymph node involvement in either breast.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a 44-year-old female with a history of bilateral breast core biopsies, revealing infiltrating ductal carcinoma on the right and DCIS with cribriform features on the left. The left breast lumpectomy revealed papillary carcinoma in situ with surrounding ductal carcinoma in situ, multifocal, and microcalcifications. The right breast lumpectomy revealed an invasive ductal adenocarcinoma, moderately differentiated, with associated papillary carcinoma and ductal carcinoma in situ, multifocal. The tumor size was 1.8 cm, and it was less than 1.0 mm from the superior margin, anterior margin, and 1.5 mm from the posterior margin. The patient's AJCC stage is pT1 pNO(i-) MX. No lymph node involvement was found in either breast.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0CQ.964DFAC8-91EC-4C0E-B499-3ED5F2D70096',\n",
       "  'report_length_cl100k_base': 1752,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient is a 47-year-old female with invasive lobular carcinoma of the left breast, measuring 9 cm. The tumor is ell-differentiated with angiolymphatic invasion and focal dermal lymphatic involvement. The deep margin is within 1 mm of the tumor. There are no positive lymph nodes out of 16 identified. The tumor is stage IIB (T3 NO MX) with focal lobular carcinoma in situ and intraductal hyperplasia. The patient's cancer has not metastasized.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 47-year-old female with left breast carcinoma. The tumor size is 9 cm, with angiolymphatic invasion identified and focal dermal lymphatic involvement. The tumor is within 1 mm of the deep margin. 16 lymph nodes were identified, all negative for malignancy. The AJCC stage is IIB (T3 NO MX). There is focal lobular carcinoma in situ and intraductal hyperplasia, florid. The final diagnosis is invasive lobular carcinoma.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A2-A0CR.A3167E2D-3588-41D4-99AA-6DCB660D55A4',\n",
       "  'report_length_cl100k_base': 834,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with extracapsular extension and a tumor size of 7.0 cm. Lymph node involvement is present, with seven out of eleven examined lymph nodes showing metastatic carcinoma, and the extent of extranodal tumor is at least 6 mm. The tumor is classified as pT4b (ulceration) N2aMX.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 40-year-old white female with invasive ductal carcinoma in the left breast, measuring 7.0 cm in size, involving the dermis, epidermis, and nipple with ulceration. The tumor extends into skeletal muscle and is classified as pT4b. Seven out of eleven examined lymph nodes have metastatic carcinoma with extracapsular extension present and a maximum dimension of the largest deposit being 1.8 cm. The extracapsular extension is at least 6 mm. The tumor is well differentiated with a Nottingham score of 5, tubule formation of 20%, and nuclear pleomorphism of 2.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A2-A0CS.A985FB5C-9E91-40E1-864E-CEA887B3866D',\n",
       "  'report_length_cl100k_base': 1185,\n",
       "  't_label': 3},\n",
       " {'abstract': \"The patient's cancer is an infiltrating ductal carcinoma, well differentiated with a maximum tumor size of 2.4 cm. There is no lymphatic or perineural invasion, and the margins are negative for tumors. Two sentinel lymph nodes were biopsied and found to be negative for tumors. The patient's cancer is classified as AJCC stage pT2NOMX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a white female with a well-differentiated infiltrating ductal carcinoma in the right breast, measuring 2.4 cm. There is no lymphatic or perineural invasion, and the margins are negative for tumor. Two sentinel lymph nodes were biopsied and found to be negative for tumor by H&E and immunohistochemistry. The patient's AJCC stage is pT2NOMX.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0CT.FDF38AA6-DC65-4043-8277-71BAE47902B1',\n",
       "  'report_length_cl100k_base': 995,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient is a 44-year-old female with right breast cancer. The tumor size is 3.4 cm, and it is located within 0.2 cm of the inferior-anterior margin. There is no lymph-vascular invasion identified. Isolated tumor cells are present in the lymph node capsule, and the AJCC pathologic stage is pT2, pNO (i+), Mx.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 44-year-old female with right breast cancer. The tumor is 3.4 cm in size and is located in the lower outer quadrant of the breast. There is no lymph-vascular invasion identified. The tumor is classified as pT2 and pNO (i+), with isolated tumor cells identified in the lymph node capsule. The AJCC pathologic stage is pT2, pNO (i+), Mx. The nipple and areola complex is not affected, and the remaining tissue is mostly fatty with some fibrous patches. The tumor is moderately differentiated and is classified as NOS C50.9.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0CU.D503E73D-8B94-46A0-A24F-93069A56DC7D',\n",
       "  'report_length_cl100k_base': 734,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is invasive ductal carcinoma, with a tumor size of 4.1 cm and nodular margins. Lymph node involvement is present with 2/18 positive lymph nodes, including extranodal extension of 4 mm. The cancer is estrogen and progesterone receptor-positive and Her2-negative. The patient's cancer has been pathologically staged as pT2N1aMX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a 40-year-old Asian-Pacific Islander who underwent a mastectomy with axillary and sentinel lymph node dissection. The tumor is invasive, with a Nottingham score of 6 and a grade II (moderately differentiated) nuclear grade. The tumor size is 4.1 cm, with margins negative for lymphatic invasion and extranodal extension present (4 mm). One sentinel lymph node (out of eighteen) and one non-sentinel lymph node are positive for metastasis. The patient's hormone receptors are positive (estrogen and progesterone) and Her2 is negative. The final pathological staging is pT2N1aMX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A0CV.FBDDD9EE-0A5C-4CAB-9EB3-48B6431A9A84',\n",
       "  'report_length_cl100k_base': 1457,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is stage pT2 N1a MX. The tumor size is 2.7 cm, with venous/lymphatic invasion present. The cancer has spread to the sentinel lymph node, with the largest focus measuring 0.4 cm, and one non-sentinel lymph node completely replaced by metastatic carcinoma, measuring 1.5 cm. The tumor is hormone receptor positive and HER 2 neu positive.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 43-year-old female with right breast invasive cancer. The tumor is poorly differentiated, with a Nottingham score of 9/9 and measures 2.7 cm. It is positive for hormone receptors and HER 2 neu. The pathologic stage is pT2 N1a MX, as there is one positive sentinel lymph node with the largest focus measuring 0.4 cm, and one non-sentinel lymph node completely replaced by metastatic carcinoma, measuring 1.5 cm. The tumor involves the smooth muscle of the nipple, and extranodal extension cannot be assessed due to a lack of perinodal soft tissue. The margins are negative, with the distance of the tumor from the nearest margin being 0.6 cm. The invasive tumor has venous/lymphatic invasion present.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A0CW.7D1C2CD8-9842-48AC-BB16-897E2A45B88D',\n",
       "  'report_length_cl100k_base': 1054,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a tumor size of 3.1 cm, no lymphovascular invasion, and no lymph node involvement. The tumor is poorly differentiated with a Nottingham score of 8/9 and is estrogen and progesterone receptor positive, but HER 2 neu positive. The pathological stage is pT2 N0 MX, and the AJCC stage is IIA.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 43-year-old white female with left breast cancer. The tumor is 3.1 cm in size, with no lymphovascular invasion and negative margins. Two lymph nodes were identified, both negative for malignancy. The tumor is poorly differentiated with a Nottingham score of 8/9 and is ER and PR positive, but Her 2 neu positive. The pathologic stage is pT2 NO MX, and the AJCC stage is IIA.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0CX.28AFD5DD-B607-4837-819F-688C9218ED06',\n",
       "  'report_length_cl100k_base': 1100,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient has invasive ductal carcinoma in the left breast with a tumor size of 3.5 cm, Nottingham grade III/III, and N1 metastasis. Lymph nodes 1 of 222 are positive for tumor, with one positive non-sentinel lymph node. The patient's cancer is classified as pT2 N1 MX. Estrogen and progesterone receptors are positive, and HER 2 neu is negative. The patient's cancer is stage 2A.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 43-year-old white female with a history of left breast cancer. The left breast tumor is invasive ductal carcinoma, Nottingham grade III/III, measuring 3.5 cm, with positive estrogen receptors, negative HER2 and progesterone receptors, and lymph node involvement (1/222 positive). The pathological stage is pT2 N1 MX. The right breast tumor is benign breast tissue with fibrocystic changes. One sentinel lymph node is negative for metastatic carcinoma, while one non-sentinel lymph node is positive.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A0CY.CB780DE7-E98C-4F7E-9487-8F25FE80DC21',\n",
       "  'report_length_cl100k_base': 1777,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is classified as pT2NO (i-)MX, with a moderately differentiated invasive ductal carcinoma with lobular features in the right breast. Tumor 1 in the upper inner quadrant has a greatest dimension of at least 1.1 cm and is extensively involved in the margin, while tumor 2 in the central area has a greatest dimension of 2.5 cm. Both tumors are estrogen and progesterone receptor-positive, and HER-2 is negative. There is no lymph node involvement or metastasis identified in the sentinel lymph nodes.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is classified as pT2NO (i-)MX, with invasive ductal carcinoma with lobular features, moderately differentiated (G2), and a Nottingham score of 6/9. The tumor size is 1.1cm (upper inner quadrant) and 2.5cm (central mass), with no tumor necrosis, venous invasion, or nipple/skin involvement. The cancer is hormone receptor positive and HER-2 negative. No metastatic deposits were identified in the sentinel lymph nodes.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0CZ.57153075-9055-4D7E-9CD6-9167D165E860',\n",
       "  'report_length_cl100k_base': 1725,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an infiltrating ductal carcinoma, with a tumor size of 3.5 cm and no lymph node involvement. The tumor is poorly differentiated, with a Nottingham score of 9. Estrogen and progesterone receptors are negative, and HER 2 neu is negative. The pathologic stage is pT2 NO MX. The skin and subcutaneous soft tissue are unremarkable, with no evidence of malignancy.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a 46-year-old female with breast cancer. The tumor is an infiltrating ductal carcinoma, with a greatest dimension of 3.5 cm, and is poorly differentiated (G3). There is no venous/lymphatic invasion or multicentricity, and the margins are negative. Ten lymph nodes were found negative for tumor, and the tumor is estrogen and progesterone receptor negative. The patient's HER 2 neu is negative. The pathologic stage is pT2 NO MX. Additional findings include periductal chronic inflammation. The skin and subcutaneous soft tissue are unremarkable, and there is no evidence of malignancy.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0D0.D8B44020-EC34-4788-B7FB-790B9C12D886',\n",
       "  'report_length_cl100k_base': 1190,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an infiltrating ductal carcinoma with neuroendocrine features, measuring 3.0 cm, Nottingham grade 3, and a Nottingham score of 8/9. It is HER2 positive, estrogen and progesterone receptors are negative. Three lymph nodes were negative for tumor, and there is no evidence of metastasis. The pathological stage is pT2 N0 Mx.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 44-year-old female with left breast cancer. The tumor is an infiltrating ductal carcinoma with neuroendocrine features, measuring 3.0 cm, Nottingham grade 3, and HER 2 neu positive. There is no venous/lymphatic invasion, and the margins are 0.5 cm from the invasive tumor. Three lymph nodes were negative for tumor, and the pathologic stage is pT2 NO Mx. The patient\\'s estrogen and progesterone receptors are negative. Additional pathologic changes include a benign intraductal papilloma, and the specimen is designated as \"FIBROUS TISSUE AT SUPERIOR-LATERAL MARGIN.\"',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0D1.5DFA7970-3F68-4FC3-B2BA-5A42E866ECC3',\n",
       "  'report_length_cl100k_base': 1316,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's right breast tumor is 2.5 cm in size, with no lymph node involvement. The left breast has a 2.5 cm tumor, with one lymph node positive for isolated tumor cells (ITC) by immunostains, and five nodes negative for tumor. The tumors are invasive ductal carcinomas, with estrogen and progesterone receptors negative, and HER 2 neu negative. The pathological stage is pT2 NO (i+), MX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 43-year-old female with left breast cancer. The tumor is an infiltrating ductal carcinoma, measuring 2.5 cm, with no lymph node involvement. The cancer is classified as pT2 NO (i+) MX. Estrogen and progesterone receptors are negative, and HER 2 neu is negative. The Nottingham grade is poorly differentiated, with a Nottingham score of 9/9. The tumor has venous/lymphatic invasion and microcalcifications associated with the prior biopsy and benign breast tissue. The patient has a unifocal, intraductal component absent multicentricity.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0D2.B0DE3388-7826-40D3-ADEE-0B25FE201F4A',\n",
       "  'report_length_cl100k_base': 2046,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is a well-differentiated (Grade I/III) infiltrating ductal carcinoma with a tumor size of 1.9 cm. It is negative for venous/lymphatic invasion and estrogen and progesterone receptors are positive. The cancer is HER2 negative. There is no lymph node involvement (pT1cNO (i-)Mx). The final pathologic stage is pT1cNO (i-)Mx.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 42-year-old female with left breast cancer and a strong family history. The left breast tumor is well-differentiated (Grade I/III) infiltrating ductal carcinoma, with a tumor size of 1.9 cm, negative venous/lymphatic invasion, and negative margins. The tumor is estrogen and progesterone receptor positive, HER2 negative, and has a Nottingham score of 5 out of 9. The left axillary sentinel node is negative for tumor. The pathologic stage is pT1cNO (i-)Mx. The right breast tissue shows focal usual ductal hyperplasia, focal lactational/secretory change, and apocrine metaplasia, but no evidence of malignancy. The left lower inner quadrant tissue shows benign breast tissue with no evidence of tumor.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0D3.5C563F73-3793-4902-ACBB-82F432AED592',\n",
       "  'report_length_cl100k_base': 1758,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient has a moderately differentiated (Grade II) invasive ductal carcinoma in the left breast, with a maximum tumor size of 3 cm. The cancer is present 0.27 cm from the anterior tissue edge. One out of 23 lymph nodes is positive for metastatic carcinoma, showing focal extranodal extension. The patient's cancer is Estrogen and Progesterone receptor-positive and HER 2 Neu is 2+. The pathological stage is pT2N1MX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Moderately differentiated (Grade II) infiltrating ductal carcinoma with a maximum tumor size of 3cm. Venous/lymphatic invasion is present, and the tumor is 0.27cm from the anterior tissue edge. One of 23 lymph nodes is positive for metastatic carcinoma, and the tumor is estrogen and progesterone receptor positive. HER 2 neu status is 2+, and the pathologic stage is pT2N1MX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A0D4.990F5885-8EDD-42A2-AEFE-9DEE3E95A0B1',\n",
       "  'report_length_cl100k_base': 1321,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, size 1 cm, with cribriform pattern, well-differentiated, AJCC T1bNOMx. The margins are negative, and there is no lymphovascular space invasion. The sentinel lymph node is negative for tumor by H&E and immunohistochemistry. The superior medial border tissue is benign fibrofatty connective tissue.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a white female with right breast cancer. The tumor size is 1 cm, with negative margins and no lymphovascular space invasion. The lymph nodes are negative for tumor by H&E and immunohistochemistry. The specimen is classified as AJCC T1bNOMx. The superior medial border tissue is benign fibrofatty connective tissue. The tumor is an infiltrative ductal carcinoma with a cribriform pattern, well-differentiated, and associated with fibrocystic changes.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0EM.454CB5E9-3778-4666-9CED-913E08CB3615',\n",
       "  'report_length_cl100k_base': 740,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has multifocal invasive lobular carcinoma in the right breast, with a maximal tumor size of 2.8 cm. The surgical margin is positive for tumor. There is no information on lymph node involvement or metastasis in the provided report. The tumor is hormone receptor-positive and HER2-negative.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a white individual with a multifocal invasive lobular carcinoma in the right breast, measuring approximately 2.8 cm. The tumor is present on seven consecutive sections, and the surgical margin is positive for tumor. The cancer is estrogen and progesterone receptor-positive and HER 2 neu-negative. The specimen was a needle localization biopsy, and the patient's history indicates a BIRADS IV mammogram and a pre-operative diagnosis of breast cancer.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0EN.8169AA00-E396-4A3E-A91C-F67B1F0B8E3E',\n",
       "  'report_length_cl100k_base': 564,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a multifocal invasive ductal carcinoma in the left breast, with two foci measuring 1.5 cm and 0.6 cm. There is no lymphovascular invasion, and the tumor is grade 2. Both sentinel lymph nodes are negative for malignancy.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with multifocal invasive ductal carcinoma in the left breast, with two foci measuring 1.5 cm and 0.6 cm. There is no lymphovascular invasion, and the in-situ component is intermediate grade, cribriform pattern comprising 10% of the tumor. The sentinel lymph nodes (2) are negative for malignancy by routine and immunohistochemical stains. The tumor is 2.0 mm from the superior margin and 1.5 mm from the smaller tumor's superior margin.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0EO.61BC91AE-CD06-432D-BCBA-6FAE2209C610',\n",
       "  'report_length_cl100k_base': 948,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer stage is T1 (tumor size 2cm), with no lymph node involvement (N0) and no metastasis (M0). The tumor is estrogen receptor positive, progesterone receptor negative, and HER2 neu not amplified.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 43-year-old with breast cancer. The right breast carcinoma is classified as T1 (tumor size 2cm), with one positive axillary lymph node (N1), estrogen receptor positive, progesterone receptor negative, and HER2 neu not amplified. The left breast has focal lobular carcinoma in situ. The AJCC stage for the right breast carcinoma is T1N1MX (ER/PR+, Her2 neu-).',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0EP.F76120C1-B2B2-46EE-AAE1-57B05D258ED1',\n",
       "  'report_length_cl100k_base': 1200,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is stage pT2, with a 2.5 cm invasive ductal carcinoma, negative lymph node involvement, and no evidence of metastasis.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a black female with a 2.5 cm invasive ductal carcinoma in the left breast, categorized as pT2 NO (i-) Mx. The tumor is 1 mm from the anterior margin and negative for lymph vascular space invasion. The sentinel lymph node is negative for tumor, and the non-sentinel lymph node is also negative. The patient's additional left breast inferior margin shows fibrocystic changes, including fibrosis and apocrine metaplasia, but is negative for tumor.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0EQ.60569C8B-7209-4A3F-A177-F337085E9146',\n",
       "  'report_length_cl100k_base': 1171,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, moderately differentiated with a maximum size of 1.4cm. The tumor is located 0.3cm from the deep margin and 0.3cm from the inferior anterior margin. One of the two sentinel lymph nodes is positive for micrometastasis, with the largest deposit being 0.6mm. The other lymph node is negative for metastasis. The deep margin is negative for tumor, and the specimen shows benign fibroadipose tissue and skeletal muscle.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a 43-year-old female with a history of a right breast mass. The pathological report indicates an invasive ductal carcinoma, moderately differentiated by combined histological criteria, with a maximum size of 1.4 cm. The tumor is located 0.3 cm from the deep margin and 0.3 cm from the inferior anterior margin. One of the two sentinel lymph nodes is positive for micrometastasis, with the largest deposit being 0.6 mm. The other lymph node is negative for metastasis. The deep margin is negative for tumor, and the specimen shows benign fibroadipose tissue and skeletal muscle. The patient's cancer is classified as stage IA due to the tumor size and lymph node involvement.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0ER.A5D94D02-5423-4055-96E3-B5AA5799DC02',\n",
       "  'report_length_cl100k_base': 1068,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is a moderately differentiated (Grade II/III) infiltrating lobular carcinoma with a tumor size of 3.5 cm. There is no necrosis, venous/lymphatic invasion, or lymph node involvement. The cancer is estrogen receptor positive, progesterone receptor negative, and HER2/neu weakly positive by immunohistochemistry (2+). The pathological stage is pT2 NO MX. Additional pathologic changes include florid usual ductal hyperplasia, fibroadenomatoid changes, and fibrocystic changes. The specimen margins are negative, and the cancer is not present in the skin or nipple.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a white female with a moderately differentiated (Grade II/III) invasive lobular carcinoma in the left breast, measuring 3.5 cm. The tumor has no necrosis, venous/lymphatic invasion, or nipple/skin involvement. One sentinel lymph node is negative, and the cancer is estrogen and progesterone receptor-positive, with a weakly positive HER2/neu status. The pathological stage is pT2 NO MX, and additional pathological changes include usual ductal hyperplasia, fibroadenomatoid changes, and apocrine metaplasia. The tumor is oriented with sutures and inked, with a 3.5 x 3.5 x 3.0 cm firm mass located at the 2-3:00 position, 0.2 cm from the deep margin. The specimen includes skin, tumor, and grossly normal breast sections for analysis.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0ES.6860A718-FAAB-44A1-A3C1-E4A9EC1ECB05',\n",
       "  'report_length_cl100k_base': 981,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a tumor size of 1.9 cm, moderately differentiated (G2), with estrogen receptors positive and progesterone receptors negative. Lymph nodes: 5 out of 16 positive for tumor. The pathological stage is pT1c N2a Mx.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 47-year-old female with a 1.9 cm invasive ductal carcinoma in the right breast, moderately differentiated (G2), with estrogen and progesterone receptors positive, and HER 2 negative. The tumor has a Nottingham score of 6/9, and five out of sixteen lymph nodes were found to be positive for metastatic carcinoma. The final pathologic stage is pT1c N2a Mx.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A2-A0ET.E9D3FFF1-5FB2-4F17-9C1D-D9775E3CC5AC',\n",
       "  'report_length_cl100k_base': 1236,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a multifocal, invasive ductal carcinoma with a tumor size of 1.0 cm, 0.5 cm, and 1.2 cm, with positive estrogen and progesterone receptors, negative HER 2 neu, and no lymph node involvement. The pathological stage is pT1c NO MX.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a 43-year-old female with a multifocal, invasive ductal carcinoma in the right breast, measuring 1.0 cm, 0.5 cm, and 1.2 cm. The tumor is grade III/III (G3), with estrogen and progesterone receptors positive (95%). Lymph nodes are negative for metastatic carcinoma. The tumor is HER 2 neu negative (1+), and there is no venous/lymphatic invasion identified. The pathologic stage is pT1c NO MX. The specimen shows fibrocystic changes and mammark. The patient's race is white.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0EU.42649B9A-29D4-4D05-A78C-AC801792ADEB',\n",
       "  'report_length_cl100k_base': 1253,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an infiltrating ductal carcinoma, with a tumor size of 1.3 cm, and is estrogen and progesterone receptor-positive. There is no lymph node involvement or metastasis found in the sentinel lymph nodes. The pathological stage is pT1c NO (i-) MX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a white female with a left breast lump. The tumor is an infiltrating ductal carcinoma, measuring 1.3 cm, with no necrosis, venous/lymphatic invasion, or microcalcifications. It is hormone receptor positive, HER 2 negative, and Nottingham grade 2. Lymph nodes are negative for malignancy. The pathologic stage is pT1c NO (i-) MX. The report also mentions fibrocystic changes and two lymph nodes negative for malignancy in parts B-D, and non-sentinal node tissue negative for malignancy in part E.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0EV.2A62DD22-EFE6-48CD-8BE6-59B08168F78A',\n",
       "  'report_length_cl100k_base': 1632,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient has invasive lobular carcinoma in both breasts, with tumor sizes of 1.0 cm and 1.2 cm. Lymph node involvement is present in the right axilla, with four positive lymph nodes. The patient's cancer is classified as stage pT1c N2 MX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 40-year-old female with a history of right breast cancer. The right breast mastectomy specimen contained two separate tumors, both invasive lobular carcinomas, with the largest measuring 1.0 cm. Lymph nodes were positive for tumor by conventional H&E and immunohistochemical staining. The final pathologic stage is pT1c N2 MX (AJCC, 6th ED). The left breast mastectomy specimen was negative for malignancy.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A2-A0EW.2620E5E7-ED7D-4F04-A8AF-1499E9711E8A',\n",
       "  'report_length_cl100k_base': 2462,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient has an invasive lobular carcinoma of the left breast, with a tumor size of 2.3 cm and positive estrogen and progesterone receptors. The tumor is 0.3 cm from the closest superior margin and 0.3 cm from the closest inferior margin. There is no venous/lymphatic invasion, but perineural invasion is present. The patient's lymph nodes are involved, with rare individual tumor cells found on cytokine immunohistochemistry. The pathologic stage is pT2 NO (i+) Mx. Additional superior margin and deep margin specimens were collected and found to be negative for malignancy.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \" The patient is a female with a history of left breast mass. The tumor is an infiltrating lobular carcinoma, with a greatest dimension of 2.3 cm, and is positive for estrogen and progesterone receptors. The tumor is negative for venous/lymphatic invasion and perineural invasion is present. The margins are positive at the lateral and posterior margins, and the tumor is 0.3 cm from the superior and inferior margins. The patient's lymph nodes are involved, with rare individual tumor cells found on cytokine immunohistochemistry. The pathologic stage is pT2 NO (i+) Mx (AJCC, 6th edition). The additional superior margin and deep margin specimens are negative for malignancy.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0EX.5B82545F-2636-4A8A-88DD-1B387DE678FF',\n",
       "  'report_length_cl100k_base': 1590,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, with a tumor size of 2.8 cm, positive estrogen and HER2 receptors, and negative progesterone receptors. One of the two sentinel lymph nodes is positive for metastatic carcinoma. The tumor is graded as N1a, and there is no evidence of skin involvement or metastasis. The pathological stage is pT2 N1a MX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an infiltrating ductal carcinoma, with a tumor size of 2.8 cm, positive estrogen and HER 2 neu receptors, and negative progesterone receptors. The tumor is graded as moderately differentiated with a Nottingham score of 6/9. One of the two sentinel lymph nodes is positive for metastatic carcinoma, and the pathologic stage is pT2 N1a MX. The margins are uninvolved, and there is no evidence of venous/lymphatic invasion or skin involvement. The patient's cancer is staged as stage IIA due to the involvement of one lymph node.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A0EY.61462D57-DF98-4F89-BAEF-E8156A47E2DD',\n",
       "  'report_length_cl100k_base': 1704,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a tumor size of 2.0 cm. The tumor is less than 0.1 cm from the anterior and medial surgical margins. Two sentinel lymph nodes are positive for metastatic carcinoma, one with a tumor size of approximately 0.5 cm and the other with a tumor size of less than 0.1 cm. The cancer is estrogen receptor negative, progesterone receptor positive, and HER2/neu non-amplified.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 43-year-old female with a 2.0 cm poorly differentiated invasive ductal carcinoma in the right breast, classified as Bloom-Richardson grade 9. The tumor is less than 0.1 cm from the anterior and medial surgical margins. One lymph node from each of the sentinel lymph node groups #1 and #2 is positive for metastatic carcinoma. The tumor is negative for estrogen and progesterone receptors, and HER2/neu is not amplified.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A0ST.1E8B978E-3D1B-46E8-80EE-3A11EE571CEC',\n",
       "  'report_length_cl100k_base': 1135,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's left breast invasive cancer measures 2.2 x 1.6 x 1.5 cm, with two smaller lesions, one of which is 0.9 x 0.1 x 0.9 cm and the other is 0.5 cm in the greatest dimension. The largest lesion is 4 cm from the deep margin. The cancer is multicentric, moderately differentiated, and has an intraductal component. Lymph node involvement is present in the first sentinel node with an isolated focus of tumor cells measuring 0.01 mm. The second and third sentinel nodes are negative for tumor. The patient's right breast tissue is fibroadenopathy without malignancy.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's left breast mastectomy specimen revealed multicentric moderately differentiated intraductal and infiltrating duct carcinomas, with tumor sizes of 2.2, 1.0, and 1.0 cm, one of which involved the superficial margin. Ductal carcinoma in situ was present in the deep ducts of the nipple, but the nipple, skin, and deep margins were free of neoplasm. Foci suspicious for lymphatic invasion were found. The first sentinel lymph node contained an isolated focus of tumor cells, while the second and third sentinel lymph nodes were negative for tumor. The patient's Oncotype score was 14, with an average rate of distant recurrence at 10 years of 9%.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0SU.BC75790C-FBC7-4897-B228-762245C48740',\n",
       "  'report_length_cl100k_base': 1899,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma with a tumor size of 4.5 cm, with venous/lymphatic invasion and multicentricity present in the right breast. The tumor is poorly differentiated (G3) with a Nottingham score of 9/9. Eight lymph nodes were found positive for tumors with extensive extracapsular extension, and deposits larger than 2 mm. The patient's cancer is pathologically staged as pT4d N2a MX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a white female with a 4.5 cm invasive ductal carcinoma in the right breast, with necrosis, multicentricity, and skin and nipple involvement. The tumor is poorly differentiated (G3) with a Nottingham score of 9/9. Estrogen and progesterone receptors are positive, and HER 2 Neu is weakly positive. Eight lymph nodes were found positive for tumors with extensive extracapsular extension, and deposits larger than 2 mm. The pathological stage is pT4d N2a MX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A2-A0SV.161E2817-7DB2-46F8-BFEB-256DBBEFE633',\n",
       "  'report_length_cl100k_base': 1324,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a poorly differentiated, infiltrating ductal carcinoma measuring 3.5 cm, with tumor margins close to the anterior and posterior surgical margins (less than 1 mm). Lymphovascular invasion is present, and microcalcifications are identified. One sentinel lymph node is positive for metastatic carcinoma (1/1), and 2 out of 13 axillary lymph nodes are positive for malignancy (2/13). The cancer is classified as PTNM stage PIIIa, T2, N2, MX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is diagnosed with poorly differentiated infiltrating ductal carcinoma in the right breast, measuring 3.5 cm with focal close margins (less than 1 mm) to anterior and posterior surgical margins. Lymphovascular invasion is identified, and microcalcifications are present. One sentinel lymph node is positive for metastatic carcinoma (1/1), and 2 out of 13 lymph nodes in the axillary contents are positive for malignancy (2/13). The cancer is classified as PTNM Classification: PIIIa, T2, N2, MX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A2-A0SW.8401DFCF-8793-461A-B17E-E6584CE2423B',\n",
       "  'report_length_cl100k_base': 510,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an infiltrating ductal carcinoma, with a poorly differentiated grade 3 Nottingham score of 9 out of 9. The tumor size is 1.3 cm, with venous/lymphatic invasion present. The margins are 0.8 mm from the anterior margin and 0.2 mm from the posterior margin. There is no lymph node involvement, and the cancer has not metastasized. The pathological stage is pT1 NO MX (AJCC Stage I).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 43-year-old with left breast cancer. The tumor is an infiltrating ductal carcinoma, poorly differentiated, with a multifocal, largest contiguous focus of 1.3 cm. Venous/lymphatic invasion is present. Margins are 0.8 mm from the anterior margin and 0.2 mm from the posterior margin. Lymph nodes are negative. The pathologic stage is pT1 NO MX (AJCC Stage I).',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0SX.63F76DB5-8433-4EFE-9054-6C04F065DF2D',\n",
       "  'report_length_cl100k_base': 854,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is classified as stage IIIA with a tumor size of 7 cm, with metastasis identified in one lymph node (1/1) and no further lymph node involvement (0/1).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with a diagnosis of left breast cancer. The tumor size is 7 cm, and it is invasive lobular carcinoma. The cancer has spread to the sentinel lymph node #1, which is positive for metastatic carcinoma, measuring 0.6 cm in diameter. There is no tumoral calcification or necrosis identified. The cancer has not spread to other lymph nodes or organs. The patient's PTNM classification is T3 N1 MX, which indicates stage IIIA. The tumor has unfavorable nuclear features, and the ER, PR, and Her-2/neu tests have been performed. The patient's nipple, skin, and areola margins are uninvolved. The breast tissue shows fibrocystic changes, including ductal epithelial hyperplasia.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A0SY.8E6902A6-A673-46CC-9AEB-3A71EF11099F',\n",
       "  'report_length_cl100k_base': 1056,\n",
       "  't_label': 2},\n",
       " {'abstract': '\\nThe patient is a female with left breast cancer, classified as T2 (tumor size 3.2 cm), N1 (2/12 lymph nodes positive for metastasis), and MX (no distant metastasis). The tumor is invasive, poorly differentiated, ductal adenocarcinoma. Estrogen and progesterone receptors are negative, and HER-2 is not amplified.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with left breast cancer, classified as T2 N1 MX, stage IIB, ductal adenocarcinoma G3. The tumor size is 3.2cm, with invasive poorly differentiated ductal adenocarcinoma and tumor emboli seen in angiolymphatic spaces. The nearest margin is 0.1cm to the tumor, and the lymph nodes are involved with metastatic ductal adenocarcinoma in two lymph nodes out of twelve, with the largest node being 1cm in greatest dimension. The tumor is negative for estrogen and progesterone receptors, and HER-2 is not amplified.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A0T0.6F5EBE67-0A25-4B20-A1F6-9CE6C4FF4096',\n",
       "  'report_length_cl100k_base': 1549,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient is a female with a 7.5 cm poorly differentiated invasive ductal carcinoma in the right breast, extending to the superior margin. The cancer is stage T3 N3 MX, stage IIIC, G3. Ten regional lymph nodes were found positive for metastatic invasive ductal carcinoma. The remaining margins are free of tumor.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with a diagnosis of right breast cancer. She underwent a right breast lumpectomy with full axillary node dissection. The tumor is a poorly differentiated invasive ductal carcinoma, measuring 7.5 cm in greatest dimension, extending to the superior margin, and is classified as T3 N3 MX, Stage IIIC, G3. Ten regional lymph nodes were positive for metastatic invasive ductal carcinoma. The remaining margins are free of tumor, and the skin and attached fibrofatty breast tissue are negative for malignancy.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A2-A0T1.7546B7FB-1976-4994-AFB7-6270382D44D7',\n",
       "  'report_length_cl100k_base': 1038,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient is a female with a poorly differentiated infiltrating ductal carcinoma in the right breast, measuring 10.5 cm in maximum dimension. The tumor has lymphovascular invasion and is stage IIIC, T3, N3, MX. Ten out of fourteen lymph nodes are positive for metastatic carcinoma. The surgical margins are free of the lesion, with the closest margin being 1.2 mm from the tumor. The tumor is categorized as PQRI Category II: 3260F.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with a poorly differentiated infiltrating ductal carcinoma in the right breast, measuring 10.5 cm in maximum dimension. The tumor has lymphovascular invasion and is stage IIIC, T3, N3, MX. Ten out of fourteen lymph nodes are positive for metastatic carcinoma. The surgical margins are free of the lesion, with the closest margin being 1.2 mm from the tumor. The tumor is categorized as PQRI Category II: 3260F.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A2-A0T2.0DCD80E1-173E-4A1B-BDD8-74C7D12C1313',\n",
       "  'report_length_cl100k_base': 755,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's pathological report indicates a partial mastectomy of the right breast, with two separate nodules of invasive ductal carcinoma, measuring 1.5 cm and 1.2 cm. The larger lesion is poorly differentiated, nuclear grade III/III with a high mitotic index, while the smaller lesion is moderately differentiated, nuclear grade III/III with a high mitotic index. There is microscopic focus of solid type ductal carcinoma in situ at the medial margin and a microcalcification with comedecrosis suspicious for ductal carcinoma in situ at the inferior margin. The deep margin is free of tumor by at least 1 cm. The sentinel lymph node biopsy revealed metastatic invasive ductal carcinoma, with several foci present, the largest contiguous focus spanning approximately 1 mm. The second axillary lymph node biopsy showed no evidence of metastatic disease.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's pathology report indicates a partial mastectomy of the right breast, with two separate nodules of invasive ductal carcinoma, measuring 1.5 cm and 1.2 cm. The larger lesion is poorly differentiated, nuclear grade III/III with a high mitotic index, while the smaller lesion is moderately differentiated, nuclear grade III/III with a high mitotic index. There is microscopic focus of solid type ductal carcinoma in situ at the medial margin and a microcalcification with comedecrosis suspicious for ductal carcinoma in situ at the inferior margin. The deep margin is free of tumor by at least 1 cm. The sentinel lymph node biopsy revealed metastatic invasive ductal carcinoma, with several foci present, the largest contiguous focus spanning approximately 1 mm. The second axillary lymph node biopsy showed no evidence of metastatic disease.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0T3.E339A88E-3B39-465A-9545-FBA4F79727CC',\n",
       "  'report_length_cl100k_base': 1832,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's pathological report indicates a tumor size of 2.3 x 3.3 x 1.7 cm in the upper inner quadrant of the right breast, with no evidence of metastasis in the sentinel or non-sentinel lymph nodes of either breast. The left breast specimen shows diffuse proliferative fibrocystic changes and atypical ductal and lobular hyperplasia, but no evidence of invasive carcinoma.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's pathology report indicates a right breast cancer in situ with a 3.3 cm tumor in the upper inner quadrant, with no evidence of metastatic disease in the right axillary sentinel lymph node or the right axillary non-sentinel lymph node. The left breast specimen shows diffuse proliferative fibrocystic changes, atypical ductal hyperplasia, and extensive microcalcification, but no evidence of invasive carcinoma. The left axillary sentinel lymph nodes (2) also show no evidence of metastatic disease.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0T4.5B685F7F-917D-41BA-A7AB-D0E15D457BC5',\n",
       "  'report_length_cl100k_base': 1995,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe pathology report describes the specimens received from a breast cancer surgery, including a re-excision of the left breast upper outer quadrant, a simple mastectomy of the right breast, and a simple mastectomy of the left breast. The left breast specimen has a pink-tan firm granular mass measuring 4.5 cm in the greatest dimension, with no evidence of neoplasm in the deep and superficial margins. The right breast specimen shows fibrocystic disease with patchy fibrosis and a small fibroadenoma, with no evidence of atypia or malignancy. The report also mentions lymphatic invasion and biopsy site change with reactive fibrosis and organizing fat necrosis. The specimens show fibrocystic changes, dense fibrous tissue, and cyst formation. The tumor size, lymph node involvement, and metastasis status are not explicitly mentioned in the report.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The pathology report describes the specimens received from a surgical breast cancer procedure, including a re-excision of the left breast upper outer quadrant, a simple mastectomy of the right breast, and a simple mastectomy of the left breast. The report notes the dimensions and characteristics of the specimens, as well as the presence of fibrous and fatty tissue. The report also notes the presence of a pink-tan firm granular mass in the left breast and a moderately differentiated intraductal and infiltrating duct carcinoma in the right breast. The tumor measures 4.5 cm in the greatest dimension, and the nipple, deep and superficial margins are free of neoplasm. The report also notes focal suspicion for lymphatic invasion and biopsy site change with reactive fibrosis and organizing fat necrosis. The fibrocystic changes, including patchy dense fibrous and cyst formation, are also mentioned.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0T5.7B1E6EEB-3B61-4CE8-B695-ED11C2EF169F',\n",
       "  'report_length_cl100k_base': 1531,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive lobular carcinoma, with a multicentric in situ and infiltrating tumor spanning 7 cm in the left breast. There is no evidence of metastatic disease in the lymph nodes, which are supported by negative cytokeratin immunohistochemical staining. The tumor is nuclear grade II/III with a low mitotic index. The superficial and deep margins are free of tumor by at least 1 cm. The right breast shows fibrocystic changes with focally marked non-atypical intraductal hyperplasia, but no evidence of malignancy. The patient's cancer is stage I, T2 (tumor size 2.5-5 cm), N0 (no lymph node involvement), and M0 (no metastasis).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's pathological report indicates a multicentric in situ and infiltrating lobular carcinoma in the left breast, with a 7 cm span from medial to lateral and a distinct separate 1 cm nodule in the upper outer quadrant. The tumor is nuclear grade II/III with a low mitotic index. The superficial and deep margins are free of tumor by at least 1 cm. There is no evidence of metastatic disease in the lymph nodes, supported by negative cytokeratin immunohistochemistry. The right breast shows fibrocystic changes with focally marked non-atypical intraductal hyperplasia, but no evidence of malignancy. The patient's staging is T2 (tumor size 7 cm), N0 (no lymph node involvement), and M0 (no metastasis).\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0T6.377F7050-F900-4345-A326-568F00050BC3',\n",
       "  'report_length_cl100k_base': 2317,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's pathology report indicates a moderately differentiated invasive ductal carcinoma in the right breast, measuring 2.6 cm, with no evidence of malicious activity in the left breast. The tumor is located in the upper inner quadrant, with a microscopic tendril extending to the superficial margin. The medial margin is free of tumor by 5mm and the deep margin by approximately 1cm. One axillary lymph node contained an isolated tumor cluster, while the other was clear. The patient's staging information includes a 1.7cm lesion, no lymph node involvement, and no metastasis.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's pathology report indicates a moderately differentiated infiltrating ductal carcinoma in the upper inner quadrant of the right breast, with a tumor size of 2.6 cm and no evidence of malicious activity in the left breast. There is one isolated tumor cell cluster found in the right axillary sentinel lymph node #2, and the medial margin is free of tumors by 5mm, and the deep margin by approximately 1cm. The report also notes proliferative fibrocystic changes and intraductal hyperplasia in breast tissue away from the primary tumor site.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0T7.383EC600-FBF3-4F91-8FAC-41E3DDE6589E',\n",
       "  'report_length_cl100k_base': 1647,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer stage is T2, N1mic, MX. The tumor size is 2.6 cm, with one positive lymph node (1/1, micrometastatic ductal carcinoma, 1 mm in maximal dimension). All surgical margins are free of the lesion, and there is no evidence of metastasis.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with right breast cancer, stage IIB (T2, N1mic, MX). The tumor is a moderately differentiated infiltrating ductal carcinoma, measuring 2.6 cm in maximum dimension. The excised margins are free of the lesion, with the closest margins being 1 mm from the tumor (deep/posterior) and 4 mm from the inferior margin. There is one positive lymph node (1/1, micrometastatic ductal carcinoma, 1 mm in maximal dimension) and one negative lymph node (0/1). Immunostain for Cytokeratin was negative for metastatic adenocarcinoma.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0YC.9BAD4BD4-A54B-4115-A00E-6AA88F344FE1',\n",
       "  'report_length_cl100k_base': 1381,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient is a female with left breast cancer, and the surgical report indicates a total mastectomy was performed along with a sentinel lymph node biopsy. The pathology findings show a moderately differentiated infiltrating lobular carcinoma, measuring 6.6 cm, with foci of lobular carcinoma in-situ involving terminal ductules. The Scarff-Bloom-Richardson breast cancer histologic score is 6 (3+2+1). The sentinel lymph nodes (#1 and #2) were negative for malignancy, and all designated surgical margins were free of tumor. The pathologic TNM stage is T3 PNO(I+) MX, stage IIB, G2, infiltrating lobular carcinoma. The patient's cancer is categorized as PQRI Category II: 3260F.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with left breast cancer, and the surgical report indicates a total mastectomy was performed along with a sentinel lymph node biopsy. The pathology findings show moderately differentiated infiltrating lobular carcinoma, measuring 6.6 cm, with foci of lobular carcinoma in-situ involving terminal ductules. The Scarff-Bloom-Richardson breast cancer histologic score is 6 (3+2+1). The sentinel lymph nodes (#1 and #2) were negative for malignancy, and all designated surgical margins were free of tumor. The pathologic TNM stage is T3 PNO(I+) MX, stage IIB, G2, infiltrating lobular carcinoma. The patient's cancer is categorized as PQRI Category II: 3260F. Immunohistochemical stains on the first sentinel lymph node revealed seven positive cells with Cytokeratin stain in the subcapsular space, indicating incidental microscopic micromet\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0YD.10DA3573-BD53-4579-AD90-E770CEF08498',\n",
       "  'report_length_cl100k_base': 1099,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient is a female with a diagnosis of right breast cancer. The tumor size is 4.7 cm, with metastasis found in one sentinel lymph node (1/1), making it stage IIB. There are no other lymph node involvements. The cancer is classified as ductal adenocarcinoma, grade 3. The patient's cancer is hormone receptor negative (ER and PR negative), and HER2 negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with a pre-operative diagnosis of right breast cancer. The tumor size is 4.7 cm and is poorly differentiated ductal adenocarcinoma. The patient is N1 (one positive lymph node out of 15 total) and MX (metastasis status unknown). The tumor is stage IIB, grade 3. Estrogen and progesterone receptors are negative. The patient's cancer is classified as PQRI category II: 3260F.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A0YE.C58701EF-98C4-448E-978C-B39D125CC7E8',\n",
       "  'report_length_cl100k_base': 1800,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's pathology report indicates a multifocal, moderately differentiated invasive ductal carcinoma in the right breast, with tumor sizes ranging from 2 to 7 mm and a Nottingham score of 7. Atypical lobular hyperplasia is present in the left breast tissue. The sentinel lymph node biopsy reveals metastatic breast carcinoma, with isolated tumor cells found in the subcapsular sinus/cortex. No lymphovascular invasion is identified.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's pathology report indicates a multifocal, moderately differentiated invasive ductal carcinoma in the right breast, with tumor sizes ranging from 2-7mm. There is no lymphovascular invasion identified. Atypical lobular hyperplasia is found in the left breast tissue, and metastatic breast carcinoma is identified in the right axillary sentinel lymph node.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0YF.C4C7D190-F0EC-4A70-8136-534EA3419217',\n",
       "  'report_length_cl100k_base': 1641,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's pathology report indicates a poorly differentiated intraductal and infiltrating duct carcinoma in the left breast, with a maximum tumor dimension of 4 cm and lymphovascular invasion present. The report also notes that the tumor is 6 mm or more from the inked margins of excision and that DCIS of the solid type comprises approximately 5% of the tumor. Additionally, metastatic breast carcinoma is identified in 14 of 18 nodes examined, with multifocal extension present.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's pathology report indicates a poorly differentiated intraductal and infiltrating duct carcinoma in the left breast, with a maximum dimension of 4 cm and lymphovascular invasion present. The tumor is 6 mm or more from the inked margins of excision. DCIS of the solid type comprises approximately 5% of the tumor. The report also notes metastatic breast carcinoma identified in 14 of 18 nodes examined, with extranodal extension present in Part A (left axillary node dissection). The tumor has a Nottingham score of 8, and biopsy changes are also present.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A2-A0YG.B3D6A0F7-5E3C-4921-8399-6458E5222CC5',\n",
       "  'report_length_cl100k_base': 1108,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's pathological report indicates a 2.4 x 2.2 x 2.7 cm pink-tan mass with invasive ductal carcinoma present in a microscopic satellite nodule 1 mm from the deep margin and 1.5 mm from the superior margin. The inferior margin is clear by 3 mm, and there is no lymph node involvement. The superficial, medial, and lateral margins are clear by over 1 cm. There is a focus of atypical ductal hyperplasia 3 mm from the medial margin. Five of 28 axillary lymph nodes were positive for metastatic carcinoma. A 1 mm focus of infiltrating duct carcinoma was found in the reexcised specimen from the inferior and superficial margin, separate from the adipose tissue.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's pathology report indicates a 2.4 x 2.2 x 2.7 cm pink-tan mass was found in the left partial mastectomy specimen, with the tumor approaching the superior, deep, and inferior margins, and being greater than 1 cm from the other margins. A total of 5 axillary lymph nodes were identified with metastatic carcinoma out of 28 nodes examined. Additionally, a 1 mm focus of infiltrating duct carcinoma was found in the left breast inferior and superficial margin re-excision specimen. The tumor is categorized as poorly differentiated, with nuclear grade III/III and a high mitotic index.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A2-A0YH.0C344CD7-6FAB-462B-9A8E-75B720F2D626',\n",
       "  'report_length_cl100k_base': 1682,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive right breast cancer, with a tumor size of 1.7 x 1.4 x 2.0 cm. There is no lymph node involvement, and no metastasis is reported. The tumor is moderately differentiated, with mixed ductal and lobular differentiation, and nuclear grade I with a low mitotic index. The patient's margins are free of neoplasm by a distance of 5 mm or greater. One minute focus of isolated tumor cells is found in the sentinel node #1, and the additional posterior margin is free of neoplasm.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's pathology report indicates a moderately differentiated in situ and infiltrating carcinoma with mixed ductal and lobular differentiation, predominantly lobular, nuclear grade I with a low mitotic index and an in situ component of approximately 20% of solid and cribriform type. The tumor size is measured at 1.7cm and 0.5cm, and all resection margins are free of neoplasm by a distance of 5mm or greater. Lymphatic invasion is not identified, and the patient's lymph nodes are negative for tumor, with the exception of a minute focus of isolated tumor cells in the sentinel node #1, measuring approximately 0.05mm in greatest dimension. The additional posterior margin is free of neoplasm, and the patient's breast tissue shows fibrocystic changes with duct hyperplasia of the usual type, apocrine metaplasia, and cyst formation.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0YI.CEFD12BB-1AF7-400D-8A84-49650DFDD8A5',\n",
       "  'report_length_cl100k_base': 1731,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive breast cancer with a tumor size of 70mm. It is grade 3 out of 3 with high mitotic index. Lymphatic space invasion is present, and the cancer is located 1.1mm from the deep margin. 5 out of 18 axillary lymph nodes are positive for metastasis. The deep margin re-excision specimen is clear of tumor.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive left breast cancer, with a tumor measuring 70mm. There is lymphatic space invasion and 5 out of 18 axillary lymph nodes are positive for metastasis. The deep margin is involved and the tumor is classified as poorly differentiated, nuclear grade 3 of 3, with a high mitotic index. The specimen is a modified radical mastectomy with a re-excision of the deep margin, which is found to be clear of tumor.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A2-A0YJ.90F13DE2-7C8F-4FA2-B9BF-D68EEC37D514',\n",
       "  'report_length_cl100k_base': 1300,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's left breast invasive cancer is multicentric and measures approximately 1.6 x 1.3 x 3.5 cm, with no lymphatic invasion identified. The deep margin is free of neoplasm, and the tumor is 0.5 cm from the deep margin. The patient's right breast shows proliferative fibrocystic disease without atypia or malignancy. Two sentinel lymph nodes from the left breast, measuring 2.1 x 1.7 x 1.0 cm and 2 x 1.2 x 0.5 cm, are negative for tumor.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's pathology report indicates a multicentric invasive lobular carcinoma of the breast, with tumor nodules ranging from 2mm to 35mm in size. The deep margin is free of neoplasm, and lymphatic invasion is not identified. One small intra-mammary lymph node is negative for tumor. The report also mentions proliferative fibrocystic disease with dense fibrosis, sclerosing adenosis, apocrine metaplasia, and radial scar formation in the right breast. Microcalcifications are present, but atypia or malignancy is not identified. Two sentinel lymph nodes from the left breast are negative for tumor by step section and cytokeratin stain.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0YK.C3B5F075-864A-4D8B-B0CB-1B1FA28ACF4F',\n",
       "  'report_length_cl100k_base': 1748,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a multifocal and multicentric invasive lobular carcinoma, with a maximum tumor size of 9 cm. There is lymphovascular invasion and metastasis identified in three sentinel lymph nodes. The tumor is greater than 1 cm from the margins of excision.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is a multifocal and multicentric invasive lobular carcinoma, with the tumor being greater than 1 cm from the margins of excision. Lymphovascular invasion is identified, and metastatic breast carcinoma is found in three lymph nodes in the left axilla. There is no evidence of metastatic tumor in the right breast or right axilla. The tumor has a nuclear grade of II, a low mitotic index, and tubule formation score of 3, with a total Nottingham score of 6.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A2-A0YL.AB083371-A2AB-4F57-8FBF-0DB2C91CEDDE',\n",
       "  'report_length_cl100k_base': 2425,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient is a female with left breast cancer, and the tumor size is 2.4 cm. There is no involvement of lymph nodes in parts D, E, F, G, and H. The patient's cancer is classified as T2, NO, MX, Stage IIA.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with left breast cancer, stage IIA (T2, NO, MX). The tumor size is 2.4 cm, with no lymph node involvement. All surgical margins were free of tumor, and the patient's sentinel lymph nodes (#1, #2, #3, and #4) were negative for malignancy. The tumor showed minimal tubule formations, high nuclear grade, and high mitotic index.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A0YM.E1D8F2CB-25F1-49E0-92D3-132DCA8FD533',\n",
       "  'report_length_cl100k_base': 2010,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient is diagnosed with left breast cancer, with a tumor size of 13.6 cm, grade 3 of 3, and angiolymphatic invasion present. There are five positive lymph nodes with extracapsular extension, and the tumor involves three-fourths of the node. The overlying nipple, areola, and skin have focal extension of the tumor into the epidermis without ulceration. The additional inferior skin left breast has a positive infiltrative duct carcinoma that involves the dermis. The surgical margins are uninvolved, and the ER, PR, and Her-2/neu have been performed. The PTNM classification is T4B, N2a, MX, stage grouping IIIB.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is diagnosed with left breast cancer, with a confluent region measuring 13.6 cm, grade 3 of 3, angiolymphatic invasion present, and multifocal. The tumor involves three-fourths of the largest node measuring 1.6 cm. The overlying nipple, areola, and skin have focal extension of the tumor into the dermis without ulceration. The satellite nodule is positive for infiltrative duct carcinoma, involving the dermis without extension to the epidermis. The surgical margins are uninvolved. The tumor is classified as T4B, N2a, MX, stage grouping IIIB.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A2-A0YT.1C420F6B-8720-4CB0-9FB3-86A0EC05FBBD',\n",
       "  'report_length_cl100k_base': 1111,\n",
       "  't_label': 3},\n",
       " {'abstract': '\\nThe patient has invasive lobular carcinoma, with a tumor size of greater than 5 cm and multifocal lesions. Lymph node involvement is present with isolated tumor cells detected in one of the two sentinel lymph nodes examined. There is no evidence of lymph-vascular invasion or extranodal extension. The tumor is hormone receptor positive and HER 2 negative. The pathological stage is pT3 (m) NO (i+) (sn).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 53-year-old female with invasive lobular carcinoma. The tumor size is greater than 5 cm, and it is located in the outer upper and mid regions of the breast. There is evidence of lymph-vascular invasion, and one of two sentinel lymph nodes has isolated tumor cells. The tumor is hormone receptor positive and HER 2 negative. The pathologic stage is pT3 (m) NO (i+) (sn). The margins are negative for malignancy, and there is no evidence of extranodal extension. The patient has multifocal tumors, and the Nottingham score is 6. The final diagnosis is invasive lobular carcinoma.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A1FV.074223E9-5E1C-47E8-BE40-1C4442CAE9F0',\n",
       "  'report_length_cl100k_base': 1932,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient is a female with a right breast invasive ductal carcinoma, measuring 7.5 cm in the greatest dimension, with extensive angiolymphatic invasion and lymph node metastasis (5 out of 19 lymph nodes positive for metastatic carcinoma). The tumor is classified as stage IIIA, grade 3, with a Scarff-Bloom-Richardson breast cancer histologic score of 9. There is no evidence of metastasis in other organs.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with a right breast cancer (invasive ductal carcinoma) measuring 7.5 cm in greatest dimension, with extensive angiolymphatic invasion and lymph node metastases (5 out of 19 lymph nodes positive for metastatic carcinoma). The cancer is classified as stage IIIA (T3, N2a, M0) with a Scarff-Bloom-Richardson breast cancer histologic score of 9. The patient's ER and PR status are unknown as they were not mentioned in the report.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A2-A1FW.849E9FA7-3420-427B-A310-3346CFA9F0CC',\n",
       "  'report_length_cl100k_base': 2531,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's cancer stage is T2 N2a, MX, Stage IIIA. The tumor size is 4.7 cm, with focal extension to superior, inferior, and medial margins and extension to within 1/2 mm of the anterior and lateral margins. There is one positive sentinel lymph node (1/1), and four out of 22 axillary lymph nodes are positive for metastasis. The cancer has not metastasized to distant sites.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is diagnosed with stage IIIA breast cancer. The tumor measures 4.7 cm and is close to the posterior and lateral margins. One sentinel lymph node is positive for metastatic breast cancer, and four out of 22 lymph nodes are positive for metastasis. The cancer has focal extension to the superior, inferior, and medial margins, with extension to within 1/2 mm of the anterior and lateral margins. The cancer is also positive for additional carcinoma with focal extension to the lateral, anterior, superior, and inferior surgical margins of resection. The patient's cancer is classified as T2 N2a, MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A2-A1FX.EAFC71A1-D6FC-46EA-BC47-D054C497D705',\n",
       "  'report_length_cl100k_base': 1788,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive, poorly differentiated infiltrating duct carcinoma, with a tumor size of 22mm and no evidence of lymphatic space invasion. The pathology report indicates no lymph node involvement, and there is no mention of metastasis.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive, poorly differentiated infiltrating duct carcinoma, with a tumor size of 22mm and no evidence of lymphatic space invasion. The cancer is located in the central portion of the breast, approximately 2cm from the deep margin and 2cm from the skin, greater than 3cm from all other margins. There is no evidence of metastasis, and the sentinel lymph nodes (numbers 1-3) are free of malignant disease.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A1FZ.F93E326D-F4E0-4000-8A67-AA19C4D3637A',\n",
       "  'report_length_cl100k_base': 1165,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient is a female with a pre-operative diagnosis of right breast cancer. A right breast lumpectomy and sentinel lymph node biopsy were performed. The tumor measures 3cm in maximum dimension with lymphovascular invasion identified inside the tumor. One positive lymph node out of one was found. The patient's cancer is classified as stage IIB, T2 N1 MX. The tumor is a poorly differentiated infiltrating ductal carcinoma. Margins are free of tumor.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with a pre-operative diagnosis of right breast cancer. A right breast lumpectomy and sentinel lymph node biopsy were performed. The tumor measures 3x2.5x1cm with lymphovascular invasion identified inside the tumor. Margins are free of tumor. One positive lymph node out of one was found. The patient is classified as stage IIB, T2 N1 MX. The tumor is a poorly differentiated infiltrating ductal carcinoma.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A1G1.E2E6CA22-AFE4-4B8F-90AC-32639687A590',\n",
       "  'report_length_cl100k_base': 866,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive breast cancer with a tumor size of 4.8 x 2.2 x 0.6 cm. There is no evidence of lymphatic invasion, and metastasis status is positive in 1 of 15 axillary lymph nodes. The tumor is a moderately differentiated lobular carcinoma with a nuclear grade of II and a low mitotic index. Estrogen receptor and progesterone receptor are positive, and Her-2/neu is negative. Ki-67 is low. The pathological staging of the cancer is T1, N1, and M0.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive breast cancer identified in the left breast, measuring approximately 21 mm in the lower inner quadrant; no lymphatic invasion found; proliferative fibrocystic disease with lobular carcinoma in situ identified in the upper outer quadrant; estrogen receptor positive, progesterone receptor negative, Her-2/neu negative, Ki-67 low; invasive ductal carcinoma in the right breast, spanning 65 mm, with lymphatic invasion present, one axillary lymph node with metastatic carcinoma; estrogen receptor positive, progesterone receptor negative, Her-2/neu negative, Ki-67 low.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A1G4.5AD3B697-F097-496C-978B-F73BDA5394A7',\n",
       "  'report_length_cl100k_base': 2267,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive right breast cancer, with a tumor size of 3.5cm and a moderately differentiated nuclear grade 3/3. There is no evidence of dermal lymphatic space invasion, but lymph node involvement is present in 4 out of 9 nodes. No metastasis is reported.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive right breast cancer, with a 3.5cm tumor size. There is no dermal lymphatic space invasion identified. The deep margin is free of tumor by a distance of 10mm. 4 out of 9 lymph nodes are involved with metastatic carcinoma. The skin and subcutaneous fat away from the primary tumor show proliferative fibrocystic disease, but the skin margins closest to the tumor are negative for cancer.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A2-A1G6.02B4C31E-38F0-4AF3-8DAD-527D5F27C11A',\n",
       "  'report_length_cl100k_base': 1307,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive ductal carcinoma, with a tumor size of 1.5 cm. There is no lymphatic invasion or metastasis found in the sentinel lymph nodes. The tumor is hormone receptor-positive and HER2-negative. The pathological stage is pT1cNO (i-).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive ductal carcinoma, with a tumor size of 1.5 cm, moderately differentiated (Nottingham Grade 2), and estrogen and progesterone receptors positive. There is no lymphatic invasion or metastasis, but the tumor is close to the superior margin (0.95 mm) and composed of both invasive carcinoma and intraductal carcinoma in situ. Two lymph nodes were examined, with no metastatic involvement found. The pathologic stage is pT1cNO (i-), and HER 2 neu is negative (1+).\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A259.33569E07-D7BF-491B-A352-CEEA81556800',\n",
       "  'report_length_cl100k_base': 1034,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient is a year-old with left infiltrating lobular carcinoma and right lobular carcinoma in situ. The left breast mastectomy specimen revealed a 3.2 x 3.0 x 2.0 cm tumor in the upper inner quadrant, extending into the skin of the nipple and involving the upper outer quadrant, but not involving the deep surgical margin. Atypical lobular hyperplasia was found in the lower inner and outer quadrants. The right breast mastectomy specimen showed lobular carcinoma in situ with extensive lobular hyperplasia and atypical lobular hyperplasia. Estrogen receptors were negative, while progesterone receptors were positive in 80-90% of nuclei. HER2/neu was not amplified. The patient's cancer has not metastasized.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a year-old with left infiltrating lobular carcinoma and right lobular carcinoma in situ. The left breast mastectomy specimen had a 3.2 x 3.0 x 2.0 cm tumor in the upper inner quadrant, not involving the deep surgical margin, while the right breast mastectomy specimen showed lobular carcinoma in situ and atypical lobular hyperplasia. Estrogen receptors were negative, progesterone receptors were positive in 80-90% of nuclei, and HER2/neu was not amplified. The patient's clinical diagnosis was left breast carcinoma, and the histological findings confirm the presence of cancer in both breasts.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A25A.3971CA42-F1B0-4D85-9AD3-210B98E76A9C',\n",
       "  'report_length_cl100k_base': 1063,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is invasive ductal carcinoma with a maximum tumor size of 4cm. Lymphovascular invasion is present, and metastatic breast carcinoma is identified in one of two examined lymph nodes in the left axilla. There is no evidence of extranodal extension. The cancer is stage T1 (tumor size ≤ 2cm), N1 (one to three lymph nodes involved), and M0 (no distant metastasis).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive breast carcinoma is present in the left breast, with a maximum gross dimension of 4cm and focal invasion identified approximately 2mm from the nearest inked superficial margin. Lymphovascular invasion is identified and metastatic breast carcinoma is present in one of two lymph nodes examined in Part A, and in one of six lymph nodes examined in Part C. There is no evidence of extranodal extension. DCIS is also present, with areas of comedocarcinoma identified surrounding and within the tumor. The second biopsy site was not initially identified, but additional sections will be submitted after X-raying the specimen to locate the clip.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A25B.FCE29F34-5D13-4A21-A950-A8577C957C10',\n",
       "  'report_length_cl100k_base': 2382,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive left breast cancer, with two discrete gray fibrous nodules, the largest measuring 2.2 cm. One lesion is located at 3 o'clock and the other at 6 o'clock, both with clear margins. Lymphovascular invasion is identified. Two sentinel lymph nodes were removed, both of which tested positive for metastatic breast carcinoma, with the largest focus measuring 3 mm. The tumor is HER-2/neu negative with a Nottingham score of 6.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive ductal carcinoma with two separate lesions, one measuring 1.5 cm and the other 2.2 cm, both of which are located in the breast tissue. There is lymphovascular invasion present. The cancer has spread to the sentinel lymph nodes, with multifocal metastatic breast carcinoma identified in both the left axillary sentinel lymph nodes. The margins of excision, nipple skin, and random sections of the remaining quadrants are free of tumor. The tumor is HER2-negative.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A25C.1D4CA1BA-B534-4CEA-ABA5-EF9B31694204',\n",
       "  'report_length_cl100k_base': 1486,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has invasive lobular carcinoma in the right outer breast, with a tumor size of 3.2 cm and positive estrogen receptors. The cancer has spread to 23 out of 23 examined lymph nodes, with extracapsular extension present. The tumor is graded as poorly differentiated (G3) with a Nottingham score of 8/9. There is no evidence of metastasis to other parts of the body. The AJCC pathologic stage is pT2 N3a.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a white female with invasive lobular carcinoma in the right outer breast. The tumor size is 3.2 cm, with positive margins and venous/lymphatic invasion. The cancer is poorly differentiated (G3) with a Nottingham score of 8/9. 23 lymph nodes are positive for metastatic carcinoma, with extracapsular extension present. The patient's estrogen receptors are positive, but progesterone receptors are negative. HER 2 neu is negative. The AJCC pathologic stage is pT2 N3a. The mass has a single focus of invasive carcinoma, and the lymph nodes show multiple foci of extracapsular extension.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A2-A25D.BE63B06A-E3E0-4E00-9B9F-5E7DE8852E07',\n",
       "  'report_length_cl100k_base': 1399,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is classified as stage T2N2MX according to the AJCC staging system. The tumor consists of two separate masses, one in the lower outer quadrant measuring approximately 3 cm and another in the upper outer quadrant measuring 2 cm. The cancer has spread to 6/10 axillary lymph nodes with extra capsular extension. There is no evidence of metastasis to other parts of the body. The tumor margins are within 1 mm of the superior surgical margin and within 1.0 mm of the deep surgical margin in one section. The skin and nipple are free of carcinoma.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with invasive ductal carcinoma in the left breast, with an estimated tumor size of 3cm. There is evidence of ductal carcinoma in situ in the biopsy site, and the tumor extends within 1mm of the superior surgical margin. The deep margin is involved, with tumor extending within 1mm of the deep surgical margin in one section. There is metastasis to 6/10 axillary lymph nodes with extra capsular extension. The skin and nipple are negative for carcinoma. The AJCC stage is T2N2MX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A2-A25E.B81555D4-78D9-4235-AABE-F852CA6F15B5',\n",
       "  'report_length_cl100k_base': 879,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient is a female with a right breast lump that measured 2.6 cm in maximum dimension. The tumor had a grade III nuclear feature and showed angiolymphatic invasion. The surgical margins were uninvolved. Two sentinel lymph nodes were examined and found to be negative for metastasis. The patient's cancer is classified as pT2, pNO, and MX. The ER, PR, and Her-2/neu (IHC) were performed and showed the following results: ER 0%, PR 2%, and Her-2/neu IHC negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with a pre-operative diagnosis of right breast cancer. A right breast lumpectomy with sentinel lymph node biopsy was performed. The tumor mass measured 2.6 cm in maximum dimension, and all surgical margins were free of lesion. Two sentinel lymph nodes were removed and found to be negative for cancer. The breast tissue was found to have invasive ductal carcinoma, with DCIS present and comprising about 6% of the tumor. The cancer was graded as III, with angiolymphatic invasion probable. The ER, PR, and Her-2/neu (IHC) were performed and found to be negative for micrometastases in the right sentinel lymph nodes. The final pathologic staging was pT2 pNO MX.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A25F.AC60F5BB-9371-4F69-BAA0-099AD7FC2A0B',\n",
       "  'report_length_cl100k_base': 1428,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer stage is T2 (tumor size 3.5 cm), N1 (metastasis to 1 axillary lymph node), and M0 (no distant metastasis).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer stage is T2 (tumor size 3.5cm), N1 (metastasis to 1 axillary lymph node), M0 (no distant metastasis). The malignancy is invasive lobular carcinoma of the breast, with nuclear grade 2/3 and low mitotic index. LCIS comprises approximately 50% of the tumor. The margins of resection and nipple skin are free of tumor, and lymphovascular invasion is not identified.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A3KC.593AF241-8F84-4BA0-8878-7C1CE72A460B',\n",
       "  'report_length_cl100k_base': 2522,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient is a young female with a right breast cancer. The tumor is well-differentiated, measuring 4 cm, and is present at the inked margins. One out of four sentinel lymph nodes is positive for micrometastasis and isolated tumor cells. The patient's cancer is ER and PR positive, and HER2neu negative. The pathological stage is pT2N1mi.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a year-old female with right breast cancer. The tumor is well-differentiated, grade I/III infiltrating mucinous carcinoma, measuring 4cm. One out of four sentinel lymph nodes is positive for micrometastasis (0.27mm) and isolated tumor cells. The tumor is estrogen and progesterone receptor positive, HER2neu negative. The mass is present at the inked blue, orange, red, and black tissue edges. The specimen shows stromal sclerosis and focal microcyst formation. The patient's pathologic stage is pT2N1mi.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A3KD.3E4717BA-E9AE-45F9-9696-F8928D9FCECC',\n",
       "  'report_length_cl100k_base': 1361,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's cancer is classified as stage pT2, with a tumor size of 3 cm and involvement at the inferior, superior, and anterior margins. There is no evidence of metastasis in the axillary contents, but the sentinel lymph node is positive for metastatic carcinoma. The cancer is categorized as pN1c, with one positive lymph node. The tumor is invasive and infiltrating, with a Bloom-Richardson grade of 9 (3 + 3 + 3). The patient's cancer is HER2 weakly positive (2+), and HER2 amplification is not detected by FISH analysis.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a year-old with a diagnosis of left breast cancer. The tumor is invasive and infiltrating, with a size of 3 cm and Comedo-type carcinoma. It is grade 9 (3 + 3 + 3) with involvement at the inferior, superior, and anterior margins. The new medial margin biopsy shows high-grade intraductal carcinoma, and the sentinel lymph node biopsy is positive for metastatic carcinoma. The axillary contents biopsy shows no evidence of malignancy. The patient's cancer is classified as pT2 pN1c pMX. HER2 analysis by immunohistochemistry is weakly positive (2+), and FISH analysis previously performed was not amplified (1.3).\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A2-A3XS.DD5295D4-3896-4AA5-AF75-30AEA45D1652',\n",
       "  'report_length_cl100k_base': 1412,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a poorly differentiated, infiltrating ductal carcinoma in the left breast, with a tumor size of 4 cm and extensive lymphovascular invasion. The margins are positive (inferior and anterior), and there is no intraductal component identified. The tumor is estrogen and progesterone receptor negative, and HER2 is also negative. The report suggests that the cancer is consistent with a metastatic process, but a primary breast origin cannot be entirely excluded.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 40-year-old with a 4cm poorly differentiated adenocarcinoma in the left breast. The tumor has extensive lymphovascular invasion, and margins are positive (inferior and anterior). There is no intraductal component identified, and the tumor is estrogen and progesterone receptor negative. HER2 is also negative. The report suggests that the tumor is consistent with infiltrating ductal carcinoma, but a metastatic process cannot be entirely excluded.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A3XT.A614B6B7-256F-4148-8941-6145B2D9B8B5',\n",
       "  'report_length_cl100k_base': 886,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is classified as T2, N1mi, MX, Stage Grouping IIB. The tumor measures 4.6cm in the greatest dimension, with focal involvement of the superior margin (0.1cm). There is no evidence of DCIS, but angiolymphatic invasion is present. Lymph node involvement is noted with micrometastases found in sentinel nodes 2, 3, and 4. The cancer is invasive ductal carcinoma (4.5cm), grade III of III with absent tubule formation and high mitotic index. The tumor exhibits epitheloid features and focal mucinous differentiation with infiltrating and pushing borders. The patient's cancer is estrogen and progesterone receptor negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is classified as T2, N1mi, MX, stage grouping IIB. The tumor measures 4.6cm in the greatest dimension, with focal involvement of the superior margin (0.1cm). There is no evidence of DCIS, but angiolymphatic invasion is present. The cancer is grade III of III with absent tubule formation, high-grade nuclear features, and a high mitotic index. The patient's cancer is estrogen and progesterone receptor negative. Lymph node involvement is present in nodes 2, 3, and 4, with micrometastases found in each. Nodes 1, 5, and 6 are benign reactive lymph nodes. The remaining surgical margins are 0.2-0.5cm from the tumor mass.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A2-A3XU.5018EC57-96C6-4D63-B708-45559B4D8527',\n",
       "  'report_length_cl100k_base': 1997,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's pathology report indicates an invasive right breast cancer. The tumor size is 2.7 cm, and it is located 7 mm or more from the inked margins of resection. There is no lymphovascular invasion, and the tumor is grade 3/3 with a high mitotic index. The patient's sentinel lymph nodes 1 and 2 showed no evidence of metastatic tumor. The reexcision of the deep and lateral margins resulted in clear margins and no residual tumor.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's pathology report indicates a right breast cancer - invasive, with a maximum tumor size of 2.7cm. The specimen shows in situ and invasive ductal carcinoma with apocrine differentiation, high nuclear grade, and a Nottingham score of 9. Lymphovascular invasion is not identified, and the tumor is located 7mm or more from the inked margins of resection. The sentinel lymph node biopsies show no evidence of metastatic tumor. The reexcision of deep and lateral margins shows clear margins and no residual tumor.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A2-A3XV.405B9D03-6200-4DFA-A7D1-C622D3A48AEA',\n",
       "  'report_length_cl100k_base': 1516,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an infiltrating ductal carcinoma, with a tumor size of 3 cm and focal necrosis present. The cancer is grade 2, estrogen and progesterone receptor positive, and HER2 negative. Lymph node involvement is noted with one sentinel lymph node positive for metastatic carcinoma and the largest metastatic focus being 1.5 cm. The cancer is classified as pT2 N1a Mx. Additional pathologic changes include fibrocystic changes, nodular sclerosing adenosis, and columnar cell change without atypia.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 30-year-old with a 3.0 cm invasive ductal carcinoma in the right breast, with focal necrosis, venous/lymphatic invasion, and estrogen and progesterone receptors positive (95-100% and 10% respectively). Lymph nodes involved with metastatic carcinoma in sentinel and non-sentinel lymph nodes. The tumor is graded as N1a, and pathologic staging is pT2 N1a Mx.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A3XW.A4621FE7-E898-40BA-B45E-3DC9EF607F37',\n",
       "  'report_length_cl100k_base': 1983,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient is a 43-year-old with left breast cancer. The tumor is an invasive ductal carcinoma, grade 3 out of 3, with a tumor size of 2.2 cm. There is no lymph node involvement, and the tumor is estrogen and progesterone receptor negative, and HER 2 neu is negative. The pathological stage is pT2 NO (i-) MX. The patient's sentinel lymph node is negative for metastatic carcinoma.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a 44-year-old with left breast cancer. The tumor is an invasive ductal carcinoma, grade 3 out of 3, with a tumor size of 2.2 cm. There is no lymph node involvement, and the margins are negative. The tumor is estrogen and progesterone receptor negative, and HER 2 neu is negative. The pathologic stage is pT2 NO (i-) MX. The specimen also shows intraductal papilloma, fibroadenomatous changes, and fibrocystic changes. The patient's lymph node is negative for metastatic carcinoma.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A2-A3XX.770EEADF-19CD-4AB9-A7FA-1A05EE17984C',\n",
       "  'report_length_cl100k_base': 1289,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is stage pT2 N1a according to the AJCC staging system. The tumor is invasive ductal carcinoma (2.5 cm in size) with a histologic grade of 3, unifocal, and located in the left breast's upper outer quadrant. There is no venous/lymphatic invasion, and the margins are clear. 3 out of 17 lymph nodes are positive for metastatic carcinoma, with the largest metastatic focus being 1.2 cm. The tumor is estrogen and progesterone receptor negative, and HER2 is negative as well.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 43-year-old with a 2.5 cm invasive ductal carcinoma in the left breast, unifocal, with a Nottingham score of 9/9 and lymph node involvement (3 out of 17 nodes positive for metastatic carcinoma). The tumor is grade 3, with a focality of 1.2 cm and negative estrogen and progesterone receptors. The pathologic stage is pT2 N1a. Additional pathological changes include fibroadenoma, usual ductal hyperplasia, and small peripheral papilloma.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A3XY.EC1BB6E8-6897-4E70-80A6-5A4E4B9C4E1F',\n",
       "  'report_length_cl100k_base': 1655,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a multicentric invasive ductal carcinoma with four separate tumor foci, the largest being 1.9 cm. Two sentinel lymph nodes were negative for metastatic disease. The tumor is 5 mm from the deep margin and less than 1 mm from the superficial margin. The upper outer quadrant of the breast had 1.1 cm of ductal carcinoma in situ and 0.5 cm of invasive carcinoma. The upper inner quadrant biopsy site showed changes from a previous biopsy but no residual tumor. The breast superficial margin reexcision site was negative for malignancy.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's pathological report indicates a multicentric invasive ductal carcinoma in the left breast with tumor sizes of 1.0 cm, 1.2 cm, and 1.9 cm in the 10 and 11 o'clock positions, and associated with previous biopsy sites. There is no evidence of metastatic disease in the axillary sentinel lymph nodes. The breast tissue itself shows diffuse induration and a yellow-gray appearance. The superficial margin is involved in the tumor, and the deep margin is clear. The patient's case is T1, N0, and M0.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A2-A3XZ.A7B6FCF6-1B81-40B5-AD92-54681CBC8FE0',\n",
       "  'report_length_cl100k_base': 2177,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is classified as stage 2B based on the pathological report. The tumor size is 4cm, with poorly differentiated invasive ductal carcinoma and periductal chronic mastitis. There is one positive intramammary lymph node and 37 negative axillary lymph nodes. The cancer is estrogen receptor (ER) positive (95%) and progesterone receptor (PR) negative. Her-2/neu is scored as 1+.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a left breast cancer case with a modified radical mastectomy performed. The tumor size is 4cm, poorly differentiated, and is an infiltrating duct carcinoma. There is one intra-mammary lymph node marked and confirmed with a previous biopsy site. 37 axillary lymph nodes were examined, with metastatic carcinoma found in one. The patient is staged as having N1 disease.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A3Y0.0FEAEEBA-A72C-4207-AC21-6AF5B5ED1AFC',\n",
       "  'report_length_cl100k_base': 1920,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive lobular carcinoma of the breast, measuring 4 cm in diameter. The tumor is located in the right breast and is 30% composed of LCIS. It is 4 mm from the nearest inked superficial margin and 4 mm from the skin surface. Lymphovascular invasion is not identified, but perineural invasion is present. There is focal metastatic breast carcinoma in 27/27/20 lymph nodes, with extension into the perinodal fat. A biopsy site, including a rod-shaped metal clip, is also present.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Intralobular and infiltrating lobular carcinoma with a maximum gross dimension of 4 cm; invasive tumor identified 4 mm from the nearest inked superficial margin and 4 mm from the skin surface; perineural invasion present; 27/27 lymph nodes examined with metastatic focal breast extranodal carcinoma; extension into the perinodal fat present.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A2-A4RW.C1D4D6BB-AF86-4208-A729-C61365941217',\n",
       "  'report_length_cl100k_base': 1326,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a mixed epithelial/mesenchymal metaplastic carcinoma (carcinosarcoma) with a tumor size of 2.5 cm. There is no lymph node involvement and no metastasis. The cancer is estrogen and progesterone receptor positive, and HER 2 neu negative. The pathological stage is pT2 (m) NO (sn).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a stage 2 breast cancer case with a mixed epithelial/mesenchymal metaplastic carcinoma (carcinosarcoma) in the right breast, with a tumor size of 2.5 cm. The cancer is poorly differentiated, hormone receptor positive, and HER2 negative. There is no lymph node involvement, and the patient's axillary sentinel lymph nodes are negative for malignancy.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A2-A4RX.CA88491F-5572-4B0D-8E3D-D536E3CE5069',\n",
       "  'report_length_cl100k_base': 2451,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer stage is T1 (tumor size 8 mm), with metastasis found in 12 out of 28 lymph nodes. The cancer is described as multicentric in situ and of the lobular type, with nuclear grade 2-3 and a low mitotic index.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer stage is 3a, with a multicentric in situ and infiltrating lobular carcinoma of the pleomorphic type, nuclear grade 2-3, and a mitotic index documented. The tumor spans a distance of at least 78 mm in a superior to inferior direction, is 8 mm from the closest deep margin, and has focal microscopic perinodal soft tissue invasion present. There is no evidence of malignancy or atypia in the left mastectomy specimen. Metastatic carcinoma is identified in 12 out of 20 axillary lymph nodes.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A2-A4RY.2D6815B5-7704-4D67-93D1-78EDD924F131',\n",
       "  'report_length_cl100k_base': 2617,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's pathology report indicates a invasive mucinous carcinoma (2) grade I with nuclear grade 1 and low mitotic index, measuring 4.5 and 1.0 cm in greatest dimension. The lymph node (1) is negative for tumor by step section and cytokeratin stain.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive mucinous carcinoma (2) grade I with nuclear grade 1 and low mitotic index, tumors measuring 4.5 and 1.0 cm, no lymphatic invasion, negative sentinel lymph node, proliferative fibrocystic disease with calcifications present.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A2-A4S0.0118D9AE-B923-4EEF-BBBC-82D559763FF9',\n",
       "  'report_length_cl100k_base': 1053,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient underwent a partial mastectomy, ultrasonic needle loc breast biopsy, and sentinel node biopsy. The pathology report indicates the presence of a poorly differentiated malignant neoplasm with osteosarcomatous features, which likely represents a metaplastic carcinoma of the breast. The invasive neoplasm measures 34 mm in the greatest dimension and is present 2 mm from the posterior margin and 5 mm or greater from all other margins. The patient also has ductal carcinoma in situ (DCIS) with a focus of atypical ductal hyperplasia and duct hyperplasia of the usual type. There is no evidence of lymphatic invasion. The excised margins are free of neoplasm. The sentinel node biopsy is negative for tumor. The final diagnosis is breast cancer, invasive.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': '\\nThe report describes a surgical procedure performed on a patient with breast cancer, specifically a partial mastectomy, ultrasonic needle loc breast biopsy, and sentinel node biopsy. The specimen was received in nine parts, including the partial mastectomy, medial and lateral margins, superior and inferior margins, and anterior and posterior margins. The mass was found to be greater than 1 cm from all margins and was submitted for further testing. The report also includes descriptions of the margins and the sentinel node biopsy. The final diagnosis was a poorly differentiated malignant neoplasm with osteosarcomatous features, lymphatic invasion not identified, and DCIS present 1 mm from the inferior margin and 2 mm from the lateral margin. The other margins were free of neoplasm. The report also notes the presence of fibrocystic disease, ductal carcinoma in situ, and sclerosing adenosis. The sentinel node biopsy was negative for tumor. The report concludes with a comment that the tumor is likely a metaplastic',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A2-A4S1.041580F0-700A-4A47-83A6-207ED267E844',\n",
       "  'report_length_cl100k_base': 3002,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive lobular carcinoma with a maximum gross dimension of 5.8 cm in the central portion of the breast, extending into the extranodal soft tissue. Lymphovascular invasion is identified, and metastatic breast cancer is found in 4 out of 6 axillary lymph nodes (4/6), with the largest area of metastatic tumor measuring 1.1 cm in greatest microscopic dimension. There is no evidence of perineural invasion, and biopsy changes are not identified in the nodal dissection. The pathological staging indicates stage IV breast cancer.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer diagnosis includes invasive lobular carcinoma with lymphovascular invasion, and metastatic breast carcinoma was found in 4 out of 6 axillary lymph nodes. The tumor has a maximum gross dimension of 5.8 cm and extends into the extranodal soft tissue. The patient's nipple, skin, and breast margins of the resection are free of tumors, but calcifications are present within the tumor and benign portions of the breast.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A2-A4S2.4A5630FF-0ADC-4E69-B22A-02F1F34F61F9',\n",
       "  'report_length_cl100k_base': 2037,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's pathological report indicates a multicentric in situ and infiltrating duct carcinoma in the left breast, with tumor sizes ranging from 4 to 35 mm. Lymphatic invasion is present, with metastatic carcinoma found in 2 of 7 axillary lymph nodes. The posterior and anterior margins and nipple are free of neoplasm. The right breast mastectomy showed breast tissue with fibrocystic changes, duct hyperplasia, and apocrine metaplasia, but no evidence of atypia or malignancy.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's pathology report indicates a multicentric in situ and infiltrating duct carcinoma in the left breast, with multiple invasive tumors measuring between 4 and 35 mm in greatest dimension. Lymphatic invasion is present, with metastatic carcinoma found in 2 of 7 axillary lymph nodes. The posterior and anterior margins and nipple are free of neoplasm. The right breast mastectomy specimen shows breast tissue with fibrocystic changes, duct hyperplasia, and apocrine metaplasia, but no evidence of atypia or malignancy.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A2-A4S3.351D8E38-6E04-4F54-8CB1-975AEB7DB552',\n",
       "  'report_length_cl100k_base': 2230,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, with a tumor size of 1.5 cm. There is no vessel invasion or calcification present. The cancer is 1 cm from the nearest inked margin. Two sentinel lymph nodes were negative for metastatic carcinoma. No additional carcinomas were identified in the additional biopsy pieces taken from the specimen. The cancer is classified as T1, N0, M0.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's left breast mass is an invasive ductal carcinoma, measuring 1.5 cm, with no lymph node involvement. The pathology report indicates a tumor grade 2, with a mitotic index of 0 mitoses/10 HPFs. The specimen margins are negative for malignancy, and vessel invasion is absent. The patient's prognostic markers are mentioned in a previous biopsy. Additional biopsies from the 6 o'clock, 12 o'clock, 9 o'clock, and 3 o'clock positions show mild fibrocystic changes but are negative for malignancy. The final diagnosis includes fibrocystic changes and intraductal epithelial hyperplasia without atypia.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A0CD.DEB67EB8-155C-4ACF-B3D4-595E4CBE2E5C',\n",
       "  'report_length_cl100k_base': 1235,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's left breast tissue sample revealed an invasive ductal carcinoma, with a tumor size of 2.8 cm (pT2) and negative margins. There is no vessel invasion identified definitively. The lymph node, left axillary sentinel node, excision was negative for metastatic carcinoma (0/1).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's left breast cancer is an invasive ductal carcinoma, with a tumor size of 2.8 cm (pT2) and margins negative for malignancy. There is no vessel invasion identified definitively. The cancer is present in the lymph node, with 1 out of 1 lymph nodes showing metastatic carcinoma.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A7-A0CE.8A853D7F-979F-4112-9659-1FDE84EF5102',\n",
       "  'report_length_cl100k_base': 803,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient is a 45-year-old white female with lobular carcinoma. The right axillary sentinel lymph node specimen contained four lymph nodes, with no metastasis identified (0/4). The left axillary sentinel lymph node specimen had no metastasis identified in one lymph node (0/1). The right breast biopsy revealed a mixed infiltrating lobular and grade I ductal carcinoma, with a maximum dimension of 2.3 cm and DCIS present. The left breast biopsy showed ductal carcinoma in situ, with a maximum dimension of less than 2 mm and no invasive carcinoma identified. The superior margin of the left breast had a mixed grade 1 ductal and invasive lobular carcinoma with a maximum dimension of 1.2 cm and invasive carcinoma extending to the medial and inferior margins.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 45-year-old white female with lobular carcinoma. The right axillary sentinel lymph node specimen contained four lymph nodes, with no metastasis identified (0/4). The left axillary sentinel lymph node specimen had no metastasis identified in one lymph node (0/1). The right breast biopsy revealed a mixed infiltrating lobular and grade I ductal carcinoma, with a greatest dimension of 2.3 cm (pT2), and DCIS present. The left breast biopsy showed DCIS, with a tumor size of less than 2 mm. The superior margin of the left breast had a mixed grade 1 ductal and invasive lobular carcinoma, with a greatest dimension of 1.2 cm (pT1), and invasive carcinoma extending to the medial and inferior margins of resection.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A7-A0CG.2BE28F5D-2DBB-476F-9AFF-6B2103ECF0CE',\n",
       "  'report_length_cl100k_base': 1903,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's pathology report indicates a 3.3 cm invasive ductal carcinoma in the left breast with no lymph node involvement and negative margins. There is focal ductal carcinoma in situ present, and the tumor is grade 1-2 with no vascular invasion or calcifications. The sentinel lymph nodes from both the breast and the axilla are benign.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma in the left breast, with a tumor size of 3.3 cm (pT2) and no lymph node involvement. The skin, nipple, and margins are negative for malignancy. The lymph nodes are also negative for malignancy. The histologic grade is 1, and the nuclear grade is 2. There is focal ductal carcinoma in situ present, with the majority of the carcinoma being invasive. The tumor is cribriform in pattern and has no central necrosis. The patient's prognostic markers were previously performed at an outside institution.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A7-A0CH.F70DA7E5-2AB3-487F-8B2C-72EEE91E58E0',\n",
       "  'report_length_cl100k_base': 884,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient is a -year-old female with left breast cancer. The left axillary sentinel lymph node excision showed no metastasis identified. The left breast biopsy revealed an invasive ductal carcinoma, with a tumor mass measuring 2.2 x 1.5 x 1.8 cm, extending to the posterior margin of resection. The tumor is grade 3, with ductal carcinoma in situ present and a nuclear grade of 2-3. The specimen margins are positive, and vessel invasion is not identified. The patient's cancer has not metastasized, and the tumor size is 2.2 cm (pT2).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a -year-old white female with left breast cancer. The left axillary sentinel lymph node specimen contained no metastasis. The left breast biopsy revealed an invasive ductal carcinoma with a greatest dimension of 2.2 cm (pT2) and an overall grade of 3. The tumor extended to the green ink on the inferior margin and involved the inferior margin. There was no vessel invasion and calcification was present. Ductal carcinoma in situ was also present with a nuclear grade of 2-3 and an extensive intraductal component. The specimen margins were close, with in situ carcinoma less than 1 mm from the anterior, posterior, medial, and inferior margins. Proliferative changes were noted in the non-tumorous breast tissue.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A7-A0CJ.019F390D-7479-4CDC-8C82-45A27910E782',\n",
       "  'report_length_cl100k_base': 752,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's left breast cancer is an invasive ductal carcinoma, measuring 3.5 x 2.5 x 3 cm, with no lymph node involvement (pN0) and no evidence of metastasis (pM0). The tumor has a histologic grade of 2, nuclear grade of 3, and mitotic score of 1. The deep margin of the mastectomy is free of tumor, and there is no invasion of the skin or chest wall. The patient also has multifocal ductal carcinoma in situ with a nuclear grade of 3 and central necrosis present. The sentinel lymph node is negative for metastatic carcinoma.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with multifocal breast cancer. The left axillary sentinel node is negative for metastatic carcinoma. The left breast specimen has a 3.5 x 2.5 x 3 cm invasive ductal carcinoma, which is negative for vessel invasion and invasion of skin or chest wall. The deep margin of the mastectomy is free of tumor. There is no lymph node involvement (pN: pNO) and no distant metastasis (pM: Could not be assessed). The tumor is grade 2 with a greatest dimension of pT2. The specimen also has residual DCIS at the second biopsy site, measuring maximally 1.9 cm, with 10% of the tumor being DCIS at the invasive site.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A7-A0D9.7D5763F7-7284-4AF5-BBFC-5D8B5CB7F495',\n",
       "  'report_length_cl100k_base': 1029,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's left breast cancer is classified as pT2 (tumor measures 4 cm in greatest dimension), with lymphatic invasion present and high-grade ductal carcinoma in situ extending to the anterior and lateral margins of resection. The left axillary sentinel node biopsy revealed no metastatic disease.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a 45-year-old white female with left breast cancer. The left axillary sentinel node biopsy revealed no metastatic disease. The resected breast tissue specimen measured 7x5.7x4.1 cm and contained a poorly circumscribed, 4 cm tumor mass. The tumor is invasive ductal carcinoma, grade III, with lymphatic invasion and extension to the anterior and lateral margins of resection. High-grade ductal carcinoma in situ was also present, extending to the anterior margin of resection. The patient's prognostic markers have been previously performed.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A7-A0DA.69AC5937-3FFD-40FB-9922-79DB3CED7510',\n",
       "  'report_length_cl100k_base': 1038,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a stage 2A carcinoma of the right breast. The tumor measures 2.5 cm in greatest dimension (pT2) and is a moderately differentiated, invasive ductal carcinoma. There is no vessel invasion and no metastasis identified (pNO, pMX). Focal perineural invasion is present. Ductal carcinoma in situ is present, with calcifications identified in the specimen. The cancer extends to 2 mm from the anterior margin of excision. Lymph nodes 1, 2, and 3 are negative for metastatic disease (0/4).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is stage 2A, with a 2.5 cm invasive carcinoma in the right breast and no lymph node metastasis. The tumor extends to 2 mm from the anterior margin of excision, and there is no vessel invasion. Ductal carcinoma in situ is present 0.5 mm from the anterior margin of excision. The patient's lymph nodes, including sentinel nodes 1, 2, and 3, are negative for metastatic disease.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A7-A0DB.511CB4C5-FCEE-4EC4-98A4-4DD32ECA83C3',\n",
       "  'report_length_cl100k_base': 1419,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has been diagnosed with bilateral breast carcinoma. The left breast tumor is invasive ductal carcinoma, grade II, with a size of no less than 1.5 cm and associated ductal carcinoma in-situ, grade 3, with necrosis. The right breast tumor is ductal carcinoma in-situ, grade 2, involving a 5 cm area and the large ducts of the nipple. No invasive carcinoma was identified in the right breast. The patient has no lymph node involvement in either the left or right axilla.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has been diagnosed with bilateral breast carcinoma. The left breast had an invasive ductal carcinoma, grade II, with a size of no less than 1.5 cm, and associated ductal carcinoma in-situ, grade 3, with necrosis. The right breast had ductal carcinoma in-situ, grade 2, involving a 5 cm area and the large ducts of the nipple. No invasive carcinoma was identified. The patient's lymph nodes were negative for metastatic carcinoma (0/1 in the left sentinel lymph node, 0/3 in the left breast stitch 12 o'clock, 0/1 in the right axilla). The patient's prognostic markers were estrogen receptor positive, progesterone receptor negative, and Her2/neu negative.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A7-A0DC.43D912CD-BD3C-4E69-B28B-AB2E173C0BC2',\n",
       "  'report_length_cl100k_base': 2976,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma in the right breast, with a tumor size of 3.0 cm (pT2) and no vessel invasion. There is no evidence of calcification or necrosis. The cancer is close to the margins in the main resection specimen, 1.5 mm from the inferior margin, 1 mm from the posterior margin, and 1 mm from the anterior margin. The superior and posterior wall margins are negative for carcinoma. The patient has fibroadenoma in the retroareolar area. Four sentinel lymph nodes were biopsied, and all were negative for cancer (0/4).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has right breast cancer with an invasive ductal carcinoma, grade III, and a greatest dimension of 3.0 cm. There is no vessel invasion or calcification present. The tumor is close to the margins in the main resection specimen, but additional margin specimens are negative for carcinoma. Four sentinel lymph nodes were biopsied, all of which were negative for cancer. A fibroadenoma was also identified in the retroareolar area. The patient's prognostic markers are listed in the core biopsy report.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A7-A13D.6F3784B2-4A75-447C-9EAE-F146461C737E',\n",
       "  'report_length_cl100k_base': 1458,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, with a tumor size of 3.5 cm (pT2) and grade 3 histology. The cancer has spread to 2 out of 3 left sentinel lymph nodes (N1), with extracapsular extension and a metastasis size of 1.2 cm. There is no evidence of metastasis in the additional 9 left axillary lymph nodes.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's left breast cancer is characterized as infiltrating ductal carcinoma, grade 3, with a tumor size of 3.5 cm and negative margins. There is ductal carcinoma in situ present, grade 2, with negative margins. Two of three left sentinel lymph nodes are positive for metastatic carcinoma, with a largest metastasis size of 1.2 cm and extracapsular extension. Nine additional left axillary lymph nodes show no evidence of metastasis.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A7-A13E.2180850C-CC8D-4376-B2EE-1ADC3F5B3EC1',\n",
       "  'report_length_cl100k_base': 988,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma with focal lobular features, measuring 4x6x7 cm. It is classified as T3 pN1a, with metastatic carcinoma present in 2 of 2 lymph nodes, up to 3.5 mm in size. There is no evidence of extranodal tumor or matted lymph nodes.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient\\'s cancer stage is T3 pN1a with metastatic carcinoma present in 2 of 2 lymph nodes (sentinel nodes) in the right axilla, and 1 of 9 axillary lymph nodes in the right breast. The tumor size is 4 x 6 x 7 cm, and there is no extranodal tumor or matted lymph nodes. The cancer is classified as infiltrating ductal carcinoma with focal lobular features, with a mitotic index of 4 mitoses/10 HPFs. The patient\\'s prognostic markers are listed as \"see previous biopsy.\"',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A7-A13F.D64FFDC0-38BB-456E-9621-AF89B79D0C68',\n",
       "  'report_length_cl100k_base': 1193,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient is a young female with a 2.8 cm well-differentiated invasive ductal carcinoma (pT2, grade 1) in the left breast, with no lymph node involvement (pNO), negative margins, and no evidence of metastasis (pM).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a young female with a pre-op diagnosis of left breast cancer. The frozen section analysis of the left axillary sentinel lymph node was negative for metastatic disease. The gross examination of the left breast specimen revealed a well-circumscribed, 2.8 cm x 1.8 cm x 1.6 cm rubbery tan-white lesion at the junction of the lower inner and outer quadrants. The lesion focally extends to within 0.6 cm of the inked deep margin and is 1 cm from the anterior surface. The microscopic examination showed an infiltrating ductal carcinoma, well differentiated, with an overall grade of 1. The tumor measures 2.8 cm, and there is no vessel invasion or calcification present. The specimen margins, skin, and nipple are negative for tumor, and fibrocystic changes, including a 1 cm fibroadenoma, are also noted. The patient's prognostic markers were previously performed.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A13G.50782829-35B6-4A61-A3CE-F105A31EDB42',\n",
       "  'report_length_cl100k_base': 1101,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient is a 45-year-old female with a pre-operative diagnosis of right breast cancer. The pathology report indicates an invasive lobular carcinoma in the right breast, with a tumor size of 2.2 cm (pT2) and no evidence of vessel invasion or Paget's disease. The cancer is present in one of three lymph nodes (pN1a), with a metastatic tumor measuring 8 mm in greatest dimension. The patient's cancer is estrogen and progesterone receptor positive, and Her-2 status is equivocal, with a block sent for FISH testing. The report also mentions proliferative fibrocystic changes and prior biopsy site effects.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a 45-year-old female with a pre-op diagnosis of right breast cancer. The specimen consists of a 5.5 x 3.0 x 1.5 cm piece of fatty yellow tissue, with three separate lymph nodes, the largest measuring 4 cm in greatest dimension. The lymph nodes were negative for malignancy on frozen section. The breast specimen is 24.5 cm x 19.0 cm x 5.0 cm, with a 2.2 cm x 1.6 cm x 1.3 cm tan white lesion at the junction of the four quadrants. The lesion is 4 cm from the inked deep margin and 1.7 cm from the overlying skin ellipse. The microscopic examination reveals invasive lobular carcinoma, with a greatest dimension of 2.2 cm (pT2). The specimen margins are negative for tumor. The patient's prognostic markers are positive for estrogen and progesterone receptors, and Her2/neu is equivocal, with a block sent for\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A7-A13H.642B4B50-E227-4484-904E-E629F7F9DBC1',\n",
       "  'report_length_cl100k_base': 1707,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has been diagnosed with left breast carcinoma, with a 5.5 cm lobular carcinoma and a minor focus of invasive ductal carcinoma. The tumor extends to the inked deep margin and is 1.1 cm from the anterior/skin surface. There is ductal carcinoma in situ present, and a 3 mm metastasis with minimal extra-capsular extension was found in one lymph node. The patient's cancer is stage pT3, pN1A, pM cannot be assessed.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has been diagnosed with left breast carcinoma, with a 5.5 cm lobular carcinoma and a minor focus of invasive ductal carcinoma. The tumor extends to the inked deep margin and is 1.1 cm from the anterior/skin surface. There is ductal carcinoma in situ present, and a 3 mm metastasis with minimal extra-capsular extension was found in one lymph node. The patient's cancer is grade 2, with a pT3 classification. 16 lymph nodes were examined, with one containing metastatic carcinoma. The cancer has not metastasized distantly.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A7-A26E.EA830A26-3DF5-4731-AD0A-F20A61D58817',\n",
       "  'report_length_cl100k_base': 2733,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's left breast tumor measures 1.8 cm and is classified as poorly differentiated, with metaplastic features and a grade of 3. The tumor involves the inferior margin and there is no evidence of metastasis in the left axillary sentinel lymph node (0/1). Ductal carcinoma in situ is present, with a nuclear grade of 3 and necrosis, while margins are negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a year-old with left breast metaplastic cancer. The left axillary sentinel lymph node excision showed no evidence of metastasis in 1 node (0/1). The left breast excisional biopsy revealed an invasive carcinoma with squamous differentiation, metaplastic, measuring 1.8 cm (pT1). The tumor involves the inferior margin over a distance of greater than 1 cm and there is focal suspicious vessel invasion. Ductal carcinoma in situ is present, with a solid pattern and nuclear grade 3 with necrosis. The margins are negative, and calcification is present. The patient's prognostic markers are being tested, and the HER-2 status is currently equivocal.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A26F.46A75AD3-BAD1-4A16-873E-0099BD10FA8C',\n",
       "  'report_length_cl100k_base': 726,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma with metaplastic features, measuring 2.3 cm in greatest dimension (pT2). There is no lymph node involvement (N0) and no metastasis (M0). The tumor is located at the 1 o'clock position in the right breast, and the deep margins are negative for malignancy. The patient also has lobular neoplasia and fibrocystic changes.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's right breast specimen shows a 2.3 cm invasive ductal carcinoma with metaplastic features (sarcomatoid carcinoma component) in the 1 o'clock position. The tumor has a grade 3 histology and no vessel invasion or calcification is identified. The right axillary sentinel lymph node specimen does not show any identifiable tumor on H&E stained sections, but isolated keratin-positive cells are present. The skin and deep margins are negative for malignancy, and there is lobular neoplasia in the nipple. The patient's breast also shows fibrocystic changes and microcalcifications.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A7-A26G.6BE810A6-3D30-4F75-89B7-00C866553165',\n",
       "  'report_length_cl100k_base': 1005,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer has an invasive ductal carcinoma in both breasts, with tumor sizes of 1.5 cm and 1.2 cm, respectively. There is metastatic carcinoma in one left axillary lymph node, but the right axillary lymph nodes are negative for malignancy. There is no evidence of vessel invasion or calcification, and the pTNM stage is T1 pN1a for the left breast and T1 for the right breast. Prognostic markers are requested. The patient's cancer has an Elston SBR grade of 1 for the left breast and 2 for the right breast.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive ductal carcinoma, with tumor size being 1.5 cm and 1.2 cm in the left and right breast respectively. There is no vessel invasion or calcification evident. The cancer is stage T1 pN1a. The left axillary sentinel lymph node is positive for carcinoma, while the right axillary sentinel nodes 1 and 2 are negative. No extranodal tumors are present.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A7-A26H.1159E2EF-6407-4D90-8ED6-7AB04CF4FB32',\n",
       "  'report_length_cl100k_base': 1597,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient is a 44-year-old white female with left breast cancer. The tumor size is 3.2 cm (pT2) and there is no lymphovascular space invasion. The tumor is 2 mm from the resection margins (superior and anterior) and 3 mm from the posterior margin. There is associated high-grade ductal carcinoma in situ. Two sentinel lymph nodes were negative for metastatic tumor.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a 44-year-old white female with left breast cancer. The tumor size is 3.2 cm (pT2) and is invasive ductal carcinoma, Elston's SBR grade 2. There is associated high-grade solid ductal carcinoma in situ. The tumor is 2 mm from the resection margins designated superior and anterior and 3 mm from the resection margin designated posterior. No lymphovascular space invasion was identified. Two lymph nodes were negative for metastatic tumor (0/2).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A26I.CCE33A95-774E-4242-B2A1-05FF002ED1D9',\n",
       "  'report_length_cl100k_base': 1000,\n",
       "  't_label': 1},\n",
       " {'abstract': 'Invasive ductal carcinoma with a tumor size of 3.0 cm, lymphovascular invasion, and two negative sentinel lymph nodes (0/2).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive ductal carcinoma with lobular features, grade III, 3.0 cm in greatest dimension, negative specimen margins, lymphovascular invasion present, two negative sentinel lymph nodes (0/2).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A26J.5CC0C09F-70F6-458A-B8E6-18BDC074BE74',\n",
       "  'report_length_cl100k_base': 1079,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's right breast had two invasive ductal carcinomas, measuring 3.8cm and 2cm, both with extensive lymphatic invasion and high-grade ductal carcinoma in situ. Eight out of ten lymph nodes were positive for metastatic carcinoma. The patient's left breast had a large biopsy cavity and lobular carcinoma in situ, but no invasive tumor or ductal carcinoma in situ was present.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has multifocal invasive breast tumors in the right breast, with one measuring 3.8 cm and the other 2 cm. There is extensive lymphatic invasion, and eight out of ten lymph nodes contain metastatic carcinoma (pN2a). The left breast has a prior biopsy cavity and lobular carcinoma in situ, but no invasive tumors or ductal carcinoma in situ are present.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A7-A2KD.3C301346-4594-4071-A754-04F8B3BE894C',\n",
       "  'report_length_cl100k_base': 2397,\n",
       "  't_label': 1},\n",
       " {'abstract': 'Invasive mucinous carcinoma (Nottingham grade 1) found in the right breast with a tumor size of 1.3 cm, no lymph node involvement, and negative margins. No vessel invasion or calcification present. TNM stage T1c. Sentinel lymph node biopsy negative for malignancy.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive mucinous carcinoma, Nottingham grade 1, tumor size 1.3 cm, negative margins, no vessel invasion, no calcification, TNM stage T1c, sentinel lymph node negative for malignancy, prognostic markers pending.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A3IY.63F5F3D8-6393-4DA7-BB74-7D587199D7FD',\n",
       "  'report_length_cl100k_base': 784,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an invasive lobular carcinoma, measuring 2.6 cm and extending to the inferior and lateral margins of the right breast. There are rare isolated cytokeratin positive cells (pNOi+) found in the sentinel lymph node. The cancer is stage T2, with positive margins and no lymph node metastasis.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive lobular carcinoma in the right breast, measuring 2.6 cm, with rare isolated cytokeratin positive cells (pNOi+) found in sentinel lymph node #1. The cancer extends to the inferior and lateral margins, and calcification is present. There is no vessel invasion or ductal carcinoma in situ identified. The tumor is graded as overall grade 2, with architectural score 3, nuclear score 2, and mitotic score 1. Prognostic markers have been previously performed.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A7-A3IZ.90F83655-038B-412C-91BD-84CC3A4201D4',\n",
       "  'report_length_cl100k_base': 563,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive mucinous carcinoma, grade 1, with a tumor size of 2.5 cm. There is no lymph node involvement, and the tumor is 1.9 mm from the red (anterior) margin. Vessel invasion is absent, and there is no evidence of metastasis. The TNM stage is T2 NO.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive mucinous carcinoma of the right breast, with a tumor size of 2.5 cm and no lymph node involvement. The tumor is grade 1 with negative margins and no vessel invasion. The patient's TNM stage is T2 NO. Prognostic markers are not provided in the report.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A3J0.A5AED5F0-A144-4615-AF78-539B8523D15F',\n",
       "  'report_length_cl100k_base': 644,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive lobular carcinoma with a tumor size of 1.7 cm, grade 2 Nottingham score, and negative margins for malignancy. There is no lymph node involvement or metastasis. The cancer is stage T1c NO. Lobular carcinoma in situ is present in the posterior lateral margin of the breast.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive lobular carcinoma, grade 2, with a tumor size of 1.7 cm. The margins are negative for malignancy, and there is no lymph node involvement. The cancer is staged as pT1c NO. Lobular carcinoma in situ is present in the posterior lateral margin biopsy.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A3J1.D8EFFB62-6A23-4033-8144-24B751DECB08',\n",
       "  'report_length_cl100k_base': 845,\n",
       "  't_label': 0},\n",
       " {'abstract': '\\nThe patient has invasive mucinous carcinoma in the left breast with a tumor size of 3.7 cm. There is no vessel invasion, and the tumor is less than 1 mm from the deep margin and extremely close to the lateral margin. Two sentinel lymph nodes were removed and found to be negative for metastatic disease. The cancer has not spread to other parts of the body.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"\\nThe patient's cancer is an invasive mucinous carcinoma with a grade 2 Elston SBR score. The tumor has a greatest dimension of 3.7 cm and is located less than 1 mm from the deep margin and extremely close to the lateral margin. There is no vessel invasion and the lymph nodes are negative for metastatic disease. The tumor is present in the adipose tissue at the inked medial margin of resection. The patient's skin and remaining tissue are negative for tumor.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A3RF.4AF67A51-97C1-4D58-9E60-03FDFFACD38A',\n",
       "  'report_length_cl100k_base': 1032,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nInvasive lobular carcinoma, 7.5 cm in size, with 12 positive lymph nodes out of 19 examined. Extracapsular extension present. No distant metastasis identified.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is invasive lobular carcinoma, with a tumor size of 7.5 cm (pT3) and 12 out of 19 lymph nodes positive for metastatic carcinoma (pN3a). There is vessel invasion present and extracapsular extension. The cancer has not spread to distant sites (pMX).\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A7-A425.F969E3E4-0053-44E9-85BC-BEFDBD62C512',\n",
       "  'report_length_cl100k_base': 1212,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has invasive lobular carcinoma in both breasts, with tumor sizes of approximately 6cm (right breast) and 5x5x3mm (left breast). The right breast had 13 positive lymph nodes out of 20, while the left breast had 0 positive lymph nodes out of 1. No distant metastases were reported. The tumors were estrogen and progesterone receptor positive and showed normal expression for HER-2/neu.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive lobular carcinoma in both breasts, with tumor sizes of approximately 6cm (right breast) and 5x5x3mm (left breast). The right breast had 13 positive lymph nodes out of 20, while the left breast had 0 positive lymph nodes out of 1. No distant metastases were reported. The tumors were estrogen and progesterone receptor positive and showed normal expression for HER-2/neu.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A7-A426.B644AEB6-7D46-4D4D-BA00-D42BCDDCB164',\n",
       "  'report_length_cl100k_base': 1768,\n",
       "  't_label': 2},\n",
       " {'abstract': '\\nThe patient has invasive pleomorphic lobular carcinoma in the left breast, with a tumor size of 2.2 cm and negative margins of excision. One out of ten lymph nodes in the left axilla is positive for metastatic carcinoma. There is no vessel invasion or ductal carcinoma in situ. The prognostic markers from the previous core biopsy are not provided in this report.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive pleomorphic lobular carcinoma in the left breast, with a tumor size of 2.2 cm and negative margins of excision. One of the ten lymph nodes removed had metastatic carcinoma, and the largest metastasis was 7 mm. There is no vessel invasion or ductal carcinoma in situ. The prognostic markers from a previous core biopsy are not provided in this report.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A7-A4SA.2649764C-9566-49DB-B8E9-B4B86DBB763C',\n",
       "  'report_length_cl100k_base': 942,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive lobular carcinoma, with a tumor size of 5.3 cm. It is present at the posterior and inferior/medial margins of the breast and less than 1 mm from the anterior margin, suggesting possible lymphatic space invasion. One of the two lymph nodes from the right axillary sentinel node biopsy was positive for micrometastasis (0.98 mm).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive lobular carcinoma, grade 2, with a tumor size of 5.3 cm. It is present at the posterior and inferior/medial margins and less than 1 mm from the anterior margin, with suspicion of lymphatic space invasion. One of the two lymph nodes from the right axillary sentinel node biopsy was positive for micrometastasis (0.98mm).\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A7-A4SB.03B39A59-0068-4276-8340-7B97A1395E68',\n",
       "  'report_length_cl100k_base': 1036,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive lobular carcinoma, grade 1, with a tumor size of 7.5 cm (pT3). The resection margin is negative for tumor, and there is no lymph node involvement (pN0). No metastasis is identified (pMX). The cancer is hormone receptor-negative, with a Her2 score of 2+, and FISH testing is ordered. The patient's prognostic markers are as follows: Progesterone receptor: 0%, HER-2 testing: Equivocal by IHC, and Estrogen receptor: Negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive lobular carcinoma, grade 1, with a tumor size of 7.5 cm (pT3). The resection margin is negative for tumor, and there is no lymph node involvement (pN0). The cancer is estrogen receptor negative, progesterone receptor negative, and HER2 equivocal by IHC. The patient's cancer is considered stage I due to the lack of lymph node involvement and no evidence of metastasis (pMX).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A4SC.5E14E7CA-3417-4379-8EE3-7F00D6D4A02B',\n",
       "  'report_length_cl100k_base': 1255,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, grade 3, with a tumor size of 4.3 cm. There is no evidence of metastasis in the 6 examined lymph nodes. Surgical margins are negative but close (0.4 cm to deep margin). No vessel invasion or calcification is identified. Ductal carcinoma in situ is not present.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive ductal carcinoma, grade 3, with a tumor size of 4.3 cm. There is no evidence of metastasis in the 6 lymph nodes examined from both sentinel lymph node biopsies. The surgical margins are negative but close (0.4 cm to deep margin). No vessel invasion or calcification is identified, and ductal carcinoma in situ is not present. The cancer is confined to the breast tissue, making it stage I.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A4SD.563D1ED2-1A8B-4D90-BD42-AC3790D04913',\n",
       "  'report_length_cl100k_base': 960,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nInvasive ductal carcinoma, grade 3, size 2.8 cm, negative margins, no lymph node involvement, no metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive ductal carcinoma, grade 3, size 2.8 cm, negative margins of excision, no lymph node involvement, negative for malignancy or atypia in adjacent breast tissue, sentinel lymph nodes negative, prognostic markers not mentioned.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A4SE.C0C49D41-AA66-435B-9312-FAD8E2DC3305',\n",
       "  'report_length_cl100k_base': 1644,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma grade 2, with a tumor size of approximately 2.5-4.0 cm. There is no lymph node involvement, and the tumor is present at the medial and posterior margins. Ductal carcinoma in-situ is also present at the inferior margin. No vessel invasion or metastasis is identified.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma grade 2, size not less than 2.5 cm, present at the medial and posterior margins, with ductal carcinoma in-situ grade 2 present at the inferior margin. There is no lymph node involvement (0/2) and no vessel invasion or calcification identified. The tumor is not less than 2.5 cm and possibly as much as 4.0 cm, and invasive carcinoma is broadly present at the medial and posterior margins.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A4SF.C1B1FAA6-EB15-43BB-B3A3-D11511C76060',\n",
       "  'report_length_cl100k_base': 875,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive ductal carcinoma, grade 3, with a tumor size of 3.2 cm. There is no evidence of metastasis in the sentinel lymph node or in the 7 lymph nodes removed from the left axillary contents. The surgical margins of the tumor are negative but close, less than 2 mm over a distance of 5 mm. There is no vessel invasion or calcification present. The prognostic markers have been previously performed.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's left breast had an invasive ductal carcinoma of grade 3, with a tumor size of 3.2 cm. The surgical margins were negative but close, less than 2 mm. No metastasis was found in the left axillary sentinel lymph node or in the 7 lymph nodes removed from the left axillary contents.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A56D.D564A7FB-4F0A-4589-AB32-A6CD8B547219',\n",
       "  'report_length_cl100k_base': 1047,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive mammary carcinoma with a high combined histologic grade and high proliferative rate, measuring 4.2 cm (pT2). The tumor has expansile growth patterns, and the margins are adequate. There is no vessel invasion or calcification identified. Lymph nodes A and B are negative for malignancy, and lymph nodes from the left axillary sentinel are also negative. No metastasis is found.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive mammary carcinoma with a high combined histologic grade and high proliferative rate. The tumor has an expansile growth pattern and is circumscribed, with no lymph node involvement. The margins are adequate, and vessel invasion and calcification are not identified. The tumor has a greatest dimension of 4.2 cm (pT2). Ductal carcinoma in situ is not present. Prognostic markers were tested, but the report does not mention the results. The patient's left breast was removed through segmental mastectomy, and the posterior margin was tested and found negative for malignancy.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A5ZV.FA5CF5A2-F44A-4303-9200-32250FAEF374',\n",
       "  'report_length_cl100k_base': 1001,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma in the right breast, with a tumor size of 1.7 cm (pT1c) and grade 2. The resection margins are negative for invasive and in situ carcinoma. The right axillary sentinel lymph node biopsy reveals metastatic ductal carcinoma, with a size of 7 mm and extranodal extension (snpNla). The cancer is stage T1c, N1, and M0.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive ductal carcinoma, grade 2, 1.7 cm (pT1c) in the right breast with ductal carcinoma in situ, cribriform type, nuclear grade 2. Resection margins negative for invasive and in situ carcinoma. Right axillary sentinel lymph node biopsy revealed metastatic ductal carcinoma, 7 mm size with extranodal extension (snpNla).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A7-A5ZW.A56585F9-9651-472B-BF53-C708A686EB7D',\n",
       "  'report_length_cl100k_base': 950,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient has invasive lobular carcinoma in both breasts, with tumor sizes of 0.5 cm (pT1b) in the right breast and 3.2 cm (pT2) in the left breast. There is metastatic carcinoma in 21 out of 24 lymph nodes (pN3a), with involvement of the superior-most lymph node. The patient's cancer is estrogen and progesterone receptor-positive (ER 80%, PR 5%, Her2 negative). No distant metastases (pM) were reported.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient has invasive lobular carcinoma in both breasts, with metastatic carcinoma in 21 out of 24 lymph nodes (pN3a). The largest lymph node is 2.5 cm in greatest dimension, with metastatic carcinoma present in the superior-most lymph node. The tumor is ER-positive, PR-weakly positive, and Her2-negative. The patient also has lobular carcinoma-in-situ. The largest invasive lobular carcinoma mass is 3.2 cm in greatest dimension (pT2). The deep margins are negative, but tumor is present very near (<1 mm from) and possibly at the deep margin in separate foci. The skin and nipple are negative for malignancy.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A7-A5ZX.A8834D03-81F5-43BC-A4AB-F215C89CB095',\n",
       "  'report_length_cl100k_base': 2158,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, grade 3, with a tumor size of 4.5 cm. There is no lymph node involvement, and the margins of excision are negative. Ductal carcinoma in situ is present with central necrosis, and the patient has fibrocystic changes in the breast tissue. No distant metastasis is detected.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive ductal carcinoma, grade 3, size 4.5 cm, with ductal carcinoma in-situ, grade 3 with necrosis; negative margins of excision. One negative lymph node (0/1). Four negative lymph nodes (0/4). No vessel invasion or invasion of skin/chest wall. No distant metastasis (pM unknown). No lymph node involvement (pN: pNO).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A6VV.C26EAF0E-202B-4F3E-9E59-3395A1BFCAB8',\n",
       "  'report_length_cl100k_base': 853,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, grade 3, with a tumor size of 3.0 cm. There is no vessel invasion or ductal carcinoma in situ identified. The cancer is close to the medial and inferior margins, with two negative lymph nodes (0/2). Distant metastasis status is unknown.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma, grade 3, with a tumor size of 3.0 cm in the greatest dimension. The carcinoma is well-demarcated and is close to the medial and inferior margins. There is no vessel invasion or ductal carcinoma in situ identified. The patient has two negative sentinel lymph nodes (0/2). The prognostic markers are unknown, and there is no information on distant metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A6VW.BE19CEFA-7A66-480C-BEC0-AF52F4C8A04C',\n",
       "  'report_length_cl100k_base': 506,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an infiltrating ductal carcinoma, grade 3, with a tumor size of 2.5 cm. There is no evidence of metastasis in the 2 lymph nodes examined. The tumor extends to within 0.5 mm from the inferior margin of resection, and there is no vessel invasion identified. The patient's cancer is stage T2, N0, M0.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 43-year-old black female with left breast cancer. The pathology report indicates an invasive ductal carcinoma, grade 3, measuring 2.5 cm. There is no evidence of metastasis in the 2 lymph nodes examined. The tumor extends to within 0.5 mm from the inferior margin of resection, with no vessel invasion identified. Ductal carcinoma in situ is also present, with a nuclear grade of 3 and central necrosis. The specimen margins are positive for in situ carcinoma at the posterior margin.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A7-A6VX.80EDDCAC-B87B-47E6-A48C-F166D227DA6C',\n",
       "  'report_length_cl100k_base': 756,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma in the right breast, with a tumor size of 3.5 cm and grade 3. There is metastasis in 2 out of 14 lymph nodes, with the largest metastasis being 3.4 cm and extracapsular extension present. The margins of the tumor are uninvolved, but close, with 1 mm from the posterior margin. Ductal carcinoma in situ is also present, accounting for less than 5% of the tumor.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive ductal carcinoma, grade 3, 3.5 cm in greatest dimension; 2/14 lymph nodes positive for metastasis with largest metastasis measuring 3.4 cm and extracapsular extension present.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A7-A6VY.BB85F844-C710-41D5-8620-E246DC9D2C6A',\n",
       "  'report_length_cl100k_base': 819,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive ductal carcinoma tumor, measuring 17 cm in diameter, with skin ulcerations. The tumor is classified as NOS, G III, pT4bpNOLOVORO, indicating a high-grade tumor, with close margins, and no lymph node or metastatic involvement.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated invasive ductal carcinoma, with a tumor diameter of 17 cm and minimum distance from preparation margins being less than 0.1 cm. The tumor classification is NOS, G III, pT4bpNOLOVORO, indicating a high-grade tumor with no lymph node involvement and no observed metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A06N.2F0333BC-E9BB-4903-B3E2-8AE241DDDF84',\n",
       "  'report_length_cl100k_base': 74,\n",
       "  't_label': 3},\n",
       " {'abstract': 'The patient has poorly differentiated invasive ductal carcinoma with a maximum tumor diameter of 1.5 cm and focal intraductal spread. The tumor is ulcerated and is located 0.8 cm from the dorsal margin and 1 cm from the lateral resection margin. There is no lymph node involvement and no evidence of metastasis. The tumor is classified as NOS, G III, pT1c(m)pNO(0/13)LOVORO.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has poorly differentiated invasive ductal carcinoma with a maximum microscopic tumor diameter of 1.5 cm and focal intraductal spread. The tumor is ulcerated and is located less than 0.1 cm from the nearest resection margin. The patient also has another focus of poorly differentiated invasive ductal carcinoma with a tumor diameter of 1.5 cm and is 0.8 cm from the dorsal margin and 1 cm from the nearest lateral resection margin. The tumor is classified as NOS, G III, pT1c(m)pNO(0/13)LOVORO.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A06O.EB9B8904-F6CC-451F-8628-50CC71F1F7C3',\n",
       "  'report_length_cl100k_base': 140,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a bifocal invasive ductal breast carcinoma, with tumor sizes of 1.1 cm and 0.8 cm. The cancer has spread to 7/25 lymph nodes (pN2a) but there is no evidence of metastasis (MX). The tumor has been completely resected with a clear margin of 0.5 cm and is classified as pT1c (m). There is no involvement of lymphatic vessels (L0) or blood vessels (V0).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has a bifocal invasive ductal breast carcinoma grade II, with tumor sizes of 1.1 cm and 0.8 cm. The tumor has been completely resected with a caudal margin of 0.5 cm. The tumor is classified as pT1c (m), pN2a (7/25), MX, R0, G2 (L0, V0).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A8-A06P.AADFAF8B-92B8-4292-96A3-912D55EB9C31',\n",
       "  'report_length_cl100k_base': 114,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has multifocal moderately differentiated invasive breast carcinoma, with the larger tumor being 5.3 cm and the smaller tumor being 1.5 cm. There is focal angioinvasion and intraductal components. The tumor has spread to the lymph nodes (N2a) but no metastasis is detected (L1V0R0).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has multifocal moderately differentiated invasive breast carcinoma, with a larger tumor size of 5.3 cm and a smaller tumor size of 1.5 cm. There are focal angioinvasion and intraductal components present. The tumor has spread to the lymph nodes (N2a) but has not metastasized (L1V0R0). The dorsal resection margin is tumor-free.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A8-A06Q.8FE77EF7-C83A-431F-B3BA-D93B5ECC70AF',\n",
       "  'report_length_cl100k_base': 164,\n",
       "  't_label': 2},\n",
       " {'abstract': ' The patient has a poorly differentiated invasive ductal carcinoma tumor with a diameter of 2.8 cm (pT2) and one affected lymph node (N1a), but no distant metastasis (M0). The tumor is classified as G III, and the final classification is LOVORO.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated invasive ductal carcinoma, with a tumor diameter of 2.8 cm. The tumor is classified as NOS, G III, pT2N1aLOVORO.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A06R.B6B7939C-63AF-4B52-B494-AA09A9C03871',\n",
       "  'report_length_cl100k_base': 51,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 55 mm moderately differentiated invasive ductal breast carcinoma with complete circumscribed invasion of lymph vessels, no intraductal tumor component, and a minimum basal margin of 3 mm. The tumor is classified as pT3, pL1, pN1a (1/13), pMx, and stage III A. The patient has a 13% lymph node involvement and no metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has a 55 mm moderately differentiated invasive ductal breast carcinoma with completely circumscribed invasion of the lymph vessels and no intraductal tumor component. The tumor has a minimum basal margin of 3 mm, a 6 mm margin at 12 o'clock, and is surrounded by fibrocystic and proliferating mastopathy with ductal hyperplasia and sclerotic intraductal papillomas. The tumor is classified as M-8500/3, G2, pT3, pL1, pN1a (1/13), pMx, stage IIIA, and has no metastasis.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A06T.5D888D65-685F-4598-884F-AD057DE5FD1D',\n",
       "  'report_length_cl100k_base': 161,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has a multicentric, poorly differentiated, invasive ductal breast carcinoma with four foci ranging from 0.7 to 3 cm in size. There is no evidence of skin or nipple involvement, and the resection margins are tumor-free. The cancer has spread to 2/25 lymph nodes, and there is no distant metastasis. The tumor is classified as M-8500/3, G3, pT2 (m), pN1a, and pMX, indicating stage II B.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has a multicentric, poorly differentiated, invasive ductal breast carcinoma with four foci ranging from 0.7 to 3 cm in size. The tumor is surrounded by mastopathy and high-grade intraductal carcinoma with comedo necrosis. There is no evidence of skin or nipple involvement, and the resection margins are clear. The patient has 2/25 positive lymph nodes and no distant metastasis, resulting in a stage IIB classification.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A06U.A314FB55-F20A-4485-965D-D7894D070A16',\n",
       "  'report_length_cl100k_base': 193,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has invasive ductal breast carcinoma, with a tumor size of 5.5 cm (pT3) and no evidence of lymph node involvement (Nx, pN0). The cancer has not spread to distant sites (Mx), and the tumor is classified as G3 (L0, V0) with a mediocranial safety margin of at least 3 mm.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient has invasive ductal breast carcinoma with a maximum diameter of 5.5 cm, malignancy grade III, and angioinvasion. The tumor classification is G3 (L0, V0), pT3, Nx, Mx. The lymph nodes are tumor-free (total N = 11, pN0).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A06X.738B601A-24D8-4261-B000-198648213070',\n",
       "  'report_length_cl100k_base': 84,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has invasive ductal breast carcinoma, with a tumor size of pT2 (2.5 cm in diameter) and no lymph node involvement (pNO sn). The cancer has not metastasized (MX), and the tumor is classified as G2 (LO, V0).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with invasive ductal breast carcinoma (malignancy grade II) along with high-grade comedo-type DCIS. The tumor has a maximum diameter of 2.5 cm and is classified as pT2. There is no lymph node involvement (pNO sn) and no evidence of metastasis (MX). The tumor is categorized as G2 (LO, V0). The resection margins are free of atypia.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A06Y.5664F531-9D45-4302-A455-63E46B5EDD26',\n",
       "  'report_length_cl100k_base': 156,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a moderately differentiated invasive ductal carcinoma with a tumor diameter of 8 cm. The distance to the dorsal resection margin is less than 0.1 cm. The tumor classification for the right breast is NOS, G II, pT3LOVORX, indicating no lymph node involvement and no metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with moderately differentiated invasive ductal carcinoma with a tumor diameter of 8 cm. The distance to the dorsal resection margin is less than 0.1 cm. The tumor classification for the right breast is NOS, G II, pT3LOVORX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A06Z.956F45E5-A8C6-4A4A-9D1F-D31912180584',\n",
       "  'report_length_cl100k_base': 59,\n",
       "  't_label': 2},\n",
       " {'abstract': ' The patient has a poorly differentiated invasive ductal carcinoma tumor with a diameter of 2.2 cm. The tumor is classified as NOS, G III, pT2, N1a, L1, and V0, indicating no specific subtype, grade 3, stage 2 tumor size, 1-3 involved lymph nodes, and no regional or distant metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient has been diagnosed with poorly differentiated invasive ductal carcinoma with a tumor diameter of 2.2 cm. The tumor classification is NOS, G III, pT2N1aL1V0R0, indicating a moderately differentiated tumor, stage 2A, with no lymph node involvement, and no distant metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A075.6643B290-5D7A-4649-B57D-47A5BA4E8D31',\n",
       "  'report_length_cl100k_base': 51,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive ductal carcinoma with a tumor diameter of 2.5 cm and no skin infiltration. The carcinoma was excised in toto with no lymph node involvement and no metastasis. The tumor is classified as NOS, G III, pT2NOLOVORO.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has poorly differentiated invasive ductal carcinoma with a tumor diameter of 2.5 cm and no skin infiltration. The carcinoma was excised in toto with no lymph node involvement and no metastasis. The tumor is classified as NOS, G III, pT2NOLOVORO (6th edition, 2003).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A076.DD669244-34D8-4725-A52C-F3AAF59852F9',\n",
       "  'report_length_cl100k_base': 88,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a multifocal poorly differentiated invasive ductal carcinoma with tumor sizes of 7 cm, 2.2 cm, and 1.7 cm. The largest tumor focus has focal ulceration of the skin and circumscribed intraductal spread, as well as focal angioinvasion. The tumor-free dorsal resection margin is classified as NOS, G III, pT4b(mult)N3aL1V0R0.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has a multifocal poorly differentiated invasive ductal carcinoma with tumor diameters of 7 cm, 2.2 cm, and 1.7 cm. The largest tumor focus has focal ulceration of the skin and circumscribed intraductal spread, with focal angioinvasion. The tumor-free dorsal resection margin is classified as NOS, G III, pT4b(mult)N3aL1V0R0.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A8-A079.81ADDBAB-C02F-4DA8-9429-76293FB42E42',\n",
       "  'report_length_cl100k_base': 117,\n",
       "  't_label': 3},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive ductal carcinoma with a tumor diameter of 3.0 cm. There is no information on lymph node involvement or metastasis status provided in the report.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated invasive ductal carcinoma, with a tumor diameter of 3.0 cm. The tumor classification is NOS, G III, pT2LOVORO, indicating a moderately differentiated tumor, stage IIA, with no lymph node involvement and no evidence of metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A07B.F24A752C-1AAE-4C70-B6D4-DD0E8C89D9AA',\n",
       "  'report_length_cl100k_base': 40,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has bifocal poorly differentiated invasive ductal carcinoma, with tumor sizes of 2.8 cm and 0.8 cm. There is no lymph node involvement or metastasis. The tumors are classified as NOS, G III, pT2(mult)NOLOVORO.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has bifocal poorly differentiated invasive ductal carcinoma with tumor diameters of 2.8 and 0.8 cm, classified as NOS, G III, pT2(mult)NOLOVORO.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A07C.DC5B662B-1ADD-4D6E-A6E3-3EF8B922BC71',\n",
       "  'report_length_cl100k_base': 60,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a moderately differentiated invasive ductal carcinoma with a tumor diameter of 3.5 cm and no involvement in other margins. The cancer has spread to the lymph nodes (N3a) but has not metastasized (M0). The tumor is classified as pT2, NOS, G II, and LOV0R0.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with moderately differentiated invasive ductal carcinoma. The tumor has a diameter of 3.5 cm and is located 3 cm dorsally, with free margins. The cancer has spread to the lymph nodes (N3a) but has not metastasized (LOV0R0).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A8-A07E.E20AC0FF-43C4-49EA-9E33-764E553933B7',\n",
       "  'report_length_cl100k_base': 59,\n",
       "  't_label': 3},\n",
       " {'abstract': 'The patient has a moderately differentiated invasive ductal carcinoma with a tumor diameter of 5.0 cm and is classified as T2. There is lymph node involvement (N1a) with no evidence of metastasis (MO).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The pathology report states that the patient has a moderately differentiated invasive ductal carcinoma with an intraductal component, with a tumor diameter of 5.0 cm. The tumor classification is NOS, G II, pT2N1aLOVORO.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A07F.D1456192-83E7-4FC8-B783-90D615830156',\n",
       "  'report_length_cl100k_base': 62,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 1.9 cm moderately differentiated invasive ductal carcinoma tumor with intraductal spread, classified as NOS, G II, pT1cN1aLOVORO, indicating tumor size of 1-2 cm, lymph node involvement, and no evidence of metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with moderately differentiated invasive ductal carcinoma with a tumor diameter of 1.9 cm. The tumor is classified as NOS, G II, pT1cN1aLOVORO, indicating that it has spread to the intraductal lymph nodes.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A07G.1ED901DF-BCDC-44C8-A7DF-AB895ECA0952',\n",
       "  'report_length_cl100k_base': 66,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has multifocal poorly differentiated invasive ductal breast carcinoma, with the largest tumor focus being 2.6 cm. There are three additional tumor foci, with one being microscopically visible. The cancer has spread to 5 out of 15 lymph nodes and there is no evidence of metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has multifocal poorly differentiated invasive ductal breast carcinoma with a small intraductal component, graded as G III. The largest tumor focus is 2.6 cm, and there are three additional tumor foci, one of which is microscopically visible. The cancer has spread to 5 out of 15 lymph nodes and there is no evidence of metastasis.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A8-A07I.5DA3A8E1-7EE6-45EC-89EC-69423E2B866B',\n",
       "  'report_length_cl100k_base': 122,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a bifocal invasive ductal carcinoma with a tumor diameter of 3cm and 0.8cm, with lymph node involvement (pN1a(1/18)) and no evidence of metastasis (pT2(m) pN1a(1/18)LOV0R0).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has a bifocal invasive ductal carcinoma (tumor diameter 3cm and 0.8cm) with focal intraductal components, classified as NOS, G II, pT2(m) pN1a(1/18)LOV0R0.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A07J.2243F29C-191C-4D33-8483-09BB3AD36598',\n",
       "  'report_length_cl100k_base': 72,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive ductal breast carcinoma, measuring 3.4 cm with carcinomatous lymphangitis and two axillary lymph node metastases out of 20 nodes studied. The tumor is classified as pT3, pN1a (2/20), MX, R0, L1, V0.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has a poorly differentiated invasive ductal breast carcinoma measuring 3.4 cm with carcinomatous lymphangitis and two axillary lymph node metastases out of 20 nodes studied. The tumor classification is M-8500/3, G3, pT3, pN1a (2/20), MX, R0, L1, V0. The follow-up resection samples in nos 2 and 3 were carcinoma-free.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A07L.5D93AE27-79A0-4809-AE7C-54814CED0851',\n",
       "  'report_length_cl100k_base': 129,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive solid carcinoma, consistent with ductal breast carcinoma, with a maximum reconstructed tumor diameter of 3.0 cm. The tumor-free resection margin indicates no lymph node involvement (pN0) and no metastasis (M0).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated invasive solid carcinoma, specifically ductal breast carcinoma. The tumor has a maximum reconstructed diameter of 3.0 cm and the resection margin is tumor-free. There is no lymph node involvement (pN0) and no evidence of metastasis (MO). The tumor is classified as T2, N0, and M0.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A07O.9ECA4450-A550-44DE-B2E5-FD1CFF02A9FE',\n",
       "  'report_length_cl100k_base': 131,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has a 3.5 cm invasive ductal breast carcinoma grade 3 in the left breast at 2 o'clock with a minimum distance of 1 mm from the dorsal resection margin and a cranial resection margin of 3 mm. There are very small components of ductal carcinoma in situ grade 3 with comedo necrosis and one positive lymph node (1/11). The tumor classification is pT2, pN1, and MX grade 3 with a LO/V0 rating. The patient is R0 (dorsal 1 mm, cranial 3 mm).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has a 3.5 cm invasive ductal breast carcinoma grade 3 in the left breast at 2 o'clock with a minimum distance of 1 mm from the dorsal resection margin and a cranial resection margin of 3 mm. There are very small components of ductal carcinoma in situ grade 3 with comedo necrosis and one lymph node with a tumor (1/11). The tumor classification is pT2, pN1 (1/11), MX grade 3 (LO/V0), and R0 (dorsal 1 mm, cranial 3 mm).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A07P.6C7D956E-1247-4663-9ED5-D406AE6E2959',\n",
       "  'report_length_cl100k_base': 148,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has a poorly differentiated invasive ductal carcinoma in the left breast at 2 o'clock, measuring 4.6 cm with high-grade DCIS III and comedo necroses. The tumor classification is pT2, with 15/22 positive lymph nodes (pN3a), and metastasis status is unknown (MX). The cancer has spread to the chest wall (T4), and there is evidence of vascular invasion (V1) and lymphatic invasion (L1).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has been diagnosed with a poorly differentiated invasive ductal carcinoma in the left breast at 2 o'clock, with a maximum size of 4.6 cm, along with high-grade DCIS III with comedo necroses. The tumor classification based on preliminary findings is pT2 (4.6 cm), pN3a (15/22), MX, R1, indicating a peripheral invasive carcinoma, grade 3, with lymph node involvement (L1, V1).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A8-A07R.FD75D315-EED7-4350-A890-8FB94648E9FC',\n",
       "  'report_length_cl100k_base': 97,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has invasive breast carcinoma with a 28mm tumor (pT2) and no lymph node involvement (pM0). The tumor is grade 1 with no evidence of vascular or lymphatic invasion (L0, R1). There is also extensive lobular neoplasia and DCIS grade 1, corresponding to pTis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \" The patient has invasive breast carcinoma of mixed differentiation in the left breast at 3 o'clock, with a tumor size of 28 mm (pT2) and no lymph node involvement (pM0). The tumor is classified as grade 1 (L0, V0, R1) with associated extensive lobular neoplasia and DCIS grade 1, corresponding to pTis RI ventral.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A07S.AC2E3DDC-3AF6-45F0-8269-E9DA68F4367A',\n",
       "  'report_length_cl100k_base': 75,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 2.2 cm poorly differentiated invasive ductal breast carcinoma in the right breast with no intraductal tumor component and tumor-free overlying skin. The tumor has spread to 1-3 axillary lymph nodes (pN2a) and there is no evidence of metastasis (pMX). The tumor is classified as stage IIIA.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has a 2.2 cm poorly differentiated invasive ductal breast carcinoma in the right breast with no evidence of intraductal tumor component and tumor-free overlying skin, including the nipple. The tumor has spread to 1-3 axillary lymph nodes (pN2a) and there is no evidence of metastasis (pMX). The tumor classification is M-8500/3, G3, pT2, pN2a, pMX, stage IIIA. The margins of the tumor are almost 1 cm basally and at 6 o'clock and surrounding fibrolipomatous atrophic glandular tissue. The patient is considered to be at stage IIIA.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A8-A07U.1E7788D8-B5FC-473A-8A10-79910443799A',\n",
       "  'report_length_cl100k_base': 132,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 3 cm moderately differentiated invasive ductal breast carcinoma without lymph or blood vessel invasion. The tumor is classified as pT2, pL0, pV0 (0/1), pNX, and pMX. The excision material also includes a multifocal intraductal non-high-grade carcinoma, max. 5 mm in size, with comedo necrosis, not extending beyond the invasive tumor component.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The pathology report describes a 3 cm moderately differentiated invasive ductal breast carcinoma that was excised without any visible invasion of lymph or blood vessels. The tumor is classified as M-8500/3, G 2, pT 2, pL 0, pV 0 (0/1), pNX, pMX, and R0, indicating no lymph node involvement and no metastasis.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A8-A07W.C39563FD-CD7F-47C6-A257-5CB70A01C67C',\n",
       "  'report_length_cl100k_base': 130,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal breast carcinoma (pT2), with no lymph node involvement (pNO: 0/11), no metastasis (MX), and no evidence of lymphatic invasion (pL0) or vascular invasion (pV0). The tumor has a minimum dorsal margin of less than 0.1 cm and a ventral margin of 0.5 cm, with the remaining resection margins being markedly greater than 1 cm.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The pathology report describes a moderately differentiated ductal breast carcinoma with invasive growth and a minimum dorsal margin of less than 0.1 cm. The tumor classification is M-8500/3, G 2 (seven points), pT2, pNO (0/11), MX, pL0, pV0. The assessment shows that the dorsal margin of the carcinoma is less than 0.1 cm, the ventral margin is 0.5 cm, and the remaining resection margins are markedly greater than 1 cm.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A07Z.DD558354-3BF1-4037-881E-011E6BFC0987',\n",
       "  'report_length_cl100k_base': 129,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a moderately differentiated invasive ductal carcinoma with a tumor diameter of 3.0 cm. The tumor margins are free except for the dorsal margin, which is 0.3 cm away. There is no lymph node involvement, and no metastasis is detected. The tumor classification is NOS, G II, pT2N0(sn)LOVORO.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The pathology report describes a moderately differentiated invasive ductal carcinoma in the right breast, with a tumor diameter of 3.0 cm and clear margins (except for the dorsal margin, which is 0.3 cm). There is no lymph node involvement and no evidence of metastasis. The tumor is classified as NOS, G II, pT2N0(sn)LOVORO.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A081.DE25BF82-5F7A-489B-BFC1-9386C44E7D62',\n",
       "  'report_length_cl100k_base': 92,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive ductal carcinoma with two tumors, one measuring 2.3 cm and the other 2 cm. The larger tumor is bifocal and has a distance of 2.2 cm from the resection margins cranially, 2.5 cm dorsally, 3 cm laterally, and caudally, and 5 cm medially. The smaller tumor has a distance of less than 0.1 cm dorsally, 0.2 cm caudally, 1.5 cm laterally, 3.5 cm cranially, and 7 cm medially. There is no evidence of lymph node involvement or metastasis. The tumor is classified as NOS, G II, pT2N2aL1V0R0.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has a poorly differentiated invasive ductal carcinoma with two tumors, one measuring 2.3 cm and the other 2 cm. The larger tumor is bifocal and has a distance of 2.2 cm from the resection margins cranially, 2.5 cm dorsally, 3 cm laterally, and caudally, and 5 cm medially. The smaller tumor is moderately differentiated and has a distance of less than 0.1 cm dorsally, 0.2 cm caudally, 1.5 cm laterally, 3.5 cm cranially, and 7 cm medially from the resection margins. The patient's tumor classification is NOS, G II, pT2N2aL1V0R0.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A082.3E967C4F-B916-4A80-A9A1-A5E94F02322C',\n",
       "  'report_length_cl100k_base': 192,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a highly differentiated invasive ductal carcinoma with a tumor diameter of 9 cm and tumor-free dorsal resection margin. There is no lymph node involvement or metastasis. The tumor is classified as NOS, GI, pT3NOLOVORO.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The pathology report describes a highly differentiated invasive carcinoma in the breast with a tumor diameter of 9 cm and circumscribed intraductal components. The tumor-free dorsal resection margin indicates that the tumor has not spread to nearby tissues. The tumor classification is NOS, G I, pT3NOLOVORO, which suggests that there is no lymph node involvement and no metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A083.AF0A2220-DEEC-44C8-B15C-B6442D5B7517',\n",
       "  'report_length_cl100k_base': 78,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive ductal carcinoma tumor, measuring 3.5 cm in diameter, with focally marked intraductal patterns of spread. The tumor is classified as NOS, G III, pT2, N1a, LOV0, RX.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated invasive ductal carcinoma, with a tumor diameter of 3.5 cm and focally marked intraductal patterns of spread. The tumor classification is NOS, G III, pT2N1aLOV0RX, indicating a size of 2-5 cm, lymph node involvement, and no metastasis. The IGA-A8-A0S4-01A-PR result suggests the presence of hormone receptors.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A084.6A49B3F9-6B43-4D74-A28B-C83BFE61EC7B',\n",
       "  'report_length_cl100k_base': 70,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive carcinoma with a tumor diameter of 2.5 cm and in situ spread. There is infiltration of corial connective tissue and focal tumor spread within lymph vessels. The tumor is classified as NOS, G III, pT2N1aL1V0R0, indicating no ulceration, no lymph node involvement, and no distant metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The report describes a poorly differentiated invasive carcinoma with a tumor diameter of 2.5 cm and in situ spread. There is infiltration of the corial connective tissue of superficial adjacent skin and focal tumor spread within lymph vessels. The tumor is classified as NOS, G III, pT2N1aL1V0R0.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A085.64F84FF4-A477-4E1E-B4BB-E5614517229E',\n",
       "  'report_length_cl100k_base': 94,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 1.9 cm moderately differentiated invasive ductal carcinoma tumor with focal intraductal components, classified as NOS, G II, pT1cN1aL1V0R0. This indicates tumor size of 1.9 cm, involvement of one to three axillary lymph nodes, and no regional lymph node involvement or metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with moderately differentiated invasive ductal carcinoma with a tumor diameter of 1.9 cm and focal intraductal components. The tumor classification is NOS, G II, pT1cN1aL1V0R0, indicating cancer in the breast tissue, with no lymph node involvement, and no signs of metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A086.D4E86E20-B75E-4CDA-83F2-22C481D4B9E8',\n",
       "  'report_length_cl100k_base': 69,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a 1.7 cm well-differentiated invasive ductal carcinoma in the left breast segment (upper medial) with tumor stage pT1c, G1, pLO, pV0, pNO (0/1, SLN), and pRO. The tumor was completely excised with carcinoma-free resection margins and skin. There is no lymph node involvement or metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has a 1.7 cm well differentiated invasive ductal carcinoma in the left breast segment (upper medial) with carcinoma-free resection margins and skin. The tumor stage is pT1c, G1, pLO, pV0, pNO (0/1, SLN), pRO, indicating no lymph node involvement and no metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A08A.6D2212CE-C80F-4545-A895-3F1B6E4C6DB6',\n",
       "  'report_length_cl100k_base': 99,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has bifocal poorly differentiated invasive ductal carcinoma, with tumor sizes of 2.5 cm and 0.7 cm, and no lymph node involvement. The cancer has not metastasized.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has bifocal poorly differentiated invasive ductal carcinoma with tumor diameters of 2.5 cm and 0.7 cm, with focal intraductal components. The tumor classification is NOS, G III, pT2(mult)NO(sn)LOVORO.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A08B.2261B407-340D-4BB3-94BC-F06096FBDA80',\n",
       "  'report_length_cl100k_base': 67,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive ductal carcinoma with a tumor diameter of 3.5 cm. The tumor is classified as T2NOLOVORO, indicating no lymph node involvement and no metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated invasive ductal carcinoma. The tumor diameter is 3.5 cm and the minimum distance dorsally is 1 cm, with free margins otherwise. The tumor classification for the left breast is NOS, G III, pT2NOLOVORO.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A08C.6E136F3D-A6E1-4541-AA4B-65BC5872DE06',\n",
       "  'report_length_cl100k_base': 61,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a multifocal invasive ductal carcinoma with tumor diameters of 2.8 cm, 3.0 cm, and 1 cm. There is no lymph node involvement (N0) and no metastasis (M0). The tumor is classified as NOS, G III, pT2(mult)N3aL1V0R0. The margins are tumor-free with minimum margins of 0.5 cm, 1.5 cm, and 0.7 cm for each focus.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has multifocal invasive ductal carcinoma with intraductal components and focal angioinvasion. The tumor diameter of the poorly differentiated invasive ductal carcinoma is 2.8 cm, and there are two further foci of moderately invasive ductal carcinoma with tumor diameters of 3.0 cm and 1 cm. The dorsal resection margin is tumor-free with minimum margins of 0.5 cm, 1.5 cm, and 0.7 cm for the respective tumor foci. The tumor classification is NOS, G III, pT2(mult)N3aL1V0R0. There is no lymph node involvement or metastasis.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A8-A08F.683AAF99-3B91-4501-B701-C3A4E8439647',\n",
       "  'report_length_cl100k_base': 180,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive ductal carcinoma with a tumor diameter of 2.8 cm and focal intraductal components. The tumor is classified as NOS and mucinous carcinoma, G III, pT2(mult)NOLOVORX. There is no information provided about lymph node involvement or metastasis status.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The pathology report describes a poorly differentiated invasive ductal carcinoma with a tumor diameter of 2.8 cm and focal intraductal components. The tumor-free dorsal resection margin indicates that the tumor was successfully removed. The tumor classification is NOS and mucinous carcinoma, G III, pT2(mult)NOLOVORX, which suggests that there is no lymph node involvement and no evidence of metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A08G.6DCA5C2C-F28A-409D-9623-24AB748FB4E7',\n",
       "  'report_length_cl100k_base': 79,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal breast carcinoma, with a tumor size of 2.5 cm and no lymph node involvement. The tumor is classified as G2 (L0, V0), pTlc, pN0 (sn), MX, R0, with a minimum width of dorsocranial safety margin of 1 cm.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The report describes a 2.5 cm invasive ductal breast carcinoma (grade II) with no lymph node involvement (pN0), no metastasis (MX), and a tumor-free margin of 1 cm. The tumor includes high-grade DCIS and coarse calcification. The remaining glandular tissue is free of atypia.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A08H.33188769-D86E-41AD-A74D-31A7C2DD08B7',\n",
       "  'report_length_cl100k_base': 152,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive ductal breast carcinoma, with a tumor diameter of 3 cm and no evidence of lymph node involvement or metastasis. The tumor margins are clear in all directions except for the cranial margin, which is 0.6 cm from the tumor. The cancer is classified as NOS, G III, pT2 NO(O/3sn)LOVORO.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated invasive ductal breast carcinoma, with a tumor diameter of 3 cm and no evidence of lymph node involvement. The tumor margins are within the acceptable range, and there are small areas of necrosis and secondary inflammation. The cancer is classified as NOS, G III, pT2 NO(O/3sn)LOVORO.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A08I.F2077079-D683-4D18-94B9-84C760674AF6',\n",
       "  'report_length_cl100k_base': 117,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has a moderately differentiated invasive focal ductal carcinoma in the right breast, with a tumor size of at least 7 cm, Paget's disease of the nipple, and no evidence of angioinvasion. The tumor is classified as NOS, G II, pT4bN1aL1 1VORO. The dorsal margin is tumor-free, but there is lymph node involvement. There is no information provided on metastasis status.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has been diagnosed with moderately differentiated invasive focal ductal carcinoma in the right breast, with a tumor size of at least 7 cm, Paget's disease of the nipple, and angioinvasion. The tumor has spread to the skin and is classified as T4bN1aL1 1VORO. The dorsal margin is tumor-free.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A8-A08J.C1D59BA7-FC3E-46EA-B095-3B6DF42892B0',\n",
       "  'report_length_cl100k_base': 95,\n",
       "  't_label': 3},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive ductal breast carcinoma, measuring 6 cm, with lymph vessel invasion, extension to the nipple, pectoral muscle, and basal epidermis. There is no skin infiltration or pagetoid tumor propagation. The tumor is classified as M-8500/3, G3, pT3, pN2a (5/13), pMX, stage IIIA, with R0 resection margin.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has a poorly differentiated invasive ductal breast carcinoma measuring up to 6 cm with lymph vessel invasion, extension to the base of the nipple, pectoral muscle, and basal epidermis. There is no pagetoid tumor propagation or skin infiltration. The tumor is classified as M-8500/3, G3, pT3, pN2a (5/13), pMX, and stage III A, with R0 indicating no evidence of residual disease after surgery.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A8-A08L.BC0E0F93-B183-44E8-B551-EA463B2FBCE4',\n",
       "  'report_length_cl100k_base': 116,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has invasive ductal breast carcinoma, with a tumor size of pT2 (max. diameter 3.8 cm) and lymph node involvement of pN3a (12/17). There is no evidence of metastasis (pM1, R0) and the tumor is classified as G2 (L1, V0) with EIC.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal breast carcinoma, with a tumor size of pT2 (max. diameter 3.8 cm) and lymph node involvement of pN3a (12/17). There is no evidence of skin infiltration, but the tumor has penetrated the retromamillary fibromuscular tissue and fascia. The resection margins are free of atypia, and the tumor is classified as G2 (L1, V0) with no metastasis (pM1).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A8-A08O.2F102533-4B6B-4411-9080-3697ED3099EA',\n",
       "  'report_length_cl100k_base': 168,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal breast carcinoma, measuring 3 cm with lymph vessel invasion and an invasive satellite node. There is no evidence of metastasis (MX) and the tumor is classified as pT2m pN2a (4/15), indicating 4 positive lymph nodes out of 15 removed. The tumor is grade 3 with no DCIS formation and the nipple is tumor-free.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal breast carcinoma with a maximum diameter of 3 cm, lymph vessel invasion, and an invasive satellite node. The tumor is classified as pT2m pN2a (4/15), MX, R0; G3 (L1, V0). There is no calcification and no DCIS formation. The tumor-free nipple and wide safety margins are noted.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A8-A08P.7DB1F816-A55F-449A-8DF9-6724B5100CA1',\n",
       "  'report_length_cl100k_base': 119,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has a 4 cm poorly differentiated invasive ductal carcinoma in the left breast (pT2), with lymph node involvement (N1a) and no evidence of metastasis (M0). The tumor is classified as NOS, G III, and LOVORO.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The pathology report describes a poorly differentiated invasive ductal carcinoma with a tumor diameter of 4 cm. The tumor classification for the left breast is NOS, G III, pT2N1aLOVORO, indicating a specific type and stage of breast cancer.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A08R.FC0C1BF3-74C3-4DFC-B9B5-2FD1728E287A',\n",
       "  'report_length_cl100k_base': 45,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive ductal carcinoma with a tumor diameter of 1.8 cm. The tumor is classified as NOS, G III, pT1, and Nla(sn)LOVORO, indicating no lymph node involvement and no metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated invasive ductal carcinoma, with a tumor diameter of 1.8 cm. The tumor classification is NOS, G III, pT1Nla(sn)LOVORO, indicating the cancer has not spread to the lymph nodes or metastasized to other parts of the body.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A08S.0D293DF8-374D-4681-9B2A-ACC98601AA25',\n",
       "  'report_length_cl100k_base': 46,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a moderately differentiated invasive ductal carcinoma with two foci, measuring 3 cm and 2 cm in diameter, with no skin infiltration or ulceration. The tumor is classified as NOS, G II, pT2(mult)N1aL1VOM1RO, indicating lymph node involvement and no distant metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with moderately differentiated invasive ductal carcinoma, with two tumor foci having diameters of 3 cm and 2 cm, respectively. The tumor has focal intraductal components and circumscribed angioinvasion. There is no skin infiltration or ulceration. The tumor classification is NOS, G II, pT2 (mult) N1a L1 VOM1 RO.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A08T.5780D50C-5BF0-4392-BC9B-894D1369866A',\n",
       "  'report_length_cl100k_base': 82,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive ductal carcinoma with a maximum microscopic tumor diameter of 4.0 cm. The tumor has focal intraductal components and angioinvasion. The ablated breast sample shows extensive further invasive and angioinvasive tumor components, with a maximum spread of 8 cm. There are foci of intraductal tumor components in the cavity region of the sample excision. The dorsal resection margin is tumor-free. The patient has massive subepidermal carcinomatous lymphangitis of the skin spindle, which could be correlated with the clinical appearance of an inflammatory carcinoma. The tumor classification is NOS, G III, pT3N3aL1V1R0.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Poorly differentiated invasive ductal carcinoma with focal intraductal components and angioinvasion, maximum microscopic tumor diameter 4.0 cm. Ablated left breast sample with extensive further invasive and angioinvasive tumor components, maximum spread 8 cm, foci of intraductal tumor components in the cavity region, and massive subepidermal carcinomatous lymphangitis of the skin spindle. Dorsal resection margin tumor-free. Tumor classification NOS, G III, pT3N3aL1V1R0.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A8-A08X.CA911D90-5DDA-49F1-993F-68FCA77A8558',\n",
       "  'report_length_cl100k_base': 191,\n",
       "  't_label': 3},\n",
       " {'abstract': 'The patient has been diagnosed with a moderately differentiated invasive ductal carcinoma, with a tumor diameter of 5.0 cm and focal angioinvasion and ulceration of the skin spindle. The tumor has spread to the lymph nodes (N3a) and there is no evidence of metastasis (M0). The tumor is classified as pT4bN3aLIVORO.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with a moderately differentiated invasive ductal carcinoma, with a tumor diameter of 5.0 cm and focal angioinvasion and ulceration of the skin spindle. The tumor has spread to the dorsal resection margin and is classified as NOS, G II, pT4bN3aLIVORO.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A8-A08Z.DA7BD84B-C00E-40A0-9AE2-33FCE7995696',\n",
       "  'report_length_cl100k_base': 100,\n",
       "  't_label': 3},\n",
       " {'abstract': 'The patient has a moderately differentiated invasive ductal carcinoma with a tumor diameter of 2.7 cm. The tumor-free dorsal resection margin indicates no local invasion. There is no lymph node involvement and no evidence of metastasis. The tumor is classified as NOS, G II, pT2, N0, L0, V0, and RO.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with moderately differentiated invasive ductal carcinoma with a tumor diameter of 2.7 cm. The tumor-free dorsal resection margin indicates that the tumor has not spread to nearby tissues. The tumor classification is NOS, G II, pT2N0LOVORO, indicating no lymph node involvement and no distant metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A090.549E825B-F206-4FF9-835B-2FBE51C7B831',\n",
       "  'report_length_cl100k_base': 60,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive breast carcinoma with a tumor diameter of 2.2 cm and focal in situ spread. There is no lymph node involvement and no evidence of metastasis. The tumor is classified as NOS, G III, pT2N0(sn)LOVORO.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with a poorly differentiated invasive breast carcinoma with a tumor diameter of 2.2 cm. The cancer has not spread to the lymph nodes (N0) and there is no evidence of metastasis (M0). The tumor is classified as T2, N0, and M0.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A091.FECA34F6-CEF7-4A6D-AA7E-F88542EAF6F7',\n",
       "  'report_length_cl100k_base': 84,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has a 3.8 cm moderately differentiated invasive ductal carcinoma with focal intraductal components and focal angioinvasion, but no information on lymph node involvement or metastasis is provided.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with moderately differentiated invasive ductal carcinoma, with a tumor diameter of 3.8 cm and focal intraductal components and focal angioinvasion. The report does not mention any lymph node involvement or metastasis.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A8-A092.93D66EAD-B7D3-4688-8EC9-75C4380619D9',\n",
       "  'report_length_cl100k_base': 41,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 2.7 cm invasive ductal carcinoma (pT2) with no lymph node involvement (N0) and no metastasis (M0). The tumor is classified as NOS (not otherwise specified), grade 1 (G1), and hormone receptor-positive (estrogen and progesterone receptor-positive, HER2-negative).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with invasive ductal carcinoma, with a tumor diameter of 2.7 cm. The tumor is classified as NOS, GI, pT2NOLOVORX, indicating no lymph node involvement and no evidence of metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A093.9DCF000D-D996-49A6-950A-0CD1E90CC6C7',\n",
       "  'report_length_cl100k_base': 50,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 5 cm poorly differentiated invasive ductal carcinoma with focal intraductal spread. The tumor has not spread to the lymph nodes or metastasized.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has a 5 cm poorly differentiated invasive ductal carcinoma with focal intraductal spread. The tumor was classified as NOS, G III, pT2NOLOVORO, and the dorsal resection margin was tumor-free.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A094.85288EC6-0BDC-4955-8B88-1DEECBF0E235',\n",
       "  'report_length_cl100k_base': 57,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal breast carcinoma with a maximum diameter of 1.8 cm, grade II malignancy, and angioinvasion. There is also a concomitant DCIS (grade II, procomponent < 10%) in the tumor periphery. The tumor is classified as G2 (L1, V0), pT1c, pNO (sn), MX, R0, with a minimum width of dorsocranial safety margin of 1 cm.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal breast carcinoma with a maximum diameter of 1.8 cm, malignancy grade II, and angioinvasion. There is also infiltration of the neural sheath and a concomitant DCIS in the tumor periphery. The tumor is classified as G2 (L1, V0), pTlc, pNO (sn), MX, R0, with a minimum width of dorsocranial safety margin of 1 cm.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A095.41A41A7F-E4DD-4D3A-B97D-B4657CA211E1',\n",
       "  'report_length_cl100k_base': 144,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a moderately differentiated invasive ductal carcinoma tumor with a diameter of 4.0 cm. There is no lymph node involvement, and no metastasis has been detected. The tumor classification is NOS, G II, pT2NOi+(sn)LOVORO.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with moderately differentiated invasive ductal carcinoma with a tumor diameter of 4.0 cm. The tumor classification is NOS, G II, pT2NOi+(sn)LOVORO, indicating a moderate grade, stage II tumor with no lymph node involvement and no evidence of metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A096.91BFC77A-E56F-49F0-A294-A5EE9F266FB6',\n",
       "  'report_length_cl100k_base': 59,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive ductal carcinoma tumor with a diameter of 2.8 cm. The tumor is classified as NOS, G III, pT2 N1mi(sn)LOVORO, indicating lymph node involvement.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated invasive ductal carcinoma with a tumor diameter of 2.8 cm and a provisional tumor classification of NOS, G III, pT2 N1mi(sn)LOVORO.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A097.5B867CB6-F94D-435D-83E3-0ADB814B8077',\n",
       "  'report_length_cl100k_base': 56,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a moderately differentiated invasive ductal carcinoma with a tumor diameter of 105 cm and a satellite node of 0.9 cm in the skin. The tumor has focal ulceration and is classified as NOS, G II, pT4b pN3a(11/22)LOVORO.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with moderately differentiated invasive ductal carcinoma with a tumor diameter of 105 cm and a satellite node of 0.9 cm in the skin. The tumor has focal ulceration of the skin and is classified as NOS, G II, pT4b pN3a(11/22)LOVORO. The dorsal resection margin is tumor-free.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A8-A099.34499A83-DFCE-4DB8-BAA0-A7590AF8BC07',\n",
       "  'report_length_cl100k_base': 124,\n",
       "  't_label': 3},\n",
       " {'abstract': 'The patient has a 3 cm poorly differentiated invasive ductal carcinoma with lymph node involvement, categorized as pT2LOVORO.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The pathology report indicates a diagnosis of poorly differentiated invasive ductal carcinoma with a tumor diameter of 3 cm and a focal intraductal component. The tumor classification is NOS, G II, pT2LOVORO.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-A8-A09A.5A6E0F10-758E-4DC1-A5C7-57D5DF9B25EF',\n",
       "  'report_length_cl100k_base': 53,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 3.5 cm invasive ductal breast carcinoma with focal lymph vessel invasion, skin infiltration, and intraductal non-high-grade carcinoma. The tumor is classified as pT4b, pL1, pN1a (2/21), pMX, and stage IIIB. The margins are 0.8 cm and 0.6 cm at the 6 \"clock position. There is no evidence of metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has a 3.5 cm well-differentiated invasive ductal breast carcinoma with focal invasion of lymph vessels, skin infiltration, and intraductal non-high-grade carcinoma. The tumor is classified as M-8500/3, G1, pT4b, pL1, pN1a (2/21), pMX, stage IIIB. The margins are 0.8 cm and 0.6 cm at 6 \"clock. There is proliferating mastopathy with cylindrical epithelial metaplasia and areas of scleradenosis. The patient is considered R0.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A09B.5D439E4F-F1B7-41F7-BF1D-1F6E93D6427D',\n",
       "  'report_length_cl100k_base': 161,\n",
       "  't_label': 3},\n",
       " {'abstract': \"The patient has a 2.2 cm moderately differentiated invasive ductal breast carcinoma. The tumor extends cranially to within 5 mm of the resection margin at 3 and 12 o'clock. There is no lymph node involvement, and no metastasis is found. The tumor is classified as M-8500/3, G2, pT2, pN0 (sn), MX, R0.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with moderately differentiated invasive ductal breast carcinoma, with a tumor diameter of 2.2 cm. The cancer has not spread to the sentinel lymph nodes (pN0) and there is no evidence of distant metastasis (MX). The tumor is classified as pT2 and R0, indicating no residual tumor in the resection margin.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A09C.1E002C47-CEC6-491C-9E67-B289687D5B66',\n",
       "  'report_length_cl100k_base': 87,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive ductal carcinoma tumor with a diameter of 2.2 cm and focal intraductal components, classified as NOS, G III, pT2N1aLOVORO.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated invasive ductal carcinoma, with a tumor diameter of 2.2 cm and focal intraductal components. The tumor classification is NOS, G III, pT2N1aLOVORO.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A09D.C4A1A482-6AE5-4807-BA05-C73AC0898546',\n",
       "  'report_length_cl100k_base': 60,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive ductal breast carcinoma, measuring 55 mm, with lymph and blood vessel invasion, slight paracentral erosion, and margin infiltration. The tumor is classified as M-8500/3, G3, pT4b, pLI, pV1, pNla (1/11), pMx, stage III B, and R1, indicating a high grade, advanced stage cancer with lymph node involvement and uncertain metastasis status.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with a poorly differentiated invasive ductal breast carcinoma, measuring 55 mm, with lymph and blood vessel invasion, and extension to the basal resection margin. There is slight paracentral erosion and the nipple is tumor-free. The tumor classification is M-8500/3, G3, pT4b, pLI, pV1, pNla (1/11), pMx, stage III B, R1.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A09E.C55B6F4B-1248-4FBF-83C2-B0A1B33DEA03',\n",
       "  'report_length_cl100k_base': 175,\n",
       "  't_label': 3},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive carcinoma with a tumor diameter of 5.5 cm. The tumor is classified as NOS, G III, pT3, N3a, L0, V0, and R0, indicating no specific subtype, grade 3, stage T3 due to tumor size, 3 or more affected lymph nodes, no local invasion, and no distant metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated invasive carcinoma with a tumor diameter of 5.5 cm. The tumor classification is NOS, G III, pT3N3aL0V0R0, indicating a high-grade tumor with lymph node involvement but no metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A8-A09G.2728DB14-66D5-4E67-B9B6-63D93DBF509C',\n",
       "  'report_length_cl100k_base': 44,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive ductal right breast carcinoma, measuring up to 4.4 cm with no lymph node involvement (pNO) and no distant metastasis (pMX). The tumor is classified as stage II A.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated invasive ductal right breast carcinoma, measuring up to 4.4 cm with a minimum dorsal margin of 2.9 cm in the ablated breast tissue. There is circumscribed ductal carcinoma in situ (high-grade DCIS with comedo necrosis) in the tumor center, about 0.2 cm in diameter. The tumor classification is M-8500/3, G 3, pT2, pNO (0/16), pMX, stage II A. Sixteen right axillary lymph nodes were found to be free of metastases.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A09I.AF12859A-D67A-488D-8BC2-ED28698F2ACA',\n",
       "  'report_length_cl100k_base': 147,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 1.4 cm poorly differentiated invasive ductal breast carcinoma. The tumor has not spread to nearby lymph nodes (pN1mi) and there is no evidence of metastasis (MX). The margins of the resected material are free of carcinoma, and the skin is also free of carcinoma. The tumor is classified as stage pTlc.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has a 1.4 cm poorly differentiated (G3) invasive ductal breast carcinoma. The resection margins and skin are free of carcinoma. The tumor stage is pT1c pN1mi (intranodal micrometastasis), MX, R0; G3 (L0, V0).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A09K.56C24ABB-CF1D-447F-A5A8-B762C4B01566',\n",
       "  'report_length_cl100k_base': 88,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient has a poorly differentiated invasive ductal breast carcinoma measuring 4.3 cm with lymph vessel invasion. The tumor has a margin of 3 mm at 6 o'clock and 10 mm at 12 o'clock and 1.5 cm or more at 3 and 9 o'clock. There is no intraductal tumor component. The tumor is classified as M-8500/3, G3, pT 2, pN 3a (14/28), pMx, stage III c. The patient has achieved R 0.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has a poorly differentiated invasive ductal breast carcinoma measuring 4.3 cm with lymph vessel invasion. The tumor has a minimum margin of 3 mm at 6 o'clock and 10 mm at 12 o'clock, and 1.5 cm or more at 3 and 9 o'clock. There is no intraductal tumor component. The tumor classification is M-8500/3, G3, pT 2, pN 3a (14/28), pMx, and stage III c. The patient has achieved R 0.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A8-A09M.EBBF2A70-2773-40FA-823A-E608ABFEF591',\n",
       "  'report_length_cl100k_base': 124,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal breast carcinoma with a maximum diameter of 2.2 cm, grade III malignancy, and angioinvasion in the immediate tumor periphery. There is concomitant high-grade DCIS and unsettled to atypical ductal hyperplasia in the distant fibrolipomatous parenchyma of the breast. The tumor is classified as G3 (L1, V0), pT2, pN3a, MX, R0, with no lymph node involvement or metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal breast carcinoma with a maximum diameter of 2.2 cm, grade III malignancy, and angioinvasion in the immediate tumor periphery. There is concomitant high-grade DCIS and unsettled to atypical ductal hyperplasia in the distant fibrolipomatous parenchyma of the breast. The tumor is classified as G3 (L1, V0), pT2, pN3a, MX, R0, with a minimal width of caudal and dorsal safety margin of 0.7-0.8 cm.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A8-A09N.F5A97F05-4B5C-4B10-BF10-5DDE7D412BCF',\n",
       "  'report_length_cl100k_base': 156,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated ductal breast carcinoma, with a tumor size of 4.5 cm and widespread skin infiltration. There is invasion of lymph vessels and neural sheaths, and the cancer is classified as pT4b pN2 (with at least one conglomerate tumor), MX, and R1 (with cutaneous/subcutaneous tumor infiltrates in the cranial resection line). The cancer has not spread to the axillary lymph nodes (L1) and there is no evidence of metastasis (V0).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated ductal breast carcinoma, with a tumor diameter of 4.5 cm and grade III malignancy. The tumor has spread to the skin, lymph vessels, and neural sheaths. There is no evidence of DCIS. The tumor is classified as pT4b, pN2 (at least), MX, and R1 (axillary soft tissue), with no calcification and cystic duct ectasia present. The safety margins are free of atypia.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-A8-A09Q.46C0AB7B-82FC-4D06-9F26-22AEC8BEEDA7',\n",
       "  'report_length_cl100k_base': 199,\n",
       "  't_label': 3},\n",
       " {'abstract': \"The patient has a 3 cm invasive ductal carcinoma in the left breast at 12 o'clock with low-grade DCIS grade II. The resection margins are healthy, and 2 out of 16 lymph nodes have metastases. The tumor classification is pT2, pN1a (2/16), MX, R0; G2, L0, V0.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has a 3 cm moderately differentiated invasive ductal carcinoma in the left breast at 12 o'clock with concomitant low-grade DCIS grade II. The resection margins are in healthy tissue on all sides. Two out of 16 lymph nodes have metastases. The tumor classification is pT2, pN1a (2/16), MX, R0; G2, L0, V0.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A09R.5E615F92-6FD0-48C7-AC37-78526974BCFC',\n",
       "  'report_length_cl100k_base': 98,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has a 1.8 cm moderately differentiated tubulolobular breast carcinoma with no lymph node involvement and no evidence of metastasis. The tumor has a minimum margin of 5 mm at 12 o'clock and over 10 mm at 3 o'clock and about 1 mm at 6 o'clock. The tumor classification is M-8500/3, G2, pTlc, pLO, pSNO (0/2), pMx, stage I.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has a 1.8 cm moderately differentiated tubulolobular breast carcinoma with a minimum margin of 5 mm at 12 o'clock and over 10 mm at 3 o'clock and about 1 mm at 6 o'clock. There is no evidence of invasion of the lymph vessels. The tumor is classified as M-8500/3, G2, pTlc, pLO, pSNO (0/2), pMx, stage I.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A09T.C616E97C-8352-4FED-9E83-558318216FB6',\n",
       "  'report_length_cl100k_base': 145,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a moderately differentiated invasive lobular carcinoma tumor with a diameter of 2.2 cm and several satellite foci up to 0.1 cm. There is no lymph node involvement (N0) and no evidence of metastasis (M0). The tumor is classified as pT2.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with moderately differentiated invasive lobular carcinoma with a tumor diameter of 2.2 cm and several satellite foci measuring up to 0.1 cm. There is focal in situ spread and no lymph node involvement (pT2N0). The tumor classification is lobular carcinoma, G II, pT2N0(0/3;sn)LOVORO.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A09V.E0B04FB6-9500-4786-B6D9-303165EF9090',\n",
       "  'report_length_cl100k_base': 84,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 2.5 cm lobular carcinoma (poorly differentiated) with slight intraductal spread and invasion of lymph vessels. There is no regional lymph node involvement (N3a) and no distant metastasis (M0). The tumor is classified as T2, N1, M0 (TNM staging).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with poorly differentiated lobular carcinoma (oT2N3aL1V0RX). The tumor diameter is 2.5 cm with focal slight intraductal spread and invasion of lymph vessels.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A8-A09W.B73AF7B0-EED3-413C-B249-C97F27E4EA1C',\n",
       "  'report_length_cl100k_base': 69,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a poorly differentiated invasive malignant tumor with a diameter of 3.5 cm, focal in situ spread, and marked angioinvasion. The tumor is classified as lobular carcinoma, NOS, G III, oT2N3aL1V1RX. The primary tumor is in the breast, and there is no evidence of metastasis. Lymph node involvement is present, with the involvement of 1-3 axillary lymph nodes.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The pathology report describes a poorly differentiated invasive malignant tumor with a diameter of 3.5 cm and focal in situ spread and marked angioinvasion. The tumor is classified as lobular carcinoma, NOS, G III, oT2N3aL1V1RX. The primary tumor is noted, but there is no mention of lymph node involvement or metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A8-A09X.F72703A2-2C57-459A-9015-94BD3D302491',\n",
       "  'report_length_cl100k_base': 81,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has been diagnosed with lobular carcinoma in the right breast, with a tumor diameter of 8 cm and tumor-free dorsal resection margin. The cancer has not spread to the lymph nodes or distant sites, resulting in a pathological staging of pT3N0L0V0R1.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with lobular carcinoma in the right breast, with a tumor diameter of 8 cm and tumor-free dorsal resection margin. The tumor classification is pT3N0L0V0R1, indicating no lymph node involvement and no metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A09Z.DF890966-D14E-4EDF-B6E3-E10E40BA5B5D',\n",
       "  'report_length_cl100k_base': 68,\n",
       "  't_label': 2},\n",
       " {'abstract': ' The patient has invasive lobular breast carcinoma with a tumor size of 2.5 cm (pT2), no lymph node involvement (pNO), no metastasis (MX), and a malignancy grade of II (G2). The tumor was excised with healthy tissue margins (R0) and no lymphovascular invasion was found (L0, V0).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with invasive lobular breast carcinoma, with a tumor size of 2.5 cm (pT2) and no lymph node involvement (pNO sn, 0/1). There is no evidence of metastasis (MX), and the tumor has been completely removed (R0). The malignancy grade is II (G2), and there is no vascular invasion (V0).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A0A1.3BC6CE69-2641-4B6D-85DF-E8FE838015D0',\n",
       "  'report_length_cl100k_base': 80,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a well-differentiated invasive lobular carcinoma of the right breast, measuring 3.3 cm with circumscribed infiltration into the dorsal resection margin and tumor-free follow-up dorsal resection material, indicating a tumor-free dorsal margin of at least 1.2 cm. There is no invasion of lymph vessels and fifteen right axillary lymph nodes are free of metastases. The tumor classification is M-8500/3, G 1, pT 2, L0, V/0, pN 0 (0/15), pMX, R 0, which corresponds to stage II a.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has a well-differentiated invasive lobular carcinoma of the right breast, measuring up to 3.3 cm with circumscribed infiltration into the dorsal resection margin and tumor-free follow-up dorsal resection material. The minimum margin is 0.5 cm at 3 o'clock and carcinoma-free follow-up resection material at 3 o'clock. There is no invasion of lymph vessels and fifteen right axillary lymph nodes are free of metastases with pre-existing lymphatic hyperplasia and slight scarring in isolated larger lymph nodes. The tumor classification is M-8500/3, G 1, pT 2, L0, V/0, pN 0 (0/15), pMX, R 0, and the stage is II a.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A0A2.6443B16E-E6D9-4A1D-B950-BEEC7BAEDBBE',\n",
       "  'report_length_cl100k_base': 218,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has been diagnosed with invasive lobular breast carcinoma, G II, with a tumor diameter of 3 cm and no skin ulceration. The tumor has no lymph node involvement (pN0) and is negative for C-erb B-2 oncoprotein, but positive for estrogen and progesterone receptors. There is no evidence of metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with invasive lobular breast carcinoma, G II, with a tumor diameter of 3 cm and no ulceration of the skin. The tumor has extensive infiltration of the skin but is not classified as pN0(0/10)LOVORO. The patient is positive for estrogen and progesterone receptors and negative for C-erb B-2 oncoprotein. There is no evidence of metastatic infiltration or influx of individual cells of the invasive lobular breast carcinoma into the excised axillary lymph node. The pNO status is confirmed.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A0A4.25F8F043-2CD0-4344-9B4A-5BBB691B5BF9',\n",
       "  'report_length_cl100k_base': 155,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a moderately differentiated invasive lobular carcinoma with a tumor diameter of 3.0 cm, with focal in situ spread and angioinvasion. The tumor classification is lobular carcinoma, G II, pT2N3a(15/19)L1V0R0, indicating tumor size of 2 cm or less, 1-3 lymph node involvement, and no metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with moderately differentiated invasive lobular carcinoma with a tumor diameter of 3.0 cm. The tumor has spread to nearby lymph nodes (pT2N3a(15/19)L1V0R0), indicating stage IIB cancer. There is no evidence of distant metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-A8-A0A6.161A2735-C3CF-466D-AE21-C6A2C987BB1E',\n",
       "  'report_length_cl100k_base': 63,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has been diagnosed with polymorphocellular undifferentiated breast cancer (G II), with a tumor diameter of 2.8 cm. The tumor shows infiltrative growth and has spread to the skin. There is focal invasion of lymph vessels and lymph node metastasis (pT2pN1a(1/14)L1). The cancer is negative for estrogen and progesterone receptors but positive for C-erb B-2 oncoprotein.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with polymorphocellular undifferentiated breast cancer (G II), with a maximum tumor diameter of 2.8 cm. The tumor shows infiltrative growth and has spread to the skin. There is focal invasion of lymph vessels and lymph node metastasis (pT2pN1a(1/14)L1). The cancer is negative for estrogen and progesterone receptors but positive for C-erb B-2 oncoprotein.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-A8-A0A7.E306BE26-0358-4BE4-AEF6-AD42CC0DA020',\n",
       "  'report_length_cl100k_base': 164,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has a well-differentiated invasive ductal breast carcinoma, 2.2 cm in size, with no lymphatic invasion and a 3 mm margin at 6 o'clock. There is no intraductal tumor component, and the tumor is classified as M-8500/3, G1, pT2, pL0, pSN0 (0/2), pMX, stage II A, R0.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The pathology report describes a well-differentiated invasive ductal breast carcinoma, with a maximum size of 2.2 cm, no visible lymph vessel invasion, and a minimum margin of 3 mm at 6 o'clock. There is no intraductal tumor component, and the tumor classification is M-8500/3, G1, pT2, pL0, pSN0 (0/2), pMX, stage II A, R0.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A0A9.8612388B-3680-4BD8-986C-E7ABE9F92F91',\n",
       "  'report_length_cl100k_base': 114,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has been diagnosed with invasive lobular breast carcinoma, with a maximum tumor diameter of 2.7 cm and a malignancy grade of 2. There is an invasive satellite node and multicentric, in parts confluent LIN formations (grade I). The tumor has not spread to the lymph nodes (pNO sn) and there is no evidence of metastasis (MX, R0, G2). The resection margins are tumor-free and the minimum width of the dorsal safety margin is 0.6 cm. The submitted tissue samples of cutaneous/subcutaneous tissue are histologically unremarkable.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with invasive lobular breast carcinoma, with a maximum tumor diameter of 2.7 cm and a malignancy grade of 2. There is an invasive satellite node and multicentric, in parts confluent LIN formations (grade I). The tumor is classified as pT2m (maximum diameter 2.7 cm), pNO sn (0/2), MX, R0, G2 (L0, V0). The patient has tumor-free resection margins and a minimum width of dorsal safety margin of 0.6 cm. The submitted tissue samples of cutaneous/subcutaneous tissue are histologically unremarkable.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A0AB.E4D30B42-383A-40BF-BB91-511A90227655',\n",
       "  'report_length_cl100k_base': 194,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive breast carcinoma of mixed differentiation, with a tumor size of 1.5 cm (pT1c), no lymph node involvement (pN0), and no metastasis (MX). The tumor is classified as G2 (LO, V0), and the margins are free of atypia.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive breast carcinoma of mixed differentiation, with a maximum tumor diameter of 1.5 cm and a malignancy grade of II. There is no angioinvasion or coarse calcification. The tumor is classified as pT1c, with no lymph node involvement (pN0 sn) and no metastasis (MX). The minimum width of the ventral safety margin is 0.5 cm, and the fibrolipomatous parenchyma of the breast and adjacent skin is free of atypia. The tumor classification is G2 (LO, V0).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-A8-A0AD.BD2AE048-BE93-4421-AD3E-BE6F9646484F',\n",
       "  'report_length_cl100k_base': 123,\n",
       "  't_label': 0},\n",
       " {'abstract': \" The patient is a 65-year-old female who underwent a left modified radical mastectomy with sentinel node mapping for invasive ductal carcinoma. The pathology report indicates that the tumor is ER-positive, PR-positive, and Ki-67 (MIB1) 33%. The patient also had a breast MRI which showed multiple scattered nodules in the left breast, some of which are suspicious for satellite lesions. The FISH test revealed amplification of the HER2 oncogene. The patient's medical history includes rheumatoid arthritis and a family history of breast cancer. The patient was taking various medications, including an a bisphosphonate, and had a history of surgical procedures related to breast cancer. The patient's vital signs were within normal limits, and the physical exam was unremarkable. The patient was admitted for surgery and the treatment plan was discussed.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \" The patient is a 65-year-old female who underwent a left modified radical mastectomy with sentinel node mapping for invasive ductal carcinoma. The pathology report indicates that the tumor is ER-positive, PR-positive, and Ki-67 (MIB1) 33%. The patient also had a breast MRI which showed multiple scattered nodules in the left breast, some of which are suspicious for satellite lesions. The FISH test revealed amplification of the HER2 oncogene. The patient's medical history includes rheumatoid arthritis and a family history of breast cancer. The patient was taking various medications, including an a bisphosphonate, and had a history of surgical procedures related to breast cancer. The patient's vital signs were within normal limits, and the physical exam was unremarkable. The patient was admitted for surgery and the treatment plan was discussed.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AC-A23C.926E93B6-EF7C-4F13-824D-13D08B7F7938',\n",
       "  'report_length_cl100k_base': 3635,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is classified as pT2 (tumor size 3.8 cm), pN1 (one positive lymph node with metastatic adenocarcinoma, size 2 cm), and Mx (no evidence of metastasis). The tumor is invasive ductal carcinoma, grade I, and there is no evidence of skin or nipple involvement.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma in the right breast, with a size of 3.8 cm and no evidence of skin or nipple involvement. The cancer has spread to the sentinel lymph node, which is 2 cm in size. Another sentinel lymph node was found without metastatic carcinoma. The patient's pTNM classification is pT2 pN1 Mx. The cancer is grade I with a total score of 5 out of 9.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AC-A23E.C976ACED-7FF8-4287-9D68-C6FD17895FC0',\n",
       "  'report_length_cl100k_base': 834,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is stage T1cN1MX, stage llA, with a tumor size of 2.0 cm, metastatic adenocarcinoma involving the right axillary sentinel lymph nodes, and no evidence of metastasis.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is diagnosed with stage T1cN1MX, stage llA invasive lobular carcinoma. The tumor size is measured at 2.0 cm and there is no evidence of in situ component. The cancer has spread to the lymph nodes, with metastatic adenocarcinoma found in the right axillary sentinel lymph nodes. There is no evidence of angiolymphatic invasion. Estrogen and progesterone receptors are positive at 94% and 89%, respectively. KI-67 (MIB1) proliferation marker is borderline at 18%. The patient needs to be referred to a breast surgeon for further treatment.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AC-A23G.810663DD-1718-4FD6-B9C2-77B4C091B3F1',\n",
       "  'report_length_cl100k_base': 2072,\n",
       "  't_label': 0},\n",
       " {'abstract': '\\nThe patient is a female with a right breast cancer diagnosis. The tumor size is 4.2 x 3.7 x 2.9 cm, located in the upper inner and lower inner quadrants. It extends to within 0.4 mm of the deep margin and is not present in the skin or nipple. There is no lymph node involvement, and metastasis status is not applicable as no lymph nodes were sampled. The cancer is classified as invasive ductal carcinoma, grade 2. Estrogen and HER2/neu receptors are positive, while progesterone receptor is negative. The pathological staging is pT2NXG2.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female who underwent a right breast simple mastectomy. The tumor is an invasive ductal carcinoma, grade 2, measuring 4.2 x 3.7 x 2.9 cm, located in the upper and lower inner quadrants of the breast. The tumor extends to within 0.4 mm of the deep margin and directly invades the dermis without skin ulceration. There is no lymph node involvement (pNX) and no distant metastasis (M). The tumor is estrogen and progesterone receptor positive and HER2/neu amplified (score 3+). The patient's cancer is classified as pT2NXG2.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AC-A23H.A7C7D409-D086-4A9B-8C8F-E7E231D5891D',\n",
       "  'report_length_cl100k_base': 1238,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient is a female with a right breast invasive lobular carcinoma, measuring 8 cm. The tumor has a nuclear score of 2 out of 3 and an architectural score of 3 out of 3, resulting in a total score of 6 out of 9, which corresponds to a grade 2 cancer. The deep margin of excision is free of carcinoma, and there is no evidence of metastatic disease in the sentinel lymph node. The patient's cancer is classified as T3pNO (|-) MX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with a right breast invasive lobular carcinoma, measuring 8 cm. The tumor involves portions of the nipple, but the deep margin of excision is free of carcinoma. The patient's PTNM classification is T3pNO (|-) MX. The sentinel lymph node is negative for metastatic carcinoma. The tumor is grade 2, with an architectural score of 3/3, nuclear score of 2/3, and mitotic score of 1/3. The patient's ER and PR are positive, and Ki-67 (MIB1) is high at 28%.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AC-A2B8.3D878253-22B3-4A53-AE54-C0D95E085DB1',\n",
       "  'report_length_cl100k_base': 695,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's left breast specimen shows an invasive ductal carcinoma with a size of 2.8 cm in the upper outer quadrant, with metastases in 6 out of 23 examined axillary lymph nodes (pN2a), and no evidence of distant metastasis (PMX). The tumor is grade 3/3 (Nottingham score), with venous/lymphatic invasion present. Estrogen and progesterone receptor status, as well as HER2 status, are pending and will be reported later.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is diagnosed with invasive ductal carcinoma in the left breast, with a tumor size of 2.8 cm in the upper outer quadrant. The cancer has spread to 6 out of 23 axillary lymph nodes (pN2a) and there is evidence of venous/lymphatic invasion (V/L). The cancer has not metastasized to distant sites (PMX). The histologic grade is Nottingham score 3/3, and the tumor margins are uninvolved by invasive carcinoma with a distance of 1.0 cm to the deep margin. Immunohistochemical stains for estrogen and progesterone receptors and HER2 are pending.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AC-A2BK.3E54B0CE-8863-4728-BC95-A47C1869F52A',\n",
       "  'report_length_cl100k_base': 830,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient has invasive ductal carcinoma (NOS) with a tumor size of 2.5 cm. One out of 13 lymph nodes is involved, and there is no evidence of metastasis. The cancer is estrogen and progesterone receptor-positive. The tumor is located 3 cm away from the deep margin, with no lymphovascular invasion or Paget's disease detected. The patient's HER2 status is not amplified.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with invasive ductal carcinoma (NOS) in the left breast, with a tumor size of 2.5 cm. The cancer is classified as pT2 pN1a pMX. One lymph node out of 13 examined was involved, and the cancer is estrogen and progesterone receptor positive. The tumor is located 3 cm away from the deep margin, with no lymphovascular invasion or Paget's disease detected. There is no evidence of distant metastasis. The patient's HER2 status is not amplified.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AC-A2BM.9F00B6F4-EE91-4A18-B533-127E39EF8554',\n",
       "  'report_length_cl100k_base': 1616,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive lobular adenocarcinoma, pleomorphic variant, with a size of 2.8 cm. There is no lymph node involvement, and metastasis status is unknown. The cancer is classified as pT2, pNO, and pMX. Margins are uninvolved by invasive carcinoma, and venous/lymphatic invasion is absent. The patient has proliferative fibrocystic changes with ductal hyperplasia, columnar cell change, sclerosing adenosis, apocrine metaplasia, and associated microcalcifications. Estrogen and progesterone receptors are positive, and HER2/neu is negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive lobular adenocarcinoma, pleomorphic variant, with a tumor size of 2.8 cm in the upper inner quadrant of the breast. There is no lymph node involvement, and no metastasis is present. The tumor is estrogen and progesterone receptor positive and HER2/neu negative.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AC-A2FB.F6CFE506-16BA-475A-A81F-1AC4B2EFE24A',\n",
       "  'report_length_cl100k_base': 1234,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive lobular carcinoma of the right breast, measuring approximately 4.5 cm, with evidence of extranodal spread involving the soft tissue surrounding several lymph nodes. Eighteen out of eighteen lymph nodes were involved by metastatic carcinoma, and the tumor is classified as T3, N3a, MX. Immunohistochemical evaluation showed that 66% of the tumor cells were positive for estrogen receptor (ER), 7% were positive for progesterone receptor (PR), and the Ki-67 proliferation index was 11%. The patient's cancer is considered to have a Nottingham Prognostic Index/Grade of II.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer diagnosis is right breast carcinoma, specifically infiltrating mammary lobular carcinoma. The tumor size is approximately 4.5 cm, and the cancer has spread to eighteen out of eighteen lymph nodes with evidence of extranodal spread. The cancer is classified as T3, N3a, and MX in the TNM staging system. Immunoevaluation using Assisted Quantitative Image Analysis has been completed, showing that the patient's cancer is hormone receptor-positive (ER and PR) and Her2/neu negative, which is considered favorable. The Ki-67 level is borderline at 11%.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-AC-A2FE.F694CBD6-880D-40C7-AB17-D0AD02B7F06B',\n",
       "  'report_length_cl100k_base': 1888,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive lobular carcinoma, with a tumor size of approximately 5 cm, and is categorized as T2. The cancer has spread to the lymph nodes, with metastatic carcinoma present in one sentinel lymph node (1/1) and two other lymph nodes, making a total of three positive lymph nodes out of seven. The cancer is graded as II, with a Nottingham score of 7 (3+2+2). The patient's cancer is estrogen receptor (ER) positive (37%), progesterone receptor (PR) positive (71%), and HER-2/neu negative (1.7).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer diagnosis is invasive ductal carcinoma in the retroareolar space of the right breast, with a tumor size of approximately 5 cm. The cancer is grade II with a Nottingham score of 7 (3+2+2). There is evidence of lymph node involvement, with three out of seven lymph nodes positive for metastatic carcinoma, including the sentinel lymph node. Breast cancer prognostic panel studies are pending on block B/BPC-3. The tumor is likely lobular carcinoma, and an E-cadherin immunostain will be performed to confirm.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AC-A2FF.E6897E14-465A-486A-A6AD-FCFED21629F2',\n",
       "  'report_length_cl100k_base': 2293,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive lobular carcinoma of the left breast with a size of 2.1 cm, grade 2, and no lymphovascular space invasion. One out of ten examined lymph nodes is positive for metastatic carcinoma with a size of 0.25 cm and extra-capsular extension present. There is no skin involvement, and the tumor is not transected with a 0.7 cm distance to the closest margin. The patient's cancer is classified as pT2N1MX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive lobular carcinoma with a size of 2.1 cm, Elston modified Bloom-Richardson grade 2, no lymphovascular space invasion, and negative skin involvement. The tumor is not transected, with a distance of 0.7 cm from the deep margin. 10 lymph nodes were examined, with 1 containing metastatic carcinoma, and the largest metastasis size is 0.25 cm. Extracapsular extension is present. The patient's cancer is classified as pTNM: T2N1MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AC-A2FG.C1ABCD83-40EA-4FF7-BEB6-69679589E8E7',\n",
       "  'report_length_cl100k_base': 912,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive lobular carcinoma in the left breast with a tumor size of 3.4 cm. All three sentinel lymph nodes are positive for metastatic lobular carcinoma, indicating a nodal stage of at least pN1a. There is no evidence of lymphovascular invasion or Paget's disease, and distant metastasis cannot be assessed. The pathological stage is pT2, pNX, pMX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive lobular carcinoma in the left breast with a tumor size of 3.4 cm. All three sentinel lymph nodes are positive for metastatic lobular carcinoma, indicating a nodal stage of at least pN1a. There is no evidence of lymphovascular invasion or Paget's disease, and distant metastasis cannot be assessed. The tumor is located in the upper outer quadrant and comes within 1.8 cm of the deep margin and 1 cm of the nearest superficial margin. The patient's pathological stage is pT2, pNX, pMX.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-AC-A2FK.1CF3FA64-EAE6-4A18-9B51-F5980A885371',\n",
       "  'report_length_cl100k_base': 1644,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer summary includes a 0.5 cm metastatic carcinoma in two sentinel lymph nodes, a 3 x 3 x 2.8 cm grade II invasive mammary carcinoma in the right breast with no angioinvasion, and no evidence of metastasis. The closest surgical margin is 0.2 cm deep and free of carcinoma.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with right breast cancer, with a tumor size of 3 x 3 x 2.8 cm and a grade II score. The sentinel lymph nodes have small foci of metastatic carcinoma, approximately 0.5 cm in size. The closest surgical margin is deep and free of carcinoma, at approximately 0.2 cm. There is no significant component of in situ carcinoma, and angio invasion is not identified. The mass extends up to 0.1 cm of the deep margin and is located 1 cm below the skin margin. No other lesions are grossly identified.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AC-A2FM.83BA3E82-E8E4-4A70-ADEE-A1360940EECE',\n",
       "  'report_length_cl100k_base': 640,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is classified as T2N1MX with a tumor size of 2.5 x 2 x 1.8 cm, 1 positive lymph node out of 10 examined, and no metastasis. Estrogen receptor is positive (95%), progesterone receptor is negative (0%), and KI-67 proliferation marker is low (<10%). The tumor is an infiltrating lobular carcinoma with an Elston modification of Bloom-Richardson grade of II, and lymphovascular space invasion is absent. The Her2/neu gene amplification by FISH was unable to be determined, but the results of other tests suggest a diploid DNA index and no clear presence of Her2/neu.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is classified as T2N1MX with a tumor size of 2.5 x 2 x 1.8 cm, Elston modification of Bloom-Richardson grade of II, and lymph node involvement with 1/2 sentinel lymph nodes and 1/8 Level 1 and II lymph nodes containing metastatic carcinoma. The cancer is estrogen receptor positive (95%), progesterone receptor negative (0%), and has a KI-67 proliferation marker of low (<10%). The Her2/neu gene amplification by FISH was unable to be determined, but the sample is diploid. The specimen showed no lymphovascular space invasion, skin involvement, or microcalcifications associated with the tumor.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AC-A2FO.5A7EB73F-E681-46CC-B2D6-C87EEAB0AC99',\n",
       "  'report_length_cl100k_base': 1704,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive high-grade sarcomatoid carcinoma with areas of matrix-producing carcinoma in the right breast, measuring 95mm in diameter. Lymphatic invasion is present near the periphery of the tumor, but no tumor is present in 22 axillary lymph nodes. The patient's cancer is classified as stage IIB, with negative lymph nodes (pNO) and no distant metastasis (pMX). The tumor is estrogen and progesterone receptor negative, Her2/neu is not overexpressed, and the Ki-67 proliferative index is 50%.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient has been diagnosed with high-grade sarcomatoid carcinoma, with areas of matrix-producing carcinoma, in the right breast. The invasive tumor measures 95mm in diameter, with lymphatic invasion identified near the periphery of the tumor. There is no evidence of metastasis to axillary lymph nodes, and distant metastasis is marked as pMX. The tumor is classified as stage IIB, with negative margins (RO). The report also mentions the presence of multiple intraductal papillomas with atypical ductal hyperplasia (ADH) in the left breast, but no invasive carcinoma was found.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AC-A2QH.C2A0E948-2B9E-4E49-90C4-57CE4C4A95B3',\n",
       "  'report_length_cl100k_base': 3039,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient has invasive lobular carcinoma (grade 2) with a main tumor mass measuring 57 mm in diameter, located in the central breast. The tumor is multicentric, with LCIS present in representative sections taken away from the main tumor mass. The tumor cells diffusely infiltrate a relatively discrete dense fibrous area in the central breast. The pathology findings show metastatic carcinoma present in two sentinel lymph nodes (2/2), with metastatic carcinoma diffusely present throughout both lymph nodes. The patient's pathological stage is IIIA, with lymphovascular invasion present. Estrogen receptors are positive (100% positive cells, strong intensity), progesterone receptors are negative (less than 1% positive cells), and Her2/neu is not overexpressed (IHC score 1+).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive lobular carcinoma, grade 2, with a main tumor mass measuring 57mm in diameter. The tumor is multicentric and diffusely infiltrates a relatively discrete dense fibrous area in the central breast. LCIS is present in representative sections taken away from the main tumor mass, but the main tumor burden is in the central breast. The cancer is present in two sentinel lymph nodes, and there is no extranodal extension. The pathologic stage is IIIA, with lymphovascular invasion present. Estrogen receptors are positive, progesterone receptors are negative, and Her2/neu is not overexpressed. The patient's cancer is staged as pT3, pN1a, and pMX.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AC-A2QI.5CF85AF1-D227-430C-99CD-C2A524CFFA29',\n",
       "  'report_length_cl100k_base': 1819,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient is a female with left breast cancer. The tumor size is 7 cm, located in the upper and lower outer quadrants of the breast. There is no lymph node involvement, and no metastasis is identified. The cancer is classified as invasive metaplastic carcinoma, grade 3 (3+3+3), with no ductal or lobular carcinoma in situ (DCIS or LCIS) present. Margins are uninvolved by invasive carcinoma, and the distance of the invasive carcinoma to the closest margin is 3 mm (0.3 cm) superiorly. The patient's cancer is stage pT4b (skin ulceration), pNO (no regional lymph node metastasis), and M0 (no distant metastasis). Estrogen and progesterone receptors are negative, and HER2/neu immunoperoxidase studies are negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with left breast cancer. The tumor size is 7 cm, located in the upper and lower outer quadrants of the breast. There is no lymph node involvement, and metastasis is not identified. The cancer is classified as invasive metaplastic carcinoma, grade 3 (3+3+3), with no ductal or lobular carcinoma in situ (DCIS or LCIS) present. Margins are uninvolved by invasive carcinoma, and the distance of the tumor to the closest margin is 3 mm (0.3 cm) superiorly. The patient's estrogen and progesterone receptors are negative, and HER2/neu immunoperoxidase studies are negative.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AC-A2QJ.E422C6E8-084F-42B8-84E7-4EF387F098C7',\n",
       "  'report_length_cl100k_base': 2227,\n",
       "  't_label': 3},\n",
       " {'abstract': \"\\nThe patient has invasive lobular carcinoma, grade 2, with a tumor size of at least 65 mm. The surgical margins are negative, and five out of fourteen lymph nodes are positive for carcinoma (5/14). The patient's pathologic stage is IIIA, with no evidence of lymphatic invasion or metastasis. The patient's cancer is estrogen and progesterone receptor-positive and HER2/neu negative. The patient also has lobular carcinoma in situ.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive lobular carcinoma, grade 2, with a tumor size of at least 65 mm. The surgical margins are negative, and five of fourteen lymph nodes are positive for carcinoma (5/14). The patient's pathologic stage is IIIA, with no lymphatic invasion identified. The patient's tumor is estrogen and progesterone receptor positive (95-100% positive cells, strong intensity) and Her2/neu negative (0, scale 0-3+). The patient also has lobular carcinoma in situ.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AC-A3BB.4D864947-076C-4A66-940D-682E75E525A2',\n",
       "  'report_length_cl100k_base': 1872,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient is a female with a 10cm unifocal pleomorphic lobular carcinoma in the right breast. Lymphovascular space invasion is present, and the tumor is grade II. 12 lymph nodes were received, with 3 containing metastatic carcinoma, and the largest metastasis measuring 2.5cm. The deep surgical margin is free of tumor by 2.5cm. The patient's pTNM stage is pT3 N2.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with a 10cm pleomorphic lobular carcinoma in the right breast, with lymphovascular space invasion and microcalcifications. The tumor is grade II with a pTNM stage of pT3 N2. The surgical margins are free of tumor by 2.5cm. Out of 12 received lymph nodes, 3 contain metastatic carcinoma with the largest metastasis measuring 2.5cm. Extracapsular extension of the tumor is present.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-AC-A3EH.3094774B-B764-4D60-BFF3-48FEF39F4BEA',\n",
       "  'report_length_cl100k_base': 848,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's left breast cancer is invasive lobular carcinoma, measuring 3.0 cm in size, located in the upper inner quadrant. The cancer is classified as T2 N1a stage, with one sentinel lymph node involved by metastatic mammary carcinoma (9 mm, negative for extracapsular extension) and one sentinel lymph node involved by micrometastatic mammary carcinoma (1 mm, negative for extracapsular extension). The cancer has a low combined histologic grade with a low proliferative rate. Surgical margins are negative for tumor.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's left breast cancer is classified as invasive lobular carcinoma, measuring 3.0 cm in size, with a low combined histologic grade and low proliferative rate. The tumor is located in the upper inner quadrant, and surgical margins are negative for tumor. Two sentinel lymph nodes were examined, with one involved by metastatic mammary carcinoma (9 mm, negative for extracapsular extension) and the other by micrometastatic mammary carcinoma (1 mm, negative for extracapsular extension). The patient's TNM stage is pT2 N1a. Ancillary studies for estrogen receptor, progesterone receptor, HER2/neu, and Ki-67 were performed on a previous specimen.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AC-A3HN.F0308FC8-D8B4-487F-A072-05E66D01842A',\n",
       "  'report_length_cl100k_base': 1851,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive lobular carcinoma, grade 1, with a tumor size of 50 mm. One of three lymph nodes is positive for micrometastasis (1/3), and there is no evidence of metastasis. The pathologic stage is IIB, with estrogen and progesterone receptors positive (100% positive cells, strong intensity) and Her2/neu negative (1+, scale 0-3+). Surgical margins are negative, and the Ki-67 proliferative index is intermediate (15% of cells).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive lobular carcinoma, grade 1, with a tumor size of 50 mm. The cancer is present in one lymph node with micrometastasis (1/3). The patient's pathologic stage is IIB, with no lymphatic invasion identified. Estrogen and progesterone receptors are positive, and Her2/neu is negative. Surgical margins are negative, and the patient's Ki-67 proliferative index is intermediate (15% of cells).\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AC-A3OD.9F7E2B98-29E7-465F-AE12-33D78FDFD71A',\n",
       "  'report_length_cl100k_base': 2414,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive lobular carcinoma, with a tumor size of 2.8 cm and additional tiny foci of invasive lobular carcinoma up to 5 mm in greatest dimension. The cancer is located approximately 4-5 mm from the superior margin of the excised tissue. One sentinel lymph node (part B) is involved by metastatic adenocarcinoma, with the largest metastatic focus being 2 mm. The other sentinel lymph node (part C) is benign. The cancer is estrogen and progesterone receptor positive (70% and over 90% strong, respectively), and HER-2/NEU is reported as equivocal (2+) by immunohistochemistry, with FISH pending. The pathological TNM is T2 N1mic MX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's right breast lumpectomy revealed a 2.8 cm invasive lobular carcinoma, with additional tiny foci of invasive lobular carcinoma up to 5 mm in greatest dimension. The tumor was located approximately 4-5 mm from the superior margin and was free of skin and nipple involvement. One sentinel lymph node (part B) was involved by metastatic adenocarcinoma (largest tumor focus 2 mm) (1/2), while another sentinel lymph node (part C) was benign. The cancer was graded as intermediate (Grade 2) with no lymphovascular invasion identified. Hormone receptors were reported as estrogen positive (70%, strong) and progesterone positive (over 90%, strong). HER-2/NEU status was equivocal (2+) by immunohistochemistry, with FISH pending. The pathological TNM was T2 N1mic MX.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AC-A3QP.14E2FC4E-7205-4929-81B5-7FF3006F08AD',\n",
       "  'report_length_cl100k_base': 1425,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive lobular carcinoma of the right breast, measuring 1.7 x 1.5 x 1.3 cm, located at the 12 o'clock position. There is no evidence of lymph node involvement, and metastasis status is pending. The tumor is estrogen and progesterone receptor positive, HER2 overexpression is positive (3+), and Ki-67 proliferation index is unfavorable (46%). The patient's previous right axillary sentinel lymph node biopsies showed no macrometastasis or micrometastasis.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with a right breast invasive lobular carcinoma, measuring 1.7 x 1.5 x 1.3 cm, located at the 12 o'clock position. The tumor is grade II with no lymph-vascular invasion and lobular carcinoma in situ present. The deep margin is involved, with an invasive carcinoma to deep margin distance of 1.5 mm. Lymph nodes were not submitted with the current specimen, but a previous right axillary sentinel lymph node biopsy showed no macrometastasis. Immunohistochemical assays show the tumor to be estrogen and progesterone receptor positive (3+ intensity) and HER-2 overexpression positive (3+). Ki-67 proliferation index is unfavorable at 46%.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AC-A3QQ.07833A91-F827-4708-AECC-728C708F8E2D',\n",
       "  'report_length_cl100k_base': 2680,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient is a female with a 7 cm invasive lobular carcinoma in the right breast, with metastatic lobular carcinoma found in the right axillary sentinel lymph nodes (2/4 nodes). The cancer is classified as T3N1 (mi) stage. There is no evidence of angiolymphatic invasion, and the tumor is estrogen and progesterone receptor positive. The patient's nipple shows extensive lobular carcinoma in situ.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with a 7 cm invasive lobular carcinoma in the right breast, with metastatic lobular carcinoma involving subcapsular sinuses in two sentinel lymph nodes, but negative for angiolymphatic invasion. The cancer is ER and PR positive, and the patient is classified as T3N1 (mi) stage.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AC-A3TM.87DB9AD3-7640-4A78-B401-D5562D03BA76',\n",
       "  'report_length_cl100k_base': 1074,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient has invasive lobular carcinoma in their right breast, measuring approximately 8 cm in diameter. Two axillary lymph nodes were removed, with no tumor present (0/2). The tumor is multicentric and measures 8 cm in diameter. The closest margin is approximately 1 cm from the invasive carcinoma, which is at least 1 cm from all other margins. The patient also has lobular carcinoma in situ (LCIS) throughout the right breast. The cancer is classified as stage IIB. There is no evidence of lymphatic invasion or metastasis. Estrogen and progesterone receptors are present, and the Ki-67 proliferative index is between 1-2%. The patient's left breast was also removed prophylactically and found to be negative for tumors.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with multicentric invasive lobular carcinoma, Nottingham grade 1-2, with an area of invasive carcinoma measuring approximately 8 cm in diameter in the right breast. Two axillary lymph nodes were sampled, with no tumor present (0/2). The closest margin is approximately 1 cm from the carcinoma, and the resection margins are free of tumor. The patient also has lobular carcinoma in situ (LCIS), classic type, throughout the right breast. The pathologic stage is IIB.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AC-A3TN.1A0D203A-BC4B-441F-97F6-D1FF7E959262',\n",
       "  'report_length_cl100k_base': 2697,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive lobular carcinoma, pleomorphic type, with a tumor size of 2.6 cm and no lymph node involvement. The cancer is triple positive for estrogen, progesterone, and HER2 receptors. The patient's margins are negative, except for a focal positive margin for pleomorphic LCIS on the caudal margin, with a total Nottingham score of 8 out of 9 (Grade III). There is no evidence of metastasis.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is invasive lobular carcinoma, pleomorphic type, with a tumor size of 2.6 cm and a Nottingham score of 8 out of 9 (grade III). The cancer is triple positive on prior core and ER and PR assays are positive on prior core (3+, 50%). HER2 test is positive on prior core (IHC score 3+, FISH positive). The patient's lymph nodes are negative for metastasis (0/1) and the status of breast tissue away from the lesion is benign. The surgical margins are negative, except for a focal pleomorphic LCIS (0.4 cm) on the medial margin and a focal pleomorphic LCIS (0.1 cm) on the caudal margin, with a final negative margin of 0.5 cm. The patient's cancer is classified as pathologic stage pT2 pNO (sn) (i-).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AC-A3W5.CA0CD57E-DA92-463E-A004-D554825A22D6',\n",
       "  'report_length_cl100k_base': 2212,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive lobular carcinoma with a size of 5.3 cm, grade 2. It involves the sections of the nipple but does not involve the overlying epidermis and is not seen in dermal lymphatics. The cancer has metastasized to three out of three sentinel lymph nodes, with a size of involvement within the node of 1 cm and extracapsular extension present. The cancer is classified as T3N1MX. The patient's cancer is estrogen and progesterone receptor positive.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive lobular carcinoma, size 5.3 cm, grade 2. Carcinoma involves sections of the nipple but does not involve the overlying epidermis and is not seen in dermal lymphatics. Right sentinel lymph nodes: three lymph nodes, metastatic carcinoma in three of three nodes, size of involvement within the node 1 cm, extracapsular extension of carcinoma present. TNM: T3N1MX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AC-A3W6.B52E150F-5B34-482A-84E7-1739B9AC09B7',\n",
       "  'report_length_cl100k_base': 761,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient has invasive lobular carcinoma, grade 1, with a tumor size of 40 mm, 14 mm, and 5 mm in greatest dimension. Lymph node involvement is present with 1 of 2 lymph nodes positive for metastatic carcinoma. The tumor is estrogen and progesterone receptor positive and HER2/neu negative. The patient's pathological stage is IIB. Surgical margins are negative, and there is no evidence of lymphatic invasion. The patient also has lobular carcinoma in situ (LCIS) and sclerosing adenosis, usual ductal hyperplasia, columnar cell change, and apocrine metaplasia in the left breast.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is diagnosed with invasive lobular carcinoma, grade 1, with a tumor size of 40 mm, 14 mm, and 5 mm in greatest dimension. Lymph node involvement is present with 1 of 2 lymph nodes positive for metastatic carcinoma. The tumor is estrogen and progesterone receptor positive and Her2/neu negative. The patient's pathologic stage is IIB. Surgical margins are negative, and there is no evidence of lymphatic invasion. The patient also has lobular carcinoma in situ (LCIS).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AC-A3W7.3B77A3E1-AB8F-47B2-A5CC-A3B593A055CE',\n",
       "  'report_length_cl100k_base': 2493,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive lobular carcinoma, Nottingham grade 1-2, with focal atypical ductal hyperplasia (ADH) and atypical lobular hyperplasia (ALH). The tumor size is 1.8 cm, and it is 0.5 cm from the inferior margin, 0.8 cm from the medial, and at least 1 cm from all other margins. There is metastatic carcinoma in 12 of 13 axillary lymph nodes, with the largest metastatic focus measuring 1.1 cm in diameter and extranodal extension identified in at least five lymph nodes. The patient's cancer is stage IIIC with negative margins. The tumor is estrogen and progesterone receptor-positive and Her2/neu positive.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is diagnosed with invasive lobular carcinoma, Nottingham grade 1-2. The tumor size is 1.8 cm, and it is 0.5 cm from the inferior margin, 0.8 cm from the medial, and at least 1 cm from all other margins. There is metastasis in twelve of thirteen axillary lymph nodes, with the largest metastatic focus measuring 1.1 cm in diameter and extranodal extension identified in at least five lymph nodes. The patient's cancer is stage IIIC, with negative margin status and indeterminate lymphatic invasion. The patient's cancer is estrogen and progesterone receptor-positive, with a Ki-67 proliferative index of 25%.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-AC-A3YI.52CEF542-0F5B-4660-8746-2CF4A27B214E',\n",
       "  'report_length_cl100k_base': 1973,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is classified as T2pNO(i-)MX with invasive papillary carcinoma in the right breast, measuring 3 cm in the largest area. There is no evidence of skin or nipple involvement, and the deep margin of excision is free of carcinoma. The patient's cancer is hormone receptor positive and there is no evidence of metastasis.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer stage is T2pNO(i-)MX, with a 3 cm invasive papillary carcinoma in the right breast, confirmed by a negative sentinel lymph node biopsy. The cancer is grade 1, with an architectural score of 1/3, nuclear score of 2/3, and mitotic score of 1/3. There is no evidence of skin or nipple involvement, and the deep margin of excision is free of carcinoma. The patient's cancer is estrogen and progesterone receptor positive.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AC-A3YJ.0F890724-8554-4B2B-B4EC-6B9B24C757D8',\n",
       "  'report_length_cl100k_base': 1011,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has invasive lobular carcinoma in the right breast, with a tumor size of 7.8 x 7.0 x 6.0 cm, Nottingham grade II of III. The tumor is estrogen and progesterone receptor positive, with a Ki-67 of 25%. There is no lymph node involvement (0/1) and no metastasis identified.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Right breast lobular carcinoma, Nottingham grade II of III, tumor size 7.8 x 7.0 x 6.0 cm, negative invasive margins, lymph nodes: sentinel 0/1 (positive/total), estrogen receptor positive (strong, 95%), progesterone receptor positive (strong, 50%), Her-2/neu 0+ (0-3+ scale), KI-67 25%. Left breast benign with areas of stromal fibrosis, no atypia or malignancy identified.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AC-A4ZE.6931CAAE-6DFE-4A61-84D5-4EC804C2F2C6',\n",
       "  'report_length_cl100k_base': 1858,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma, Nottingham grade 2, with two foci of 2.3 cm and 0.7 cm in the lower outer and inner quadrants of the left breast, respectively. There is associated ductal carcinoma in situ, intermediate nuclear grade, spanning approximately 3.8 cm. The margins of resection are widely free of invasive and in situ tumors. One of fourteen axillary lymph nodes has micrometastatic carcinoma (1.7 mm), and there is no extranodal extension identified. The patient's cancer is stage IIB, with no lymphovascular invasion. Estrogen and progesterone receptors are positive, and HER2 is negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with invasive ductal carcinoma in the left breast, with two foci of the tumor measuring 2.3 cm and 0.7 cm, respectively. The cancer is grade 2 on the Nottingham scale. There is associated ductal carcinoma in situ, intermediate nuclear grade, spanning approximately 3.8 cm. Margins of resection are free of tumor, but there is a focus suspicious for lymphovascular invasion. One of the 14 axillary lymph nodes has micrometastatic carcinoma (1.7 mm). The cancer is stage IIB, with no distant metastasis. Estrogen and progesterone receptors are positive, and HER2 is negative. The patient's cancer is hormone receptor-positive and HER2-negative.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AC-A5EH.C49EB2B9-A19F-43FC-9A77-18BBB43F5B10',\n",
       "  'report_length_cl100k_base': 2018,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma with a tumor size of 1.2 cm in the lower inner quadrant of the right breast, and a malignant phyllodes tumor with a size of 3.2 cm in the upper outer quadrant. The tumor is 0.5 cm from the deep margin and at least 1 cm from all other margins. There is micrometastatic carcinoma in one of two sentinel lymph nodes (1/2), with a size of metastatic focus of 0.1 cm. The patient's cancer is stage IB.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with invasive ductal carcinoma in the right breast, with a tumor size of 1.2 cm and Nottingham grade 1. There is also a malignant phyllodes tumor present in the upper outer quadrant, measuring 3.2 cm in diameter. The mastectomy margins are free of tumor, and the invasive carcinoma is 0.5 cm from the deep margin and at least 1 cm from all other margins. The phyllodes tumor is at least 1.5 cm from all margins. There is micrometastatic carcinoma in one of two sentinel lymph nodes, with a size of metastatic focus of 0.1 cm. The patient's stage is IB. The tumor is estrogen and progesterone receptor positive, and HER2 score is 0. Ki-67 is 5% positive cells.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AC-A5EI.C0F7848A-DD0B-47B2-956F-A24D597D70BC',\n",
       "  'report_length_cl100k_base': 2777,\n",
       "  't_label': 0},\n",
       " {'abstract': '\\nThe patient has invasive lobular carcinoma in the left breast, measuring 2.6 cm with a single focus. The tumor is grade 1 (Nottingham scoring), ER-positive, and PR-positive. HER2 is negative (1+). Eight sentinel lymph nodes were sampled, and none showed metastatic carcinoma. The skin and nipple are free of cancer involvement, and there is no lymphovascular invasion. The margins of excision are negative for carcinoma.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Left breast cancer, invasive lobular carcinoma, 2.6 cm, single focus, Nottingham grade 1, ER positive, PR positive, HER2 negative (1+), lymph nodes negative for metastatic carcinoma.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AC-A5XS.C4F259BA-7C00-4326-ACB2-924C4AE33E87',\n",
       "  'report_length_cl100k_base': 1094,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient is a female with invasive ductal carcinoma (pT3) and no lymph node involvement (pNO(i-)(sn). The tumor size is 6.8 cm in diameter and is of high nuclear grade with neuroendocrine differentiation. The inferior margin is involved by DCIS, and carcinoma is identified 0.2 cm from the anterior and superior margins. The patient's cancer is classified as stage IIB, with no evidence of lymphovascular invasion or metastasis.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with invasive ductal carcinoma (pT3) and no lymph node involvement (pNO(i-)(sn), stage IIB. The tumor size is 6.8 cm in diameter and has neuroendocrine differentiation. The margins are involved by DCIS, but invasive carcinoma is not identified at any margin. The patient's cancer is estrogen and progesterone receptor positive and HER2 negative. The tumor is not associated with skin or chest wall invasion.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AC-A5XU.D61D4CCC-2AB5-4268-AEB7-C8928E0AF964',\n",
       "  'report_length_cl100k_base': 1945,\n",
       "  't_label': 2},\n",
       " {'abstract': ' The comprehensive report shows that the patient was diagnosed with invasive ductal carcinoma in the right breast, with a tumor size of 4.7 cm and focal features of invasive micropapillary carcinoma. The cancer is grade 3 on the Nottingham scale, with tubule formation, nuclear pleomorphism, and mitotic rate all scoring 3 out of 3. Lymphovascular invasion is present, and the cancer has spread to 3 out of 17 axillary lymph nodes. The patient is stage IV due to metastasis to the left iliac bone. The cancer is estrogen and progesterone receptor-positive and HER2-negative. The left breast was also removed as a prophylactic mastectomy and found to be free of cancer.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The comprehensive report shows that the patient was diagnosed with invasive ductal carcinoma in the right breast, with a tumor size of 4.7 cm and focal features of invasive micropapillary carcinoma. The cancer is grade 3 on the Nottingham scale, with tubule formation, nuclear pleomorphism, and mitotic rate all scoring 3 out of 3. Lymphovascular invasion is present, and the cancer has spread to 3 out of 17 axillary lymph nodes. The patient is stage IV due to metastasis to the left iliac bone. The cancer is estrogen and progesterone receptor-positive and HER2-negative. The left breast was also removed as a prophylactic mastectomy and found to be free of cancer.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AC-A62V.BBA96852-E70C-4D37-A185-611F568BE90C',\n",
       "  'report_length_cl100k_base': 4303,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient is a female with invasive ductal carcinoma, Nottingham grade 3, with a tumor size of 2.7 cm. There is no lymph node involvement, and the margins are negative. The tumor is at least 1.5 cm from the superior-superficial margin and at least 2 cm from all other margins. The patient also has ductal carcinoma in situ (DCIS), high nuclear grade, solid type, present at the periphery of the invasive carcinoma, comprising less than 10% of the tumor volume. The patient has a papilloma and fibroadenoma in the inferior-central breast. The pathologic stage is IIA, with no lymphovascular invasion or distant metastasis. The estrogen receptor is positive in 5% of tumor cells, and the HER2 score is 1+. The patient's cancer is classified as basal-like phenotype.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with invasive ductal carcinoma, Nottingham grade 3, with a tumor size of 2.7 cm. There is no lymph node involvement (pNO) and no metastasis (pM). The tumor is at least 1.5 cm from the superior-superficial margin and at least 2 cm from all other margins. The patient also has ductal carcinoma in situ (DCIS), high nuclear grade, solid type, present at the periphery of the invasive carcinoma, comprising less than 10% of the tumor volume. The patient's cancer is classified as stage IIA.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AC-A62X.6BB72835-1002-4B35-9304-495E12A30905',\n",
       "  'report_length_cl100k_base': 2064,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient is a female with a right breast modified radical mastectomy. The tumor size is 2.8 and 1.8 cm, with a total score of 6 out of 9. There is no evidence of angiolymphatic invasion, skin or nipple involvement. One lymph node was found with metastatic carcinoma, measuring 0.4 cm with no evidence of extracapsular extension. The patient's cancer is classified as T2pN1. Clinical history reveals ER and PR positivity, and Her-2 negativity.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with a right breast modified radical mastectomy. The tumor size is 2.8 and 1.8 cm, with a total score of 6 out of 9. There is no evidence of angiolymphatic invasion, and the deep margin of excision is involved by carcinoma. One lymph node was found with metastatic carcinoma, measuring 0.4 cm with no evidence of extracapsular extension. The patient's cancer is classified as T2pN1. The patient's ER and PR are positive, and Her-2 is negative.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AC-A62Y.83BCCC3C-0384-45CD-84B4-67E2EDE822EE',\n",
       "  'report_length_cl100k_base': 690,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is invasive mammary carcinoma, with a tumor size of 2.2 cm, grade 2. It is estrogen and progesterone receptor-positive, with a Ki-67 proliferation rate of 32%. Her2 by IHC is equivocal (2+ staining). There is metastasis to the right axillary sentinel lymph node, with a size of involvement of 0.3 cm and no evidence of extracapsular extension. The closest surgical margin is 1.5 cm deep.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with a right breast mastectomy and sentinel lymph node biopsy. The tumor size is 2.2 cm, and it is invasive mammary carcinoma, grade 2. It is estrogen and progesterone receptor positive, with a Ki-67 proliferation marker of 32%. Her2 by IHC is equivocal (2+ staining). The patient has one positive lymph node (metastatic carcinoma, size of involvement 0.3 cm) with no evidence of extracapsular extension. Surgical margins are free of carcinoma, and the closest margin is deep at 1.5 cm. The patient's cancer is classified as T2pN1.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AC-A6IV.5B978086-7443-4721-854B-877CE0FC10C0',\n",
       "  'report_length_cl100k_base': 1539,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma, Nottingham grade 3, with a tumor size of 2.6 cm. There is no lymphovascular invasion identified and the margins are widely free of all margins. Two sentinel lymph nodes were examined and found to be negative for carcinoma. The patient's cancer is stage IIA.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is diagnosed with invasive ductal carcinoma, Nottingham grade 3, with a tumor size of 2.6 cm in the greatest dimension. The cancer is widely free of all margins and there is no lymphovascular invasion identified. Two sentinel lymph nodes were examined and found negative for carcinoma. The cancer is staged as IIA. The patient's breast parenchyma is uninvolved with focal fibroadenomatoid changes.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AC-A6IW.302E69E0-39F0-4CDB-97F9-A6CDDB3D7233',\n",
       "  'report_length_cl100k_base': 1973,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is classified as pT2, with a tumor size of 4.0 cm and four smaller masses ranging from 1.0-1.6 cm. There is no evidence of skin or nipple involvement, and the cancer is ER+, PR+, and HER2-. The patient's lymph nodes are involved, with two out of 16 positive for metastatic carcinoma, and no extranodal extension.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is classified as multifocal invasive ductal carcinoma, intermediate grade, with four foci of invasive tumor, all with identical histology. The tumor size ranges from 0.6 to 4.0 cm, and the cancer is ER+, PR+, and HER2-. The lymph node status is N0, with metastatic carcinoma found in 2 out of 16 lymph nodes, and no extranodal extension. The cancer is staged as pT2 pN1a.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AC-A6NO.A81EB5E0-305E-4657-94AD-0922CD1D79C6',\n",
       "  'report_length_cl100k_base': 1366,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has multifocal invasive ductal carcinoma, with the largest tumor nodule measuring 1.5 cm in diameter. There is ductal carcinoma in situ (high nuclear grade, solid type) in the biopsy tissue. The cancer has spread to three of fifteen lymph nodes, with the largest metastatic focus being 0.9 cm in diameter and extranodal extension present. The tumor is 3 cm from the inferior margin and at least 6 cm from all other margins. The patient's cancer is stage IIA, with negative margins and indeterminate lymphovascular invasion. Estrogen receptor is positive in 85-96% of cells, progesterone receptor is 0% positive, and HER2 status is pending.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is diagnosed with multifocal invasive ductal carcinoma, Nottingham grades 2-3, with a tumor size of 1.5 cm in diameter. There are two smaller nodules, 0.6 and 0.8 cm, and ductal carcinoma in situ (DCIS), high nuclear grade, solid type. The cancer is 3 cm from the inferior margin and at least 6 cm from all other margins. There are metastases in three of fifteen lymph nodes, with the largest metastatic focus being 0.9 cm in diameter and extranodal extension present. The patient's stage is IIA, with negative margins and indeterminate lymphovascular invasion. Estrogen receptor is 85-96% positive, progesterone receptor is 0% positive, and HER2 results are pending.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AC-A7VB.53881871-C36B-4622-BFC6-4DA3635D7B26',\n",
       "  'report_length_cl100k_base': 2501,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient is a female with a left breast mastectomy revealing a 11 cm metaplastic carcinoma with no evidence of in situ carcinoma, angiolymphatic invasion, or skin/nipple involvement. The tumor is grade 3 with a T3pNO(i-) classification. No metastatic carcinoma was found in the sentinel lymph node.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with a left breast mastectomy revealing a 11 cm metaplastic carcinoma with no evidence of in situ carcinoma, angiolymphatic invasion, or skin/nipple involvement. The tumor is grade 3 with a T3pNO(i-) TMN classification. One sentinel lymph node was removed and showed no evidence of metastatic carcinoma. The patient's prognostic panel is yet to follow.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AC-A7VC.A1681334-684E-41E0-B3FA-EFFE1E5A8B7F',\n",
       "  'report_length_cl100k_base': 785,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient is a female with a 18mm invasive ductal carcinoma (Nottingham grade 2) in the right breast, with no lymph node involvement (pN0), and no evidence of metastasis (pMX). The tumor is 15mm from the nearest margin and there is no lymphovascular invasion. The patient also has ductal carcinoma in situ (DCIS) with a nuclear grade 2. Estrogen and progesterone receptors are positive, and Her2/neu is not overexpressed. The pathologic stage is IA.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with a 18mm invasive ductal carcinoma in the right breast, classified as Nottingham grade 2. There is no lymph node involvement (pN0) and no distant metastasis (pMX). The tumor is 15mm from the nearest margin and the resection margins are free of tumor. The patient also has ductal carcinoma in situ (DCIS) with a nuclear grade of 2. The tumor is estrogen and progesterone receptor positive and Her2/neu is not overexpressed. The pathologic stage is IA.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AC-A8OP.F4F5C477-30BB-41EE-B188-B20DE019F30A',\n",
       "  'report_length_cl100k_base': 973,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma, Nottingham grade 3, with a tumor size of 3.8 cm. The cancer is located 0.3 cm from the deep margin and is at least 0.5 cm from all other margins. One of two sentinel lymph nodes is involved, with a metastatic focus measuring 1.2 cm in diameter and no extranodal extension. The cancer is staged as IIB, with lymphovascular invasion present. Estrogen and progesterone receptors are 0% positive, and the Ki-67 proliferative index is 70% positive.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive ductal carcinoma, Nottingham grade 3; tumor size 3.8cm; DCIS, high nuclear grade, solid type with comedo necrosis and calcifications; metastatic carcinoma identified in one of two sentinel lymph nodes, the involved lymph node is sentinel lymph node with count 414; metastatic focus measures 1.2cm in diameter; no extranodal extension identified; metastatic carcinoma comprises approximately 40% of the involved lymph node volume; stage IIB; lymphovascular invasion present; margin status negative (R0).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AC-A8OQ.FFA6F9F3-71C1-4AF9-B9F7-0466550EBC90',\n",
       "  'report_length_cl100k_base': 1695,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient is a female with invasive mucinous carcinoma of the left breast, with a tumor size of 1.7 cm, located subareolar. There is no lymphovascular invasion identified, and margins of resection are negative, with a distance of at least 3.5 cm from all margins. One sentinel and one non-sentinel lymph node were examined, both negative for tumor (0/2). The patient's cancer is stage IA, with no metastasis identified.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with invasive mucinous carcinoma of the left breast, with a tumor size of 1.7 cm, located subareolar. There is no in situ component identified, and margins of resection are negative, with invasive carcinoma at least 3.5 cm from all margins. One sentinel and one non-sentinel lymph node were examined, both negative for tumor (0/2). The patient's cancer is stage IA, with no lymph node involvement (pN0(i-)(sn) and no distant metastasis (pM). Estrogen and progesterone receptors are positive (100% and 9% strong intensity, respectively), and HER2 is negative (score 1+).\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AC-A8OR.1E706FF8-F42C-4FC6-8976-BEB4213BD730',\n",
       "  'report_length_cl100k_base': 2236,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient has invasive lobular carcinoma, Nottingham grade 2, with a tumor size of 3 cm in the right breast. There is no lymph node involvement (pN0(i-)(sn)) and no distant metastasis (pM: N/A). The tumor is multifocal with lobular carcinoma in situ (LCIS) present. The patient's stage is IIA. There is no lymphovascular invasion, and margins are negative. Estrogen and progesterone receptors are positive, and HER2 is score 1+.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with a multifocal invasive lobular carcinoma in the right breast, with tumor size being 3 cm (largest nodule) and smaller nodules ranging from 0.1-0.6 cm in diameter. There are no benign lymph nodes involved, and the cancer is staged as IIA. The patient's left breast showed benign breast tissue with fibrocystic changes, including fibrosis, cysts, and apocrine metaplasia, along with lobular carcinoma in situ (LCIS), low nuclear grade.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AC-A8OS.EEF4E8C6-6D80-4C6A-BFC6-E529692088C1',\n",
       "  'report_length_cl100k_base': 2708,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the left breast, with a tumor size of T2 and no lymph node involvement (N0). There is no evidence of metastasis (M0). The tumor has been classified as grade 1. No treatment has been administered yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma in the left breast. The tumor is classified as T2, with no lymph node involvement (N0) and no metastasis (M0). The tumor was procured through a radical mastectomy and is graded as 1. No treatment has been given yet. Samples from the blood have also been taken for analysis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A03X.1F6200B4-B53B-4E9F-B01B-12D2C0D4270E',\n",
       "  'report_length_cl100k_base': 124,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the left breast, with a tumor size of T2 and no lymph node involvement (N0) or metastasis (M0). The tumor was procured through a radical mastectomy, and the patient has not undergone any treatment yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma in the left breast. The tumor is classified as T2, with no lymph node involvement (N0) and no metastasis (M0). The tumor was procured through a radical mastectomy and is graded as 2. There is no information on treatment or additional samples.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A03Y.76734A82-9137-4DA4-871E-D4EC1BC33831',\n",
       "  'report_length_cl100k_base': 124,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma breast cancer. The tumor size is specified as T2, with no lymph node involvement (N0), and no evidence of metastasis (M0). The cancer has not received any treatment yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma. The tumor is located in the breast and has a size of T2. There is no lymph node involvement (N0) and no evidence of metastasis (M0). The tumor grade is 2 and the patient has not received any treatment.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AN-A041.26C566AF-C710-4856-AC21-83D73370EA84',\n",
       "  'report_length_cl100k_base': 124,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the right breast, with a tumor size of T2 and no lymph node involvement (N0) or metastasis (M0). The tumor was procured through a radical mastectomy, and the patient has not undergone any treatment yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with a diagnosis of infiltrative ductal carcinoma in the right breast. The tumor is classified as T2, N0, and M0, indicating a size of 2 cm, no lymph node involvement, and no metastasis. The tumor was procured through a radical mastectomy and is grade 2. There is no information on treatment or additional samples.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A046.1304FB17-A20A-4EBC-9CC8-1554808AC1F6',\n",
       "  'report_length_cl100k_base': 124,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the left breast, with a tumor size of T2 and no lymph node involvement (N0) or metastasis (M0). The tumor was procured through a radical mastectomy, and the patient has not undergone any treatment yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma in the left breast. The tumor is classified as T2, with no lymph node involvement (N0) and no metastasis (M0). The tumor was procured through a radical mastectomy and is graded as 2. There is no information on treatment or additional samples.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A049.8C2B719A-D45A-4DF3-BA61-908A2E1F6D1D',\n",
       "  'report_length_cl100k_base': 124,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the left breast, with a tumor size of T2 and lymph node involvement of N2. There is no evidence of metastasis (M0). The tumor was obtained through a radical mastectomy, and the patient has not received any treatment.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma in the left breast. The tumor specimen was obtained through radical mastectomy and has a grade of 2. The cancer has spread to 2 lymph nodes (N stage 2) but has no metastasis (M stage 0). No treatment has been given yet.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AN-A04A.6FB7A794-C3E7-4501-A844-CF65B9C3D32C',\n",
       "  'report_length_cl100k_base': 122,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the left breast, with a tumor size of T2 and lymph node involvement of N1. There is no evidence of metastasis (M0). The tumor has a grade of 2 and was obtained through a radical mastectomy. No treatment has been given yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma in the left breast. The tumor is classified as T2, N1, and M0, indicating a size of 2 cm, one lymph node involvement, and no metastasis. The tumor was procured through a radical mastectomy and has a grade of 2. No treatment has been given yet.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AN-A04C.045B2852-E1FF-4376-8F39-60FC940224D0',\n",
       "  'report_length_cl100k_base': 122,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma breast cancer. The tumor size is not specified in the report. There is no lymph node involvement (N Stage: 1) and no evidence of metastasis (M Stage: 0).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma. The tumor is located in the breast and has a size of T2. There is no lymph node involvement (N1) and no metastasis (M0). The cancer is grade 2, and the patient has not received any treatment.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AN-A04D.A3CB59DE-5893-4FA2-B4D5-EDA612480E76',\n",
       "  'report_length_cl100k_base': 121,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal-lobular carcinoma in the left breast, with a tumor size of T3 and no lymph node involvement (N0) or metastasis (M0). The tumor was procured through surgery and has a grade of 2. There is no information on treatment provided.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal-lobular carcinoma in the left breast. The tumor specimen was obtained through surgery and is categorized as T2, meaning the tumor is between 1-5 cm in size. There is no lymph node involvement (N0) and no evidence of metastasis (M0). The cancer grade is 2, and treatment details are not available. A normal blood sample was also collected.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0AJ.6E2365F3-0875-4949-8409-7E26BBCDE700',\n",
       "  'report_length_cl100k_base': 123,\n",
       "  't_label': 2},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the left breast, with a tumor size of T2 and no lymph node involvement (N0) or metastasis (M0). The tumor was procured through surgery and has a grade of 2. No treatment has been given yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma in the left breast. The tumor specimen was obtained through surgery and is categorized as T2, N0, and M0. The cancer has not spread to the lymph nodes or metastasized. The tumor grade is 2. No treatment has been given yet. A blood sample was also taken for analysis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0AK.12683FCC-4828-4D9A-9B35-E4B7295CC417',\n",
       "  'report_length_cl100k_base': 120,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the left breast, with a tumor size of T4 and no lymph node involvement (N0) or metastasis (M0). The cancer is classified as stage 2.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma in the left breast. The tumor specimen was obtained through surgery and is categorized as T2, with no lymph node involvement (N0) and no metastasis (M0). The patient has not received any treatment.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0AL.20F4DBD9-02FA-4FFD-AEF5-234910D31263',\n",
       "  'report_length_cl100k_base': 122,\n",
       "  't_label': 3},\n",
       " {'abstract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma in the left breast. The tumor size is not specified, but there is no lymph node involvement (N Stage: 0) and no metastasis (M Stage: 0). The tumor was procured through a radical mastectomy and has a grade of 2. No treatment has been given yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with breast cancer, specifically infiltrative ductal carcinoma in the left breast. The tumor is classified as T2, with no lymph node involvement (N0) and no metastasis (M0). The tumor was procured through a radical mastectomy and is graded as 2. No treatment has been given yet.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0AM.7189A8A8-EB8B-4795-B7FE-725CCC4B7FA7',\n",
       "  'report_length_cl100k_base': 129,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the right breast, with a tumor size of T2 and no lymph node involvement (N0). There is no evidence of metastasis (M0). The tumor has a grade of 3. The patient has not received any treatment.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with a diagnosis of infiltrative ductal carcinoma in the right breast. The tumor is classified as T2, N0, and M0, indicating a size of 2 cm, no lymph node involvement, and no metastasis. The tumor was procured through a radical mastectomy and has a grade of 3. No treatment has been given yet. The report also includes a normal blood sample for comparison.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0AR.0E27F140-3D60-4027-A370-68127564DE38',\n",
       "  'report_length_cl100k_base': 124,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the left breast, with a tumor size of T2 and lymph node involvement of N2a. There is no evidence of metastasis (M0). The tumor has a grade of 2 and was obtained through a radical mastectomy. No treatment has been given yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma in the left breast. The tumor is classified as T2, N2a, and M0, indicating a moderate-sized tumor with some lymph node involvement but no metastasis. The report does not mention any treatment details.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AN-A0AS.0D1ACC76-910E-4243-A229-5F76B5A3299A',\n",
       "  'report_length_cl100k_base': 127,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the right breast, with a tumor size of T2 and no lymph node involvement (N0). There is no evidence of metastasis (M0). The tumor has a grade of 3. The patient has not received any treatment.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with a diagnosis of infiltrative ductal carcinoma in the right breast. The tumor is classified as T2, N0, and M0, indicating a size of 2 cm, no lymph node involvement, and no metastasis. The tumor was procured through a radical mastectomy and has a grade of 3. No treatment has been given yet. The report also includes a normal blood sample for comparison.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0AT.3E8F2012-A457-4358-9C8B-23292374A743',\n",
       "  'report_length_cl100k_base': 124,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the right breast, with a tumor size of T2 and no lymph node involvement (N0) or metastasis (M0). The tumor was procured through surgery and has a grade of 2. No treatment has been given yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with a diagnosis of breast cancer, specifically infiltrative ductal carcinoma, in the right breast. The tumor specimen was obtained through surgery and is categorized as T2, N0, and M0, indicating tumor size of 2 cm, no lymph node involvement, and no metastasis. The tumor grade is 2, and no treatment has been administered yet. Additionally, a normal blood sample was drawn for comparison.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0FD.F124155D-6131-47F6-8320-46A41AB125D3',\n",
       "  'report_length_cl100k_base': 120,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the left breast, with a tumor size of T1 and no lymph node involvement (N0) or metastasis (M0). The cancer is classified as stage 1.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma in the left breast. The tumor is graded as 2, with T stage 1, N stage 0, and M stage 0. No treatment has been given yet.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0FF.9B4BA15D-A071-4213-AD2C-075A04ED48CD',\n",
       "  'report_length_cl100k_base': 120,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has been diagnosed with infiltrative ductal carcinoma in the left breast, with a tumor size of T2 and lymph node involvement of N1. There is no evidence of metastasis (M0). The tumor has a grade of 2 and no treatment has been given yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with breast cancer, specifically infiltrative ductal carcinoma in the left breast. The tumor specimen was obtained through surgery and is categorized as T2, N1, and M1. The cancer has not spread to nearby lymph nodes or distant organs. The patient has not received any treatment yet.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AN-A0FJ.59163BD6-41E8-4489-81F0-036484447886',\n",
       "  'report_length_cl100k_base': 121,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the right breast, with a tumor size of T4 and no lymph node involvement (N0) or metastasis (M0). The cancer is classified as stage T4, N0, M0.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \" The patient is a female with a diagnosis of infiltrative ductal carcinoma in the right breast. The tumor is classified as T4, with no lymph node involvement (N0) and no metastasis (M0). The tumor specimen was obtained through surgery and is a tissue specimen in an OCT format. The patient's blood was also drawn for analysis, but no treatment has been given.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0FK.5F5FF3CA-2DBB-4DE1-9190-1FE36E2B5ACB',\n",
       "  'report_length_cl100k_base': 120,\n",
       "  't_label': 3},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the left breast, with a tumor size of T2 and no lymph node involvement (N0) or metastasis (M0). The tumor was procured through surgery and has a grade of 2. No treatment has been given yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma in the left breast. The tumor specimen was obtained through surgery and is categorized as T2, N0, and M0. The cancer has not spread to the lymph nodes or metastasized. The tumor grade is 2. No treatment has been given yet. A blood sample was also taken for analysis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0FL.049A2CA6-951A-452F-963A-F54FE87ECA31',\n",
       "  'report_length_cl100k_base': 120,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with lobular carcinoma of the right breast, with a tumor size of T1 and no lymph node involvement (N0) or metastasis (M0). The tumor was surgically removed and no further treatment is required.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with infiltrative lobular carcinoma in the right breast, with a tumor size of T1 and no lymph node involvement (N0) or metastasis (M0). The tumor was procured through surgery and has a grade of 2. No treatment has been given yet.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0FN.6B53F577-5EB6-4AF5-9773-3654D3432BE4',\n",
       "  'report_length_cl100k_base': 117,\n",
       "  't_label': 0},\n",
       " {'abstract': ' The patient has been diagnosed with lobular carcinoma of the right breast, with a tumor size of T1 and no lymph node involvement (N0) or metastasis (M0). The tumor was surgically removed and no further treatment is required.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with infiltrative lobular carcinoma in the right breast, with a tumor size of T1 and no lymph node involvement (N0) or metastasis (M0). The tumor was procured through surgery and has a grade of 2. No treatment has been given yet.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0FS.3CD1D537-29E4-479B-99FA-26D27E192948',\n",
       "  'report_length_cl100k_base': 117,\n",
       "  't_label': 0},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the right breast, with a tumor size of T2 and lymph node involvement of N1. There is no evidence of metastasis (M0). The tumor has a grade of 2 and no treatment has been given yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma, in her right breast. The tumor specimen was obtained through surgery and is categorized as T2, N1, and M0, indicating a tumor size of approximately 2 cm, one lymph node involvement, and no distant metastasis. The cancer grade is 2, and no treatment has been administered yet.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AN-A0FT.338D5387-0CFB-4D91-944F-1F054C21C769',\n",
       "  'report_length_cl100k_base': 120,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the right breast, with a tumor size of T2 and no lymph node involvement (N0) or metastasis (M0). The tumor was procured through a radical mastectomy, and the patient has not undergone any treatment yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with a diagnosis of infiltrative ductal carcinoma in the right breast. The tumor is classified as T2, N0, and M0, indicating a size of 2 cm, no lymph node involvement, and no metastasis. The tumor was procured through a radical mastectomy and is grade 2. There is no information on treatment or additional samples.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0FV.5AEE90E0-A9A1-4944-AD6A-2675764D869D',\n",
       "  'report_length_cl100k_base': 124,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the left breast, with a tumor size of T2 and lymph node involvement of N1. There is no evidence of metastasis (M0). The tumor has a grade of 2 and was obtained through a radical mastectomy. No treatment has been given yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma in the left breast. The tumor is classified as T2, N1, and M0, indicating a size of 2 cm, one lymph node involvement, and no metastasis. The tumor was procured through a radical mastectomy and is graded as 2. No treatment has been given yet. Samples from the blood have also been taken for analysis.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AN-A0FW.03BD8920-CA01-4818-BBD7-925DDD3F6908',\n",
       "  'report_length_cl100k_base': 124,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with metaplastic carcinoma of the left breast, with a tumor size of T2 and no lymph node involvement (N0). There is no evidence of metastasis (M0). The tumor was procured through a radical mastectomy, and the patient has not received any treatment.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with a diagnosis of metaplastic carcinoma in the left breast. The tumor is classified as T2, N0, and M0, indicating a size of 2 cm or less, no lymph node involvement, and no distant metastasis. The tumor was procured through a radical mastectomy and is grade 3. No treatment has been given yet. The report also mentions a normal blood sample collected through a blood draw.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0FX.0CC079D3-EB90-47B5-B554-599A67C9E12A',\n",
       "  'report_length_cl100k_base': 122,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the left breast, with a tumor size of T1c and no lymph node involvement (N0). There is no evidence of metastasis (M0). The tumor was obtained through a radical mastectomy, and the patient has not received any treatment.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma in the left breast. The tumor is graded as 3 and staged as T1c, with no lymph node involvement (N0) and no metastasis (M0). No treatment has been given yet.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0FY.6C520037-2A9B-41CB-8362-97FFCA2AA6E2',\n",
       "  'report_length_cl100k_base': 134,\n",
       "  't_label': 0},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the left breast, with a tumor size of T2 and lymph node involvement of N2. There is no evidence of metastasis (M0). The tumor was obtained through a radical mastectomy, and the patient has not received any treatment.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma in the left breast. The tumor is classified as T2, N2, and M0, indicating a moderate-sized tumor with lymph node involvement but no metastasis. The report does not mention any treatment details.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AN-A0FZ.8CC70CDC-01EC-4E2B-84C1-F1C946602CCE',\n",
       "  'report_length_cl100k_base': 124,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the right breast, with a tumor size of T2 and no lymph node involvement (N0) or metastasis (M0). The tumor was procured through a radical mastectomy, and the patient has not received any treatment.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with a diagnosis of infiltrative ductal carcinoma in the right breast. The tumor is classified as stage 2 with no lymph node involvement (N stage 0) and no metastasis (M stage 0). The tumor was procured through a radical mastectomy and has a grade of 3. No treatment has been given yet. The report also includes a normal blood sample for comparison.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0G0.08519263-5ADD-4BA3-9BC6-C737ACA7DFE4',\n",
       "  'report_length_cl100k_base': 125,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma breast cancer. The tumor is in the primary location, with a size of T2 and no lymph node involvement (N0). There is no evidence of metastasis (M0). The cancer grade is 2, and no treatment has been administered yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma. The tumor is located in the breast and has a size of T2. There is no lymph node involvement (N0) and no metastasis (M0). The tumor grade is 2. No treatment has been given yet.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0XL.A85A959B-F18C-43D3-8BBF-770DA2189462',\n",
       "  'report_length_cl100k_base': 119,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma breast cancer, with a tumor size of T2 and lymph node involvement of N1. There is no evidence of metastasis (M0). The cancer has not received any treatment yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma. The tumor is located in the breast and has a size of T2. There is no lymph node involvement (N1) and no metastasis (M0). The cancer is graded as 2, and no treatment has been given yet.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AN-A0XN.4C9C9D24-07E1-47BE-8D34-F94693576BD2',\n",
       "  'report_length_cl100k_base': 120,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma breast cancer, with a tumor size of T2 and lymph node involvement of N1. There is no evidence of metastasis (M0). The cancer has not received any treatment yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma. The tumor is located in the breast and has a size of T2. There is no lymph node involvement (N1) and no metastasis (M0). The cancer is graded as 2, and no treatment has been given yet.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AN-A0XO.3423E8AE-CE73-4212-BB72-2AF92FD0BC2D',\n",
       "  'report_length_cl100k_base': 119,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma breast cancer, with a tumor size of T2 and lymph node involvement of N1. There is no evidence of metastasis (M0). The cancer has not received any treatment yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma. The tumor is located in the breast and has a size of T2. There is no lymph node involvement (N1) and no metastasis (M0). The cancer is graded as 2, and no treatment has been given yet.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AN-A0XP.80E9B7CE-0D5D-4C01-A8E3-E6345BE145EC',\n",
       "  'report_length_cl100k_base': 119,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma breast cancer, with a tumor size of T2 and lymph node involvement of N2b. There is no evidence of metastasis (M0). The cancer has not received any treatment yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma. The tumor is located in the breast and has a size of T2. There is lymph node involvement (N2b) but no metastasis (M0). The cancer is graded as 2, and no treatment has been given yet.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AN-A0XR.1351520E-9B6A-4F06-B631-DF374396C7E6',\n",
       "  'report_length_cl100k_base': 120,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma breast cancer, with a tumor size of 1c and no lymph node involvement (N Stage 1a). There is no evidence of metastasis (M Stage 0). No treatment has been given yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma. The tumor is located in the breast and is classified as stage 1c. There is no lymph node involvement (N stage 1a) and no evidence of metastasis (M stage 0). The tumor specimen was obtained through surgery and is stored in a block format. The patient has not received any treatment. Additionally, a normal blood sample was taken for comparison.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AN-A0XS.D5C9D3FF-3799-4773-8A86-B000DBE42BD8',\n",
       "  'report_length_cl100k_base': 120,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma breast cancer, with a tumor size of T1c and no lymph node involvement (N0). There is no evidence of metastasis (M0). The cancer has not received any treatment yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma. The tumor is located in the breast and is categorized as T1c. There is no lymph node involvement (N1a) and no evidence of metastasis (M0). The tumor grade is 2. No treatment has been given yet.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AN-A0XT.3C94BBAC-923E-43F0-B5DC-01207868AD05',\n",
       "  'report_length_cl100k_base': 121,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient is a female with breast cancer (infiltrative ductal carcinoma) in the primary tumor location. The tumor size is not specified, but there is no lymph node involvement (N Stage 0) and no metastasis (M Stage 0). The tumor grade is 3. No treatment has been given yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma. The tumor is located in the breast and has a grade of 3. The T stage is 2, with no lymph node involvement (N stage 0) and no metastasis (M stage 0). No treatment has been given yet.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AN-A0XU.8216B837-DCF3-4E7F-A72A-212655F394F0',\n",
       "  'report_length_cl100k_base': 123,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the right breast, with a tumor size of T2 and lymph node involvement of N1. There is no evidence of metastasis (M0). The tumor has a grade of 2 and no treatment has been given yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma, in the right breast. The tumor specimen was obtained through surgery and is categorized as T2, N1, and M0. The cancer has not spread to nearby lymph nodes or metastasized. The tumor grade is 2, and no treatment has been given yet. A normal blood sample was also taken.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AN-A0XV.5F626AB6-EEB5-4005-97C5-9E48D9FA7730',\n",
       "  'report_length_cl100k_base': 121,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient has been diagnosed with infiltrative ductal carcinoma in the left breast, with a tumor size of T2 and lymph node involvement of N1. There is no evidence of metastasis (M0). The tumor has a grade of 2 and no treatment has been given yet.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female with breast cancer, specifically infiltrative ductal carcinoma in the left breast. The tumor is classified as T2, N1, and M0, indicating a size of 2 cm, one lymph node involvement, and no metastasis. The tumor was procured through surgery and has a grade of 2. No treatment has been given yet. The report also mentions a normal blood sample taken from the patient.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AN-A0XW.5CBC6417-4E3D-4E9C-AE93-A56B777EF2F4',\n",
       "  'report_length_cl100k_base': 121,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has invasive ductal carcinoma in the right breast, measuring 6.5 cm in the largest dimension. The nipple lymphatics are involved, and there is extensive vascular invasion. Lymph node status shows 3 positive lymph nodes out of 9 examined in level 1 and 0 positive lymph nodes out of 7 examined in level 2. The tumor is HER2-positive.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is diagnosed with invasive ductal carcinoma, measuring 6.5 cm in the largest dimension, located in the central area of the right breast. The nipple lymphatics are involved, and there is extensive vascular invasion. Lymph node status shows 3 positive lymph nodes out of 9 examined in level 1 and no involvement in level 2. The tumor is ER-negative, PR-negative, and HER2-positive.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AO-A03L.FF7212E5-9A44-4659-B3B9-3EF2DB7A9E6D',\n",
       "  'report_length_cl100k_base': 1437,\n",
       "  't_label': 2},\n",
       " {'abstract': 'Invasive ductal carcinoma, poorly differentiated, grade III/III, measuring 1.7 cm, located in the upper outer quadrant of the left breast. Lymphovascular invasion present, but no nipple or skin involvement. Surgical margins are tumor-free. Immunohistochemical stains show ER and PR positive, while HER-2/neu is negative.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive ductal carcinoma, poorly differentiated, grade III/III, measuring 1.7 cm, located in the upper outer quadrant, with lymphovascular invasion present. No in situ component identified, no nipple involvement, and surgical margin free of tumor. Immunohistochemical stains show ER and PR positive, and HER-2/neu 2+.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A03M.967287FE-7751-4A90-9465-0A1AD007061D',\n",
       "  'report_length_cl100k_base': 864,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma in the left breast, measuring 2.5 cm, with focal lobular carcinoma in situ (LCIS) and ductal carcinoma in situ (DCIS). One out of four sentinel lymph nodes in the left axilla is involved with metastatic carcinoma. Vascular invasion is present, but the tumor does not involve the nipple or skin. The patient's ER and PR status are negative, and HER2-neu is equivocal.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is diagnosed with invasive ductal carcinoma, NOS type, histological grade III/III, nuclear grade III/III, measuring 2.5 cm in the largest dimension, with vascular invasion present. The cancer is located in the upper outer and inner quadrants of the breast. DCIS is also identified, solid and cribriform types with intermediate nuclear grade and minimal necrosis. LCIS is also identified, classical type. Two out of four sentinel lymph nodes in the left axilla are involved, with metastatic carcinoma identified in single clusters. The cancer is HER2-negative, ER-negative, and PR-negative.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A03N.44527CD3-6EC3-4861-8394-CEA005A17A9E',\n",
       "  'report_length_cl100k_base': 2597,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient is a 35-year-old woman with a right breast mass that was found to be invasive ductal carcinoma, NOS type, histological grade III/III, measuring 3.5 cm in the largest dimension. The tumor is located in the upper outer quadrant, with lymphovascular and perineural invasion present. The lymph node status is 0/15, and immunohistochemical studies for estrogen and progesterone receptors are positive. The pathological staging shows no evidence of metastatic tumor in the sentinel lymph nodes.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 43-year-old woman with a right breast mass. The pathology report indicates invasive ductal carcinoma, NOS type, with a tumor size of 3.5 cm. There is lymphovascular invasion and perineural invasion present, but the lymph node status is 0/15. The tumor is located in the upper outer quadrant, and there is no involvement of the nipple. The report also mentions ductal carcinoma in situ with high nuclear grade and extensive necrosis, constituting less than 25% of the total tumor mass. The tumor is hormone receptor positive and HER2 negative. The sentinel lymph nodes are benign, and there is no evidence of metastatic tumor.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A03O.FE9C56C4-B6D4-4054-A58C-13642370052E',\n",
       "  'report_length_cl100k_base': 1690,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has invasive ductal carcinoma in the right breast, measuring up to 3.7 cm, with no vascular invasion and negative margins. Two sentinel lymph nodes were removed and found to be benign, with results of deeper level recuts and special stains pending in an addendum. The tumor is ER positive, PR positive at 40%, and HER2-negative.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with two foci of carcinoma in the right breast, one of which is invasive ductal carcinoma. The tumor is 3.7 cm in size and is located 0.15 cm from the nearest margin. There is no vascular invasion and the lymph nodes are benign. The cancer is ER and PR positive and HER2-negative. The patient has ductal carcinoma in situ with high nuclear grade and minimal necrosis, which constitutes less than 25% of the total tumor mass. The cancer is stage IA.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A03P.0BFAB667-8B40-46AE-A224-535573E268C7',\n",
       "  'report_length_cl100k_base': 1751,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive poorly differentiated ductal carcinoma in the left breast, measuring 5cm in the largest dimension, with ductal carcinoma in situ (DCIS) present in the upper inner and lower inner quadrants. The tumor is located in the upper outer and upper inner quadrants, with extensive vascular and perineural invasion. There is no skin involvement by carcinoma. Lymph node status is 3/26, with metastatic carcinoma in 1/18 lymph nodes. The patient's cancer is classified as T2, pN1a, MX Stage Grouping IIB.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \" The patient has invasive poorly differentiated ductal carcinoma in the left breast, measuring 5cm in the largest dimension, with ductal carcinoma in situ (DCIS) also identified. The tumor is located in the upper outer and inner quadrants, with no involvement of the nipple. There is extensive vascular invasion and positive perineural invasion. The lymph node status is 3/26, with metastatic carcinoma in one lymph node (1/1) in level one, and micrometastatic carcinoma in one out of eighteen lymph nodes (1/18) in levels one and two. The tumor is ER-negative, PR-negative, and HER2-negative. The patient's cancer is classified as T2, pN1a, MX stage grouping IIB.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A03R.D779EEF8-C83C-4CCA-A140-9BF15DCF14AE',\n",
       "  'report_length_cl100k_base': 2440,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma (IDC) in the left breast, measuring 2.5 cm, with vascular invasion and moderate nuclear grade. DCIS is also present, constituting <=25% of the total tumor mass. Two out of three sentinel lymph nodes in the left axilla are positive for metastatic carcinoma, with no extranodal extension. The patient's cancer is ER+ and PR+, but HER2-. No skin involvement by carcinoma is identified.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma in the left breast, measuring 2.5 cm, with vascular invasion and presence in the upper outer quadrant and central area. Two out of three sentinel lymph nodes in the left axilla level one are positive for metastatic carcinoma, with no extranodal extension. There is also ductal carcinoma in situ present, which constitutes less than 25% of the total tumor mass. The patient's cancer is estrogen and progesterone receptor-positive and HER2-negative. Nine lymph nodes from levels one and two in the left axilla are benign.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A03T.D5EF8C37-811E-42B7-84E5-E6ED71217971',\n",
       "  'report_length_cl100k_base': 1877,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nInvasive ductal carcinoma, secretory type, measuring 1.8 cm in largest dimension, left breast; no lymph node involvement with benign lymph nodes in left and right axilla; no metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive ductal carcinoma, secretory type, measuring 1.8 cm in largest dimension microscopically. DCIS is also identified, secretory type. The DCIS constitutes >= 25% of the total tumor mass, and is present admixed with and away from the invasive component. No involvement of the nipple by either in situ or invasive carcinoma is identified. No vascular invasion is noted. No involvement of the surgical margins by either invasive or in situ carcinoma is identified. No skin involvement by carcinoma is identified. Lymph nodes: 1 benign lymph node (0/1) in Level 1, left axilla; 4 benign lymph nodes (0/4) in Level 1, left axilla; 1 benign lymph node (0/1) in Level 2, left axilla; 2 benign lymph nodes (0/2) in non-sentinel, left axilla; 1 benign lymph node (0/1) in right axilla. Negative controls for HER2, estrogen re',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A03U.A8AF94A0-F3C2-4AB0-AB0C-22BDA51AF546',\n",
       "  'report_length_cl100k_base': 2618,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's left breast invasive ductal carcinoma (IDC) measures approximately 1.5 cm, with DCIS also identified and constituting less than 25% of the total tumor mass. The tumor is located in the upper inner quadrant, with no nipple involvement. The patient's right breast shows benign breast tissue with fibrocystic changes. No lymph node involvement is found in either axilla. Immunohistochemical stains show estrogen receptor (ER) and progesterone receptor (PR) positivity, and HER2 negativity.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's left breast invasive ductal carcinoma is 1.5 cm in size, with no lymph node involvement. The tumor is located in the upper inner quadrant, with no involvement of the nipple or skin. DCIS is also present, constituting less than 25% of the total tumor mass. The right breast shows benign breast tissue with fibrocystic changes. Immunohistochemical stains show estrogen and progesterone receptors present, and HER2 negative.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A03V.63E34973-F630-4295-AC1B-94F81BBEBE41',\n",
       "  'report_length_cl100k_base': 2276,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient is a 50-year-old with invasive ductal carcinoma in the left breast, measuring 1.7 cm in the largest dimension. There is no involvement of the nipple or skin, and no vascular invasion is noted. The patient's lymph nodes from both axillae are benign. The cancer is histological grade III/III with a lymphocyte infiltrate, and DCIS is present but does not exceed 25% of the total tumor mass. The patient's right breast and axillary tail are benign. Immunohistochemical stains (ER, PR, HER-2/neu) results are pending.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a 45-year-old with invasive ductal carcinoma in the left breast, measuring 1.7 cm in the largest dimension. There is no involvement of the nipple or skin, and no vascular invasion is noted. The patient's lymph nodes from both axillae are benign. The cancer is histological grade III/III with nuclear grade III/III. DCIS is present, constituting less than 25% of the total tumor mass. The patient's right breast and axillary tail are benign. No metastasis is found.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A0J2.DB0B1C9D-6B94-46EF-A84E-3D912E08B7FD',\n",
       "  'report_length_cl100k_base': 2623,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma with neuroendocrine differentiation, histologic grade III/III, with a dominant tumor mass measuring 4.2 cm in the greatest dimension and multiple satellite nodules spanning an area of 9 cm. Ductal carcinoma in situ (DCIS) is also identified, making up less than 25% of the total tumor mass. The lymph node status is level I: 0/23, level II: 0/11, and intra-mammary (eleven o'clock): 1/1. There is no vascular invasion or skin involvement by carcinoma. The metastatic focus measures 1.9 cm, and there is no extranodal extension of carcinoma.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma with neuroendocrine differentiation, histologic grade III/III, with a dominant tumor mass measuring 4.2 cm in the greatest dimension and multiple satellite nodules spanning an area of 9 cm. Ductal carcinoma in situ (DCIS) is also identified, making up less than 25% of the total tumor mass. The lymph node status is level 1: 0/23, level 2: 0/11, and intra-mammary (eleven o'clock): 1/1. There is no vascular invasion or skin involvement by carcinoma. The metastatic focus measures 1.9 cm, and there is no extranodal extension of carcinoma.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A0J3.29C262B5-D49D-4125-9661-19033A8EC6A8',\n",
       "  'report_length_cl100k_base': 1635,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's left breast invasive ductal carcinoma measures 1.7cm, with no vascular invasion and scant high-grade ductal carcinoma in situ (DCIS) mixed with the invasive component. The patient's sentinel lymph nodes are benign, and the remaining breast parenchyma is benign with no evidence of metastatic tumor. Immunohistochemical stains show 0% nuclear staining for estrogen and progesterone receptors, and HER2 negativity (0).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's left breast palpable mass biopsy showed invasive ductal carcinoma, measuring 1.7cm in the largest dimension. There is no vascular invasion and the lymph nodes are benign. The breast tissue shows fibroadenomatous changes. The patient's cancer is ER and PR negative and HER2 negative. The sentinel lymph nodes are clear of metastatic tumor.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A0J4.846851BE-3D24-46F0-A6BE-CEB22C7D0F62',\n",
       "  'report_length_cl100k_base': 2240,\n",
       "  't_label': 0},\n",
       " {'abstract': '\\nThe patient is a female with stage IV breast carcinoma. The tumor is invasive and measures at least 10 cm in the largest dimension, with moderate to high nuclear grade. The nipple and skin are involved, and vascular invasion is present. Lymph nodes are involved, with metastatic carcinoma found in two out of two level I lymph nodes. The carcinoma is positive for E-cadherin, supporting lobular differentiation. The HER2 test is equivocal, and FISH will be performed. The ER and PR rabbit monoclonal antibodies are FDA-approved. The specimen is received fresh and consists of a breast with attached axillary contents. The tumor bed occupies almost the entire breast volume, extending throughout all four quadrants. The tumor is located close to the nearest deep margin, and the attached skeletal muscle is extensively involved by direct extension.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 45-year-old female with stage IV breast carcinoma. The tumor is invasive carcinoma, moderate to poorly differentiated, measuring at least 10 cm in the largest dimension, with vascular invasion and involvement of the nipple, skin, and skeletal muscle. DCIS is also present, involving all four quadrants of the breast. Lymph nodes are involved, with metastatic carcinoma found in two out of two level I lymph nodes. Immunohistochemical stains show the carcinoma to be positive for E-cadherin, estrogen receptor, and HER2 (equivocal). The carcinoma is negative for progesterone receptor.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A0J5.5EFC16F4-7FC7-479E-93F7-AEDC2D350A22',\n",
       "  'report_length_cl100k_base': 1718,\n",
       "  't_label': 3},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive ductal carcinoma, poorly differentiated, measuring 4.5 cm in the largest dimension. There is no vascular invasion and the margins of resection are negative for carcinoma. The cancer is estrogen and progesterone receptor-positive, HER2-negative. Lymph nodes 1, 2, and 3 show no evidence of metastatic tumors. Non-neoplastic breast tissue shows fibroadipose and biopsy site changes.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer stage is 1A, with an invasive ductal carcinoma of the left breast measuring 4.5 cm in the largest dimension, no vascular invasion, and no lymph node involvement. The tumor is poorly differentiated with a histological grade of III/III, and the patient's margins of resection are negative for carcinoma. The cancer is estrogen and progesterone receptor-positive and HER2-negative.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A0J6.CE2FF4D3-B82C-4435-AE1C-3E2E6F104271',\n",
       "  'report_length_cl100k_base': 2193,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma with a tumor size of 28mm and 2mm, with nipple involvement. There is also a 2.5mm focus of invasive mucinous carcinoma. Lymph node involvement is present with 2/3 sentinel lymph nodes and 1/1 non-sentinel lymph node positive for metastasis. The tumor is ER and PR positive, and HER2 negative. The patient also has ductal carcinoma in situ (DCIS) with a high nuclear grade. The invasive carcinoma is 3.6cm from the closest margin. The patient's cancer is classified as stage IIA due to the lymph node involvement.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma with two foci, spanning 28mm and 2mm, and is 3.6cm from the closest inked margin. The nipple dermis is involved by invasive ductal carcinoma. DCIS is present and is 3.6cm from the closest inked margin. Sentinel lymph nodes: 2/3. Non-sentinel lymph nodes: 1/1. Total lymph nodes: 3/4. Type of metastasis: macrometastasis (6mm) to an intramammary lymph node. The metastatic carcinoma is negative for WT1. The invasive ductal carcinoma is negative for WT1. ER positive, HER2 negative.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A0J7.4022B2EB-04C3-43F6-9D2C-1A47D80EF6EE',\n",
       "  'report_length_cl100k_base': 2826,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has invasive lobular carcinoma spanning 2.2 cm, with no involvement of separately submitted margins. Sentinel lymph nodes are positive for metastasis in 1/2, and non-sentinel lymph nodes are negative. The cancer is classified as stage IA due to the tumor size and lymph node involvement. There is no evidence of vascular invasion, and HER2 staining is negative.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \" The patient has invasive lobular carcinoma spanning 2.2 cm, with no involvement in separately submitted margins. Sentinel lymph nodes are positive for metastasis (1/2), with non-sentinel lymph nodes being negative. The cancer is characterized as lobular carcinoma in situ (LCIS) and there is no vascular invasion. The tumor is HER2 negative, and the patient's margins are clear of cancer cells.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A0J8.03C7A677-C223-47D6-869E-E6C3250B0C08',\n",
       "  'report_length_cl100k_base': 2420,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has invasive lobular carcinoma, classical type, measuring 0.4 cm in the largest dimension microscopically. Focal ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS) are also identified. The nipple base is involved by invasive carcinoma, but there is no vascular invasion or involvement of surgical margins by invasive carcinoma. Four benign intramammary lymph nodes (0/4) are identified.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with right invasive lobular carcinoma. The tumor measures 0.4 cm in its largest dimension, and there is no vascular invasion noted. The nipple base is involved by invasive carcinoma, but the surgical margins are not involved. Four benign intramammary lymph nodes were identified. The skin shows an ulcer, and the attached skeletal muscle is uninvolved by carcinoma.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-AO-A0J9.1E3F3136-6D86-4470-85AA-55B11C9E24CD',\n",
       "  'report_length_cl100k_base': 947,\n",
       "  't_label': 1},\n",
       " {'abstract': \" The patient is a 47-year-old female who had a bilateral mastectomy and axillary dissection for invasive ductal carcinoma of the breast. Grossly, there were two masses identified in the right breast, measuring 3.6 cm and 2.5 cm, respectively. There were no grossly identifiable lesions in the left breast. The patient had metastatic carcinoma in the lymph nodes of both axilla. The patient's lymph nodes were positive for metastatic carcinoma. The patient's estrogen and progesterone receptors were positive, and her HER2 was negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \" The patient is a 47-year-old female who had a bilateral mastectomy and axillary dissection for invasive ductal carcinoma of the breast. Grossly, there were two masses identified in the right breast, measuring 3.6 cm and 2.5 cm, respectively. There were no grossly identifiable lesions in the left breast. The patient had metastatic carcinoma in the lymph nodes of both axilla. The patient's lymph nodes were positive for metastatic carcinoma. The patient's estrogen and progesterone receptors were positive, and her HER2 was negative.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-AO-A0JA.2E8A1816-E963-4063-B2F0-6289514084A5',\n",
       "  'report_length_cl100k_base': 3964,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's invasive ductal carcinoma (IDC) is grade III/III with areas of lobular growth, measuring 11.0 cm in the largest dimension. Ductal carcinoma in situ (DCIS) is also identified, solid type, with moderate high nuclear grade and extensive necrosis. The lymph node status is level I: 1/10, with extranodal extension of carcinoma >2 mm. The tumor is estrogen and progesterone receptor positive, HER2 negative. The patient's cancer has no skin involvement, and there is no involvement of the surgical margins or the attached skeletal muscle.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with invasive ductal carcinoma (IDC) in the left breast, measuring 11.0 cm in the largest dimension. Ductal carcinoma in situ (DCIS) is also identified, with moderate high nuclear grade and extensive necrosis. The lymph node status is as follows: level I: 1/10, with extranodal extension of carcinoma >2 mm. The tumor is estrogen and progesterone receptor positive, and HER2 negative. The patient's skin, right upper abdominal skin tag, and level 2 and 3 left axillary lymph nodes were also examined, with no involvement of carcinoma identified.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A0JB.6C202D3E-5670-4B63-82A2-9EE7AC385089',\n",
       "  'report_length_cl100k_base': 2100,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive ductal carcinoma, measuring 5.0 cm in the largest dimension, located in the upper and lower outer quadrants of the right breast. There is no involvement of the nipple or skin by the carcinoma. The cancer is grade III/III (slight/no tubule formation) with a nuclear grade of II/III (moderate variation in size and shape). The lymph node status is 0/5 in level 1 and 0/5 in level 2. The tumor is estrogen and progesterone receptor positive and HER2 negative. No vascular invasion is noted, but perineural invasion is present. The patient's cancer has not metastasized.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with a 4.5 cm right breast mass that was biopsied and found to be positive for intraductal carcinoma. The sentinel lymph node biopsy showed no evidence of metastatic tumor. The invasive ductal carcinoma was located in the upper and lower outer quadrants of the breast, measuring 5 cm in the largest dimension. There was no involvement of the nipple or skin by the carcinoma. The lymph node status was level I: 0/5. The tumor was estrogen and progesterone receptor positive and HER2 negative. The tumor cells were positive for cytokeratin 7, BRST-2, and E-cadherin, and negative for CK20, SMA, HHF35, synaptophysin, and chromogranin. Five benign lymph nodes were found in level II of the left axilla. The pathological staging is T1, N0, M0.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A0JC.A1F0FEB5-6FEF-4FF7-AA1E-8EAAE551138B',\n",
       "  'report_length_cl100k_base': 1939,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is invasive ductal carcinoma, nuclear grade III/III, measuring 6 cm in the largest dimension, located in the upper outer quadrant of the left breast. The lymph node status is 2/4, with no extranodal extension of carcinoma. Vascular invasion is present, and the tumor is not involved in the nipple. There is no skin involvement by carcinoma, and the attached skeletal muscle is negative for tumor. The patient's cancer is HER2-negative, and the pathological staging is based on the personal examination of the slides.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer diagnosis includes invasive ductal carcinoma, nuclear grade III/III, measuring 6 cm in the largest dimension, located in the upper outer quadrant of the left breast, with vascular invasion present. The lymph node status is 2/4, with no extranodal extension of carcinoma. The report also mentions papillomatosis of the nipple, biopsy site changes, and fibrocystic changes, and sclerosing adenosis. Additional findings include calcifications in benign breast parenchyma and no involvement of the nipple or skin by carcinoma. The pathological staging includes two benign intra-mammary lymph nodes (0/1), eight benign lymph nodes (0/10) in levels I and II of the left axilla, and nine benign lymph nodes (0/9) in levels II and III of the left axilla.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A0JD.E8A43FF3-3D98-45EE-9567-6EED4DA38274',\n",
       "  'report_length_cl100k_base': 1819,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient is a 45-year-old female with right breast cancer. The tumor is an invasive ductal carcinoma, measuring 2.5 cm in the largest dimension, with ductal carcinoma in situ (DCIS) present in the mass. One out of six sections of the anterior shaved margin shows a microscopic focus of invasive carcinoma (<1 mm). The patient has lymph node involvement with metastatic carcinoma in one lymph node (1/1) in level 1, right axilla, and six out of nineteen lymph nodes positive for metastatic carcinoma (6/19) in level 2, right axilla. Extranodal extension is identified, measuring 0.5 cm. The patient's cancer is hormone receptor-positive and HER2-negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a 47-year-old female with right breast cancer. The tumor is an invasive ductal carcinoma, NOS type, measuring 2.5 cm in the largest dimension. DCIS is also identified, solid type, with high nuclear grade and extensive necrosis. Lymph node involvement is present, with one lymph node positive for metastatic carcinoma (1/1) in level 1, right axilla, and six out of nineteen lymph nodes positive for metastatic carcinoma (6/19) in level 2. Extranodal extension is identified and measures 0.5 cm. The patient's cancer is stage IIA.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AO-A0JE.15CAD156-1E40-4C83-B3ED-484964FE407F',\n",
       "  'report_length_cl100k_base': 1906,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma, NOS type, histologic grade II/III with a tumor size of 2.0 cm in the largest dimension. The cancer has spread to the lymph nodes, with metastatic adenocarcinoma found in one lymph node (1/1) in level one of the left axilla, and extranodal extension present. The patient's cancer is hormone receptor-positive, with 95% of nuclei staining for estrogen receptor and 70% for progesterone receptor. The cancer is HER2-negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \" The patient has invasive ductal carcinoma, NOS type, histologic grade II/III with a tumor size of 2.0 cm in the largest dimension. The cancer has spread to the lymph nodes, with metastatic adenocarcinoma found in one lymph node (1/1) in level one of the left axilla, and extranodal extension present. The patient's cancer is hormone receptor-positive, with 95% nuclear staining for estrogen receptor and 70% nuclear staining for progesterone receptor. The cancer is HER2-negative.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A0JF.D58E5D64-B5B9-4487-8E46-225AE3617C14',\n",
       "  'report_length_cl100k_base': 2871,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient is a 45-year-old female with a 2.7 cm right breast cancer in the lower outer quadrant. The tumor is invasive ductal carcinoma, mixed mucinous and nos type with solid-papillary features, histologic grade III/III, and nuclear grade II/III. Vascular invasion is present, and the tumor is close to the surgical margin (less than or equal to 1 mm). The non-neoplastic breast tissue shows biopsy site changes and proliferative fibrocystic changes. Level 1 lymph nodes show metastatic adenocarcinoma in four out of ten lymph nodes, with the largest metastatic focus measuring 2.5 cm. Level 2 lymph nodes are benign. Immunohistochemical stain shows HER2 negative (0/1+) and ER and PR positive. The patient's cancer is stage IIA.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a 45-year-old female with a 2.7 cm right breast cancer in the lower outer quadrant. The cancer is invasive ductal carcinoma, mixed mucinous and nos type with solid-papillary features, histologic grade III/III, and nuclear grade II/III. Vascular invasion is present, and the cancer is close to the surgical margin. The DCIS is also identified, solid and cribriform types with intermediate nuclear grade and minimal necrosis. The cancer is located in the lower outer quadrant and lower inner quadrant, and there is no involvement of the nipple. Lymph node involvement is present, with metastatic adenocarcinoma in four out of ten lymph nodes, and the largest metastatic focus measures 2.5 cm. The HER2 test is negative, and the ER and PR rabbit monoclonal antibodies are also FDA approved. The patient's cancer is stage IIA.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AO-A0JG.3671D46F-6D69-42DA-9830-24F67EB8B0B6',\n",
       "  'report_length_cl100k_base': 1599,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer stage is T1 (tumor size 1.1 cm), N1 (metastatic carcinoma in one sentinel lymph node), and M0 (no distant metastasis). The tumor is invasive ductal carcinoma, poorly differentiated, with DCIS present but not involving the nipple. The patient's cancer is estrogen and progesterone receptor-positive and HER2-negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer stage is 1A, with a 1.1cm invasive ductal carcinoma in the left breast, poorly differentiated, with DCIS present but not involving the nipple. One sentinel lymph node in the left axilla showed micrometastatic clusters and single cells, while another sentinel lymph node was benign. The cancer is estrogen and progesterone receptor-positive and HER2-negative.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A0JI.468411B5-1719-46B4-835D-E469D6AEFF12',\n",
       "  'report_length_cl100k_base': 2142,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient has invasive lobular carcinoma of the left breast, with involvement of the nipple and lymphovascular invasion. One axillary lymph node is positive for metastatic mammary carcinoma (1/1), and the remaining non-neoplastic breast tissue shows focal ductal hyperplasia with atypia. The tumor is estrogen and progesterone receptor-positive and HER2-negative. The patient's cancer is stage IA, T1, N1, M0.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with invasive lobular carcinoma of the left breast, classical type, involving approximately 4.5 cm of the breast tissue and the base of the nipple. One axillary lymph node is positive for metastatic mammary carcinoma (1/1), with no extranodal tumor extension. The tumor is estrogen and progesterone receptor-positive and HER2-negative. Lymph node involvement is present in level 1 of the left axilla, with 222 benign lymph nodes found in level 1 and 16 benign lymph nodes in level 2. The surgical margins are clear of carcinoma.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A0JJ.EB9B6625-6674-4665-9BEE-D4DFD9366A02',\n",
       "  'report_length_cl100k_base': 2414,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient is a female with a left breast mass that was found to be invasive ductal carcinoma, poorly differentiated, measuring 3.9 cm in the largest dimension. There is also DCIS present in the breast. The lymph node status is positive with extranodal tumor extension. The patient's cancer is ER and PR negative, and HER2-negative. The tumor has vascular invasion and calcifications are present. The skin and surgical margins are not involved by the carcinoma. The patient's cancer is stage IIA due to the presence of extranodal tumor extension.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with left breast mass. The breast specimen shows two tumor nodules, one invasive ductal carcinoma in the upper outer quadrant, measuring 3.9 cm, and the second, composed of predominantly ductal carcinoma in situ (DCIS) with several foci of invasive ductal carcinoma. Vascular invasion is present, and the lymph node status shows extranodal tumor extension. The remaining breast tissue displays mild fibrocystic changes. The axillary contents specimens show benign lymph nodes. The patient's cancer is ER-negative, PR-negative, and HER2-negative.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AO-A0JL.C2976F78-89AF-4461-8D22-BFEBC0504722',\n",
       "  'report_length_cl100k_base': 1642,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive ductal carcinoma with DCIS, poorly differentiated, with a tumor size ranging from 0.1 to 3 cm. Lymph node involvement is present in 2 out of 13 level 1 lymph nodes, 0 out of 9 level 2 lymph nodes, and 0 out of 2 level 3 lymph nodes. No extranodal extension is observed. Vascular invasion is present, and the tumor is located in the lower inner and outer quadrants of the breast. The patient's cancer is hormone receptor positive (ER and PR) and HER2 positive.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with right lower inner quadrant carcinoma IDC/DCIS with microcalcifications. The lymph node status is as follows: level I: 0/13, level II: 0/9, and level III: 0/2. The invasive carcinoma is located in the lower outer quadrant and lower inner quadrant, and DCIS is also identified. Vascular invasion is present, but no involvement of the surgical margins by invasive carcinoma is identified. The metastasis is present in one out of six lymph nodes (1/6) and one out of one lymph node (1/1) in levels I and II, respectively. No skin involvement by carcinoma is identified, and the attached skeletal muscle is negative for tumor. The ER, PR, and HER2-neu stains will be reported as an addendum.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A0JM.3023C34B-CF59-43EA-9241-33B738D19B05',\n",
       "  'report_length_cl100k_base': 2042,\n",
       "  't_label': 1},\n",
       " {'abstract': ' The patient is a female, with a malignant neoplasm of the breast, with no lymph node involvement.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient is a female, with a malignant neoplasm of the breast, with no lymph node involvement.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A124.9009B4A7-3570-4AD6-878E-90CE8DA7980A',\n",
       "  'report_length_cl100k_base': 4003,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has multicentric DCIS and invasive cancer of the left breast, with a tumor measuring 3cm in the greatest dimension. There is no lymph node involvement, and metastasis status is pending further testing. The invasive carcinoma is 0.3cm from the nearest superior margin, and DCIS is also identified. The patient's cancer is hormone receptor positive and HER2 negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has multicentric DCIS and invasive cancer of the left breast, with a tumor measuring 3cm in the greatest dimension. There is no involvement of the nipple by either in-situ or invasive carcinoma. The invasive carcinoma is located in the central/superior area and the DCIS is located in the central/superior area and medial aspect at the previous biopsy site. The patient's lymph nodes are benign, and the cancer is ER and PR positive, but HER2-negative. The tumor is 0.3cm from the nearest superior margin and there is no vascular invasion. The non-neoplastic breast tissue shows biopsy site changes, fibrocystic changes, benign papillomas, and sclerosing adenosis.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A125.AE348902-0573-4A57-BBD6-037FA2AF1872',\n",
       "  'report_length_cl100k_base': 2323,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient is a 42-year-old with newly diagnosed right breast cancer. The tumor measures 2.5 cm in the largest dimension, and there is no involvement of the nipple. Four sentinel lymph nodes were removed, all of which were negative for tumor (0/1). The invasive carcinoma is located in the upper-inner quadrant and is 0.5 cm from the nearest margin. Vascular invasion is not noted, and there is no skin involvement by carcinoma. The patient's cancer is ER-positive, PR-positive, and HER2-negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 42-year-old with newly diagnosed right breast cancer. The pathology report indicates invasive ductal carcinoma in the right breast, measuring 2.5 cm in the largest dimension. The cancer is located in the upper-inner quadrant, with no involvement of the nipple. There is no vascular invasion and the carcinoma is 0.5 cm from the nearest margin. Four sentinel lymph nodes were removed, all negative for tumor. The cancer is histologic grade II/III and nuclear grade II/III. Immunohistochemical stains for hormone receptors are positive, and HER2-neu is negative.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A126.A4BFA94D-166F-43D4-90B5-3C547F4026A0',\n",
       "  'report_length_cl100k_base': 2203,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is invasive ductal carcinoma, measuring 4.0 cm in the largest dimension, with no vascular invasion or involvement of surgical margins. There is no ductal carcinoma in situ. The tumor is negative for ER, PR, and HER2-neu. Lymph node involvement is absent, with three benign lymph nodes in level 1, right axilla (sentinal node 1), two benign lymph nodes in level 2, right axilla (sentinal node 2), and one benign lymph node in level 2, right axilla (sentinal node 3). No metastases are identified.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is invasive ductal carcinoma, measuring 4.0 cm in the largest dimension, with no ductal carcinoma in situ. The tumor is negative for ER, PR, and HER2-neu. Lymph nodes 1, 2, and 3 are benign. No vascular invasion is noted, and surgical margins are not involved by invasive carcinoma.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A128.03526CFD-0C3E-4ACB-AB26-3E0B0ED0ADA2',\n",
       "  'report_length_cl100k_base': 2197,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has invasive ductal carcinoma with medullary features, measuring 2.3 cm in the largest dimension, located in the lower outer quadrant of the left breast. There is no involvement of the nipple or skin, and no vascular invasion. The lymph node status is 2/13 in level 1 and 0/4 in level 2. The tumor is HER2-negative, ER-negative, and PR-negative. Two benign lymph nodes were found in level 3 of the left axilla, and no lymph nodes were identified in the right axilla.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma with medullary features, measuring 2.3 cm in the largest dimension, located in the lower outer quadrant of the left breast. There is no involvement of the nipple, vascular invasion, or skin involvement. The lymph node status is 2/13 in level 1 and 0/4 in level 2. The tumor is surrounded by thickened fibrous tissue, and there is extranodal extension of carcinoma. The patient's right breast is benign with secretory changes. No lymph nodes were identified in the right axillary tail. The sentinel lymph nodes in the right axilla are benign. Special stains for ER, PR, and HER2-NEU are negative.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A129.DD973A0E-3CC3-4ED7-BE2C-7E5E3C55032B',\n",
       "  'report_length_cl100k_base': 2056,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's invasive ductal carcinoma measures 3.1 cm in the largest dimension and is located in the upper outer quadrant of the right breast. There is no involvement of the nipple or skin, and no vascular invasion is noted. The patient's cancer is ER-positive, PR-positive, and HER2-negative. Lymph node involvement is present in level one of the right axilla, with micrometastasis identified in sentinel lymph node #3. The other sentinel lymph nodes (#1, #2, #4, and #5) show no evidence of metastatic tumor.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' Invasive ductal carcinoma, poorly differentiated, measuring 3.1 cm in largest dimension, located in the upper outer quadrant of the right breast; no involvement of the nipple by either in situ or invasive carcinoma; no vascular invasion noted; no skin involvement by carcinoma identified; ER-positive, PR-negative, HER2-negative; no lymph node metastasis found in levels 1, 2, 3, and 4 of the right axilla; additional superior mastectomy flap tissue shows no residual carcinoma.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A12A.A54E82A4-D7C2-4A5C-A69C-C66976F0282F',\n",
       "  'report_length_cl100k_base': 2727,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient has invasive ductal carcinoma in the right breast with no lymph node involvement. The tumor is 2.3 cm in size and is located in the upper and lower inner quadrants and central area. Ductal carcinoma in situ is also present but constitutes less than 25% of the total tumor mass. The patient has a benign lymph node in the left breast. The tumor is histologic grade III/III and nuclear grade II/III. No vascular invasion is noted, and the surgical margins are not involved. The patient's cancer is ER and PR positive and HER2-negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma in the right breast with solid papillary architecture, measuring 2.3 cm in the largest dimension, and ductal carcinoma in situ (DCIS) present away from the invasive component. There is no involvement of the nipple by either invasive or in situ carcinoma, and no vascular invasion is noted. The patient has one benign lymph node in the right axilla, and the DCIS constitutes <25% of the total tumor mass. The invasive carcinoma is located in the upper and lower inner quadrants and central area, and the DCIS is located in the central area. The patient's left breast shows duct hyperplasia without atypia and stromal fibrosis. The results of special stains (ER, PR, HER2-neu, and neuroendocrine markers) will be reported in an addendum.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A12B.CF071D24-7BA2-43BE-B3E7-A981DBDFCA0F',\n",
       "  'report_length_cl100k_base': 1947,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's left breast invasive ductal carcinoma (IDC) extends to the lateral, inferior, anterior, and posterior margins, measuring up to 2.5 cm. There is prominent vascular invasion and lymphatic tumor emboli at the margins. One of three lymph nodes in level 1 axilla is positive for metastatic mammary carcinoma, and extranodal extension is present (>2 mm). Eighteen benign lymph nodes are found in level II, and six benign lymph nodes in level III. The patient's cancer is ER-positive, PR-positive, and HER2-positive (3+).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' Invasive ductal carcinoma, NOS type with prominent vascular invasion, measuring up to 2.5 cm, extending to lateral, inferior, anterior, and posterior margins; DCIS present with intermediate nuclear grade; metastatic mammary carcinoma in one of four sentinel lymph nodes (1/4); additional level 3 nodes benign with tumor embolus in perinodal lymphatic vessels; ER-negative, PR-negative, HER2-positive (3+).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A12C.7E9202F6-F2DB-4CC0-A10F-3D9A82E84242',\n",
       "  'report_length_cl100k_base': 2337,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nInvasive ductal carcinoma in left breast, measuring 1.9cm, with lymph node involvement in level II (1/7) and extranodal extension. Negative for metastasis. HER2/neu positive.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive ductal carcinoma in left breast with a minor component of ductal carcinoma in situ; tumor size 1.9cm; lymph node involvement in levels 1 and 2 with extranodal extension; negative surgical margins; no metastasis to right breast; ER, PR, and HER-2/neu negative; lymph node status: level 1 - 0/8, level 2 - 1/7; special stains show focal necrosis and lymphovascular invasion.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A12D.9363D53D-BC3B-4AC0-8185-536C6DB3A6AE',\n",
       "  'report_length_cl100k_base': 2146,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient has a 5.5 cm multicentric invasive lobular carcinoma in the right breast, with lobular carcinoma in situ, involving the nipple and extending to the cauterized anterior flap margin and skin. There is perineural invasion, but no vascular invasion or lymph node involvement. The tumor is ER+ and PR+, while HER2 is negative. The patient's tumor stage is T3, PNO (I+), MX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 55-year-old female with a 5.5 cm right breast cancer. The tumor is multicentric invasive lobular carcinoma, classical type, with solid pattern. LCIS is also identified. The nipple is involved by invasive carcinoma, and perineural invasion is present. The lymph node status is level I: 0/7, level II: 0/6. The tumor stage is T3, PNO (I+), MX. ER: 85Z nuclear staining with moderate intensity, PR: 408 nuclear staining with moderate intensity, and HER2: negative (staining intensity of 0).',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A12E.332675C9-53CB-4244-8480-82E1546DA7F2',\n",
       "  'report_length_cl100k_base': 1059,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's right breast cancer is invasive ductal carcinoma, NOS type, with a tumor size of 4.3 cm in the largest dimension. There is no lymph node involvement, and metastasis is not identified. The cancer is located in the upper-outer quadrant of the breast, with no involvement of the nipple. The lymph node status is 0/1, and the patient's ER, PR, and HER2 results are negative. The cancer is staged as T1, N0, M0.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's right breast cancer is invasive ductal carcinoma, NOS type, with a tumor size of 4.3 cm in the largest dimension. There is no involvement of the nipple or skin by carcinoma, and the lymph node status is 0/1. The cancer is located in the upper-outer quadrant, with DCIS also identified in the same area. The patient's cancer is ER-negative, PR-negative, and HER2-negative. The lymph nodes are benign.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A12F.96B43BA2-7099-436C-8AFD-FD53E55E7F51',\n",
       "  'report_length_cl100k_base': 2687,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has invasive lobular carcinoma of the right breast, measuring 2.5 cm in the largest dimension. There is no involvement of the nipple or skin. The lymph node status is level I: 0/3, with metastatic carcinoma identified in one lymph node (micrometastasis). The tumor is hormone receptor-positive (ER and PR) and HER2-positive. LCIS is also present.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a female with a 2.6 cm invasive lobular carcinoma of the right breast. The lymph node status is as follows: level I, 0/3; level II, 0/2; level III, 1/1 (micrometastasis). The tumor is located in the upper outer quadrant, with no involvement of the nipple or skin. The breast tissue shows fibrocystic changes, and calcifications are present in the in situ carcinoma. The patient's cancer is ER+ (1000% nuclear staining), PR+ (30% nuclear staining), and HER2+ (staining intensity of 2+).\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A12G.6CE21603-4200-40BA-94AA-15F24EE4AC7F',\n",
       "  'report_length_cl100k_base': 1948,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive ductal carcinoma, moderately differentiated with a solid-papillary growth pattern and mucinous differentiation, measuring 2.2 cm in the largest dimension. The tumor is estrogen and progesterone receptor-positive and HER-2/neu negative. There is no lymphovascular invasion. The patient's lymph nodes, sentinel and non-sentinel, are benign (0/1, 0/1, 0/2, 0/5). The cancer is classified as T1, N0, M0.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer stage is T1 with no lymph node involvement. The tumor is invasive ductal carcinoma, measuring 2.2 cm in the largest dimension, with a solid-papillary growth pattern and mucinous differentiation. The cancer is estrogen and progesterone receptor-positive and HER-2/neu negative. The patient's nipple, surgical margins, and non-sentinel lymph nodes are tumor-free.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A12H.2FDFCEB5-74F7-417E-9FD1-ECC81B27803B',\n",
       "  'report_length_cl100k_base': 2272,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive lobular carcinoma in the left breast, with multiple foci distributed over an area spanning about 6cm, and extensive lobular carcinoma in situ. The tumor is located in the upper outer quadrant and lower outer quadrant, with no involvement of the nipple. The patient has one benign lymph node in the left axilla, and metastatic carcinoma in the form of microscopic clusters and single cells in several lymph nodes, totaling about 3000-400 cells. The invasive carcinoma is 0.6cm from the nearest margin, and there is no vascular or perineural invasion. The patient's breast tissue shows estrogen and progesterone receptor positivity, and HER2 negativity.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \" The patient has invasive lobular carcinoma in the left breast, with multiple foci distributed over an area spanning about 6 cm, and extensive lobular carcinoma in situ. The tumor is located in the upper outer quadrant and lower outer quadrant, with no involvement of the nipple. The patient has one benign lymph node in the left axilla, and metastatic carcinoma in the form of microscopic clusters and single cells in another lymph node. The patient's cancer is estrogen and progesterone receptor positive, and HER2 negative.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A1KO.15FB8CBD-85EF-45BE-8065-9F4E922D457E',\n",
       "  'report_length_cl100k_base': 3037,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's cancer is invasive ductal carcinoma, with multiple foci ranging from 0.3 to 1.8 cm. One sentinel lymph node out of two is positive for metastatic carcinoma, measuring 0.3 cm. There is extranodal extension, vascular invasion, and no involvement of the nipple or skin. The tumor is located in the lower inner quadrant and between the lower outer and lower inner quadrants. DCIS is present, comprising less than 25% of the total tumor mass. The patient's cancer is ER and PR positive and HER2-negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer stage is T1 (tumor size ranges from 0.3 to 1.8 cm), with extranodal extension and lymph node involvement (1/1) in the left axilla. The cancer is classified as invasive ductal carcinoma, NOS type, with a moderate tubular formation and nuclear grade II/III. DCIS is also present, comprising less than 25% of the total tumor mass. Vascular invasion is identified, but there is no skin involvement by carcinoma. The cancer is ER-positive, PR-positive, and HER2-negative.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A1KP.467172CC-6EA1-435D-BDC1-D65FBF8EA0E8',\n",
       "  'report_length_cl100k_base': 2114,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient is a male with invasive ductal carcinoma (IDC) in the left breast. The tumor measures 2.2 cm and is located in the lower inner quadrant, involving the nipple with perineural invasion. There is DCIS present, making up less than 25% of the total tumor mass. One out of eight lymph nodes (1/8) is positive for metastatic carcinoma, with no extranodal extension. The patient's cancer is ER-positive, PR-positive, and HER2-negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a male with invasive ductal carcinoma (IDC) in the left breast. The tumor measures 2.2 cm and is located in the lower inner quadrant and central area, involving the nipple. There is a focus of perineural invasion in the nipple region and calcifications are present in the in situ carcinoma. One out of eight lymph nodes (1/8) is positive for metastatic carcinoma, with no extranodal extension. The lymph node with metastasis measures at least 2 mm. The patient's cancer is classified as N1, with no evidence of extranodal extension (Nc). The tumor is ER-positive, PR-positive, and HER2-negative.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A1KQ.EB5199BA-6164-4CFB-AFAA-B41544B83103',\n",
       "  'report_length_cl100k_base': 1454,\n",
       "  't_label': 3},\n",
       " {'abstract': \"\\nThe patient's right breast has invasive poorly differentiated ductal carcinoma, measuring 2.4 cm, with no lymph node involvement, vascular invasion, or skin involvement. The left breast has ductal hyperplasia without atypia. The patient's cancer is ER negative, PR negative, and HER2 negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's right breast had invasive poorly differentiated ductal carcinoma, measuring 2.4 cm, with no vascular invasion or involvement of the nipple, surgical margins, or skin. Lymph node involvement was absent in both the right and left axilla, with benign lymph nodes (0/1) in levels 1 and 2. The left breast had ductal hyperplasia without atypia. The patient's cancer is ER negative (0% nuclear staining), PR negative (0% nuclear staining), and HER2 negative (staining intensity of 1+).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AO-A1KR.FF188295-E139-4AEE-8EE8-364536F2BBE8',\n",
       "  'report_length_cl100k_base': 2103,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive lobular carcinoma of the left breast with a tumor size of 2.6cm. There is no lymph node involvement in the axillary nodes, and the cancer has not metastasized. Estrogen and progesterone receptors are positive, and HER2 is equivocal. The Oncotype test result shows a 15% average rate of distant recurrence.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \" The patient has invasive lobular carcinoma of the left breast with a tumor size of 2.6cm. Lymph node status is negative, with no carcinoma present in the sentinel lymph nodes. The patient's cancer is hormone receptor-positive, with positive estrogen and progesterone receptor expression. HER2 status is equivocal (2+), and FISH testing will be performed. The Oncotype test resulted in a score of 23, indicating an average rate of distant recurrence of 15%. Surgical margins are clear, and the patient's cancer is stage I.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AO-A1KS.0FB93D92-81F6-4241-9094-4AABF70E6A0F',\n",
       "  'report_length_cl100k_base': 2947,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive ductal carcinoma, poorly differentiated, measuring 1.9 cm. One lymph node showed microscopic clusters of tumor cells, while the other two sentinel lymph nodes were benign. There is focal ductal carcinoma in situ, solid and cribriform type, with intermediate to high nuclear grade and necrosis. The DCIS constitutes <25% of the total tumor mass and is present admixed with and adjacent to the invasive component. The cancer is HER2/neu gene non-amplified.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's pathology report indicates an invasive ductal carcinoma in the left breast, measuring 1.9 cm, with focal ductal carcinoma in situ. The cancer is poorly differentiated, with a histological grade of III/III and a nuclear grade of III/III. The tumor has not spread to the sentinel lymph nodes, which are benign, and there is no evidence of metastatic tumor in the additional lymph nodes. The patient's HER2/CEP 17 ratio is 1.4, indicating that the Her-2/neu gene is not amplified.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AO-A1KT.D9432167-0F2E-4377-9DB4-EA4E59A6C9B9',\n",
       "  'report_length_cl100k_base': 1626,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient has been diagnosed with infiltrating ductal carcinoma with micropapillary features, with two separate invasive tumor masses in the lower inner quadrant of the left breast. The larger mass is 2.5 cm, and the smaller mass is 1.4 cm. Lymphatic space invasion is present between the masses. The patient has multifocal ductal carcinoma in situ, with a high nuclear grade of 3. Four axillary lymph nodes with metastases have been identified. The tumor is classified as T2, N2a, and Mx. The patient's cancer is hormone receptor-positive and HER2/neu indeterminate.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with infiltrating ductal carcinoma with micropapillary features, with a tumor size of 2.5cm and 1.4cm, respectively, in the left breast. Lymphovascular invasion is present, with 4 axillary lymph nodes showing metastasis. The tumor is hormone receptor positive and HER2/neu indeterminate. The AJCC pathologic TNM stage is pT2 pN2a pMx.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AQ-A04H.D40D0424-E1DA-4AEF-AD00-126038E80218',\n",
       "  'report_length_cl100k_base': 2886,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive ductal carcinoma with a tumor size of 2.7 cm. There is no lymph node metastasis identified in the right axillary sentinel lymph nodes (0/1), but an isolated tumor cell cluster was found in one of the left axillary sentinel lymph nodes. The cancer is stage pT2 pN0(i+) pMx. Hormone receptor studies showed negative results. The patient's cancer is not overexpressing HER2/neu.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is stage pT2, with a tumor size of 2.7 cm and no lymph node metastasis (pN0(i+)). There is an isolated tumor cell cluster in one lymph node, but no extracapsular extension was found. The tumor is invasive ductal carcinoma with lobular carcinoma in situ in the left breast. The patient's cancer is hormone receptor negative and HER2/neu negative.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AQ-A04J.71CEC5F6-16E5-46E1-A91B-B5E0F699B231',\n",
       "  'report_length_cl100k_base': 2126,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient is a female with right breast invasive ductal carcinoma and left breast non-proliferative fibrocystic change. The right breast tumor size is 2.5 cm, with lymphovascular space invasion and surgical margins free of invasive carcinoma. The tumor is estrogen receptor positive, progesterone receptor negative, and HER2/neu overexpressed (score=3+). Ductal carcinoma in situ is present, comprising approximately 5% of the tumor, with a comedo subtype and nuclear grade 3 necrosis. No atypia or malignancy are identified in the left breast. Two sentinel lymph nodes are benign, negative for malignancy.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with right breast carcinoma and a left breast mass who underwent bilateral mastectomy and sentinel node biopsy mapping. The right breast specimen revealed invasive ductal carcinoma, measuring 2.5 cm, with lymphovascular space invasion and surgical margins free of invasive carcinoma. The tumor was estrogen receptor positive, progesterone receptor negative, and HER2/neu overexpressed (score=3+). Ductal carcinoma in situ was also present, comprising approximately 5% of the tumor, with a nuclear grade of 3 and necrosis. The sentinel lymph nodes were negative for carcinoma.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-AQ-A04L.40B58A7A-2A05-4AAF-B1D4-B418E4A56115',\n",
       "  'report_length_cl100k_base': 1801,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is classified as stage pT2 pN2a according to the AJCC PATHOLOGIC TNM STAGE. The tumor size is 2.4 cm, and there is evidence of metastatic adenocarcinoma in 5 out of 17 right axillary lymph nodes, with the largest metastasis being 0.6 cm. Extracapsular extension is present and extensive. The cancer is invasive ductal carcinoma, with a Nottingham combined histologic grade of 3 and lymphovascular invasion present. The patient's cancer is also characterized by fibrocystic changes and microcalcifications.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is invasive ductal carcinoma, with a tumor size of 2.4cm and Nottingham combined histologic grade of 3. The cancer has spread to 5 out of 17 right axillary lymph nodes, with the largest metastasis being 0.6cm. Extracapsular extension is present and extensive. The cancer is stage pT2 pN2a. Microcalcifications are present, and perineural invasion is identified. The patient's cancer is hormone receptor-positive and HER2-negative.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AQ-A0Y5.5BC01981-366E-44EC-A986-087DB7904E5C',\n",
       "  'report_length_cl100k_base': 2076,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma with a tumor size of 3.5 cm and lymph node involvement (7 out of 10 axillary lymph nodes with metastasis, largest metastasis 1.3 cm). The cancer is stage pT2 pN2a. The tumor is hormone receptor positive (estrogen receptor and progesterone receptor positive, HER2/neu negative) and shows lymphovascular invasion and extracapsular extension. There is no evidence of skin or nipple involvement, and the margins are clear.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient has invasive ductal carcinoma with extensive fibrosis, measuring 3.5 cm, with lymphovascular invasion and axillary lymph node involvement (7 out of 10 nodes with metastasis, largest metastasis 1.3 cm). The cancer is staged as pT2 pN2a. Immunohistochemical stains show the tumor to be estrogen and progesterone receptor positive, and HER2/neu negative (1+).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AQ-A1H2.1B5FA34B-E3B4-4D4B-AF0A-1C90016CC532',\n",
       "  'report_length_cl100k_base': 2870,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma in the right breast with a size of 3.7cm, with lymph node metastases in the right axillary sentinel and non-sentinel lymph nodes. There are also findings of ductal carcinoma in situ, lobular carcinoma in situ, and atypical lobular hyperplasia. The patient's cancer is classified as stage pT2(m) pN3a.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma in the right breast with a size of 3.7cm, with metastases found in 14 out of 23 axillary lymph nodes, including extracapsular extension. There is lymphovascular invasion present, and the cancer is classified as AJCC PATHOLOGIC TNM STAGE pT2(m) pN3a.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-AQ-A1H3.6EB1A616-E99C-4AF6-9C0A-0FDC521A79CD',\n",
       "  'report_length_cl100k_base': 2382,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma in the left breast with a tumor size of 4.9 cm. There is no lymphovascular invasion or lymph node involvement. The tumor is unifocal and the margins are negative. The patient's AJCC pathologic TNM stage is pT2 pNO.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma in the left breast with a tumor size of 4.9 cm. There is no lymphovascular invasion or lymph node involvement. The tumor is unifocal and the margins are negative. The patient's AJCC pathologic TNM stage is pT2 pNO. The sentinel lymph node is negative for carcinoma. The remaining breast tissue is composed of yellow lobulated fat with no lesions identified.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AQ-A54N.9BF0E34A-F78C-4BFD-AC4C-926FA1D60342',\n",
       "  'report_length_cl100k_base': 1283,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an infiltrating ductal carcinoma with a tumor size of 35mm, unifocal, and Nottingham combined histologic grade 3. There is no lymphovascular invasion, and the cancer is stage pT2 pNO. The sentinel lymph node and 13 axillary lymph nodes were examined, with no evidence of metastatic carcinoma found (0/14). The invasive component margins are widely clear, and the in situ component is negative with a linear extent of 2mm. The patient's cancer is hormone receptor-positive, and HER2 is negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an infiltrating ductal carcinoma with a tumor size of 35mm, unifocal, and Nottingham combined histologic grade 3. There is no lymphovascular invasion, and the cancer is stage pT2 pNO. The axillary lymph nodes are clear of metastasis, with no evidence of metastatic carcinoma in 14 examined lymph nodes. The invasive component has negative margins, and the in situ component is negative and widely clear of all margins. The report also mentions gynecomastia and biopsy site changes. The immunohistochemical studies support a diagnosis of reactive lymph nodes and do not indicate a lymphoproliferative disorder.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AQ-A54O.B3884493-D0D2-445C-B9BB-BC475021EBA4',\n",
       "  'report_length_cl100k_base': 1588,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive lobular carcinoma with a single focus, measuring 4.1 cm in size. There is no lymphovascular invasion or nipple involvement, but LCIS is present. Two out of seven axillary lymph nodes are positive for metastasis, with the largest metastatic focus being 0.7 cm. The patient's cancer is classified as stage IIB based on the available information.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a 45-year-old female with invasive lobular carcinoma in the left breast. The tumor has a Nottingham combined histologic grade of 2 and a focality of single focus. The tumor size is 4.1 cm, with no lymphovascular invasion or nipple involvement. The patient has 2 positive lymph nodes out of 7 examined, with the largest metastatic focus being 0.7 cm. The tumor is estrogen and progesterone receptor positive and HER2/neu negative. The patient's AJCC pathologic TNM stage is pT2 pN1a and breast stage grouping is IIB.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AQ-A7U7.2B30A85F-7A5F-46E4-BE22-28C902D5DFA3',\n",
       "  'report_length_cl100k_base': 2060,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has an infiltrating ductal carcinoma with a size of 3 x 3 x 2.5 cm, grade III (of III), with no vascular invasion and clear margins. There is no lymph node involvement in the sentinel lymph nodes or axillary lymph nodes, and no evidence of metastasis. The cancer is classified as AJCC pT2 and pNO(i-).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has an infiltrating ductal carcinoma grade III (of III) with a 3 x 3 x 2.5 cm mass, with less than 10% of the tumor being in situ, and no vascular invasion identified (AJCC pT2). The margins of excision are free of tumor. The sentinel lymph nodes No.1 and No.2 are negative for tumor, and three left axillary lymph nodes are also negative for tumor.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A0TP.E1A92F92-1DD2-4E33-9C16-3FD0371D1431',\n",
       "  'report_length_cl100k_base': 168,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma in the right breast, with a tumor size of 7.2 x 4.5 x 3.4 cm (AJCC pT2), no angiolymphatic invasion, and negative surgical margins. Two of nine right axillary lymph nodes are positive for metastatic carcinoma, with the largest lymph node measuring 1.4 cm, and no extranodal extension is identified. The left breast shows nonproliferative fibrocystic changes, and Her-2/NEU results are pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma in the right breast, measuring 7.2 x 4.5 x 3.4 cm, with no angiolymphatic invasion and negative surgical margins. Two of nine right axillary lymph nodes are positive for metastatic carcinoma, with the largest measuring 1.4 cm. The left breast shows nonproliferative fibrocystic changes. Her-2/NEU results are pending.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A0TQ.6061FCA5-A113-4985-905D-E17020F6933E',\n",
       "  'report_length_cl100k_base': 311,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a tumor size of 2.3 x 2.1 x 1.7 cm, located in the superior/central aspect of the breast (AJCC pT2). The tumor has angiolymphatic invasion and does not involve the nipple, overlying skin, or underlying chest wall. Surgical resection margins are negative for tumor. 22 left mid/low axillary lymph nodes are negative for metastatic carcinoma, but 1 out of 3 left high axillary lymph nodes is positive for metastatic adenocarcinoma (AJCC pN1). No extranodal extension is present.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma grade II (pT2) with a tumor size of 2.3 x 2.1 x 1.7 cm, located in the superior/central aspect of the breast. The tumor has angiolymphatic invasion and does not involve the nipple, overlying skin, or underlying chest wall. Surgical resection margins are negative for tumor, and multiple left mid/low axillary lymph nodes are negative for metastatic carcinoma. However, a single left axillary sentinel lymph node is positive for metastatic adenocarcinoma with one metastasis measuring 2.5 x 2.5 x 1.3 cm (pN1). Extranodal extension is not present.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A0TR.6535D911-D718-4794-9D5E-6E06553464FF',\n",
       "  'report_length_cl100k_base': 312,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma (pT2) with angiolymphatic invasion and 5% ductal carcinoma in situ. Two out of three sentinel lymph nodes are positive for metastatic carcinoma (pN1), with extranodal extension. Thirteen axillary lymph nodes were negative for tumor.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has infiltrating ductal carcinoma with a size of 2.4 x 2.1 x 1.5 cm, with angiolymphatic invasion and ductal carcinoma in situ present. Surgical resection margins are negative for tumor, but two out of three sentinel lymph nodes are positive for metastatic carcinoma with extranodal extension. Thirteen axillary lymph nodes were negative for tumor.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A0TS.39A0AD32-D372-422F-94F2-173F963C7AAB',\n",
       "  'report_length_cl100k_base': 286,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a size of 2.3 x 1.9 x 1.8 cm (AJCC pT2) and no lymph node involvement (AJCC pN0). However, 3 out of 6 sentinel lymph nodes and 2 out of 13 axillary lymph nodes are positive for metastatic carcinoma (AJCC pN2), and extranodal extension is present. The tumor is grade III (of III) with a Nottingham score of 8/9. Her-2/NEU results are pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has infiltrating ductal carcinoma grade III with a mass size of 2.3 x 1.9 x 1.8 cm (AJCC pT2) and no ductal carcinoma in situ. Surgical margins are negative for tumor with a minimum margin of 0.5 cm. Three of six sentinel lymph nodes and two of 13 axillary lymph nodes are positive for metastatic carcinoma (AJCC pN2), indicating lymph node involvement. Extranodal extension is present, and Her-2/NEU results are pending.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AR-A0TT.E9231B33-E1CE-4396-9F9E-03DBF049919A',\n",
       "  'report_length_cl100k_base': 270,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma (pT2), with no lymph node involvement (pN0), and no metastasis (pM0). The tumor is 4.2 x 4.0 x 3.0 cm in size, with necrosis present and negative surgical margins. HER2/neu protein overexpression is negative, and hormone receptors for estrogen and progesterone are also negative.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Infiltrating ductal carcinoma, grade III, 4.2 x 4.0 x 3.0 cm, in lower outer quadrant (AJCC pT2); no in situ component, nipple uninvolved, surgical margins negative, 4 right axillary sentinel lymph nodes negative (AJCC pNO(sn)), HER2/neu protein overexpression negative, Estrogen and Progesterone receptors negative.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A0TU.81A39E94-059E-4307-A75A-E8C051E9D0C3',\n",
       "  'report_length_cl100k_base': 325,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 2.6 x 2.4 x 2.0 cm (AJCC pT2) grade III ductal carcinoma in the left breast with no angiolymphatic invasion and no ductal carcinoma in situ component. Three left axillary sentinel lymph nodes were removed and found to be negative for tumor (AJCC pN0(i-)). Her-2/NEU results are pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has a 2.6 x 2.4 x 2.0 cm Nottingham grade III ductal carcinoma in the left breast with no angiolymphatic invasion and no significant ductal carcinoma in situ component. A separate hyalinized fibroadenoma is present superior to the tumor mass. Three left axillary sentinel lymph nodes were excised and found to be negative for tumor. Her-2/NEU status is pending.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A0TV.7594A7F8-1806-4B74-99EF-4E4C889E7BEA',\n",
       "  'report_length_cl100k_base': 235,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a multifocal ductal carcinoma in the right breast, with the largest tumor being 5.5 cm. There are three additional tumors, all grade II, with sizes ranging from 2.0 to 1.0 cm. The surgical margins are negative, but metastatic adenocarcinoma is present in three of the 27 right axillary lymph nodes, with the largest node measuring 3.5 cm. There is no extracapsular extension. The left breast shows nonproliferative fibrocystic changes, and the nipples are negative for malignancy.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has multifocal ductal carcinoma in the right breast, with the largest tumor being 5.5 cm in greatest dimension and three additional tumors ranging from 2.0 cm to 1.0 cm. The surgical margins are negative, but metastatic adenocarcinoma is present in three of 27 right axillary lymph nodes, with the largest node measuring 3.5 cm. There is no definite extracapsular extension. The left breast shows nonproliferative fibrocystic changes, and the nipples are negative for malignancy.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A0TW.F832C787-3668-475F-8F67-6342DA3777F4',\n",
       "  'report_length_cl100k_base': 196,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma (pT1c) with no angiolymphatic invasion, no lymphovascular invasion, and 3 positive lymph nodes (pN1) with extranodal extension. The tumor size is 1.5 x 1.2 x 1.0 cm and the margins are clear after re-excision. Her-2/NEU results are pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma (pT1c) with no angiolymphatic invasion and no evidence of metastasis. The tumor is 1.5 x 1.2 x 1.0 cm in size and is grade II (of III). Ductal carcinoma in-situ is present outside the main tumor mass. Three out of 25 lymph nodes are positive for metastatic carcinoma with extranodal extension (pN1). The surgical resection margins are negative for tumor, and the skin is without diagnostic abnormality. Her-2/NEU results are pending.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A0TX.4FC34715-9004-4F53-B914-F0004AEA88C8',\n",
       "  'report_length_cl100k_base': 212,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma in the right breast, measuring 2.4 x 2.2 x 1.8 cm (AJCC pT2), with no evidence of in situ carcinoma. The tumor margins are free of cancer, and 8 right axillary lymph nodes are negative for tumor involvement (AJCC pNo(sn-)). The left breast shows benign tissue with non-proliferative fibrocystic changes and a negative single axillary lymph node for tumor. Estrogen and progesterone receptor analysis, as well as Her-2/NEU, are pending on the right breast tissue.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma in the right breast, measuring 2.4 x 2.2 x 1.8 cm (AJCC pT2), with no evidence of in situ carcinoma. The tumor margins are free of skin, nipple, and resection. Eight right axillary lymph nodes are negative for tumor (AJCC pNo(sn-)). The left breast shows benign tissue with non-proliferative fibrocystic changes and a negative single axillary lymph node. Estrogen, progesterone, and Her-2/NEU receptor analysis is pending on the right breast tissue.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A0TY.12A4A731-1ADF-4D36-88F3-16C9642484F3',\n",
       "  'report_length_cl100k_base': 379,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma in the left breast, with multiple masses ranging from 0.5 to 3.2 cm in size, with 10% ductal carcinoma in situ. The tumor is stage T2 (AJCC), and the lymph nodes are stage N2 (AJCC), as 6 out of 30 axillary lymph nodes are positive for metastatic carcinoma, including 2 matted lymph nodes. The HER2/neu status is pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma in the left breast, with multiple masses ranging from 0.5 to 3.2 cm in size, with 10% ductal carcinoma in situ. The cancer has spread to 6 out of 30 axillary lymph nodes, including 2 matted lymph nodes. The results of HER2/neu testing on paraffin-embedded tissues are pending.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AR-A0TZ.48F86416-8304-479E-B477-7C37A2F951A2',\n",
       "  'report_length_cl100k_base': 190,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma in the left breast, with a tumor size of 2.3 x 1.8 x 1.5 cm, grade III (pT2). Vascular invasion is present, and the surgical margins are negative. Two sentinel lymph nodes show micrometastasis (less than 0.2 mm), while other axillary lymph nodes are negative for tumor. The patient's cancer is estrogen and progesterone receptor negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Infiltrating ductal carcinoma, grade III, 2.3 x 1.8 x 1.5 cm mass, situated in the lower inner quadrant, vascular invasion identified, surgical margins negative, 2 left axillary sentinel lymph nodes with micrometastasis (less than 0.2 mm), Estrogen and Progesterone negative, ER test not cleared or approved by the U.S. Food and Drug Administration.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A0U0.322BB8BB-100F-4838-9771-EAEE5A3B817A',\n",
       "  'report_length_cl100k_base': 307,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a tumor size of 2.3 x 2.2 x 2.0 cm (AJCC pT2) and negative surgical margins. There is metastatic adenocarcinoma in the left breast intramammary lymph node, but no extranodal extension is identified. The left axillary sentinel lymph nodes are negative for tumor, and the left axillary (23) lymph nodes are also negative for tumor. Her-2/NEU results are pending on paraffin embedded tissue.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive ductal carcinoma, grade 3, 2.3 x 2.2 x 2.0 cm mass with negative surgical margins. Metastatic adenocarcinoma found in left breast intramammary lymph node. Negative for tumor in left axillary sentinel lymph nodes (5) and left axillary lymph nodes (23). Her-2/NEU results pending.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A0U1.007C609A-7874-4E39-BC4D-1EA81F4722EA',\n",
       "  'report_length_cl100k_base': 190,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma in the left breast, with a tumor size of 3.2 x 2.2 x 1.6 cm (AJCC pT2) and angiolymphatic invasion. The surgical resection margins are negative for tumor. Four out of 16 axillary lymph nodes are involved with metastatic adenocarcinoma (AJCC pN2), with the largest metastatically involved node measuring 3.0 cm. Estrogen and progesterone receptor analysis and her2-Neu status are pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma in the left breast, with a 3.2 x 2.2 x 1.6 cm mass, grade III (pT2), and angiolymphatic invasion. Four out of 16 axillary lymph nodes are metastatically involved (pN2), with the largest measuring 3.0 cm. The surgical resection margins are clear, and there are no abnormalities found in the fallopian tubes or ovaries. Estrogen, progesterone, and Her2-Neu receptor analyses are pending.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AR-A0U2.51F69645-9564-4257-A86E-3A574C27034F',\n",
       "  'report_length_cl100k_base': 251,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal adenocarcinoma with a tumor size of 2.3 x 2.0 x 2.0 cm (AJCC pT2) and 1 positive sentinel lymph node (AJCC pN1mi). The tumor is estrogen and progesterone positive, with >10% and 1-10% nuclear staining, respectively. Surgical margins are negative for tumor, and 3 left axillary lymph nodes are negative for tumor (AJCC pNO).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal adenocarcinoma with a tumor size of 2.3 x 2.0 x 2.0 cm (AJCC pT2) and 10% ductal carcinoma in-situ. One left axillary sentinel lymph node is positive for tumor (AJCC pN1mi), while three left axillary lymph nodes are negative. The tumor is estrogen-positive and progesterone-focally positive.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A0U3.ED2D1BA8-8FEB-43E1-9174-91F9D59565F9',\n",
       "  'report_length_cl100k_base': 221,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma in the left breast, measuring 4.7 x 4.0 x 2.7 cm, with no lymph node involvement (AJCC pT2, N0). The tumor is estrogen and progesterone receptor negative and HER2/neu protein overexpression is negative. The right breast parenchymal tissue is negative for tumor, with focal calcifications and a negative sentinel lymph node.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma in the left breast, measuring 4.7 x 4.0 x 2.7 cm, with no lymph node involvement (AJCC N0(1-)(sn). The tumor is estrogen and progesterone receptor negative and HER2/neu protein overexpression is negative. The right breast parenchymal tissue is negative for tumor, with focal calcifications identified, and a single intraparenchymal lymph node is negative for tumor.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A0U4.6424BA69-DA2B-4CCD-ADDF-DB1BEDA11EBF',\n",
       "  'report_length_cl100k_base': 371,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a tumor size of 3.1 x 2.3 x 2.1 cm, with angiolymphatic invasion and one positive micrometastatic lymph node (pN1mi). Estrogen receptor is focally positive, while progesterone receptor is negative, and HER2/neu protein overexpression is negative. Surgical margins are tumor-free, and there is no evidence of metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma with a tumor size of 3.1 x 2.3 x 2.1 cm, with extensive angiolymphatic invasion and proliferative fibrocystic changes. One of the two right axillary lymph nodes is positive for micrometastatic carcinoma, and the other is negative. The patient's cancer is estrogen-focally positive and HER2/neu protein overexpression is negative.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A1AH.75F29A17-B6AF-43B9-BE12-3ABF850F23BA',\n",
       "  'report_length_cl100k_base': 360,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 4.5 x 2.0 x 2.0 cm well-circumscribed medullary carcinoma in the left breast (AJCC pT2) with no lymph node involvement (AJCC pN0(i-)) and negative surgical margins. No metastasis is detected.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has medullary carcinoma with a tumor size of 4.5 x 2.0 x 2.0 cm in the left breast, classified as AJCC pT2. The surgical margins are negative, and there is no lymph node involvement (AJCC pN0(i-)). The immunohistochemical cytokeratin stain confirms the H&E impression.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A1AI.F5CAE962-5347-46FA-86EE-169121BED547',\n",
       "  'report_length_cl100k_base': 149,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma (pT1c) with no angiolymphatic invasion and negative surgical margins. Two sentinel lymph nodes and six axillary lymph nodes are negative for tumor (pN0), and there is no HER2/neu protein overexpression.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has infiltrating ductal carcinoma grade III (of III), with a tumor size of 1.2 x 1.1 x 0.9 cm (AJCC pTIc). There is no angiolymphatic invasion, and surgical margins are negative for tumor. The right axillary sentinel lymph nodes are negative for tumor, and HER2/neu protein overexpression is negative.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A1AJ.0DEAC35F-8B73-4A9F-B7FA-2F501B736B0E',\n",
       "  'report_length_cl100k_base': 221,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient has invasive mammary carcinoma with multiple masses ranging from 0.7 cm to 1.6 cm in size, minimal ductal carcinoma in situ (5%), and no angiolymphatic invasion. The tumor closely approaches the inferior margin (0.1 cm) and the skin, nipple, and final surgical margins are negative for tumor. The patient's right axillary sentinel lymph nodes are negative for tumor (AJCC pN0(sn)(i-)), and HER2/neu protein overexpression is negative (score of 1+).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive mammary carcinoma with predominantly lobular features, forming multiple masses ranging from 0.7 cm to 1.6 cm in size, situated in various quadrants. There is a minimal component of ductal carcinoma in situ, intermediate nuclear grade, and no angiolymphatic invasion. The tumor closely approaches the inferior margin and skin, nipple, and final surgical margins are negative for tumor. Multiple right axillary sentinel lymph nodes are negative for tumor, and HER2/neu protein overexpression is negative.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A1AK.F4DBFC71-9CD0-41C3-9F20-77FA0605D4A8',\n",
       "  'report_length_cl100k_base': 267,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a 6.5 x 5.2 x 3.5 cm infiltrating lobular carcinoma in the superior portion of the left breast (AJCC pT3), with lobular carcinoma in situ present. The tumor does not involve the nipple, overlying skin, or underlying chest wall. One out of six lymph nodes is positive for metastatic carcinoma (AJCC pN1), and there is no evidence of metastasis (AJCC M0). Estrogen and progesterone receptor analysis and Her-2/NEU results are pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with infiltrating lobular carcinoma in the left breast, with a mass size of 6.5 x 5.2 x 3.5 cm, which is classified as AJCC pT3. The tumor does not involve the nipple, overlying skin, or underlying chest wall. One out of six lymph nodes is positive for metastatic carcinoma, classified as AJCC pN1. Estrogen and progesterone receptor analysis and Her-2/NEU have been ordered on paraffin-embedded tissue.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A1AL.E3D44C6B-4497-4212-8CA1-AC9444B4CC54',\n",
       "  'report_length_cl100k_base': 466,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has two invasive breast carcinomas, one of which has metastasized to a right axillary sentinel lymph node. Both tumors show HER2/neu protein overexpression (score 2+). The first lesion is a 1.1 cm lobular carcinoma in the upper outer quadrant (AJCC pT1c), and the second is a 1.7 cm ductal carcinoma located 0.6 cm inferior and medial to the first mass (AJCC pT1c). The remaining 11 right axillary sentinel lymph nodes are negative for metastatic cancer. No angiolymphatic invasion is observed, and all surgical resection margins are tumor-free. HER2/neu amplification was not demonstrated by fluorescence in situ hybridization (FISH).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with invasive mammary carcinoma with two nodules, one of lobular and one of ductal carcinoma, both of which show HER2/neu protein overexpression (score 2+). The lobular carcinoma has metastasized to the right axillary sentinel lymph node No. 1D, while the ductal carcinoma has not. The tumors have no angiolymphatic invasion and surgical resection margins are clear. The patient is also diagnosed with ductal carcinoma in situ. HER2/neu amplification was not demonstrated by fluorescence in situ hybridization (FISH).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A1AM.10C43124-3C21-443C-8268-23BF8A4D317E',\n",
       "  'report_length_cl100k_base': 908,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma (pT2) with no lymph node involvement (pNO) and no signs of metastasis (pM0). The tumor size is 2.2 x 1.6 x 1.6 cm, and the pathological report shows no evidence of angiolymphatic invasion or ductal carcinoma in situ. The patient's lymph nodes were tested and found to be negative for metastatic carcinoma.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma (pT2) with no ductal carcinoma in situ, no angiolymphatic invasion, and negative surgical margins. The tumor size is 2.2 x 1.6 x 1.6 cm. There is no lymph node involvement (pNO) and no metastasis (M0). The immunohistochemical cytokeratin stain confirms the H&E impression, and Her-2/NEU results are pending.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A1AN.DA251274-7966-4F48-A02F-393ABBDAB4E9',\n",
       "  'report_length_cl100k_base': 271,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a tumor size of 1.7 x 1.6 x 1.2 cm, grade III (Nottingham score 8/9). There is no angiolymphatic invasion, and all surgical resection margins are negative for tumor. One intramammary lymph node is positive for metastatic carcinoma, and one of two left axillary sentinel lymph nodes is also positive (AJCC pN1). Estrogen and progesterone receptor analysis and Her-2/NEU results are pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma with a tumor size of 1.7 x 1.6 x 1.2 cm, grade III (Nottingham score 8/9), with no angiolymphatic invasion. The surgical resection margins are negative for tumor, but a single intramammary lymph node is positive for metastatic carcinoma. One of the two left axillary sentinel lymph nodes is also positive for metastatic carcinoma (AJCC pN1). The remaining 36 left axillary lymph nodes are negative for tumor. Estrogen and progesterone receptor analysis and Her-2/NEU have been ordered.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A1AO.37EF1828-0A53-4358-97C7-A7849EC653AF',\n",
       "  'report_length_cl100k_base': 328,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with mucinous features, measuring 1.9 x 1.0 x 0.9 cm, with no angiolymphatic invasion and negative margins after re-excisions. Ductal carcinoma in situ is present, comprising 5-25% of the tumor volume. The sentinel lymph node is negative for metastatic carcinoma, and the final pathologic stage is pT1c, pNO (sn). Her-2/NEU results are pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma with mucinous features, grade III, with a tumor size of 1.9 x 1.0 x 0.9 cm. There is no angiolymphatic invasion, but the medial margin is positive for ductal carcinoma in situ. The sentinel lymph node is negative for metastatic carcinoma, and the skin, nipple, and deep surgical margin are free of neoplasm. The Her-2/NEU results are pending.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A1AP.0BFF09DE-6F36-4F68-AC13-8BC16AA0DCBE',\n",
       "  'report_length_cl100k_base': 286,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a tumor size of 3.5 x 2.5 x 2.5 cm (AJCC pT2) and no angiolymphatic invasion. The surgical resection margins are negative for tumor, and the sentinel lymph nodes are negative for metastatic carcinoma (AJCC pN0(i-)). A single non-sentinel lymph node is also negative for tumor.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma with a tumor size of 3.5 x 2.5 x 2.5 cm, grade III (Nottingham score 9/9), with no angiolymphatic invasion. The surgical resection margins are negative for tumor, and the sentinel lymph nodes are negative for metastatic carcinoma (AJCCpN0(i-)). A single non-sentinel lymph node is also negative for tumor.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A1AQ.FC236604-AAE5-4394-9D39-270FFEFB635A',\n",
       "  'report_length_cl100k_base': 248,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a tumor size of 1.8 x 1.5 x 1.5 cm (pT1c) and angiolymphatic invasion. The cancer has spread to 5 out of 14 left axillary lymph nodes with extranodal extension (pN2). There is no evidence of metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with infiltrating ductal carcinoma, grade III, with a tumor size of 1.8 x 1.5 x 1.5 cm and angiolymphatic invasion. The cancer has spread to multiple lymph nodes in the left axilla with extranodal extension, indicating stage pN2. All surgical resection margins are negative for tumor.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AR-A1AR.747FB91B-F523-4FA0-91DD-6014EF55643D',\n",
       "  'report_length_cl100k_base': 202,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with two masses (0.7 x 0.3 x 0.3 cm and 4.3 x 3.4 x 3.2 cm) with angiolymphatic invasion. The surgical margins are negative for tumor, and five high axillary lymph nodes are negative for tumor. However, one mid/low axillary lymph node is positive for metastatic adenocarcinoma, measuring 1.0 x 0.9 x 0.7 cm.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma with two masses (0.7 x 0.3 x 0.3 cm and 4.3 x 3.4 x 3.2 cm) with angiolymphatic invasion. The surgical resection margins are negative for tumor, but one out of 12 left mid/low axillary lymph nodes is positive for metastatic adenocarcinoma, measuring 1.0 x 0.9 x 0.7 cm.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A1AS.180AA688-0B63-4DD9-BA29-708E80FBC4C9',\n",
       "  'report_length_cl100k_base': 306,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive lobular carcinoma of the breast, 2.5 x 2.1 x 1.9 cm in size, with no angiolymphatic invasion and negative surgical margins. One out of three left axillary sentinel lymph nodes is positive for isolated tumor cells, with a total of five isolated tumor cells/clusters, the largest measuring 0.05 mm. The tumor is grade III (of III) and is characterized by a lobular immunophenotype.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with Infiltrating mammary carcinoma with predominantly lobular features, solid variant, Nottingham grade III, forming a 2.5 x 2.1 x 1.9 cm mass. Focal lobular carcinoma in situ is also present. Angiolymphatic invasion is absent. All surgical resection margins are negative for tumor. One of three left axillary sentinel lymph nodes is positive for isolated tumor cells, with multiple isolated tumor cells/clusters, the largest measuring 0.05 mm.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A1AT.D52A6E4B-C80A-4947-96FE-3295E418EC67',\n",
       "  'report_length_cl100k_base': 343,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's right breast had multiple masses, with the largest being 2.6cm, and a fibroadenoma (0.3cm). The tumor did not involve the nipple, skin, or chest wall. Two of three right axillary non-sentinel lymph nodes and two of 27 right mid/low axillary lymph nodes were positive for metastatic carcinoma, with focal extracapsular extension. The left breast showed benign tissue with non-proliferative fibrocystic changes.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma in the right breast, with two masses measuring 2.6 x 2.2 x 1.6 cm and 0.3 x 0.2 x 0.2 cm, respectively. The tumor is grade III (of III) and does not involve the nipple, overlying skin, or underlying chest wall. The patient's cancer has spread to two of three non-sentinel lymph nodes and two of 27 mid/low axillary lymph nodes, but not to the sentinel lymph nodes. The left breast is benign with non-proliferative fibrocystic changes.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AR-A1AU.5654FC27-47D3-4C7F-A0E7-A5B6140991C2',\n",
       "  'report_length_cl100k_base': 529,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a size of 2.8 x 2.3 x 2.1 cm, no ductal carcinoma in situ, and no angiolymphatic invasion. The tumor involves the overlying skin (AJCC pT4). One out of 23 left axillary mid/low lymph nodes is positive for metastatic carcinoma, showing extranodal extension. Two left high axillary lymph nodes are negative for tumor.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma with a size of 2.8 x 2.3 x 2.1 cm, grade II out of III, located in the retroareolar region of the left breast. There is no ductal carcinoma in situ, angiolymphatic invasion, or calcifications. The tumor involves the overlying skin (AJCC pT4). One out of 23 left axillary mid/low lymph nodes is positive for metastatic carcinoma, with extranodal extension. The positive lymph node is 1.7 cm in greatest dimension. Multiple left high axillary lymph nodes are negative for tumor.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A1AV.5AD5B38F-5CC1-4A2F-96E6-F344D8FE0149',\n",
       "  'report_length_cl100k_base': 227,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma (pT2) with no ductal carcinoma in situ, negative angiolymphatic invasion, and negative lymph nodes. The tumor is 2.7 x 2.5 x 2.0 cm, with a circumscribed, sclerotic mass and a minimum tumor-free margin of 0.8 cm. ER/PR and Her2/neu results are pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with infiltrating ductal carcinoma with medullary-like features, measuring 2.7 x 2.5 x 2.0 cm, with no ductal carcinoma in situ or angiolymphatic invasion. The tumor is classified as AJCCpT2. The surgical resection margins are negative for tumor, with a minimum tumor-free margin of 0.8 cm. A single left axillary sentinel lymph node is negative for tumor. ER/PR and Her2/neu results are pending on paraffin-embedded tissue.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A1AW.BB485405-199C-48C7-96D7-8C315DEA66B4',\n",
       "  'report_length_cl100k_base': 225,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma (pT1c) with no lymph node involvement (pN0) and no signs of metastasis (pM0). The tumor size is 1.9 x 1.8 x 1.2 cm, and it consists of 25% ductal carcinoma in situ. All surgical margins are clear, and immunohistochemical cytokeratin stain confirms the results.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma (pT1c) with a tumor size of 1.9 x 1.8 x 1.2 cm, intermediate nuclear grade ductal carcinoma in situ (comprising approximately 5-25% of tumor volume), and no angiolymphatic invasion. The surgical resection margins are negative for tumor, and the patient's left axillary sentinel lymph nodes are negative for metastatic carcinoma (pN0).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A1AX.4FDBA110-6E14-428C-BF82-168AE28A14E4',\n",
       "  'report_length_cl100k_base': 264,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a tumor size of 2.0 x 1.8 x 1.5 cm, with focal high-grade ductal carcinoma in situ and no angiolymphatic invasion. The tumor is grade III (Nottingham score 8/9). One out of three sentinel lymph nodes is positive for an isolated tumor cell cluster, measuring 0.11 mm. The resection margins are negative for tumor, and a non-sentinel lymph node is negative for metastatic carcinoma.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma with a tumor size of 2.0 x 1.8 x 1.5 cm, with focal high-grade ductal carcinoma in situ and no angiolymphatic invasion. The tumor is grade III (of III) with a Nottingham score of 8/9. One out of three sentinel lymph nodes is positive for an isolated tumor cell cluster, measuring 0.11 mm. The patient's cancer is stage pT1cN1mi.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A1AY.01D97550-C616-4001-85A5-5502D35FA38E',\n",
       "  'report_length_cl100k_base': 358,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive lobular carcinoma in the right breast, measuring 2.8 x 2.6 x 6 cm, with no lymphovascular involvement or carcinoma in situ component. The surgical resection margins are negative for tumor, and the uninvolved breast tissue shows duct ectasia and stromal fibrosis. The sentinel lymph node is negative for tumor, and multiple right axillary lymph nodes are also negative for tumor. The cancer is hormone receptor-positive.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive lobular carcinoma, size 2.8 x 2.6 x 6 cm, no lymphovascular involvement or carcinoma in situ component, surgical resection margins negative for tumor, uninvolved breast tissue shows duct ectasia and stromal fibrosis, sentinel lymph node negative for tumor, multiple right axillary lymph nodes negative for tumor, estrogen and progesterone receptors positive.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A24H.C373F2EE-C601-4E17-8E2D-D9BC6AC0301A',\n",
       "  'report_length_cl100k_base': 159,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a tumor size of 2.7 x 2.7 x 1.5 cm (AJCC pT2) and negative margins. The left axillary sentinel lymph nodes are also negative for tumor (AJCC pNO). No evidence of metastasis is found.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma with a tumor size of 2.7 x 2.7 x 1.5 cm (AJCC pT2) and negative margins. The left axillary sentinel lymph nodes are also negative for tumor (AJCC pNO (i-sn)).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A24K.BC7B3577-CA6C-41AD-98E2-89D357D29D37',\n",
       "  'report_length_cl100k_base': 161,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma, grade 2, with a tumor size of 2.5 x 2.1 x 1.0 cm (PT2) and angiovascular invasion present. Two of five sentinel lymph nodes are positive for metastatic breast carcinoma (pN1), and seven right axillary lymph nodes are negative for tumor. Estrogen/progesterone analysis and Her2/Neu results are pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma grade 2, forming a 2.5 x 2.1 x 1.0 cm mass with angiovascular invasion. The tumor is stage PT2. Two of five sentinel lymph nodes are positive for metastatic breast carcinoma, making the patient node-positive (N1). Seven right axillary lymph nodes were negative for tumor. Estrogen/progesterone analysis and Her2/Neu testing have been ordered.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A24L.BF82AD23-B40E-459F-83EC-590D392664FD',\n",
       "  'report_length_cl100k_base': 197,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive mammary carcinoma with a tumor size of 2.5 x 2.4 x 2.2 cm (AJCC pT2) and mixed ductal and lobular features. Two out of 24 lymph nodes are positive for metastatic mammary carcinoma (AJCC pN2), and no metastasis is reported. The Her-2/Neu status is pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive mammary carcinoma with mixed ductal and lobular features, grade II, with a tumor mass of 2.5 x 2.4 x 2.2 cm (AJCC pT2). The surgical resection margins are negative for tumor. A fibroadenoma is also identified. Two out of three left axillary sentinel lymph nodes are positive for metastatic mammary carcinoma (AJCC pN2).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AR-A24M.56DFBCCE-A9D9-4F08-AC7E-33998F3439B2',\n",
       "  'report_length_cl100k_base': 235,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma (pT1c) with a tumor size of 1.9 x 1.2 x 1.0 cm and a minor component of ductal carcinoma in situ. The surgical resection margins are negative for tumor with a deep margin of 0.2 cm. Three sentinel lymph nodes were removed and found to be negative for tumor, confirming pN0 status. Her-2/NEU analysis is pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma (pT1c) with a tumor size of 1.9 x 1.2 x 1.0 cm, and a minor component of ductal carcinoma in situ. The surgical resection margins are negative for tumor with a deep margin of 0.2 cm. Three left axillary sentinel lymph nodes were removed and found to be negative for tumor, confirming by immunohistochemical cytokeratin stain. The patient's lymph node status is AJCC pN0. Her-2/NEU analysis is pending on paraffin embedded tissue.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A24N.AAF32BB7-716A-4C0E-AE7E-04F6A5BF5628',\n",
       "  'report_length_cl100k_base': 228,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a multifocal lobular carcinoma with focal ductal features, with two separate masses in the left breast measuring 5.3 x 2.7 x 1.4 cm and 1.2 x 1.0 x 1.0 cm. There is no lymphovascular space invasion, but 6 out of 17 left axillary lymph nodes are involved with metastatic lobular carcinoma. The margins of resection are negative for tumor, and Her-2/NEU results are pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has multifocal lobular carcinoma with focal ductal features, grade I, forming two separate masses in the left breast. The tumor size is 5.3 x 2.7 x 1.4 cm and 1.2 x 1.0 x 1.0 cm. Lymphovascular space invasion is not seen, but multiple (6 of 17) left axillary lymph nodes are involved by metastatic lobular carcinoma. Margins of resection are negative for tumor. The patient's cancer is stage III (AJCC pT3, pN2). Her-2/NEU has been ordered on paraffin embedded tissue.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AR-A24O.887F0E3A-DC70-4CD4-AAAF-3C613195D895',\n",
       "  'report_length_cl100k_base': 213,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has a 1.5 x 1.4 x 1.2 cm infiltrating ductal carcinoma (pT1c) with associated ductal carcinoma in situ (AJCC pN0(i-), and no lymph node involvement. The tumor is grade II (of III) on the Nottingham scale.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma with a tumor size of 1.5 x 1.4 x 1.2 cm (AJCC pT1c) and 20% ductal carcinoma in situ. The resection margins are tumor-free, and the sentinel lymph nodes (Nos. 1, 2, and 3) are negative for tumor (AJCC pN0(i-)).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A24P.0BF7CB67-49F1-42EA-8B41-988BD7E0DE61',\n",
       "  'report_length_cl100k_base': 173,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma in both breasts, with tumor sizes of 6.0 x 4.0 x 3.5 cm (pT3) in the left breast and 1.7 x 1.3 x 1.0 cm (pT1c) in the right breast. The margins of resection are negative for tumor, and the overlying skin and nipples are not involved. The left axillary sentinel lymph nodes are negative for metastatic carcinoma (pNO), and the right axillary sentinel lymph nodes are also negative (pN0). Her-2/NEU results are pending for the left breast.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The pathology report describes two invasive ductal carcinomas, one in each breast, with tumor sizes of 6.0 x 4.0 x 3.5 cm (pT3) and 1.7 x 1.3 x 1.0 cm (pT1c), respectively. Both tumors have negative margins and are not involved with the overlying skin or nipple. The left axillary sentinel lymph nodes are negative for metastatic carcinoma (pNO), and the right axillary sentinel lymph nodes are also negative (pN0). Immunohistochemical cytokeratin stains confirm the H&E impressions. Her-2/NEU testing has been ordered for the left breast tumor.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A24Q.CCE8E855-2582-4214-B9B1-25F0431065CB',\n",
       "  'report_length_cl100k_base': 379,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has invasive Nottingham grade III ductal carcinoma with a tumor size of 1.8 x 1.4 x 1.4 cm (AJCC pT1c) and angiolymphatic invasion. There is no ductal carcinoma in situ. Surgical margins are free of tumor, with the closest deep margin being 0.3 cm away. The patient has multiple (6 out of 28) positive right axillary lymph nodes with metastatic adenocarcinoma, including matted nodes forming a 1.4 x 1.2 x 1.2 cm mass with extracapsular extension into soft tissue (AJCC pN2). Her-2/NEU results are pending on paraffin-embedded tissue.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive Nottingham grade III ductal carcinoma with a tumor mass of 1.8 x 1.4 x 1.4 cm (AJCC pT1c) and angiolymphatic invasion. Surgical margins are free of tumor, with the closest deep margin being 0.3 cm away. There is metastatic adenocarcinoma in multiple (6 of 28) right axillary lymph nodes, with three positive lymph nodes forming a 1.4 x 1.2 x 1.2 cm mass with extracapsular extension into soft tissue (AJCC pN2). Her-2/NEU results are pending on paraffin-embedded tissue.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AR-A24R.C3259BD1-1A2A-40C4-A106-FA2EF0201811',\n",
       "  'report_length_cl100k_base': 193,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a tumor size of 1.3 x 1.1 x 1.0 cm, grade II (Nottingham score 6/9). There is no ductal carcinoma in situ, angiolymphatic invasion, or lymph node involvement. The tumor is AJCC pT1c, and lymph nodes are pN0(i-)(sn). All surgical resection margins are negative for tumor, and HER2/neu results are pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma with a tumor size of 1.3 x 1.1 x 1.0 cm, grade II (Nottingham score 6/9). There is no ductal carcinoma in situ, and the surgical resection margins are negative for tumor. The right axillary sentinel lymph nodes are negative for metastatic carcinoma (pN0(i-)(sn)). The patient's HER2/neu status is yet to be determined.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A24S.C0A8A457-8790-4745-BD5D-AFBE55254A1C',\n",
       "  'report_length_cl100k_base': 308,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive lobular carcinoma in the right breast, measuring 5.7 x 4.8 x 2.1 cm, with angiolymphatic invasion and negative surgical margins. One of the sentinel lymph nodes is positive for metastatic carcinoma, and 14 of 16 axillary lymph nodes are also positive (AJCC pN3). The left breast shows proliferative fibrocystic disease without atypia. Her-2/NEU results are pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with infiltrating lobular carcinoma in the right breast, measuring 5.7 x 4.8 x 2.1 cm, with angiolymphatic invasion and lobular carcinoma in situ present. The tumor does not involve the nipple, overlying skin, or underlying chest wall. One of the right axillary sentinel lymph nodes is positive for metastatic carcinoma, and 14 of 16 axillary lymph nodes are positive for metastatic carcinoma. The left breast shows proliferative fibrocystic disease without atypia.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-AR-A24T.226031B3-D9C2-4343-B3F7-4E0C36B901E7',\n",
       "  'report_length_cl100k_base': 326,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with two masses in the left breast, measuring 1.1 x 1.0 x 1.0 cm and 1.6 x 1.5 x 1.5 cm, with angiolymphatic invasion. One out of five axillary lymph nodes is positive for metastatic carcinoma with extranodal extension. There is no evidence of metastasis to other organs.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Infiltrating ductal carcinoma with micropapillary differentiation, grade III, forming multiple masses (1.1 x 1.0 x 1.0 cm and 1.6 x 1.5 x 1.5 cm) with angiolymphatic invasion, negative surgical margins, and one positive left axillary lymph node with extranodal extension.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A24U.B481795F-C52C-4FCE-827A-07991C7A7C2E',\n",
       "  'report_length_cl100k_base': 276,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has infiltrating ductal carcinoma grade II (tubules 2/3, nuclei 2/3, mitoses 2/3; Nottingham score 7/9), with a tumor mass measuring 2.4 x 1.7 x 1.6 cm (AJCC pT2). The cancer has extended to the axillary sentinel lymph nodes, with one node positive for micrometastasis (AJCC pN1mi(sn)), and two metastases measuring 1.0 mm and 0.5 mm. There is no evidence of angiolymphatic invasion. All surgical resection margins are negative for tumor, with a minimum tumor-free margin of 1.0 cm.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has been diagnosed with infiltrating ductal carcinoma, Nottingham grade II, with a tumor mass measuring 2.4 x 1.7 x 1.6 cm. The tumor has intermediate nuclear grade and 5-25% of it is composed of ductal carcinoma in situ, solid and micropapillary type. There is angiolymphatic invasion. The surgical resection margins are negative for tumor, with a minimum tumor-free margin of 1.0 cm. One of the two axillary sentinel lymph nodes is positive for micrometastasis, with two metastases measuring 1.0 mm and 0.5 mm. The patient's cancer is classified as AJCC pT2, pN1mi(sn).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A24V.468CD293-C9F7-43C6-A40A-18FCDD22F6AA',\n",
       "  'report_length_cl100k_base': 266,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma in the right breast (pT2), with a tumor size of 2.1 x 1.4 x 1.1 cm, intermediate nuclear grade, and angiolymphatic invasion present. Three out of four right axillary sentinel lymph nodes are positive for metastatic carcinoma (pN1(5n)). The patient also has ductal carcinoma in situ in the left breast (pTis), with a tumor size of 5.7 x 2.3 x 1.4 cm, low nuclear grade, and no lymph node involvement.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma in the right breast, grade II (score 6/9), with a mass of 2.1 x 1.4 x 1.1 cm (pT2), with angiolymphatic invasion and negative surgical margins. Three of four sentinel lymph nodes are positive for metastatic carcinoma (pN1(5n)), with no extranodal extension. The left breast has ductal carcinoma in situ, micropapillary and cribriform types, low nuclear grade, involving an area of 5.7 x 2.3 x 1.4 cm (pTis), with negative surgical margins.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A24W.0F2464F7-4108-4700-B2EC-17BC6C432D42',\n",
       "  'report_length_cl100k_base': 462,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive ductal and lobular carcinoma (mixed features) in the right breast, measuring 2.1 x 1.4 x 1.3 cm, with no involvement in the nipple, overlying skin, or underlying chest wall. The tumor is grade II (of III) with a Nottingham score of 5/9. There is a separate nodule of ductal carcinoma in situ (0.6 x 0.6 x 0.5 cm) in the upper inner quadrant and lobular carcinoma in situ present. The patient's right axillary sentinel lymph nodes are negative for metastatic carcinoma (AJCC pNO (i-)(sn)). The left breast shows mild proliferative changes with ductal hyperplasia without atypia. Estrogen and progesterone receptor analysis and Her-2/NEU results are pending.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal and lobular carcinoma (mixed features) in the right breast, measuring 2.1 x 1.4 x 1.3 cm, with a separate nodule of ductal carcinoma in situ in the upper inner quadrant. The tumor does not involve the nipple, overlying skin, or underlying chest wall. All surgical resection margins, including the deep margin, are negative for tumor. Seven right axillary sentinel lymph nodes are negative for metastatic carcinoma. The patient's left breast shows mild proliferative changes characterized by ductal hyperplasia without atypia. Estrogen and progesterone receptor analysis and Her-2/NEU have been ordered on paraffin-embedded tissue.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A24X.B537A19C-C7E8-42EB-BA3F-673417F3A9BA',\n",
       "  'report_length_cl100k_base': 360,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a tumor size of 4.2 x 4.0 x 3.0 cm, falling under AJCC pT2 classification. The cancer does not involve the nipple, overlying skin, or underlying chest wall. Surgical resection margins, including the deep margin, are negative for tumor, with a minimum tumor-free margin of 1.5 cm. Eight left axillary sentinel lymph nodes were removed, and all were negative for tumor (AJCC pN0(i-)). Estrogen and progesterone receptor analysis, as well as HER2/neu, are pending on paraffin-embedded tissues.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma (pT2) with a 4.2 x 4.0 x 3.0 cm mass in the upper outer quadrant of the left breast, Nottingham grade II (score 7/9), with focal ductal carcinoma in situ. The tumor does not involve the nipple, overlying skin, or underlying chest wall. All surgical resection margins, including the deep margin (minimum tumor-free margin of 1.5 cm), are negative for tumor. Eight left axillary sentinel lymph nodes were removed and found to be negative for tumor (pN0(i-)). Estrogen and progesterone receptor analysis and HER2/neu have been ordered.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A24Z.AD07F611-0EEA-4890-A02C-6DA3F5F57C45',\n",
       "  'report_length_cl100k_base': 328,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 2.4 x 2.0 x 1.6 cm infiltrating ductal carcinoma (AJCC pT2) with extensive ductal carcinoma in-situ, high nuclear grade, and no angiolymphatic invasion. The tumor does not involve the nipple, overlying skin, or underlying chest wall. Three left axillary sentinel lymph nodes are negative for metastatic carcinoma (AJCC pNO (i-)(sn), and a single left axillary non-sentinel lymph node is also negative for metastatic carcinoma. Estrogen and progesterone receptor analysis and Her-2/NEU results are pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma, measuring 2.4 x 2.0 x 1.6 cm, with extensive ductal carcinoma in-situ, high nuclear grade, and no angiolymphatic invasion. The tumor does not involve the nipple, overlying skin, or underlying chest wall. Surgical margins are negative for tumor, and there is no lymph node involvement. Estrogen and progesterone receptor analysis and Her-2/NEU results are pending.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A250.16BE833B-E17B-4B8A-9D71-B0D83D73D9DE',\n",
       "  'report_length_cl100k_base': 431,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has an invasive ductal carcinoma with a size of 2.7 x 2.4 x 2.0 cm, with angiolymphatic invasion and extensive ductal carcinoma in situ. The medial/inferior margin is positive for ductal carcinoma in-situ. 4 lymph nodes are positive for metastatic carcinoma with the largest metastatic focus measuring 2.2 x 1.9 x 1.5 cm and extranodal extension present. No residual carcinoma is identified in the left breast after total mastectomy.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has been diagnosed with infiltrating ductal carcinoma, grade III, with a 2.7 x 2.4 x 2.0 cm mass and is AJCC pT2 staged. There is extensive ductal carcinoma in situ with high nuclear grade and angiolymphatic invasion. The medial/inferior margin is positive for ductal carcinoma in-situ. Four lymph nodes are positive for metastatic carcinoma, with the largest focus measuring 2.2 x 1.9 x 1.5 cm, and extranodal extension is present. The patient's cancer is AJCC pN2 staged.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AR-A251.F5B17108-8904-48E7-9B3D-182F0EA388B7',\n",
       "  'report_length_cl100k_base': 350,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma (pT1c) with no lymph node involvement (pNO) and no signs of metastasis (pM0). The tumor size is 1.5 x 1.2 x 1.0 cm, and it shows proliferative fibrocystic changes. Sentinel lymph nodes are negative for metastatic carcinoma.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has been diagnosed with infiltrating ductal carcinoma, Nottingham grade II (of III), with a tumor size of 1.5 x 1.2 x 1.0 cm. There is no angiolymphatic invasion, and the surgical resection margins are negative for tumor. The sentinel lymph nodes are negative for metastatic carcinoma, and a single left axillary lymph node is negative for tumor. The patient's breast parenchyma shows proliferative fibrocystic changes, and a fibroadenoma was also found.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A252.8C52C92F-26CA-4E72-BE47-CA2ED1746785',\n",
       "  'report_length_cl100k_base': 377,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a tumor size of 2.7 x 2.3 x 2.2 cm (AJCC pT2) with no angiolymphatic invasion. The resection margins are negative for tumor, and 2 of 2 sentinel lymph nodes and 7 of 28 axillary lymph nodes are positive for metastatic carcinoma (AJCC pN2). Estrogen and progesterone receptor analysis and Her-2/NEU results are pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with infiltrating ductal carcinoma, grade III, with a tumor size of 2.7 x 2.3 x 2.2 cm, and no angiolymphatic invasion. The skin and breast parenchyma are negative for tumor, and all surgical resection margins are clear. However, 2 of 2 sentinel lymph nodes and 7 of 28 axillary lymph nodes are positive for metastatic carcinoma, with the largest lymph node measuring 2.1 x 1.4 x 1.4 cm. Estrogen and progesterone receptor analysis and Her-2/NEU have been ordered.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AR-A254.C026CFCE-1A82-446D-AC78-8CF4788FD9EB',\n",
       "  'report_length_cl100k_base': 345,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma (pT1c) with a tumor size of 1.3 x 1.3 x 1.2 cm, intermediate nuclear grade, and no angiolymphatic invasion. The surgical resection margins are negative for tumor, and the axillary sentinel lymph nodes are negative for metastatic carcinoma (pNO). The tumor comprises 7/9 Nottingham score, with <5% ductal carcinoma in situ.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma (pT1c) with a tumor size of 1.3 x 1.3 x 1.2 cm, Nottingham grade II (score 7/9), and no lymph node involvement (pNO). The tumor is negative for angiolymphatic invasion and comprises <5% ductal carcinoma in situ. Surgical resection margins are tumor-free, and the sentinel lymph nodes are negative for metastatic carcinoma.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A255.492DDF00-858B-4420-A43F-4FED2DF61C15',\n",
       "  'report_length_cl100k_base': 249,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a tumor size of 2.5 x 2.5 x 2 cm (AJCC pT2) and no lymph node involvement. There is no evidence of metastasis, and immunohistochemical stains for estrogen and progesterone receptors are negative in neoplastic cells.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma with a 2.5 x 2.5 x 2 cm mass, grade III (of III), with negative surgical margins and nipple. There is no evidence of ductal carcinoma in-situ. The right sentinel axillary (No. 1 and No. 2) and right axillary lymph nodes are negative for tumor. The left breast shows proliferative fibrocystic changes with a 0.5 cm fibroadenoma, but no evidence of metastatic carcinoma. Immunohistochemical stains for estrogen and progesterone receptors are negative in neoplastic cells.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A256.0FDC2801-71F8-4D45-BFF1-89445E621A41',\n",
       "  'report_length_cl100k_base': 244,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 1.6 x 1.5 x 1.3 cm infiltrating lobular carcinoma in the right breast (AJCC pT1c), with no angiolymphatic involvement and negative surgical resection margins. The cancer is estrogen receptor-positive and progesterone receptor-negative. No lymph node involvement is found in the right sentinel lymph node excision.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with infiltrating lobular carcinoma in the right breast, with a tumor size of 1.6 x 1.5 x 1.3 cm (AJCC pT1c). There is no angiolymphatic involvement, and the surgical resection margins are negative for tumor. The sentinel lymph nodes are also negative for tumor. The cancer is positive for estrogen receptor and negative for progesterone receptor.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A2LE.95DC80AB-C070-4613-8C11-A124AEDF9754',\n",
       "  'report_length_cl100k_base': 146,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive lobular carcinoma in the right breast, measuring 8 x 7.5 x 5 cm, with no involvement in the nipple, skin, or chest wall. The tumor is grade II out of III. There is no evidence of metastasis in the left breast. The patient has multiple positive lymph nodes (27 out of 35) in the right axillary region, indicating pN3 status. The left breast shows benign proliferative fibrocystic changes with no malignancy. The hormone receptor and Her-2/NEU status are pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive lobular carcinoma in the right breast, measuring 8 x 7.5 x 5 cm, with no involvement in the nipple, skin, or chest wall. The tumor is grade II out of III, with a Nottingham score of 7/9. There is no evidence of metastasis in the left breast. The patient has multiple positive lymph nodes (27 out of 35) in the right axillary region, indicating pN3 status. The left breast shows benign proliferative fibrocystic changes with no diagnostic abnormalities. The patient's estrogen and progesterone receptor analysis and Her-2/NEU status are pending.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-AR-A2LH.4E3FDA72-93E1-4961-B1DE-5BFDAC7E947D',\n",
       "  'report_length_cl100k_base': 267,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has a 11.5 x 7.0 x 6.0 cm infiltrating lobular carcinoma in the left breast (AJCCpT3), with one positive axillary sentinel lymph node (AJCCpN1(sn)), and no evidence of extranodal extension.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with infiltrating lobular carcinoma, forming a 11.5 x 7.0 x 6.0 cm mass extensively involving the breast (AJCCpT3). One of the 17 axillary lymph nodes is positive for metastatic carcinoma with extensive involvement of the subcapsular sinus (AJCCpN1 (sn)). All surgical resection margins are negative for tumor, and there is no evidence of extranodal extension.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A2LJ.5411AC07-09E4-40C3-844F-2DFAA216D947',\n",
       "  'report_length_cl100k_base': 274,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient has invasive lobular carcinoma in the right breast, measuring 5.2 x 3.0 x 2.6 cm, with lobular carcinoma in situ present in less than 5% of the tumor volume. Angiolymphatic invasion is present, and the tumor does not involve the nipple, overlying skin, or underlying chest wall. The inferior and medial margins are positive for invasive carcinoma. Five of 18 right axillary lymph nodes are positive for metastatic carcinoma, with the largest measuring 4.2 x 2.6 x 2.4 cm and extranodal extension present. The patient's cancer is classified as AJCC pN2.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive lobular carcinoma in the right breast, with a tumor size of 5.2 x 3.0 x 2.6 cm, grade II (of III), with lobular carcinoma in situ present in less than 5% of the tumor volume. Angiolymphatic invasion is present, and the margins are positive for invasive carcinoma. The patient's right axillary lymph nodes are positive for metastatic carcinoma (5 out of 18 nodes), with the largest measuring 4.2 x 2.6 x 2.4 cm, and extranodal extension is present. The final surgical margins after mastectomy are widely free of involvement.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-AR-A2LK.73FFBADB-37C0-4F17-8C95-F8DC94EF1AD3',\n",
       "  'report_length_cl100k_base': 468,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has invasive pleomorphic lobular carcinoma in the left breast, measuring 9.2 x 4.2 x 3.2 cm, with a separate nodule of 0.8 x 0.7 x 0.6 cm. There is no angiolymphatic invasion, and the tumor does not involve the nipple, skin, or chest wall. Surgical margins are negative, and sentinel lymph nodes are clear of metastatic carcinoma (AJCC pNO). Awaiting Her-2/Neu results.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with pleomorphic lobular carcinoma, forming a mass of 9.2 x 4.2 x 3.2 cm in the central region of the breast with a separate nodule of 0.8 x 0.7 x 0.6 cm located adjacent to the main mass on the inferior aspect. The tumor does not involve the nipple, skin, or underlying chest wall. All surgical resection margins, including the deep margin, are negative for tumor. Sentinel lymph nodes; left axillary Nos. 1, 2, 3, and 4; sentinel biopsy: Multiple (4) left axillary sentinel lymph nodes without blue dye are negative for metastatic carcinoma.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A2LL.B2314041-3E85-4E3F-8924-39FC285B08B2',\n",
       "  'report_length_cl100k_base': 346,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's right breast had multiple foci of infiltrating lobular carcinoma, with the largest mass being 1.8 x 1.3 x 1.2 cm. There was no angiolymphatic invasion, and the surgical margins were negative for tumor. One of three axillary sentinel lymph nodes was positive for micrometastasis, with the largest metastasis measuring 0.6 mm. The cancer has not metastasized to other organs.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has multiple foci of infiltrating lobular carcinoma in the right breast, with a bilobed mass measuring 1.8 x 1.3 x 1.2 cm and two smaller lesions. There is no angiolymphatic invasion, and the surgical margins are negative for tumor. One of three axillary sentinel lymph nodes is positive for micrometastasis, with the largest measuring 0.6 mm. The patient's cancer is classified as AJCC pT1c and pN1mi(sn).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A2LM.F868DC95-23CA-4DFC-BAA3-FBF5BF6F45A9',\n",
       "  'report_length_cl100k_base': 445,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has two separate breast tumors, one in each breast. The right breast tumor is 2.8 x 2.0 x 1.2 cm and is classified as pT2. It has angiolymphatic invasion and one positive lymph node with extranodal extension, making it pN1. The left breast tumor is 4.1 x 3.8 x 2.4 cm and is classified as pT2. It does not involve the chest wall or skin and has no lymph node involvement, making it pN0(i-)(sn).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with invasive lobular carcinoma in both breasts, with tumor sizes of 2.8 x 2.0 x 1.2 cm (right breast) and 4.1 x 3.8 x 2.4 cm (left breast). There is angiolymphatic invasion in the right breast and no lymph node involvement in the left axillary nodes. The right axillary nodes have one positive lymph node with extranodal extension, measuring 2.0 cm.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A2LN.128D4F7D-017D-459F-9664-AF509AE4555E',\n",
       "  'report_length_cl100k_base': 615,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has an infiltrating lobular carcinoma in the left breast, measuring 4.8 x 2.7 x 1.9 cm, with negative surgical margins and no involvement in the nipple, overlying skin, or underlying chest wall. There is no evidence of metastasis to the right breast. 14 left axillary lymph nodes are negative for tumor, but the pathological staging is pT2NXMX due to the absence of lymph nodes in the left lowest axillary area.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has been diagnosed with infiltrating lobular carcinoma in the left breast, measuring 4.8 x 2.7 x 1.9 cm, with negative surgical margins and no involvement in the nipple, overlying skin, or underlying chest wall. There is also lobular carcinoma in situ present. The patient's lymph nodes in the left axillary are negative for tumor, but the pathology report does not provide information on the lymph node status in the right breast. The AJCC staging is pT2NXMX.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A2LO.E5B6771D-450A-49AD-AEBC-7FC056BFCDBE',\n",
       "  'report_length_cl100k_base': 263,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is classified as stage AJCC pT1bN0(i-) for the left breast and AJCC pT3N0(i+) for the right breast. The left breast tumor is 0.9 x 0.7 x 0.5 cm and the right breast tumor is 12.5 x 6.3 x 2.2 cm. No lymph node metastasis is found in the left axillary sentinel lymph nodes, while the right axillary sentinel lymph node is positive for isolated tumor cells.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive lobular carcinoma in both breasts, with tumor sizes of 0.9 x 0.7 x 0.5 cm (left breast) and 12.5 x 6.3 x 2.2 cm (right breast). Lymph node involvement is present in the right axillary sentinel lymph node with isolated tumor cells (less than 200 cells), while the left axillary sentinel lymph nodes are negative for metastatic carcinoma. No angiolymphatic invasion is observed, and both cases are classified as Nottingham grade I (of III). The tumors do not involve the nipple, overlying skin, or underlying chest wall. All surgical resection margins are negative for tumor, and the minimum tumor-free margin is 0.2 cm. The patient's cancer is staged as AJCC pT1bN0(i-) (sn) for the left breast and AJCC pT3N0(i+)(sn) for the right breast.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A2LQ.C3537961-4636-4BD1-BC89-892580B36E43',\n",
       "  'report_length_cl100k_base': 829,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's right breast has a 2.7 x 2.3 x 1.7 cm metaplastic carcinoma, grade III, with no angiolymphatic invasion and negative surgical margins. Five right axillary sentinel lymph nodes are negative for metastatic carcinoma. The left breast is benign, and three left axillary sentinel lymph nodes are negative for metastatic carcinoma. No metastatic carcinoma is found in the left breast tissue or nipple.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has metaplastic carcinoma in the right breast, measuring 2.7 x 2.3 x 1.7 cm, with no angiolymphatic invasion and negative surgical margins. The tumor does not involve the nipple, overlying skin, or underlying chest wall. Five right axillary sentinel lymph nodes are negative for metastatic carcinoma. The left breast is benign with negative surgical margins and no lymph node involvement.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A2LR.C310F4EC-D8B1-45C4-8D55-705A9EE35902',\n",
       "  'report_length_cl100k_base': 504,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has two separate breast cancer masses, one in each breast. The left breast mass is 4.7 x 2.2 x 1.5 cm and is classified as AJCC pT2. It has no angiolymphatic invasion and the resection margins are negative for tumor. Four left breast intramammary lymph nodes were removed and found to be negative for tumor, but the left sentinel lymph node was positive for isolated tumor cells. The right breast mass is 1.4 x 1.0 x 0.9 cm and is classified as AJCC pT1c. It has angiolymphatic invasion and the patient has extensive ductal carcinoma in situ. Four of 25 right axillary lymph nodes were positive for metastatic breast carcinoma, with the largest metastatic focus being 3.0 x 1.9 x 1.6 cm.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with invasive lobular carcinoma in the left breast, with a tumor size of 4.7 x 2.2 x 1.5 cm (AJCC pT2). Lobular carcinoma in situ is present, and all surgical resection margins are negative for tumor. Four left breast intramammary lymph nodes are negative for tumor, but a single left intramammary sentinel lymph node is positive for isolated tumor cells (AJCC pN0 (i+) (sn)). The patient also has invasive ductal carcinoma in the right breast, with a tumor size of 1.4 x 1.0 x 0.9 cm (AJCC pT1c). Extensive ductal carcinoma in situ is present, and angiolymphatic invasion is present. Four of 25 right axillary lymph nodes are positive for metastatic breast carcinoma (AJCC pN2), with the largest metastatic focus being a collection of matted lymph nodes measuring 3.0 x 1.9 x',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-AR-A5QM.4C3E3E5B-E24E-447B-A688-68D6EBE15A9F',\n",
       "  'report_length_cl100k_base': 635,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive lobular carcinoma in the left breast, with multiple masses ranging from 0.5 to 3.2 cm. The tumor does not involve the nipple, skin, or chest wall. 10 out of 19 left axillary lymph nodes are positive for metastatic carcinoma, with the largest metastasis measuring 11.0 mm. There is no evidence of extranodal extension. The final pathology report is based on gross/macroscopic examination and frozen section histologic evaluation, and permanent section review will be reflected in a revised report if necessary.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive lobular carcinoma in the left breast, with multiple masses ranging from 0.5 to 3.2 cm in size. The tumor does not involve the nipple, overlying skin, or underlying chest wall. The patient's lymph nodes are positive for metastatic carcinoma, with the largest metastasis measuring 11.0 mm. Ductal carcinoma in situ and lobular carcinoma in situ are present, and the non-neoplastic breast parenchyma shows nonproliferative fibrocystic changes. The patient's thyroid and left axillary lymph nodes are negative for tumor, but the right axillary lymph nodes are positive for metastatic carcinoma. The patient's left margins are negative for invasive carcinoma by 1.2 cm.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-AR-A5QN.A9015F6A-F6BB-4AC8-B681-099232A6DFAC',\n",
       "  'report_length_cl100k_base': 639,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 2.2 x 2.1 x 1.6 cm infiltrating lobular carcinoma in the left breast with no angiolymphatic invasion. One of the two sentinel lymph nodes is positive with multiple metastases, the largest measuring 3.5 mm, and extranodal extension is present. The tumor is classified as AJCC pT2N1 (sn) (7th edition, 2010).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive lobular carcinoma in the left breast, measuring 2.2 x 2.1 x 1.6 cm, with no angiolymphatic invasion. The tumor is grade I (Nottingham score 5/9). One of the 2 sentinel lymph nodes is positive with 5 metastases, the largest being 3.5 mm, and focal extranodal extension is present. The tumor is stage T2 and N1 (AJCC 7th edition, 2010).',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A5QP.F2409024-D848-4B02-A371-92BEA1105EC4',\n",
       "  'report_length_cl100k_base': 224,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 5.2 x 5.0 x 4.7 cm moderately differentiated squamous carcinoma in the right breast with skin ulceration, angiolymphatic invasion, and extranodal extension. One intramammary lymph node is positive for metastatic carcinoma (6.5 x 5.0 x 4.7 cm). All surgical resection margins, including skin and deep margins (1.7 cm), are negative for tumor. 21 right axillary lymph nodes are negative for metastatic carcinoma. The pathological staging is [AJCC pT3N1]. Estrogen receptor, progesterone receptor, and HER2 results are pending.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has a moderately differentiated squamous carcinoma forming a 5.2 x 5.0 x 4.7 cm mass in the central aspect of the right breast with skin ulceration and angiolymphatic invasion. A single intramammary lymph node is positive for metastatic carcinoma forming a solid and cystic mass (6.5 x 5.0 x 4.7 cm) located in the lateral aspect of the breast with extranodal extension. All surgical resection margins, including skin and deep margins, are negative for tumor. The patient's cancer is classified as AJCC pT3N1 (7th edition, 2010).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-AR-A5QQ.511282C5-02AC-4105-8B52-5BBEC8B45D22',\n",
       "  'report_length_cl100k_base': 268,\n",
       "  't_label': 2},\n",
       " {'abstract': '\\nThe patient has invasive ductal carcinoma in the left breast, with a tumor size of 3.5 x 2 x 2 cm. There is no lymphatic/vascular invasion, and 1 of 7 lymph nodes are involved. In-situ carcinoma is present, occupying approximately 50% of the tumor. The tumor is estrogen and progesterone receptor negative. The surgical margins are negative, and there is no evidence of metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma in the left breast, with a tumor size of 3.5 x 2 x 2 cm. There is no lymphatic or vascular invasion, and the surgical margins are negative. The tumor is a complex admixture of invasive and in-situ carcinoma, with the exact percentage of invasive carcinoma estimated at approximately 50%. The patient's estrogen and progesterone receptors were judged to be negative. Seven lymph nodes were examined and showed no evidence of malignancy.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-B6-A0I1.1E498731-FE74-493E-A330-477643800305',\n",
       "  'report_length_cl100k_base': 1384,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has bilateral breast carcinoma. The right breast tumor measures 4.5 x 2.3 x 2.5 cm and is classified as invasive and infiltrating ductal carcinoma, grade 3. The left breast tumor measures 1.3 x 1.3 x 1.3 cm and is classified as invasive and infiltrating ductal carcinoma, grade 3. There is no lymph node involvement in either breast. No metastasis is reported.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has bilateral breast carcinoma. The right breast biopsy sample is a poorly differentiated adenocarcinoma, measuring 1.3 x 1.3 x 1.3 cm, with vascular space invasion identified and extending to within 1 mm of the superior margin of resection. The left breast tumor is an invasive and intraductal carcinoma, measuring 4.5 x 2.3 x 2.5 cm, with vascular space invasion not identified, but approaches within 100 microns of the resection margin. No regional lymph nodes are involved in either breast.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0I2.CA834E5F-30DC-46CF-AF33-AD11226FC09E',\n",
       "  'report_length_cl100k_base': 1571,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient is a female with a right breast mass that is multifocal and infiltrating, consisting of ductal carcinoma grade 2/3 with a moderately differentiated nuclear grade. The tumor is within 0.1mm of the surgical margin, indicating potential lymph node involvement.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a female with a breast mass on the right side. The mass is multifocal and infiltrating, with a grade 2/3 ductal carcinoma that is moderately differentiated. The tumor extends to within 0.1mm of the surgical margin.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0I5.FA43414D-3757-43CC-8949-77F82DF4FA4D',\n",
       "  'report_length_cl100k_base': 119,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's left breast specimen shows a 5.0 x 5.0 x 4.0 cm infiltrating ductal carcinoma, with nuclear grade 3 of 3 and histologic grade 3 of 3. There is no evidence of carcinoma in the surgical margins. The axillary contents reveal metastatic carcinoma in 6 out of 32 lymph nodes, with focal carcinoma in perinodal blood vessels.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's left breast and axillary contents were submitted for examination. A 5.0 x 5.0 x 4.0 cm mass was found in the breast, and a couple of satellite nodules were noted. The tumor was determined to be an infiltrating ductal carcinoma with a nuclear grade of 3 out of 3 and a histologic grade of 3 out of 3. There was prominent vascular invasion by carcinoma, but no carcinoma was identified in the surgical margins. 6 out of 32 lymph nodes were found to have metastatic carcinoma, and focal carcinoma was found in perinodal blood vessels. The patient's diagnosis is stage III breast cancer.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0I6.2D3D759B-D06A-4FC6-855A-5E9F83ADBED9',\n",
       "  'report_length_cl100k_base': 876,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has a history of left breast carcinoma with probable involvement of the right breast. The right breast biopsy reveals infiltrating ductal carcinoma, NSABP and nuclear grade 3, histologic grade 3. The surgical margins were not evaluated.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The pathology report indicates a diagnosis of infiltrating ductal carcinoma in the right breast with a nuclear grade of 3 and histologic grade of 3. The surgical margins were not evaluated. The report also mentions a history of recurrent left breast carcinoma and a probable involvement of the right breast. The tissue samples were taken from two pieces of pink-tan tissue embedded within yellow fibroadipose tissue.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0I8.E958CD3C-EE14-4CE1-B55C-7830E320F6AE',\n",
       "  'report_length_cl100k_base': 261,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient is a 45-year-old white female with a 6 cm breast mass in her left breast, which was determined to be intraductal carcinoma, solid and comedotype, and infiltrating duct carcinoma. The cancer has vascular invasion and is of moderate nuclear grade. The margins of the specimen were not inked, so the status of the margins is unknown. No lymph node involvement or metastasis information is provided in the report.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The pathology report describes a 6 cm breast mass in a female patient with a probable metastatic breast cancer history. The mass is diagnosed as an intraductal carcinoma, solid and comedotype, and infiltrating duct carcinoma. The tumor has a nuclear grade of moderately differentiated and shows vascular invasion. The specimen was taken from the left breast and was submitted in blocks A1 through A6. The report also mentions a fracture in the left femur, but it is unclear if it is related to the breast cancer.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0I9.291884D2-FDFD-4C98-BA19-1A0824ABB68F',\n",
       "  'report_length_cl100k_base': 277,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's pathology report indicates a 2.0 cm invasive ductal carcinoma in the right breast with no residual carcinoma found in the surgical specimen. There is no evidence of metastasis, and 15 axillary lymph nodes were removed, with no tumor found in these lymph nodes.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has a 2.0 cm invasive ductal carcinoma in the right breast with no residual carcinoma found in the surgical specimen. There is no evidence of tumor in the fifteen axillary lymph nodes examined. The tumor is classified as N.S.A.B.P. nuclear grade - moderately-differentiated, and histologic grade - two of three.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0IA.55F3F917-E441-4C10-A3E3-0645A4E8374E',\n",
       "  'report_length_cl100k_base': 880,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has a 6 x 3.5 x 3.0 cm invasive ductal carcinoma in the right breast with extensive residual cancer in the deep dermis (Block A8). The tumor is grade III histologically and nuclear grade III. Lymph nodes at level I are negative for cancer, but levels II and III show positive results in 6 out of 9 and 2 out of 5 nodes, respectively. The patient's surgical margins are clear of cancer.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has right breast cancer with a 6 x 3.5 x 3.0 cm tumor in the inner upper and inner lower quadrant, and a smaller 3 cm tumor in the same breast. The tumor is invasive ductal carcinoma extending into the deep dermis, with a histologic grade of III and nuclear grade of III. The lymph nodes at level I are negative for cancer, but levels II and III have positive cancerous nodes. All surgical margins are clear, and the patient is ER-positive.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-B6-A0IB.CFC4801B-04BD-4FFC-911A-7B88E2FA4B49',\n",
       "  'report_length_cl100k_base': 602,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient is a 35-year-old white female with a 2.5 cm invasive papillary adenocarcinoma in the right breast. The tumor is composed of well-formed papillary structures and cribriform and tubular foci. The margins of resection are free of tumor, and there is no evidence of lymph node involvement or metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 38-year-old white female with a right breast mass that measures 2.5 x 2 x 1.5 cm. The mass is composed of tan firm friable tissue with focal areas of hemorrhage and is sharply circumscribed. The tumor is an invasive papillary adenocarcinoma of the breast, and the margins of resection are free of tumor. There is no evidence of lymph node involvement or metastasis.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0IC.8AABC46F-03C7-4FBF-AC20-2C862E303A8B',\n",
       "  'report_length_cl100k_base': 345,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The pathology report describes a poorly differentiated carcinoma with extensive vascular invasion in the left breast. There is no evidence of in situ carcinoma. The tumor has features of lobular carcinoma, but an in situ component is not present. The report does not provide information on tumor size, lymph node involvement, or metastasis status.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The pathology report describes a left breast biopsy of a patient with inflammatory breast cancer. The tumor is poorly differentiated with extensive vascular invasion and has features of lobular carcinoma, but an in situ component is not present. The specimen is a fragment of a larger lesion, and the margins are not required for evaluation. The report does not mention lymph node involvement or metastasis status.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0IE.DFCA9C6E-710E-4645-9CFC-A908AAD583F3',\n",
       "  'report_length_cl100k_base': 280,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's breast cancer is an infiltrating ductal carcinoma, with a tumor size of 3.5 x 3.5 x 3.0 cm. It is grade 2/3 on nuclear grading and grade 3/3 on histological grading. There is focal vascular invasion, but no Paget's disease in the nipple. All surgical margins are free of tumor, and the cancer has spread to 4 out of 16 axillary lymph nodes, with one macroscopically positive lymph node in the low axilla exhibiting extracapsular extension.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma with a tumor size of 3.5 x 3.5 x 3.0 cm. The tumor is located in the upper inner quadrant of the breast and approaches the deep and lateral margins. There is focal vascular invasion and no Paget's disease. The patient has residual tumor in the breast and metastatic adenocarcinoma in 4 of 16 axillary lymph nodes, with one macroscopically positive lymph node in the low axilla exhibiting extracapsular extension. All surgical margins are free of tumor, and the remaining breast tissue shows papillary apocrine metaplasia, cystic change, and inter- and intralobular fibrosis.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0IG.4379DEE0-F7CB-4A73-8828-21EA0AA830F5',\n",
       "  'report_length_cl100k_base': 1031,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive adenocarcinoma of the breast, with a tumor size greater than 6 cm and metastasis present in 25 out of 27 axillary lymph nodes. The cancer has extended into sections of the lactiferous duct and nipple and is present in random sections of the breast quadrant. All surgical margins appear to be free of involvement.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive adenocarcinoma of the breast, with a tumor size of approximately 6.2 x 4 x 2.7 cm. The cancer has extended into sections of the lactiferous duct and nipple, as well as random sections of the breast quadrant. There is metastatic carcinoma present in 25 out of 27 axillary lymph nodes. All surgical margins appear to be free of involvement, and there is no evidence of extracapsular extension.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0IH.12C64846-1CB3-42E4-B307-54C7AD12F530',\n",
       "  'report_length_cl100k_base': 1460,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma with a tumor size of 5 cm in the greatest dimension, located 2 cm from the deep surgical margin and 1 cm from the skin ellipse. There is no evidence of lymph node involvement, with 27 lymph nodes examined and all negative for malignancy. The operative margins are free of malignancy.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma with a tumor measuring 5 cm in the greatest dimension, located in the mid upper outer quadrant of the right breast. The tumor is 2 cm from the deep surgical margin and 1 cm from the skin ellipse. There is no evidence of intraductal carcinoma. The patient has no lymph node involvement, and all operative margins are free of malignancy. The cancer is classified as NSABP histologic grade III and cytologic grade III.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0IJ.F3BAF04C-35EE-450F-BFA8-E9DFE9F984FD',\n",
       "  'report_length_cl100k_base': 546,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has inflammatory breast cancer with a 2.2 cm tumor in the left breast. The tumor is moderately differentiated with a nuclear grade of 3 and comedo type intraductal carcinoma present in 5% of the tumor volume. Lymphatic/vascular invasion is present, but no tumor is seen in dermal lymphatics. Surgical margins are positive for carcinoma, indicating a high likelihood of lymph node involvement and metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has inflammatory breast cancer with a 2.2 cm tumor in the left breast. The tumor is moderately differentiated with a nuclear grade of 3 and comedo type intraductal carcinoma present. Lymphatic/vascular invasion is present, but no tumor is seen in dermal lymphatics. Surgical margins are positive for carcinoma.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0IK.3A38A97C-2CBB-4802-9528-A4BBD62AEA4A',\n",
       "  'report_length_cl100k_base': 308,\n",
       "  't_label': 3},\n",
       " {'abstract': 'The patient has a 9 cm infiltrating ductal carcinoma with a prominent cribriform pattern in the right breast, located in the upper outer quadrant. There is no lymphatic/vascular invasion, and 9 lymph nodes were sampled with no carcinoma identified. The tumor is estrogen receptor positive (FMOL value of 13) and progesterone receptor borderline (FMOL value of 14).',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma with a prominent cribriform component in the right breast, with a tumor size of 7 cm in the greatest dimension. There is no lymphatic/vascular invasion, and 9 lymph nodes were sampled with no carcinoma identified. The estrogen receptor activity was positive, and the progesterone receptor activity was borderline. The results of the assay for estrogen and progesterone receptors were reported in an addendum.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0IM.4A86A028-C56D-455E-A5CD-47D8A34B5734',\n",
       "  'report_length_cl100k_base': 1174,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient has been diagnosed with ductal carcinoma in situ (DCIS) in the right breast, with a tumor size of 2.2 cm. There is no evidence of lymphatic/vascular invasion, and the surgical margins are positive for DCIS. The patient's cancer is hormone receptor-positive and HER2-negative. No metastasis is reported.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has been diagnosed with intermediate grade ductal carcinoma in situ in the right lateral breast, with no evidence of invasive carcinoma. The tumor size is 2.2 cm, with multifocal tumors present and no lymphatic or vascular invasion. The patient's cancer is HER2/neu positive and estrogen and progesterone receptor positive. The surgical margins are positive for ductal carcinoma in situ. The patient's cancer is stage IIA.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0IN.267F1EFD-AB89-4124-B803-00CC0E8E9CD2',\n",
       "  'report_length_cl100k_base': 1930,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive carcinoma of the left breast, with a tumor size of 2.8 x 2.5 x 1.6 cm in the upper-outer quadrant and 1 cm in the lower-inner quadrant. There is no lymphatic/vascular invasion identified, and the lymph node status is negative (0/17). The tumor is estrogen and progesterone receptor positive, with a HER2/neu score of 0. The proliferation index is high, with 29% positive nuclear area percentage. Surgical margins are free of tumor, and there is no evidence of metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': ' The patient has invasive carcinoma of the left breast with a tumor size of 2.8 x 2.5 x 1.6 cm in the upper-outer quadrant and 1 cm in the lower-inner quadrant. There is no lymphatic/vascular invasion identified, and the lymph node status is negative (0/17). The tumor is estrogen and progesterone receptor positive, with a positive proliferation index. HER2/neu immunohistochemical analysis shows no overexpression of the oncoprotein. The surgical margins are free of tumor, and there is no evidence of metastasis.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0IO.9B3F0B22-8442-4720-A21B-7EF12CBCD2CE',\n",
       "  'report_length_cl100k_base': 1425,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive lobular carcinoma of the left breast, measuring 1.7 x 1.6 x 1.4 cm, with no lymphatic/vascular invasion or multifocal tumors. The tumor is estrogen and progesterone receptor-positive. The surgical margins are negative for tumor, and no metastasis is found in the 16 left axillary lymph nodes examined.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive lobular carcinoma of the left breast, measuring 1.7 x 1.6 x 1.4 cm, with no lymphatic/vascular invasion, multifocal tumors, or metastasis. Estrogen and progesterone receptors are positive, and the surgical margins are negative for tumor. The patient's axillary lymph nodes are clear, with no evidence of malignancy found in 16 nodes.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0IP.6C91D49C-9738-4A4F-A480-E71CD8EE5268',\n",
       "  'report_length_cl100k_base': 1448,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma in the left breast, with a tumor size of 5.5 x 4 x 3.5 cm and no lymphatic invasion. The cancer is within 1 mm of the deep margin and less than 5% of the tumor is identifiable as intraductal carcinoma. There are benign changes in the breast, including apocrine metaplasia and duct ectasia. The nipple has no pathologic diagnosis. Out of 26 lymph nodes examined, one lymph node is positive for carcinoma.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma in the left breast, with a tumor size of 5.5 x 4 x 3.5 cm, and no lymphatic invasion. The cancer is grade 3, with a moderately differentiated nucleus. There is no evidence of malignancy in the 26 lymph nodes examined. The Rotter's node excision resulted in one positive lymph node for carcinoma.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0IQ.0ED7357E-662C-4D65-82ED-29739919068F',\n",
       "  'report_length_cl100k_base': 703,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has an invasive ductal carcinoma in the left breast, with a tumor size of 7.0 cm and histologic grade 2, nuclear grade 3. The regional lymph nodes are negative for cancer, and all final surgical margins are negative for cancer.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma in the left breast, with a tumor size of 7.0 cm and histologic grade 2, nuclear grade 3. The regional lymph nodes are negative for cancer, and all final surgical margins are negative for cancer. The breast and axillary contents were examined, and the diagnosis was made based on the presence of invasive carcinoma.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0RG.0429FA9A-AD19-424C-94ED-1A902119E559',\n",
       "  'report_length_cl100k_base': 545,\n",
       "  't_label': 2},\n",
       " {'abstract': '\\nThe patient has invasive ductal carcinoma with a predominantly cribriform pattern, measuring 2.5 cm in greatest dimension. The cancer extends to within 1.2 cm of the deep surgical margin and involves mammary lymphatics adjacent to the tumor. There is no evidence of metastasis in the examined lymph nodes.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma with a predominantly cribriform pattern, measuring 2.5 cm in greatest dimension, located in the left breast at the junction of the inner-upper and inner-lower quadrant. The cancer has moderately differentiated nuclear grade, histologic grade 2 of 3, and local tumor invasion of mammary lymphatics adjacent to the tumor is identified. The deep surgical margins are free of tumor, and there is no evidence of tumor in the 23 axillary lymph nodes examined. The breast parenchyma shows intraductal carcinoma, cribriform type, adjacent to the infiltrating carcinoma, and focal atypical epithelial hyperplasia in the upper-outer quadrant. The rest of the breast displays sclerosing adenosis, microcalcifications, blunt duct adenosis, papillary apocrine metaplasia, and duct ectasia.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0RH.3801F39A-6F4B-40C0-9625-9E0818266819',\n",
       "  'report_length_cl100k_base': 1379,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma in the right breast, measuring 1.5 x 2.8 x 1.0 cm, located in the upper outer quadrant, with vascular invasion and 6 out of 15 lymph nodes positive for metastatic carcinoma.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma in the right breast, measuring 1.5 x 2.8 x 1.0 cm, located in the upper outer quadrant, with vascular invasion present. 1 out of 2 lymph nodes are involved, and the tumor comes within 0.2 cm of the deep margin. The cancer is classified as NSABP histologic grade 3, with a moderately differentiated nuclear grade.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0RI.F2B21F52-74F4-44C5-9991-60EBCC4E43A6',\n",
       "  'report_length_cl100k_base': 764,\n",
       "  't_label': 3},\n",
       " {'abstract': \"The patient's left breast biopsy reveals an infiltrating ductal carcinoma, measuring 3 cm in diameter, with a spindle cell component and focal intraductal carcinoma of comedo type. The surgical margins are free of malignancy, and no lymph nodes are positive for metastatic disease out of the 16 examined.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma with a tumor size of 3cm in the left breast. The surgical margins are free of malignancy and none of the 16 lymph nodes are positive for metastatic disease. The cancer is classified as NSABP Nuclear Grade 2 to 3 and Histologic Grade II.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0RL.6C50D456-A828-4514-92D2-01A5900B74F1',\n",
       "  'report_length_cl100k_base': 770,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's breast tissue specimen measures 5 x 8.5 x 5 cm and contains a densely fibrotic area with a central reddish-brown nodule, which is 1.5 cm in size and located 0.1 cm from the closest surgical margin. The tumor consists of nests and cords of atypical cells with round to oval vesicular nuclei and vacuolated cytoplasm, with no unequivocal vascular invasion identified. The pathologic diagnosis is invasive ductal carcinoma, NSABP histologic grade 2, nuclear grade moderately differentiated. Eighteen lymph nodes were examined, with no tumor found.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma of the breast, measuring 1.5 cm in maximum dimension, with no vascular invasion identified. The tumor is present in the inked surgical margin in blocks A5 and A11. Eighteen lymph nodes were examined, with no tumor seen.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0RN.5F08632D-BC1D-4414-80C1-75F67F3A07AF',\n",
       "  'report_length_cl100k_base': 625,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an infiltrating ductal carcinoma, measuring 3.5 x 2 x 1.5 cm, with no vascular invasion identified. The deep surgical margin is negative for tumor. Out of 17 lymph nodes examined, 2 are positive for metastatic adenocarcinoma. The cancer is classified as NSABP histologic grade II/III with a moderately differentiated nuclear grade.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an infiltrating ductal carcinoma, measuring 3.5 x 2 x 1.5 cm, with no vascular invasion identified. The deep surgical margin is negative for tumor, but a non-comedo intraductal component is present, comprising less than 10% of the carcinoma. Two out of seventeen lymph nodes are positive for metastatic adenocarcinoma. The cancer is classified as NSABP histologic grade II/III with a moderately differentiated nuclear grade.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0RO.EFA0354A-641D-4EC2-A1BE-4ACC7CE421DF',\n",
       "  'report_length_cl100k_base': 793,\n",
       "  't_label': 3},\n",
       " {'abstract': '\\nThe patient has three separate foci of breast carcinoma in the left breast, with tumor sizes ranging from 1.0 to 2.6 cm. Two of the tumors are invasive ductal carcinomas, while the third is a tubulolobular carcinoma. There is no vascular invasion in the second and third tumors, but the first tumor shows vascular invasion. The patient has intraductal carcinoma in the left breast, with cancerization of lobules and intraductal papillomas. Two of the 15 left axillary lymph nodes are involved with metastatic carcinoma. The right breast shows evidence of a healing biopsy site with no residual tumor, intraductal carcinoma, and other benign findings. No lymph nodes are identified in the limited axillary dissection on the right side.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with breast cancer, with three separate foci of breast carcinoma in the left breast, and one focus of intraductal carcinoma in the right breast. The largest tumor in the left breast measures 2.6 x 2.5 x 1.5 cm and is an infiltrating duct carcinoma. There is evidence of vascular invasion and the deep margin is free of carcinoma. Two of fifteen left axillary lymph nodes are involved with metastatic carcinoma. The patient also has a healing biopsy site in the right breast with no evidence of malignancy, but intraductal carcinoma is present in the surrounding tissue.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0RP.889D6E80-A656-49FA-9DFA-1674EB3877F6',\n",
       "  'report_length_cl100k_base': 2539,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive lobular carcinoma in the right breast, measuring approximately 7.0 x 3.5 x 2.5 cm, with a focal carcinoma in situ component. The tumor extends to within 1 mm of the deep resection margin at the medial aspect of the specimen. There are benign proliferative changes, including apocrine metaplasia and duct ectasia. Fourteen axillary lymph nodes were examined, none of which contained metastatic carcinoma.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive lobular carcinoma in the right breast, with a tumor size of approximately 7.0 x 3.5 x 2.5 cm. The carcinoma extends to within 1 mm of the deep resection margin at the medial aspect of the specimen. There is a focal carcinoma in situ component. Fourteen axillary lymph nodes were examined, none of which contained metastatic carcinoma. The patient also has benign proliferative changes, including apocrine metaplasia and duct ectasia.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0RQ.46B892B9-82C8-4305-BCB9-805F6F5FC90A',\n",
       "  'report_length_cl100k_base': 1185,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's left breast specimen shows an invasive ductal carcinoma, measuring 2.5 x 2.0 x 2.5 cm, with no carcinoma identified in the surgical margins. The tumor is poorly differentiated, and there is no lymph node involvement. The lymph nodes from the axillary dissection are negative for carcinoma.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's left breast specimen shows an invasive ductal carcinoma, measuring 2.5 x 2.0 x 2.5 cm, with no carcinoma identified in the surgical margins. The tumor is poorly differentiated, with a nuclear grade of 3 out of 3. There are no findings of carcinoma in the 15 lymph nodes examined through axillary dissection. The patient's history includes fibrosis, focal moderate epithelial hyperplasia, small cysts, and apocrine metaplasia.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0RS.6E169005-180B-42C5-9CDC-F6699FAB5AB5',\n",
       "  'report_length_cl100k_base': 590,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient is a 65-year-old female with breast cancer. The tumor size is 3.5 x 2.2 x 1.7 cm, and it is an infiltrative adenocarcinoma of ductal type, with lymphatic/vascular invasion present. The cancer extends to surgical margins multifocally. One out of 23 lymph nodes is positive for carcinoma (1/23). Estrogen and progesterone receptors are negative, and the proliferation index is high at 70%.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient is a 65-year-old female with breast cancer. The tumor size is 3.5 x 2.2 x 1.7 cm and is an infiltrative adenocarcinoma of ductal type. Lymphatic/vascular invasion is present, and one of 23 lymph nodes is positive for carcinoma (1/23). Estrogen and progesterone receptors were judged as negative, and the proliferation index was estimated to be high with a PI of 70%. The final stage of the cancer is pending, and the results of the assay will be issued in an addendum.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0RT.64D53A4B-4735-4AD2-A413-520797F5F9CB',\n",
       "  'report_length_cl100k_base': 1518,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has an infiltrating ductal carcinoma mixed with other types, specifically comedo intraductal carcinoma, with a tumor size of 2.7 cm in greatest diameter. The tumor extends to the surgical margins and shows lymphatic invasion. There is no evidence of metastasis.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with a poorly differentiated, 2.7 cm invasive ductal carcinoma with comedo characteristics and sarcomatous metaplasia. The tumor extends to the surgical margins and shows lymphatic invasion. The adjacent breast tissue reveals duct ectasia and papillary apocrine metaplasia.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0RU.39C689CA-F7BA-4554-BEC8-11F9C8142D9C',\n",
       "  'report_length_cl100k_base': 469,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient is a 63-year-old woman with a large right breast cancer. The tumor size is 12 x 9.5 x 4 cm and is located approximately 0.5 cm from the closest superior margin, 1.5 cm from the inferior margin, 0.1 cm from the deepest margin, 1.5 cm from the medial margin, and 3 cm from the axillary appendage. The tumor is present in all quadrants of the breast and is multifocal. Lymphatic/vascular invasion is present, and the tumor is present in five of ten lymph nodes, with the largest involved lymph node being 2.4 cm. The patient's cancer is ER/PR positive, and extracapsular extension is present. The methodology used was fresh tissue, and the results of the Estrogen and Progesterone receptors assay are pending.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient is a 63-year-old woman with a large right breast cancer. The tumor size is 12 x 9.5 x 4 cm and is located approximately 0.5 cm from the closest superior margin, 1.5 cm from the inferior margin, 0.1 cm from the deepest margin, 1.5 cm from the medial margin, and 3 cm from the axillary appendage. The tumor is present in all quadrants of the breast and is multifocal. Lymphatic/vascular invasion is present, and the tumor is present in five of ten lymph nodes, with the largest involved lymph node being 2.4 cm. The patient's cancer is ER/PR positive, and extracapsular extension is present. The histologic type is ductal with a prominent lobular component, and the histologic grade is 3 of 3. The nuclear grade is 2 of 3.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-B6-A0RV.FF5D000A-4600-4C42-8802-4BCD29F61CA6',\n",
       "  'report_length_cl100k_base': 913,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's left breast biopsy revealed an excisional biopsy of invasive ductal carcinoma, with a tumor size of 1.6 cm and no lymphatic/vascular invasion. The tumor was located 0.8 cm from the closest resection margin and 1 cm from the deep margin. The surgical margins were negative, and the status of uninvolved breast tissue showed mild fibrocystic change. Estrogen receptor activity was positive, while progesterone receptor activity was negative. The complete report on the assay of the estrogen and progesterone receptors is pending.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's left breast biopsy revealed an excisional biopsy of invasive ductal carcinoma with a tumor size of 1.6 cm. The cancer is not unequivocally present in lymphatic/vascular invasion and the surgical margins are negative. The patient's uninvolved breast tissue shows mild fibrocystic changes. Estrogen receptor activity is positive (FMOL value of 39), while progesterone receptor activity is negative (FMOL value of 0). A complete report on the results of the assay will be issued separately.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0WS.36AE47A6-B881-4C1D-8436-EB65783243CF',\n",
       "  'report_length_cl100k_base': 612,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma in the left breast with a maximum tumor size of 3.5 cm. The cancer is histologic grade 3 and nuclear grade 2. There is no evidence of malignancy in the breast tissue, but 1 out of 15 lymph nodes is positive for metastatic carcinoma. The patient's cancer is classified as T1, N1, and M0.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma in the left breast with a maximum tumor size of 3.5 cm. The in situ ductal component represents approximately 15-20% of the tumor mass. There is no evidence of malignancy in the breast tissue, but 1 out of 15 lymph nodes is positive for metastatic carcinoma. The patient's breast tissue shows benign proliferative changes, including extensive fibrosis, duct ectasia, and apocrine metaplasia. An addendum was issued to the report stating that a reprocessed block (B18) showed no evidence of malignancy in the lymph nodes.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0WT.BACD800B-F320-472C-ACFF-175E9F525E9F',\n",
       "  'report_length_cl100k_base': 967,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has a 3.5 cm moderately differentiated invasive ductal carcinoma in the right breast with no evidence of residual tumor in the mastectomy specimen. The cancer has spread to 4 out of 7 axillary lymph nodes, with the largest lymph node being 2.1 cm, and exhibits extracapsular spread.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has a 3.5 cm breast adenocarcinoma (NSABP grade 2 of 3, nuclear grade moderately differentiated) with vascular invasion identified. The mastectomy specimen shows no residual carcinoma, but metastatic carcinoma is present in 4 of 7 lymph nodes with extracapsular spread. The largest lymph node is 2.1 cm.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0WV.506BFD3B-240B-440E-B7A0-E596FC0B7F72',\n",
       "  'report_length_cl100k_base': 810,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient has been diagnosed with invasive ductal carcinoma of the breast, with a tumor size of 4.1 x 2.6 x 4 cm, located in the upper inner quadrant. Lymphatic/vascular invasion is present, and the tumor is graded as N.S.A.B.P. nuclear grade 2 of 3 and histologic grade 3 of 3. The patient also has papillary squamous cell carcinoma in situ in the cervix. The breast tumor is multifocal, and in situ carcinoma occupies approximately 5% of the tumor. Eight out of 15 right axillary lymph nodes are positive for metastatic carcinoma, with the largest metastasis measuring 1.5 cm. The patient's estrogen and progesterone receptors are positive.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with invasive ductal carcinoma in the breast, with a tumor size of 4.1 x 2.6 x 4 cm. The cancer is present in eight of 15 right axillary lymph nodes, indicating lymph node involvement. The estrogen and progesterone receptors are positive, with FMOL values of 9 and 15, respectively. The cervical tumor is diagnosed as polyploid papillary squamous cell carcinoma in situ with equivocal early stromal invasion.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0WW.F05F5886-DC5D-4685-B2BF-57A68A0BB7B9',\n",
       "  'report_length_cl100k_base': 1407,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has invasive pleomorphic lobular carcinoma in the left breast, measuring 3.1 x 2.4 x 1.3 cm. There is no lymphatic or vascular invasion, and in-situ carcinoma is absent. The tumor is estrogen and progesterone receptor negative, and HER2/neu oncoprotein expression is not present.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive pleomorphic lobular carcinoma in the left breast, with a tumor size of 3.1 x 2.4 x 1.3 cm. There is no lymphatic/vascular invasion or in-situ carcinoma present. The cancer is estrogen and progesterone receptor negative, and HER2/neu oncoprotein expression is not present. Surgical margins are not applicable as this is an incisional biopsy. The patient's cancer is classified as stage I due to the absence of lymph node involvement and metastasis.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0WX.EE5BB205-D59B-4FEF-8D8F-D5720EDEB075',\n",
       "  'report_length_cl100k_base': 813,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's breast excision sample measured 9.5 x 8.8 x 2.3 cm, with a 1.6 cm invasive carcinoma component. Lymphatic/vascular invasion was present and extensive, with tumor involving all margins. Three out of 21 lymph nodes were positive for metastatic carcinoma, one showing extracapsular extension. Estrogen receptor was positive, and progesterone receptor was negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma in the left breast, with a tumor size of 1.6 cm and lymph node involvement. Three out of twenty-one lymph nodes are positive for metastatic carcinoma, with one showing extracapsular extension. The cancer is estrogen receptor-positive and progesterone receptor-negative. The surgical margins are technically free of malignancy.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0WY.C0E92852-4146-468C-9713-2DE9C3316B9F',\n",
       "  'report_length_cl100k_base': 896,\n",
       "  't_label': 2},\n",
       " {'abstract': 'The patient has invasive ductal carcinoma of the right breast, with a tumor size of 3 cm in the upper outer quadrant. There is lymphatic/vascular invasion, and 11 out of 21 lymph nodes are positive for carcinoma with extracapsular extension present in 4 nodes. The largest involved lymph node is 1.6 cm. The tumor is estrogen and progesterone receptor positive.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma of the right breast, measuring 3cm in size, located in the upper outer quadrant. There is lymphatic/vascular invasion and 11 out of 21 lymph nodes are positive for carcinoma with extracapsular extension present in 4 nodes. The tumor is estrogen and progesterone receptor positive.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0WZ.B5B7CCDD-1ED2-437A-BDF0-684AF474A8A6',\n",
       "  'report_length_cl100k_base': 888,\n",
       "  't_label': 1},\n",
       " {'abstract': '\\nThe patient has invasive ductal carcinoma of no special type, measuring 3 cm across, with extensive lymphatic channel invasion and tumor necrosis. The biopsy cavity wall contains residual high-grade invasive ductal carcinoma, and the deep margin is free of tumor. The tumor is multifocal, with separate foci in the upper inner quadrant. There is metastatic tumor present in 16 of 21 lymph nodes, with extracapsular invasion. The patient also has multiple seborrheic keratosis on the skin adjacent to the nipple.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma of no special type, measuring 3 cm across, with extensive lymphatic channel invasion and tumor necrosis. The biopsy cavity wall contains residual high-grade invasive ductal carcinoma, and the deep margin is free of tumor. The tumor is multifocal, with metastatic tumor present in 16 of 21 lymph nodes, including extracapsular invasion. The patient also has multiple seborrheic keratosis on the skin adjacent to the nipple.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0X1.D792031E-2CCE-4341-B3B3-C7D1D84F8F6B',\n",
       "  'report_length_cl100k_base': 828,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's breast cancer tumor measures 3 x 2.5 x 2 cm. The cancer has spread to two of the 21 examined lymph nodes and the metastasis status is positive.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's breast cancer tumor measured 3 x 2.5 x 2 cm. The cancer has spread to two of the 21 lymph nodes. The tumor is an infiltrating ductal carcinoma, with lymphovascular invasion identified. The cancer is estrogen and progesterone receptor positive. The surgical margins are free of carcinoma, and the patient's breast tissue shows benign proliferative changes.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0X4.CA935E8D-ED8A-4485-BDC6-02C07CCE2EA5',\n",
       "  'report_length_cl100k_base': 1652,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's left breast cancer is an invasive ductal carcinoma, measuring 3 x 2.5 x 1.5 cm, with a well-differentiated nuclear grade and N.S.A.B.P. histology grade 1 of 3. Three out of fourteen axillary lymph nodes contain metastatic carcinoma, with the largest metastatic focus measuring 1.8 x 1.1 cm. There is no extranodal extension, and all surgical margins, skin, nipple, and lactiferous duct are free of tumor.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The pathology report describes a left breast mass measuring 3x2.5x1.5cm, which is an infiltrating ductal carcinoma with a nuclear grade of 1 out of 3 and N.S.A.B.P. histologic grade 1 out of 3. The tumor has a component of colloid carcinoma representing less than 25% of the total tumor volume. Three out of fourteen axillary lymph nodes contain metastatic carcinoma, with the largest metastatic focus measuring 1.8x1.1cm. All surgical margins are free of tumor, and there is no tumor present in the skin, nipple, or lactiferous duct.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A0X5.29811BAC-AFD1-4951-BDF8-7B859941B634',\n",
       "  'report_length_cl100k_base': 1050,\n",
       "  't_label': 1},\n",
       " {'abstract': 'The patient has bilateral breast tumors. The left breast tumor is 1.2 x 1 x 1 cm and the right breast tumor is 2.0 x 1.0 x 1.0 cm. Both tumors have infiltrative borders and extend to within 0.3 cm of the closest margin of excision. There is no vascular invasion present. The tumors are invasive and intraductal carcinomas, with nuclear grade 2 and histologic grade 2. The intraductal carcinoma accounts for less than 5% of the total tumor volume. Tissue has been sent for Estrogen and Progesterone essays. No lymph node involvement or metastasis is mentioned in the report.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The pathology report describes bilateral breast tumors, with the left breast tumor measuring 1.2 x 1 x 1 cm and the right breast tumor measuring 2.0 x 1.0 x 1.0 cm. Both tumors have infiltrative borders and extend to within 0.3 cm of the closest margin of excision. There is no evidence of vascular invasion. The left tumor is invasive and intraductal carcinoma, with a nuclear grade of 2 and histologic grade of 2, and the right tumor is also invasive and intraductal carcinoma, with a nuclear grade of 2 and histologic grade of 3. Both tumors have been submitted for Estrogen and Progesterone receptor analysis. The report also notes apocrine metaplasia in the benign breast tissue surrounding the left tumor, and epithelial hyperplasia in the benign breast tissue surrounding the right tumor.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A0X7.0FB6BB0F-C3F9-43E6-8BDE-90D1DBA298CA',\n",
       "  'report_length_cl100k_base': 767,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive ductal carcinoma of the breast, with a tumor size of 2.0 x 1.8 x 1.0 cm. There is metastasis in one lymph node (1/1), with a size of metastasis of 0.8 cm and no evidence of extracapsular extension. The cancer is multifocal and has lymphatic/vascular invasion. The patient's cancer is estrogen/progesterone receptor-positive, HER2/neu-negative, and has a Nottingham combined histologic grade of 3 out of 3. The surgical margins are close, with the tumor approaching within 0.2 cm of the anterior margin.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma of the breast with a tumor size of 2.0 x 1.8 x 1.0 cm. The cancer is present in one lymph node (1/1) with a size of 0.8 cm and is negative for extracapsular extension. The cancer is also present in the skin, with microcalcifications in association with in-situ carcinoma. The patient's estrogen/progesterone receptor, cell cycle, and HER2/neu analysis were performed previously. The surgical margins are close, with the tumor approaching within 0.2 cm of the anterior margin. The patient's in-situ carcinoma is cribriform and comedo, with a nuclear grade of 3 out of 3. The final anterior, inferior margin is negative for malignancy.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A1KC.E1FDF8EB-9D75-4629-9C78-6019DAF8190E',\n",
       "  'report_length_cl100k_base': 1217,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has invasive ductal carcinoma in the right breast, measuring approximately 2.4 x 2.4 x 1.5 cm. There is no lymphatic or vascular invasion, and the tumor is estrogen and progesterone receptor negative. However, the tumor is HER2/neu positive. Two out of fourteen axillary lymph nodes are metastatic, with the largest metastasis measuring 1.0 cm. The patient's cancer is classified as stage IIA due to the presence of metastasis in the axillary lymph nodes.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive carcinoma in the right breast with a tumor size of 2.4 x 2.4 x 1.5 cm. There is no lymphatic/vascular invasion, and the lymph node involvement is absent. The cancer is hormone receptor-negative and HER2-positive. The surgical margins are negative, and there is no evidence of metastasis.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A1KF.40EE8416-9DD8-457D-94AC-A871B5C62873',\n",
       "  'report_length_cl100k_base': 1705,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma of the breast, with a tumor size of 1.6 cm and no lymphatic/vascular invasion. The cancer is not multifocal, and there is no evidence of metastasis. The patient's cancer is considered stage I.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive adenocarcinoma of the breast with a tumor size of 1.6 cm and no lymphatic/vascular invasion. The sentinel node is negative for malignancy. The tumor is multifocal and in-situ carcinoma is present, specifically, solid type DCIS. The Nottingham combined histologic grade is 2 of 3, and the cytokeratin immunohistochemical stain is negative. Estrogen/progesterone receptor, cell cycle, and HER2/neu analysis are pending. Surgical margins are close, with invasive carcinoma less than 0.5 mm from the superior surgical margin.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-B6-A1KI.C2711492-0BDD-487E-9C9B-CEF20BBE57C3',\n",
       "  'report_length_cl100k_base': 812,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is a ductal carcinoma with a tumor size of 6.4 x 5.2 x 2.5 cm, located centrally in the breast. The cancer has extended into the skin and nipple, with lymph node involvement (24/30 nodes positive for metastasis, largest metastasis 1.2 cm). Lymphatic and vascular invasion is present and extensive, with intraductal carcinoma in situ (comedo type) occupying 5% of the tumor. Estrogen receptor activity is positive (FMOL value 169), while progesterone receptor activity is negative (FMOL value 0). Surgical margins are not clear, as the tumor is present focally at the lateral margin and invasive carcinoma is found at the deep margin (less than 1 mm).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is a residual infiltrating ductal carcinoma, nuclear grade 3 of 3, with a tumor size of 6.4 x 5.2 x 2.5 cm. Lymphatic/vascular invasion is present and extensive, and intraductal carcinoma is identified. The cancer is multifocal, and the nipple and skin are directly invaded by the tumor. Surgical margins are not clear, with focal invasion at the lateral margin and intraductal carcinoma approaching the deep margin within 1 mm. Lymph node status reveals metastasis in 24 out of 30 nodes, with the largest metastatic lymph node measuring 1.2 cm. Extranodal extension is present. Estrogen receptor activity is positive (FMOL value of 169), while progesterone receptor activity is negative (FMOL value of 0).\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A1KN.72996825-1FFA-4C51-8DB0-DA74BCB595EB',\n",
       "  'report_length_cl100k_base': 1143,\n",
       "  't_label': 3},\n",
       " {'abstract': \"The patient has invasive lobular carcinoma of the right breast, measuring 5.0 x 5.0 x 2.8 cm, with no lymphatic/vascular invasion and no lymph node involvement (0/28). The tumor is multifocal and extensive, involving all four quadrants of the breast. The patient's estrogen and progesterone receptors are positive.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive lobular carcinoma of the right breast, measuring 5.0 x 5.0 x 2.8 cm, with no lymphatic/vascular invasion and no lymph node involvement (0/28). The tumor is multifocal and extensive, involving all four quadrants of the breast. The estrogen receptor activity is positive with an estimated FMOL value of 30, and the progesterone receptor activity is positive with an estimated FMOL value of 101.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-B6-A2IU.EE769039-220E-4158-8999-09F17AFB4C46',\n",
       "  'report_length_cl100k_base': 925,\n",
       "  't_label': 1},\n",
       " {'abstract': 'Invasive ductal carcinoma with lobular features, 3+ Nottingham combined histologic grade, with solid in-situ carcinoma, estrogen/progesterone receptor, HER2/neu, and EGFR analysis pending. Lymph node metastasis present.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'Invasive adenocarcinoma of the breast with lymph node metastasis. Tumor size and characteristics described. ER, PR, EGFR, and HER2/Neu results pending.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A3ZX.B3CFFF02-89AA-43AE-B19B-BEE6817AA997',\n",
       "  'report_length_cl100k_base': 567,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's cancer is stage pT2, pN2a, pMX. The tumor size is 2.3 x 2.1 x 1.2 cm, with a secondary lesion of 1.2 x 0.8 x 0.5 cm. There is no evidence of metastasis in the non-sentinel lymph node (0/1), but the sentinel lymph nodes 1 and 2 have metastatic adenocarcinoma (3/3) and (1/1) respectively. The tumor is invasive adenocarcinoma of the breast, with lymphatic/vascular invasion present. The cancer is estrogen/progestone receptor pending, and HER2/neu analysis is also pending. The patient's cancer has an extranodal extension and is classified as Nottingham combined histologic grade 3 of 3.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is stage pT2, with a 2.3 x 2.1 x 1.2 cm tumor, and stage pN2a, as metastatic adenocarcinoma was found in three left axillary lymph nodes, with the largest metastasis being 6 millimeters. There is no evidence of extranodal extension. The cancer is also stage pMX, as the report mentions metastasis in the lymph nodes but does not mention the presence or absence of distant metastasis.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-B6-A400.AF83CCA2-3AA4-4933-B6AD-9C11DF501DDD',\n",
       "  'report_length_cl100k_base': 2833,\n",
       "  't_label': 1},\n",
       " {'abstract': \"\\nThe patient's cancer is classified as stage pT1c due to a 2.0 cm tumor size, pN1a (sn) as one sentinel lymph node tested positive for metastasis, and pMX as there is no information on distant metastasis. The tumor is invasive adenocarcinoma, with a Nottingham combined histologic grade of 3 out of 3, and estrogen/progesterone receptor, cell cycle, EGFR, and HER2/neu analysis is pending. The surgical margins are clear, and there is no evidence of lymphatic or vascular invasion.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is classified as stage pT1c pN1a (sn) pMX according to the AJCC staging system. The tumor size is 2 x 1.5 x 1 cm, with no lymphatic or vascular invasion. One out of three lymph nodes was found to have metastatic adenocarcinoma, measuring 5 millimeters. The cancer is categorized as invasive ductal carcinoma, with a Nottingham combined histologic grade of 3 out of 3. Estrogen/progesterone receptor, cell cycle, EGFR, and HER2/neu analyses are pending. The surgical margins are negative for tumor, and the in-situ carcinoma is present and measures 2 cm.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-B6-A401.D76CF03A-54CD-4769-87AA-466473F41FC7',\n",
       "  'report_length_cl100k_base': 1727,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has been diagnosed with invasive adenocarcinoma of the breast, with a tumor size of 2.1 x 0.2 x 0.1 cm. Vascular invasion is absent, and there is no evidence of in-situ carcinoma. The results of ER, PR, EGFR, and HER2/Neu are pending and will be issued in an addendum.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with invasive adenocarcinoma of the breast, with a Nottingham combined histologic grade of 3 out of 3. Vascular invasion is absent, and there is no in-situ carcinoma identified. The results of ER, PR, EGFR, and HER2/Neu analyses are pending and will be issued in an addendum. The tumor size is 2.1 x 0.2 x 0.1 cm, and calcification is present.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A402.9BC704DE-0914-49F1-80F9-36CFE52B8484',\n",
       "  'report_length_cl100k_base': 411,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient has invasive ductal carcinoma with lobular features in the left breast. The tumor size is 2.1 x 2 x 1.2 cm, located at lateral 3:00, with lymphatic/vascular invasion present. Ten out of twenty-three lymph nodes are positive for metastatic carcinoma. The patient's cancer is classified as pT2 pN3a pMX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma with lobular features in the left breast. The tumor size is 2.1 x 2 x 1.2 cm and is located at lateral 3:00. Lymphatic/vascular invasion is present, and the cancer is multifocal. Ten out of twenty-three lymph nodes are positive for metastatic carcinoma. The patient's cancer is classified as pT2 pN3a pMX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-B6-A408.F5A14797-6676-4331-9424-D8B820008924',\n",
       "  'report_length_cl100k_base': 1118,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient has been diagnosed with invasive adenocarcinoma of the breast in the right breast's 10:00 area. The tumor size is 1.7 inches x 0.2 cm, with a Nottingham combined histologic grade of 3 out of 3. Lymphatic/vascular invasion has not been identified, and in-situ carcinoma is present, specifically comedo type, with a nuclear grade of 3 out of 3. The results for estrogen/progesterone receptor, HER2/neu, and EGFR analysis are pending and will be issued in an addendum.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with invasive adenocarcinoma of the breast in the right 10:00 area. The tumor is of ductal histologic type with a Nottingham combined histologic grade of 3 out of 3. There is no lymphatic or vascular invasion identified, but in-situ carcinoma is present, specifically comedo type. Nuclear grade of in-situ carcinoma is 3 out of 3. The results for ER, PR, EGFR, and HER2/Neu are pending and will be issued in an addendum.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-B6-A409.CC77BA51-CE5A-4839-A27A-DD8F389A2733',\n",
       "  'report_length_cl100k_base': 443,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is classified as stage pT1b (tumor size 1 x 0.7 x 0.7 cm), with no lymph node involvement (pNO), and no metastasis (pMX). The tumor is histologically type lobular, with a Nottingham combined histologic grade of 2 out of 3, and estrogen/progesterone receptor, cell cycle, EGFR, and HER2/neu analysis not performed.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's pathology report indicates a pT1b breast tumor (1 cm in size), with no lymph node involvement (pNO), and no metastasis (pMX). The tumor is histologically categorized as invasive adenocarcinoma of the breast, specifically lobular carcinoma. The Nottingham combined histologic grade is 2 out of 3, and the tumor is negative for lymphatic/vascular invasion. The surgical margins are negative, and the patient's skin is negative for malignancy.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A40B.CB2E56BC-16AC-4BFE-AB6C-2FC7E48943BB',\n",
       "  'report_length_cl100k_base': 1567,\n",
       "  't_label': 0},\n",
       " {'abstract': 'The patient has been diagnosed with invasive lobular adenocarcinoma of the breast, with a Nottingham combined histologic grade of 2 out of 3. The tumor size is 1.5 x 1.0 x 0.3 cm, and the results for estrogen/progesterone receptor, HER2/neu, and EGFR are pending. The presence of microcalcifications and in-situ carcinoma is also noted. Lymph node involvement and metastasis status are not mentioned in the report.',\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has been diagnosed with invasive lobular adenocarcinoma of the breast, with a Nottingham combined histologic grade of 2 out of 3. The tumor size is 1.5 x 1.0 x 0.3 cm, and microcalcifications are present in association with the invasive carcinoma. Estrogen/progesterone receptor, HER2/neu, and EGFR analysis are pending and will be issued in a separate report. The results of supplementary tests will also be provided in a separate report.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-B6-A40C.87B150CC-1C5D-42D5-9951-9157A81316D5',\n",
       "  'report_length_cl100k_base': 472,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, grade 2, measuring 2.2 cm with lymphovascular space invasion. The tumor is negative for metastatic carcinoma and is 5 mm from the closest margin of resection. The cancer is estrogen and progesterone receptor positive and Her-2/neu is equivocal with a score of 2+. No lymph nodes were involved, and the patient's cancer is classified as pT2, pNO(i-), and pma.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's breast cancer is invasive ductal carcinoma, grade 2, measuring 2.2 cm with lymphovascular space invasion. The tumor is negative for metastatic carcinoma and lymph nodes are clear (pNO(i-)). Margins of resection are negative for invasive carcinoma and DCIS, with the invasive tumor being 5 mm from the closest posterior margin. The tumor is positive for estrogen and progesterone receptors and equivocal for HER-2/neu with a score of 2+.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-BH-A0AU.4C942A1D-53B2-43A6-9B96-5155CCDEEC34',\n",
       "  'report_length_cl100k_base': 716,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, measuring 1.5 cm, with margins free of neoplasm at 0.6 cm. There is no lymphovascular invasion, and the tumor is estrogen and progesterone receptor negative, with no HER-2/neu amplification. The pathological stage is pT1c, with no lymph node involvement (pNo) and no metastasis (pMX). Ductal carcinoma in situ is present in four of the 15 sections, outside of the invasive component. The patient's cancer is grade 3, with a Nottingham score of 8/9.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive ductal carcinoma, measuring 1.5 cm, with margins free of neoplasm at 0.6 cm. There is no lymphovascular invasion, and the tumor is ER negative, PR negative, and HER-2/neu not amplified. The pathologic stage is pT1c, pNo, pMX. Ductal carcinoma in situ is present in four of fifteen sections, outside of the invasive component. The sentinel lymph node biopsy and non-sentinel lymph node biopsy are both negative for metastatic carcinoma.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-BH-A0AV.6DFA6F0F-09BC-4246-87B9-247207B74A39',\n",
       "  'report_length_cl100k_base': 772,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is invasive ductal carcinoma, Nottingham grade 2, measuring 2.0 cm in the greatest dimension. There is no lymphovascular space invasion, and margins of resection are negative for invasive component. DCIS is present admixed and outside of the invasive component in 8 out of 19 slides, comprising approximately 50% of the total tumor volume. Two out of twelve lymph nodes are positive for metastatic carcinoma, with the largest metastasis over 2 cm. The tumor is weakly positive for estrogen receptor, negative for progesterone receptor, and positive for HER-1/neu (score 3+).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma with a maximum size of 2.0 cm, Nottingham grade 2, and DCIS present in approximately 50% of the tumor volume. The margins of resection are negative for invasive component, but DCIS is less than 1 mm from the anterior margin and 1.5 mm from the posterior margin of resection. Two out of twelve lymph nodes are positive for metastatic carcinoma, with the largest metastasis being over 2 cm. The tumor is weakly positive for estrogen receptor, negative for progesterone receptor, and positive for HER-1/neu (score 3+). The patient's cancer is classified as T1c, N1a, and MX.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-BH-A0AW.D1B30DA1-FF63-4FC7-AB8B-818331EE6D72',\n",
       "  'report_length_cl100k_base': 876,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is stage pT2, pNO, pMX with a 2.2 cm invasive ductal carcinoma in the left breast, with no lymph node involvement and negative metastasis. The tumor is located in the lower outer quadrant and is not associated with angiolymphatic invasion. The patient's cancer is estrogen and progesterone receptor positive and HER2/neu positive (1+).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is stage pT2, with a 2.2-cm invasive ductal carcinoma in the left breast, negative for angiolymphatic invasion, and a smaller 1.3-cm invasive ductal carcinoma. The tumor is grade 2, with mitosis 1, and perineural involvement is present. The patient's lymph nodes are negative for tumor, and there is no metastasis. The patient's cancer is hormone receptor-positive and HER2/neu positive (1+).\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-BH-A0AY.06905BD3-4D17-4625-8631-46CA81D1B47B',\n",
       "  'report_length_cl100k_base': 885,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a multifocal and multicentric invasive ductal carcinoma with a tumor size of 2.5 cm. There is no lymphovascular invasion, and the margins of resection are free of tumor. The cancer is estrogen receptor-positive and progesterone receptor-positive. The patient has one positive lymph node with metastasis and extracapsular extension. The cancer is stage pT2, pN1, and pMX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is a multifocal and multicentric invasive ductal carcinoma with a tumor size of 2.5 x 2 x 2.1 cm, and additional smaller tumors. There is no lymphovascular invasion, and margins of resection are free of tumor. The cancer is estrogen and progesterone receptor-positive, and Her-2/neu is equivocal. The patient has one positive lymph node with extracapsular extension, and three negative lymph nodes. The cancer is classified as pT2, pN1, and pMX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-BH-A0AZ.6721193F-FE9D-4573-BF2A-ABAECF57DFD9',\n",
       "  'report_length_cl100k_base': 1155,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's cancer is invasive ductal carcinoma, with a tumor size of 1.8 cm and no lymphovascular space invasion. The cancer is 0.8 cm from the nearest anterior margin and there is no evidence of metastatic mammary carcinoma in the examined lymph nodes (0/2). The patient's cancer is estrogen and progesterone receptor-positive, HER2/neu is zero or 1+, and the Nottingham score is 5/9.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's left breast segmental mastectomy revealed invasive ductal carcinoma, measuring 1.8 cm in the largest dimension, with no lymphovascular space invasion. The tumor is 0.8 cm from the nearest anterior margin, and there is no evidence of metastatic mammary carcinoma in the examined lymph nodes (0/2). The Nottingham score is 5, and the tumor is ER and PR positive, with HER2/neu being zero or 1+. The patient's cancer is classified as pT1c, pNo, and pMX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-BH-A0B0.EB09D890-879C-4874-AE3F-47E41C2C66FE',\n",
       "  'report_length_cl100k_base': 581,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is a multicentric infiltrating ductal carcinoma with a Nottingham score of 6/9. The tumor size ranges from 0.2 to 4.8 cm, with the largest aggregate being 14.3 cm. The tumor is located centrally and involves all four quadrants, with focal extracapsular extension. The margins are free of tumor, but there is extensive lymphovascular space involvement. The patient has one positive lymph node with metastatic ductal carcinoma, measuring 0.9 cm. The patient's cancer is stage pT2, N1, and MX. The tumor is estrogen and progesterone receptor positive and HER2/neu positive.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is a multicentric infiltrating ductal carcinoma with a Nottingham score of 6/9. The tumor nodules range from 0.2 to 4.8 cm, with the largest aggregate being 14.3 cm. The tumor is located centrally and involves all four quadrants, with focal lobular carcinoma in situ. The tumor is 0.8 cm from the lower inner quadrant deep margin and the margins are free of tumor. The patient has one positive lymph node with metastatic ductal carcinoma, 0.9 cm with focal extracapsular extension. Fourteen right axillary lymph nodes were negative for tumor. The patient's cancer is stage pT2, pN1, and pMX. The tumor is estrogen and progesterone receptor positive and HER2/neu positive.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-BH-A0B1.BAEB6705-FCDC-4B40-B1CB-D926B8287F92',\n",
       "  'report_length_cl100k_base': 962,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, with a tumor size of 2.5 cm and mixed DCIS, comprising approximately 10% of the total tumor volume. There is no lymphovascular invasion, and the margins of resection are negative. Two out of four lymph nodes are positive for tumor, with the largest lymph node metastasis measuring 0.7 cm. The cancer is negative for estrogen and progesterone receptors and HER-2/neu (score 1+).\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma with a maximum dimension of 2.5 cm, Nottingham grade 3, and DCIS with a nuclear grade of 3. The tumor is negative for estrogen and progesterone receptors and HER-2/neu. The margins of resection are negative, and the invasive tumor is 0.7 cm away from the closest margin. Two out of four lymph nodes are positive for tumor, with the largest lymph node metastasis measuring 0.7 cm. The patient's T stage is pT2, N stage is pN1a, and M stage is pMX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-BH-A0B3.A6E2735B-AAD3-48D7-8289-306257CB5B6F',\n",
       "  'report_length_cl100k_base': 845,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is invasive ductal carcinoma, grade 3, measuring 2.2 cm. It extensively involves the nipple papillary dermis and has a Nottingham score of 9/9. Six out of ten axillary lymph nodes are positive for metastatic carcinoma with extracapsular extension. There is no lymphatic invasion, and the tumor is estrogen and progesterone receptor-positive, with a HER2/neu score of 2+. The pathological staging is pT2, pN2a, and pMX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma with a tumor size of 2.2 cm, extensively involving the nipple papillary dermis. There is no lymphatic invasion noted, but six out of ten axillary lymph nodes are positive for metastatic carcinoma with extracapsular extension. The tumor is estrogen and progesterone receptor positive and HER2/neu is 2+. The patient's cancer is classified as T2, N2a, and MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-BH-A0B4.00C75246-4343-490D-9782-E6C0068C77B2',\n",
       "  'report_length_cl100k_base': 813,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is characterized by a multifocal, multicentric invasive lobular carcinoma in the left breast, measuring between 1.5 to 2.7 cm. Five out of 21 lymph nodes were positive for metastatic lobular carcinoma, with the largest metastatic tumor measuring 1.4 cm. There is no lymphovascular invasion, but focal extracapsular extension is present. The cancer is estrogen and progesterone receptor-positive, and the Nottingham score is 6/9, indicating a grade 2 classification.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is characterized by multifocal and multicentric invasive lobular carcinoma, with the largest tumor mass measuring 2.7 cm. Five out of 21 axillary lymph nodes were positive for metastatic lobular carcinoma, and the deep resection margin in the lower inner quadrant tested positive for invasive lobular carcinoma. The metastatic tumor measures 0.8 cm with focal extracapsular extension. The patient's nipple showed lobular carcinoma in situ with ductal extension of 5 mm to the skin surface. The cancer is estrogen and progesterone receptor-positive.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-BH-A0B5.F44C515D-5A58-4382-A147-4429A78D434F',\n",
       "  'report_length_cl100k_base': 886,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a ductal adenocarcinoma, with a tumor size of 1.5 x 1.2 x 1.1 cm. It is 1 mm from the nearest anterior resection margin. There is no lymphovascular permeation and the Nottingham score is 6/9. The cancer is estrogen and progesterone receptor positive, and HER2/neu negative. Four lymph nodes were examined, all free of tumor (0/4). The cancer is stage pT1c, N0, M0.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is a ductal adenocarcinoma, with a tumor size of 1.5 x 1.2 x 1.1 cm. It is 1 mm from the nearest anterior resection margin. There is no lymphovascular permeation and the Nottingham score is 6/9. The cancer is estrogen and progesterone receptor positive, and HER2/neu negative. Four lymph nodes were examined and found to be free of tumor. The patient's cancer is stage pT1c, with no lymph node involvement (pNo), and is metastasis-free (M0).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-BH-A0B6.06602AD0-AC4D-4674-B4B0-2D207C3E78DC',\n",
       "  'report_length_cl100k_base': 965,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is stage pT2, with two invasive tumors measuring 2.4 cm and 1.1 cm, both located in the right breast. There is lymph node involvement with one positive sentinel lymph node and one positive non-sentinel lymph node out of 17 examined. The cancer is ER and PR positive, HER-2/neu positive, and features apocrine and solid types of ductal carcinoma in situ (DCIS) with comedocarcinoma. The tumor is free from the nipple, and skin is negative for tumor. Lymphovascular invasion is identified, and extracapsular extension is present.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer has a tumor size of 2.4cm, located at the 9 o'clock position in the right breast. There is lymph node involvement with 1/17 lymph nodes positive for metastatic carcinoma and extracapsular extension identified. The cancer is ER positive, PR positive, and HER-2/neu positive. The patient's cancer is classified as pT2, pN1a, and no metastasis (M0).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-BH-A0B7.B5E5A3B8-108E-47D3-99DA-EC7A64B5FA9C',\n",
       "  'report_length_cl100k_base': 1082,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is stage pT1b, with no lymph node involvement (pNO) and no metastasis (pMX). The tumor size is 0.9 cm, and it is estrogen and progesterone receptor positive, with a weakly positive HER-2/neu score of 2+. Surgical margins are negative for both invasive and in situ components, and there is no lymphovascular invasion identified.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is stage pT1b, with a 0.9cm invasive ductal carcinoma, no lymph node involvement (pNO), and no metastasis (pMX). The tumor is estrogen and progesterone receptor positive, and Her-2/neu weakly positive (score 2+). Surgical margins are negative for both invasive and in situ components, and there is no lymphovascular invasion identified.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-BH-A0B8.11E1BCE2-F246-4930-A97C-A14B34BCF840',\n",
       "  'report_length_cl100k_base': 708,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, measuring 1.5 x 1.4 x 1.4 cm, with no lymphovascular invasion identified. The tumor is estrogen, progesterone, and HER2/neu negative. The surgical margins are negative for invasive tumor and ductal carcinoma in situ. One lymph node was examined and found to be negative for tumor. The tumor has a Nottingham score of 9 (tubules 3, nuclear 3, mitoses 3) and is classified as a basal-like type.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive ductal carcinoma, 1.5 x 1.4 x 1.4 cm in size, with no lymphovascular invasion identified. The tumor is estrogen, progesterone, and HER2/neu negative. The Nottingham score is 9/9, with tubules 3, nuclear 3, and mitoses 3. The surgical margins are negative for invasive tumor and ductal carcinoma in situ. The tumor is cytokeratin 5 and 6 negative, and cytokeratin 14, cytokeratin 17, epidermal growth factor, and vimentin positive. The patient's lymph nodes are negative for tumor (0/1).\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-BH-A0B9.EB00527B-1E37-420E-85E4-10063DB4BC1C',\n",
       "  'report_length_cl100k_base': 784,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is stage pT3 with a 6cm multifocal, multicentric mixed ductal and lobular carcinoma. The tumor is estrogen and progesterone receptor positive, Her-2/neu negative, with lymph node involvement in the left axilla (27 out of 27 nodes positive, including the sentinel lymph node). There is evidence of angiolymphatic invasion and extracapsular spread.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is stage pT3 with a multifocal, multicentric tumor measuring 6.0 x 5.5 x 2.5 cm located in the upper outer, lower outer, upper inner, and lower inner quadrants of the breast. The tumor is estrogen and progesterone receptor positive, HER-2/neu negative, and lymph node metastasis is present in the axillary sentinel lymph node (1/1) and level 3 lymph nodes (6/6). The tumor has angiolymphatic invasion and is admixed with 10% lobular carcinoma in situ. All margins are negative for invasive mixed ductal and lobular carcinoma, and the nipple shows focal invasive carcinoma in the deep stromal tissue. The patient's cancer has an extracapsular spread.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-BH-A0BA.142F03FE-5B60-416D-8DCD-EC34DB5495DB',\n",
       "  'report_length_cl100k_base': 1054,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma with lobular features, measuring 3.2 cm, with extensive lymphovascular invasion and free margins. One sentinel lymph node is positive for metastatic carcinoma, with a focus of 1.2 cm in greatest diameter and extracapsular extension of 0.5 cm x 0.2 cm. The cancer is estrogen and progesterone receptor-positive and HER2/neu is zero or 1+. The pathological stage is pT2, pN1, and pMX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma with lobular features in the right breast, measuring 3.2 cm, with extensive lymphovascular invasion and margins free within 0.5 cm. One sentinel lymph node is positive for metastatic carcinoma, with a focus of 1.2 cm and extracapsular extension of 0.5 cm x 0.2 cm. The tumor is estrogen and progesterone receptor positive and HER2/neu is zero or 1+. The pathological stage is pT2, pN1, and pMX.',\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 3,\n",
       "  'patient_filename': 'TCGA-BH-A0BC.9714A9F8-B507-43E6-9D56-1852F5D1F675',\n",
       "  'report_length_cl100k_base': 997,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, with a focal metastatic adenocarcinoma in the axillary sentinel lymph node measuring 0.8 cm in maximum diameter. The tumor is multifocal, ranging from 0.2 cm to 1.6 cm in size, with lymphovascular invasion identified. The cancer is estrogen and progesterone receptor-positive, and HER-2/neu negative. Resection margins are clear, and there is no extranodal extension.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive ductal carcinoma, Nottingham Grade III, with a focal metastatic adenocarcinoma in the axillary sentinel lymph node #1, measuring 0.8 cm in maximum diameter. The tumor is multifocal, ranging from 0.2 cm to 1.6 cm in size. Lymphovascular invasion is identified, but resection margins are negative for carcinoma. The tumor is estrogen and progesterone receptor-positive, HER-2/neu negative, and has some foci of ductal carcinoma in situ.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-BH-A0BD.CE70DD1E-BCA4-4F89-AA5B-D90FE18A36FF',\n",
       "  'report_length_cl100k_base': 399,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, with a tumor size of 2.7 x 2.5 x 2.4 cm and extensive lymphovascular invasion. One out of two lymph nodes (1/2) in the right axillary sentinel are involved with micrometastatic adenocarcinoma, measuring up to 1.5 mm. The tumor margins, nipple, and skin are free of cancer, and immunohistochemical staining for hormone receptors and HER-2/neu are pending.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an infiltrating ductal carcinoma, with a tumor size of 2.7 x 2.5 x 2.4 cm and extensive lymphovascular invasion. The Nottingham score is 9/9. One out of two lymph nodes in the right axillary sentinel group showed micrometastatic adenocarcinoma, measuring up to 1.5 mm. The margins of resection are free of tumor, and there is no evidence of tumor in the nipple or skin. Immunohistochemical staining for hormone receptors and HER-2/neu is pending.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-BH-A0BF.0D76394C-40B4-4E74-8A80-FAE00E21FD10',\n",
       "  'report_length_cl100k_base': 637,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, grade 3, measuring 1.8 cm with no lymph node involvement. The margins of resection are negative for invasive carcinoma, and there is no lymphovascular invasion. The cancer is negative for estrogen and progesterone receptors and negative for HER-2/neu. DCIS is present outside of the invasive carcinoma component and at the inferior margin of resection.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \" The patient's left axillary sentinel lymph node biopsy was negative for tumor. The invasive ductal carcinoma measures 1.8 cm in greatest dimension, with margins of resection negative for invasive carcinoma. The cancer is negative for estrogen and progesterone receptors and negative for Her-2/neu. DCIS is present outside of the invasive carcinoma component and at the inferior margin of resection, with no lymphovascular invasion identified. The tumor is Nottingham Grade 3, and the patient's previous biopsy showed vascular space invasion.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-BH-A0BG.CB0C2E8E-2D5D-492C-9C7E-0ECD0458425A',\n",
       "  'report_length_cl100k_base': 512,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's breast cancer is classified as invasive ductal carcinoma, measuring 2.5 cm with a Nottingham score of 6/9 (overall grade 2/3). There is no lymphovascular invasion, and the margins of resection are free of carcinoma. The cancer is estrogen and progesterone receptor positive, and HER-2/neu negative. One out of two lymph nodes in the left axilla is positive for metastatic carcinoma, measuring 1 cm. Extracapsular extension is identified. The patient's cancer is classified as T2, N1, and stage IIA.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \" The patient has invasive ductal carcinoma with a tumor size of 2.5 cm, moderate differentiation, and no lymphovascular invasion. The tumor margins are free of carcinoma, and the patient is estrogen and progesterone receptor positive, with a Her-2/neu negative score of 1+. One out of two lymph nodes in the left axilla is positive for metastatic carcinoma, measuring 1 cm. Extracapsular extension is identified. The patient's cancer is classified as stage pT2 and pN1.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-BH-A0BJ.A3CDF051-4162-47EC-BE8A-1519A5564518',\n",
       "  'report_length_cl100k_base': 1052,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a grade 3 invasive ductal carcinoma, with a tumor size of 1.3 cm. There is no evidence of lymph node involvement or angiolymphatic invasion. The margins are negative for neoplasm, and the cancer has not metastasized. The tumor is estrogen and progesterone receptor unknown, and HER2/neu status is also unknown.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \" The patient's cancer is a grade 3 invasive ductal carcinoma, with a tumor size of 1.3 cm. There is no evidence of angiolymphatic invasion, and the margins are negative for neoplasm. The cancer is classified as T1c, with no lymph node involvement (N0), and no distant metastasis (MX). Estrogen, progesterone, and HER2/neu receptor status are unknown.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-BH-A0BL.DD647293-3CEA-4845-A0B3-D7000CBAB4C0',\n",
       "  'report_length_cl100k_base': 552,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is stage pT2, pN1, pMX with a tumor size of 2.8 cm and metastasis in one sentinel lymph node (1/1). The cancer is ER positive, PR negative, and HER-2/NEU negative. The lymph nodes are negative for metastatic carcinoma (0/19) after axillary dissection. The tumor is a mixed in situ and invasive component, with the in situ component being cribriform and micropapillary types, nuclear grade 1, and associated with microcalcifications and focal comedonecrosis. The invasive component has a Nottingham score of 4/9, grade 1, and does not extend to the anterior margin of resection.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive ductal carcinoma, measuring 2.8 cm in maximum dimension, with no lymphovascular invasion identified. The cancer is ER positive, PR negative, and HER-2/NEU negative. The pathological stage is pT2, pN1, pMX, with one positive sentinel lymph node (1/1) for metastatic carcinoma and nineteen negative lymph nodes (0/19) for metastatic carcinoma in the right axillary area. The tumor has a Nottingham score of 4/9, Grade 1, and is a mixed type of cribriform and micropapillary ductal carcinoma in situ with associated microcalcifications and focal comedonecrosis. The margins of resection are free of neoplasm, except for the posterior margin which is close to the tumor (0.3 cm).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-BH-A0BM.7F75F15A-2476-4FFD-97B3-313F06568E21',\n",
       "  'report_length_cl100k_base': 1131,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a invasive ductal carcinoma, sized at 1.0 x 1.0 x 0.9 cm, with no lymphovascular invasion identified. The tumor is estrogen and progesterone receptor positive, and HER-2/neu negative. Three lymph nodes were examined, all negative for tumor. Surgical margins were negative, and the tumor is classified as Nottingham score 6 out of 9. The cancer is stage pT1b, pNO, and pMX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is a ductal carcinoma, measuring 1.0 x 1.0 x 0.9 cm, with no lymphovascular invasion identified. The tumor is estrogen and progesterone receptor positive, and HER-2/neu negative. The Nottingham score is 6 out of 9, with tubules 3, nuclei 2, and mitosis 1. The surgical margins are negative, and the tumor is composed of 1% ductal carcinoma in-situ, cribriform type, nuclear grade 2. The patient's lymph nodes are negative for tumor (0/3), and the tumor is associated with microcalcifications and fibrocystic changes. The case synopsis indicates a primary invasive carcinoma of the breast, left laterality, and a pT1b pathologic stage.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-BH-A0BO.DDAB2FC2-D9F0-4D8F-A7FE-6C0B823E6823',\n",
       "  'report_length_cl100k_base': 846,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is invasive ductal carcinoma, with two foci of 0.7cm and 1.5cm, and a tumor aggregate size of 2.2cm. There is no lymphovascular space involvement, and the margins are free of tumor. The cancer is 0.2cm from the anterior margin and 0.1cm from the posterior margin. The patient's cancer is stage pT1c, with no lymph node involvement (pNO), and no metastasis (pMX). The tumor is estrogen and progesterone receptor-positive and HER2/neu is zero or 1+.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma with a tumor aggregate size of 2.2 cm, Nottingham score of 6/9, and DCIS present in both foci of the tumor. Lymphovascular space invasion is not prominent, and margins are free of tumor. The patient's lymph nodes are negative for tumor, and there is no evidence of metastasis. The patient's breast tissue shows fibrocystic changes, atypical ductal epithelial hyperplasia, and a microscopic radial scar. The tumor is estrogen and progesterone receptor-positive and HER2/neu negative. The pathological staging is pT1c, pNO, and pMX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-BH-A0BP.2444E1FE-E0AB-4AA0-9081-967426B90EE6',\n",
       "  'report_length_cl100k_base': 841,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma with a maximum tumor size of 1.5 cm, Nottingham score of 6 (grade 2), and no lymph node involvement. There is no lymphovascular space invasion, and the tumor is estrogen and progesterone receptor-positive, with a HER2/neu score of 2+. The pathological staging is pT1c, pNo, and pMX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma in the left breast, with a maximum tumor size of 1.5 cm and no lymph node involvement. The tumor is grade 2, with tubule formation 3, nuclear pleomorphism 2, and mitotic activity 1. There is no lymphovascular space invasion. The patient's cancer is estrogen and progesterone receptor-positive and HER2/neu 2+.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-BH-A0BQ.24245506-25BA-411D-8A43-52DB8F6B6037',\n",
       "  'report_length_cl100k_base': 647,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, sized at 1.1 cm, with no lymph node involvement. The tumor is negative for lymphovascular space invasion and the margins are free of tumor. The cancer is estrogen and progesterone receptor-positive, and HER2/neu is zero or 1+. The pathological staging is pT1c, pNO, and pMX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive ductal carcinoma, with a tumor size of 1.1 cm and a Nottingham score of 6/9. The tumor is located in the left breast, and the margins are free of tumor. There is no lymph node involvement, and the cancer has not metastasized. The tumor is estrogen and progesterone receptor-positive, and HER2/neu is zero or 1+. The patient's cancer is classified as pT1c, pNO, and pMX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-BH-A0BR.6122CE59-23C0-4205-91B5-B71E39C6EAB8',\n",
       "  'report_length_cl100k_base': 769,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is stage pT3, pN1a, pMX with a multifocal, invasive ductal carcinoma measuring 6cm in the largest dimension. Two out of 14 lymph nodes were positive for metastatic tumors, and extracapsular extension was identified. The tumor is estrogen and progesterone receptor-positive and Her2-neu negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is stage pT3, pN1a, pMX with a multifocal, invasive ductal carcinoma measuring 6cm in the largest dimension. The tumor is estrogen and progesterone receptor positive, and Her2/neu negative. Two out of 14 lymph nodes were positive for metastatic tumor, with one measuring 1.1cm. There is no lymphovascular space invasion, and the resection margins are negative for both invasive and in-situ carcinoma. The ductal carcinoma in-situ constitutes 10% of the total tumor mass and is present admixed with and away from the invasive component.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-BH-A0BS.A231BC51-EFA3-4FEB-A83F-C793FFF8E607',\n",
       "  'report_length_cl100k_base': 1356,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, measuring 2.0 cm, with a Nottingham score of 5/9 (grade 1). The tumor is positive for estrogen and progesterone receptors but negative for Her-2/neu. One lymph node out of four examined is positive for micrometastasis (1/4), with no extracapsular spread. Surgical margins are free of invasive tumor, and the tumor is negative for angiolymphatic invasion. The patient's cancer is classified as T1c, N1mi, and MX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an infiltrating ductal carcinoma, measuring 2.0 cm, with a Nottingham score of 5/9. The tumor is negative for estrogen and progesterone receptors, but positive for HER-2/neu. One lymph node out of four examined is positive for micrometastasis, with no extracapsular spread. Surgical margins are free of invasive tumor, and the tumor is negative for angiolymphatic invasion. The patient's cancer is classified as T1c, N1mi, and MX.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-BH-A0BT.18E4043D-34BF-4CD1-9E2D-F906C7C7B019',\n",
       "  'report_length_cl100k_base': 1136,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is classified as stage T2 N1 MX with a 3.0 cm invasive ductal carcinoma, lymphovascular invasion, and one positive lymph node with extracapsular extension out of 25 examined. The tumor is estrogen and progesterone receptor positive, HER-2/neu negative, and has a Nottingham score of 7/9, grade 2.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is classified as stage T2 N1 MX with a 3.0 cm invasive ductal carcinoma, lymphovascular invasion, and one positive lymph node with extracapsular extension. The tumor is estrogen and progesterone receptor positive, HER-2/neu negative, and has a Nottingham score of 7/9, grade 2. The margins of resection are free of neoplasm, and the closest anterior margin is 2.0 cm. The report also mentions ductal carcinoma in situ, atypical ductal hyperplasia, intraductal papilloma, and pseudoangiomatous stromal hyperplasia.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-BH-A0BV.7C877EE0-B4BC-4B17-94AB-81B67C7B6DB3',\n",
       "  'report_length_cl100k_base': 1064,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, grade 3, measuring 2.0 cm, with no lymphovascular invasion identified. The tumor is negative for metastatic carcinoma, and the lymph nodes examined are also negative for metastatic carcinoma (0/8). The pathologic stage is pT1, pN0, pMX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive ductal carcinoma, grade 3, with a size of 2.0 cm and no lymphovascular invasion. The tumor is negative for metastatic carcinoma in all examined lymph nodes (0/8). The cancer is stage pNO, with no lymph nodes positive for cancer.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-BH-A0BW.14CE78F3-8FB4-476D-A09C-AE87F7919D77',\n",
       "  'report_length_cl100k_base': 962,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma with a maximum dimension of 8.3 cm, with lymphovascular permeation and margins of resection free of tumor. The cancer is estrogen and progesterone receptor-positive and HER-2/neu negative. One out of 23 left axillary lymph nodes is involved, with a diameter of 1.1 cm. The patient's cancer is stage T3, N1, and M0.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient has invasive ductal carcinoma with a maximum dimension of 8.3 cm, Nottingham score of 8/9, lymphovascular permeation, and margins of resection free of tumor. The tumor is positive for estrogen and progesterone receptors and negative for HER-2/neu. One out of 23 left axillary lymph nodes is positive for metastatic adenocarcinoma, with a diameter of 1.1 cm. The patient also has ductal carcinoma in situ, solid and cribriform types, nuclear grade 3, with comedocarcinoma. Paget's disease of the nipple is absent, and the skin is free of tumor.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-BH-A0BZ.1B56E5A6-35B8-4C60-8BC5-68716C946799',\n",
       "  'report_length_cl100k_base': 849,\n",
       "  't_label': 2},\n",
       " {'abstract': \"The patient's cancer is invasive ductal carcinoma, Nottingham grade 3, with a tumor size of 1.7 cm. It is mixed with ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS). Lymphovascular space invasion is identified, and one out of 28 lymph nodes is positive for carcinoma. The tumor is positive for estrogen and progesterone receptors and weakly positive for HER2/neu. The patient's cancer is stage pT1c, pN1a, and pMX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': 'The patient has invasive ductal carcinoma with a tumor size of 1.7 cm, lymphovascular space invasion, and one positive lymph node out of 28. The tumor is positive for estrogen and progesterone receptors and weakly positive for HER2/neu. The patient also has ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS). The surgical margins are negative, and the posterior margin is 1 mm from the invasive tumor. The patient has fibrocystic changes and benign epithelial calcifications. The cancer is stage pT1c, pN1a, and pMX.',\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-BH-A0C0.53DD68D0-C2BE-4EC2-907E-3F1F11D31052',\n",
       "  'report_length_cl100k_base': 963,\n",
       "  't_label': 0},\n",
       " {'abstract': \"The patient's cancer is an infiltrating lobular carcinoma, measuring 7.0 cm with a Nottingham score of 8/9. The tumor is multifocal and multicentric, present in the lower outer quadrant, upper outer quadrant, and upper inner quadrant. There is no definitive lymphovascular invasion identified. The tumor extends through the nipple into the upper papillary dermis of the skin. The patient's cancer is ER-positive, PR-positive, and HER-2/neu negative. One out of one lymph node is positive for metastatic carcinoma, and eight out of ten lymph nodes are positive for metastatic carcinoma. The greatest dimension of the metastatic focus is 2.0 cm, and extracapsular extension is identified.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an infiltrating lobular carcinoma, pleomorphic and classical subtypes, with a tumor size of 7.0 cm and a Nottingham score of 8/9. The tumor is multifocal and multicentric, present in the lower outer quadrant, upper outer quadrant, and upper inner quadrant. The patient's cancer is ER-positive, PR-positive, and HER-2/neu negative. One out of one lymph node was positive for metastatic carcinoma, and eight out of ten lymph nodes were positive for metastatic carcinoma. The greatest dimension of the metastatic focus is 2.0 cm, and extracapsular extension is identified. The patient's cancer is stage pT3, pN2a, and pMX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 2,\n",
       "  'patient_filename': 'TCGA-BH-A0C1.1EC74EB3-9ECC-49B6-AE25-048A5F6A1D02',\n",
       "  'report_length_cl100k_base': 990,\n",
       "  't_label': 2},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive ductal and lobular carcinoma, measuring 1.9 cm in the greatest dimension. There is no lymph node involvement (pNO), no metastasis (pMX), and the tumor is estrogen receptor-positive. The pathological staging is pT1c, pNO, pMX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an infiltrating mammary carcinoma with mixed ductal and lobular phenotypes, measuring 1.9 cm in the greatest dimension. The tumor is grade 2/3, with a Nottingham score of 7/9. There is no lymphovascular invasion identified, and surgical margins are negative for invasive carcinoma and DCIS. The cancer is estrogen receptor positive and progesterone receptor negative. The patient's lymph nodes are negative for carcinoma, with two sentinel lymph nodes examined. The cancer is classified as T1c, NO, and MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-BH-A0C3.3A54CF6E-AFDB-4609-A827-77D75BB376A7',\n",
       "  'report_length_cl100k_base': 881,\n",
       "  't_label': 0},\n",
       " {'abstract': \"\\nThe patient's cancer is an invasive ductal carcinoma, with a tumor size of 3.0 cm and a Nottingham grade of 3/3. Lymphovascular space invasion is present, and the cancer has spread to one lymph node (1/1) with a micrometastasis of 1.5 mm. The patient's cancer is estrogen receptor-positive and progesterone receptor-negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive ductal carcinoma with a maximum tumor dimension of 3.0 cm, Nottingham grade 3/3, and lymphovascular space invasion. The cancer is present in one lymph node with a 1.5 mm metastasis. The nipple and skin are negative for tumor, and the surgical resection margins are negative. The patient's cancer is estrogen receptor positive and progesterone receptor negative.\",\n",
       "  'is_goodsum_n': False,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': -1,\n",
       "  'patient_filename': 'TCGA-BH-A0C7.880F3DC6-4342-4232-A04E-A128F1A8201D',\n",
       "  'report_length_cl100k_base': 990,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, with a tumor size of 3.0 cm and a Nottingham score of 8. There is one positive lymph node with a metastatic focus measuring 3.0 cm in the greatest diameter and extracapsular extension. The cancer is estrogen and progesterone receptor-positive and HER2/neu is 2+. The pathological stage is pT1, pN1a, and pMX.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive ductal carcinoma, with a maximum tumor size of 3.0 cm and a Nottingham score of 8. The cancer has spread to one lymph node, which measures 3.0 cm in diameter. Extracapsular extension is identified. The cancer is estrogen and progesterone receptor-positive and HER2/neu is 2+. The patient's lymph nodes were examined, with 22 nodes removed and 1 positive for metastasis. The tumor is free from the resection margins and there is no evidence of Paget's disease of the nipple. The pathological staging is T1, N1a, and MX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-BH-A0DD.35FFF2A4-7956-47AC-B6B8-1AA6775E332B',\n",
       "  'report_length_cl100k_base': 772,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, with a tumor size of 2.5 cm, located in the upper outer and lower outer quadrants of the breast. There is no lymph node involvement, and metastasis status is not identified. The tumor is positive for estrogen and progesterone receptors and negative for HER-2. The Nottingham score is 2, and the tumor is classified as NOS. The surgical margins are negative for invasive carcinoma, and the patient's cancer is staged as pT2, pN0, and pMx.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive ductal carcinoma, with a tumor size of 2.5 cm, located in the upper outer and lower outer quadrants of the breast. The cancer is grade 2 on the Nottingham scale, with no lymphovascular invasion. The resection margins are negative for invasive carcinoma, and the lymph nodes examined are negative for metastasis. The cancer is estrogen and progesterone receptor positive and HER-2 negative. The patient's cancer is classified as stage pT2, with no lymph node involvement (pNo), and no metastasis (pMx).\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-BH-A0DE.E8EA922D-A851-4D36-B70D-372DE9352548',\n",
       "  'report_length_cl100k_base': 779,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is a multifocal invasive ductal carcinoma with a tumor size of 4.8 cm, located in the upper outer quadrant of the right breast. There is no lymph node involvement, and the tumor is estrogen receptor positive, progesterone receptor negative, and HER2/neu negative. The cancer is stage PT2, N0, Mx. Surgical margins are free of tumor, and the patient's breast tissue shows fibrocystic changes, fibroadenoma, and epithelial hyperplasia.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is a multifocal invasive ductal carcinoma with a tumor size of 4.8 cm, located in the upper outer quadrant of the right breast. There is no lymph node involvement, and the tumor is estrogen receptor positive, progesterone receptor negative, and HER2/neu negative. The cancer is classified as pathologic stage pT2, N0, Mx. Surgical margins are free of tumor, and the patient's breast tissue shows fibrocystic changes, fibroadenoma, and epithelial hyperplasia.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 0,\n",
       "  'patient_filename': 'TCGA-BH-A0DG.46B16DD0-68E6-4A7A-919B-758219D1E85C',\n",
       "  'report_length_cl100k_base': 1075,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, with a tumor size of 3.5 cm, involving the posterior and inferior resection margins. Lymphovascular invasion is present, and the cancer is Nottingham score 6/9. There is evidence of ductal carcinoma in situ, with a 2% tumor volume involvement. Three out of 28 lymph nodes are involved, with extranodal extension of 0.2 cm. The cancer is estrogen and progesterone receptor-positive, and HER2/neu negative.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's pathology report indicates a metastatic adenocarcinoma in the left axillary contents, with three out of twenty-eight lymph nodes involved, up to 1.5 cm in size, with extracapsular extension (0.2 cm). The tumor size is 3.5 x 2.5 x 1.7 cm, with lymphovascular invasion present. The Nottingham score is 6/9, with nuclear grade 2, and ductal carcinoma in situ is present, mixed with invasive tumor. The report also mentions atypical ductal hyperplasia, ductal papillomas, radial scars, and proliferative fibrocystic changes. The tumor is estrogen and progesterone receptor-positive and HER2/neu negative. The surgical margins are free of tumor, and the patient has a pT2, pN1a, and pMX stage.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': False,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-BH-A0DH.79B22278-2BA1-4904-BCA6-2B1368C77475',\n",
       "  'report_length_cl100k_base': 1316,\n",
       "  't_label': 1},\n",
       " {'abstract': \"The patient's cancer is an invasive ductal carcinoma, measuring 4.0 cm in the largest dimension, with lymphovascular invasion and positive estrogen and progesterone receptors. The cancer is present in three out of 28 examined lymph nodes, making it pN1a. There is no evidence of metastasis.\",\n",
       "  'cancer_type': 'BRCA',\n",
       "  'extract': \"The patient's cancer is an invasive ductal carcinoma, measuring 4.0 cm in the largest dimension, with lymphovascular invasion identified. The cancer is positive for metastatic carcinoma in the axillary sentinel lymph nodes, with metastatic tumor measuring 3.0 mm, 4.0 mm, and 6.0 mm in the largest dimension. The cancer is mixed with radial scar, sclerosing adenosis, and other benign lesions. The patient's cancer is positive for ER and PR and negative for HER-2/neu. Twenty-five lymph nodes were examined, with no metastatic carcinoma found (0/29). The patient's cancer is classified as pT2, pN1a, and pMX.\",\n",
       "  'is_goodsum_n': True,\n",
       "  'is_goodsum_t': True,\n",
       "  'n_label': 1,\n",
       "  'patient_filename': 'TCGA-BH-A0DI.5B7CE4A4-E1D5-4D0B-B9B4-71B94E32D782',\n",
       "  'report_length_cl100k_base': 1217,\n",
       "  't_label': 1},\n",
       " ...]"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result = full_report_collection.get(include = [\"metadatas\"])\n",
    "result['metadatas']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1277"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result = full_summary_collection2.get(include = [\"metadatas\"], where={'n_label':{'$in': [0, 1, 2, 3]}})\n",
    "len(result['ids'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df[(df['type']==\"LUAD\") & (df['n']!=-1)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df[(df['type']==\"LUAD\") & (df['is_goodsum_n']) & (df['n']==3)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.read_csv(\"/secure/shared_data/rag_tnm_results/summary/5_folds_summary/Updated_withSummary_merged_df.csv\")\n",
    "for mode, folds in loaded_dict.items():\n",
    "    for i, fold in enumerate(folds):\n",
    "        print(f\"{mode} {i+1}st fold\")\n",
    "        label = mode.split(\"_\")[1]\n",
    "        print(label)\n",
    "        for j in [0, 1, 2, 3]:\n",
    "            print(f\"\\tlable{j}: \", len(df[(df['patient_filename'].isin(fold['train']))&(df[f'is_goodsum_{label}'])&(df[label]==j)]))\n",
    "        print()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "len(fold['train'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "summary_collection.get(where={\"$and\":[{\"patient_filename\": {'$in': fold['train']}},\n",
    "                                      {f'is_goodsum_t':{\"$eq\":True}},\n",
    "                                      {f't_label':{\"$eq\":3}}]})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "emb1 = full_summary_collection.peek()['embeddings'][0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'cancer_type': 'LUAD',\n",
       " 'is_goodsum_n': True,\n",
       " 'is_goodsum_t': True,\n",
       " 'n_label': 2,\n",
       " 'patient_filename': 'TCGA-05-4244.3a844132-f813-4d8e-8f7d-dbae0b23d7fd',\n",
       " 'report_length_cl100k_base': 82,\n",
       " 't_label': 1}"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result = full_summary_collection.query(query_embeddings=emb1, include = [\"metadatas\", \"documents\"], n_results=3)\n",
    "\n",
    "result['metadatas'][0][0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "summary_df[\"is_goodsum_n\"]"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "rag_tnm_env",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.1"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
